0001906324-24-000045.txt : 20240801 0001906324-24-000045.hdr.sgml : 20240801 20240801151332 ACCESSION NUMBER: 0001906324-24-000045 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 86 CONFORMED PERIOD OF REPORT: 20240630 FILED AS OF DATE: 20240801 DATE AS OF CHANGE: 20240801 FILER: COMPANY DATA: COMPANY CONFORMED NAME: QuidelOrtho Corp CENTRAL INDEX KEY: 0001906324 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 874496285 FISCAL YEAR END: 0101 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-41409 FILM NUMBER: 241166150 BUSINESS ADDRESS: STREET 1: 9975 SUMMERS RIDGE ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 552-1100 MAIL ADDRESS: STREET 1: 9975 SUMMERS RIDGE ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: Coronado Topco, Inc. DATE OF NAME CHANGE: 20220124 10-Q 1 qdel-20240630.htm 10-Q qdel-20240630
000190632412/292024Q2falsehttp://fasb.org/us-gaap/2024#OtherLiabilitiesCurrenthttp://fasb.org/us-gaap/2024#OtherLiabilitiesCurrenthttp://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrentxbrli:sharesiso4217:USDiso4217:USDxbrli:sharesxbrli:pureqdel:segmentqdel:defendantqdel:stockholder00019063242024-01-012024-06-3000019063242024-07-2400019063242024-06-3000019063242023-12-3100019063242024-04-012024-06-3000019063242023-04-032023-07-0200019063242023-01-022023-07-020001906324us-gaap:CommonStockMember2023-12-310001906324us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2023-12-310001906324us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310001906324us-gaap:RetainedEarningsMember2023-12-310001906324us-gaap:CommonStockMember2024-01-012024-03-310001906324us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2024-01-012024-03-3100019063242024-01-012024-03-310001906324us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-310001906324us-gaap:RetainedEarningsMember2024-01-012024-03-310001906324us-gaap:CommonStockMember2024-03-310001906324us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2024-03-310001906324us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-310001906324us-gaap:RetainedEarningsMember2024-03-3100019063242024-03-310001906324us-gaap:CommonStockMember2024-04-012024-06-300001906324us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2024-04-012024-06-300001906324us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-04-012024-06-300001906324us-gaap:RetainedEarningsMember2024-04-012024-06-300001906324us-gaap:CommonStockMember2024-06-300001906324us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2024-06-300001906324us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-06-300001906324us-gaap:RetainedEarningsMember2024-06-300001906324us-gaap:CommonStockMember2023-01-010001906324us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2023-01-010001906324us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-010001906324us-gaap:RetainedEarningsMember2023-01-0100019063242023-01-010001906324us-gaap:CommonStockMember2023-01-022023-04-020001906324us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2023-01-022023-04-0200019063242023-01-022023-04-020001906324us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-022023-04-020001906324us-gaap:RetainedEarningsMember2023-01-022023-04-020001906324us-gaap:CommonStockMember2023-04-020001906324us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2023-04-020001906324us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-04-020001906324us-gaap:RetainedEarningsMember2023-04-0200019063242023-04-020001906324us-gaap:CommonStockMember2023-04-032023-07-020001906324us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2023-04-032023-07-020001906324us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-04-032023-07-020001906324us-gaap:RetainedEarningsMember2023-04-032023-07-020001906324us-gaap:CommonStockMember2023-07-020001906324us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2023-07-020001906324us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-07-020001906324us-gaap:RetainedEarningsMember2023-07-0200019063242023-07-020001906324srt:RevisionOfPriorPeriodReclassificationAdjustmentMember2023-04-032023-07-020001906324srt:RevisionOfPriorPeriodReclassificationAdjustmentMember2023-01-022023-07-020001906324us-gaap:CostOfSalesMembersrt:RevisionOfPriorPeriodReclassificationAdjustmentMember2023-04-032023-07-020001906324us-gaap:CostOfSalesMembersrt:RevisionOfPriorPeriodReclassificationAdjustmentMember2023-01-022023-07-020001906324us-gaap:ResearchAndDevelopmentExpenseMembersrt:RevisionOfPriorPeriodReclassificationAdjustmentMember2023-04-032023-07-020001906324us-gaap:ResearchAndDevelopmentExpenseMembersrt:RevisionOfPriorPeriodReclassificationAdjustmentMember2023-01-022023-07-020001906324us-gaap:StockCompensationPlanMember2024-01-012024-06-300001906324us-gaap:StockCompensationPlanMember2024-04-012024-06-300001906324us-gaap:StockCompensationPlanMember2023-04-032023-07-020001906324us-gaap:StockCompensationPlanMember2023-01-022023-07-020001906324us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2024-06-300001906324us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2023-12-310001906324qdel:CustomerOneMember2023-12-310001906324qdel:CustomerOneMember2024-06-300001906324qdel:ExpectedValueContractCustomersMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2024-06-300001906324qdel:ExpectedValueContractCustomersMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2023-12-310001906324qdel:CustomerTwoMember2023-12-310001906324qdel:CustomerTwoMember2024-06-300001906324us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember2024-04-012024-06-300001906324us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember2024-01-012024-06-300001906324us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember2023-04-032023-07-020001906324us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember2023-01-022023-07-020001906324us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementAndThirdPartyMember2024-04-012024-06-300001906324us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementAndThirdPartyMember2024-01-012024-06-300001906324us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementAndThirdPartyMember2023-04-032023-07-020001906324us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementAndThirdPartyMember2023-01-022023-07-020001906324qdel:LabsMember2024-04-012024-06-300001906324qdel:LabsMember2023-04-032023-07-020001906324qdel:LabsMember2024-01-012024-06-300001906324qdel:LabsMember2023-01-022023-07-020001906324qdel:TransfusionMedicineMember2024-04-012024-06-300001906324qdel:TransfusionMedicineMember2023-04-032023-07-020001906324qdel:TransfusionMedicineMember2024-01-012024-06-300001906324qdel:TransfusionMedicineMember2023-01-022023-07-020001906324qdel:PointOfCareMember2024-04-012024-06-300001906324qdel:PointOfCareMember2023-04-032023-07-020001906324qdel:PointOfCareMember2024-01-012024-06-300001906324qdel:PointOfCareMember2023-01-022023-07-020001906324qdel:MolecularDiagnosticsMember2024-04-012024-06-300001906324qdel:MolecularDiagnosticsMember2023-04-032023-07-020001906324qdel:MolecularDiagnosticsMember2024-01-012024-06-300001906324qdel:MolecularDiagnosticsMember2023-01-022023-07-020001906324us-gaap:SalesMemberus-gaap:CustomerConcentrationRiskMemberqdel:CustomerThreeMember2024-01-012024-06-300001906324us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMemberqdel:CustomersWithBalancesDueInExcessOf10OfAccountsReceivableMember2023-12-310001906324us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMemberqdel:RespiratoryMember2024-04-012024-06-300001906324us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMemberqdel:RespiratoryMember2024-01-012024-06-300001906324us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMemberqdel:RespiratoryMember2023-04-032023-07-020001906324us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMemberqdel:RespiratoryMember2023-01-022023-07-020001906324qdel:NorthAmericaSegmentMember2024-04-012024-06-300001906324qdel:NorthAmericaSegmentMember2023-04-032023-07-020001906324qdel:NorthAmericaSegmentMember2024-01-012024-06-300001906324qdel:NorthAmericaSegmentMember2023-01-022023-07-020001906324qdel:EMEASegmentMember2024-04-012024-06-300001906324qdel:EMEASegmentMember2023-04-032023-07-020001906324qdel:EMEASegmentMember2024-01-012024-06-300001906324qdel:EMEASegmentMember2023-01-022023-07-020001906324qdel:ChinaMember2024-04-012024-06-300001906324qdel:ChinaMember2023-04-032023-07-020001906324qdel:ChinaMember2024-01-012024-06-300001906324qdel:ChinaMember2023-01-022023-07-020001906324qdel:OtherMember2024-04-012024-06-300001906324qdel:OtherMember2023-04-032023-07-020001906324qdel:OtherMember2024-01-012024-06-300001906324qdel:OtherMember2023-01-022023-07-020001906324us-gaap:CorporateDebtSecuritiesMemberqdel:ShortTermMarketableSecuritiesMember2023-12-310001906324qdel:ShortTermMarketableSecuritiesMemberus-gaap:AssetBackedSecuritiesMember2023-12-310001906324qdel:ShortTermMarketableSecuritiesMemberqdel:AgencyBondsMember2023-12-310001906324qdel:ShortTermMarketableSecuritiesMember2023-12-310001906324us-gaap:CorporateDebtSecuritiesMemberqdel:LongTermMarketableSecuritiesMember2023-12-310001906324qdel:LongTermMarketableSecuritiesMemberus-gaap:AssetBackedSecuritiesMember2023-12-310001906324qdel:LongTermMarketableSecuritiesMemberus-gaap:ForeignGovernmentDebtSecuritiesMember2023-12-310001906324qdel:NorthAmericaSegmentMember2023-12-310001906324qdel:EMEASegmentMember2023-12-310001906324qdel:ChinaMember2023-12-310001906324qdel:OtherMember2023-12-310001906324qdel:NorthAmericaSegmentMember2024-06-300001906324qdel:EMEASegmentMember2024-06-300001906324qdel:ChinaMember2024-06-300001906324qdel:OtherMember2024-06-300001906324srt:MinimumMember2024-03-310001906324srt:MaximumMember2024-03-310001906324us-gaap:LineOfCreditMemberus-gaap:SecuredDebtMemberqdel:BankOfAmericaCreditFacilityMember2024-06-300001906324us-gaap:LineOfCreditMemberus-gaap:SecuredDebtMemberqdel:BankOfAmericaCreditFacilityMember2023-12-310001906324us-gaap:LineOfCreditMemberqdel:BankOfAmericaCreditFacilityMemberus-gaap:RevolvingCreditFacilityMember2024-06-300001906324us-gaap:LineOfCreditMemberqdel:BankOfAmericaCreditFacilityMemberus-gaap:RevolvingCreditFacilityMember2023-12-310001906324us-gaap:LineOfCreditMemberus-gaap:SecuredDebtMemberqdel:BankOfAmericaCreditFacilityMember2022-05-270001906324us-gaap:LineOfCreditMemberqdel:BankOfAmericaCreditFacilityMemberus-gaap:RevolvingCreditFacilityMember2022-08-040001906324us-gaap:LineOfCreditMemberus-gaap:LetterOfCreditMemberqdel:BankOfAmericaCreditFacilityMember2024-01-012024-06-300001906324us-gaap:LineOfCreditMemberus-gaap:SecuredDebtMemberqdel:BankOfAmericaCreditFacilityMember2024-01-012024-06-300001906324qdel:OnOrBeforeJune302023Memberus-gaap:LineOfCreditMemberqdel:BankOfAmericaCreditFacilityMember2024-06-300001906324us-gaap:LineOfCreditMemberqdel:AfterJune302023ToJune302024Memberqdel:BankOfAmericaCreditFacilityMember2024-06-300001906324qdel:AfterJune302024ToDecember312024Memberus-gaap:LineOfCreditMemberqdel:BankOfAmericaCreditFacilityMember2024-06-300001906324us-gaap:LineOfCreditMemberqdel:BankOfAmericaCreditFacilityMemberqdel:AfterDecember312024ToJune302025Member2024-06-300001906324qdel:AfterJune302025Memberus-gaap:LineOfCreditMemberqdel:BankOfAmericaCreditFacilityMember2024-06-300001906324us-gaap:LineOfCreditMemberqdel:BankOfAmericaCreditFacilityMember2024-06-300001906324us-gaap:LineOfCreditMemberus-gaap:SecuredDebtMemberqdel:BankOfAmericaCreditFacilityMember2024-04-012024-06-300001906324us-gaap:LineOfCreditMemberus-gaap:SecuredDebtMemberqdel:BankOfAmericaCreditFacilityMember2023-04-032023-07-020001906324us-gaap:LineOfCreditMemberus-gaap:SecuredDebtMemberqdel:BankOfAmericaCreditFacilityMember2023-01-022023-07-020001906324us-gaap:LineOfCreditMemberqdel:BankOfAmericaCreditFacilityMemberus-gaap:RevolvingCreditFacilityMember2024-04-012024-06-300001906324us-gaap:LineOfCreditMemberqdel:BankOfAmericaCreditFacilityMemberus-gaap:RevolvingCreditFacilityMember2023-04-032023-07-020001906324us-gaap:LineOfCreditMemberqdel:BankOfAmericaCreditFacilityMemberus-gaap:RevolvingCreditFacilityMember2024-01-012024-06-300001906324us-gaap:LineOfCreditMemberqdel:BankOfAmericaCreditFacilityMemberus-gaap:RevolvingCreditFacilityMember2023-01-022023-07-020001906324us-gaap:CostOfSalesMember2024-04-012024-06-300001906324us-gaap:CostOfSalesMember2023-04-032023-07-020001906324us-gaap:CostOfSalesMember2024-01-012024-06-300001906324us-gaap:CostOfSalesMember2023-01-022023-07-020001906324us-gaap:SellingAndMarketingExpenseMember2024-04-012024-06-300001906324us-gaap:SellingAndMarketingExpenseMember2023-04-032023-07-020001906324us-gaap:SellingAndMarketingExpenseMember2024-01-012024-06-300001906324us-gaap:SellingAndMarketingExpenseMember2023-01-022023-07-020001906324us-gaap:ResearchAndDevelopmentExpenseMember2024-04-012024-06-300001906324us-gaap:ResearchAndDevelopmentExpenseMember2023-04-032023-07-020001906324us-gaap:ResearchAndDevelopmentExpenseMember2024-01-012024-06-300001906324us-gaap:ResearchAndDevelopmentExpenseMember2023-01-022023-07-020001906324us-gaap:AcquisitionRelatedCostsMember2024-04-012024-06-300001906324us-gaap:AcquisitionRelatedCostsMember2023-04-032023-07-020001906324us-gaap:AcquisitionRelatedCostsMember2024-01-012024-06-300001906324us-gaap:AcquisitionRelatedCostsMember2023-01-022023-07-0200019063242024-04-1200019063242024-06-2100019063242024-04-250001906324us-gaap:FairValueInputsLevel1Member2024-06-300001906324us-gaap:FairValueInputsLevel2Member2024-06-300001906324us-gaap:FairValueInputsLevel3Member2024-06-300001906324us-gaap:FairValueInputsLevel1Member2023-12-310001906324us-gaap:FairValueInputsLevel2Member2023-12-310001906324us-gaap:FairValueInputsLevel3Member2023-12-310001906324qdel:InterestRateSwapOneMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-06-300001906324qdel:InterestRateSwapTwoMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-06-300001906324qdel:InterestRateSwapThreeMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-06-300001906324qdel:InterestRateSwapFourMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-06-300001906324qdel:InterestRateSwapFiveMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-06-300001906324us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-06-300001906324us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2024-06-300001906324us-gaap:ForeignExchangeForwardMemberus-gaap:SalesMember2024-04-012024-06-300001906324us-gaap:ForeignExchangeForwardMemberus-gaap:CostOfSalesMember2024-04-012024-06-300001906324us-gaap:InterestRateSwapMemberus-gaap:InterestExpenseMember2024-04-012024-06-300001906324us-gaap:ForeignExchangeForwardMemberus-gaap:SalesMember2024-01-012024-06-300001906324us-gaap:ForeignExchangeForwardMemberus-gaap:CostOfSalesMember2024-01-012024-06-300001906324us-gaap:InterestRateSwapMemberus-gaap:InterestExpenseMember2024-01-012024-06-300001906324us-gaap:ForeignExchangeForwardMemberus-gaap:SalesMember2023-04-032023-07-020001906324us-gaap:ForeignExchangeForwardMemberus-gaap:CostOfSalesMember2023-04-032023-07-020001906324us-gaap:InterestRateSwapMemberus-gaap:InterestExpenseMember2023-04-032023-07-020001906324us-gaap:ForeignExchangeForwardMemberus-gaap:SalesMember2023-01-022023-07-020001906324us-gaap:ForeignExchangeForwardMemberus-gaap:CostOfSalesMember2023-01-022023-07-020001906324us-gaap:InterestRateSwapMemberus-gaap:InterestExpenseMember2023-01-022023-07-020001906324us-gaap:NetInvestmentHedgingMemberus-gaap:ForeignExchangeContractMember2024-04-012024-06-300001906324us-gaap:NetInvestmentHedgingMemberus-gaap:ForeignExchangeContractMemberus-gaap:OtherNonoperatingIncomeExpenseMember2024-04-012024-06-300001906324us-gaap:NetInvestmentHedgingMemberus-gaap:ForeignExchangeContractMember2024-01-012024-06-300001906324us-gaap:NetInvestmentHedgingMemberus-gaap:ForeignExchangeContractMemberus-gaap:OtherNonoperatingIncomeExpenseMember2024-01-012024-06-300001906324us-gaap:ForeignExchangeForwardMemberus-gaap:OtherNonoperatingIncomeExpenseMember2024-04-012024-06-300001906324us-gaap:ForeignExchangeForwardMemberus-gaap:OtherNonoperatingIncomeExpenseMember2024-01-012024-06-300001906324us-gaap:ForeignExchangeForwardMemberus-gaap:OtherNonoperatingIncomeExpenseMember2023-04-032023-07-020001906324us-gaap:ForeignExchangeForwardMemberus-gaap:OtherNonoperatingIncomeExpenseMember2023-01-022023-07-020001906324us-gaap:InterestRateSwapMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-06-300001906324us-gaap:InterestRateSwapMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-12-310001906324us-gaap:OtherAssetsMemberus-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-06-300001906324us-gaap:OtherAssetsMemberus-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-12-310001906324us-gaap:InterestRateSwapMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-06-300001906324us-gaap:InterestRateSwapMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-12-310001906324us-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-06-300001906324us-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-12-310001906324us-gaap:OtherAssetsMemberus-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-06-300001906324us-gaap:OtherAssetsMemberus-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-12-310001906324us-gaap:ForeignExchangeContractMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-06-300001906324us-gaap:ForeignExchangeContractMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-12-310001906324us-gaap:ForeignExchangeContractMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-06-300001906324us-gaap:ForeignExchangeContractMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-12-310001906324us-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2024-06-300001906324us-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2023-12-310001906324us-gaap:ForeignExchangeContractMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:NondesignatedMember2024-06-300001906324us-gaap:ForeignExchangeContractMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:NondesignatedMember2023-12-310001906324us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2024-03-310001906324us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2024-03-310001906324us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember2024-03-310001906324us-gaap:AccumulatedTranslationAdjustmentMember2024-03-310001906324us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2024-04-012024-06-300001906324us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2024-04-012024-06-300001906324us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember2024-04-012024-06-300001906324us-gaap:AccumulatedTranslationAdjustmentMember2024-04-012024-06-300001906324us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2024-06-300001906324us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2024-06-300001906324us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember2024-06-300001906324us-gaap:AccumulatedTranslationAdjustmentMember2024-06-300001906324us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2023-12-310001906324us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2023-12-310001906324us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember2023-12-310001906324us-gaap:AccumulatedTranslationAdjustmentMember2023-12-310001906324us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2024-01-012024-06-300001906324us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2024-01-012024-06-300001906324us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember2024-01-012024-06-300001906324us-gaap:AccumulatedTranslationAdjustmentMember2024-01-012024-06-300001906324us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2023-04-020001906324us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2023-04-020001906324us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember2023-04-020001906324us-gaap:AccumulatedTranslationAdjustmentMember2023-04-020001906324us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2023-04-032023-07-020001906324us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2023-04-032023-07-020001906324us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember2023-04-032023-07-020001906324us-gaap:AccumulatedTranslationAdjustmentMember2023-04-032023-07-020001906324us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2023-07-020001906324us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2023-07-020001906324us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember2023-07-020001906324us-gaap:AccumulatedTranslationAdjustmentMember2023-07-020001906324us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2023-01-010001906324us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2023-01-010001906324us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember2023-01-010001906324us-gaap:AccumulatedTranslationAdjustmentMember2023-01-010001906324us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2023-01-022023-07-020001906324us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2023-01-022023-07-020001906324us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember2023-01-022023-07-020001906324us-gaap:AccumulatedTranslationAdjustmentMember2023-01-022023-07-02

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 ____________________________________________________________________________
FORM 10-Q
  ____________________________________________________________________________
(Mark One)
☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2024
or
☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                      to                     
Commission File Number: 001-41409
 ____________________________________________________________________________ 
QUIDELORTHO CORPORATION
(Exact name of registrant as specified in its charter)
  ____________________________________________________________________________
Delaware 87-4496285
(State or other jurisdiction of
incorporation or organization)		 (I.R.S. Employer
Identification No.)
9975 Summers Ridge Road, San Diego, California
92121
(Address of principal executive offices)
(zip code)
(858) 552-1100
(Registrant’s telephone number, including area code)
Not Applicable
(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $0.001 Par ValueQDELThe Nasdaq Stock Market
____________________________________________________________________________ 
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☒    No  ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  ☒    No  ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
☒
Accelerated filer☐
Non-accelerated filer☐Smaller reporting company☐
Emerging growth company☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ☐   No  ☒
As of July 24, 2024, 67,235,394 shares of the registrant’s common stock were outstanding.



INDEX
 

2

PART I    FINANCIAL INFORMATION
 
ITEM 1.    Financial Statements
3

QUIDELORTHO CORPORATION
CONSOLIDATED BALANCE SHEETS
(Unaudited)
(In millions, except par value)
June 30, 2024December 31, 2023
ASSETS
Current assets:
Cash and cash equivalents$107.0 $118.9 
Marketable securities— 48.4 
Accounts receivable, net269.5 303.3 
Inventories602.0 577.8 
Prepaid expenses and other current assets310.0 262.1 
Assets held for sale52.8 — 
Total current assets1,341.3 1,310.5 
Property, plant and equipment, net1,326.7 1,443.8 
Marketable securities— 7.4 
Right-of-use assets177.2 169.6 
Goodwill732.5 2,492.0 
Intangible assets, net2,836.0 2,934.3 
Deferred tax asset24.7 25.9 
Other assets250.8 179.6 
Total assets$6,689.2 $8,563.1 
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable$237.4 $294.8 
Accrued payroll and related expenses86.0 84.8 
Income tax payable3.5 11.1 
Current portion of borrowings356.4 139.8 
Other current liabilities249.1 303.3 
Total current liabilities932.4 833.8 
Operating lease liabilities177.7 172.8 
Long-term borrowings2,207.2 2,274.8 
Deferred tax liability127.9 192.2 
Other liabilities70.5 83.6 
Total liabilities3,515.7 3,557.2 
Commitments and contingencies (Note 11)
Stockholders’ equity:
Preferred stock, $0.001 par value per share; 5.0 shares authorized; none issued or outstanding at June 30, 2024 and December 31, 2023
— — 
Common stock, $0.001 par value per share; 126.2 shares authorized; 67.1 and 66.7 shares issued and outstanding at June 30, 2024 and December 31, 2023, respectively
0.1 0.1 
Additional paid-in capital2,863.9 2,848.0 
Accumulated other comprehensive loss(24.6)(30.0)
Retained earnings334.1 2,187.8 
Total stockholders’ equity3,173.5 5,005.9 
Total liabilities and stockholders’ equity$6,689.2 $8,563.1 
See accompanying notes.
4

QUIDELORTHO CORPORATION
CONSOLIDATED STATEMENTS OF LOSS
(Unaudited)
(In millions, except per share data)
 
 Three Months EndedSix Months Ended
June 30, 2024July 2, 2023June 30, 2024July 2, 2023
Total revenues$637.0 $665.1 $1,348.0 $1,511.2 
Cost of sales, excluding amortization of intangibles361.0 368.6 739.9 766.1 
Selling, marketing and administrative188.2 179.1 392.9 381.5 
Research and development56.3 62.4 115.5 124.2 
Amortization of intangible assets51.9 51.4 103.6 102.2 
Integration related costs30.9 24.2 53.5 53.9 
Goodwill impairment charge— — 1,743.9 — 
Asset impairment charge56.9 0.5 56.9 1.0 
Other operating expenses9.3 5.8 17.3 9.6 
Operating (loss) income(117.5)(26.9)(1,875.5)72.7 
Interest expense, net41.0 36.5 80.0 73.2 
Other expense, net4.4 1.0 6.3 3.9 
Loss before income taxes(162.9)(64.4)(1,961.8)(4.4)
Benefit from income taxes(15.2)(11.2)(108.1)— 
Net loss$(147.7)$(53.2)$(1,853.7)$(4.4)
Basic loss per share$(2.20)$(0.80)$(27.67)$(0.07)
Diluted loss per share$(2.20)$(0.80)$(27.67)$(0.07)
Weighted-average shares outstanding - basic67.1 66.8 67.0 66.7 
Weighted-average shares outstanding - diluted67.1 66.8 67.0 66.7 

See accompanying notes.

5

QUIDELORTHO CORPORATION
CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME
(Unaudited)
(In millions)
 
 Three Months EndedSix Months Ended
 June 30, 2024July 2, 2023June 30, 2024July 2, 2023
Net loss$(147.7)$(53.2)$(1,853.7)$(4.4)
Other comprehensive (loss) income
Changes in cumulative translation adjustment, net of tax(5.3)7.4 (26.1)38.1 
Changes in unrealized (losses) gains from investments, net of tax— (0.1)— 0.1 
Changes in unrealized gains from cash flow hedges, net of tax:
Net unrealized gains on derivative instruments13.1 40.0 43.6 23.1 
Reclassification of net realized gains on derivative instruments included in net income(6.2)(4.3)(12.1)(10.0)
Total change in unrealized gains from cash flow hedges, net of tax6.9 35.7 31.5 13.1 
Comprehensive (loss) income$(146.1)$(10.2)$(1,848.3)$46.9 

See accompanying notes.

6

QUIDELORTHO CORPORATION
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(Unaudited)
(In millions)
Common StockAdditional
paid-in
capital		Accumulated
other
comprehensive
(loss) income		Retained
earnings 		Total
stockholders’
equity
SharesPar
Balance at December 31, 202366.7 $0.1 $2,848.0 $(30.0)$2,187.8 $5,005.9 
Issuance of common stock under equity compensation plans0.2 — 0.8 — — 0.8 
Stock-based compensation expense— — 9.0 — — 9.0 
Tax withholdings related to vesting of stock-based awards(0.1)— (5.8)— — (5.8)
Other comprehensive income, net of tax— — — 3.8 — 3.8 
Net loss— — — — (1,706.0)(1,706.0)
Balance at March 31, 202466.8 0.1 2,852.0 (26.2)481.8 3,307.7 
Issuance of common stock under equity compensation plans0.4 — 4.1 — — 4.1 
Stock-based compensation expense— — 10.3 — — 10.3 
Tax withholdings related to vesting of stock-based awards(0.1)— (2.5)— — (2.5)
Other comprehensive income, net of tax— — — 1.6 — 1.6 
Net loss— — — — (147.7)(147.7)
Balance at June 30, 202467.1 $0.1 $2,863.9 $(24.6)$334.1 $3,173.5 
Common StockAdditional
paid-in
capital		Accumulated
other
comprehensive
(loss) income		Retained
earnings		Total
stockholders’
equity
SharesPar
Balance at January 1, 202366.4 $— $2,804.3 $(67.6)$2,197.9 $4,934.6 
Issuance of common stock under equity compensation plans0.3 0.1 3.8 — — 3.9 
Stock-based compensation expense— — 10.4 — — 10.4 
Tax withholdings related to vesting of stock-based awards(0.1)— (9.5)— — (9.5)
Other comprehensive income, net of tax— — — 8.3 — 8.3 
Net income— — — — 48.8 48.8 
Balance at April 2, 202366.6 0.1 2,809.0 (59.3)2,246.7 4,996.5 
Issuance of common stock under equity compensation plans0.2 — 5.5 — — 5.5 
Stock-based compensation expense— — 13.7 — — 13.7 
Tax withholdings related to vesting of stock-based awards— — (3.0)— — (3.0)
Other comprehensive income, net of tax— — — 43.0 — 43.0 
Net loss— — — — (53.2)(53.2)
Balance at July 2, 202366.8 $0.1 $2,825.2 $(16.3)$2,193.5 $5,002.5 

See accompanying notes.
7

QUIDELORTHO CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
(In millions)
 Six Months Ended
 June 30, 2024July 2, 2023
OPERATING ACTIVITIES
Net loss$(1,853.7)$(4.4)
Adjustments to reconcile net loss to net cash (used for) provided by operating activities:
Depreciation and amortization231.0 228.7 
Goodwill impairment charge1,743.9 — 
Asset impairment charge56.9 1.0 
Stock-based compensation expense20.2 25.2 
Net change in operating lease right-of-use assets and liabilities0.1 0.2 
Change in deferred tax assets and liabilities(73.6)0.6 
Payment of accreted interest on deferred consideration— (9.7)
Other non-cash, net(7.4)(2.3)
Changes in assets and liabilities:
Accounts receivable24.2 214.5 
Inventories(95.2)(86.0)
Prepaid expenses and other current and non-current assets(11.7)(37.8)
Accounts payable(23.9)(35.0)
Accrued payroll and related expenses2.6 (57.0)
Income taxes payable(58.2)(46.3)
Other current and non-current liabilities(53.8)(33.4)
Net cash (used for) provided by operating activities(98.6)158.3 
INVESTING ACTIVITIES
Acquisitions of property, plant, equipment, investments and intangibles(101.4)(117.3)
Proceeds from government assistance allocated to fixed assets— 2.8 
Purchases of marketable securities(7.2)(50.6)
Proceeds from sale of marketable securities63.1 53.9 
Other payments(10.0)— 
Net cash used for investing activities(55.5)(111.2)
FINANCING ACTIVITIES
Proceeds from issuance of common stock4.6 7.3 
Short-term borrowings, net(1.6)— 
Revolving credit facility, net253.0 — 
Payments on long-term borrowings(103.7)(123.8)
Payments of tax withholdings related to vesting of stock-based awards(8.3)(12.5)
Principal payments of deferred consideration— (30.3)
Net cash provided by (used for) financing activities144.0 (159.3)
Effect of exchange rates on cash(1.9)(2.1)
Net decrease in cash, cash equivalents and restricted cash(12.0)(114.3)
Cash, cash equivalents and restricted cash at beginning of period119.5 293.9 
Cash, cash equivalents and restricted cash at end of period$107.5 $179.6 
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Purchase of property, equipment and intangibles by incurring current liabilities$9.6 $18.6 
Transfer of instrument inventories to fixed assets$69.2 $67.3 
Reduction of accrued payroll and related expenses upon issuance of restricted share units$0.3 $1.9 
See accompanying notes.
8

QuidelOrtho Corporation
Notes to Consolidated Financial Statements
(Unaudited)
Note 1. Basis of Presentation and Summary of Significant Accounting Policies
Basis of Presentation
The accompanying unaudited Consolidated Financial Statements of QuidelOrtho Corporation and its subsidiaries (the “Company” or “QuidelOrtho”) have been prepared in accordance with GAAP for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation (consisting of normal recurring accruals) have been included. Refer to the Summary of Abbreviated Terms at the end of this Quarterly Report for definitions of terms used throughout the document.
The information at June 30, 2024, and for the three and six months ended June 30, 2024 and July 2, 2023, is unaudited. For further information, refer to the Company’s Consolidated Financial Statements and notes thereto for the fiscal year ended December 31, 2023 included in QuidelOrtho’s Annual Report. Operating results for any quarter are historically seasonal in nature and are not necessarily indicative of the results expected for the full year.
The Company follows the concept of a fiscal year that ends on the Sunday nearest to the end of the month of December, and fiscal quarters that end on the Sunday nearest to the end of the months of March, June and September. For 2024 and 2023, the Company’s fiscal year will end or has ended on December 29, 2024 and December 31, 2023, respectively. For 2024 and 2023, the Company’s second quarter ended on June 30, 2024 and July 2, 2023, respectively. The three and six months ended June 30, 2024 and July 2, 2023 each included 13 and 26 weeks, respectively.
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and the related disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Reclassifications
Certain reclassifications have been made to prior periods amounts to conform to the current period presentation. Such amounts include a reclassification of $0.5 million and $1.0 million recognized in the three and six months ended July 2, 2023, respectively, related to impairment of long-lived assets from (i) Cost of sales, excluding amortization of intangibles (excludes $0.1 million for both the three and six months ended July 2, 2023), and (ii) Research and development (excludes $0.4 million and $0.9 million for the three and six months ended July 2, 2023, respectively), to Asset impairment charge.
The reclassifications did not have an impact on the Company’s previously reported Consolidated Balance Sheets, Consolidated Statements of Comprehensive (Loss) Income, Consolidated Statements of Stockholders’ Equity or Consolidated Statements of Cash Flows.
Recent Accounting Pronouncements
There have been no accounting pronouncements issued or adopted during the six months ended June 30, 2024 that are expected to have a material impact on the Company’s Consolidated Financial Statements.
Note 2. Computation of Earnings Per Share
The following table presents the calculation of the weighted-average shares used in computing basic and diluted EPS in the respective periods:
Three Months EndedSix Months Ended
(In millions)June 30, 2024July 2, 2023June 30, 2024July 2, 2023
Basic weighted-average shares of common stock outstanding67.1 66.8 67.0 66.7 
Dilutive potential shares issuable from stock options and RSUs(1)
— — — — 
Diluted weighted-average shares of common stock outstanding67.1 66.8 67.0 66.7 
(1) In the three and six months ended June 30, 2024 and July 2, 2023, all potential shares of common stock issuable for stock options and RSUs were excluded from the dilutive calculations above because the effect of including them would have been anti-dilutive. The dilutive
9

effect of potential shares of common stock issuable for stock options and RSUs on the weighted-average number of shares of common stock outstanding would have been as follows:
Three Months EndedSix Months Ended
(In millions)June 30, 2024July 2, 2023June 30, 2024July 2, 2023
Basic weighted-average shares of common stock outstanding67.1 66.8 67.0 66.7 
Dilutive potential shares issuable from stock options and RSUs0.2 0.4 0.3 0.5 
Diluted weighted-average shares of common stock outstanding67.3 67.2 67.3 67.2 
Stock options and RSUs where the combined exercise price and unrecognized stock-based compensation was greater than the average market price for the Company’s common stock were not included in the computations of diluted weighted-average shares because the effect would have been anti-dilutive under the treasury stock method. These stock options and RSUs represented 2.1 million shares of common stock for both the three and six months ended June 30, 2024, and 1.2 million and 1.1 million shares of common stock for the three and six months ended July 2, 2023, respectively.
Note 3. Revenue
Contract Balances
Timing of revenue recognition may differ from timing of invoicing to customers. The Company records an asset when revenue is recognized prior to invoicing a customer (a “contract asset”). Contract assets are included within Prepaid expenses and other current assets in the Company’s Consolidated Balance Sheets and are transferred to accounts receivable when the right to payment becomes unconditional. The balance of contract assets recorded in the Company’s Consolidated Balance Sheets as of June 30, 2024 and December 31, 2023 was $44.1 million and $46.2 million, respectively.
The contract asset balance consisted of the following components:
•a customer supply agreement under which the difference between the timing of invoicing and revenue recognition resulted in a contract asset of $1.9 million as of December 31, 2023. There was no contract asset remaining as of June 30, 2024;
•contractual arrangements with certain customers under which the Company invoices the customers based on reportable results generated by its reagents; however, control of the goods transfers to the customers upon shipment or delivery of the products, as determined under the terms of the contract. Using the expected value method, the Company estimates the number of reagents that will generate a reportable result. The Company records the revenue upon shipment and an associated contract asset, and relieves the contract asset upon completion of the invoicing. The balance of the contract asset related to these arrangements was $44.1 million and $41.8 million as of June 30, 2024 and December 31, 2023, respectively; and
•one of the Company’s contract manufacturing agreements that recognizes revenue as the products are manufactured resulted in a contract asset of $2.5 million as of December 31, 2023. There was no contract asset remaining as of June 30, 2024.
The Company reviews contract assets for expected credit losses resulting from the collectability of customer accounts. Expected losses are established based on historical losses, customer mix and credit policies, current economic conditions in customers’ country or industry, and expectations associated with reasonable and supportable forecasts. No credit losses related to contract assets were recognized during the three and six months ended June 30, 2024 and July 2, 2023.
The Company recognizes a contract liability when a customer pays an invoice prior to the Company transferring control of the goods or services (“contract liabilities”). The Company’s contract liabilities consist of deferred revenue primarily related to customer service contracts. The Company classifies deferred revenue as current or non-current based on the timing of the transfer of control or performance of the service. The balance of the Company’s current deferred revenue was $40.1 million and $36.8 million as of June 30, 2024 and December 31, 2023, respectively, and was included in Other current liabilities in the Consolidated Balance Sheets. The Company has one arrangement with a customer where the revenue is expected to be recognized beyond one year. The balance of the deferred revenue included in long-term liabilities was $15.9 million and $13.9 million as of June 30, 2024 and December 31, 2023, respectively, and was included in Other liabilities in the Consolidated Balance Sheets. The amount of deferred revenue as of December 31, 2023 that was recorded in Total revenues during the three and six months ended June 30, 2024 was $9.2 million and $27.0 million, respectively.
Joint Business with Grifols
The Company has an ongoing Joint Business between Ortho and Grifols, under which Ortho and Grifols agreed to pursue a collaboration relating to Ortho’s Hepatitis and HIV diagnostics business. The governance of the Joint Business is shared
10

through a supervisory board made up of equal representation by Ortho and Grifols, which is responsible for all significant decisions relating to the Joint Business that are not exclusively assigned to either Ortho or Grifols, as defined in the Joint Business agreement. The Company’s portion of the pre-tax net profit shared under the Joint Business was $8.9 million and $17.0 million during the three and six months ended June 30, 2024, respectively, and $6.1 million and $29.7 million during the three and six months ended July 2, 2023, respectively. These amounts included the Company’s portion of the pre-tax net profit of $6.5 million and $11.5 million during the three and six months ended June 30, 2024, respectively, and $5.5 million and $6.7 million during the three and six months ended July 2, 2023, respectively, on sales transactions with third parties where the Company is the principal. The Company recognized revenues, cost of sales, excluding amortization of intangibles, and operating expenses, on a gross basis on these sales transactions in their respective lines in the Consolidated Statements of Loss. The Company’s portion of the pre-tax net profit also included revenue from collaboration and royalty agreements of $2.4 million and $5.5 million during the three and six months ended June 30, 2024, respectively, and $0.6 million and $23.0 million during the three and six months ended July 2, 2023, respectively, which is presented on a net basis within Total revenues.
Disaggregation of Revenue
The following table summarizes Total revenues by business unit:
Three Months EndedSix Months Ended
(In millions)June 30, 2024July 2, 2023June 30, 2024July 2, 2023
Labs$354.2 $361.4 $711.1 $732.1 
Transfusion Medicine161.3 163.3 321.6 319.2 
Point of Care117.1 134.2 303.7 442.3 
Molecular Diagnostics4.4 6.2 11.6 17.6 
Total revenues$637.0 $665.1 $1,348.0 $1,511.2 
Concentration of Revenue and Credit Risk
For the six months ended June 30, 2024, one customer represented 11% of Total revenues. For the six months ended July 2, 2023, no customers individually accounted for more than 10% of Total revenues.
As of June 30, 2024, no customers had a balance due in excess of 10% of Accounts receivable, net. As of December 31, 2023, customers with a balance due in excess of 10% of Accounts receivable, net totaled $63.5 million. Revenue related to the Company’s respiratory products accounted for 9% and 14% of Total revenues for the three and six months ended June 30, 2024, respectively, and 13% and 23% for the three and six months ended July 2, 2023, respectively.
Note 4. Segment and Geographic Information
The Company operates in three geographically-based reportable segments: North America, EMEA and China.
Effective January 1, 2024, Japan and Asia Pacific operating segments were combined into one operating segment: JPAC. The CODM reviews the Company’s performance and allocates resources based on five operating segments: North America, EMEA, China, Latin America and JPAC. North America, EMEA and China are the Company’s reportable segments; Latin America and JPAC are immaterial operating segments that are not considered reportable segments and are included in “Other.”
Total revenues by reportable segment are as follows:
Three Months EndedSix Months Ended
(In millions)June 30, 2024July 2, 2023June 30, 2024July 2, 2023
North America$350.1 $378.8 $784.0 $961.6 
EMEA81.1 80.6 165.9 161.9 
China81.6 81.3 157.7 151.9 
Other124.2 124.4 240.4 235.8 
Total revenues$637.0 $665.1 $1,348.0 $1,511.2 
11

The following table sets forth Adjusted EBITDA by segment and the reconciliations to Loss before income taxes for the three and six months ended June 30, 2024 and July 2, 2023:
Three Months EndedSix Months Ended
(In millions)June 30, 2024July 2, 2023June 30, 2024July 2, 2023
North America$173.9 $176.3 $392.7 $454.7 
EMEA11.4 5.3 24.2 12.5 
China35.8 30.2 60.5 58.7 
Other34.1 36.3 66.1 58.1 
Total segment Adjusted EBITDA255.2 248.1 543.5 584.0 
Corporate (1)
(165.3)(134.8)(321.6)(225.4)
Interest expense, net(41.0)(36.5)(80.0)(73.2)
Depreciation and amortization(116.1)(114.5)(231.0)(228.7)
Integration related costs(30.9)(24.2)(53.5)(53.9)
Goodwill impairment charge— — (1,743.9)— 
Asset impairment charge(56.9)(0.5)(56.9)(1.0)
Credit Agreement amendment fees (4.0)— (4.0)— 
Amortization of deferred cloud computing implementation costs(3.0)(1.5)(5.9)(3.1)
EU medical device regulation transition costs (2)
(0.5)(0.7)(1.1)(1.5)
Employee compensation charges— — (5.6)— 
Tax indemnification income— 0.4 — 0.1 
Gain (loss) on investments0.7 (0.2)— (0.2)
Other adjustments(1.1)— (1.8)(1.5)
Loss before income taxes$(162.9)$(64.4)$(1,961.8)$(4.4)
(1) Primarily consists of costs related to executive and staff functions, including certain finance, human resources, manufacturing and IT functions, which benefit the Company as a whole. These costs are primarily related to the general management of these functions on a corporate level and the design and development of programs, policies and procedures that are then implemented in the individual segments, with each segment bearing its own cost of implementation. The Company’s corporate function also includes debt and stock-based compensation associated with all employee stock-based awards.
(2) Represents incremental consulting costs and R&D manufacturing site costs to align compliance of the Company’s existing, on-market products that were previously registered under the European In Vitro Diagnostics Directive regulatory framework with the requirements under the EU’s In Vitro Diagnostic Regulation, which generally apply from May 2022 onwards.
The CODM does not review capital expenditures, total depreciation and amortization or assets by segment, and therefore this information has been excluded as it does not comprise part of management’s key performance metrics.
Note 5. Income Taxes
The Company calculates its interim income tax provision in accordance with ASC 270, Interim Reporting, and ASC 740, Accounting for Income Taxes. At the end of each interim period, the Company estimates its annual effective tax rate and applies that rate to its ordinary quarterly earnings to calculate the tax related to ordinary income. The tax effects for other items that are excluded from ordinary income are discretely calculated and recognized in the period in which they occur.
For the three months ended June 30, 2024, the Company recognized an income tax benefit of $15.2 million in relation to loss before income taxes of $162.9 million, resulting in an effective benefit tax rate of 9.3%. For the three months ended July 2, 2023, the Company recognized an income tax benefit of $11.2 million in relation to loss before income taxes of $64.4 million, resulting in an effective benefit tax rate of 17.4%. For the three months ended June 30, 2024, the effective tax rate differed from the U.S. federal statutory rate primarily due to Subpart F income and the Base Erosion and Anti-Abuse Tax liability. For the three months ended July 2, 2023, the effective tax rate differed from the U.S. federal statutory rate primarily due to non-U.S. earnings being taxed at rates that were different than the U.S. statutory rate, operating losses in certain subsidiaries not being benefited due to the establishment of valuation allowances, R&D credits and foreign tax credits, partially offset by foreign exchange losses and the Global Intangible Low-Tax Income.
12

For the six months ended June 30, 2024, the Company recognized an income tax benefit of $108.1 million in relation to loss before income taxes of $1,961.8 million, resulting in an effective tax rate of 5.5%. For the six months ended July 2, 2023, the recognized amount of income tax benefit was not material in relation to loss before income taxes of $4.4 million, resulting in an effective benefit tax rate of 0.7%. For the six months ended June 30, 2024, the effective tax rate differed from the U.S. federal statutory rate primarily due to goodwill impairment charges that are nondeductible for tax purposes. For the six months ended July 2, 2023, the effective tax rate differed from the U.S. federal statutory rate primarily due to net operating losses in certain subsidiaries not being benefited due to the establishment of valuation allowances and the Global Intangible Low-Tax Income, partially offset by U.S. earnings being taxed at rates that were different than the U.S. statutory rate, R&D credits, foreign tax credits and foreign exchange losses.
The balance of unrecognized tax benefits at June 30, 2024, not including interest and penalties, was $29.3 million, of which $22.0 million could affect the effective income tax rate in future periods, if recognized. The Company also recognizes interest and penalties related to unrecognized tax benefits in tax expense. At June 30, 2024, the Company had approximately $4.1 million of interest and penalties accrued related to unrecognized tax benefits. The Company estimates that within the next 12 months, its uncertain tax positions, excluding interest, should decrease by $11.7 million.
The Company is subject to periodic audits by domestic and foreign tax authorities. Due to the carryforward of unutilized credits, the Company’s federal tax years from 2012 and onwards are subject to examination by the U.S. authorities. The Company’s state and foreign tax years for 2001 and onwards are subject to examination by applicable tax authorities. The Company believes that it has appropriate support for the income tax positions taken on its tax returns and that its accruals for tax liabilities are adequate for all open years based on an assessment of many factors, including past experience and interpretations of tax laws applied to the facts of each matter.
Indemnification Assets
Ortho is currently under audit in certain jurisdictions for tax years under the responsibility of Johnson & Johnson. Pursuant to the stock and asset purchase agreement entered into by Ortho and Johnson & Johnson in January 2014, Johnson & Johnson retained all income tax liabilities accrued as of the date of acquisition, including reserves for unrecognized tax benefits. Accordingly, all tax liabilities related to these tax years are required to be indemnified by Johnson & Johnson. The indemnification receivable from Johnson & Johnson totaled $3.0 million as of June 30, 2024 and December 31, 2023, and is included as a component of Prepaid expenses and other current assets on the Consolidated Balance Sheet.
Note 6. Balance Sheet Account Details
Cash, Cash Equivalents and Restricted Cash
(In millions)June 30, 2024December 31, 2023
Cash and cash equivalents$107.0 $118.9 
Restricted cash included in Other assets0.5 0.6 
Cash, cash equivalents and restricted cash$107.5 $119.5 
Marketable Securities
The Company had no marketable securities outstanding as of June 30, 2024. The following table is a summary of marketable securities as of December 31, 2023:
December 31, 2023
(In millions)Amortized CostGross Unrealized LossesFair Value
Corporate bonds$38.1 $(0.1)$38.0 
Corporate asset-backed securities8.9 — 8.9 
Agency bonds1.5 — 1.5 
Total marketable securities, current48.5 (0.1)48.4 
Corporate bonds, non-current4.5 — 4.5 
Corporate asset-backed securities, non-current0.9 — 0.9 
Sovereign government bonds, non-current2.0 — 2.0 
Total marketable securities$55.9 $(0.1)$55.8 
13

Accounts Receivable, Net
Accounts receivables primarily consist of trade accounts receivables with maturities of one year or less and are presented net of reserves:
(In millions)June 30, 2024December 31, 2023
Accounts receivable$347.2 $395.1 
Allowance for contract rebates and discounts(63.9)(77.2)
Allowance for doubtful accounts(13.8)(14.6)
Total accounts receivable, net$269.5 $303.3 
Inventories
Inventories are stated at the lower of cost (first-in, first-out) or net realizable value. Inventories consisted of the following:
(In millions)June 30, 2024December 31, 2023
Raw materials$222.3 $212.7 
Work-in-process (materials, labor and overhead)99.3 92.3 
Finished goods (materials, labor and overhead)319.0 318.1 
Total inventories$640.6 $623.1 
Inventories$602.0 $577.8 
Other assets (1)
38.6 45.3 
Total inventories$640.6 $623.1 
(1) Other assets includes inventory expected to remain on hand beyond one year.
Prepaid Expenses and Other Current Assets
Prepaid expenses and other current assets consisted of the following:
(In millions)June 30, 2024December 31, 2023
Income taxes and other tax receivables$156.4 $104.7 
Prepaid expenses68.3 67.0 
Contract assets44.1 46.2 
Other receivables27.3 34.2 
Derivatives11.0 6.9 
Other2.9 3.1 
Total prepaid expenses and other current assets$310.0 $262.1 
Other Current Liabilities
Other current liabilities consisted of the following:
(In millions)June 30, 2024December 31, 2023
Accrued commissions, rebates and returns$67.1 $63.8 
Deferred revenue40.1 36.8 
Operating lease liabilities29.5 26.7 
Accrued other taxes payable21.6 17.9 
Derivatives4.7 12.1 
Accrued interest1.4 30.3 
Other84.7 115.7 
Total other current liabilities$249.1 $303.3 
14

Note 7. Assets Held for Sale
The following criteria are considered before concluding assets are classified as held for sale: 1) management’s commitment to a plan to sell, 2) availability for immediate sale in its present condition, 3) initiation of an active program to identify a buyer, 4) probability of a completed sale within one year, 5) actively marketed for sale at a reasonable price in relation to its current fair value, and 6) likelihood of significant changes to the plan will be made or that the plan will be withdrawn. If all of the criteria are met as of the balance sheet date, the net assets are presented separately in the balance sheet as held for sale at the lower of its carrying amount or fair value less costs to sell and is no longer depreciated or amortized while classified as held for sale. The Company assesses the fair value of a long-lived asset less any costs to sell at each reporting period and until the asset is no longer classified as held for sale.
As part of the Company’s cost-savings initiatives, the Company has been evaluating its real estate footprint with the goal to relocate and consolidate its operations to improve long-term results. As a result, the Company has decided to (i) sell the McKellar, San Diego, CA facility and (ii) sell the Raritan, NJ, facility with the intent to subsequently lease back the right to use the property. In the second quarter of 2024, the properties met the requirements for reclassification from property, plant and equipment, net to assets held for sale when it became probable that the properties would be sold within one year. The carrying value of the assets was reduced to its estimated relative fair value less costs to sell resulting in an impairment charge of $56.9 million that was included in Asset impairment charge.
Note 8. Goodwill and Intangible Assets, Net
Changes in goodwill were as follows:
(In millions)North AmericaEMEAChinaOtherTotal
Balance at December 31, 2023$1,743.9 $582.4 $85.7 $80.0 $2,492.0 
Impairment charge(1,743.9)— — — (1,743.9)
Foreign currency translation— (7.6)(1.5)(6.5)(15.6)
Balance at June 30, 2024$— $574.8 $84.2 $73.5 $732.5 
The Company tests goodwill for impairment on an annual basis on the first day of the fourth quarter and monitors throughout the year for impairment triggering events that indicate that the carrying value of one or more of its reporting units exceeds its fair value.
During the first quarter of 2024, the Company concluded that (i) the sustained decline in the Company’s stock price and market capitalization occurred during the first quarter of 2024, (ii) the faster than expected decline in COVID-19 and flu markets, and (iii) the recent delay in the timing of expected commercialization for Savanna were triggering events requiring an interim goodwill impairment assessment for all reporting units.
Based on the Company’s interim goodwill impairment assessment, the Company concluded that the North America reporting unit’s carrying value exceeded its estimated fair value. As a result, the Company recorded a non-cash goodwill impairment charge of $1.7 billion in the first quarter of 2024 for the North America reporting unit, which represented a full impairment of the goodwill allocated to the North America reporting unit. The decline in the estimated fair value of the North America reporting unit and the resulting impairment was primarily driven by revised short-term and mid-term forecasts for revenue and EBITDA expectations in North America.
The estimated fair values of the EMEA, Latin America and JPAC reporting units as of the interim testing date exceeded their respective carrying values. The excess of the estimated fair value over carrying value (expressed as a percentage of carrying value for the respective reporting unit) ranged from approximately 30% to 150%. Due to the significant excess of fair value over carrying value of these reporting units, they are less sensitive to changes in forecast assumptions. To evaluate the sensitivity of the fair value calculations used in the interim goodwill impairment test for the EMEA, Latin America and JPAC reporting units, the Company applied a hypothetical 5% decrease to the fair values of each reporting unit and compared those hypothetical values to the reporting unit carrying values. Based on this hypothetical 5% decrease, the excess of the estimated fair value over carrying value (expressed as a percentage of carrying value for the respective reporting unit) for each of the Company’s reporting units ranged from approximately 25% to 140%.
The quantitative goodwill impairment assessment for all reporting units consisted of a fair value calculation that combines an income approach, using a discounted cash flow method, and a market approach, using the guideline public company method. The quantitative goodwill impairment assessment requires the application of a number of significant assumptions, including estimates of future revenue growth rates, EBITDA margins, discount rates and market multiples. The projected future revenue growth rates and EBITDA margins, and the resulting projected cash flows are based on historical experience and internal annual operating plans reviewed by management, extrapolated over the forecast period. Discount rates are determined using a
15

weighted average cost of capital adjusted for risk factors specific to the reporting units. Market multiples are based on the guideline public company method using comparable publicly traded company multiples of revenue and EBITDA for a group of benchmark companies.
The Company believes the assumptions that were used in the quantitative goodwill impairment assessment are reasonable and consistent with assumptions that would be used by other marketplace participants.
The Company also reviews long-lived assets, including intangible assets, for impairment when events or changes in circumstances indicate the carrying value of an asset group may not be recoverable. Given the indications of possible impairment that occurred during the first quarter of 2024, the Company tested its North America long-lived asset group for recoverability and impairment as of March 31, 2024. Recoverability of long-lived assets is measured by a comparison of the carrying value of an asset group to future undiscounted net cash flows expected to be generated by the asset group. The undiscounted cash flows for the North America long-lived asset group were above the carrying value and the Company determined that the long-lived asset group was recoverable, and no impairment existed as of June 30, 2024.
Note 9. Borrowings
The components of borrowings were as follows:
(In millions)June 30, 2024December 31, 2023
Term Loan$2,317.1 $2,420.2 
Revolving Credit Facility253.0 — 
Financing lease obligation 0.1 0.4 
Other short-term borrowings— 1.6 
Other long-term borrowings0.2 0.4 
Unamortized deferred financing costs(6.8)(8.0)
Total borrowings2,563.6 2,414.6 
Less: current portion(356.4)(139.8)
Long-term borrowings$2,207.2 $2,274.8 
The Credit Agreement, dated May 27, 2022, by and among the Company, as borrower, Bank of America, N.A., as administrative agent and swing line lender, and the other lenders and L/C issuers party thereto consists of a $2,750.0 million Term Loan and an $800.0 million Revolving Credit Facility. Availability under the Revolving Credit Facility, after deducting letters of credit of $13.0 million and $253.0 million borrowings outstanding, was $534.0 million as of June 30, 2024. During the six months ended June 30, 2024, the Company made $103.1 million in payments on the Term Loan.
The Credit Agreement contains affirmative and negative covenants that are customary for credit agreements of this nature. The negative covenants include, among other things, limitations on asset sales, mergers, indebtedness, liens, investments and transactions with affiliates.
On April 25, 2024, the Company entered into Amendment No. 2 (the “Amendment”), by and among the Company, the lenders party thereto, and Bank of America, N.A., as administrative agent, which amends the Credit Agreement. The Amendment sets a maximum Consolidated Leverage Ratio (as defined in the Credit Agreement) for the applicable measurement period as of the last day of each fiscal quarter of (a) 4.50 to 1.00 on or prior to June 30, 2023, (b) 4.00 to 1.00 after June 30, 2023 and on or prior to June 30, 2024, (c) 4.25 to 1.00 after June 30, 2024 and on or prior to December 31, 2024, (d) 4.00 to 1.00 after December 31, 2024 and on or prior to June 30, 2025 and (e) 3.75 to 1.00 each fiscal quarter after June 30, 2025. The Credit Agreement contains a minimum Consolidated Interest Coverage Ratio (as defined in the Credit Agreement) of 3.00 to 1.00 as of the end of any fiscal quarter for the most recently completed four fiscal quarters. The Company was in compliance with the financial covenants as of June 30, 2024.
16

The following table provides the detailed amounts within Interest expense, net for the three and six months ended June 30, 2024 and July 2, 2023:
Three Months EndedSix Months Ended
(In millions)June 30, 2024July 2, 2023June 30, 2024July 2, 2023
Term Loan$44.4 $44.2 $88.9 $85.1 
Revolving Credit Facility3.4 0.5 5.2 1.0 
Amortization of deferred financing costs0.8 0.8 1.6 1.6 
Derivative instruments and other(7.1)(7.2)(14.3)(11.7)
Interest income(0.5)(1.8)(1.4)(2.8)
Interest expense, net$41.0 $36.5 $80.0 $73.2 
Note 10. Stock-based Compensation
Stock-based compensation expense was as follows:
Three Months EndedSix Months Ended
(In millions)June 30, 2024July 2, 2023June 30, 2024July 2, 2023
Cost of sales, excluding amortization of intangibles$1.5 $1.1 $2.7 $2.1 
Selling, marketing and administrative6.7 10.0 11.8 17.2 
Research and development0.9 1.3 1.9 2.6 
Integration related costs2.1 4.6 3.9 9.1 
Total stock-based compensation expense$11.2 $17.0 $20.3 $31.0 
The table above includes compensation expense related to liability-classified awards of $2.8 million and $5.8 million for the three and six months ended July 2, 2023, respectively, which has been or is expected to be settled in cash. Amounts related to the three and six months ended June 30, 2024 were not material.
Note 11. Commitments and Contingencies
On April 12, 2024, a purported stockholder of the Company filed a putative class action complaint under the federal securities laws against the Company and three of its current and former executives. The complaint, which is captioned Bristol County Retirement System v. QuidelOrtho Corporation, et al., Case No. 1:24-cv-02804-MKV (S.D.N.Y.) (the “Bristol County Complaint”), asserts claims for violations of Sections 10(b) and 20(a) of the Exchange Act and Rule 10b-5 promulgated thereunder related to statements regarding sales of the Company’s COVID-19 diagnostic tests and the 510(k) submission for its Savanna RVP4 assay. The Bristol County Complaint seeks a judgment determining that the lawsuit can be maintained as a class action and awarding the plaintiff and putative class damages, pre- and post-judgment interest, attorneys’ and experts’ fees, and costs.
On April 25, 2024, and June 21, 2024, two purported stockholders of the Company filed separate stockholder derivative complaints, purportedly on behalf of the Company, against the current and certain former members of the Company’s Board of Directors and three of its current and former executives. The complaints, which are captioned Matthew Whitfield v. Kenneth F. Buechler, Ph.D., et al., Case No. 1:24-cv-03176-MKV (S.D.N.Y.) (the “Whitfield Complaint”), and Steven Pinkney v. Douglas Bryant, et al., Case No. 1:24-cv-4753-MKV (S.D.N.Y.) (the “Pinkney Complaint”), assert claims for violations of Sections 10(b), 14(a), and 20(a) of the Exchange Act and Rules 10b-5 and 14a-9 promulgated thereunder, breach of fiduciary duty, aiding and abetting breach of fiduciary duty, unjust enrichment, abuse of control, gross mismanagement, and waste of corporate assets related to statements regarding sales of the Company’s COVID-19 diagnostic tests and the 510(k) submission for its Savanna RVP4 assay. The Whitfield and Pinkney Complaints seek judgments awarding compensatory and punitive damages against the individual defendants, directing an accounting by the individual defendants, directing the Company and the individual defendants to take actions to improve the Company’s governance and procedures, and awarding the costs and disbursements of the action, including attorneys’ fees, accountants’ and experts’ fees, costs, and expenses.
The Company disputes the allegations of wrongdoing and intends to defend itself vigorously in these matters. Nevertheless, the outcomes of these lawsuits are uncertain and cannot be predicted with any certainty. Accordingly, at this time, the Company is not able to estimate a possible loss or range of loss that may result from these lawsuits or to determine whether such loss, if any, would have a material adverse effect on its business, financial condition, results of operations or liquidity.
17

From time to time, the Company is involved in other litigation and legal proceedings, including matters related to product liability claims, commercial disputes and intellectual property claims, as well as regulatory, employment, and other claims related to its business. The Company accrues for legal claims when, and to the extent that, amounts associated with the claims become probable and are reasonably estimable. If the reasonable estimate of a known or probable loss is a range, and no amount within the range is a better estimate than any other, the minimum amount of the range is accrued. When determining the estimated loss or range of loss, significant judgment is required to estimate the amount and timing of a loss to be recorded. Estimates of probable losses resulting from these matters are inherently difficult to predict. The actual costs of resolving legal claims may be substantially higher or lower than the amounts accrued for those claims. For those matters as to which the Company is not able to estimate a possible loss or range of loss, the Company is not able to determine whether the loss will have a material adverse effect on its business, financial condition, results of operations or liquidity.
Management believes that all such current legal actions, in the aggregate, are not expected to have a material adverse effect on the Company. However, the resolution of, or increase in any accruals for, one or more matters may have a material adverse effect on the Company’s results of operations and cash flows.
Note 12. Fair Value Measurements
The following table presents the Company’s hierarchy for its assets and liabilities measured at fair value on a recurring basis as of the following periods:
 June 30, 2024December 31, 2023
(In millions)Level 1Level 2Level 3TotalLevel 1Level 2Level 3Total
Assets:
Marketable securities$— $— $— $— $— $55.8 $— $55.8 
Derivative assets— 42.2 — 42.2 — 6.9 — 6.9 
Total assets measured at fair value$— $42.2 $— $42.2 $— $62.7 $— $62.7 
Liabilities:
Derivative liabilities$— $5.6 $— $5.6 $— $27.5 $— $27.5 
Contingent consideration— — — — — — 0.1 0.1 
Total liabilities measured at fair value$— $5.6 $— $5.6 $— $27.5 $0.1 $27.6 
There were no transfers of assets or liabilities into or out of Level 3 of the fair value hierarchy during the six months ended June 30, 2024 and fiscal year 2023.
Marketable securities consist of investment-grade corporate and government debt securities, corporate asset-backed securities and commercial paper. Derivative financial instruments are based on observable inputs that are corroborated by market data. Observable inputs include broker quotes, daily market foreign currency rates and forward pricing curves.
Financial Instruments Not Measured at Fair Value
The estimated fair value of the Company’s borrowings under the Term Loan was $2,296.8 million at June 30, 2024, compared to the carrying amount, excluding debt issuance costs, of $2,317.1 million. The estimated fair value of the Company’s borrowings under the Term Loan was $2,396.0 million at December 31, 2023, compared to the carrying amount, excluding debt issuance costs, of $2,420.2 million. The estimate of fair value is generally based on the quoted market prices for similar issuances of long-term debt with the same maturities, which is classified as a Level 2 input.
Note 13. Derivative Instruments and Hedging Activities
The Company selectively uses derivative and non-derivative instruments to manage market risk associated with changes in interest rates and foreign currency exchange rates. The use of derivatives is intended for hedging purposes only, and the Company does not enter into derivative transactions for speculative purposes.
Credit risk represents the Company’s gross exposure to potential accounting loss on derivative instruments that are outstanding or unsettled if all counterparties failed to perform according to the terms of the contract. The Company generally enters into master netting arrangements that reduce credit risk by permitting net settlement of transactions with the same counterparty. The Company does not have any derivative instruments with credit-risk related contingent features that would require it to post collateral.
18

Interest Rate Hedging Instruments
The Company’s interest rate risk relates primarily to interest rate exposures on variable rate debt, including the Revolving Credit Facility and Term Loan. Refer to “—Note 9. Borrowings” for additional information on the currently outstanding components of the Revolving Credit Facility and Term Loan. The Company entered into interest rate swap agreements to hedge the related risk of the variability to the Company’s cash flows due to the rates specified for these credit facilities.
The Company designates its interest rate swaps as cash flow hedges. The Company records gains and losses due to changes in fair value of the derivatives within OCI and reclassifies these amounts to Interest expense, net in the same period or periods for which the underlying hedged transaction affects earnings. In the event the Company determines the hedged transaction is no longer probable to occur or concludes the hedge relationship is no longer effective, the hedge is prospectively de-designated. Pre-tax unrealized gains of $20.4 million as of June 30, 2024 are expected to be reclassified from OCI to earnings in the next 12 months.
The following table summarizes the Company’s interest rate derivative agreements as of June 30, 2024, all of which were interest rate swaps:
Notional Amount
(In millions)		DescriptionHedge DesignationEffective DateExpiration Date
$550.0 
Pay 3.765% fixed, receive floating rate
(1-month USD-SOFR)
Designated cash flow hedgeDecember 30, 2022May 27, 2027
$200.0 
Pay 3.7725% fixed, receive floating rate
(1-month USD-SOFR)
Designated cash flow hedgeDecember 30, 2022May 27, 2027
$300.0 
Pay 3.7675% fixed, receive floating rate
(1-month USD-SOFR)
Designated cash flow hedgeDecember 30, 2022May 27, 2027
$400.0 
Pay 3.7575% fixed, receive floating rate
(1-month USD-SOFR)
Designated cash flow hedgeDecember 30, 2022May 27, 2027
$350.0 
Pay 3.7725% fixed, receive floating rate
(1-month USD-SOFR)
Designated cash flow hedgeDecember 30, 2022May 27, 2027
Currency Hedging Instruments
The Company has currency risk exposures relating primarily to foreign currency denominated monetary assets and liabilities and forecasted foreign currency denominated intercompany and third-party transactions. The Company uses foreign currency forward contracts and may use option contracts and cross currency swaps to manage its currency risk exposures. The Company’s foreign currency forward contracts are denominated primarily in Australian Dollar, Brazilian Real, British Pound, Canadian Dollar, Chilean Peso, Chinese Yuan/Renminbi, Colombian Peso, Czech Koruna, Danish Krone, Euro, Indian Rupee, Japanese Yen, Mexican Peso, Philippine Peso, South Korean Won, Swiss Franc and Thai Baht.
The Company designates certain foreign currency forward contracts as cash flow hedges. The Company records gains and losses due to changes in fair value of the derivatives within OCI and reclassifies these amounts to Total revenues and Cost of sales, excluding amortization of intangibles in the same period or periods for which the underlying hedged transaction affects earnings. In the event the Company determines the hedged transaction is no longer probable to occur or concludes the hedge relationship is no longer effective, the hedge is prospectively de-designated. Pre-tax unrealized gains of $0.7 million as of June 30, 2024 is expected to be reclassified from OCI to earnings in the next 12 months.
The Company also enters into foreign currency forward contracts that are not part of designated hedging relationships and which are intended to mitigate exchange rate risk of monetary assets and liabilities and related forecasted transactions. The Company records these non-designated derivatives at mark-to-market with gains and losses recognized in earnings within Other expense, net.
The following table provides details of the currency hedging instruments outstanding as of June 30, 2024:
DescriptionNotional Amount
(In millions)		Hedge Designation
Foreign currency forward contracts$217.0 Cash Flow Hedge
Foreign currency forward contracts$710.4 Non-designated
19

The following table summarizes pre-tax gains and losses from designated derivative and non-derivative instruments within AOCI for the three and six months ended June 30, 2024 and July 2, 2023:
Designated Hedging Instruments
(In millions)Amount of Loss (Gain) Recognized in OCI on HedgesLocation of Amounts Reclassified From AOCI Into IncomeAmount of Loss (Gain) Reclassified From AOCI Into Income
Three Months Ended June 30, 2024
Foreign currency forward contracts (sales)$(3.2)Total revenues$0.7 
Foreign currency forward contracts (purchases)$— Cost of sales, excluding amortization of intangibles$0.1 
Interest rate derivatives$(10.8)Interest expense, net$(7.0)
Six Months Ended June 30, 2024
Foreign currency forward contracts (sales)$(6.0)Total revenues$2.1 
Foreign currency forward contracts (purchases)$0.8 Cost of sales, excluding amortization of intangibles$— 
Interest rate derivatives$(45.8)Interest expense, net$(14.2)
Three Months Ended July 2, 2023
Foreign currency forward contracts (sales)$(0.4)Total revenues$1.8 
Foreign currency forward contracts (purchases)$(2.1)Cost of sales, excluding amortization of intangibles$1.3 
Interest rate derivatives$(47.0)Interest expense, net$(7.4)
Six Months Ended July 2, 2023
Foreign currency forward contracts (sales)$1.7 Total revenues$0.9 
Foreign currency forward contracts (purchases)$(2.1)Cost of sales, excluding amortization of intangibles$1.7 
Interest rate derivatives$(26.1)Interest expense, net$(12.6)
The Company also uses forward exchange contracts to hedge a portion of its net investment in foreign operations against movements in exchange rates. The forward exchange contracts are designated as hedges of the net investment in foreign operations. The unrealized gains or losses on these contracts are recorded in foreign currency translation adjustments within OCI, and remain in AOCI until either the sale or complete or substantially complete liquidation of the subsidiary. The Company excludes certain portions of the change in fair value of its derivative instruments from the assessment of hedge effectiveness (excluded components). Changes in fair value of the excluded components are recognized in OCI. The Company recognizes in earnings the initial value of the excluded components on a straight-line basis over the life of the derivative instrument.
The effect of the Company’s net investment hedges on OCI and the Consolidated Statements of Loss are shown below:
Net Investment Hedging Relationships
(In millions)Amount of Pre-tax (Gain) Loss Recognized in OCIAmount of Pre-tax (Gain) Loss Recognized in Other Expense (Income), Net for Amounts Excluded from Effectiveness Testing
Three Months Ended June 30, 2024
Foreign exchange contracts$(7.3)$(2.9)
Six Months Ended June 30, 2024
Foreign exchange contracts$(18.3)$(4.9)
Fair value gains on foreign currency forward contracts, as determined using Level 2 inputs, that do not qualify for hedge accounting treatment are recorded in Other expense, net and were $5.7 million for both the three and six months ended June 30,
20

2024. Fair value gains that do not qualify for hedge accounting treatment were $3.2 million and $0.5 million for the three and six months ended July 2, 2023, respectively.
The following table summarizes the fair value of designated and non-designated hedging instruments recognized within the Consolidated Balance Sheets as of June 30, 2024 and December 31, 2023:
(In millions)June 30, 2024December 31, 2023
Designated cash flow hedges
Interest rate derivatives:
Prepaid expenses and other current assets$0.2 $0.2 
Other assets24.6 — 
Other liabilities— 6.9 
Foreign currency forward contracts:
Prepaid expenses and other current assets4.7 3.2 
Other assets6.6 — 
Other current liabilities3.6 9.4 
Other liabilities0.9 8.5
Non-designated hedging instruments
Foreign currency forward contracts:
Prepaid expenses and other current assets6.1 3.5 
Other current liabilities1.1 2.7 
Note 14. Accumulated Other Comprehensive Loss
The following table summarizes the changes in AOCI by component:
Three Months Ended June 30, 2024
(In millions)Pension and Other Post-
Employment Benefits		Cash Flow HedgesAvailable-for-Sale InvestmentsForeign Currency Translation AdjustmentsAccumulated Other Comprehensive (Loss) Income
Balance at March 31, 2024$(1.3)$14.8 $— $(39.7)$(26.2)
Current period deferrals (1)
— 13.1 — (2.4)10.7 
Amounts reclassified to Net loss
— (6.2)— (2.9)(9.1)
Net change— 6.9 — (5.3)1.6 
Balance at June 30, 2024$(1.3)$21.7 $— $(45.0)$(24.6)
Six Months Ended June 30, 2024
(In millions)Pension and Other Post-
Employment Benefits		Cash Flow HedgesAvailable-for-Sale InvestmentsForeign Currency Translation AdjustmentsAccumulated Other Comprehensive (Loss) Income
Balance at December 31, 2023$(1.3)$(9.8)$— $(18.9)$(30.0)
Current period deferrals (1)
— 43.6 — (21.2)22.4 
Amounts reclassified to Net loss
— (12.1)— (4.9)(17.0)
Net change— 31.5 — (26.1)5.4 
Balance at June 30, 2024$(1.3)$21.7 $— $(45.0)$(24.6)
21

Three Months Ended July 2, 2023
(In millions)Pension and Other Post-
Employment Benefits		Cash Flow HedgesAvailable-for-Sale InvestmentsForeign Currency Translation AdjustmentsAccumulated Other Comprehensive (Loss) Income
Balance at April 2, 2023$0.7 $(21.1)$(0.3)$(38.6)$(59.3)
Current period deferrals (2)
— 40.0 (0.1)7.4 47.3 
Amounts reclassified to Net loss
— (4.3)— — (4.3)
Net change— 35.7 (0.1)7.4 43.0 
Balance at July 2, 2023$0.7 $14.6 $(0.4)$(31.2)$(16.3)
Six Months Ended July 2, 2023
(In millions)Pension and Other Post-
employment Benefits		Cash Flow HedgesAvailable-for-Sale InvestmentsForeign Currency Translation AdjustmentsAccumulated Other Comprehensive (Loss) Income
Balance at January 1, 2023$0.7 $1.5 $(0.5)$(69.3)$(67.6)
Current period deferrals (2)
— 23.1 0.1 38.1 61.3 
Amounts reclassified to Net loss
— (10.0)— — (10.0)
Net change— 13.1 0.1 38.1 51.3 
Balance at July 2, 2023$0.7 $14.6 $(0.4)$(31.2)$(16.3)
(1) Includes tax impact of (i) $0.9 million and $7.4 million related to cash flow hedges for the three and six months ended June 30, 2024, respectively, and (ii) $0.9 million and $2.9 million related to foreign currency translation adjustments for the three and six months ended June 30, 2024, respectively.
(2) Includes tax impact of $9.5 million and $3.4 million related to cash flow hedges for the three and six months ended July 2, 2023, respectively.
22

ITEM 2.    Management’s Discussion and Analysis of Financial Condition and Results of Operations
In this Quarterly Report, all references to “we,” “our” and “us” refer to QuidelOrtho Corporation and its subsidiaries.
Future Uncertainties and Forward-Looking Statements
This Quarterly Report contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act, and Section 21E of the Exchange Act. These statements are any statement contained herein that is not strictly historical, including, but not limited to, certain statements under Part I, Item 2, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and located elsewhere herein regarding our commercial, integration and other strategic goals, our cost-savings initiatives, industry prospects, our expected results of operations or financial position, and future plans, objectives, strategies, expectations and intentions. Without limiting the foregoing, the words “may,” “will,” “would,” “should,” “might,” “expect,” “anticipate,” “believe,” “estimate,” “plan,” “intend,” “goal,” “project,” “strategy,” “future,” “continue” or similar words, expressions or the negative of such terms or other comparable terminology are intended to identify forward-looking statements. Such statements are based on the beliefs and expectations of our management as of the date of this Quarterly Report and are subject to significant known and unknown risks and uncertainties. Actual results or outcomes may differ significantly from those set forth or implied in the forward-looking statements. The following factors, among others, could cause actual results to differ from those set forth or implied in the forward-looking statements: supply chain, production, logistics, distribution and labor disruptions and challenges; the challenges and costs of integrating, restructuring and achieving anticipated synergies as a result of the Combinations; and other macroeconomic, geopolitical, market, business, competitive and/or regulatory factors affecting our business generally, including those discussed under Part II, Item 1A, “Risk Factors” of this Quarterly Report and Part I, Item 1A, “Risk Factors” of our Annual Report. Investors should not rely on forward-looking statements as predictions of future events because these statements are based on assumptions that may not come true and are speculative by their nature. All forward-looking statements are based on information currently available to us and speak only as of the date of this Quarterly Report. We undertake no obligation to update any of the forward-looking information or time-sensitive information included in this Quarterly Report, whether as a result of new information, future events, changed expectations or otherwise, except as required by law.
Information Available on Our Website
This Quarterly Report and each of our other periodic and current reports, including any amendments thereto, are available, free of charge, on our website, www.quidelortho.com, as soon as reasonably practicable after such material is electronically filed with or furnished to the SEC. From time to time, we may use our website as a channel of distribution of material information related to the Company. Financial and other material information regarding the Company is routinely posted on and accessible at https://ir.quidelortho.com/. The information contained on or connected to our website is not deemed to be incorporated by reference into this Quarterly Report or filed with or furnished to the SEC and should not be considered part of this Quarterly Report.
Overview
Our vision is to advance diagnostics to power a healthier future. With our expertise in immunoassay and molecular testing, clinical chemistry and transfusion medicine, we aim to support clarity for clinicians and patients to help create better health outcomes. Our global infrastructure and commercial reach support our customers across more than 130 countries and territories with quality diagnostics, a broad test portfolio and market-leading service. We operate globally with manufacturing facilities in the U.S. and U.K. and with sales centers, administrative offices and warehouses located throughout the world.
We manage our business geographically to better align with the market dynamics of the specific geographic regions in which we operate, with our reportable segments being North America, EMEA and China. Latin America and JPAC (Japan and Asia Pacific) are immaterial operating segments that are not considered reportable segments and are included in “Other.” We generate our revenue in the following business units: Labs, Transfusion Medicine, Point of Care and Molecular Diagnostics.
For the six months ended June 30, 2024, Total revenues decreased by 11% to $1,348.0 million as compared to the same period in the prior year, primarily driven by variability of our U.S. respiratory products. Currency exchange rates had an unfavorable impact of 100 basis points on our growth rate. Our revenues can be highly concentrated over a small number of products, including certain of our respiratory products. For the six months ended June 30, 2024 and July 2, 2023, revenues related to our respiratory products accounted for approximately 14% and 23% of our Total revenues, respectively.
Planned Wind-Down of U.S. Donor Screening Portfolio
In February 2024, we initiated a wind-down plan to transition out of the U.S. donor screening portfolio. Specifically, we plan to wind-down only the ORTHO VERSEIA® Integrated Processor platform and microplate assays, which are only sold in the U.S., and have a lower growth and margin profile than other parts of our Transfusion Medicine business. This wind-down will not
23

affect any donor screening portfolio outside of the U.S. While our goal is to wind-down this U.S. donor screening portfolio, we will continue to support our existing customers and honor our contractual commitments.
Outlook
Our financial performance and results of operations will depend on future developments and other factors that are highly uncertain, continuously evolving and unpredictable, including the occurrence, spread, severity, duration and emergence of new variants of respiratory diseases, including flu, strep, RSV and COVID-19, as well as ongoing supply, production and logistics challenges.
We expect overall demand for our non-respiratory and respiratory products to continue to fluctuate and pricing pressures on certain products to persist as a result of a number of factors, including increased supply, emergence and spread of new variants, and the seasonal demands of the respiratory seasons, which are typically more prevalent during the fall and winter.
Because our business environment is highly competitive, our long-term growth and profitability will depend in part on our ability to retain and grow our current customers and attract new customers through developing and delivering new and improved products and services that meet our customers’ needs and expectations, including with respect to product performance, product offerings, cost, automation and other work-flow efficiencies. As a result, we expect to continue to maintain our emphasis on R&D investments for longer term growth, including for our next generation platforms and assays, as well as additional assays to be launched on our current platforms. In addition, we expect to continue to evaluate strategic opportunities to (i) expand our product lines and services, production capabilities, technologies and geographic footprint and address other business challenges and opportunities, and (ii) rationalize and consolidate facilities with the goal to improve our long term results.
While we expect the revenues and financial results from our non-respiratory and respiratory products to be affected by the highly competitive environment and seasonal demands of the respiratory seasons, we intend to continue our focus on prudently managing our business and delivering improved financial results, while at the same time striving to introduce new products and services into the market.
Seasonality
Revenues from our respiratory products are subject to, and significantly affected by, the seasonal demands of the cold, flu and RSV seasons, which are typically more prevalent during the fall and winter. Historically, revenues from our influenza products have varied from year to year based, in large part, on the severity, length and timing of the onset of the cold, flu and RSV seasons. In addition, the SARS-CoV-2 virus may have similar seasonal demands and impacts on our revenues in the future.
Results of Operations
Revenues
The following table compares Total revenues by business unit for the three and six months ended June 30, 2024 and July 2, 2023:
Three Months EndedSix Months Ended
(Dollars in millions)June 30, 2024July 2, 2023% ChangeJune 30, 2024July 2, 2023% Change
Labs$354.2 $361.4 (2)%$711.1 $732.1 (3)%
Transfusion Medicine161.3 163.3 (1)%321.6 319.2 1 %
Point of Care117.1 134.2 (13)%303.7 442.3 (31)%
Molecular Diagnostics4.4 6.2 (29)%11.6 17.6 (34)%
Total revenues$637.0 $665.1 (4)%$1,348.0 $1,511.2 (11)%
For the three months ended June 30, 2024, Total revenues decreased to $637.0 million from $665.1 million for the same period in the prior year. Labs revenue decreased 2% compared to the prior year period, primarily due to a decline in instrument revenue, partially offset by growth in recurring revenue, which includes reagents, consumables and services in our Labs revenue. Transfusion Medicine revenue decreased 1% compared to the prior year period, primarily due to the wind-down of the U.S. donor screening business. The decrease in Point of Care revenue of $17.1 million was driven primarily by lower demand for QuickVue SARS Antigen assays, partially offset by an increase in sales of Sofia SARS Antigen assays. Molecular Diagnostics sales decreased by $1.8 million compared to the prior year period. Currency exchange rates had an unfavorable impact of approximately 100 basis points on our growth rate for the three months ended June 30, 2024.
24

For the six months ended June 30, 2024, Total revenues decreased to $1,348.0 million from $1,511.2 million for the same period in the prior year. Labs revenue decreased by $21.0 million, primarily due to a $19.2 million settlement award from a third party related to one of our collaboration agreements in the prior year period. The Point of Care business unit contributed to revenue decline, driven by a decrease of $184.6 million in sales of QuickVue SARS Antigen assays primarily due to a COVID-19 government award in the prior year period, partially offset by an increase of $36.9 million in sales of Sofia SARS Antigen assays. Molecular Diagnostics sales decreased by $6.0 million, driven primarily by lower demand. Currency exchange rates had an unfavorable impact of approximately 100 basis points on our growth rate for the six months ended June 30, 2024.
Cost of Sales, Excluding Amortization of Intangible Assets
Cost of sales, excluding amortization of intangible assets, decreased to $361.0 million, or 56.7% of Total revenues, for the three months ended June 30, 2024, compared to $368.6 million, or 55.4% of Total revenues, for the three months ended July 2, 2023. Cost of sales, excluding amortization of intangible assets, was impacted by revenue decline, partially offset by a shift in product mix.
Cost of sales, excluding amortization of intangible assets, decreased to $739.9 million, or 54.9% of Total revenues, for the six months ended June 30, 2024, compared to $766.1 million, or 50.7% of Total revenues, for the six months ended July 2, 2023. The decrease in cost of sales, excluding amortization of intangible assets, was driven primarily by a prior year period COVID-19 government award, along with the corresponding inventory release of $39 million, partially offset by an increase in sales of Sofia SARS Antigen assays.
Operating Expenses
The following table summarizes operating expenses for the three and six months ended June 30, 2024 and July 2, 2023:
Three Months EndedSix Months Ended
(Dollars in millions)June 30, 2024% of
Total Revenues		July 2, 2023% of
Total Revenues		June 30, 2024% of
Total Revenues		July 2, 2023% of
Total Revenues
Selling, marketing and
  administrative		$188.2 29.5 %$179.1 26.9 %$392.9 29.1 %$381.5 25.2 %
Research and development56.3 8.8 %62.4 9.4 %115.5 8.6 %124.2 8.2 %
Amortization of intangible assets51.9 8.1 %51.4 7.7 %103.6 7.7 %102.2 6.8 %
Integration related costs30.9 4.9 %24.2 3.6 %53.5 4.0 %53.9 3.6 %
Goodwill impairment charge— N/M— N/M1,743.9 N/M— N/M
Asset impairment charge56.9 N/M0.5 N/M56.9 N/M1.0 N/M
Other operating expenses9.3 1.5 %5.8 0.9 %17.3 1.3 %9.6 0.6 %
* N/M - Not meaningful
Selling, Marketing and Administrative Expenses
Selling, marketing and administrative expenses for the three months ended June 30, 2024 increased by $9.1 million, or 5.1%, to $188.2 million from $179.1 million for the same period in the prior year, primarily due to employee compensation costs.
Selling, marketing and administrative expenses for the six months ended June 30, 2024 increased by $11.4 million, or 3.0%, to $392.9 million from $381.5 million for the same period in the prior year, primarily due to employee compensation costs.
Research and Development Expense
Research and development expense for the three months ended June 30, 2024 decreased by $6.1 million, or 9.8%, to $56.3 million from $62.4 million for the same period in the prior year, primarily due to lower compensation costs and outside services.
Research and development expense for the six months ended June 30, 2024 decreased by $8.7 million, or 7.0%, to $115.5 million from $124.2 million for the same period in the prior year, primarily due to lower compensation costs and outside services.
Amortization of Intangible Assets
Amortization of intangible assets was $51.9 million and $103.6 million for the three and six months ended June 30, 2024, respectively, and $51.4 million and $102.2 million for the three and six months ended July 2, 2023, respectively.
25

Integration Related Costs
Integration related costs were $30.9 million and $53.5 million for the three and six months ended June 30, 2024, respectively, and $24.2 million and $53.9 million for the three and six months ended July 2, 2023, respectively. The increase in costs for the three months ended June 30, 2024 compared to the prior year period was primarily due to increases in compensation related charges, partially offset by decreases in consulting costs.
Goodwill Impairment Charge
During the six months ended June 30, 2024, we identified a triggering event requiring an interim goodwill impairment assessment for our reporting units. As a result, we recognized a non-cash goodwill impairment charge of $1.7 billion for the North America reporting unit. Refer to Item 1, “Financial Statements—Note 8. Goodwill and Intangible Assets, Net” for more information.
Asset Impairment Charge
During the three and six months ended June 30, 2024, we recognized an impairment charge of $56.9 million related to the long-lived assets classified as assets held for sale. Refer to Item 1, “Financial Statements—Note 7. Assets Held for Sale” for more information. Asset impairment charge was $0.5 million and $1.0 million for the three and six months ended July 2, 2023, respectively.
Other Operating Expenses
Other operating expenses were $9.3 million and $17.3 million for the three and six months ended June 30, 2024, respectively, and $5.8 million and $9.6 million for the three and six months ended July 2, 2023, respectively. Other operating expenses were primarily related to the profit share expense for our Joint Business with Grifols.
Non-operating Expenses
Interest Expense, Net
Interest expense, net was $41.0 million and $80.0 million for the three and six months ended June 30, 2024, respectively, and $36.5 million and $73.2 million for the three and six months ended July 2, 2023, respectively. Refer to Item 1, “Financial Statements—Note 9. Borrowings” for more information.
Other Expense, Net
Other expense, net was $4.4 million and $6.3 million for the three and six months ended June 30, 2024, respectively, and $1.0 million and $3.9 million for the three and six months ended July 2, 2023, respectively. The increases from prior year periods were primarily related to the Credit Agreement amendment fees. Refer to Item 1, “Financial Statements—Note 9. Borrowings” for more information.
Income Taxes
For the three months ended June 30, 2024, we recognized an income tax benefit of $15.2 million in relation to loss before income taxes of $162.9 million, resulting in an effective tax rate of 9.3%. For the three months ended July 2, 2023, we recognized an income tax benefit of $11.2 million in relation to loss before income taxes of $64.4 million, resulting in an effective benefit tax rate of 17.4%. For the three months ended June 30, 2024, the effective tax rate differed from the U.S. federal statutory rate primarily due to Subpart F income and the Base Erosion and Anti-Abuse Tax liability. For the three months ended July 2, 2023, the effective tax rate differed from the U.S. federal statutory rate primarily due to non-U.S. earnings being taxed at rates that are different than the U.S. statutory rate, operating losses in certain subsidiaries not being benefited due to the establishment of valuation allowances, R&D credits and foreign tax credits, partially offset by foreign exchange losses and Global Intangible Low-Tax Income.
For the six months ended June 30, 2024, we recognized an income tax benefit of $108.1 million in relation to loss before income taxes of $1,961.8 million, resulting in an effective benefit tax rate of 5.5%. For the six months ended July 2, 2023, the recognized amount of income tax benefit was not material in relation to loss before income taxes of $4.4 million, resulting in an effective benefit tax rate of 0.7%. For the six months ended June 30, 2024, the effective tax rate differed from the U.S. federal statutory rate primarily due to goodwill impairment charges that are nondeductible for tax purposes. For the six months ended July 2, 2023, the effective tax rate differed from the U.S. federal statutory rate primarily due to net operating losses in certain subsidiaries not being benefited due to the establishment of valuation allowances and Global Intangible Low-Tax Income, partially offset by U.S. earnings being taxed at rates that are different than the U.S. statutory rate, R&D credit, foreign tax credits and foreign exchange losses.
26

Segment Results
We operate under three geographically-based reportable segments: North America, EMEA and China. Our operations in Latin America and JPAC (Japan and Asia Pacific) are immaterial operating segments that are not considered reportable segments and are included in “Other.”
The key indicators that we monitor are as follows:
•Total revenues — This measure is discussed in the section entitled “Results of Operations.”
•Adjusted EBITDA — Adjusted EBITDA by reportable segment is used by our management to measure and evaluate the internal operating performance of our reportable segments. It is also the basis for calculating certain management incentive compensation programs. We believe that this measurement is useful to investors as a way to analyze the underlying trends in our core business, including at the segment level, consistently across the periods presented and to evaluate performance under management incentive compensation programs. Adjusted EBITDA consists of Net loss before Interest expense, net, Benefit from income taxes and depreciation and amortization and eliminates (i) certain non-operating income or expense items, and (ii) impacts of certain non-cash, unusual or other items that are included in Net loss and that we do not consider indicative of our ongoing operating performance. Refer to Item 1, “Financial Statements—Note 4. Segment and Geographic Information” for a reconciliation of Adjusted EBITDA by reportable segment to Loss before income taxes.
North America
Total revenues and Adjusted EBITDA for North America were as follows:
Three Months EndedSix Months Ended
(Dollars in millions)June 30, 2024July 2, 2023% ChangeJune 30, 2024July 2, 2023% Change
Total revenues$350.1 $378.8 (8)%$784.0 $961.6 (18)%
Adjusted EBITDA$173.9 $176.3 (1)%$392.7 $454.7 (14)%
Total revenues were $350.1 million for the three months ended June 30, 2024, compared to $378.8 million for the three months ended July 2, 2023. The decrease was primarily driven by lower demand for QuickVue SARS Antigen assays, partially offset by an increase in revenues for Sofia SARS Antigen assays.
Total revenues were $784.0 million for the six months ended June 30, 2024, compared to $961.6 million for the six months ended July 2, 2023. The decrease was primarily driven by a COVID-19 government award in the prior year period, partially offset by an increase in revenues for Sofia SARS Antigen assays.
Adjusted EBITDA was $173.9 million for the three months ended June 30, 2024, which decreased slightly compared to $176.3 million for the three months ended July 2, 2023.
Adjusted EBITDA was $392.7 million for the six months ended June 30, 2024, compared to $454.7 million for the six months ended July 2, 2023. The decrease was primarily driven by a prior year period COVID-19 government award, along with the corresponding inventory release of $39 million, partially offset by an increase in revenues for Sofia SARS Antigen assays.
EMEA
Total revenues and Adjusted EBITDA for EMEA were as follows:
Three Months EndedSix Months Ended
(Dollars in millions)June 30, 2024July 2, 2023% ChangeJune 30, 2024July 2, 2023% Change
Total revenues$81.1 $80.6 1 %$165.9 $161.9 2 %
Adjusted EBITDA$11.4 $5.3 115 %$24.2 $12.5 94 %
Total revenues were $81.1 million for the three months ended June 30, 2024, which increased slightly compared to $80.6 million for the three months ended July 2, 2023.
Total revenues were $165.9 million for the six months ended June 30, 2024, compared to $161.9 million for the six months ended July 2, 2023, primarily driven by an increase in Labs and Transfusion Medicine revenues.
Adjusted EBITDA was $11.4 million for the three months ended June 30, 2024, compared to $5.3 million for the three months ended July 2, 2023. The increase was primarily driven by higher Transfusion Medicine revenues, product mix and lower operating expenses.
27

Adjusted EBITDA was $24.2 million for the six months ended June 30, 2024, compared to $12.5 million for the six months ended July 2, 2023, primarily driven by an increase in Labs and Transfusion Medicine revenues and product mix.
China
Total revenues and Adjusted EBITDA for China were as follows:
Three Months EndedSix Months Ended
(Dollars in millions)June 30, 2024July 2, 2023% ChangeJune 30, 2024July 2, 2023% Change
Total revenues$81.6 $81.3 0 %$157.7 $151.9 4 %
Adjusted EBITDA$35.8 $30.2 19 %$60.5 $58.7 3 %
Total revenues were $81.6 million for the three months ended June 30, 2024, which increased slightly compared to $81.3 million for the three months ended July 2, 2023 driven by an increase in Labs revenues, offset by a decrease in Point of Care revenue.
Total revenues were $157.7 million for the six months ended June 30, 2024, compared to $151.9 million for the six months ended July 2, 2023, primarily driven by an increase in Labs revenues.
Adjusted EBITDA was $35.8 million for the three months ended June 30, 2024, compared to $30.2 million for the three months ended July 2, 2023. The increase was primarily driven by higher Labs revenues and the impact from changes in product mix.
Adjusted EBITDA was $60.5 million for the six months ended June 30, 2024, compared to $58.7 million for the six months ended July 2, 2023. The increase was primarily driven by higher Labs revenues and the impact from changes in product mix.
Other
Total revenues and Adjusted EBITDA for Other were as follows:
Three Months EndedSix Months Ended
(Dollars in millions)June 30, 2024July 2, 2023% ChangeJune 30, 2024July 2, 2023% Change
Total revenues$124.2 $124.4 0 %$240.4 $235.8 2 %
Adjusted EBITDA$34.1 $36.3 (6)%$66.1 $58.1 14 %
Total revenues were $124.2 million for the three months ended June 30, 2024, which decreased slightly compared to $124.4 million for the three months ended July 2, 2023.
Total revenues were $240.4 million for the six months ended June 30, 2024, compared to $235.8 million for the six months ended July 2, 2023, primarily driven by an increase in Labs revenues.
Adjusted EBITDA was $34.1 million for the three months ended June 30, 2024, compared to $36.3 million for the three months ended July 2, 2023. The decrease was primarily driven by higher operating expenses.
Adjusted EBITDA was $66.1 million for the six months ended June 30, 2024, compared to $58.1 million for the six months ended July 2, 2023, primarily driven by an increase in Labs revenues and product mix.
Liquidity and Capital Resources
As of June 30, 2024 and December 31, 2023, our principal sources of liquidity consisted of the following:
(Dollars in millions)June 30, 2024December 31, 2023
Cash and cash equivalents$107.0 $118.9 
Marketable securities, current— 48.4 
Marketable securities, non-current— 7.4 
Total cash, cash equivalents and marketable securities$107.0 $174.7 
Amount available to borrow under the Revolving Credit Facility$534.0 $787.1 
Working capital including cash and cash equivalents and marketable securities, current$408.9 $476.7 
As of June 30, 2024, we had $107.0 million in Cash and cash equivalents, a $11.9 million decrease from December 31, 2023. Our cash requirements fluctuate as a result of numerous factors, including cash generated from operations, progress in R&D,
28

capital expansion projects and acquisition and business development activities. We believe our organizational structure allows us the necessary flexibility to move funds throughout our subsidiaries to meet our operational working capital needs.
Debt Capitalization
Our Credit Agreement consists of a $2,750.0 million Term Loan and an $800.0 million Revolving Credit Facility. Availability under the Revolving Credit Facility, after deducting letters of credit of $13.0 million and $253.0 million borrowings outstanding, was $534.0 million as of June 30, 2024.
On April 25, 2024, we entered into the Amendment, by and among us, the lenders party thereto, and Bank of America, N.A., as administrative agent, which amended the Credit Agreement. The Amendment sets a maximum Consolidated Leverage Ratio (as defined in the Credit Agreement) for the applicable measurement period as of the last day of each fiscal quarter of (a) 4.50 to 1.00 on or prior to June 30, 2023, (b) 4.00 to 1.00 after June 30, 2023 and on or prior to June 30, 2024, (c) 4.25 to 1.00 after June 30, 2024 and on or prior to December 31, 2024, (d) 4.00 to 1.00 after December 31, 2024 and on or prior to June 30, 2025 and (e) 3.75 to 1.00 each fiscal quarter after June 30, 2025. The Credit Agreement contains a minimum Consolidated Interest Coverage Ratio (as defined in the Credit Agreement) of 3.00 to 1.00 as of the end of any fiscal quarter for the most recently completed four fiscal quarters. We were in compliance with the financial covenants as of June 30, 2024.
Capital Expenditures
Capital expenditures, including investments, were $101.4 million for the six months ended June 30, 2024. We continue to make capital expenditures in connection with the expansion of our manufacturing capabilities and other facility-related activities.
Cash Flow Summary
Six Months Ended
(In millions)June 30, 2024July 2, 2023
Net cash (used for) provided by operating activities$(98.6)$158.3 
Net cash used for investing activities(55.5)(111.2)
Net cash provided by (used for) financing activities144.0 (159.3)
Effect of exchange rates on cash(1.9)(2.1)
Net decrease in cash, cash equivalents and restricted cash$(12.0)$(114.3)
Six Months Ended June 30, 2024
Cash used for operating activities was $98.6 million for the six months ended June 30, 2024, and reflected a net loss of $1,853.7 million and non-cash adjustments of $1,971.1 million, primarily associated with a goodwill impairment charge and change in deferred tax assets and liabilities as well as depreciation and amortization, asset impairment charge and stock-based compensation expense. In addition, we benefited from collections on accounts receivables, which contributed cash inflows of $24.2 million, offset by other changes in working capital, including $95.2 million cash outflows for inventories.
Cash used for investing activities was $55.5 million for the six months ended June 30, 2024, and was primarily related to $101.4 million in purchases of property, plant, equipment, investments and intangibles. We also sold $63.1 million of marketable securities.
Cash provided by financing activities was $144.0 million for the six months ended June 30, 2024, and was primarily related to net proceeds from the Revolving Credit Facility of $253.0 million, partially offset by payments on long-term borrowings of $103.7 million.
Six Months Ended July 2, 2023
Cash provided by operating activities was $158.3 million for the six months ended July 2, 2023, and reflected a net loss of $4.4 million and non-cash adjustments of $243.7 million, primarily associated with depreciation and amortization, stock-based compensation expense and accretion of interest on deferred consideration. We benefited from collections on accounts receivables of $214.5 million, primarily due to a COVID-19 government award, offset by other changes in working capital.
Cash used for investing activities was $111.2 million for the six months ended July 2, 2023, and was primarily related to $117.3 million in purchases of property, plant, equipment, investments and intangibles. We also purchased $50.6 million and sold $53.9 million of marketable securities.
29

Cash used for financing activities was $159.3 million for the six months ended July 2, 2023, and was primarily related to payments on long-term borrowings of $123.8 million, payments for deferred consideration of $30.3 million and payments of tax withholdings related to vesting of stock-based awards of $12.5 million.
Liquidity Outlook
Short-term Liquidity Outlook
Our primary source of liquidity, other than our holdings of Cash and cash equivalents, has been cash flows from operations. Cash generated from operations provides us with the financial flexibility we need to meet normal operating, investing and financing needs. We anticipate that our current Cash and cash equivalents, together with cash provided by operating activities and amounts available under our Revolving Credit Facility, will be sufficient to fund our near-term capital and operating needs for at least the next 12 months.
Normal operating needs include the planned costs to operate our business, including amounts required to fund working capital, R&D and capital expenditures. Our primary short-term needs for capital, which are subject to change, include expenditures related to:
•interest on and repayments of our long-term borrowings and lease obligations;
•acquisitions of property, equipment and other fixed assets in support of our manufacturing facility expansions;
•the continued advancement of R&D efforts;
•our integration of the Ortho business arising from the Combinations;
•support of commercialization efforts related to our current and future products, including support of our direct sales force and field support resources; and
•potential strategic acquisitions and investments.
Due to the risks inherent in the product development process, we are unable to estimate with meaningful certainty the costs we will incur in the continued development of our product candidates for commercialization. Our R&D costs may be substantial as we move product candidates into preclinical and clinical trials and advance our existing product candidates into later stages of development.
The primary purposes of our capital expenditures are to invest in manufacturing capacity expansion, acquire certain of our instruments, acquire scientific equipment, purchase or develop IT and implement facility improvements. We plan to fund the capital expenditures with the cash on our balance sheet.
We are focused on expanding the number of instruments placed in the field and solidifying long-term contractual relationships with customers. In order to achieve this goal, in certain jurisdictions where it is permitted, we have leveraged a reagent rental model that has been recognized as more attractive to certain customers. In this model, we lease, rather than sell, instruments to our customers. Over the term of the contract, the purchase price of the instrument is embedded in the price of the assays and reagents. Going forward, we intend to increase the number of reagent rental placements in developed markets, a strategy that we believe is beneficial to our commercial goals because it lowers our customers’ upfront capital costs and therefore allows purchasing decisions to be made at the lab manager level. For these same reasons, the reagent rental model also benefits our commercial strategy in emerging markets. We believe that the shift in our sales strategy will grow our installed base, thereby increasing sales of higher-margin assays, reagents and other consumables over the life of the customer contracts and enhancing our recurring revenue and cash flows. During the six months ended June 30, 2024, we transferred $69.2 million of instrument inventories from Inventories to Property, plant and equipment, net, further increasing our investment in property, plant and equipment.
Long-term Liquidity Outlook
Our future capital requirements and the adequacy of our available funds to service any long-term debt outstanding and to fund working capital expenditures and business development efforts will depend on many factors, including:
•our ability to successfully integrate the Ortho business and realize cross-selling revenue synergies;
•our ability to realize revenue growth from our new technologies and create innovative products in our markets;
•outstanding debt and covenant restrictions;
•our ability to leverage our operating expenses to realize operating profits as we grow revenue;
•competing technological and market developments; and
•our entry into strategic collaborations with other companies or acquisitions of other companies or technologies to enhance or complement our product and service offerings.
30

On March 1, 2024, our lease for warehouse space in the U.S. commenced. Information regarding the lease is included in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report.
Recent Accounting Pronouncements
There have been no accounting pronouncements issued or adopted during the six months ended June 30, 2024 that are expected to have a material impact on the Company’s financial statements.
Critical Accounting Estimates
Our discussion and analysis of our financial condition and results of operations are based on our Consolidated Financial Statements, which have been prepared in accordance with GAAP. The preparation of these financial statements requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities and the reported amounts of revenues and expenses. Our critical accounting estimates are those that significantly affect our financial condition and results of operations and require the most difficult, subjective or complex judgments, often because of the need to make estimates about the effect of matters that are inherently uncertain. Because of this uncertainty, actual results may vary from these estimates.
A comprehensive discussion of our critical accounting estimates is included in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report. Other than the following, there have been no significant changes to our critical accounting policies and estimates during the six months ended June 30, 2024:
Goodwill Impairment
We test goodwill for impairment on an annual basis on the first day of the fourth quarter and monitor throughout the year for impairment triggering events that indicate that the carrying value of one or more of our reporting units exceeds its fair value.
During the first quarter of 2024, we concluded that (i) the sustained decline in our stock price and market capitalization occurred during the first quarter of 2024, (ii) the faster than expected decline in COVID-19 and flu markets, and (iii) the recent delay in the timing of expected commercialization for Savanna were triggering events requiring an interim goodwill impairment assessment for all reporting units.
Based on our interim goodwill impairment assessment, we concluded that the North America reporting unit’s carrying value exceeded its estimated fair value. As a result, we recorded a non-cash goodwill impairment charge of $1.7 billion in the first quarter of 2024 for the North America reporting unit, which represented a full impairment of the goodwill allocated to the North America reporting unit. The decline in the estimated fair value of the North America reporting unit and the resulting impairment was primarily driven by revised short-term and mid-term forecasts for revenue and EBITDA expectations in North America.
The estimated fair values of our EMEA, Latin America and JPAC reporting units as of the interim testing date exceeded their respective carrying values. The excess of the estimated fair value over carrying value (expressed as a percentage of carrying value for the respective reporting unit) ranged from approximately 30% to 150%. Due to the significant excess of fair value over carrying value of these reporting units, they are less sensitive to changes in forecast assumptions. To evaluate the sensitivity of the fair value calculations used in the interim goodwill impairment test for the EMEA, Latin America and JPAC reporting units, we applied a hypothetical 5% decrease to the fair values of each reporting unit and compared those hypothetical values to the reporting unit carrying values. Based on this hypothetical 5% decrease, the excess of the estimated fair value over carrying value (expressed as a percentage of carrying value for the respective reporting unit) for each of our reporting units ranged from approximately 25% to 140%.
The quantitative goodwill impairment assessment for all reporting units consisted of a fair value calculation that combines an income approach, using a discounted cash flow method, and a market approach, using the guideline public company method. The quantitative goodwill impairment assessment requires the application of a number of significant assumptions, including estimates of future revenue growth rates, EBITDA margins, discount rates and market multiples. The projected future revenue growth rates and EBITDA margins, and the resulting projected cash flows are based on historical experience and internal annual operating plans reviewed by management, extrapolated over the forecast period. Discount rates are determined using a weighted average cost of capital adjusted for risk factors specific to the reporting units. Market multiples are based on the guideline public company method using comparable publicly traded company multiples of revenue and EBITDA for a group of benchmark companies.
We believe the assumptions that were used in the quantitative goodwill impairment assessment are reasonable and consistent with assumptions that would be used by other marketplace participants.
31

ITEM 3.    Quantitative and Qualitative Disclosures About Market Risk
There has been no material change in our exposure to market risk from that described in “Item 7A. Quantitative and Qualitative Disclosures About Market Risk” in our Annual Report.
ITEM 4.    Controls and Procedures
Evaluation of disclosure controls and procedures: We have performed an evaluation under the supervision and with the participation of our management, including our CEO and CFO, of the effectiveness of our disclosure controls and procedures, as defined in Exchange Act Rules 13a-15(e) and 15d-15(e). Based on that evaluation, our CEO and CFO concluded that our disclosure controls and procedures were effective as of June 30, 2024 at a reasonable assurance level to ensure that information required to be disclosed by us in the reports filed or submitted by us under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost benefit relationship of possible controls and procedures.
Changes in internal control over financial reporting: There were no changes in our internal control over financial reporting during the fiscal quarter ended June 30, 2024 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

32


PART II OTHER INFORMATION
ITEM 1.    Legal Proceedings
The information set forth in Part I—Financial Information, Item 1, “Financial Statements—Note 11. Commitments and Contingencies” is incorporated herein by reference.
ITEM 1A.    Risk Factors
There has been no material change in our risk factors as previously disclosed in our Annual Report. For a detailed description of our risk factors, refer to Part I, Item IA, “Risk Factors” of our Annual Report.
ITEM 2.    Unregistered Sales of Equity Securities and Use of Proceeds
Issuer Purchases of Equity Securities
On August 17, 2022, our Board of Directors authorized the Stock Repurchase Program, allowing us to repurchase up to $300.0 million of our common stock through August 17, 2024. As of June 30, 2024, we had approximately $218.4 million available under the Stock Repurchase Program. We did not repurchase any shares of our common stock during the fiscal quarter ended June 30, 2024.
ITEM 3.    Defaults Upon Senior Securities
None.
ITEM 4.    Mine Safety Disclosures
Not applicable.
ITEM 5.    Other Information
(a)None.
(b)None.
(c)During the last fiscal quarter, no director or officer (as defined in Exchange Act Rule 16a-1(f)) adopted or terminated any Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement (within the meaning of SEC rules).
33

ITEM 6.    Exhibits
Exhibit Number
3.1
3.2
3.3
4.1
10.1
10.2(1)
10.3(1)*
31.1*
31.2*
32.1**
101The following financial statements, formatted in Inline XBRL: (i) Consolidated Balance Sheets, (ii) Consolidated Statements of Loss, (iii) Consolidated Statements of Comprehensive (Loss) Income, (iv) Consolidated Statements of Stockholders’ Equity, (v) Consolidated Statements of Cash Flows, and (vi) Notes to Consolidated Financial Statements, tagged as blocks of text and including detailed tags
104The cover page, formatted in Inline XBRL (included as Exhibit 101)
_________________________
*    Filed herewith.
**    Furnished herewith.
(1) Indicates a management plan or compensatory plan or arrangement.
34

SUMMARY OF ABBREVIATED TERMS
QuidelOrtho Corporation and its consolidated subsidiaries may be referred to as QuidelOrtho, the Company, we, our or us in this Quarterly Report, unless the context otherwise indicates. Throughout this Quarterly Report, we have used terms which are defined below:
Annual Report
Annual Report on Form 10-K for the fiscal year ended December 31, 2023, as amended by Amendment No. 1 to the Annual Report
AOCI
Accumulated other comprehensive loss
CEOChief Executive Officer
CFOChief Financial Officer
CODMChief Operating Decision Maker
CombinationsBusiness combination consummated by Quidel and Ortho on May 27, 2022, pursuant to a Business Combination Agreement entered into as of December 22, 2021, by and among Quidel, Ortho, QuidelOrtho (formerly Coronado Topco, Inc.), Orca Holdco, Inc., Laguna Merger Sub, Inc., and Orca Holdco 2, Inc.
Credit AgreementCredit agreement, dated May 27, 2022, by and among the Company, as borrower, Bank of America, N.A., as administrative agent and swing line lender, and the other lenders and
L/C issuers party thereto
EBITDAEarnings Before Interest, Taxes, Depreciation and Amortization
EMEAEurope, the Middle East and Africa
EPS(Loss) earnings per share
Exchange ActSecurities Exchange Act of 1934, as amended
GAAPGenerally Accepted Accounting Principles in the U.S.
GrifolsGrifols Diagnostic Solutions, Inc.
ITInformation technology
Joint BusinessOngoing collaboration arrangement between Ortho and Grifols
JPACJapan and Asia Pacific
OCI
Other comprehensive (loss) income
OrthoOrtho Clinical Diagnostics Holdings plc
Quarterly Report
Quarterly Report on Form 10-Q for the quarter ended June 30, 2024
QuidelQuidel Corporation
R&DResearch and development
Revolving Credit Facility$800.0 million revolving credit facility under the Credit Agreement
RSURestricted Stock Unit
RSVRespiratory Syncytial Virus
SECSecurities and Exchange Commission
Securities ActSecurities Act of 1933, as amended
SOFRSecured Overnight Financing Rate
Stock Repurchase Program
A stock repurchase program allowing the Company to repurchase up to $300.0 million of its common stock through August 17, 2024, which was authorized by our Board of Directors on August 17, 2022
Term Loan$2,750.0 million senior secured term loan facility under the Credit Agreement
U.K.United Kingdom
U.S.United States
USDUnited States Dollar
35

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
Date: August 1, 2024QUIDELORTHO CORPORATION
/s/ BRIAN J. BLASER
Brian J. Blaser
President and Chief Executive Officer
(Principal Executive Officer)
/s/ JOSEPH M. BUSKY
Joseph M. Busky
Chief Financial Officer
(Principal Financial and Accounting Officer)

36
 EX-10.3 2 ex1036302024.htm EX-10.3 Document

Exhibit 10.3

QuidelOrtho Corporation
Retention Compensation Agreement

QuidelOrtho Corporation (the “Company”) has awarded to you (the “Participant”) a cash retention award in the amount and on the terms set forth below (the “Cash Retention Award”) and has granted you an award of restricted stock units pursuant to the Company’s 2018 Equity Incentive Plan (the “Plan”) and the applicable form of award agreement thereunder (the “Equity Retention Award”). Your Cash Retention Award and Equity Retention Award (collectively, the “Retention Awards”) are subject to all of the terms and conditions as set forth in this Retention Compensation Agreement (this “Agreement”).

Participant:[____________]
Date of Grant:February 27, 2024
Cash Retention Award:USD$[ ]
Equity Retention Award (# of RSUs):[____]
Vesting Date:                         June 30, 2025

Vesting Schedule:    Except as set forth below, the Retention Awards shall vest on the Vesting Date.

Termination without Cause:

(1)Voluntary Termination: Notwithstanding the foregoing vesting schedule, except as set forth in clause (b) below, vesting and any right to future payment of the Cash Retention Award and/or vesting of the Equity Retention Award shall terminate upon the Participant’s termination of employment for any reason prior to the Vesting Date and Participant shall forfeit and have no further right or interest in the Retention Awards.

(2)Involuntary Termination: If, prior to the Vesting Date, the Participant’s employment is terminated by the Company without Cause (as defined in Participant’s Severance and Change in Control Agreement (the “Severance and CIC Agreement”)), then, subject to Participant executing a customary general release of claims in favor of the Company and such release becoming effective and irrevocable in accordance with its terms, and Participant’s continued compliance, in all material respects, with the terms of the Severance and CIC Agreement, including Participant’s obligations thereunder, the Retention Awards shall become fully vested. For avoidance of doubt, the Retention Awards are in addition to, and not in lieu of, any benefits that may become payable under the Severance and CIC Agreement; provided that the Cash Retention Award shall not be treated as a cash bonus or cash incentive compensation payment for purposes of the


Severance and CIC Agreement and shall be expressly excluded from the calculation of any Bonus Increment or Compensation (each, as defined under the Severance and CIC Agreement).

Payment of Cash Retention Award:  Any portion of the Cash Retention Award that becomes vested in accordance with the terms set forth in this Agreement shall be payable to Participant, in cash, net of applicable withholding taxes, within thirty (30) days after the vesting date.

Terms and Conditions of Equity Retention Award: The remaining terms and conditions of the Equity Retention Award shall be as set forth in the Plan and the applicable award agreement thereunder.
[Signature Page Follows]

2



Participant Acknowledgements: By your signature below or by electronic acceptance or authentication in a form authorized by the Company, you understand and agree that:

•The Cash Retention Award is governed by this Agreement, and the Equity Retention Award is governed by this Agreement, the Plan and applicable award agreement thereunder.
•This Agreement may not be modified, amended or revised except in a writing signed by you and a duly authorized officer of the Company.
•This Agreement, the Plan and equity award agreement set forth the entire understanding between you and the Company regarding the Retention Awards and supersede all prior oral and written agreements, promises and/or representations on that subject.

QUIDELORTHO CORPORATION
PARTICIPANT:
By:
SignatureSignature
Title:Date:
Date:

3
 EX-31.1 3 ex3116302024.htm EX-31.1 Document

Exhibit 31.1
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Brian J. Blaser, certify that:
1.    I have reviewed this quarterly report on Form 10-Q of QuidelOrtho Corporation;
2.    Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.    Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.    The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.    The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: August 1, 2024
 
/s/ BRIAN J. BLASER
Brian J. Blaser
President and Chief Executive Officer
(Principal Executive Officer)


 EX-31.2 4 ex3126302024.htm EX-31.2 Document

Exhibit 31.2
CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Joseph M. Busky, certify that:
 
1.    I have reviewed this quarterly report on Form 10-Q of QuidelOrtho Corporation;
2.    Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.    Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.    The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.    The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: August 1, 2024
 
/s/ JOSEPH M. BUSKY
Joseph M. Busky
Chief Financial Officer
(Principal Financial Officer)


 EX-32.1 5 ex3216302024.htm EX-32.1 Document

Exhibit 32.1
Certifications by the Principal Executive Officer and Principal Financial Officer of Registrant Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
Each of the undersigned hereby certifies, in his capacity as an officer of QuidelOrtho Corporation, a Delaware corporation (the “Company”), for purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge:
 
•the Company’s Quarterly Report on Form 10-Q for the period ended June 30, 2024 (the “Report”), as filed with the Securities and Exchange Commission on the date hereof, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
•the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: August 1, 2024
 
/s/ BRIAN J. BLASER
Brian J. Blaser
President and Chief Executive Officer
(Principal Executive Officer)
/s/ JOSEPH M. BUSKY
Joseph M. Busky
Chief Financial Officer
(Principal Financial Officer)


 EX-101.SCH 6 qdel-20240630.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink 9952151 - Statement - Consolidated Balance Sheets (Unaudited) link:presentationLink link:calculationLink link:definitionLink 9952152 - Statement - Consolidated Balance Sheets (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 9952153 - Statement - Consolidated Statements of Loss (Unaudited) link:presentationLink link:calculationLink link:definitionLink 9952154 - Statement - Consolidated Statements of Comprehensive (Loss) Income (Unaudited) link:presentationLink link:calculationLink link:definitionLink 9952155 - Statement - Consolidated Statements of Stockholders' Equity (Unaudited) link:presentationLink link:calculationLink link:definitionLink 9952156 - Statement - Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 9952157 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 9952158 - Disclosure - Computation of Earnings Per Share link:presentationLink link:calculationLink link:definitionLink 9952159 - Disclosure - Revenue link:presentationLink link:calculationLink link:definitionLink 9952160 - Disclosure - Segment and Geographic Information link:presentationLink link:calculationLink link:definitionLink 9952161 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 9952162 - Disclosure - Balance Sheet Account Details link:presentationLink link:calculationLink link:definitionLink 9952163 - Disclosure - Assets Held for Sale link:presentationLink link:calculationLink link:definitionLink 9952164 - Disclosure - Goodwill and Intangible Assets, Net link:presentationLink link:calculationLink link:definitionLink 9952165 - Disclosure - Borrowings link:presentationLink link:calculationLink link:definitionLink 9952166 - Disclosure - Stock-based Compensation link:presentationLink link:calculationLink link:definitionLink 9952167 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 9952168 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 9952169 - Disclosure - Derivative Instruments and Hedging Activities link:presentationLink link:calculationLink link:definitionLink 9952170 - Disclosure - Accumulated Other Comprehensive Loss link:presentationLink link:calculationLink link:definitionLink 9954471 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 9954472 - Disclosure - Computation of Earnings Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 9954473 - Disclosure - Revenue (Tables) link:presentationLink link:calculationLink link:definitionLink 9954474 - Disclosure - Segment and Geographic Information (Tables) link:presentationLink link:calculationLink link:definitionLink 9954475 - Disclosure - Balance Sheet Account Details (Tables) link:presentationLink link:calculationLink link:definitionLink 9954476 - Disclosure - Goodwill and Intangible Assets, Net (Tables) link:presentationLink link:calculationLink link:definitionLink 9954477 - Disclosure - Borrowings (Tables) link:presentationLink link:calculationLink link:definitionLink 9954478 - Disclosure - Stock-based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 9954479 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 9954480 - Disclosure - Derivative Instruments and Hedging Activities (Tables) link:presentationLink link:calculationLink link:definitionLink 9954481 - Disclosure - Accumulated Other Comprehensive Loss (Tables) link:presentationLink link:calculationLink link:definitionLink 9954482 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954483 - Disclosure - Computation of Earnings Per Share - Calculation of Basic and Diluted Earnings Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 9954484 - Disclosure - Computation of Earnings Per Share - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954485 - Disclosure - Revenue - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954486 - Disclosure - Revenue - Disaggregation of Revenue (Details) link:presentationLink link:calculationLink link:definitionLink 9954487 - Disclosure - Segment and Geographic Information - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954488 - Disclosure - Segment and Geographic Information - Total Revenues by Reportable Segment (Details) link:presentationLink link:calculationLink link:definitionLink 9954489 - Disclosure - Segment and Geographic Information - Reconciliation to Income (Details) link:presentationLink link:calculationLink link:definitionLink 9954490 - Disclosure - Income Taxes (Detail) link:presentationLink link:calculationLink link:definitionLink 9954491 - Disclosure - Balance Sheet Account Details Cash, Cash Equivalents and Restricted Cash (Details) link:presentationLink link:calculationLink link:definitionLink 9954492 - Disclosure - Balance Sheet Account Details - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954493 - Disclosure - Balance Sheet Account Details Marketable Securities (Details) link:presentationLink link:calculationLink link:definitionLink 9954494 - Disclosure - Balance Sheet Account Details Accounts Receivable (Details) link:presentationLink link:calculationLink link:definitionLink 9954495 - Disclosure - Balance Sheet Account Details Inventories (Details) link:presentationLink link:calculationLink link:definitionLink 9954495 - Disclosure - Balance Sheet Account Details Inventories (Details) link:presentationLink link:calculationLink link:definitionLink 9954496 - Disclosure - Balance Sheet Account Details Prepaid expenses and other current assets (Details) link:presentationLink link:calculationLink link:definitionLink 9954497 - Disclosure - Balance Sheet Account Details Other Current Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 9954498 - Disclosure - Assets Held for Sale (Details) link:presentationLink link:calculationLink link:definitionLink 9954499 - Disclosure - Goodwill and Intangible Assets, Net - Goodwill Rollforward (Details) link:presentationLink link:calculationLink link:definitionLink 9954500 - Disclosure - Goodwill and Intangible Assets, Net - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954501 - Disclosure - Borrowings - Schedule of Borrowings (Details) link:presentationLink link:calculationLink link:definitionLink 9954501 - Disclosure - Borrowings - Schedule of Borrowings (Details) link:presentationLink link:calculationLink link:definitionLink 9954502 - Disclosure - Borrowings - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954503 - Disclosure - Borrowings - Interest Expense (Details) link:presentationLink link:calculationLink link:definitionLink 9954504 - Disclosure - Stock-based Compensation - Compensation Expense Related to Stock-Based Compensation Plans (Details) link:presentationLink link:calculationLink link:definitionLink 9954505 - Disclosure - Stock-based Compensation - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954506 - Disclosure - Commitments and Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink 9954507 - Disclosure - Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) link:presentationLink link:calculationLink link:definitionLink 9954508 - Disclosure - Fair Value Measurements - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954509 - Disclosure - Derivative Instruments and Hedging Activities - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954510 - Disclosure - Derivative Instruments and Hedging Activities - Schedule of Interest Rate Derivatives (Details) link:presentationLink link:calculationLink link:definitionLink 9954511 - Disclosure - Derivative Instruments and Hedging Activities - Schedule of Currency Hedging Instruments (Details) link:presentationLink link:calculationLink link:definitionLink 9954512 - Disclosure - Derivative Instruments and Hedging Activities - Schedule of Gain (Loss) (Details) link:presentationLink link:calculationLink link:definitionLink 9954513 - Disclosure - Derivative Instruments and Hedging Activities - Schedule of Net Investment Hedge (Details) link:presentationLink link:calculationLink link:definitionLink 9954514 - Disclosure - Derivative Instruments and Hedging Activities - Schedule of Fair Value (Details) link:presentationLink link:calculationLink link:definitionLink 9954515 - Disclosure - Accumulated Other Comprehensive Loss (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 qdel-20240630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 8 qdel-20240630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 9 qdel-20240630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Reclassification [Line Items] Reclassification [Line Items] Covenant Period [Axis] Covenant Period [Axis] Covenant Period Adjustments to reconcile net loss to net cash (used for) provided by operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Statistical Measurement [Domain] Statistical Measurement [Domain] Payments on long-term borrowings Repayments of Long-Term Debt Gross Unrealized Losses Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Cover [Abstract] Net decrease in cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Other current liabilities Total other current liabilities Other Liabilities, Current Unrecognized tax benefits the could impact effective tax rate Unrecognized Tax Benefits that Would Impact Effective Tax Rate Trading Symbol Trading Symbol All Trading Arrangements All Trading Arrangements [Member] Long-term borrowings Long-Term Debt and Lease Obligation Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Pension and Other Post- Employment Benefits Accumulated Defined Benefit Plans Adjustment Including Portion Attributable to Noncontrolling Interest [Member] Derivative Asset, Fair Value, Gross Asset Derivative Asset, Subject to Master Netting Arrangement, before Offset Non-NEOs Non-NEOs [Member] Schedule of Earnings Per Share, Basic and Diluted Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Transfer of instrument inventories to fixed assets Noncash of Part Noncash Acquisition, Fixed Assets transferred from inventories Noncash of Part Noncash Acquisition, Fixed Assets transferred from inventories Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Derivative [Line Items] Derivative [Line Items] Allowance for doubtful accounts Accounts Receivable, Allowance for Credit Loss, Current Pay vs Performance Disclosure [Line Items] Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Accounts receivable Increase (Decrease) in Accounts Receivable Derivative [Table] Derivative [Table] Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Hedging Relationship [Domain] Hedging Relationship [Domain] Fair Value Measurements Fair Value Disclosures [Text Block] Changes in unrealized (losses) gains from investments, net of tax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax Award Timing Disclosures [Line Items] Net Investment Hedging Relationships Net Investment Hedging [Member] Other Performance Measure, Amount Other Performance Measure, Amount Goodwill [Line Items] Goodwill [Line Items] Common stock, shares outstanding (in shares) Common Stock, Shares, Outstanding Other receivables Other Receivables, Net, Current Total borrowings Debt and Lease Obligation Total marketable securities Long-Term Marketable Securities [Member] Long-Term Marketable Securities Interest expense, net Interest expense, net Interest expense, net Interest Income (Expense), Operating Proceeds from sale of marketable securities Proceeds from Sale and Maturity of Marketable Securities Customer Three Customer Three [Member] Customer Three Operating lease liabilities Operating Lease, Liability, Noncurrent Revenue from Contract with Customer [Abstract] Revision of Prior Period, Reclassification, Adjustment Revision of Prior Period, Reclassification, Adjustment [Member] Other assets Other Assets, Noncurrent Entity Tax Identification Number Entity Tax Identification Number Schedule of Debt Schedule of Long-Term Debt Instruments [Table Text Block] Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Assets: Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract] Net cash (used for) provided by operating activities Net Cash Provided by (Used in) Operating Activities OPERATING ACTIVITIES Net Cash Provided by (Used in) Operating Activities [Abstract] Schedule of Currency Hedging Instruments Schedule of Derivative Instruments [Table Text Block] Schedule of Accumulated Other Comprehensive Income (Loss) Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Term Loan Secured Debt [Member] Other operating expenses Other Cost and Expense, Operating Prepaid expenses Prepaid Expense, Current Equity Components [Axis] Equity Components [Axis] Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Other Other Assets, Current Award Timing Method Award Timing Method [Text Block] Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Fair Value Debt Securities, Available-for-Sale Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments and Tax Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments and Tax Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Insider Trading Policies and Procedures [Line Items] Tax indemnification income Tax Indemnification Income (Expense) Tax Indemnification Income (Expense) Use of Estimates Use of Estimates, Policy [Policy Text Block] Other long-term borrowings Other Long-Term Debt, Noncurrent Adjustment to Compensation, Amount Adjustment to Compensation Amount Compensation Amount Outstanding Recovery Compensation Amount Segment Reconciliation [Abstract] Segment Reconciliation [Abstract] Credit Agreement amendment fees Line Of Credit Facility, Amendment Fee Amount Line Of Credit Facility, Amendment Fee Amount Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] Entity Small Business Entity Small Business Company Selected Measure Amount Company Selected Measure Amount Tabular List, Table Tabular List [Table Text Block] Level 3 Fair Value, Inputs, Level 3 [Member] Selling, marketing and administrative Selling and Marketing Expense [Member] Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Accounts Receivable, Net Accounts Receivable, Allowance for Credit Loss [Table Text Block] Potentially dilutive shares excluded from calculation due to anti-dilutive effect Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Schedule of Derivative Instruments, Effect on Other Comprehensive (Loss) Income Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss) [Table Text Block] Asset impairment charge Asset impairment charge Asset impairment charge Impairment of Long-Lived Assets to be Disposed of Assets Held for Sale Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] Credit Facility [Domain] Credit Facility [Domain] Cash, cash equivalents and restricted cash at beginning of period Cash, cash equivalents and restricted cash at end of period Cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Total marketable securities, current Short-Term Marketable Securities [Member] Short-Term Marketable Securities Current assets: Assets, Current [Abstract] Goodwill Balance at December 31, 2023 Balance at June 30, 2024 Goodwill Payments of tax withholdings related to vesting of stock-based awards Payment, Tax Withholding, Share-Based Payment Arrangement Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Product and Service [Domain] Product and Service [Domain] Employee Stock Option Share-Based Payment Arrangement, Option [Member] Foreign Exchange Forward Foreign Exchange Forward [Member] Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Collaborative Arrangement, Transaction with Party to Collaborative Arrangement and Third Party Collaborative Arrangement, Transaction with Party to Collaborative Arrangement and Third Party [Member] Marketable securities Marketable Securities, Current Statement [Table] Antidilutive Security, Excluded EPS Calculation [Table] Comprehensive (loss) income Comprehensive Income (Loss), Net of Tax, Attributable to Parent Income tax payable Accrued Income Taxes, Current Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding Security Exchange Name Security Exchange Name Award Type Award Type [Axis] Corporate bonds Corporate Debt Securities [Member] Foreign currency translation Goodwill, Foreign Currency Translation Gain (Loss) Interest Rate Swap Four Interest Rate Swap Four [Member] Interest Rate Swap Four Other Other [Member] Other nonreportable segments Interest Rate Swap Two Interest Rate Swap Two [Member] Interest Rate Swap Two Business Unit [Axis] Business Unit [Axis] Business Unit Work-in-process (materials, labor and overhead) Inventory, Work in Process, Net of Reserves Property, plant and equipment, net Property, Plant and Equipment, Net Payments of term loan Repayments of Debt Total liabilities Liabilities Customer One Customer One [Member] Customer One Cash, Cash Equivalents and Restricted Cash Schedule of Cash and Cash Equivalents [Table Text Block] Common stock, par value per share (in dollars per share) Common Stock, Par or Stated Value Per Share Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Research and development Research and Development Expense Revolving Credit Facility Revolving Credit Facility [Member] Expiration Date Trading Arrangement Expiration Date INVESTING ACTIVITIES Net Cash Provided by (Used in) Investing Activities [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Schedule of Derivative Assets at Fair Value Schedule of Derivative Assets at Fair Value [Table Text Block] Operating lease liabilities Operating Lease, Liability, Current Total Shareholder Return Amount Total Shareholder Return Amount Unamortized deferred financing costs Debt Issuance Costs, Noncurrent, Net Common stock, shares issued (in shares) Common Stock, Shares, Issued Other assets Other Assets [Member] Income taxes payable Increase (Decrease) in Income Taxes Payable Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] Line of credit, maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Percentage of risk concentration Concentration Risk, Percentage After June 30, 2023 to June 30, 2024 After June 30, 2023 to June 30, 2024 [Member] After June 30, 2023 to June 30, 2024 Derivative liabilities Derivative Liability Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Labs Labs [Member] Labs Amount of Loss (Gain) Recognized in OCI on Hedges Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax Debt Instrument [Line Items] Debt Instrument [Line Items] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Research and development Research and Development Expense [Member] Common stock, shares authorized (in shares) Common Stock, Shares Authorized Net change in operating lease right-of-use assets and liabilities Change in operating lease right-of-use assets and liabilities Change in operating lease right-of-use assets and liabilities EU medical device regulation transition costs EU medical device regulation transition costs EU medical device regulation transition costs Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Weighted-average shares outstanding - diluted Diluted weighted-average shares of common stock outstanding Weighted Average Number of Shares Outstanding, Diluted Other comprehensive (loss) income Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract] Other Nonoperating Income (Expense) Other Nonoperating Income (Expense) [Member] MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] Total stockholders’ equity Balance Balance Equity, Attributable to Parent Hedging Designation [Domain] Hedging Designation [Domain] Accrued commissions, rebates and returns Customer Incentive, Payable, Current Customer Incentive, Payable, Current Balance Sheet Location [Axis] Statement of Financial Position Location, Balance [Axis] Point of Care Point of Care [Member] Point of Care Amount of Loss (Gain) Reclassified From AOCI Into Income Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax Derivatives Derivative Asset, Current Goodwill Schedule of Goodwill [Table Text Block] Assets Held for Sale Property, Plant and Equipment Disclosure [Text Block] Concentration Risk Type [Domain] Concentration Risk Type [Domain] Selling, marketing and administrative Selling, General and Administrative Expense Net change Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Current portion of borrowings Debt, Current Molecular Diagnostics Molecular Diagnostics [Member] Molecular Diagnostics Accounts receivable, net Total accounts receivable, net Accounts Receivable, after Allowance for Credit Loss, Current Cost of sales, excluding amortization of intangibles Cost of Sales [Member] Statement [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Purchase of property, equipment and intangibles by incurring current liabilities Noncash or Part Noncash Acquisition, Fixed Assets Acquired Other current and non-current liabilities Increase (Decrease) in Other Operating Liabilities Assets held for sale Asset, Held-for-Sale, Not Part of Disposal Group, Current Tax impact related to cash flow hedges Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Document Fiscal Period Focus (Q1,Q2,Q3,FY) Document Fiscal Period Focus Integration related costs Integration related costs Business Combination, Acquisition Related Costs All Executive Categories All Executive Categories [Member] Dilutive potential shares issuable from stock options and RSUs Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements Accounts receivable Accounts Receivable, before Allowance for Credit Loss, Current Balance Sheet Location [Domain] Statement of Financial Position Location, Balance [Domain] Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Derivative instruments and other Derivative instruments and other Derivative instruments and other ASSETS Assets [Abstract] Fair Value, by Balance Sheet Grouping [Table] Fair Value, by Balance Sheet Grouping [Table] Other comprehensive income, net of tax Other Comprehensive Income (Loss), Net of Tax Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items] Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items] Document Type Document Type Derivative Contract [Domain] Derivative Contract [Domain] Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block] Reporting unit, estimated percentage of decrease in fair value (in percent) Reporting Unit, Percentage Of Decrease In Fair Value Reporting Unit, Percentage Of Decrease In Fair Value Schedule of Segment Reporting Information, by Segment Schedule of Segment Reporting Information, by Segment [Table Text Block] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Purchases of marketable securities Payments to Acquire Marketable Securities Amortized Cost Debt Securities, Available-for-Sale, Amortized Cost Total revenues Sales [Member] Maximum Maximum [Member] Amortization of intangible assets Amortization of Intangible Assets Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Accounts payable Accounts Payable, Current Accounting Policies [Abstract] Accounting Policies [Abstract] Current Fiscal Year End Date Current Fiscal Year End Date Statistical Measurement [Axis] Statistical Measurement [Axis] PEO Name PEO Name Collaborative Arrangement, Transaction with Party to Collaborative Arrangement Collaborative Arrangement, Transaction with Party to Collaborative Arrangement [Member] Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Loss before income taxes Loss before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest All Award Types Award Type [Domain] Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Name Outstanding Recovery, Individual Name Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Issuance of common stock under equity compensation plans (in shares) Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture Goodwill impairment charge Goodwill impairment charge Impairment charge Goodwill, Impairment Loss Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Revision of Prior Period [Axis] Revision of Prior Period [Axis] Deferred tax asset Deferred Income Tax Assets, Net Non-PEO NEO Non-PEO NEO [Member] Hedging Relationship [Axis] Hedging Relationship [Axis] Financing lease obligation Finance Lease, Liability, Noncurrent Award Timing Predetermined Award Timing Predetermined [Flag] Restricted cash included in Other assets Restricted Cash, Noncurrent Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Diluted loss per share Earnings Per Share, Diluted Customer Two Customer Two [Member] Customer Two Change in deferred tax assets and liabilities Increase (Decrease) In Deferred Tax Assets And Liabilities Increase (Decrease) In Deferred Tax Assets And Liabilities Name Measure Name Entity Interactive Data Current Entity Interactive Data Current Other adjustments Other adjustments Other adjustments Cash Flow Hedges Accumulated Gain (Loss), Cash Flow Hedge, Including Noncontrolling Interest [Member] Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Number of operating segments Number of Operating Segments Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Customer [Axis] Customer [Axis] Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Segment Adjusted EBITDA Segment Adjusted EBITDA Segment Adjusted EBITDA China China [Member] China Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Corporate asset-backed securities Asset-Backed Securities [Member] Stock-based compensation expense Share-Based Payment Arrangement, Noncash Expense Fair value gain (loss) on derivative instruments not designated as hedging instruments Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net Benefit from income taxes Income Tax Expense (Benefit) Derivative, Notional Amount Derivative, Notional Amount Derivative assets Derivative Asset SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION Supplemental Cash Flow Information [Abstract] Schedule of Net Investment Hedges Derivative Instruments, Gain (Loss) [Table Text Block] Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Interest Rate Swap Three Interest Rate Swap Three [Member] Interest Rate Swap Three After June 30, 2025 After June 30, 2025 [Member] After June 30, 2025 Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Effective income tax rate Effective Income Tax Rate Reconciliation, Percent Net cash used for investing activities Net Cash Provided by (Used in) Investing Activities Operating (loss) income Operating Income (Loss) Number of reportable segments Number of Reportable Segments Total liabilities and stockholders’ equity Liabilities and Equity Other non-cash, net Other Operating Activities, Cash Flow Statement Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] All Adjustments to Compensation All Adjustments to Compensation [Member] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Accrued payroll and related expenses Employee-related Liabilities, Current Additional paid-in capital Additional Paid in Capital Hedging Designation [Axis] Hedging Designation [Axis] Derivatives Derivative Liability, Current Marketable securities Marketable Securities, Noncurrent Derivative Instruments and Hedging Activities Derivative Instruments and Hedging Activities Disclosure [Text Block] Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Underlying Security Market Price Change Underlying Security Market Price Change, Percent Individual: Individual [Axis] Tax withholdings related to vesting of stock-based awards Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation Accumulated other comprehensive (loss) income AOCI Attributable to Parent [Member] Inventories Inventory, Net Respiratory Respiratory [Member] Respiratory Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Product and Service [Axis] Product and Service [Axis] Entity Address, State or Province Entity Address, State or Province Statement [Line Items] Statement [Line Items] Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative Instruments and Hedging Activities Disclosure [Abstract] Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Fair Value, Option, Eligible Item or Group Financial Instruments [Domain] LIABILITIES AND STOCKHOLDERS’ EQUITY Liabilities and Equity [Abstract] Employee compensation charges Employee Benefits and Share-Based Compensation Derivative, Fixed Interest Rate Derivative, Fixed Interest Rate Minimum Minimum [Member] Restatement Determination Date Restatement Determination Date Reclassification [Table] Reclassification [Table] Adoption Date Trading Arrangement Adoption Date Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Right-of-use assets Operating Lease, Right-of-Use Asset Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Business Unit [Domain] Business Unit [Domain] Business Unit [Domain] Segments [Axis] Segments [Axis] Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] Expected Value Contract Customers Expected Value Contract Customers [Member] Expected Value Contract Customers Derivative Instrument [Axis] Derivative Instrument [Axis] Prepaid Expenses and Other Current Assets Schedule of Other Current Assets [Table Text Block] Property, Plant and Equipment [Abstract] Long-term debt Long-Term Debt, Gross Exercise Price Award Exercise Price Inventories, including noncurrent portion, net Inventories, including noncurrent portion, net Inventories, including noncurrent portion, net Computation of Earnings Per Share Earnings Per Share [Text Block] Accrued payroll and related expenses Increase (Decrease) in Employee Related Liabilities Arrangement Duration Trading Arrangement Duration Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table] Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table] Goodwill and Intangible Assets, Net Goodwill and Intangible Assets Disclosure [Text Block] Net unrealized gains on derivative instruments Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax Stockholders’ equity: Equity, Attributable to Parent [Abstract] Marketable Securities [Table] Marketable Securities [Table] Schedule of Derivative Liabilities at Fair Value Schedule of Derivative Liabilities at Fair Value [Table Text Block] Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Segments [Domain] Segments [Domain] Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Credit Agreement Bank Of America Credit Facility [Member] Bank Of America Credit Facility All Individuals All Individuals [Member] Basis of Presentation and Summary of Significant Accounting Policies Basis of Presentation and Significant Accounting Policies [Text Block] Proceeds from lines of credit Proceeds from Lines of Credit PEO PEO [Member] Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Name Trading Arrangement, Individual Name Other expense, net Other Nonoperating Income (Expense) Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Intangible assets, net Intangible Assets, Net (Excluding Goodwill) Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax Number of stockholders that filed complaints Number Of Stockholders That Filed Complaints Number Of Stockholders That Filed Complaints Agency bonds Agency bonds [Member] Agency bonds Gain (loss) on investments Income (Loss) from Equity Method Investments Share-based liabilities paid Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Share-Based Liabilities Paid Prepaid expenses and other current and non-current assets Increase (Decrease) in Prepaid Expenses, Other Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Reduction of accrued payroll and related expenses upon issuance of restricted share units Stock Issued Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] Balance (in shares) Balance (in shares) Shares, Outstanding Decrease in unrecognized tax benefits is reasonably possible Decrease in Unrecognized Tax Benefits is Reasonably Possible Reporting unit, percentage of fair value in excess of carrying amount (in percent) Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Local Phone Number Local Phone Number Prepaid expenses and other current assets Prepaid Expenses and Other Current Assets [Member] On or Before June 30, 2023 On or Before June 30, 2023 [Member] On or Before June 30, 2023 Revolving credit facility, net Proceeds from (Repayments of) Lines of Credit Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Deferred tax liability Deferred Income Tax Liabilities, Net Amortization of deferred financing costs Debt Related Commitment Fees and Debt Issuance Costs Interest expense, net Interest Expense [Member] Changes in assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] PEO Total Compensation Amount PEO Total Compensation Amount Derivative Liability, Fair Value, Gross Liability Derivative Liability, Subject to Master Netting Arrangement, before Offset Income Statement Location [Axis] Statement of Income Location, Balance [Axis] Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Amortization of deferred cloud computing implementation costs Amortization of deferred cloud computing implementation costs Amortization of deferred cloud computing implementation costs Debt Disclosure [Abstract] Debt Disclosure [Abstract] Common Stock Common Stock [Member] Measure: Measure [Axis] Issuance of common stock under equity compensation plans Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Number of executive defendants Loss Contingency, Number Of Executive Defendants Loss Contingency, Number Of Executive Defendants Line of Credit Line of Credit [Member] Available-for-Sale Investments AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Including Noncontrolling Interest [Member] Unrecognized tax benefits, income tax interest and penalties accrued Unrecognized Tax Benefits, Income Tax Penalties Accrued Entity Emerging Growth Company Entity Emerging Growth Company Total liabilities measured at fair value Liabilities, Fair Value Disclosure Tax withholdings related to vesting of stock-based awards (in shares) Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation Entity Central Index Key Entity Central Index Key Inventories Schedule of Inventory, Current [Table Text Block] Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Foreign Currency Translation Adjustments Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Integration related costs Acquisition-related Costs [Member] Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Equity Component [Domain] Equity Component [Domain] Preferred stock, par value per share (in dollars per share) Preferred Stock, Par or Stated Value Per Share Eligible Item or Group for Fair Value Option Financial Instrument [Axis] Less: current portion Long-Term Debt, Current Maturities Segment and Geographic Information Segment Reporting Disclosure [Text Block] Transfusion Medicine Transfusion Medicine [Member] Transfusion Medicine Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Amounts reclassified to Net loss Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax Stock-based compensation expense APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Entity Shell Company Entity Shell Company Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Title Trading Arrangement, Individual Title Statement [Table] Statement [Table] Interest expense, debt Interest Expense, Debt Allowance for contract rebates and discounts Allowance for contract rebates and discounts Allowance for contract rebates and discounts Unrecognized tax benefits Unrecognized Tax Benefits City Area Code City Area Code Deferred revenue, revenue recognized Deferred Revenue, Revenue Recognized Current liabilities: Liabilities, Current [Abstract] Short-term borrowings, net Proceeds from (Repayments of) Short-Term Debt, Maturing in Three Months or Less Contingent consideration Business Combination, Contingent Consideration, Liability Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Level 1 Fair Value, Inputs, Level 1 [Member] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Principal payments of deferred consideration Payment On Acquisition Deferred Consideration Payment On Acquisition Deferred Consideration Changes in cumulative translation adjustment, net of tax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Additional paid-in capital Common Stock Including Additional Paid in Capital [Member] Total current assets Assets, Current Schedule of Interest Expense Interest Income and Interest Expense Disclosure [Table Text Block] Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] After June 30, 2024 to December 31, 2024 After June 30, 2024 to December 31, 2024 [Member] After June 30, 2024 to December 31, 2024 Revision of Prior Period [Domain] Revision of Prior Period [Domain] Remaining borrowing capacity Line of Credit Facility, Remaining Borrowing Capacity Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Marketable securities Marketable Securities Interest rate cash flow hedge, pre-tax gain (loss) from reclassification Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net Other short-term borrowings Other Short-Term Borrowings Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Income Taxes Income Tax Disclosure [Text Block] Earnings Per Share [Abstract] Earnings Per Share [Abstract] Equity [Abstract] Equity [Abstract] Accrued other taxes payable Accrual for Taxes Other than Income Taxes, Current Raw materials Inventory, Raw Materials, Net of Reserves Retained earnings Retained Earnings (Accumulated Deficit) Inventories Increase (Decrease) in Inventories Other liabilities Other Noncurrent Liabilities [Member] Sovereign government bonds Debt Security, Government, Non-US [Member] Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Payment of accreted interest on deferred consideration Payment Of Accreted Interest On Contingent Consideration Liability And Deferred Consideration, Operating Activities Payment Of Accreted Interest On Contingent Consideration Liability And Deferred Consideration, Operating Activities Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Equity Awards Adjustments Equity Awards Adjustments [Member] Net cash provided by (used for) financing activities Net Cash Provided by (Used in) Financing Activities Covenant Period [Domain] Covenant Period [Domain] Covenant Period [Domain] Underlying Securities Award Underlying Securities Amount Leverage ratio maximum Debt Instrument, Covenant, Leverage Ratio, Maximum Debt Instrument, Covenant, Leverage Ratio, Maximum Deferred revenue, current Deferred revenue Deferred Revenue, Current After December 31, 2024 to June 30, 2025 After December 31, 2024 to June 30, 2025 [Member] After December 31, 2024 to June 30, 2025 Credit Facility [Axis] Credit Facility [Axis] Interest income Interest Income, Other Amendment Flag Amendment Flag Long-term debt, fair value Long-Term Debt, Fair Value PotentialWeightedAverageNumberOfDilutedSharesOutstandingDiluted weighted-average shares of common stock outstanding Potential Dilutive Effect On Weighted Average Number Of Shares Outstanding PotentialWeightedAverageNumberOfDilutedSharesOutstanding Entity Registrant Name Entity Registrant Name Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Depreciation and amortization Depreciation and amortization Depreciation, Depletion and Amortization Gross Profit Gross Profit Fair Value as of Grant Date Award Grant Date Fair Value Customer Concentration Risk Customer Concentration Risk [Member] Current period deferrals Other Comprehensive Income (Loss), before Reclassifications, Net of Tax Level 2 Fair Value, Inputs, Level 2 [Member] Borrowings Debt Disclosure [Text Block] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Interest Rate Swap Five Interest Rate Swap Five [Member] Interest Rate Swap Five EMEA EMEA Segment [Member] EMEA Segment North America North America Segment [Member] North America Segment Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Disaggregation of Revenue Disaggregation of Revenue [Table Text Block] Contract assets Unbilled Contracts Receivable Entity Address, Postal Zip Code Entity Address, Postal Zip Code Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Compensation Expense Related to Stock-Based Compensation Plans Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Interest Rate Swap Interest Rate Swap [Member] Restatement Determination Date: Restatement Determination Date [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Title of 12(b) Security Title of 12(b) Security Concentration Risk Type [Axis] Concentration Risk Type [Axis] Common stock, $0.001 par value per share; 126.2 shares authorized; 67.1 and 66.7 shares issued and outstanding at June 30, 2024 and December 31, 2023, respectively Common Stock, Value, Issued Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Other payments Payments for (Proceeds from) Other Investing Activities Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] Foreign currency cash flow hedge, gain (loss) to be reclassified during next 12 months Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months Other current liabilities Other Current Liabilities [Member] Derivative Instruments and Hedging Activities Disclosures [Line Items] Derivative Instruments and Hedging Activities Disclosures [Line Items] FINANCING ACTIVITIES Net Cash Provided by (Used in) Financing Activities [Abstract] Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] Preferred stock, $0.001 par value per share; 5.0 shares authorized; none issued or outstanding at June 30, 2024 and December 31, 2023 Preferred Stock, Value, Issued Reporting unit, percentage of fair value in excess of carrying amount, adjusted for decrease (in percent) Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount, Adjusted For Decrease Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount, Adjusted For Decrease Customers With Balances Due In Excess of 10% Of Accounts Receivable Customers With Balances Due In Excess of 10% Of Accounts Receivable [Member] Customers With Balances Due In Excess of 10% Of Accounts Receivable Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Share-Based Payment Arrangement Share-Based Payment Arrangement [Member] Basic loss per share Earnings Per Share, Basic Accounts payable Increase (Decrease) in Accounts Payable Proceeds from issuance of common stock Proceeds from Issuance of Common Stock Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] Schedule of Goodwill [Table] Goodwill [Table] Designated cash flow hedges Designated as Hedging Instrument [Member] Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Total current liabilities Liabilities, Current Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] Total assets Assets Acquisitions of property, plant, equipment, investments and intangibles Payments to Acquire Property, Plant, and Equipment Other liabilities Other Liabilities, Noncurrent Cost of sales, excluding amortization of intangibles Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Derivative Instruments and Hedging Activities Disclosures [Table] Derivative Instruments and Hedging Activities Disclosures [Table] Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract] Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract] Commitments and contingencies (Note 11) Commitments and Contingencies Termination Date Trading Arrangement Termination Date Total revenues Revenues Interest coverage ratio, minimum Debt Instrument, Covenant, Interest Coverage Ratio, Minimum Debt Instrument, Covenant, Interest Coverage Ratio, Minimum Stock-based Compensation Share-Based Payment Arrangement [Text Block] Non-designated hedging instruments Not Designated as Hedging Instrument [Member] Interest Rate Swap One Interest Rate Swap One [Member] Interest Rate Swap One Revenue from External Customers by Geographic Areas Revenue from External Customers by Geographic Areas [Table Text Block] Entity Address, City or Town Entity Address, City or Town Debt Instrument [Axis] Debt Instrument [Axis] Total stock-based compensation expense Share-Based Payment Arrangement, Expense Net loss Net loss Net loss Net Income (Loss) Attributable to Parent Trading Arrangement: Trading Arrangement [Axis] Revenue Revenue from Contract with Customer, Including Assessed Tax Income taxes and other tax receivables Income Tax Receivables And Other Tax Receivables, Current Income Tax Receivables And Other Tax Receivables, Current Accumulated Other Comprehensive Loss Comprehensive Income (Loss) Note [Text Block] Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] Entity File Number Entity File Number Liabilities: Liabilities, Fair Value Disclosure [Abstract] Total change in unrealized gains from cash flow hedges, net of tax Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax Revenue Revenue from Contract with Customer [Text Block] Document Fiscal Year Focus Document Fiscal Year Focus Income Statement [Abstract] Income Statement [Abstract] Entity Address, Address Line One Entity Address, Address Line One Product Concentration Risk Product Concentration Risk [Member] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Effect of exchange rates on cash Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations Total assets measured at fair value Assets, Fair Value Disclosure Other Other Accrued Liabilities, Current Name Forgone Recovery, Individual Name Document Period End Date Document Period End Date Deferred revenue, noncurrent Deferred Revenue, Noncurrent Schedule of Interest Rate Derivatives Schedule of Interest Rate Derivatives [Table Text Block] Finished goods (materials, labor and overhead) Inventory, Finished Goods, Net of Reserves Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Insider Trading Arrangements [Line Items] Balance Sheet Account Details Supplemental Balance Sheet Disclosures [Text Block] Contract assets Contract with Customer, Asset, after Allowance for Credit Loss Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Indemnification receivable Indemnification Receivable Indemnification Receivable PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Accrued interest Interest and Dividends Payable Marketable Securities Marketable Securities [Table Text Block] Adjustment to Compensation: Adjustment to Compensation [Axis] Prepaid expenses and other current assets Total prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Accounts Receivable Accounts Receivable [Member] Foreign exchange contracts Foreign Exchange Contract [Member] Reclassifications Reclassification, Comparability Adjustment [Policy Text Block] Document Transition Report Document Transition Report Document Quarterly Report Document Quarterly Report Reclassification of net realized gains on derivative instruments included in net income Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax Corporate Corporate Adjusted EBITDA Corporate Adjusted EBITDA Customer [Domain] Customer [Domain] Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Entity Current Reporting Status Entity Current Reporting Status Retained earnings Retained Earnings [Member] Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] Industry And Geographic Information [Abstract] Industry And Geographic Information [Abstract] Industry and Geographic Information [Abstract] Weighted-average shares outstanding - basic Basic weighted-average shares of common stock outstanding Weighted Average Number of Shares Outstanding, Basic Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Inventory, Noncurrent Inventory, Noncurrent Marketable Securities [Line Items] Marketable Securities [Line Items] Beginning balance Ending balance Equity, Including Portion Attributable to Noncontrolling Interest OCI, foreign currency transaction and translation gain (loss), arising during period, tax OCI, Foreign Currency Transaction and Translation Gain (Loss), Arising During Period, Tax Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Executive Category: Executive Category [Axis] Name Awards Close in Time to MNPI Disclosures, Individual Name Revenue Benchmark Revenue Benchmark [Member] Entity Filer Category Entity Filer Category Other Current Liabilities Other Current Liabilities [Table Text Block] Income Statement Location [Domain] Statement of Income Location, Balance [Domain] Proceeds from government assistance allocated to fixed assets Proceeds from Contribution in Aid of Construction, Investing Activity Letter of Credit Letter of Credit [Member] Company Selected Measure Name Company Selected Measure Name EX-101.PRE 10 qdel-20240630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 12 R1.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Cover Page - shares
 6 Months Ended
Jun. 30, 2024
Jul. 24, 2024
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Jun. 30, 2024  
Document Transition Report false  
Entity File Number 001-41409  
Entity Registrant Name QUIDELORTHO CORP  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 87-4496285  
Entity Address, Address Line One 9975 Summers Ridge Road  
Entity Address, City or Town San Diego  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 92121  
City Area Code 858  
Local Phone Number 552-1100  
Title of 12(b) Security Common Stock, $0.001 Par Value  
Trading Symbol QDEL  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   67,235,394
Entity Central Index Key 0001906324  
Current Fiscal Year End Date --12-29  
Document Fiscal Year Focus 2024  
Document Fiscal Period Focus (Q1,Q2,Q3,FY) Q2  
Amendment Flag false  
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Millions
Jun. 30, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 107.0 $ 118.9
Marketable securities 0.0 48.4
Accounts receivable, net 269.5 303.3
Inventories 602.0 577.8
Prepaid expenses and other current assets 310.0 262.1
Assets held for sale 52.8 0.0
Total current assets 1,341.3 1,310.5
Property, plant and equipment, net 1,326.7 1,443.8
Marketable securities 0.0 7.4
Right-of-use assets 177.2 169.6
Goodwill 732.5 2,492.0
Intangible assets, net 2,836.0 2,934.3
Deferred tax asset 24.7 25.9
Other assets 250.8 179.6
Total assets 6,689.2 8,563.1
Current liabilities:    
Accounts payable 237.4 294.8
Accrued payroll and related expenses 86.0 84.8
Income tax payable 3.5 11.1
Current portion of borrowings 356.4 139.8
Other current liabilities 249.1 303.3
Total current liabilities 932.4 833.8
Operating lease liabilities 177.7 172.8
Long-term borrowings 2,207.2 2,274.8
Deferred tax liability 127.9 192.2
Other liabilities 70.5 83.6
Total liabilities 3,515.7 3,557.2
Commitments and contingencies (Note 11)
Stockholders’ equity:    
Preferred stock, $0.001 par value per share; 5.0 shares authorized; none issued or outstanding at June 30, 2024 and December 31, 2023 0.0 0.0
Common stock, $0.001 par value per share; 126.2 shares authorized; 67.1 and 66.7 shares issued and outstanding at June 30, 2024 and December 31, 2023, respectively 0.1 0.1
Additional paid-in capital 2,863.9 2,848.0
Accumulated other comprehensive loss (24.6) (30.0)
Retained earnings 334.1 2,187.8
Total stockholders’ equity 3,173.5 5,005.9
Total liabilities and stockholders’ equity $ 6,689.2 $ 8,563.1
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares
Jun. 30, 2024
Dec. 31, 2023
Statement of Financial Position [Abstract]    
Preferred stock, par value per share (in dollars per share) $ 0.001 $ 0.001
Preferred stock, shares authorized (in shares) 5,000,000.0 5,000,000.0
Preferred stock, shares issued (in shares) 0 0
Preferred stock, shares outstanding (in shares) 0 0
Common stock, par value per share (in dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized (in shares) 126,200,000 126,200,000
Common stock, shares issued (in shares) 67,100,000 66,700,000
Common stock, shares outstanding (in shares) 67,100,000 66,700,000
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Consolidated Statements of Loss (Unaudited) - USD ($)
shares in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Jul. 02, 2023
Jun. 30, 2024
Jul. 02, 2023
Income Statement [Abstract]        
Total revenues $ 637,000,000.0 $ 665,100,000 $ 1,348,000,000 $ 1,511,200,000
Cost of sales, excluding amortization of intangibles 361,000,000.0 368,600,000 739,900,000 766,100,000
Selling, marketing and administrative 188,200,000 179,100,000 392,900,000 381,500,000
Research and development 56,300,000 62,400,000 115,500,000 124,200,000
Amortization of intangible assets 51,900,000 51,400,000 103,600,000 102,200,000
Integration related costs 30,900,000 24,200,000 53,500,000 53,900,000
Goodwill impairment charge 0 0 1,743,900,000 0
Asset impairment charge 56,900,000 500,000 56,900,000 1,000,000.0
Other operating expenses 9,300,000 5,800,000 17,300,000 9,600,000
Operating (loss) income (117,500,000) (26,900,000) (1,875,500,000) 72,700,000
Interest expense, net 41,000,000.0 36,500,000 80,000,000.0 73,200,000
Other expense, net 4,400,000 1,000,000.0 6,300,000 3,900,000
Loss before income taxes (162,900,000) (64,400,000) (1,961,800,000) (4,400,000)
Benefit from income taxes (15,200,000) (11,200,000) (108,100,000) 0
Net loss $ (147,700,000) $ (53,200,000) $ (1,853,700,000) $ (4,400,000)
Basic loss per share $ (2.20) $ (0.80) $ (27.67) $ (0.07)
Diluted loss per share $ (2.20) $ (0.80) $ (27.67) $ (0.07)
Weighted-average shares outstanding - basic 67.1 66.8 67.0 66.7
Weighted-average shares outstanding - diluted 67.1 66.8 67.0 66.7
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Consolidated Statements of Comprehensive (Loss) Income (Unaudited) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Jul. 02, 2023
Jun. 30, 2024
Jul. 02, 2023
Statement of Comprehensive Income [Abstract]        
Net loss $ (147.7) $ (53.2) $ (1,853.7) $ (4.4)
Other comprehensive (loss) income        
Changes in cumulative translation adjustment, net of tax (5.3) 7.4 (26.1) 38.1
Changes in unrealized (losses) gains from investments, net of tax 0.0 (0.1) 0.0 0.1
Net unrealized gains on derivative instruments 13.1 40.0 43.6 23.1
Reclassification of net realized gains on derivative instruments included in net income (6.2) (4.3) (12.1) (10.0)
Total change in unrealized gains from cash flow hedges, net of tax 6.9 35.7 31.5 13.1
Comprehensive (loss) income $ (146.1) $ (10.2) $ (1,848.3) $ 46.9
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
shares in Millions, $ in Millions
Total
Common Stock
Additional paid-in capital
Accumulated other comprehensive (loss) income
Retained earnings
Balance (in shares) at Jan. 01, 2023   66.4      
Balance at Jan. 01, 2023 $ 4,934.6 $ 0.0 $ 2,804.3 $ (67.6) $ 2,197.9
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock under equity compensation plans (in shares)   0.3      
Issuance of common stock under equity compensation plans 3.9 $ 0.1 3.8    
Stock-based compensation expense 10.4   10.4    
Tax withholdings related to vesting of stock-based awards (in shares)   (0.1)      
Tax withholdings related to vesting of stock-based awards (9.5)   (9.5)    
Other comprehensive income, net of tax 8.3     8.3  
Net loss 48.8       48.8
Balance (in shares) at Apr. 02, 2023   66.6      
Balance at Apr. 02, 2023 4,996.5 $ 0.1 2,809.0 (59.3) 2,246.7
Balance (in shares) at Jan. 01, 2023   66.4      
Balance at Jan. 01, 2023 4,934.6 $ 0.0 2,804.3 (67.6) 2,197.9
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (4.4)        
Balance (in shares) at Jul. 02, 2023   66.8      
Balance at Jul. 02, 2023 5,002.5 $ 0.1 2,825.2 (16.3) 2,193.5
Balance (in shares) at Apr. 02, 2023   66.6      
Balance at Apr. 02, 2023 4,996.5 $ 0.1 2,809.0 (59.3) 2,246.7
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock under equity compensation plans (in shares)   0.2      
Issuance of common stock under equity compensation plans 5.5   5.5    
Stock-based compensation expense 13.7   13.7    
Tax withholdings related to vesting of stock-based awards (3.0)   (3.0)    
Other comprehensive income, net of tax 43.0     43.0  
Net loss (53.2)       (53.2)
Balance (in shares) at Jul. 02, 2023   66.8      
Balance at Jul. 02, 2023 5,002.5 $ 0.1 2,825.2 (16.3) 2,193.5
Balance (in shares) at Dec. 31, 2023   66.7      
Balance at Dec. 31, 2023 5,005.9 $ 0.1 2,848.0 (30.0) 2,187.8
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock under equity compensation plans (in shares)   0.2      
Issuance of common stock under equity compensation plans 0.8   0.8    
Stock-based compensation expense 9.0   9.0    
Tax withholdings related to vesting of stock-based awards (in shares)   (0.1)      
Tax withholdings related to vesting of stock-based awards (5.8)   (5.8)    
Other comprehensive income, net of tax 3.8     3.8  
Net loss (1,706.0)       (1,706.0)
Balance (in shares) at Mar. 31, 2024   66.8      
Balance at Mar. 31, 2024 3,307.7 $ 0.1 2,852.0 (26.2) 481.8
Balance (in shares) at Dec. 31, 2023   66.7      
Balance at Dec. 31, 2023 5,005.9 $ 0.1 2,848.0 (30.0) 2,187.8
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (1,853.7)        
Balance (in shares) at Jun. 30, 2024   67.1      
Balance at Jun. 30, 2024 3,173.5 $ 0.1 2,863.9 (24.6) 334.1
Balance (in shares) at Mar. 31, 2024   66.8      
Balance at Mar. 31, 2024 3,307.7 $ 0.1 2,852.0 (26.2) 481.8
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock under equity compensation plans (in shares)   0.4      
Issuance of common stock under equity compensation plans 4.1   4.1    
Stock-based compensation expense 10.3   10.3    
Tax withholdings related to vesting of stock-based awards (in shares)   (0.1)      
Tax withholdings related to vesting of stock-based awards (2.5)   (2.5)    
Other comprehensive income, net of tax 1.6     1.6  
Net loss (147.7)       (147.7)
Balance (in shares) at Jun. 30, 2024   67.1      
Balance at Jun. 30, 2024 $ 3,173.5 $ 0.1 $ 2,863.9 $ (24.6) $ 334.1
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Millions
 6 Months Ended
Jun. 30, 2024
Jul. 02, 2023
OPERATING ACTIVITIES    
Net loss $ (1,853.7) $ (4.4)
Adjustments to reconcile net loss to net cash (used for) provided by operating activities:    
Depreciation and amortization 231.0 228.7
Goodwill impairment charge 1,743.9 0.0
Asset impairment charge 56.9 1.0
Stock-based compensation expense 20.2 25.2
Net change in operating lease right-of-use assets and liabilities 0.1 0.2
Change in deferred tax assets and liabilities (73.6) 0.6
Payment of accreted interest on deferred consideration 0.0 (9.7)
Other non-cash, net (7.4) (2.3)
Changes in assets and liabilities:    
Accounts receivable 24.2 214.5
Inventories (95.2) (86.0)
Prepaid expenses and other current and non-current assets (11.7) (37.8)
Accounts payable (23.9) (35.0)
Accrued payroll and related expenses 2.6 (57.0)
Income taxes payable (58.2) (46.3)
Other current and non-current liabilities (53.8) (33.4)
Net cash (used for) provided by operating activities (98.6) 158.3
INVESTING ACTIVITIES    
Acquisitions of property, plant, equipment, investments and intangibles (101.4) (117.3)
Proceeds from government assistance allocated to fixed assets 0.0 2.8
Purchases of marketable securities (7.2) (50.6)
Proceeds from sale of marketable securities 63.1 53.9
Other payments (10.0) 0.0
Net cash used for investing activities (55.5) (111.2)
FINANCING ACTIVITIES    
Proceeds from issuance of common stock 4.6 7.3
Short-term borrowings, net (1.6) 0.0
Revolving credit facility, net 253.0 0.0
Payments on long-term borrowings (103.7) (123.8)
Payments of tax withholdings related to vesting of stock-based awards (8.3) (12.5)
Principal payments of deferred consideration 0.0 (30.3)
Net cash provided by (used for) financing activities 144.0 (159.3)
Effect of exchange rates on cash (1.9) (2.1)
Net decrease in cash, cash equivalents and restricted cash (12.0) (114.3)
Cash, cash equivalents and restricted cash at beginning of period 119.5 293.9
Cash, cash equivalents and restricted cash at end of period 107.5 179.6
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION    
Purchase of property, equipment and intangibles by incurring current liabilities 9.6 18.6
Transfer of instrument inventories to fixed assets 69.2 67.3
Reduction of accrued payroll and related expenses upon issuance of restricted share units $ 0.3 $ 1.9
XML 19 R8.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Basis of Presentation and Summary of Significant Accounting Policies
 6 Months Ended
Jun. 30, 2024
Accounting Policies [Abstract]  
Basis of Presentation and Summary of Significant Accounting Policies Basis of Presentation and Summary of Significant Accounting Policies
Basis of Presentation
The accompanying unaudited Consolidated Financial Statements of QuidelOrtho Corporation and its subsidiaries (the “Company” or “QuidelOrtho”) have been prepared in accordance with GAAP for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation (consisting of normal recurring accruals) have been included. Refer to the Summary of Abbreviated Terms at the end of this Quarterly Report for definitions of terms used throughout the document.
The information at June 30, 2024, and for the three and six months ended June 30, 2024 and July 2, 2023, is unaudited. For further information, refer to the Company’s Consolidated Financial Statements and notes thereto for the fiscal year ended December 31, 2023 included in QuidelOrtho’s Annual Report. Operating results for any quarter are historically seasonal in nature and are not necessarily indicative of the results expected for the full year.
The Company follows the concept of a fiscal year that ends on the Sunday nearest to the end of the month of December, and fiscal quarters that end on the Sunday nearest to the end of the months of March, June and September. For 2024 and 2023, the Company’s fiscal year will end or has ended on December 29, 2024 and December 31, 2023, respectively. For 2024 and 2023, the Company’s second quarter ended on June 30, 2024 and July 2, 2023, respectively. The three and six months ended June 30, 2024 and July 2, 2023 each included 13 and 26 weeks, respectively.
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and the related disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Reclassifications
Certain reclassifications have been made to prior periods amounts to conform to the current period presentation. Such amounts include a reclassification of $0.5 million and $1.0 million recognized in the three and six months ended July 2, 2023, respectively, related to impairment of long-lived assets from (i) Cost of sales, excluding amortization of intangibles (excludes $0.1 million for both the three and six months ended July 2, 2023), and (ii) Research and development (excludes $0.4 million and $0.9 million for the three and six months ended July 2, 2023, respectively), to Asset impairment charge.
The reclassifications did not have an impact on the Company’s previously reported Consolidated Balance Sheets, Consolidated Statements of Comprehensive (Loss) Income, Consolidated Statements of Stockholders’ Equity or Consolidated Statements of Cash Flows.
Recent Accounting Pronouncements
There have been no accounting pronouncements issued or adopted during the six months ended June 30, 2024 that are expected to have a material impact on the Company’s Consolidated Financial Statements.
XML 20 R9.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Computation of Earnings Per Share
 6 Months Ended
Jun. 30, 2024
Earnings Per Share [Abstract]  
Computation of Earnings Per Share Computation of Earnings Per Share
The following table presents the calculation of the weighted-average shares used in computing basic and diluted EPS in the respective periods:
Three Months EndedSix Months Ended
(In millions)June 30, 2024July 2, 2023June 30, 2024July 2, 2023
Basic weighted-average shares of common stock outstanding67.1 66.8 67.0 66.7 
Dilutive potential shares issuable from stock options and RSUs(1)
— — — — 
Diluted weighted-average shares of common stock outstanding67.1 66.8 67.0 66.7 
(1) In the three and six months ended June 30, 2024 and July 2, 2023, all potential shares of common stock issuable for stock options and RSUs were excluded from the dilutive calculations above because the effect of including them would have been anti-dilutive. The dilutive
effect of potential shares of common stock issuable for stock options and RSUs on the weighted-average number of shares of common stock outstanding would have been as follows:
Three Months EndedSix Months Ended
(In millions)June 30, 2024July 2, 2023June 30, 2024July 2, 2023
Basic weighted-average shares of common stock outstanding67.1 66.8 67.0 66.7 
Dilutive potential shares issuable from stock options and RSUs0.2 0.4 0.3 0.5 
Diluted weighted-average shares of common stock outstanding67.3 67.2 67.3 67.2 
Stock options and RSUs where the combined exercise price and unrecognized stock-based compensation was greater than the average market price for the Company’s common stock were not included in the computations of diluted weighted-average shares because the effect would have been anti-dilutive under the treasury stock method. These stock options and RSUs represented 2.1 million shares of common stock for both the three and six months ended June 30, 2024, and 1.2 million and 1.1 million shares of common stock for the three and six months ended July 2, 2023, respectively.
XML 21 R10.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Revenue
 6 Months Ended
Jun. 30, 2024
Revenue from Contract with Customer [Abstract]  
Revenue Revenue
Contract Balances
Timing of revenue recognition may differ from timing of invoicing to customers. The Company records an asset when revenue is recognized prior to invoicing a customer (a “contract asset”). Contract assets are included within Prepaid expenses and other current assets in the Company’s Consolidated Balance Sheets and are transferred to accounts receivable when the right to payment becomes unconditional. The balance of contract assets recorded in the Company’s Consolidated Balance Sheets as of June 30, 2024 and December 31, 2023 was $44.1 million and $46.2 million, respectively.
The contract asset balance consisted of the following components:
•a customer supply agreement under which the difference between the timing of invoicing and revenue recognition resulted in a contract asset of $1.9 million as of December 31, 2023. There was no contract asset remaining as of June 30, 2024;
•contractual arrangements with certain customers under which the Company invoices the customers based on reportable results generated by its reagents; however, control of the goods transfers to the customers upon shipment or delivery of the products, as determined under the terms of the contract. Using the expected value method, the Company estimates the number of reagents that will generate a reportable result. The Company records the revenue upon shipment and an associated contract asset, and relieves the contract asset upon completion of the invoicing. The balance of the contract asset related to these arrangements was $44.1 million and $41.8 million as of June 30, 2024 and December 31, 2023, respectively; and
•one of the Company’s contract manufacturing agreements that recognizes revenue as the products are manufactured resulted in a contract asset of $2.5 million as of December 31, 2023. There was no contract asset remaining as of June 30, 2024.
The Company reviews contract assets for expected credit losses resulting from the collectability of customer accounts. Expected losses are established based on historical losses, customer mix and credit policies, current economic conditions in customers’ country or industry, and expectations associated with reasonable and supportable forecasts. No credit losses related to contract assets were recognized during the three and six months ended June 30, 2024 and July 2, 2023.
The Company recognizes a contract liability when a customer pays an invoice prior to the Company transferring control of the goods or services (“contract liabilities”). The Company’s contract liabilities consist of deferred revenue primarily related to customer service contracts. The Company classifies deferred revenue as current or non-current based on the timing of the transfer of control or performance of the service. The balance of the Company’s current deferred revenue was $40.1 million and $36.8 million as of June 30, 2024 and December 31, 2023, respectively, and was included in Other current liabilities in the Consolidated Balance Sheets. The Company has one arrangement with a customer where the revenue is expected to be recognized beyond one year. The balance of the deferred revenue included in long-term liabilities was $15.9 million and $13.9 million as of June 30, 2024 and December 31, 2023, respectively, and was included in Other liabilities in the Consolidated Balance Sheets. The amount of deferred revenue as of December 31, 2023 that was recorded in Total revenues during the three and six months ended June 30, 2024 was $9.2 million and $27.0 million, respectively.
Joint Business with Grifols
The Company has an ongoing Joint Business between Ortho and Grifols, under which Ortho and Grifols agreed to pursue a collaboration relating to Ortho’s Hepatitis and HIV diagnostics business. The governance of the Joint Business is shared
through a supervisory board made up of equal representation by Ortho and Grifols, which is responsible for all significant decisions relating to the Joint Business that are not exclusively assigned to either Ortho or Grifols, as defined in the Joint Business agreement. The Company’s portion of the pre-tax net profit shared under the Joint Business was $8.9 million and $17.0 million during the three and six months ended June 30, 2024, respectively, and $6.1 million and $29.7 million during the three and six months ended July 2, 2023, respectively. These amounts included the Company’s portion of the pre-tax net profit of $6.5 million and $11.5 million during the three and six months ended June 30, 2024, respectively, and $5.5 million and $6.7 million during the three and six months ended July 2, 2023, respectively, on sales transactions with third parties where the Company is the principal. The Company recognized revenues, cost of sales, excluding amortization of intangibles, and operating expenses, on a gross basis on these sales transactions in their respective lines in the Consolidated Statements of Loss. The Company’s portion of the pre-tax net profit also included revenue from collaboration and royalty agreements of $2.4 million and $5.5 million during the three and six months ended June 30, 2024, respectively, and $0.6 million and $23.0 million during the three and six months ended July 2, 2023, respectively, which is presented on a net basis within Total revenues.
Disaggregation of Revenue
The following table summarizes Total revenues by business unit:
Three Months EndedSix Months Ended
(In millions)June 30, 2024July 2, 2023June 30, 2024July 2, 2023
Labs$354.2 $361.4 $711.1 $732.1 
Transfusion Medicine161.3 163.3 321.6 319.2 
Point of Care117.1 134.2 303.7 442.3 
Molecular Diagnostics4.4 6.2 11.6 17.6 
Total revenues$637.0 $665.1 $1,348.0 $1,511.2 
Concentration of Revenue and Credit Risk
For the six months ended June 30, 2024, one customer represented 11% of Total revenues. For the six months ended July 2, 2023, no customers individually accounted for more than 10% of Total revenues.
As of June 30, 2024, no customers had a balance due in excess of 10% of Accounts receivable, net. As of December 31, 2023, customers with a balance due in excess of 10% of Accounts receivable, net totaled $63.5 million. Revenue related to the Company’s respiratory products accounted for 9% and 14% of Total revenues for the three and six months ended June 30, 2024, respectively, and 13% and 23% for the three and six months ended July 2, 2023, respectively.
XML 22 R11.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Segment and Geographic Information
 6 Months Ended
Jun. 30, 2024
Industry And Geographic Information [Abstract]  
Segment and Geographic Information Segment and Geographic Information
The Company operates in three geographically-based reportable segments: North America, EMEA and China.
Effective January 1, 2024, Japan and Asia Pacific operating segments were combined into one operating segment: JPAC. The CODM reviews the Company’s performance and allocates resources based on five operating segments: North America, EMEA, China, Latin America and JPAC. North America, EMEA and China are the Company’s reportable segments; Latin America and JPAC are immaterial operating segments that are not considered reportable segments and are included in “Other.”
Total revenues by reportable segment are as follows:
Three Months EndedSix Months Ended
(In millions)June 30, 2024July 2, 2023June 30, 2024July 2, 2023
North America$350.1 $378.8 $784.0 $961.6 
EMEA81.1 80.6 165.9 161.9 
China81.6 81.3 157.7 151.9 
Other124.2 124.4 240.4 235.8 
Total revenues$637.0 $665.1 $1,348.0 $1,511.2 
The following table sets forth Adjusted EBITDA by segment and the reconciliations to Loss before income taxes for the three and six months ended June 30, 2024 and July 2, 2023:
Three Months EndedSix Months Ended
(In millions)June 30, 2024July 2, 2023June 30, 2024July 2, 2023
North America$173.9 $176.3 $392.7 $454.7 
EMEA11.4 5.3 24.2 12.5 
China35.8 30.2 60.5 58.7 
Other34.1 36.3 66.1 58.1 
Total segment Adjusted EBITDA255.2 248.1 543.5 584.0 
Corporate (1)
(165.3)(134.8)(321.6)(225.4)
Interest expense, net(41.0)(36.5)(80.0)(73.2)
Depreciation and amortization(116.1)(114.5)(231.0)(228.7)
Integration related costs(30.9)(24.2)(53.5)(53.9)
Goodwill impairment charge— — (1,743.9)— 
Asset impairment charge(56.9)(0.5)(56.9)(1.0)
Credit Agreement amendment fees (4.0)— (4.0)— 
Amortization of deferred cloud computing implementation costs(3.0)(1.5)(5.9)(3.1)
EU medical device regulation transition costs (2)
(0.5)(0.7)(1.1)(1.5)
Employee compensation charges— — (5.6)— 
Tax indemnification income— 0.4 — 0.1 
Gain (loss) on investments0.7 (0.2)— (0.2)
Other adjustments(1.1)— (1.8)(1.5)
Loss before income taxes$(162.9)$(64.4)$(1,961.8)$(4.4)
(1) Primarily consists of costs related to executive and staff functions, including certain finance, human resources, manufacturing and IT functions, which benefit the Company as a whole. These costs are primarily related to the general management of these functions on a corporate level and the design and development of programs, policies and procedures that are then implemented in the individual segments, with each segment bearing its own cost of implementation. The Company’s corporate function also includes debt and stock-based compensation associated with all employee stock-based awards.
(2) Represents incremental consulting costs and R&D manufacturing site costs to align compliance of the Company’s existing, on-market products that were previously registered under the European In Vitro Diagnostics Directive regulatory framework with the requirements under the EU’s In Vitro Diagnostic Regulation, which generally apply from May 2022 onwards.
The CODM does not review capital expenditures, total depreciation and amortization or assets by segment, and therefore this information has been excluded as it does not comprise part of management’s key performance metrics.
XML 23 R12.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Income Taxes
 6 Months Ended
Jun. 30, 2024
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
The Company calculates its interim income tax provision in accordance with ASC 270, Interim Reporting, and ASC 740, Accounting for Income Taxes. At the end of each interim period, the Company estimates its annual effective tax rate and applies that rate to its ordinary quarterly earnings to calculate the tax related to ordinary income. The tax effects for other items that are excluded from ordinary income are discretely calculated and recognized in the period in which they occur.
For the three months ended June 30, 2024, the Company recognized an income tax benefit of $15.2 million in relation to loss before income taxes of $162.9 million, resulting in an effective benefit tax rate of 9.3%. For the three months ended July 2, 2023, the Company recognized an income tax benefit of $11.2 million in relation to loss before income taxes of $64.4 million, resulting in an effective benefit tax rate of 17.4%. For the three months ended June 30, 2024, the effective tax rate differed from the U.S. federal statutory rate primarily due to Subpart F income and the Base Erosion and Anti-Abuse Tax liability. For the three months ended July 2, 2023, the effective tax rate differed from the U.S. federal statutory rate primarily due to non-U.S. earnings being taxed at rates that were different than the U.S. statutory rate, operating losses in certain subsidiaries not being benefited due to the establishment of valuation allowances, R&D credits and foreign tax credits, partially offset by foreign exchange losses and the Global Intangible Low-Tax Income.
For the six months ended June 30, 2024, the Company recognized an income tax benefit of $108.1 million in relation to loss before income taxes of $1,961.8 million, resulting in an effective tax rate of 5.5%. For the six months ended July 2, 2023, the recognized amount of income tax benefit was not material in relation to loss before income taxes of $4.4 million, resulting in an effective benefit tax rate of 0.7%. For the six months ended June 30, 2024, the effective tax rate differed from the U.S. federal statutory rate primarily due to goodwill impairment charges that are nondeductible for tax purposes. For the six months ended July 2, 2023, the effective tax rate differed from the U.S. federal statutory rate primarily due to net operating losses in certain subsidiaries not being benefited due to the establishment of valuation allowances and the Global Intangible Low-Tax Income, partially offset by U.S. earnings being taxed at rates that were different than the U.S. statutory rate, R&D credits, foreign tax credits and foreign exchange losses.
The balance of unrecognized tax benefits at June 30, 2024, not including interest and penalties, was $29.3 million, of which $22.0 million could affect the effective income tax rate in future periods, if recognized. The Company also recognizes interest and penalties related to unrecognized tax benefits in tax expense. At June 30, 2024, the Company had approximately $4.1 million of interest and penalties accrued related to unrecognized tax benefits. The Company estimates that within the next 12 months, its uncertain tax positions, excluding interest, should decrease by $11.7 million.
The Company is subject to periodic audits by domestic and foreign tax authorities. Due to the carryforward of unutilized credits, the Company’s federal tax years from 2012 and onwards are subject to examination by the U.S. authorities. The Company’s state and foreign tax years for 2001 and onwards are subject to examination by applicable tax authorities. The Company believes that it has appropriate support for the income tax positions taken on its tax returns and that its accruals for tax liabilities are adequate for all open years based on an assessment of many factors, including past experience and interpretations of tax laws applied to the facts of each matter.
Indemnification Assets
Ortho is currently under audit in certain jurisdictions for tax years under the responsibility of Johnson & Johnson. Pursuant to the stock and asset purchase agreement entered into by Ortho and Johnson & Johnson in January 2014, Johnson & Johnson retained all income tax liabilities accrued as of the date of acquisition, including reserves for unrecognized tax benefits. Accordingly, all tax liabilities related to these tax years are required to be indemnified by Johnson & Johnson. The indemnification receivable from Johnson & Johnson totaled $3.0 million as of June 30, 2024 and December 31, 2023, and is included as a component of Prepaid expenses and other current assets on the Consolidated Balance Sheet.
XML 24 R13.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Balance Sheet Account Details
 6 Months Ended
Jun. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Balance Sheet Account Details Balance Sheet Account Details
Cash, Cash Equivalents and Restricted Cash
(In millions)June 30, 2024December 31, 2023
Cash and cash equivalents$107.0 $118.9 
Restricted cash included in Other assets0.5 0.6 
Cash, cash equivalents and restricted cash$107.5 $119.5 
Marketable Securities
The Company had no marketable securities outstanding as of June 30, 2024. The following table is a summary of marketable securities as of December 31, 2023:
December 31, 2023
(In millions)Amortized CostGross Unrealized LossesFair Value
Corporate bonds$38.1 $(0.1)$38.0 
Corporate asset-backed securities8.9 — 8.9 
Agency bonds1.5 — 1.5 
Total marketable securities, current48.5 (0.1)48.4 
Corporate bonds, non-current4.5 — 4.5 
Corporate asset-backed securities, non-current0.9 — 0.9 
Sovereign government bonds, non-current2.0 — 2.0 
Total marketable securities$55.9 $(0.1)$55.8 
Accounts Receivable, Net
Accounts receivables primarily consist of trade accounts receivables with maturities of one year or less and are presented net of reserves:
(In millions)June 30, 2024December 31, 2023
Accounts receivable$347.2 $395.1 
Allowance for contract rebates and discounts(63.9)(77.2)
Allowance for doubtful accounts(13.8)(14.6)
Total accounts receivable, net$269.5 $303.3 
Inventories
Inventories are stated at the lower of cost (first-in, first-out) or net realizable value. Inventories consisted of the following:
(In millions)June 30, 2024December 31, 2023
Raw materials$222.3 $212.7 
Work-in-process (materials, labor and overhead)99.3 92.3 
Finished goods (materials, labor and overhead)319.0 318.1 
Total inventories$640.6 $623.1 
Inventories$602.0 $577.8 
Other assets (1)
38.6 45.3 
Total inventories$640.6 $623.1 
(1) Other assets includes inventory expected to remain on hand beyond one year.
Prepaid Expenses and Other Current Assets
Prepaid expenses and other current assets consisted of the following:
(In millions)June 30, 2024December 31, 2023
Income taxes and other tax receivables$156.4 $104.7 
Prepaid expenses68.3 67.0 
Contract assets44.1 46.2 
Other receivables27.3 34.2 
Derivatives11.0 6.9 
Other2.9 3.1 
Total prepaid expenses and other current assets$310.0 $262.1 
Other Current Liabilities
Other current liabilities consisted of the following:
(In millions)June 30, 2024December 31, 2023
Accrued commissions, rebates and returns$67.1 $63.8 
Deferred revenue40.1 36.8 
Operating lease liabilities29.5 26.7 
Accrued other taxes payable21.6 17.9 
Derivatives4.7 12.1 
Accrued interest1.4 30.3 
Other84.7 115.7 
Total other current liabilities$249.1 $303.3 
XML 25 R14.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Assets Held for Sale
 6 Months Ended
Jun. 30, 2024
Property, Plant and Equipment [Abstract]  
Assets Held for Sale Assets Held for Sale
The following criteria are considered before concluding assets are classified as held for sale: 1) management’s commitment to a plan to sell, 2) availability for immediate sale in its present condition, 3) initiation of an active program to identify a buyer, 4) probability of a completed sale within one year, 5) actively marketed for sale at a reasonable price in relation to its current fair value, and 6) likelihood of significant changes to the plan will be made or that the plan will be withdrawn. If all of the criteria are met as of the balance sheet date, the net assets are presented separately in the balance sheet as held for sale at the lower of its carrying amount or fair value less costs to sell and is no longer depreciated or amortized while classified as held for sale. The Company assesses the fair value of a long-lived asset less any costs to sell at each reporting period and until the asset is no longer classified as held for sale.
As part of the Company’s cost-savings initiatives, the Company has been evaluating its real estate footprint with the goal to relocate and consolidate its operations to improve long-term results. As a result, the Company has decided to (i) sell the McKellar, San Diego, CA facility and (ii) sell the Raritan, NJ, facility with the intent to subsequently lease back the right to use the property. In the second quarter of 2024, the properties met the requirements for reclassification from property, plant and equipment, net to assets held for sale when it became probable that the properties would be sold within one year. The carrying value of the assets was reduced to its estimated relative fair value less costs to sell resulting in an impairment charge of $56.9 million that was included in Asset impairment charge.
XML 26 R15.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Goodwill and Intangible Assets, Net
 6 Months Ended
Jun. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Intangible Assets, Net Goodwill and Intangible Assets, Net
Changes in goodwill were as follows:
(In millions)North AmericaEMEAChinaOtherTotal
Balance at December 31, 2023$1,743.9 $582.4 $85.7 $80.0 $2,492.0 
Impairment charge(1,743.9)— — — (1,743.9)
Foreign currency translation— (7.6)(1.5)(6.5)(15.6)
Balance at June 30, 2024$— $574.8 $84.2 $73.5 $732.5 
The Company tests goodwill for impairment on an annual basis on the first day of the fourth quarter and monitors throughout the year for impairment triggering events that indicate that the carrying value of one or more of its reporting units exceeds its fair value.
During the first quarter of 2024, the Company concluded that (i) the sustained decline in the Company’s stock price and market capitalization occurred during the first quarter of 2024, (ii) the faster than expected decline in COVID-19 and flu markets, and (iii) the recent delay in the timing of expected commercialization for Savanna were triggering events requiring an interim goodwill impairment assessment for all reporting units.
Based on the Company’s interim goodwill impairment assessment, the Company concluded that the North America reporting unit’s carrying value exceeded its estimated fair value. As a result, the Company recorded a non-cash goodwill impairment charge of $1.7 billion in the first quarter of 2024 for the North America reporting unit, which represented a full impairment of the goodwill allocated to the North America reporting unit. The decline in the estimated fair value of the North America reporting unit and the resulting impairment was primarily driven by revised short-term and mid-term forecasts for revenue and EBITDA expectations in North America.
The estimated fair values of the EMEA, Latin America and JPAC reporting units as of the interim testing date exceeded their respective carrying values. The excess of the estimated fair value over carrying value (expressed as a percentage of carrying value for the respective reporting unit) ranged from approximately 30% to 150%. Due to the significant excess of fair value over carrying value of these reporting units, they are less sensitive to changes in forecast assumptions. To evaluate the sensitivity of the fair value calculations used in the interim goodwill impairment test for the EMEA, Latin America and JPAC reporting units, the Company applied a hypothetical 5% decrease to the fair values of each reporting unit and compared those hypothetical values to the reporting unit carrying values. Based on this hypothetical 5% decrease, the excess of the estimated fair value over carrying value (expressed as a percentage of carrying value for the respective reporting unit) for each of the Company’s reporting units ranged from approximately 25% to 140%.
The quantitative goodwill impairment assessment for all reporting units consisted of a fair value calculation that combines an income approach, using a discounted cash flow method, and a market approach, using the guideline public company method. The quantitative goodwill impairment assessment requires the application of a number of significant assumptions, including estimates of future revenue growth rates, EBITDA margins, discount rates and market multiples. The projected future revenue growth rates and EBITDA margins, and the resulting projected cash flows are based on historical experience and internal annual operating plans reviewed by management, extrapolated over the forecast period. Discount rates are determined using a
weighted average cost of capital adjusted for risk factors specific to the reporting units. Market multiples are based on the guideline public company method using comparable publicly traded company multiples of revenue and EBITDA for a group of benchmark companies.
The Company believes the assumptions that were used in the quantitative goodwill impairment assessment are reasonable and consistent with assumptions that would be used by other marketplace participants.
The Company also reviews long-lived assets, including intangible assets, for impairment when events or changes in circumstances indicate the carrying value of an asset group may not be recoverable. Given the indications of possible impairment that occurred during the first quarter of 2024, the Company tested its North America long-lived asset group for recoverability and impairment as of March 31, 2024. Recoverability of long-lived assets is measured by a comparison of the carrying value of an asset group to future undiscounted net cash flows expected to be generated by the asset group. The undiscounted cash flows for the North America long-lived asset group were above the carrying value and the Company determined that the long-lived asset group was recoverable, and no impairment existed as of June 30, 2024.
XML 27 R16.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Borrowings
 6 Months Ended
Jun. 30, 2024
Debt Disclosure [Abstract]  
Borrowings Borrowings
The components of borrowings were as follows:
(In millions)June 30, 2024December 31, 2023
Term Loan$2,317.1 $2,420.2 
Revolving Credit Facility253.0 — 
Financing lease obligation 0.1 0.4 
Other short-term borrowings— 1.6 
Other long-term borrowings0.2 0.4 
Unamortized deferred financing costs(6.8)(8.0)
Total borrowings2,563.6 2,414.6 
Less: current portion(356.4)(139.8)
Long-term borrowings$2,207.2 $2,274.8 
The Credit Agreement, dated May 27, 2022, by and among the Company, as borrower, Bank of America, N.A., as administrative agent and swing line lender, and the other lenders and L/C issuers party thereto consists of a $2,750.0 million Term Loan and an $800.0 million Revolving Credit Facility. Availability under the Revolving Credit Facility, after deducting letters of credit of $13.0 million and $253.0 million borrowings outstanding, was $534.0 million as of June 30, 2024. During the six months ended June 30, 2024, the Company made $103.1 million in payments on the Term Loan.
The Credit Agreement contains affirmative and negative covenants that are customary for credit agreements of this nature. The negative covenants include, among other things, limitations on asset sales, mergers, indebtedness, liens, investments and transactions with affiliates.
On April 25, 2024, the Company entered into Amendment No. 2 (the “Amendment”), by and among the Company, the lenders party thereto, and Bank of America, N.A., as administrative agent, which amends the Credit Agreement. The Amendment sets a maximum Consolidated Leverage Ratio (as defined in the Credit Agreement) for the applicable measurement period as of the last day of each fiscal quarter of (a) 4.50 to 1.00 on or prior to June 30, 2023, (b) 4.00 to 1.00 after June 30, 2023 and on or prior to June 30, 2024, (c) 4.25 to 1.00 after June 30, 2024 and on or prior to December 31, 2024, (d) 4.00 to 1.00 after December 31, 2024 and on or prior to June 30, 2025 and (e) 3.75 to 1.00 each fiscal quarter after June 30, 2025. The Credit Agreement contains a minimum Consolidated Interest Coverage Ratio (as defined in the Credit Agreement) of 3.00 to 1.00 as of the end of any fiscal quarter for the most recently completed four fiscal quarters. The Company was in compliance with the financial covenants as of June 30, 2024.
The following table provides the detailed amounts within Interest expense, net for the three and six months ended June 30, 2024 and July 2, 2023:
Three Months EndedSix Months Ended
(In millions)June 30, 2024July 2, 2023June 30, 2024July 2, 2023
Term Loan$44.4 $44.2 $88.9 $85.1 
Revolving Credit Facility3.4 0.5 5.2 1.0 
Amortization of deferred financing costs0.8 0.8 1.6 1.6 
Derivative instruments and other(7.1)(7.2)(14.3)(11.7)
Interest income(0.5)(1.8)(1.4)(2.8)
Interest expense, net$41.0 $36.5 $80.0 $73.2 
XML 28 R17.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Stock-based Compensation
 6 Months Ended
Jun. 30, 2024
Equity [Abstract]  
Stock-based Compensation Stock-based Compensation
Stock-based compensation expense was as follows:
Three Months EndedSix Months Ended
(In millions)June 30, 2024July 2, 2023June 30, 2024July 2, 2023
Cost of sales, excluding amortization of intangibles$1.5 $1.1 $2.7 $2.1 
Selling, marketing and administrative6.7 10.0 11.8 17.2 
Research and development0.9 1.3 1.9 2.6 
Integration related costs2.1 4.6 3.9 9.1 
Total stock-based compensation expense$11.2 $17.0 $20.3 $31.0 
The table above includes compensation expense related to liability-classified awards of $2.8 million and $5.8 million for the three and six months ended July 2, 2023, respectively, which has been or is expected to be settled in cash. Amounts related to the three and six months ended June 30, 2024 were not material.
XML 29 R18.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Commitments and Contingencies
 6 Months Ended
Jun. 30, 2024
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
On April 12, 2024, a purported stockholder of the Company filed a putative class action complaint under the federal securities laws against the Company and three of its current and former executives. The complaint, which is captioned Bristol County Retirement System v. QuidelOrtho Corporation, et al., Case No. 1:24-cv-02804-MKV (S.D.N.Y.) (the “Bristol County Complaint”), asserts claims for violations of Sections 10(b) and 20(a) of the Exchange Act and Rule 10b-5 promulgated thereunder related to statements regarding sales of the Company’s COVID-19 diagnostic tests and the 510(k) submission for its Savanna RVP4 assay. The Bristol County Complaint seeks a judgment determining that the lawsuit can be maintained as a class action and awarding the plaintiff and putative class damages, pre- and post-judgment interest, attorneys’ and experts’ fees, and costs.
On April 25, 2024, and June 21, 2024, two purported stockholders of the Company filed separate stockholder derivative complaints, purportedly on behalf of the Company, against the current and certain former members of the Company’s Board of Directors and three of its current and former executives. The complaints, which are captioned Matthew Whitfield v. Kenneth F. Buechler, Ph.D., et al., Case No. 1:24-cv-03176-MKV (S.D.N.Y.) (the “Whitfield Complaint”), and Steven Pinkney v. Douglas Bryant, et al., Case No. 1:24-cv-4753-MKV (S.D.N.Y.) (the “Pinkney Complaint”), assert claims for violations of Sections 10(b), 14(a), and 20(a) of the Exchange Act and Rules 10b-5 and 14a-9 promulgated thereunder, breach of fiduciary duty, aiding and abetting breach of fiduciary duty, unjust enrichment, abuse of control, gross mismanagement, and waste of corporate assets related to statements regarding sales of the Company’s COVID-19 diagnostic tests and the 510(k) submission for its Savanna RVP4 assay. The Whitfield and Pinkney Complaints seek judgments awarding compensatory and punitive damages against the individual defendants, directing an accounting by the individual defendants, directing the Company and the individual defendants to take actions to improve the Company’s governance and procedures, and awarding the costs and disbursements of the action, including attorneys’ fees, accountants’ and experts’ fees, costs, and expenses.
The Company disputes the allegations of wrongdoing and intends to defend itself vigorously in these matters. Nevertheless, the outcomes of these lawsuits are uncertain and cannot be predicted with any certainty. Accordingly, at this time, the Company is not able to estimate a possible loss or range of loss that may result from these lawsuits or to determine whether such loss, if any, would have a material adverse effect on its business, financial condition, results of operations or liquidity.
From time to time, the Company is involved in other litigation and legal proceedings, including matters related to product liability claims, commercial disputes and intellectual property claims, as well as regulatory, employment, and other claims related to its business. The Company accrues for legal claims when, and to the extent that, amounts associated with the claims become probable and are reasonably estimable. If the reasonable estimate of a known or probable loss is a range, and no amount within the range is a better estimate than any other, the minimum amount of the range is accrued. When determining the estimated loss or range of loss, significant judgment is required to estimate the amount and timing of a loss to be recorded. Estimates of probable losses resulting from these matters are inherently difficult to predict. The actual costs of resolving legal claims may be substantially higher or lower than the amounts accrued for those claims. For those matters as to which the Company is not able to estimate a possible loss or range of loss, the Company is not able to determine whether the loss will have a material adverse effect on its business, financial condition, results of operations or liquidity.
Management believes that all such current legal actions, in the aggregate, are not expected to have a material adverse effect on the Company. However, the resolution of, or increase in any accruals for, one or more matters may have a material adverse effect on the Company’s results of operations and cash flows.
XML 30 R19.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Fair Value Measurements
 6 Months Ended
Jun. 30, 2024
Fair Value Disclosures [Abstract]  
Fair Value Measurements Fair Value Measurements
The following table presents the Company’s hierarchy for its assets and liabilities measured at fair value on a recurring basis as of the following periods:
 June 30, 2024December 31, 2023
(In millions)Level 1Level 2Level 3TotalLevel 1Level 2Level 3Total
Assets:
Marketable securities$— $— $— $— $— $55.8 $— $55.8 
Derivative assets— 42.2 — 42.2 — 6.9 — 6.9 
Total assets measured at fair value$— $42.2 $— $42.2 $— $62.7 $— $62.7 
Liabilities:
Derivative liabilities$— $5.6 $— $5.6 $— $27.5 $— $27.5 
Contingent consideration— — — — — — 0.1 0.1 
Total liabilities measured at fair value$— $5.6 $— $5.6 $— $27.5 $0.1 $27.6 
There were no transfers of assets or liabilities into or out of Level 3 of the fair value hierarchy during the six months ended June 30, 2024 and fiscal year 2023.
Marketable securities consist of investment-grade corporate and government debt securities, corporate asset-backed securities and commercial paper. Derivative financial instruments are based on observable inputs that are corroborated by market data. Observable inputs include broker quotes, daily market foreign currency rates and forward pricing curves.
Financial Instruments Not Measured at Fair Value
The estimated fair value of the Company’s borrowings under the Term Loan was $2,296.8 million at June 30, 2024, compared to the carrying amount, excluding debt issuance costs, of $2,317.1 million. The estimated fair value of the Company’s borrowings under the Term Loan was $2,396.0 million at December 31, 2023, compared to the carrying amount, excluding debt issuance costs, of $2,420.2 million. The estimate of fair value is generally based on the quoted market prices for similar issuances of long-term debt with the same maturities, which is classified as a Level 2 input.
XML 31 R20.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Derivative Instruments and Hedging Activities
 6 Months Ended
Jun. 30, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Instruments and Hedging Activities Derivative Instruments and Hedging Activities
The Company selectively uses derivative and non-derivative instruments to manage market risk associated with changes in interest rates and foreign currency exchange rates. The use of derivatives is intended for hedging purposes only, and the Company does not enter into derivative transactions for speculative purposes.
Credit risk represents the Company’s gross exposure to potential accounting loss on derivative instruments that are outstanding or unsettled if all counterparties failed to perform according to the terms of the contract. The Company generally enters into master netting arrangements that reduce credit risk by permitting net settlement of transactions with the same counterparty. The Company does not have any derivative instruments with credit-risk related contingent features that would require it to post collateral.
Interest Rate Hedging Instruments
The Company’s interest rate risk relates primarily to interest rate exposures on variable rate debt, including the Revolving Credit Facility and Term Loan. Refer to “—Note 9. Borrowings” for additional information on the currently outstanding components of the Revolving Credit Facility and Term Loan. The Company entered into interest rate swap agreements to hedge the related risk of the variability to the Company’s cash flows due to the rates specified for these credit facilities.
The Company designates its interest rate swaps as cash flow hedges. The Company records gains and losses due to changes in fair value of the derivatives within OCI and reclassifies these amounts to Interest expense, net in the same period or periods for which the underlying hedged transaction affects earnings. In the event the Company determines the hedged transaction is no longer probable to occur or concludes the hedge relationship is no longer effective, the hedge is prospectively de-designated. Pre-tax unrealized gains of $20.4 million as of June 30, 2024 are expected to be reclassified from OCI to earnings in the next 12 months.
The following table summarizes the Company’s interest rate derivative agreements as of June 30, 2024, all of which were interest rate swaps:
Notional Amount
(In millions)		DescriptionHedge DesignationEffective DateExpiration Date
$550.0 
Pay 3.765% fixed, receive floating rate
(1-month USD-SOFR)
Designated cash flow hedgeDecember 30, 2022May 27, 2027
$200.0 
Pay 3.7725% fixed, receive floating rate
(1-month USD-SOFR)
Designated cash flow hedgeDecember 30, 2022May 27, 2027
$300.0 
Pay 3.7675% fixed, receive floating rate
(1-month USD-SOFR)
Designated cash flow hedgeDecember 30, 2022May 27, 2027
$400.0 
Pay 3.7575% fixed, receive floating rate
(1-month USD-SOFR)
Designated cash flow hedgeDecember 30, 2022May 27, 2027
$350.0 
Pay 3.7725% fixed, receive floating rate
(1-month USD-SOFR)
Designated cash flow hedgeDecember 30, 2022May 27, 2027
Currency Hedging Instruments
The Company has currency risk exposures relating primarily to foreign currency denominated monetary assets and liabilities and forecasted foreign currency denominated intercompany and third-party transactions. The Company uses foreign currency forward contracts and may use option contracts and cross currency swaps to manage its currency risk exposures. The Company’s foreign currency forward contracts are denominated primarily in Australian Dollar, Brazilian Real, British Pound, Canadian Dollar, Chilean Peso, Chinese Yuan/Renminbi, Colombian Peso, Czech Koruna, Danish Krone, Euro, Indian Rupee, Japanese Yen, Mexican Peso, Philippine Peso, South Korean Won, Swiss Franc and Thai Baht.
The Company designates certain foreign currency forward contracts as cash flow hedges. The Company records gains and losses due to changes in fair value of the derivatives within OCI and reclassifies these amounts to Total revenues and Cost of sales, excluding amortization of intangibles in the same period or periods for which the underlying hedged transaction affects earnings. In the event the Company determines the hedged transaction is no longer probable to occur or concludes the hedge relationship is no longer effective, the hedge is prospectively de-designated. Pre-tax unrealized gains of $0.7 million as of June 30, 2024 is expected to be reclassified from OCI to earnings in the next 12 months.
The Company also enters into foreign currency forward contracts that are not part of designated hedging relationships and which are intended to mitigate exchange rate risk of monetary assets and liabilities and related forecasted transactions. The Company records these non-designated derivatives at mark-to-market with gains and losses recognized in earnings within Other expense, net.
The following table provides details of the currency hedging instruments outstanding as of June 30, 2024:
DescriptionNotional Amount
(In millions)		Hedge Designation
Foreign currency forward contracts$217.0 Cash Flow Hedge
Foreign currency forward contracts$710.4 Non-designated
The following table summarizes pre-tax gains and losses from designated derivative and non-derivative instruments within AOCI for the three and six months ended June 30, 2024 and July 2, 2023:
Designated Hedging Instruments
(In millions)Amount of Loss (Gain) Recognized in OCI on HedgesLocation of Amounts Reclassified From AOCI Into IncomeAmount of Loss (Gain) Reclassified From AOCI Into Income
Three Months Ended June 30, 2024
Foreign currency forward contracts (sales)$(3.2)Total revenues$0.7 
Foreign currency forward contracts (purchases)$— Cost of sales, excluding amortization of intangibles$0.1 
Interest rate derivatives$(10.8)Interest expense, net$(7.0)
Six Months Ended June 30, 2024
Foreign currency forward contracts (sales)$(6.0)Total revenues$2.1 
Foreign currency forward contracts (purchases)$0.8 Cost of sales, excluding amortization of intangibles$— 
Interest rate derivatives$(45.8)Interest expense, net$(14.2)
Three Months Ended July 2, 2023
Foreign currency forward contracts (sales)$(0.4)Total revenues$1.8 
Foreign currency forward contracts (purchases)$(2.1)Cost of sales, excluding amortization of intangibles$1.3 
Interest rate derivatives$(47.0)Interest expense, net$(7.4)
Six Months Ended July 2, 2023
Foreign currency forward contracts (sales)$1.7 Total revenues$0.9 
Foreign currency forward contracts (purchases)$(2.1)Cost of sales, excluding amortization of intangibles$1.7 
Interest rate derivatives$(26.1)Interest expense, net$(12.6)
The Company also uses forward exchange contracts to hedge a portion of its net investment in foreign operations against movements in exchange rates. The forward exchange contracts are designated as hedges of the net investment in foreign operations. The unrealized gains or losses on these contracts are recorded in foreign currency translation adjustments within OCI, and remain in AOCI until either the sale or complete or substantially complete liquidation of the subsidiary. The Company excludes certain portions of the change in fair value of its derivative instruments from the assessment of hedge effectiveness (excluded components). Changes in fair value of the excluded components are recognized in OCI. The Company recognizes in earnings the initial value of the excluded components on a straight-line basis over the life of the derivative instrument.
The effect of the Company’s net investment hedges on OCI and the Consolidated Statements of Loss are shown below:
Net Investment Hedging Relationships
(In millions)Amount of Pre-tax (Gain) Loss Recognized in OCIAmount of Pre-tax (Gain) Loss Recognized in Other Expense (Income), Net for Amounts Excluded from Effectiveness Testing
Three Months Ended June 30, 2024
Foreign exchange contracts$(7.3)$(2.9)
Six Months Ended June 30, 2024
Foreign exchange contracts$(18.3)$(4.9)
Fair value gains on foreign currency forward contracts, as determined using Level 2 inputs, that do not qualify for hedge accounting treatment are recorded in Other expense, net and were $5.7 million for both the three and six months ended June 30,
2024. Fair value gains that do not qualify for hedge accounting treatment were $3.2 million and $0.5 million for the three and six months ended July 2, 2023, respectively.
The following table summarizes the fair value of designated and non-designated hedging instruments recognized within the Consolidated Balance Sheets as of June 30, 2024 and December 31, 2023:
(In millions)June 30, 2024December 31, 2023
Designated cash flow hedges
Interest rate derivatives:
Prepaid expenses and other current assets$0.2 $0.2 
Other assets24.6 — 
Other liabilities— 6.9 
Foreign currency forward contracts:
Prepaid expenses and other current assets4.7 3.2 
Other assets6.6 — 
Other current liabilities3.6 9.4 
Other liabilities0.9 8.5
Non-designated hedging instruments
Foreign currency forward contracts:
Prepaid expenses and other current assets6.1 3.5 
Other current liabilities1.1 2.7 
XML 32 R21.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Accumulated Other Comprehensive Loss
 6 Months Ended
Jun. 30, 2024
Equity [Abstract]  
Accumulated Other Comprehensive Loss Accumulated Other Comprehensive Loss
The following table summarizes the changes in AOCI by component:
Three Months Ended June 30, 2024
(In millions)Pension and Other Post-
Employment Benefits		Cash Flow HedgesAvailable-for-Sale InvestmentsForeign Currency Translation AdjustmentsAccumulated Other Comprehensive (Loss) Income
Balance at March 31, 2024$(1.3)$14.8 $— $(39.7)$(26.2)
Current period deferrals (1)
— 13.1 — (2.4)10.7 
Amounts reclassified to Net loss
— (6.2)— (2.9)(9.1)
Net change— 6.9 — (5.3)1.6 
Balance at June 30, 2024$(1.3)$21.7 $— $(45.0)$(24.6)
Six Months Ended June 30, 2024
(In millions)Pension and Other Post-
Employment Benefits		Cash Flow HedgesAvailable-for-Sale InvestmentsForeign Currency Translation AdjustmentsAccumulated Other Comprehensive (Loss) Income
Balance at December 31, 2023$(1.3)$(9.8)$— $(18.9)$(30.0)
Current period deferrals (1)
— 43.6 — (21.2)22.4 
Amounts reclassified to Net loss
— (12.1)— (4.9)(17.0)
Net change— 31.5 — (26.1)5.4 
Balance at June 30, 2024$(1.3)$21.7 $— $(45.0)$(24.6)
Three Months Ended July 2, 2023
(In millions)Pension and Other Post-
Employment Benefits		Cash Flow HedgesAvailable-for-Sale InvestmentsForeign Currency Translation AdjustmentsAccumulated Other Comprehensive (Loss) Income
Balance at April 2, 2023$0.7 $(21.1)$(0.3)$(38.6)$(59.3)
Current period deferrals (2)
— 40.0 (0.1)7.4 47.3 
Amounts reclassified to Net loss
— (4.3)— — (4.3)
Net change— 35.7 (0.1)7.4 43.0 
Balance at July 2, 2023$0.7 $14.6 $(0.4)$(31.2)$(16.3)
Six Months Ended July 2, 2023
(In millions)Pension and Other Post-
employment Benefits		Cash Flow HedgesAvailable-for-Sale InvestmentsForeign Currency Translation AdjustmentsAccumulated Other Comprehensive (Loss) Income
Balance at January 1, 2023$0.7 $1.5 $(0.5)$(69.3)$(67.6)
Current period deferrals (2)
— 23.1 0.1 38.1 61.3 
Amounts reclassified to Net loss
— (10.0)— — (10.0)
Net change— 13.1 0.1 38.1 51.3 
Balance at July 2, 2023$0.7 $14.6 $(0.4)$(31.2)$(16.3)
(1) Includes tax impact of (i) $0.9 million and $7.4 million related to cash flow hedges for the three and six months ended June 30, 2024, respectively, and (ii) $0.9 million and $2.9 million related to foreign currency translation adjustments for the three and six months ended June 30, 2024, respectively.
(2) Includes tax impact of $9.5 million and $3.4 million related to cash flow hedges for the three and six months ended July 2, 2023, respectively.
XML 33 R22.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Pay vs Performance Disclosure - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Mar. 31, 2024
Jul. 02, 2023
Apr. 02, 2023
Jun. 30, 2024
Jul. 02, 2023
Pay vs Performance Disclosure            
Net loss $ (147.7) $ (1,706.0) $ (53.2) $ 48.8 $ (1,853.7) $ (4.4)
XML 34 R23.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Insider Trading Arrangements
 3 Months Ended
Jun. 30, 2024
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
XML 35 R24.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Basis of Presentation and Summary of Significant Accounting Policies (Policies)
 6 Months Ended
Jun. 30, 2024
Accounting Policies [Abstract]  
Basis of Presentation
Basis of Presentation
The accompanying unaudited Consolidated Financial Statements of QuidelOrtho Corporation and its subsidiaries (the “Company” or “QuidelOrtho”) have been prepared in accordance with GAAP for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation (consisting of normal recurring accruals) have been included. Refer to the Summary of Abbreviated Terms at the end of this Quarterly Report for definitions of terms used throughout the document.
The information at June 30, 2024, and for the three and six months ended June 30, 2024 and July 2, 2023, is unaudited. For further information, refer to the Company’s Consolidated Financial Statements and notes thereto for the fiscal year ended December 31, 2023 included in QuidelOrtho’s Annual Report. Operating results for any quarter are historically seasonal in nature and are not necessarily indicative of the results expected for the full year.
The Company follows the concept of a fiscal year that ends on the Sunday nearest to the end of the month of December, and fiscal quarters that end on the Sunday nearest to the end of the months of March, June and September. For 2024 and 2023, the Company’s fiscal year will end or has ended on December 29, 2024 and December 31, 2023, respectively. For 2024 and 2023, the Company’s second quarter ended on June 30, 2024 and July 2, 2023, respectively. The three and six months ended June 30, 2024 and July 2, 2023 each included 13 and 26 weeks, respectively.
Use of Estimates
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and the related disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Reclassifications
Reclassifications
Certain reclassifications have been made to prior periods amounts to conform to the current period presentation. Such amounts include a reclassification of $0.5 million and $1.0 million recognized in the three and six months ended July 2, 2023, respectively, related to impairment of long-lived assets from (i) Cost of sales, excluding amortization of intangibles (excludes $0.1 million for both the three and six months ended July 2, 2023), and (ii) Research and development (excludes $0.4 million and $0.9 million for the three and six months ended July 2, 2023, respectively), to Asset impairment charge.
The reclassifications did not have an impact on the Company’s previously reported Consolidated Balance Sheets, Consolidated Statements of Comprehensive (Loss) Income, Consolidated Statements of Stockholders’ Equity or Consolidated Statements of Cash Flows.
Recent Accounting Pronouncements
Recent Accounting Pronouncements
There have been no accounting pronouncements issued or adopted during the six months ended June 30, 2024 that are expected to have a material impact on the Company’s Consolidated Financial Statements.
Assets Held for Sale
The following criteria are considered before concluding assets are classified as held for sale: 1) management’s commitment to a plan to sell, 2) availability for immediate sale in its present condition, 3) initiation of an active program to identify a buyer, 4) probability of a completed sale within one year, 5) actively marketed for sale at a reasonable price in relation to its current fair value, and 6) likelihood of significant changes to the plan will be made or that the plan will be withdrawn. If all of the criteria are met as of the balance sheet date, the net assets are presented separately in the balance sheet as held for sale at the lower of its carrying amount or fair value less costs to sell and is no longer depreciated or amortized while classified as held for sale. The Company assesses the fair value of a long-lived asset less any costs to sell at each reporting period and until the asset is no longer classified as held for sale.
XML 36 R25.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Computation of Earnings Per Share (Tables)
 6 Months Ended
Jun. 30, 2024
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted
The following table presents the calculation of the weighted-average shares used in computing basic and diluted EPS in the respective periods:
Three Months EndedSix Months Ended
(In millions)June 30, 2024July 2, 2023June 30, 2024July 2, 2023
Basic weighted-average shares of common stock outstanding67.1 66.8 67.0 66.7 
Dilutive potential shares issuable from stock options and RSUs(1)
— — — — 
Diluted weighted-average shares of common stock outstanding67.1 66.8 67.0 66.7 
(1) In the three and six months ended June 30, 2024 and July 2, 2023, all potential shares of common stock issuable for stock options and RSUs were excluded from the dilutive calculations above because the effect of including them would have been anti-dilutive. The dilutive
effect of potential shares of common stock issuable for stock options and RSUs on the weighted-average number of shares of common stock outstanding would have been as follows:
Three Months EndedSix Months Ended
(In millions)June 30, 2024July 2, 2023June 30, 2024July 2, 2023
Basic weighted-average shares of common stock outstanding67.1 66.8 67.0 66.7 
Dilutive potential shares issuable from stock options and RSUs0.2 0.4 0.3 0.5 
Diluted weighted-average shares of common stock outstanding67.3 67.2 67.3 67.2 
XML 37 R26.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Revenue (Tables)
 6 Months Ended
Jun. 30, 2024
Revenue from Contract with Customer [Abstract]  
Disaggregation of Revenue
The following table summarizes Total revenues by business unit:
Three Months EndedSix Months Ended
(In millions)June 30, 2024July 2, 2023June 30, 2024July 2, 2023
Labs$354.2 $361.4 $711.1 $732.1 
Transfusion Medicine161.3 163.3 321.6 319.2 
Point of Care117.1 134.2 303.7 442.3 
Molecular Diagnostics4.4 6.2 11.6 17.6 
Total revenues$637.0 $665.1 $1,348.0 $1,511.2 
XML 38 R27.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Segment and Geographic Information (Tables)
 6 Months Ended
Jun. 30, 2024
Industry And Geographic Information [Abstract]  
Revenue from External Customers by Geographic Areas
Total revenues by reportable segment are as follows:
Three Months EndedSix Months Ended
(In millions)June 30, 2024July 2, 2023June 30, 2024July 2, 2023
North America$350.1 $378.8 $784.0 $961.6 
EMEA81.1 80.6 165.9 161.9 
China81.6 81.3 157.7 151.9 
Other124.2 124.4 240.4 235.8 
Total revenues$637.0 $665.1 $1,348.0 $1,511.2 
Schedule of Segment Reporting Information, by Segment
The following table sets forth Adjusted EBITDA by segment and the reconciliations to Loss before income taxes for the three and six months ended June 30, 2024 and July 2, 2023:
Three Months EndedSix Months Ended
(In millions)June 30, 2024July 2, 2023June 30, 2024July 2, 2023
North America$173.9 $176.3 $392.7 $454.7 
EMEA11.4 5.3 24.2 12.5 
China35.8 30.2 60.5 58.7 
Other34.1 36.3 66.1 58.1 
Total segment Adjusted EBITDA255.2 248.1 543.5 584.0 
Corporate (1)
(165.3)(134.8)(321.6)(225.4)
Interest expense, net(41.0)(36.5)(80.0)(73.2)
Depreciation and amortization(116.1)(114.5)(231.0)(228.7)
Integration related costs(30.9)(24.2)(53.5)(53.9)
Goodwill impairment charge— — (1,743.9)— 
Asset impairment charge(56.9)(0.5)(56.9)(1.0)
Credit Agreement amendment fees (4.0)— (4.0)— 
Amortization of deferred cloud computing implementation costs(3.0)(1.5)(5.9)(3.1)
EU medical device regulation transition costs (2)
(0.5)(0.7)(1.1)(1.5)
Employee compensation charges— — (5.6)— 
Tax indemnification income— 0.4 — 0.1 
Gain (loss) on investments0.7 (0.2)— (0.2)
Other adjustments(1.1)— (1.8)(1.5)
Loss before income taxes$(162.9)$(64.4)$(1,961.8)$(4.4)
(1) Primarily consists of costs related to executive and staff functions, including certain finance, human resources, manufacturing and IT functions, which benefit the Company as a whole. These costs are primarily related to the general management of these functions on a corporate level and the design and development of programs, policies and procedures that are then implemented in the individual segments, with each segment bearing its own cost of implementation. The Company’s corporate function also includes debt and stock-based compensation associated with all employee stock-based awards.
(2) Represents incremental consulting costs and R&D manufacturing site costs to align compliance of the Company’s existing, on-market products that were previously registered under the European In Vitro Diagnostics Directive regulatory framework with the requirements under the EU’s In Vitro Diagnostic Regulation, which generally apply from May 2022 onwards.
XML 39 R28.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Balance Sheet Account Details (Tables)
 6 Months Ended
Jun. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Cash, Cash Equivalents and Restricted Cash
Cash, Cash Equivalents and Restricted Cash
(In millions)June 30, 2024December 31, 2023
Cash and cash equivalents$107.0 $118.9 
Restricted cash included in Other assets0.5 0.6 
Cash, cash equivalents and restricted cash$107.5 $119.5 
Marketable Securities The following table is a summary of marketable securities as of December 31, 2023:
December 31, 2023
(In millions)Amortized CostGross Unrealized LossesFair Value
Corporate bonds$38.1 $(0.1)$38.0 
Corporate asset-backed securities8.9 — 8.9 
Agency bonds1.5 — 1.5 
Total marketable securities, current48.5 (0.1)48.4 
Corporate bonds, non-current4.5 — 4.5 
Corporate asset-backed securities, non-current0.9 — 0.9 
Sovereign government bonds, non-current2.0 — 2.0 
Total marketable securities$55.9 $(0.1)$55.8 
Accounts Receivable, Net
Accounts receivables primarily consist of trade accounts receivables with maturities of one year or less and are presented net of reserves:
(In millions)June 30, 2024December 31, 2023
Accounts receivable$347.2 $395.1 
Allowance for contract rebates and discounts(63.9)(77.2)
Allowance for doubtful accounts(13.8)(14.6)
Total accounts receivable, net$269.5 $303.3 
Inventories
Inventories are stated at the lower of cost (first-in, first-out) or net realizable value. Inventories consisted of the following:
(In millions)June 30, 2024December 31, 2023
Raw materials$222.3 $212.7 
Work-in-process (materials, labor and overhead)99.3 92.3 
Finished goods (materials, labor and overhead)319.0 318.1 
Total inventories$640.6 $623.1 
Inventories$602.0 $577.8 
Other assets (1)
38.6 45.3 
Total inventories$640.6 $623.1 
(1) Other assets includes inventory expected to remain on hand beyond one year.
Prepaid Expenses and Other Current Assets
Prepaid expenses and other current assets consisted of the following:
(In millions)June 30, 2024December 31, 2023
Income taxes and other tax receivables$156.4 $104.7 
Prepaid expenses68.3 67.0 
Contract assets44.1 46.2 
Other receivables27.3 34.2 
Derivatives11.0 6.9 
Other2.9 3.1 
Total prepaid expenses and other current assets$310.0 $262.1 
Other Current Liabilities
Other current liabilities consisted of the following:
(In millions)June 30, 2024December 31, 2023
Accrued commissions, rebates and returns$67.1 $63.8 
Deferred revenue40.1 36.8 
Operating lease liabilities29.5 26.7 
Accrued other taxes payable21.6 17.9 
Derivatives4.7 12.1 
Accrued interest1.4 30.3 
Other84.7 115.7 
Total other current liabilities$249.1 $303.3 
XML 40 R29.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Goodwill and Intangible Assets, Net (Tables)
 6 Months Ended
Jun. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill
Changes in goodwill were as follows:
(In millions)North AmericaEMEAChinaOtherTotal
Balance at December 31, 2023$1,743.9 $582.4 $85.7 $80.0 $2,492.0 
Impairment charge(1,743.9)— — — (1,743.9)
Foreign currency translation— (7.6)(1.5)(6.5)(15.6)
Balance at June 30, 2024$— $574.8 $84.2 $73.5 $732.5 
XML 41 R30.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Borrowings (Tables)
 6 Months Ended
Jun. 30, 2024
Debt Disclosure [Abstract]  
Schedule of Debt
The components of borrowings were as follows:
(In millions)June 30, 2024December 31, 2023
Term Loan$2,317.1 $2,420.2 
Revolving Credit Facility253.0 — 
Financing lease obligation 0.1 0.4 
Other short-term borrowings— 1.6 
Other long-term borrowings0.2 0.4 
Unamortized deferred financing costs(6.8)(8.0)
Total borrowings2,563.6 2,414.6 
Less: current portion(356.4)(139.8)
Long-term borrowings$2,207.2 $2,274.8 
Schedule of Interest Expense
The following table provides the detailed amounts within Interest expense, net for the three and six months ended June 30, 2024 and July 2, 2023:
Three Months EndedSix Months Ended
(In millions)June 30, 2024July 2, 2023June 30, 2024July 2, 2023
Term Loan$44.4 $44.2 $88.9 $85.1 
Revolving Credit Facility3.4 0.5 5.2 1.0 
Amortization of deferred financing costs0.8 0.8 1.6 1.6 
Derivative instruments and other(7.1)(7.2)(14.3)(11.7)
Interest income(0.5)(1.8)(1.4)(2.8)
Interest expense, net$41.0 $36.5 $80.0 $73.2 
XML 42 R31.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Stock-based Compensation (Tables)
 6 Months Ended
Jun. 30, 2024
Equity [Abstract]  
Compensation Expense Related to Stock-Based Compensation Plans
Stock-based compensation expense was as follows:
Three Months EndedSix Months Ended
(In millions)June 30, 2024July 2, 2023June 30, 2024July 2, 2023
Cost of sales, excluding amortization of intangibles$1.5 $1.1 $2.7 $2.1 
Selling, marketing and administrative6.7 10.0 11.8 17.2 
Research and development0.9 1.3 1.9 2.6 
Integration related costs2.1 4.6 3.9 9.1 
Total stock-based compensation expense$11.2 $17.0 $20.3 $31.0 
XML 43 R32.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Fair Value Measurements (Tables)
 6 Months Ended
Jun. 30, 2024
Fair Value Disclosures [Abstract]  
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis
The following table presents the Company’s hierarchy for its assets and liabilities measured at fair value on a recurring basis as of the following periods:
 June 30, 2024December 31, 2023
(In millions)Level 1Level 2Level 3TotalLevel 1Level 2Level 3Total
Assets:
Marketable securities$— $— $— $— $— $55.8 $— $55.8 
Derivative assets— 42.2 — 42.2 — 6.9 — 6.9 
Total assets measured at fair value$— $42.2 $— $42.2 $— $62.7 $— $62.7 
Liabilities:
Derivative liabilities$— $5.6 $— $5.6 $— $27.5 $— $27.5 
Contingent consideration— — — — — — 0.1 0.1 
Total liabilities measured at fair value$— $5.6 $— $5.6 $— $27.5 $0.1 $27.6 
XML 44 R33.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Derivative Instruments and Hedging Activities (Tables)
 6 Months Ended
Jun. 30, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Interest Rate Derivatives
The following table summarizes the Company’s interest rate derivative agreements as of June 30, 2024, all of which were interest rate swaps:
Notional Amount
(In millions)		DescriptionHedge DesignationEffective DateExpiration Date
$550.0 
Pay 3.765% fixed, receive floating rate
(1-month USD-SOFR)
Designated cash flow hedgeDecember 30, 2022May 27, 2027
$200.0 
Pay 3.7725% fixed, receive floating rate
(1-month USD-SOFR)
Designated cash flow hedgeDecember 30, 2022May 27, 2027
$300.0 
Pay 3.7675% fixed, receive floating rate
(1-month USD-SOFR)
Designated cash flow hedgeDecember 30, 2022May 27, 2027
$400.0 
Pay 3.7575% fixed, receive floating rate
(1-month USD-SOFR)
Designated cash flow hedgeDecember 30, 2022May 27, 2027
$350.0 
Pay 3.7725% fixed, receive floating rate
(1-month USD-SOFR)
Designated cash flow hedgeDecember 30, 2022May 27, 2027
Schedule of Currency Hedging Instruments
The following table provides details of the currency hedging instruments outstanding as of June 30, 2024:
DescriptionNotional Amount
(In millions)		Hedge Designation
Foreign currency forward contracts$217.0 Cash Flow Hedge
Foreign currency forward contracts$710.4 Non-designated
Schedule of Derivative Instruments, Effect on Other Comprehensive (Loss) Income
The following table summarizes pre-tax gains and losses from designated derivative and non-derivative instruments within AOCI for the three and six months ended June 30, 2024 and July 2, 2023:
Designated Hedging Instruments
(In millions)Amount of Loss (Gain) Recognized in OCI on HedgesLocation of Amounts Reclassified From AOCI Into IncomeAmount of Loss (Gain) Reclassified From AOCI Into Income
Three Months Ended June 30, 2024
Foreign currency forward contracts (sales)$(3.2)Total revenues$0.7 
Foreign currency forward contracts (purchases)$— Cost of sales, excluding amortization of intangibles$0.1 
Interest rate derivatives$(10.8)Interest expense, net$(7.0)
Six Months Ended June 30, 2024
Foreign currency forward contracts (sales)$(6.0)Total revenues$2.1 
Foreign currency forward contracts (purchases)$0.8 Cost of sales, excluding amortization of intangibles$— 
Interest rate derivatives$(45.8)Interest expense, net$(14.2)
Three Months Ended July 2, 2023
Foreign currency forward contracts (sales)$(0.4)Total revenues$1.8 
Foreign currency forward contracts (purchases)$(2.1)Cost of sales, excluding amortization of intangibles$1.3 
Interest rate derivatives$(47.0)Interest expense, net$(7.4)
Six Months Ended July 2, 2023
Foreign currency forward contracts (sales)$1.7 Total revenues$0.9 
Foreign currency forward contracts (purchases)$(2.1)Cost of sales, excluding amortization of intangibles$1.7 
Interest rate derivatives$(26.1)Interest expense, net$(12.6)
Schedule of Net Investment Hedges
The effect of the Company’s net investment hedges on OCI and the Consolidated Statements of Loss are shown below:
Net Investment Hedging Relationships
(In millions)Amount of Pre-tax (Gain) Loss Recognized in OCIAmount of Pre-tax (Gain) Loss Recognized in Other Expense (Income), Net for Amounts Excluded from Effectiveness Testing
Three Months Ended June 30, 2024
Foreign exchange contracts$(7.3)$(2.9)
Six Months Ended June 30, 2024
Foreign exchange contracts$(18.3)$(4.9)
Schedule of Derivative Assets at Fair Value
The following table summarizes the fair value of designated and non-designated hedging instruments recognized within the Consolidated Balance Sheets as of June 30, 2024 and December 31, 2023:
(In millions)June 30, 2024December 31, 2023
Designated cash flow hedges
Interest rate derivatives:
Prepaid expenses and other current assets$0.2 $0.2 
Other assets24.6 — 
Other liabilities— 6.9 
Foreign currency forward contracts:
Prepaid expenses and other current assets4.7 3.2 
Other assets6.6 — 
Other current liabilities3.6 9.4 
Other liabilities0.9 8.5
Non-designated hedging instruments
Foreign currency forward contracts:
Prepaid expenses and other current assets6.1 3.5 
Other current liabilities1.1 2.7 
Schedule of Derivative Liabilities at Fair Value
The following table summarizes the fair value of designated and non-designated hedging instruments recognized within the Consolidated Balance Sheets as of June 30, 2024 and December 31, 2023:
(In millions)June 30, 2024December 31, 2023
Designated cash flow hedges
Interest rate derivatives:
Prepaid expenses and other current assets$0.2 $0.2 
Other assets24.6 — 
Other liabilities— 6.9 
Foreign currency forward contracts:
Prepaid expenses and other current assets4.7 3.2 
Other assets6.6 — 
Other current liabilities3.6 9.4 
Other liabilities0.9 8.5
Non-designated hedging instruments
Foreign currency forward contracts:
Prepaid expenses and other current assets6.1 3.5 
Other current liabilities1.1 2.7 
XML 45 R34.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Accumulated Other Comprehensive Loss (Tables)
 6 Months Ended
Jun. 30, 2024
Equity [Abstract]  
Schedule of Accumulated Other Comprehensive Income (Loss)
The following table summarizes the changes in AOCI by component:
Three Months Ended June 30, 2024
(In millions)Pension and Other Post-
Employment Benefits		Cash Flow HedgesAvailable-for-Sale InvestmentsForeign Currency Translation AdjustmentsAccumulated Other Comprehensive (Loss) Income
Balance at March 31, 2024$(1.3)$14.8 $— $(39.7)$(26.2)
Current period deferrals (1)
— 13.1 — (2.4)10.7 
Amounts reclassified to Net loss
— (6.2)— (2.9)(9.1)
Net change— 6.9 — (5.3)1.6 
Balance at June 30, 2024$(1.3)$21.7 $— $(45.0)$(24.6)
Six Months Ended June 30, 2024
(In millions)Pension and Other Post-
Employment Benefits		Cash Flow HedgesAvailable-for-Sale InvestmentsForeign Currency Translation AdjustmentsAccumulated Other Comprehensive (Loss) Income
Balance at December 31, 2023$(1.3)$(9.8)$— $(18.9)$(30.0)
Current period deferrals (1)
— 43.6 — (21.2)22.4 
Amounts reclassified to Net loss
— (12.1)— (4.9)(17.0)
Net change— 31.5 — (26.1)5.4 
Balance at June 30, 2024$(1.3)$21.7 $— $(45.0)$(24.6)
Three Months Ended July 2, 2023
(In millions)Pension and Other Post-
Employment Benefits		Cash Flow HedgesAvailable-for-Sale InvestmentsForeign Currency Translation AdjustmentsAccumulated Other Comprehensive (Loss) Income
Balance at April 2, 2023$0.7 $(21.1)$(0.3)$(38.6)$(59.3)
Current period deferrals (2)
— 40.0 (0.1)7.4 47.3 
Amounts reclassified to Net loss
— (4.3)— — (4.3)
Net change— 35.7 (0.1)7.4 43.0 
Balance at July 2, 2023$0.7 $14.6 $(0.4)$(31.2)$(16.3)
Six Months Ended July 2, 2023
(In millions)Pension and Other Post-
employment Benefits		Cash Flow HedgesAvailable-for-Sale InvestmentsForeign Currency Translation AdjustmentsAccumulated Other Comprehensive (Loss) Income
Balance at January 1, 2023$0.7 $1.5 $(0.5)$(69.3)$(67.6)
Current period deferrals (2)
— 23.1 0.1 38.1 61.3 
Amounts reclassified to Net loss
— (10.0)— — (10.0)
Net change— 13.1 0.1 38.1 51.3 
Balance at July 2, 2023$0.7 $14.6 $(0.4)$(31.2)$(16.3)
(1) Includes tax impact of (i) $0.9 million and $7.4 million related to cash flow hedges for the three and six months ended June 30, 2024, respectively, and (ii) $0.9 million and $2.9 million related to foreign currency translation adjustments for the three and six months ended June 30, 2024, respectively.
(2) Includes tax impact of $9.5 million and $3.4 million related to cash flow hedges for the three and six months ended July 2, 2023, respectively.
XML 46 R35.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Jul. 02, 2023
Jun. 30, 2024
Jul. 02, 2023
Reclassification [Line Items]        
Asset impairment charge $ 56.9 $ 0.5 $ 56.9 $ 1.0
Revision of Prior Period, Reclassification, Adjustment        
Reclassification [Line Items]        
Asset impairment charge   0.5   1.0
Revision of Prior Period, Reclassification, Adjustment | Cost of sales, excluding amortization of intangibles        
Reclassification [Line Items]        
Asset impairment charge   0.1   0.1
Revision of Prior Period, Reclassification, Adjustment | Research and development        
Reclassification [Line Items]        
Asset impairment charge   $ 0.4   $ 0.9
XML 47 R36.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Computation of Earnings Per Share - Calculation of Basic and Diluted Earnings Per Share (Details) - shares
shares in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Jul. 02, 2023
Jun. 30, 2024
Jul. 02, 2023
Earnings Per Share [Abstract]        
Basic weighted-average shares of common stock outstanding 67.1 66.8 67.0 66.7
Dilutive potential shares issuable from stock options and RSUs 0.0 0.0 0.0 0.0
Diluted weighted-average shares of common stock outstanding 67.1 66.8 67.0 66.7
Potentially dilutive shares excluded from calculation due to anti-dilutive effect 0.2 0.4 0.3 0.5
PotentialWeightedAverageNumberOfDilutedSharesOutstandingDiluted weighted-average shares of common stock outstanding 67.3 67.2 67.3 67.2
XML 48 R37.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Computation of Earnings Per Share - Narrative (Details) - shares
shares in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Jul. 02, 2023
Jun. 30, 2024
Jul. 02, 2023
Statement [Line Items]        
Potentially dilutive shares excluded from calculation due to anti-dilutive effect 0.2 0.4 0.3 0.5
Share-Based Payment Arrangement        
Statement [Line Items]        
Potentially dilutive shares excluded from calculation due to anti-dilutive effect 2.1 1.2 2.1 1.1
XML 49 R38.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Revenue - Narrative (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Jul. 02, 2023
Jun. 30, 2024
Jul. 02, 2023
Dec. 31, 2023
Disaggregation of Revenue [Line Items]          
Deferred revenue, current $ 40.1   $ 40.1   $ 36.8
Deferred revenue, noncurrent 15.9   15.9   13.9
Deferred revenue, revenue recognized 9.2   27.0    
Accounts receivable, net $ 269.5   $ 269.5   303.3
Revenue Benchmark | Product Concentration Risk | Respiratory          
Disaggregation of Revenue [Line Items]          
Percentage of risk concentration 9.00% 13.00% 14.00% 23.00%  
Collaborative Arrangement, Transaction with Party to Collaborative Arrangement          
Disaggregation of Revenue [Line Items]          
Gross Profit $ 8.9 $ 6.1 $ 17.0 $ 29.7  
Revenue 2.4 0.6 5.5 23.0  
Collaborative Arrangement, Transaction with Party to Collaborative Arrangement and Third Party          
Disaggregation of Revenue [Line Items]          
Gross Profit 6.5 $ 5.5 11.5 $ 6.7  
Prepaid expenses and other current assets          
Disaggregation of Revenue [Line Items]          
Contract assets 44.1   44.1   46.2
Customer One          
Disaggregation of Revenue [Line Items]          
Contract assets 0.0   0.0   1.9
Expected Value Contract Customers | Prepaid expenses and other current assets          
Disaggregation of Revenue [Line Items]          
Contract assets 44.1   44.1   41.8
Customer Two          
Disaggregation of Revenue [Line Items]          
Contract assets $ 0.0   $ 0.0   2.5
Customer Three | Total revenues | Customer Concentration Risk          
Disaggregation of Revenue [Line Items]          
Percentage of risk concentration     11.00%    
Customers With Balances Due In Excess of 10% Of Accounts Receivable | Accounts Receivable | Customer Concentration Risk          
Disaggregation of Revenue [Line Items]          
Accounts receivable, net         $ 63.5
XML 50 R39.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Revenue - Disaggregation of Revenue (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Jul. 02, 2023
Jun. 30, 2024
Jul. 02, 2023
Disaggregation of Revenue [Line Items]        
Total revenues $ 637.0 $ 665.1 $ 1,348.0 $ 1,511.2
Labs        
Disaggregation of Revenue [Line Items]        
Total revenues 354.2 361.4 711.1 732.1
Transfusion Medicine        
Disaggregation of Revenue [Line Items]        
Total revenues 161.3 163.3 321.6 319.2
Point of Care        
Disaggregation of Revenue [Line Items]        
Total revenues 117.1 134.2 303.7 442.3
Molecular Diagnostics        
Disaggregation of Revenue [Line Items]        
Total revenues $ 4.4 $ 6.2 $ 11.6 $ 17.6
XML 51 R40.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Segment and Geographic Information - Narrative (Details)
 6 Months Ended
Jun. 30, 2024
segment
Industry And Geographic Information [Abstract]  
Number of reportable segments 3
Number of operating segments 5
XML 52 R41.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Segment and Geographic Information - Total Revenues by Reportable Segment (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Jul. 02, 2023
Jun. 30, 2024
Jul. 02, 2023
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]        
Total revenues $ 637.0 $ 665.1 $ 1,348.0 $ 1,511.2
North America        
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]        
Total revenues 350.1 378.8 784.0 961.6
EMEA        
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]        
Total revenues 81.1 80.6 165.9 161.9
China        
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]        
Total revenues 81.6 81.3 157.7 151.9
Other        
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]        
Total revenues $ 124.2 $ 124.4 $ 240.4 $ 235.8
XML 53 R42.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Segment and Geographic Information - Reconciliation to Income (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Mar. 31, 2024
Jul. 02, 2023
Jun. 30, 2024
Jul. 02, 2023
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]          
Segment Adjusted EBITDA $ 255.2   $ 248.1 $ 543.5 $ 584.0
Corporate (165.3)   (134.8) (321.6) (225.4)
Interest expense, net (41.0)   (36.5) (80.0) (73.2)
Depreciation and amortization (116.1)   (114.5) (231.0) (228.7)
Integration related costs (30.9)   (24.2) (53.5) (53.9)
Goodwill impairment charge 0.0 $ (1,700.0) 0.0 (1,743.9) 0.0
Asset impairment charge (56.9)   (0.5) (56.9) (1.0)
Credit Agreement amendment fees (4.0)   0.0 (4.0) 0.0
Amortization of deferred cloud computing implementation costs (3.0)   (1.5) (5.9) (3.1)
EU medical device regulation transition costs (0.5)   (0.7) (1.1) (1.5)
Employee compensation charges 0.0   0.0 (5.6) 0.0
Tax indemnification income 0.0   0.4 0.0 0.1
Gain (loss) on investments 0.7   (0.2) 0.0 (0.2)
Other adjustments (1.1)   0.0 (1.8) (1.5)
Loss before income taxes (162.9)   (64.4) (1,961.8) (4.4)
North America          
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]          
Segment Adjusted EBITDA 173.9   176.3 392.7 454.7
Goodwill impairment charge       (1,743.9)  
EMEA          
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]          
Segment Adjusted EBITDA 11.4   5.3 24.2 12.5
Goodwill impairment charge       0.0  
China          
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]          
Segment Adjusted EBITDA 35.8   30.2 60.5 58.7
Goodwill impairment charge       0.0  
Other          
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]          
Segment Adjusted EBITDA $ 34.1   $ 36.3 66.1 $ 58.1
Goodwill impairment charge       $ 0.0  
XML 54 R43.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Income Taxes (Detail) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Jul. 02, 2023
Jun. 30, 2024
Jul. 02, 2023
Dec. 31, 2023
Income Tax Disclosure [Abstract]          
Benefit from income taxes $ (15,200,000) $ (11,200,000) $ (108,100,000) $ 0  
Loss before income taxes $ (162,900,000) $ (64,400,000) $ (1,961,800,000) $ (4,400,000)  
Effective income tax rate 9.30% 17.40% 5.50% 0.70%  
Unrecognized tax benefits $ 29,300,000   $ 29,300,000    
Unrecognized tax benefits the could impact effective tax rate 22,000,000.0   22,000,000.0    
Unrecognized tax benefits, income tax interest and penalties accrued 4,100,000   4,100,000    
Decrease in unrecognized tax benefits is reasonably possible 11,700,000   11,700,000    
Indemnification receivable $ 3,000,000.0   $ 3,000,000.0   $ 3,000,000.0
XML 55 R44.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Balance Sheet Account Details Cash, Cash Equivalents and Restricted Cash (Details) - USD ($)
$ in Millions
Jun. 30, 2024
Dec. 31, 2023
Jul. 02, 2023
Jan. 01, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]        
Cash and cash equivalents $ 107.0 $ 118.9    
Restricted cash included in Other assets 0.5 0.6    
Cash, cash equivalents and restricted cash $ 107.5 $ 119.5 $ 179.6 $ 293.9
XML 56 R45.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Balance Sheet Account Details - Narrative (Details) - USD ($)
Jun. 30, 2024
Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Fair Value $ 0 $ 55,800,000
XML 57 R46.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Balance Sheet Account Details Marketable Securities (Details) - USD ($)
Jun. 30, 2024
Dec. 31, 2023
Marketable Securities [Line Items]    
Amortized Cost   $ 55,900,000
Gross Unrealized Losses   (100,000)
Fair Value $ 0 55,800,000
Total marketable securities, current    
Marketable Securities [Line Items]    
Amortized Cost   48,500,000
Gross Unrealized Losses   (100,000)
Fair Value   48,400,000
Total marketable securities, current | Corporate bonds    
Marketable Securities [Line Items]    
Amortized Cost   38,100,000
Gross Unrealized Losses   (100,000)
Fair Value   38,000,000.0
Total marketable securities, current | Corporate asset-backed securities    
Marketable Securities [Line Items]    
Amortized Cost   8,900,000
Gross Unrealized Losses   0
Fair Value   8,900,000
Total marketable securities, current | Agency bonds    
Marketable Securities [Line Items]    
Amortized Cost   1,500,000
Gross Unrealized Losses   0
Fair Value   1,500,000
Total marketable securities | Corporate bonds    
Marketable Securities [Line Items]    
Amortized Cost   4,500,000
Gross Unrealized Losses   0
Fair Value   4,500,000
Total marketable securities | Corporate asset-backed securities    
Marketable Securities [Line Items]    
Amortized Cost   900,000
Gross Unrealized Losses   0
Fair Value   900,000
Total marketable securities | Sovereign government bonds    
Marketable Securities [Line Items]    
Amortized Cost   2,000,000.0
Gross Unrealized Losses   0
Fair Value   $ 2,000,000.0
XML 58 R47.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Balance Sheet Account Details Accounts Receivable (Details) - USD ($)
$ in Millions
Jun. 30, 2024
Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Accounts receivable $ 347.2 $ 395.1
Allowance for contract rebates and discounts (63.9) (77.2)
Allowance for doubtful accounts (13.8) (14.6)
Total accounts receivable, net $ 269.5 $ 303.3
XML 59 R48.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Balance Sheet Account Details Inventories (Details) - USD ($)
$ in Millions
Jun. 30, 2024
Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Raw materials $ 222.3 $ 212.7
Work-in-process (materials, labor and overhead) 99.3 92.3
Finished goods (materials, labor and overhead) 319.0 318.1
Inventories, including noncurrent portion, net 640.6 623.1
Inventories 602.0 577.8
Inventory, Noncurrent $ 38.6 $ 45.3
XML 60 R49.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Balance Sheet Account Details Prepaid expenses and other current assets (Details) - USD ($)
$ in Millions
Jun. 30, 2024
Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Income taxes and other tax receivables $ 156.4 $ 104.7
Prepaid expenses 68.3 67.0
Contract assets 44.1 46.2
Other receivables 27.3 34.2
Derivatives 11.0 6.9
Other 2.9 3.1
Total prepaid expenses and other current assets $ 310.0 $ 262.1
XML 61 R50.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Balance Sheet Account Details Other Current Liabilities (Details) - USD ($)
$ in Millions
Jun. 30, 2024
Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Accrued commissions, rebates and returns $ 67.1 $ 63.8
Deferred revenue $ 40.1 $ 36.8
Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Total other current liabilities Total other current liabilities
Operating lease liabilities $ 29.5 $ 26.7
Accrued other taxes payable 21.6 17.9
Derivatives 4.7 12.1
Accrued interest 1.4 30.3
Other 84.7 115.7
Total other current liabilities $ 249.1 $ 303.3
XML 62 R51.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Assets Held for Sale (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Jul. 02, 2023
Jun. 30, 2024
Jul. 02, 2023
Property, Plant and Equipment [Abstract]        
Asset impairment charge $ 56.9 $ 0.5 $ 56.9 $ 1.0
XML 63 R52.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Goodwill and Intangible Assets, Net - Goodwill Rollforward (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Mar. 31, 2024
Jul. 02, 2023
Jun. 30, 2024
Jul. 02, 2023
Goodwill [Line Items]          
Balance at December 31, 2023   $ 2,492.0   $ 2,492.0  
Impairment charge $ 0.0 (1,700.0) $ 0.0 (1,743.9) $ 0.0
Foreign currency translation       (15.6)  
Balance at June 30, 2024 732.5     732.5  
North America          
Goodwill [Line Items]          
Balance at December 31, 2023   1,743.9   1,743.9  
Impairment charge       (1,743.9)  
Foreign currency translation       0.0  
Balance at June 30, 2024 0.0     0.0  
EMEA          
Goodwill [Line Items]          
Balance at December 31, 2023   582.4   582.4  
Impairment charge       0.0  
Foreign currency translation       (7.6)  
Balance at June 30, 2024 574.8     574.8  
China          
Goodwill [Line Items]          
Balance at December 31, 2023   85.7   85.7  
Impairment charge       0.0  
Foreign currency translation       (1.5)  
Balance at June 30, 2024 84.2     84.2  
Other          
Goodwill [Line Items]          
Balance at December 31, 2023   $ 80.0   80.0  
Impairment charge       0.0  
Foreign currency translation       (6.5)  
Balance at June 30, 2024 $ 73.5     $ 73.5  
XML 64 R53.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Goodwill and Intangible Assets, Net - Narrative (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Mar. 31, 2024
Jul. 02, 2023
Jun. 30, 2024
Jul. 02, 2023
Goodwill [Line Items]          
Goodwill impairment charge $ 0.0 $ 1,700.0 $ 0.0 $ 1,743.9 $ 0.0
Reporting unit, estimated percentage of decrease in fair value (in percent)   0.05      
Minimum          
Goodwill [Line Items]          
Reporting unit, percentage of fair value in excess of carrying amount (in percent)   30.00%      
Reporting unit, percentage of fair value in excess of carrying amount, adjusted for decrease (in percent)   0.25      
Maximum          
Goodwill [Line Items]          
Reporting unit, percentage of fair value in excess of carrying amount (in percent)   150.00%      
Reporting unit, percentage of fair value in excess of carrying amount, adjusted for decrease (in percent)   1.40      
XML 65 R54.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Borrowings - Schedule of Borrowings (Details) - USD ($)
$ in Millions
Jun. 30, 2024
Dec. 31, 2023
May 27, 2022
Debt Instrument [Line Items]      
Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Other liabilities Other liabilities  
Financing lease obligation $ 0.1 $ 0.4  
Other short-term borrowings 0.0 1.6  
Other long-term borrowings 0.2 0.4  
Unamortized deferred financing costs (6.8) (8.0)  
Total borrowings 2,563.6 2,414.6  
Less: current portion (356.4) (139.8)  
Long-term borrowings 2,207.2 2,274.8  
Line of Credit | Term Loan | Credit Agreement      
Debt Instrument [Line Items]      
Long-term debt 2,317.1 2,420.2 $ 2,750.0
Line of Credit | Revolving Credit Facility | Credit Agreement      
Debt Instrument [Line Items]      
Long-term debt $ 253.0 $ 0.0  
XML 66 R55.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Borrowings - Narrative (Details) - Credit Agreement - Line of Credit
$ in Millions
 6 Months Ended
Jun. 30, 2024
USD ($)
Dec. 31, 2023
USD ($)
Aug. 04, 2022
USD ($)
May 27, 2022
USD ($)
Debt Instrument [Line Items]        
Interest coverage ratio, minimum 3.00      
On or Before June 30, 2023        
Debt Instrument [Line Items]        
Leverage ratio maximum 4.50      
After June 30, 2023 to June 30, 2024        
Debt Instrument [Line Items]        
Leverage ratio maximum 4.00      
After June 30, 2024 to December 31, 2024        
Debt Instrument [Line Items]        
Leverage ratio maximum 4.25      
After December 31, 2024 to June 30, 2025        
Debt Instrument [Line Items]        
Leverage ratio maximum 4.00      
After June 30, 2025        
Debt Instrument [Line Items]        
Leverage ratio maximum 3.75      
Term Loan        
Debt Instrument [Line Items]        
Long-term debt $ 2,317.1 $ 2,420.2   $ 2,750.0
Payments of term loan 103.1      
Revolving Credit Facility        
Debt Instrument [Line Items]        
Long-term debt 253.0 $ 0.0    
Line of credit, maximum borrowing capacity     $ 800.0  
Remaining borrowing capacity 534.0      
Letter of Credit        
Debt Instrument [Line Items]        
Proceeds from lines of credit $ 13.0      
XML 67 R56.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Borrowings - Interest Expense (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Jul. 02, 2023
Jun. 30, 2024
Jul. 02, 2023
Debt Instrument [Line Items]        
Amortization of deferred financing costs $ 0.8 $ 0.8 $ 1.6 $ 1.6
Derivative instruments and other (7.1) (7.2) (14.3) (11.7)
Interest income (0.5) (1.8) (1.4) (2.8)
Interest expense, net 41.0 36.5 80.0 73.2
Line of Credit | Term Loan | Credit Agreement        
Debt Instrument [Line Items]        
Interest expense, debt 44.4 44.2 88.9 85.1
Line of Credit | Revolving Credit Facility | Credit Agreement        
Debt Instrument [Line Items]        
Interest expense, debt $ 3.4 $ 0.5 $ 5.2 $ 1.0
XML 68 R57.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Stock-based Compensation - Compensation Expense Related to Stock-Based Compensation Plans (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Jul. 02, 2023
Jun. 30, 2024
Jul. 02, 2023
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]        
Total stock-based compensation expense $ 11.2 $ 17.0 $ 20.3 $ 31.0
Cost of sales, excluding amortization of intangibles        
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]        
Total stock-based compensation expense 1.5 1.1 2.7 2.1
Selling, marketing and administrative        
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]        
Total stock-based compensation expense 6.7 10.0 11.8 17.2
Research and development        
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]        
Total stock-based compensation expense 0.9 1.3 1.9 2.6
Integration related costs        
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]        
Total stock-based compensation expense $ 2.1 $ 4.6 $ 3.9 $ 9.1
XML 69 R58.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Stock-based Compensation - Narrative (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jul. 02, 2023
Jul. 02, 2023
Equity [Abstract]    
Share-based liabilities paid $ 2.8 $ 5.8
XML 70 R59.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Commitments and Contingencies (Details)
Jun. 21, 2024
stockholder
Apr. 25, 2024
defendant
stockholder
Apr. 12, 2024
defendant
Commitments and Contingencies Disclosure [Abstract]      
Number of executive defendants | defendant   3 3
Number of stockholders that filed complaints | stockholder 2 2  
XML 71 R60.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) - USD ($)
$ in Millions
Jun. 30, 2024
Dec. 31, 2023
Assets:    
Marketable securities $ 0.0 $ 55.8
Derivative assets 42.2 6.9
Total assets measured at fair value 42.2 62.7
Liabilities:    
Derivative liabilities 5.6 27.5
Contingent consideration 0.0 0.1
Total liabilities measured at fair value 5.6 27.6
Level 1    
Assets:    
Marketable securities 0.0 0.0
Derivative assets 0.0 0.0
Total assets measured at fair value 0.0 0.0
Liabilities:    
Derivative liabilities 0.0 0.0
Contingent consideration 0.0 0.0
Total liabilities measured at fair value 0.0 0.0
Level 2    
Assets:    
Marketable securities 0.0 55.8
Derivative assets 42.2 6.9
Total assets measured at fair value 42.2 62.7
Liabilities:    
Derivative liabilities 5.6 27.5
Contingent consideration 0.0 0.0
Total liabilities measured at fair value 5.6 27.5
Level 3    
Assets:    
Marketable securities 0.0 0.0
Derivative assets 0.0 0.0
Total assets measured at fair value 0.0 0.0
Liabilities:    
Derivative liabilities 0.0 0.0
Contingent consideration 0.0 0.1
Total liabilities measured at fair value $ 0.0 $ 0.1
XML 72 R61.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Fair Value Measurements - Narrative (Details) - Term Loan - Credit Agreement - Line of Credit - USD ($)
$ in Millions
Jun. 30, 2024
Dec. 31, 2023
May 27, 2022
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]      
Long-term debt, fair value $ 2,296.8 $ 2,396.0  
Long-term debt $ 2,317.1 $ 2,420.2 $ 2,750.0
XML 73 R62.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Derivative Instruments and Hedging Activities - Narrative (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Jul. 02, 2023
Jun. 30, 2024
Jul. 02, 2023
Derivative Instruments and Hedging Activities Disclosures [Line Items]        
Interest rate cash flow hedge, pre-tax gain (loss) from reclassification $ 20.4   $ 20.4  
Foreign currency cash flow hedge, gain (loss) to be reclassified during next 12 months 0.7   0.7  
Foreign Exchange Forward | Other Nonoperating Income (Expense)        
Derivative Instruments and Hedging Activities Disclosures [Line Items]        
Fair value gain (loss) on derivative instruments not designated as hedging instruments $ 5.7 $ 3.2 $ 5.7 $ 0.5
XML 74 R63.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Derivative Instruments and Hedging Activities - Schedule of Interest Rate Derivatives (Details) - Designated cash flow hedges
$ in Millions
Jun. 30, 2024
USD ($)
Interest Rate Swap One  
Derivative [Line Items]  
Derivative, Notional Amount $ 550.0
Derivative, Fixed Interest Rate 3.765%
Interest Rate Swap Two  
Derivative [Line Items]  
Derivative, Notional Amount $ 200.0
Derivative, Fixed Interest Rate 3.7725%
Interest Rate Swap Three  
Derivative [Line Items]  
Derivative, Notional Amount $ 300.0
Derivative, Fixed Interest Rate 3.7675%
Interest Rate Swap Four  
Derivative [Line Items]  
Derivative, Notional Amount $ 400.0
Derivative, Fixed Interest Rate 3.7575%
Interest Rate Swap Five  
Derivative [Line Items]  
Derivative, Notional Amount $ 350.0
Derivative, Fixed Interest Rate 3.7725%
XML 75 R64.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Derivative Instruments and Hedging Activities - Schedule of Currency Hedging Instruments (Details) - Foreign exchange contracts
$ in Millions
Jun. 30, 2024
USD ($)
Designated cash flow hedges  
Derivative [Line Items]  
Derivative, Notional Amount $ 217.0
Non-designated hedging instruments  
Derivative [Line Items]  
Derivative, Notional Amount $ 710.4
XML 76 R65.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Derivative Instruments and Hedging Activities - Schedule of Gain (Loss) (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Jul. 02, 2023
Jun. 30, 2024
Jul. 02, 2023
Foreign Exchange Forward | Total revenues        
Derivative Instruments and Hedging Activities Disclosures [Line Items]        
Amount of Loss (Gain) Recognized in OCI on Hedges $ (3.2) $ (0.4) $ (6.0) $ 1.7
Amount of Loss (Gain) Reclassified From AOCI Into Income 0.7 1.8 2.1 0.9
Foreign Exchange Forward | Cost of sales, excluding amortization of intangibles        
Derivative Instruments and Hedging Activities Disclosures [Line Items]        
Amount of Loss (Gain) Recognized in OCI on Hedges 0.0 (2.1) 0.8 (2.1)
Amount of Loss (Gain) Reclassified From AOCI Into Income 0.1 1.3 0.0 1.7
Interest Rate Swap | Interest expense, net        
Derivative Instruments and Hedging Activities Disclosures [Line Items]        
Amount of Loss (Gain) Recognized in OCI on Hedges (10.8) (47.0) (45.8) (26.1)
Amount of Loss (Gain) Reclassified From AOCI Into Income $ (7.0) $ (7.4) $ (14.2) $ (12.6)
XML 77 R66.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Derivative Instruments and Hedging Activities - Schedule of Net Investment Hedge (Details) - Net Investment Hedging Relationships - Foreign exchange contracts - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2024
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax $ (7.3) $ (18.3)
Other Nonoperating Income (Expense)    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments and Tax $ (2.9) $ (4.9)
XML 78 R67.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Derivative Instruments and Hedging Activities - Schedule of Fair Value (Details) - USD ($)
$ in Millions
Jun. 30, 2024
Dec. 31, 2023
Interest Rate Swap | Designated cash flow hedges | Prepaid expenses and other current assets    
Derivative [Line Items]    
Derivative Asset, Fair Value, Gross Asset $ 0.2 $ 0.2
Interest Rate Swap | Designated cash flow hedges | Other assets    
Derivative [Line Items]    
Derivative Asset, Fair Value, Gross Asset 24.6 0.0
Interest Rate Swap | Designated cash flow hedges | Other liabilities    
Derivative [Line Items]    
Derivative Liability, Fair Value, Gross Liability 0.0 6.9
Foreign exchange contracts | Designated cash flow hedges | Prepaid expenses and other current assets    
Derivative [Line Items]    
Derivative Asset, Fair Value, Gross Asset 4.7 3.2
Foreign exchange contracts | Designated cash flow hedges | Other assets    
Derivative [Line Items]    
Derivative Asset, Fair Value, Gross Asset 6.6 0.0
Foreign exchange contracts | Designated cash flow hedges | Other current liabilities    
Derivative [Line Items]    
Derivative Liability, Fair Value, Gross Liability 3.6 9.4
Foreign exchange contracts | Designated cash flow hedges | Other liabilities    
Derivative [Line Items]    
Derivative Liability, Fair Value, Gross Liability 0.9 8.5
Foreign exchange contracts | Non-designated hedging instruments | Prepaid expenses and other current assets    
Derivative [Line Items]    
Derivative Asset, Fair Value, Gross Asset 6.1 3.5
Foreign exchange contracts | Non-designated hedging instruments | Other current liabilities    
Derivative [Line Items]    
Derivative Liability, Fair Value, Gross Liability $ 1.1 $ 2.7
XML 79 R68.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Accumulated Other Comprehensive Loss (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Jul. 02, 2023
Jun. 30, 2024
Jul. 02, 2023
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Beginning balance $ (26.2) $ (59.3) $ (30.0) $ (67.6)
Current period deferrals 10.7 47.3 22.4 61.3
Amounts reclassified to Net loss (9.1) (4.3) (17.0) (10.0)
Net change 1.6 43.0 5.4 51.3
Ending balance (24.6) (16.3) (24.6) (16.3)
Tax impact related to cash flow hedges 0.9 9.5 7.4 3.4
OCI, foreign currency transaction and translation gain (loss), arising during period, tax 0.9   2.9  
Pension and Other Post- Employment Benefits        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Beginning balance (1.3) 0.7 (1.3) 0.7
Current period deferrals 0.0 0.0 0.0 0.0
Amounts reclassified to Net loss 0.0 0.0 0.0 0.0
Net change 0.0 0.0 0.0 0.0
Ending balance (1.3) 0.7 (1.3) 0.7
Cash Flow Hedges        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Beginning balance 14.8 (21.1) (9.8) 1.5
Current period deferrals 13.1 40.0 43.6 23.1
Amounts reclassified to Net loss (6.2) (4.3) (12.1) (10.0)
Net change 6.9 35.7 31.5 13.1
Ending balance 21.7 14.6 21.7 14.6
Available-for-Sale Investments        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Beginning balance 0.0 (0.3) 0.0 (0.5)
Current period deferrals 0.0 (0.1) 0.0 0.1
Amounts reclassified to Net loss 0.0 0.0 0.0 0.0
Net change 0.0 (0.1) 0.0 0.1
Ending balance 0.0 (0.4) 0.0 (0.4)
Foreign Currency Translation Adjustments        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Beginning balance (39.7) (38.6) (18.9) (69.3)
Current period deferrals (2.4) 7.4 (21.2) 38.1
Amounts reclassified to Net loss (2.9) 0.0 (4.9) 0.0
Net change (5.3) 7.4 (26.1) 38.1
Ending balance $ (45.0) $ (31.2) $ (45.0) $ (31.2)
EXCEL 80 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 81 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 82 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 84 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.2.u1 html 265 283 1 false 74 0 false 7 false false R1.htm 0000001 - Document - Cover Page Sheet http://www.quidelortho.com/role/CoverPage Cover Page Cover 1 false false R2.htm 9952151 - Statement - Consolidated Balance Sheets (Unaudited) Sheet http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited Consolidated Balance Sheets (Unaudited) Statements 2 false false R3.htm 9952152 - Statement - Consolidated Balance Sheets (Unaudited) (Parenthetical) Sheet http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical Consolidated Balance Sheets (Unaudited) (Parenthetical) Statements 3 false false R4.htm 9952153 - Statement - Consolidated Statements of Loss (Unaudited) Sheet http://www.quidelortho.com/role/ConsolidatedStatementsofLossUnaudited Consolidated Statements of Loss (Unaudited) Statements 4 false false R5.htm 9952154 - Statement - Consolidated Statements of Comprehensive (Loss) Income (Unaudited) Sheet http://www.quidelortho.com/role/ConsolidatedStatementsofComprehensiveLossIncomeUnaudited Consolidated Statements of Comprehensive (Loss) Income (Unaudited) Statements 5 false false R6.htm 9952155 - Statement - Consolidated Statements of Stockholders' Equity (Unaudited) Sheet http://www.quidelortho.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited Consolidated Statements of Stockholders' Equity (Unaudited) Statements 6 false false R7.htm 9952156 - Statement - Consolidated Statements of Cash Flows (Unaudited) Sheet http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited Consolidated Statements of Cash Flows (Unaudited) Statements 7 false false R8.htm 9952157 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies Sheet http://www.quidelortho.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies Basis of Presentation and Summary of Significant Accounting Policies Notes 8 false false R9.htm 9952158 - Disclosure - Computation of Earnings Per Share Sheet http://www.quidelortho.com/role/ComputationofEarningsPerShare Computation of Earnings Per Share Notes 9 false false R10.htm 9952159 - Disclosure - Revenue Sheet http://www.quidelortho.com/role/Revenue Revenue Notes 10 false false R11.htm 9952160 - Disclosure - Segment and Geographic Information Sheet http://www.quidelortho.com/role/SegmentandGeographicInformation Segment and Geographic Information Notes 11 false false R12.htm 9952161 - Disclosure - Income Taxes Sheet http://www.quidelortho.com/role/IncomeTaxes Income Taxes Notes 12 false false R13.htm 9952162 - Disclosure - Balance Sheet Account Details Sheet http://www.quidelortho.com/role/BalanceSheetAccountDetails Balance Sheet Account Details Notes 13 false false R14.htm 9952163 - Disclosure - Assets Held for Sale Sheet http://www.quidelortho.com/role/AssetsHeldforSale Assets Held for Sale Notes 14 false false R15.htm 9952164 - Disclosure - Goodwill and Intangible Assets, Net Sheet http://www.quidelortho.com/role/GoodwillandIntangibleAssetsNet Goodwill and Intangible Assets, Net Notes 15 false false R16.htm 9952165 - Disclosure - Borrowings Sheet http://www.quidelortho.com/role/Borrowings Borrowings Notes 16 false false R17.htm 9952166 - Disclosure - Stock-based Compensation Sheet http://www.quidelortho.com/role/StockbasedCompensation Stock-based Compensation Notes 17 false false R18.htm 9952167 - Disclosure - Commitments and Contingencies Sheet http://www.quidelortho.com/role/CommitmentsandContingencies Commitments and Contingencies Notes 18 false false R19.htm 9952168 - Disclosure - Fair Value Measurements Sheet http://www.quidelortho.com/role/FairValueMeasurements Fair Value Measurements Notes 19 false false R20.htm 9952169 - Disclosure - Derivative Instruments and Hedging Activities Sheet http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivities Derivative Instruments and Hedging Activities Notes 20 false false R21.htm 9952170 - Disclosure - Accumulated Other Comprehensive Loss Sheet http://www.quidelortho.com/role/AccumulatedOtherComprehensiveLoss Accumulated Other Comprehensive Loss Notes 21 false false R22.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 22 false false R23.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 23 false false R24.htm 9954471 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies) Sheet http://www.quidelortho.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies Basis of Presentation and Summary of Significant Accounting Policies (Policies) Policies http://www.quidelortho.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies 24 false false R25.htm 9954472 - Disclosure - Computation of Earnings Per Share (Tables) Sheet http://www.quidelortho.com/role/ComputationofEarningsPerShareTables Computation of Earnings Per Share (Tables) Tables http://www.quidelortho.com/role/ComputationofEarningsPerShare 25 false false R26.htm 9954473 - Disclosure - Revenue (Tables) Sheet http://www.quidelortho.com/role/RevenueTables Revenue (Tables) Tables http://www.quidelortho.com/role/Revenue 26 false false R27.htm 9954474 - Disclosure - Segment and Geographic Information (Tables) Sheet http://www.quidelortho.com/role/SegmentandGeographicInformationTables Segment and Geographic Information (Tables) Tables http://www.quidelortho.com/role/SegmentandGeographicInformation 27 false false R28.htm 9954475 - Disclosure - Balance Sheet Account Details (Tables) Sheet http://www.quidelortho.com/role/BalanceSheetAccountDetailsTables Balance Sheet Account Details (Tables) Tables http://www.quidelortho.com/role/BalanceSheetAccountDetails 28 false false R29.htm 9954476 - Disclosure - Goodwill and Intangible Assets, Net (Tables) Sheet http://www.quidelortho.com/role/GoodwillandIntangibleAssetsNetTables Goodwill and Intangible Assets, Net (Tables) Tables http://www.quidelortho.com/role/GoodwillandIntangibleAssetsNet 29 false false R30.htm 9954477 - Disclosure - Borrowings (Tables) Sheet http://www.quidelortho.com/role/BorrowingsTables Borrowings (Tables) Tables http://www.quidelortho.com/role/Borrowings 30 false false R31.htm 9954478 - Disclosure - Stock-based Compensation (Tables) Sheet http://www.quidelortho.com/role/StockbasedCompensationTables Stock-based Compensation (Tables) Tables http://www.quidelortho.com/role/StockbasedCompensation 31 false false R32.htm 9954479 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.quidelortho.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.quidelortho.com/role/FairValueMeasurements 32 false false R33.htm 9954480 - Disclosure - Derivative Instruments and Hedging Activities (Tables) Sheet http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesTables Derivative Instruments and Hedging Activities (Tables) Tables http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivities 33 false false R34.htm 9954481 - Disclosure - Accumulated Other Comprehensive Loss (Tables) Sheet http://www.quidelortho.com/role/AccumulatedOtherComprehensiveLossTables Accumulated Other Comprehensive Loss (Tables) Tables http://www.quidelortho.com/role/AccumulatedOtherComprehensiveLoss 34 false false R35.htm 9954482 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details) Sheet http://www.quidelortho.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details) Details http://www.quidelortho.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies 35 false false R36.htm 9954483 - Disclosure - Computation of Earnings Per Share - Calculation of Basic and Diluted Earnings Per Share (Details) Sheet http://www.quidelortho.com/role/ComputationofEarningsPerShareCalculationofBasicandDilutedEarningsPerShareDetails Computation of Earnings Per Share - Calculation of Basic and Diluted Earnings Per Share (Details) Details 36 false false R37.htm 9954484 - Disclosure - Computation of Earnings Per Share - Narrative (Details) Sheet http://www.quidelortho.com/role/ComputationofEarningsPerShareNarrativeDetails Computation of Earnings Per Share - Narrative (Details) Details 37 false false R38.htm 9954485 - Disclosure - Revenue - Narrative (Details) Sheet http://www.quidelortho.com/role/RevenueNarrativeDetails Revenue - Narrative (Details) Details 38 false false R39.htm 9954486 - Disclosure - Revenue - Disaggregation of Revenue (Details) Sheet http://www.quidelortho.com/role/RevenueDisaggregationofRevenueDetails Revenue - Disaggregation of Revenue (Details) Details 39 false false R40.htm 9954487 - Disclosure - Segment and Geographic Information - Narrative (Details) Sheet http://www.quidelortho.com/role/SegmentandGeographicInformationNarrativeDetails Segment and Geographic Information - Narrative (Details) Details 40 false false R41.htm 9954488 - Disclosure - Segment and Geographic Information - Total Revenues by Reportable Segment (Details) Sheet http://www.quidelortho.com/role/SegmentandGeographicInformationTotalRevenuesbyReportableSegmentDetails Segment and Geographic Information - Total Revenues by Reportable Segment (Details) Details 41 false false R42.htm 9954489 - Disclosure - Segment and Geographic Information - Reconciliation to Income (Details) Sheet http://www.quidelortho.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails Segment and Geographic Information - Reconciliation to Income (Details) Details 42 false false R43.htm 9954490 - Disclosure - Income Taxes (Detail) Sheet http://www.quidelortho.com/role/IncomeTaxesDetail Income Taxes (Detail) Details http://www.quidelortho.com/role/IncomeTaxes 43 false false R44.htm 9954491 - Disclosure - Balance Sheet Account Details Cash, Cash Equivalents and Restricted Cash (Details) Sheet http://www.quidelortho.com/role/BalanceSheetAccountDetailsCashCashEquivalentsandRestrictedCashDetails Balance Sheet Account Details Cash, Cash Equivalents and Restricted Cash (Details) Details 44 false false R45.htm 9954492 - Disclosure - Balance Sheet Account Details - Narrative (Details) Sheet http://www.quidelortho.com/role/BalanceSheetAccountDetailsNarrativeDetails Balance Sheet Account Details - Narrative (Details) Details 45 false false R46.htm 9954493 - Disclosure - Balance Sheet Account Details Marketable Securities (Details) Sheet http://www.quidelortho.com/role/BalanceSheetAccountDetailsMarketableSecuritiesDetails Balance Sheet Account Details Marketable Securities (Details) Details 46 false false R47.htm 9954494 - Disclosure - Balance Sheet Account Details Accounts Receivable (Details) Sheet http://www.quidelortho.com/role/BalanceSheetAccountDetailsAccountsReceivableDetails Balance Sheet Account Details Accounts Receivable (Details) Details 47 false false R48.htm 9954495 - Disclosure - Balance Sheet Account Details Inventories (Details) Sheet http://www.quidelortho.com/role/BalanceSheetAccountDetailsInventoriesDetails Balance Sheet Account Details Inventories (Details) Details 48 false false R49.htm 9954496 - Disclosure - Balance Sheet Account Details Prepaid expenses and other current assets (Details) Sheet http://www.quidelortho.com/role/BalanceSheetAccountDetailsPrepaidexpensesandothercurrentassetsDetails Balance Sheet Account Details Prepaid expenses and other current assets (Details) Details 49 false false R50.htm 9954497 - Disclosure - Balance Sheet Account Details Other Current Liabilities (Details) Sheet http://www.quidelortho.com/role/BalanceSheetAccountDetailsOtherCurrentLiabilitiesDetails Balance Sheet Account Details Other Current Liabilities (Details) Details 50 false false R51.htm 9954498 - Disclosure - Assets Held for Sale (Details) Sheet http://www.quidelortho.com/role/AssetsHeldforSaleDetails Assets Held for Sale (Details) Details http://www.quidelortho.com/role/AssetsHeldforSale 51 false false R52.htm 9954499 - Disclosure - Goodwill and Intangible Assets, Net - Goodwill Rollforward (Details) Sheet http://www.quidelortho.com/role/GoodwillandIntangibleAssetsNetGoodwillRollforwardDetails Goodwill and Intangible Assets, Net - Goodwill Rollforward (Details) Details 52 false false R53.htm 9954500 - Disclosure - Goodwill and Intangible Assets, Net - Narrative (Details) Sheet http://www.quidelortho.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails Goodwill and Intangible Assets, Net - Narrative (Details) Details 53 false false R54.htm 9954501 - Disclosure - Borrowings - Schedule of Borrowings (Details) Sheet http://www.quidelortho.com/role/BorrowingsScheduleofBorrowingsDetails Borrowings - Schedule of Borrowings (Details) Details 54 false false R55.htm 9954502 - Disclosure - Borrowings - Narrative (Details) Sheet http://www.quidelortho.com/role/BorrowingsNarrativeDetails Borrowings - Narrative (Details) Details 55 false false R56.htm 9954503 - Disclosure - Borrowings - Interest Expense (Details) Sheet http://www.quidelortho.com/role/BorrowingsInterestExpenseDetails Borrowings - Interest Expense (Details) Details 56 false false R57.htm 9954504 - Disclosure - Stock-based Compensation - Compensation Expense Related to Stock-Based Compensation Plans (Details) Sheet http://www.quidelortho.com/role/StockbasedCompensationCompensationExpenseRelatedtoStockBasedCompensationPlansDetails Stock-based Compensation - Compensation Expense Related to Stock-Based Compensation Plans (Details) Details 57 false false R58.htm 9954505 - Disclosure - Stock-based Compensation - Narrative (Details) Sheet http://www.quidelortho.com/role/StockbasedCompensationNarrativeDetails Stock-based Compensation - Narrative (Details) Details 58 false false R59.htm 9954506 - Disclosure - Commitments and Contingencies (Details) Sheet http://www.quidelortho.com/role/CommitmentsandContingenciesDetails Commitments and Contingencies (Details) Details http://www.quidelortho.com/role/CommitmentsandContingencies 59 false false R60.htm 9954507 - Disclosure - Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) Sheet http://www.quidelortho.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) Details 60 false false R61.htm 9954508 - Disclosure - Fair Value Measurements - Narrative (Details) Sheet http://www.quidelortho.com/role/FairValueMeasurementsNarrativeDetails Fair Value Measurements - Narrative (Details) Details 61 false false R62.htm 9954509 - Disclosure - Derivative Instruments and Hedging Activities - Narrative (Details) Sheet http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails Derivative Instruments and Hedging Activities - Narrative (Details) Details 62 false false R63.htm 9954510 - Disclosure - Derivative Instruments and Hedging Activities - Schedule of Interest Rate Derivatives (Details) Sheet http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofInterestRateDerivativesDetails Derivative Instruments and Hedging Activities - Schedule of Interest Rate Derivatives (Details) Details 63 false false R64.htm 9954511 - Disclosure - Derivative Instruments and Hedging Activities - Schedule of Currency Hedging Instruments (Details) Sheet http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofCurrencyHedgingInstrumentsDetails Derivative Instruments and Hedging Activities - Schedule of Currency Hedging Instruments (Details) Details 64 false false R65.htm 9954512 - Disclosure - Derivative Instruments and Hedging Activities - Schedule of Gain (Loss) (Details) Sheet http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofGainLossDetails Derivative Instruments and Hedging Activities - Schedule of Gain (Loss) (Details) Details 65 false false R66.htm 9954513 - Disclosure - Derivative Instruments and Hedging Activities - Schedule of Net Investment Hedge (Details) Sheet http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNetInvestmentHedgeDetails Derivative Instruments and Hedging Activities - Schedule of Net Investment Hedge (Details) Details 66 false false R67.htm 9954514 - Disclosure - Derivative Instruments and Hedging Activities - Schedule of Fair Value (Details) Sheet http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofFairValueDetails Derivative Instruments and Hedging Activities - Schedule of Fair Value (Details) Details 67 false false R68.htm 9954515 - Disclosure - Accumulated Other Comprehensive Loss (Details) Sheet http://www.quidelortho.com/role/AccumulatedOtherComprehensiveLossDetails Accumulated Other Comprehensive Loss (Details) Details http://www.quidelortho.com/role/AccumulatedOtherComprehensiveLossTables 68 false false All Reports Book All Reports qdel-20240630.htm qdel-20240630.xsd qdel-20240630_cal.xml qdel-20240630_def.xml qdel-20240630_lab.xml qdel-20240630_pre.xml http://fasb.org/us-gaap/2024 http://xbrl.sec.gov/dei/2024 http://xbrl.sec.gov/ecd/2024 true true JSON 87 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "qdel-20240630.htm": { "nsprefix": "qdel", "nsuri": "http://www.quidelortho.com/20240630", "dts": { "inline": { "local": [ "qdel-20240630.htm" ] }, "schema": { "local": [ "qdel-20240630.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd", "https://xbrl.sec.gov/country/2024/country-2024.xsd", "https://xbrl.sec.gov/dei/2024/dei-2024.xsd", "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd", "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" ] }, "calculationLink": { "local": [ "qdel-20240630_cal.xml" ] }, "definitionLink": { "local": [ "qdel-20240630_def.xml" ] }, "labelLink": { "local": [ "qdel-20240630_lab.xml" ] }, "presentationLink": { "local": [ "qdel-20240630_pre.xml" ] } }, "keyStandard": 258, "keyCustom": 25, "axisStandard": 20, "axisCustom": 2, "memberStandard": 45, "memberCustom": 28, "hidden": { "total": 9, "http://xbrl.sec.gov/dei/2024": 5, "http://fasb.org/us-gaap/2024": 4 }, "contextCount": 265, "entityCount": 1, "segmentCount": 74, "elementCount": 566, "unitCount": 7, "baseTaxonomies": { "http://fasb.org/us-gaap/2024": 918, "http://xbrl.sec.gov/dei/2024": 29, "http://xbrl.sec.gov/ecd/2024": 4 }, "report": { "R1": { "role": "http://www.quidelortho.com/role/CoverPage", "longName": "0000001 - Document - Cover Page", "shortName": "Cover Page", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true } }, "R2": { "role": "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited", "longName": "9952151 - Statement - Consolidated Balance Sheets (Unaudited)", "shortName": "Consolidated Balance Sheets (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:MarketableSecuritiesCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "unique": true } }, "R3": { "role": "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical", "longName": "9952152 - Statement - Consolidated Balance Sheets (Unaudited) (Parenthetical)", "shortName": "Consolidated Balance Sheets (Unaudited) (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "us-gaap:PreferredStockParOrStatedValuePerShare", "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "us-gaap:PreferredStockParOrStatedValuePerShare", "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true } }, "R4": { "role": "http://www.quidelortho.com/role/ConsolidatedStatementsofLossUnaudited", "longName": "9952153 - Statement - Consolidated Statements of Loss (Unaudited)", "shortName": "Consolidated Statements of Loss (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:Revenues", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "unique": true } }, "R5": { "role": "http://www.quidelortho.com/role/ConsolidatedStatementsofComprehensiveLossIncomeUnaudited", "longName": "9952154 - Statement - Consolidated Statements of Comprehensive (Loss) Income (Unaudited)", "shortName": "Consolidated Statements of Comprehensive (Loss) Income (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "unique": true } }, "R6": { "role": "http://www.quidelortho.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited", "longName": "9952155 - Statement - Consolidated Statements of Stockholders' Equity (Unaudited)", "shortName": "Consolidated Statements of Stockholders' Equity (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "c-30", "name": "us-gaap:SharesOutstanding", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-35", "name": "us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "unique": true } }, "R7": { "role": "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited", "longName": "9952156 - Statement - Consolidated Statements of Cash Flows (Unaudited)", "shortName": "Consolidated Statements of Cash Flows (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "7", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ShareBasedCompensation", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "unique": true } }, "R8": { "role": "http://www.quidelortho.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies", "longName": "9952157 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies", "shortName": "Basis of Presentation and Summary of Significant Accounting Policies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true } }, "R9": { "role": "http://www.quidelortho.com/role/ComputationofEarningsPerShare", "longName": "9952158 - Disclosure - Computation of Earnings Per Share", "shortName": "Computation of Earnings Per Share", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true } }, "R10": { "role": "http://www.quidelortho.com/role/Revenue", "longName": "9952159 - Disclosure - Revenue", "shortName": "Revenue", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true } }, "R11": { "role": "http://www.quidelortho.com/role/SegmentandGeographicInformation", "longName": "9952160 - Disclosure - Segment and Geographic Information", "shortName": "Segment and Geographic Information", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true } }, "R12": { "role": "http://www.quidelortho.com/role/IncomeTaxes", "longName": "9952161 - Disclosure - Income Taxes", "shortName": "Income Taxes", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true } }, "R13": { "role": "http://www.quidelortho.com/role/BalanceSheetAccountDetails", "longName": "9952162 - Disclosure - Balance Sheet Account Details", "shortName": "Balance Sheet Account Details", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true } }, "R14": { "role": "http://www.quidelortho.com/role/AssetsHeldforSale", "longName": "9952163 - Disclosure - Assets Held for Sale", "shortName": "Assets Held for Sale", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true } }, "R15": { "role": "http://www.quidelortho.com/role/GoodwillandIntangibleAssetsNet", "longName": "9952164 - Disclosure - Goodwill and Intangible Assets, Net", "shortName": "Goodwill and Intangible Assets, Net", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true } }, "R16": { "role": "http://www.quidelortho.com/role/Borrowings", "longName": "9952165 - Disclosure - Borrowings", "shortName": "Borrowings", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true } }, "R17": { "role": "http://www.quidelortho.com/role/StockbasedCompensation", "longName": "9952166 - Disclosure - Stock-based Compensation", "shortName": "Stock-based Compensation", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true } }, "R18": { "role": "http://www.quidelortho.com/role/CommitmentsandContingencies", "longName": "9952167 - Disclosure - Commitments and Contingencies", "shortName": "Commitments and Contingencies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true } }, "R19": { "role": "http://www.quidelortho.com/role/FairValueMeasurements", "longName": "9952168 - Disclosure - Fair Value Measurements", "shortName": "Fair Value Measurements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true } }, "R20": { "role": "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivities", "longName": "9952169 - Disclosure - Derivative Instruments and Hedging Activities", "shortName": "Derivative Instruments and Hedging Activities", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true } }, "R21": { "role": "http://www.quidelortho.com/role/AccumulatedOtherComprehensiveLoss", "longName": "9952170 - Disclosure - Accumulated Other Comprehensive Loss", "shortName": "Accumulated Other Comprehensive Loss", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true } }, "R22": { "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure", "longName": "995410 - Disclosure - Pay vs Performance Disclosure", "shortName": "Pay vs Performance Disclosure", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "22", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true }, "uniqueAnchor": null }, "R23": { "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "longName": "995445 - Disclosure - Insider Trading Arrangements", "shortName": "Insider Trading Arrangements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "23", "firstAnchor": { "contextRef": "c-5", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true } }, "R24": { "role": "http://www.quidelortho.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies", "longName": "9954471 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)", "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "24", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true } }, "R25": { "role": "http://www.quidelortho.com/role/ComputationofEarningsPerShareTables", "longName": "9954472 - Disclosure - Computation of Earnings Per Share (Tables)", "shortName": "Computation of Earnings Per Share (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "25", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true } }, "R26": { "role": "http://www.quidelortho.com/role/RevenueTables", "longName": "9954473 - Disclosure - Revenue (Tables)", "shortName": "Revenue (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "26", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true } }, "R27": { "role": "http://www.quidelortho.com/role/SegmentandGeographicInformationTables", "longName": "9954474 - Disclosure - Segment and Geographic Information (Tables)", "shortName": "Segment and Geographic Information (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "27", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true } }, "R28": { "role": "http://www.quidelortho.com/role/BalanceSheetAccountDetailsTables", "longName": "9954475 - Disclosure - Balance Sheet Account Details (Tables)", "shortName": "Balance Sheet Account Details (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "28", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true } }, "R29": { "role": "http://www.quidelortho.com/role/GoodwillandIntangibleAssetsNetTables", "longName": "9954476 - Disclosure - Goodwill and Intangible Assets, Net (Tables)", "shortName": "Goodwill and Intangible Assets, Net (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "29", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true } }, "R30": { "role": "http://www.quidelortho.com/role/BorrowingsTables", "longName": "9954477 - Disclosure - Borrowings (Tables)", "shortName": "Borrowings (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "30", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true } }, "R31": { "role": "http://www.quidelortho.com/role/StockbasedCompensationTables", "longName": "9954478 - Disclosure - Stock-based Compensation (Tables)", "shortName": "Stock-based Compensation (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "31", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true } }, "R32": { "role": "http://www.quidelortho.com/role/FairValueMeasurementsTables", "longName": "9954479 - Disclosure - Fair Value Measurements (Tables)", "shortName": "Fair Value Measurements (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "32", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true } }, "R33": { "role": "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesTables", "longName": "9954480 - Disclosure - Derivative Instruments and Hedging Activities (Tables)", "shortName": "Derivative Instruments and Hedging Activities (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "33", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfInterestRateDerivativesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfInterestRateDerivativesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true } }, "R34": { "role": "http://www.quidelortho.com/role/AccumulatedOtherComprehensiveLossTables", "longName": "9954481 - Disclosure - Accumulated Other Comprehensive Loss (Tables)", "shortName": "Accumulated Other Comprehensive Loss (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "34", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true } }, "R35": { "role": "http://www.quidelortho.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails", "longName": "9954482 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)", "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "35", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-54", "name": "us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "us-gaap:PriorPeriodReclassificationAdjustmentDescription", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "unique": true } }, "R36": { "role": "http://www.quidelortho.com/role/ComputationofEarningsPerShareCalculationofBasicandDilutedEarningsPerShareDetails", "longName": "9954483 - Disclosure - Computation of Earnings Per Share - Calculation of Basic and Diluted Earnings Per Share (Details)", "shortName": "Computation of Earnings Per Share - Calculation of Basic and Diluted Earnings Per Share (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "36", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "unique": true } }, "R37": { "role": "http://www.quidelortho.com/role/ComputationofEarningsPerShareNarrativeDetails", "longName": "9954484 - Disclosure - Computation of Earnings Per Share - Narrative (Details)", "shortName": "Computation of Earnings Per Share - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "37", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-61", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "unique": true } }, "R38": { "role": "http://www.quidelortho.com/role/RevenueNarrativeDetails", "longName": "9954485 - Disclosure - Revenue - Narrative (Details)", "shortName": "Revenue - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "38", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:DeferredRevenueCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OtherCurrentLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:DeferredRevenueNoncurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "unique": true } }, "R39": { "role": "http://www.quidelortho.com/role/RevenueDisaggregationofRevenueDetails", "longName": "9954486 - Disclosure - Revenue - Disaggregation of Revenue (Details)", "shortName": "Revenue - Disaggregation of Revenue (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "39", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:Revenues", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-80", "name": "us-gaap:Revenues", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "unique": true } }, "R40": { "role": "http://www.quidelortho.com/role/SegmentandGeographicInformationNarrativeDetails", "longName": "9954487 - Disclosure - Segment and Geographic Information - Narrative (Details)", "shortName": "Segment and Geographic Information - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NumberOfReportableSegments", "unitRef": "segment", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:NumberOfReportableSegments", "unitRef": "segment", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true } }, "R41": { "role": "http://www.quidelortho.com/role/SegmentandGeographicInformationTotalRevenuesbyReportableSegmentDetails", "longName": "9954488 - Disclosure - Segment and Geographic Information - Total Revenues by Reportable Segment (Details)", "shortName": "Segment and Geographic Information - Total Revenues by Reportable Segment (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:Revenues", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-102", "name": "us-gaap:Revenues", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "unique": true } }, "R42": { "role": "http://www.quidelortho.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails", "longName": "9954489 - Disclosure - Segment and Geographic Information - Reconciliation to Income (Details)", "shortName": "Segment and Geographic Information - Reconciliation to Income (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "c-5", "name": "qdel:SegmentAdjustedEBITDA", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "qdel:SegmentAdjustedEBITDA", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true } }, "R43": { "role": "http://www.quidelortho.com/role/IncomeTaxesDetail", "longName": "9954490 - Disclosure - Income Taxes (Detail)", "shortName": "Income Taxes (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:IncomeTaxExpenseBenefit", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "3", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "unique": true } }, "R44": { "role": "http://www.quidelortho.com/role/BalanceSheetAccountDetailsCashCashEquivalentsandRestrictedCashDetails", "longName": "9954491 - Disclosure - Balance Sheet Account Details Cash, Cash Equivalents and Restricted Cash (Details)", "shortName": "Balance Sheet Account Details Cash, Cash Equivalents and Restricted Cash (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:RestrictedCashNoncurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "unique": true } }, "R45": { "role": "http://www.quidelortho.com/role/BalanceSheetAccountDetailsNarrativeDetails", "longName": "9954492 - Disclosure - Balance Sheet Account Details - Narrative (Details)", "shortName": "Balance Sheet Account Details - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true }, "uniqueAnchor": null }, "R46": { "role": "http://www.quidelortho.com/role/BalanceSheetAccountDetailsMarketableSecuritiesDetails", "longName": "9954493 - Disclosure - Balance Sheet Account Details Marketable Securities (Details)", "shortName": "Balance Sheet Account Details Marketable Securities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true } }, "R47": { "role": "http://www.quidelortho.com/role/BalanceSheetAccountDetailsAccountsReceivableDetails", "longName": "9954494 - Disclosure - Balance Sheet Account Details Accounts Receivable (Details)", "shortName": "Balance Sheet Account Details Accounts Receivable (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:AccountsReceivableGrossCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:AccountsReceivableGrossCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true } }, "R48": { "role": "http://www.quidelortho.com/role/BalanceSheetAccountDetailsInventoriesDetails", "longName": "9954495 - Disclosure - Balance Sheet Account Details Inventories (Details)", "shortName": "Balance Sheet Account Details Inventories (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:InventoryRawMaterialsNetOfReserves", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:InventoryRawMaterialsNetOfReserves", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true } }, "R49": { "role": "http://www.quidelortho.com/role/BalanceSheetAccountDetailsPrepaidexpensesandothercurrentassetsDetails", "longName": "9954496 - Disclosure - Balance Sheet Account Details Prepaid expenses and other current assets (Details)", "shortName": "Balance Sheet Account Details Prepaid expenses and other current assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "c-3", "name": "qdel:IncomeTaxReceivablesAndOtherTaxReceivablesCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "qdel:IncomeTaxReceivablesAndOtherTaxReceivablesCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true } }, "R50": { "role": "http://www.quidelortho.com/role/BalanceSheetAccountDetailsOtherCurrentLiabilitiesDetails", "longName": "9954497 - Disclosure - Balance Sheet Account Details Other Current Liabilities (Details)", "shortName": "Balance Sheet Account Details Other Current Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "c-3", "name": "qdel:CustomerIncentivePayableCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OtherCurrentLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "qdel:CustomerIncentivePayableCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OtherCurrentLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true } }, "R51": { "role": "http://www.quidelortho.com/role/AssetsHeldforSaleDetails", "longName": "9954498 - Disclosure - Assets Held for Sale (Details)", "shortName": "Assets Held for Sale (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true }, "uniqueAnchor": null }, "R52": { "role": "http://www.quidelortho.com/role/GoodwillandIntangibleAssetsNetGoodwillRollforwardDetails", "longName": "9954499 - Disclosure - Goodwill and Intangible Assets, Net - Goodwill Rollforward (Details)", "shortName": "Goodwill and Intangible Assets, Net - Goodwill Rollforward (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:Goodwill", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:GoodwillForeignCurrencyTranslationGainLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "unique": true } }, "R53": { "role": "http://www.quidelortho.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails", "longName": "9954500 - Disclosure - Goodwill and Intangible Assets, Net - Narrative (Details)", "shortName": "Goodwill and Intangible Assets, Net - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "53", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:GoodwillImpairmentLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-21", "name": "qdel:ReportingUnitPercentageOfDecreaseInFairValue", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "unique": true } }, "R54": { "role": "http://www.quidelortho.com/role/BorrowingsScheduleofBorrowingsDetails", "longName": "9954501 - Disclosure - Borrowings - Schedule of Borrowings (Details)", "shortName": "Borrowings - Schedule of Borrowings (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "54", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:FinanceLeaseLiabilityNoncurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:FinanceLeaseLiabilityNoncurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true } }, "R55": { "role": "http://www.quidelortho.com/role/BorrowingsNarrativeDetails", "longName": "9954502 - Disclosure - Borrowings - Narrative (Details)", "shortName": "Borrowings - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "55", "firstAnchor": { "contextRef": "c-148", "name": "qdel:DebtInstrumentCovenantInterestCoverageRatioMinimum", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-148", "name": "qdel:DebtInstrumentCovenantInterestCoverageRatioMinimum", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true } }, "R56": { "role": "http://www.quidelortho.com/role/BorrowingsInterestExpenseDetails", "longName": "9954503 - Disclosure - Borrowings - Interest Expense (Details)", "shortName": "Borrowings - Interest Expense (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "56", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true } }, "R57": { "role": "http://www.quidelortho.com/role/StockbasedCompensationCompensationExpenseRelatedtoStockBasedCompensationPlansDetails", "longName": "9954504 - Disclosure - Stock-based Compensation - Compensation Expense Related to Stock-Based Compensation Plans (Details)", "shortName": "Stock-based Compensation - Compensation Expense Related to Stock-Based Compensation Plans (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "57", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true } }, "R58": { "role": "http://www.quidelortho.com/role/StockbasedCompensationNarrativeDetails", "longName": "9954505 - Disclosure - Stock-based Compensation - Narrative (Details)", "shortName": "Stock-based Compensation - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "58", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsShareBasedLiabilitiesPaid", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsShareBasedLiabilitiesPaid", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true } }, "R59": { "role": "http://www.quidelortho.com/role/CommitmentsandContingenciesDetails", "longName": "9954506 - Disclosure - Commitments and Contingencies (Details)", "shortName": "Commitments and Contingencies (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "59", "firstAnchor": { "contextRef": "c-174", "name": "qdel:LossContingencyNumberOfExecutiveDefendants", "unitRef": "defendant", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-174", "name": "qdel:LossContingencyNumberOfExecutiveDefendants", "unitRef": "defendant", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true } }, "R60": { "role": "http://www.quidelortho.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails", "longName": "9954507 - Disclosure - Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)", "shortName": "Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "60", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:MarketableSecurities", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:MarketableSecurities", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true } }, "R61": { "role": "http://www.quidelortho.com/role/FairValueMeasurementsNarrativeDetails", "longName": "9954508 - Disclosure - Fair Value Measurements - Narrative (Details)", "shortName": "Fair Value Measurements - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "61", "firstAnchor": { "contextRef": "c-135", "name": "us-gaap:LongTermDebtFairValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-135", "name": "us-gaap:LongTermDebtFairValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true } }, "R62": { "role": "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails", "longName": "9954509 - Disclosure - Derivative Instruments and Hedging Activities - Narrative (Details)", "shortName": "Derivative Instruments and Hedging Activities - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "62", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-204", "name": "us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "unique": true } }, "R63": { "role": "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofInterestRateDerivativesDetails", "longName": "9954510 - Disclosure - Derivative Instruments and Hedging Activities - Schedule of Interest Rate Derivatives (Details)", "shortName": "Derivative Instruments and Hedging Activities - Schedule of Interest Rate Derivatives (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "63", "firstAnchor": { "contextRef": "c-181", "name": "us-gaap:DerivativeNotionalAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfInterestRateDerivativesTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-181", "name": "us-gaap:DerivativeNotionalAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfInterestRateDerivativesTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true } }, "R64": { "role": "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofCurrencyHedgingInstrumentsDetails", "longName": "9954511 - Disclosure - Derivative Instruments and Hedging Activities - Schedule of Currency Hedging Instruments (Details)", "shortName": "Derivative Instruments and Hedging Activities - Schedule of Currency Hedging Instruments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "64", "firstAnchor": { "contextRef": "c-186", "name": "us-gaap:DerivativeNotionalAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-186", "name": "us-gaap:DerivativeNotionalAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true } }, "R65": { "role": "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofGainLossDetails", "longName": "9954512 - Disclosure - Derivative Instruments and Hedging Activities - Schedule of Gain (Loss) (Details)", "shortName": "Derivative Instruments and Hedging Activities - Schedule of Gain (Loss) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "65", "firstAnchor": { "contextRef": "c-188", "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-188", "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true } }, "R66": { "role": "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNetInvestmentHedgeDetails", "longName": "9954513 - Disclosure - Derivative Instruments and Hedging Activities - Schedule of Net Investment Hedge (Details)", "shortName": "Derivative Instruments and Hedging Activities - Schedule of Net Investment Hedge (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "66", "firstAnchor": { "contextRef": "c-200", "name": "us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-200", "name": "us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true } }, "R67": { "role": "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofFairValueDetails", "longName": "9954514 - Disclosure - Derivative Instruments and Hedging Activities - Schedule of Fair Value (Details)", "shortName": "Derivative Instruments and Hedging Activities - Schedule of Fair Value (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "67", "firstAnchor": { "contextRef": "c-208", "name": "us-gaap:DerivativeFairValueOfDerivativeAsset", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock", "us-gaap:ScheduleOfDerivativeAssetsAtFairValueTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-208", "name": "us-gaap:DerivativeFairValueOfDerivativeAsset", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock", "us-gaap:ScheduleOfDerivativeAssetsAtFairValueTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true } }, "R68": { "role": "http://www.quidelortho.com/role/AccumulatedOtherComprehensiveLossDetails", "longName": "9954515 - Disclosure - Accumulated Other Comprehensive Loss (Details)", "shortName": "Accumulated Other Comprehensive Loss (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "68", "firstAnchor": { "contextRef": "c-21", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-21", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20240630.htm", "first": true, "unique": true } } }, "tag": { "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "terseLabel": "Accounting Policies [Abstract]", "label": "Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsPayableCurrent", "crdr": "credit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable", "label": "Accounts Payable, Current", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r75", "r817" ] }, "us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsReceivableAllowanceForCreditLossTableTextBlock", "presentation": [ "http://www.quidelortho.com/role/BalanceSheetAccountDetailsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts Receivable, Net", "label": "Accounts Receivable, Allowance for Credit Loss [Table Text Block]", "documentation": "Tabular disclosure of allowance for credit loss on accounts receivable." } } }, "auth_ref": [ "r982" ] }, "us-gaap_AccountsReceivableGrossCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsReceivableGrossCurrent", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/BalanceSheetAccountDetailsAccountsReceivableDetails": { "parentTag": "us-gaap_AccountsReceivableNetCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quidelortho.com/role/BalanceSheetAccountDetailsAccountsReceivableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts receivable", "label": "Accounts Receivable, before Allowance for Credit Loss, Current", "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r178", "r284", "r760" ] }, "us-gaap_AccountsReceivableMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsReceivableMember", "presentation": [ "http://www.quidelortho.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts Receivable", "label": "Accounts Receivable [Member]", "documentation": "Due from customers or clients for goods or services that have been delivered or sold." } } }, "auth_ref": [ "r751" ] }, "us-gaap_AccountsReceivableNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsReceivableNetCurrent", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 }, "http://www.quidelortho.com/role/BalanceSheetAccountDetailsAccountsReceivableDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.quidelortho.com/role/BalanceSheetAccountDetailsAccountsReceivableDetails", "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited", "http://www.quidelortho.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts receivable, net", "totalLabel": "Total accounts receivable, net", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r971" ] }, "us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccrualForTaxesOtherThanIncomeTaxesCurrent", "crdr": "credit", "calculation": { "http://www.quidelortho.com/role/BalanceSheetAccountDetailsOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.quidelortho.com/role/BalanceSheetAccountDetailsOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued other taxes payable", "label": "Accrual for Taxes Other than Income Taxes, Current", "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for real and property taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r78", "r762", "r1013" ] }, "us-gaap_AccruedIncomeTaxesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccruedIncomeTaxesCurrent", "crdr": "credit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Income tax payable", "label": "Accrued Income Taxes, Current", "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations." } } }, "auth_ref": [ "r78", "r139" ] }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember", "presentation": [ "http://www.quidelortho.com/role/AccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Pension and Other Post- Employment Benefits", "label": "Accumulated Defined Benefit Plans Adjustment Including Portion Attributable to Noncontrolling Interest [Member]", "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans including the portion attributable to the noncontrolling interest." } } }, "auth_ref": [ "r4", "r5", "r12", "r21", "r99", "r626", "r947", "r948", "r949" ] }, "us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember", "presentation": [ "http://www.quidelortho.com/role/AccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash Flow Hedges", "label": "Accumulated Gain (Loss), Cash Flow Hedge, Including Noncontrolling Interest [Member]", "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, including portion attributable to noncontrolling interest." } } }, "auth_ref": [ "r195", "r202", "r503", "r626", "r948", "r949" ] }, "us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember", "presentation": [ "http://www.quidelortho.com/role/AccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Available-for-Sale Investments", "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Including Noncontrolling Interest [Member]", "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), including portion attributable to noncontrolling interest." } } }, "auth_ref": [ "r190", "r191", "r192", "r195", "r202", "r626", "r948", "r949" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "presentation": [ "http://www.quidelortho.com/role/AccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r202", "r203", "r550", "r552", "r553", "r554", "r555", "r557" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated other comprehensive loss", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source." } } }, "auth_ref": [ "r20", "r21", "r100", "r179", "r619", "r660", "r664" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "presentation": [ "http://www.quidelortho.com/role/AccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]", "label": "Accumulated Other Comprehensive Income (Loss) [Table]", "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r202", "r203", "r550", "r552", "r553", "r554", "r555", "r557" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedOtherComprehensiveIncomeMember", "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated other comprehensive (loss) income", "label": "AOCI Attributable to Parent [Member]", "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r2", "r12", "r21", "r515", "r518", "r568", "r655", "r656", "r947", "r948", "r949", "r958", "r959", "r960", "r961" ] }, "us-gaap_AccumulatedTranslationAdjustmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedTranslationAdjustmentMember", "presentation": [ "http://www.quidelortho.com/role/AccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign Currency Translation Adjustments", "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]", "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent." } } }, "auth_ref": [ "r3", "r12", "r21", "r97", "r98", "r203", "r204", "r552", "r553", "r554", "r555", "r557", "r947" ] }, "us-gaap_AcquisitionRelatedCostsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AcquisitionRelatedCostsMember", "presentation": [ "http://www.quidelortho.com/role/StockbasedCompensationCompensationExpenseRelatedtoStockBasedCompensationPlansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Integration related costs", "label": "Acquisition-related Costs [Member]", "documentation": "Category of acquisition-related costs allocated to (included in) reported pro forma earnings (supplemental pro forma information)." } } }, "auth_ref": [] }, "ecd_Additional402vDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "Additional402vDisclosureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Additional 402(v) Disclosure", "label": "Additional 402(v) Disclosure [Text Block]" } } }, "auth_ref": [ "r877" ] }, "us-gaap_AdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdditionalPaidInCapital", "crdr": "credit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Additional paid-in capital", "label": "Additional Paid in Capital", "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock." } } }, "auth_ref": [ "r87", "r817", "r1085" ] }, "ecd_AdjToCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Compensation, Amount", "label": "Adjustment to Compensation Amount" } } }, "auth_ref": [ "r890" ] }, "ecd_AdjToCompAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToCompAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Compensation:", "label": "Adjustment to Compensation [Axis]" } } }, "auth_ref": [ "r890" ] }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToNonPeoNeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote", "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]" } } }, "auth_ref": [ "r890" ] }, "ecd_AdjToPeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToPeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment To PEO Compensation, Footnote", "label": "Adjustment To PEO Compensation, Footnote [Text Block]" } } }, "auth_ref": [ "r890" ] }, "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation", "crdr": "debit", "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Tax withholdings related to vesting of stock-based awards", "label": "Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation", "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement." } } }, "auth_ref": [] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "crdr": "credit", "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-based compensation expense", "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition", "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement." } } }, "auth_ref": [ "r45", "r46", "r436" ] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustments to reconcile net loss to net cash (used for) provided by operating activities:", "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "qdel_AfterDecember312024ToJune302025Member": { "xbrltype": "domainItemType", "nsuri": "http://www.quidelortho.com/20240630", "localname": "AfterDecember312024ToJune302025Member", "presentation": [ "http://www.quidelortho.com/role/BorrowingsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "After December 31, 2024 to June 30, 2025", "label": "After December 31, 2024 to June 30, 2025 [Member]", "documentation": "After December 31, 2024 to June 30, 2025" } } }, "auth_ref": [] }, "qdel_AfterJune302023ToJune302024Member": { "xbrltype": "domainItemType", "nsuri": "http://www.quidelortho.com/20240630", "localname": "AfterJune302023ToJune302024Member", "presentation": [ "http://www.quidelortho.com/role/BorrowingsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "After June 30, 2023 to June 30, 2024", "label": "After June 30, 2023 to June 30, 2024 [Member]", "documentation": "After June 30, 2023 to June 30, 2024" } } }, "auth_ref": [] }, "qdel_AfterJune302024ToDecember312024Member": { "xbrltype": "domainItemType", "nsuri": "http://www.quidelortho.com/20240630", "localname": "AfterJune302024ToDecember312024Member", "presentation": [ "http://www.quidelortho.com/role/BorrowingsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "After June 30, 2024 to December 31, 2024", "label": "After June 30, 2024 to December 31, 2024 [Member]", "documentation": "After June 30, 2024 to December 31, 2024" } } }, "auth_ref": [] }, "qdel_AfterJune302025Member": { "xbrltype": "domainItemType", "nsuri": "http://www.quidelortho.com/20240630", "localname": "AfterJune302025Member", "presentation": [ "http://www.quidelortho.com/role/BorrowingsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "After June 30, 2025", "label": "After June 30, 2025 [Member]", "documentation": "After June 30, 2025" } } }, "auth_ref": [] }, "qdel_AgencyBondsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quidelortho.com/20240630", "localname": "AgencyBondsMember", "presentation": [ "http://www.quidelortho.com/role/BalanceSheetAccountDetailsMarketableSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Agency bonds", "label": "Agency bonds [Member]", "documentation": "Agency bonds" } } }, "auth_ref": [] }, "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table", "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]" } } }, "auth_ref": [ "r923" ] }, "ecd_AggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Erroneous Compensation Amount", "label": "Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r849", "r859", "r869", "r901" ] }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AggtErrCompNotYetDeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined", "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]" } } }, "auth_ref": [ "r852", "r862", "r872", "r904" ] }, "ecd_AggtPnsnAdjsSvcCstMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AggtPnsnAdjsSvcCstMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Pension Adjustments Service Cost", "label": "Aggregate Pension Adjustments Service Cost [Member]" } } }, "auth_ref": [ "r924" ] }, "ecd_AllAdjToCompMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AllAdjToCompMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Adjustments to Compensation", "label": "All Adjustments to Compensation [Member]" } } }, "auth_ref": [ "r890" ] }, "ecd_AllExecutiveCategoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AllExecutiveCategoriesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Executive Categories", "label": "All Executive Categories [Member]" } } }, "auth_ref": [ "r897" ] }, "ecd_AllIndividualsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AllIndividualsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Individuals", "label": "All Individuals [Member]" } } }, "auth_ref": [ "r853", "r863", "r873", "r897", "r905", "r909", "r917" ] }, "ecd_AllTradingArrangementsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AllTradingArrangementsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "All Trading Arrangements", "label": "All Trading Arrangements [Member]" } } }, "auth_ref": [ "r915" ] }, "us-gaap_AllocatedShareBasedCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AllocatedShareBasedCompensationExpense", "crdr": "debit", "presentation": [ "http://www.quidelortho.com/role/StockbasedCompensationCompensationExpenseRelatedtoStockBasedCompensationPlansDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Total stock-based compensation expense", "label": "Share-Based Payment Arrangement, Expense", "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized." } } }, "auth_ref": [ "r465", "r469" ] }, "qdel_AllowanceForContractRebatesAndDiscounts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quidelortho.com/20240630", "localname": "AllowanceForContractRebatesAndDiscounts", "crdr": "credit", "calculation": { "http://www.quidelortho.com/role/BalanceSheetAccountDetailsAccountsReceivableDetails": { "parentTag": "us-gaap_AccountsReceivableNetCurrent", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.quidelortho.com/role/BalanceSheetAccountDetailsAccountsReceivableDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Allowance for contract rebates and discounts", "label": "Allowance for contract rebates and discounts", "documentation": "Allowance for contract rebates and discounts" } } }, "auth_ref": [] }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "crdr": "credit", "calculation": { "http://www.quidelortho.com/role/BalanceSheetAccountDetailsAccountsReceivableDetails": { "parentTag": "us-gaap_AccountsReceivableNetCurrent", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.quidelortho.com/role/BalanceSheetAccountDetailsAccountsReceivableDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Allowance for doubtful accounts", "label": "Accounts Receivable, Allowance for Credit Loss, Current", "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current." } } }, "auth_ref": [ "r180", "r285", "r323" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentFlag", "presentation": [ "http://www.quidelortho.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "qdel_AmortizationOfDeferredCloudComputingImplementationCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quidelortho.com/20240630", "localname": "AmortizationOfDeferredCloudComputingImplementationCosts", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://www.quidelortho.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Amortization of deferred cloud computing implementation costs", "label": "Amortization of deferred cloud computing implementation costs", "documentation": "Amortization of deferred cloud computing implementation costs" } } }, "auth_ref": [] }, "us-gaap_AmortizationOfIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AmortizationOfIntangibleAssets", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedStatementsofLossUnaudited": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofLossUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization of intangible assets", "label": "Amortization of Intangible Assets", "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method." } } }, "auth_ref": [ "r10", "r349", "r350", "r782" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "presentation": [ "http://www.quidelortho.com/role/ComputationofEarningsPerShareCalculationofBasicandDilutedEarningsPerShareDetails", "http://www.quidelortho.com/role/ComputationofEarningsPerShareNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Potentially dilutive shares excluded from calculation due to anti-dilutive effect", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented." } } }, "auth_ref": [ "r244" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "presentation": [ "http://www.quidelortho.com/role/ComputationofEarningsPerShareNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Antidilutive Securities [Axis]", "label": "Antidilutive Securities [Axis]", "documentation": "Information by type of antidilutive security." } } }, "auth_ref": [ "r29" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "presentation": [ "http://www.quidelortho.com/role/ComputationofEarningsPerShareNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Line Items]", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AntidilutiveSecuritiesNameDomain", "presentation": [ "http://www.quidelortho.com/role/ComputationofEarningsPerShareNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Antidilutive Securities, Name [Domain]", "label": "Antidilutive Securities, Name [Domain]", "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented." } } }, "auth_ref": [ "r29" ] }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ArrangementsAndNonarrangementTransactionsMember", "presentation": [ "http://www.quidelortho.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]", "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r500" ] }, "us-gaap_AssetBackedSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetBackedSecuritiesMember", "presentation": [ "http://www.quidelortho.com/role/BalanceSheetAccountDetailsMarketableSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Corporate asset-backed securities", "label": "Asset-Backed Securities [Member]", "documentation": "Securities that are primarily serviced by the cash flows of a discrete pool of receivables or other financial assets for example, but not limited to, credit card receivables, car loans, recreational vehicle loans, and mobile home loans." } } }, "auth_ref": [ "r796", "r818", "r974", "r975", "r976" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Assets", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets", "label": "Assets", "documentation": "Amount of asset recognized for present right to economic benefit." } } }, "auth_ref": [ "r137", "r151", "r175", "r213", "r248", "r254", "r272", "r276", "r318", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r501", "r504", "r546", "r613", "r706", "r774", "r775", "r817", "r840", "r1008", "r1009", "r1041" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsAbstract", "presentation": [ "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "ASSETS", "label": "Assets [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Total current assets", "label": "Assets, Current", "documentation": "Amount of asset recognized for present right to economic benefit, classified as current." } } }, "auth_ref": [ "r170", "r184", "r213", "r318", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r501", "r504", "r546", "r817", "r1008", "r1009", "r1041" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsCurrentAbstract", "presentation": [ "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Current assets:", "label": "Assets, Current [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AssetsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsFairValueDisclosure", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.quidelortho.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets measured at fair value", "label": "Assets, Fair Value Disclosure", "documentation": "Fair value portion of asset recognized for present right to economic benefit." } } }, "auth_ref": [ "r526", "r527", "r804" ] }, "us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsHeldForSaleNotPartOfDisposalGroupCurrent", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Assets held for sale", "label": "Asset, Held-for-Sale, Not Part of Disposal Group, Current", "documentation": "Amount of assets held-for-sale that are not part of a disposal group, expected to be sold within a year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r122", "r817" ] }, "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax", "crdr": "debit", "presentation": [ "http://www.quidelortho.com/role/BalanceSheetAccountDetailsMarketableSecuritiesDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Gross Unrealized Losses", "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax", "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r291" ] }, "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis", "crdr": "debit", "presentation": [ "http://www.quidelortho.com/role/BalanceSheetAccountDetailsMarketableSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amortized Cost", "label": "Debt Securities, Available-for-Sale, Amortized Cost", "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r287", "r329", "r612" ] }, "us-gaap_AvailableForSaleSecuritiesDebtSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AvailableForSaleSecuritiesDebtSecurities", "crdr": "debit", "presentation": [ "http://www.quidelortho.com/role/BalanceSheetAccountDetailsMarketableSecuritiesDetails", "http://www.quidelortho.com/role/BalanceSheetAccountDetailsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value", "label": "Debt Securities, Available-for-Sale", "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r288", "r329", "r526", "r605", "r804", "r809", "r972", "r1022", "r1023", "r1024" ] }, "ecd_AwardExrcPrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardExrcPrice", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise Price", "label": "Award Exercise Price" } } }, "auth_ref": [ "r912" ] }, "ecd_AwardGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardGrantDateFairValue", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value as of Grant Date", "label": "Award Grant Date Fair Value" } } }, "auth_ref": [ "r913" ] }, "ecd_AwardTmgDiscLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgDiscLineItems", "lang": { "en-us": { "role": { "label": "Award Timing Disclosures [Line Items]" } } }, "auth_ref": [ "r908" ] }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing, How MNPI Considered", "label": "Award Timing, How MNPI Considered [Text Block]" } } }, "auth_ref": [ "r908" ] }, "ecd_AwardTmgMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing Method", "label": "Award Timing Method [Text Block]" } } }, "auth_ref": [ "r908" ] }, "ecd_AwardTmgMnpiCnsdrdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgMnpiCnsdrdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing MNPI Considered", "label": "Award Timing MNPI Considered [Flag]" } } }, "auth_ref": [ "r908" ] }, "ecd_AwardTmgMnpiDiscTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgMnpiDiscTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing MNPI Disclosure", "label": "Award Timing MNPI Disclosure [Text Block]" } } }, "auth_ref": [ "r908" ] }, "ecd_AwardTmgPredtrmndFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgPredtrmndFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing Predetermined", "label": "Award Timing Predetermined [Flag]" } } }, "auth_ref": [ "r908" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AwardTypeAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Type", "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464" ] }, "ecd_AwardUndrlygSecuritiesAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardUndrlygSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Underlying Securities", "label": "Award Underlying Securities Amount" } } }, "auth_ref": [ "r911" ] }, "ecd_AwardsCloseToMnpiDiscIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardsCloseToMnpiDiscIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Awards Close in Time to MNPI Disclosures, Individual Name" } } }, "auth_ref": [ "r910" ] }, "ecd_AwardsCloseToMnpiDiscTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardsCloseToMnpiDiscTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Awards Close in Time to MNPI Disclosures", "label": "Awards Close in Time to MNPI Disclosures [Table]" } } }, "auth_ref": [ "r909" ] }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardsCloseToMnpiDiscTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Awards Close in Time to MNPI Disclosures, Table", "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]" } } }, "auth_ref": [ "r909" ] }, "us-gaap_BalanceSheetLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BalanceSheetLocationAxis", "presentation": [ "http://www.quidelortho.com/role/BalanceSheetAccountDetailsMarketableSecuritiesDetails", "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofFairValueDetails", "http://www.quidelortho.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Balance Sheet Location [Axis]", "label": "Statement of Financial Position Location, Balance [Axis]", "documentation": "Information by location in statement of financial position where disaggregated cumulative balance has been reported." } } }, "auth_ref": [ "r360", "r1051", "r1052" ] }, "us-gaap_BalanceSheetLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BalanceSheetLocationDomain", "presentation": [ "http://www.quidelortho.com/role/BalanceSheetAccountDetailsMarketableSecuritiesDetails", "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofFairValueDetails", "http://www.quidelortho.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Balance Sheet Location [Domain]", "label": "Statement of Financial Position Location, Balance [Domain]", "documentation": "Location in statement of financial position where disaggregated cumulative balance has been reported." } } }, "auth_ref": [ "r57", "r60", "r360", "r1051", "r1052" ] }, "qdel_BankOfAmericaCreditFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quidelortho.com/20240630", "localname": "BankOfAmericaCreditFacilityMember", "presentation": [ "http://www.quidelortho.com/role/BorrowingsInterestExpenseDetails", "http://www.quidelortho.com/role/BorrowingsNarrativeDetails", "http://www.quidelortho.com/role/BorrowingsScheduleofBorrowingsDetails", "http://www.quidelortho.com/role/FairValueMeasurementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit Agreement", "label": "Bank Of America Credit Facility [Member]", "documentation": "Bank Of America Credit Facility" } } }, "auth_ref": [] }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BasisOfAccountingPolicyPolicyTextBlock", "presentation": [ "http://www.quidelortho.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Basis of Presentation", "label": "Basis of Accounting, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)." } } }, "auth_ref": [] }, "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "presentation": [ "http://www.quidelortho.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Basis of Presentation and Summary of Significant Accounting Policies", "label": "Basis of Presentation and Significant Accounting Policies [Text Block]", "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r115" ] }, "us-gaap_BusinessCombinationAcquisitionRelatedCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationAcquisitionRelatedCosts", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0, "order": 5.0 }, "http://www.quidelortho.com/role/ConsolidatedStatementsofLossUnaudited": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofLossUnaudited", "http://www.quidelortho.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Integration related costs", "negatedTerseLabel": "Integration related costs", "label": "Business Combination, Acquisition Related Costs", "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities." } } }, "auth_ref": [ "r47" ] }, "us-gaap_BusinessCombinationContingentConsiderationLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationContingentConsiderationLiability", "crdr": "credit", "calculation": { "http://www.quidelortho.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails": { "parentTag": "us-gaap_LiabilitiesFairValueDisclosure", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quidelortho.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contingent consideration", "label": "Business Combination, Contingent Consideration, Liability", "documentation": "Amount of liability recognized arising from contingent consideration in a business combination." } } }, "auth_ref": [ "r48", "r130", "r497", "r528", "r529", "r530" ] }, "qdel_BusinessUnitAxis": { "xbrltype": "stringItemType", "nsuri": "http://www.quidelortho.com/20240630", "localname": "BusinessUnitAxis", "presentation": [ "http://www.quidelortho.com/role/RevenueDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Unit [Axis]", "label": "Business Unit [Axis]", "documentation": "Business Unit" } } }, "auth_ref": [] }, "qdel_BusinessUnitDomain": { "xbrltype": "domainItemType", "nsuri": "http://www.quidelortho.com/20240630", "localname": "BusinessUnitDomain", "presentation": [ "http://www.quidelortho.com/role/RevenueDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Unit [Domain]", "label": "Business Unit [Domain]", "documentation": "Business Unit [Domain]" } } }, "auth_ref": [] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 }, "http://www.quidelortho.com/role/BalanceSheetAccountDetailsCashCashEquivalentsandRestrictedCashDetails": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quidelortho.com/role/BalanceSheetAccountDetailsCashCashEquivalentsandRestrictedCashDetails", "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and cash equivalents", "label": "Cash and Cash Equivalents, at Carrying Value", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r25", "r172", "r758" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/BalanceSheetAccountDetailsCashCashEquivalentsandRestrictedCashDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.quidelortho.com/role/BalanceSheetAccountDetailsCashCashEquivalentsandRestrictedCashDetails", "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of period", "periodEndLabel": "Cash, cash equivalents and restricted cash at end of period", "totalLabel": "Cash, cash equivalents and restricted cash", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r25", "r112", "r211" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Net decrease in cash, cash equivalents and restricted cash", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r1", "r112" ] }, "qdel_ChangeInOperatingLeaseRightOfUseAssetsAndLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quidelortho.com/20240630", "localname": "ChangeInOperatingLeaseRightOfUseAssetsAndLiabilities", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Net change in operating lease right-of-use assets and liabilities", "label": "Change in operating lease right-of-use assets and liabilities", "documentation": "Change in operating lease right-of-use assets and liabilities" } } }, "auth_ref": [] }, "ecd_ChangedPeerGroupFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ChangedPeerGroupFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Changed Peer Group, Footnote", "label": "Changed Peer Group, Footnote [Text Block]" } } }, "auth_ref": [ "r888" ] }, "qdel_ChinaMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quidelortho.com/20240630", "localname": "ChinaMember", "presentation": [ "http://www.quidelortho.com/role/GoodwillandIntangibleAssetsNetGoodwillRollforwardDetails", "http://www.quidelortho.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails", "http://www.quidelortho.com/role/SegmentandGeographicInformationTotalRevenuesbyReportableSegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "China", "label": "China [Member]", "documentation": "China" } } }, "auth_ref": [] }, "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year", "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]" } } }, "auth_ref": [ "r885" ] }, "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested", "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]" } } }, "auth_ref": [ "r883" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CityAreaCode", "presentation": [ "http://www.quidelortho.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "ecd_CoSelectedMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CoSelectedMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Company Selected Measure Amount", "label": "Company Selected Measure Amount" } } }, "auth_ref": [ "r889" ] }, "ecd_CoSelectedMeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CoSelectedMeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Company Selected Measure Name", "label": "Company Selected Measure Name" } } }, "auth_ref": [ "r889" ] }, "us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementAndThirdPartyMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementAndThirdPartyMember", "presentation": [ "http://www.quidelortho.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Collaborative Arrangement, Transaction with Party to Collaborative Arrangement and Third Party", "label": "Collaborative Arrangement, Transaction with Party to Collaborative Arrangement and Third Party [Member]", "documentation": "Collaborative arrangement transaction between party to collaborative arrangement and third party." } } }, "auth_ref": [ "r1015" ] }, "us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember", "presentation": [ "http://www.quidelortho.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Collaborative Arrangement, Transaction with Party to Collaborative Arrangement", "label": "Collaborative Arrangement, Transaction with Party to Collaborative Arrangement [Member]", "documentation": "Collaborative arrangement transaction between parties to collaborative arrangement." } } }, "auth_ref": [ "r1015" ] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommitmentsAndContingencies", "crdr": "credit", "presentation": [ "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Commitments and contingencies (Note 11)", "label": "Commitments and Contingencies", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r83", "r142", "r616", "r693" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Commitments and Contingencies Disclosure [Abstract]", "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://www.quidelortho.com/role/CommitmentsandContingencies" ], "lang": { "en-us": { "role": { "terseLabel": "Commitments and Contingencies", "label": "Commitments and Contingencies Disclosure [Text Block]", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r125", "r364", "r365", "r752", "r998", "r1003" ] }, "us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockIncludingAdditionalPaidInCapitalMember", "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Additional paid-in capital", "label": "Common Stock Including Additional Paid in Capital [Member]", "documentation": "Common stock held by shareholders with par value plus amounts in excess of par value or issuance value (in cases of no-par value stock)." } } }, "auth_ref": [] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockMember", "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Common Stock", "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r828", "r829", "r830", "r832", "r833", "r834", "r837", "r958", "r959", "r961", "r1018", "r1083", "r1086" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, par value per share (in dollars per share)", "label": "Common Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r86" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares authorized (in shares)", "label": "Common Stock, Shares Authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r86", "r694" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockSharesIssued", "presentation": [ "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares issued (in shares)", "label": "Common Stock, Shares, Issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r86" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares outstanding (in shares)", "label": "Common Stock, Shares, Outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r13", "r86", "r694", "r712", "r1086", "r1087" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, $0.001 par value per share; 126.2 shares authorized; 67.1 and 66.7 shares issued and outstanding at June\u00a030, 2024 and December\u00a031, 2023, respectively", "label": "Common Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r86", "r618", "r817" ] }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Company Selected Measure", "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]" } } }, "auth_ref": [ "r894" ] }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsNetIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Net Income", "label": "Compensation Actually Paid vs. Net Income [Text Block]" } } }, "auth_ref": [ "r893" ] }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Other Measure", "label": "Compensation Actually Paid vs. Other Measure [Text Block]" } } }, "auth_ref": [ "r895" ] }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return", "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]" } } }, "auth_ref": [ "r892" ] }, "us-gaap_ComprehensiveIncomeNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ComprehensiveIncomeNetOfTax", "crdr": "credit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedStatementsofComprehensiveLossIncomeUnaudited": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofComprehensiveLossIncomeUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Comprehensive (loss) income", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r22", "r199", "r201", "r207", "r608", "r628", "r629" ] }, "us-gaap_ComprehensiveIncomeNoteTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ComprehensiveIncomeNoteTextBlock", "presentation": [ "http://www.quidelortho.com/role/AccumulatedOtherComprehensiveLoss" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Loss", "label": "Comprehensive Income (Loss) Note [Text Block]", "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income." } } }, "auth_ref": [ "r96", "r206", "r607", "r626" ] }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskBenchmarkDomain", "presentation": [ "http://www.quidelortho.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Benchmark [Domain]", "label": "Concentration Risk Benchmark [Domain]", "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "auth_ref": [ "r30", "r31", "r71", "r72", "r282", "r751" ] }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskByBenchmarkAxis", "presentation": [ "http://www.quidelortho.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Benchmark [Axis]", "label": "Concentration Risk Benchmark [Axis]", "documentation": "Information by benchmark of concentration risk." } } }, "auth_ref": [ "r30", "r31", "r71", "r72", "r282", "r666", "r751" ] }, "us-gaap_ConcentrationRiskByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskByTypeAxis", "presentation": [ "http://www.quidelortho.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Type [Axis]", "label": "Concentration Risk Type [Axis]", "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender." } } }, "auth_ref": [ "r30", "r31", "r71", "r72", "r282", "r751", "r929" ] }, "us-gaap_ConcentrationRiskPercentage1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskPercentage1", "presentation": [ "http://www.quidelortho.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of risk concentration", "label": "Concentration Risk, Percentage", "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division." } } }, "auth_ref": [ "r30", "r31", "r71", "r72", "r282" ] }, "us-gaap_ConcentrationRiskTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskTypeDomain", "presentation": [ "http://www.quidelortho.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Type [Domain]", "label": "Concentration Risk Type [Domain]", "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "auth_ref": [ "r30", "r31", "r71", "r72", "r282", "r751" ] }, "us-gaap_ContractWithCustomerAssetNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ContractWithCustomerAssetNet", "crdr": "debit", "presentation": [ "http://www.quidelortho.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Contract assets", "label": "Contract with Customer, Asset, after Allowance for Credit Loss", "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time." } } }, "auth_ref": [ "r413", "r414", "r425" ] }, "qdel_CorporateAdjustedEBITDA": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quidelortho.com/20240630", "localname": "CorporateAdjustedEBITDA", "crdr": "credit", "calculation": { "http://www.quidelortho.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quidelortho.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Corporate", "label": "Corporate Adjusted EBITDA", "documentation": "Corporate Adjusted EBITDA" } } }, "auth_ref": [] }, "us-gaap_CorporateDebtSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CorporateDebtSecuritiesMember", "presentation": [ "http://www.quidelortho.com/role/BalanceSheetAccountDetailsMarketableSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Corporate bonds", "label": "Corporate Debt Securities [Member]", "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment." } } }, "auth_ref": [ "r796", "r798", "r804", "r818", "r826", "r1080" ] }, "us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedStatementsofLossUnaudited": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofLossUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Cost of sales, excluding amortization of intangibles", "label": "Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization", "documentation": "Cost of product sold and service rendered, excluding depreciation, depletion, and amortization." } } }, "auth_ref": [ "r931", "r932" ] }, "us-gaap_CostOfSalesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CostOfSalesMember", "presentation": [ "http://www.quidelortho.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails", "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofGainLossDetails", "http://www.quidelortho.com/role/StockbasedCompensationCompensationExpenseRelatedtoStockBasedCompensationPlansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cost of sales, excluding amortization of intangibles", "label": "Cost of Sales [Member]", "documentation": "Primary financial statement caption encompassing cost of sales." } } }, "auth_ref": [] }, "qdel_CovenantPeriodAxis": { "xbrltype": "stringItemType", "nsuri": "http://www.quidelortho.com/20240630", "localname": "CovenantPeriodAxis", "presentation": [ "http://www.quidelortho.com/role/BorrowingsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Covenant Period [Axis]", "label": "Covenant Period [Axis]", "documentation": "Covenant Period" } } }, "auth_ref": [] }, "qdel_CovenantPeriodDomain": { "xbrltype": "domainItemType", "nsuri": "http://www.quidelortho.com/20240630", "localname": "CovenantPeriodDomain", "presentation": [ "http://www.quidelortho.com/role/BorrowingsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Covenant Period [Domain]", "label": "Covenant Period [Domain]", "documentation": "Covenant Period [Domain]" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "us-gaap_CreditFacilityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CreditFacilityAxis", "presentation": [ "http://www.quidelortho.com/role/BorrowingsInterestExpenseDetails", "http://www.quidelortho.com/role/BorrowingsNarrativeDetails", "http://www.quidelortho.com/role/BorrowingsScheduleofBorrowingsDetails", "http://www.quidelortho.com/role/FairValueMeasurementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit Facility [Axis]", "label": "Credit Facility [Axis]", "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "auth_ref": [ "r371", "r1006" ] }, "us-gaap_CreditFacilityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CreditFacilityDomain", "presentation": [ "http://www.quidelortho.com/role/BorrowingsInterestExpenseDetails", "http://www.quidelortho.com/role/BorrowingsNarrativeDetails", "http://www.quidelortho.com/role/BorrowingsScheduleofBorrowingsDetails", "http://www.quidelortho.com/role/FairValueMeasurementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit Facility [Domain]", "label": "Credit Facility [Domain]", "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "auth_ref": [ "r371", "r1006", "r1007" ] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://www.quidelortho.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Current Fiscal Year End Date", "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_CustomerConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CustomerConcentrationRiskMember", "presentation": [ "http://www.quidelortho.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer Concentration Risk", "label": "Customer Concentration Risk [Member]", "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer." } } }, "auth_ref": [ "r116", "r282" ] }, "qdel_CustomerIncentivePayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quidelortho.com/20240630", "localname": "CustomerIncentivePayableCurrent", "crdr": "credit", "calculation": { "http://www.quidelortho.com/role/BalanceSheetAccountDetailsOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quidelortho.com/role/BalanceSheetAccountDetailsOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued commissions, rebates and returns", "label": "Customer Incentive, Payable, Current", "documentation": "Customer Incentive, Payable, Current" } } }, "auth_ref": [] }, "qdel_CustomerOneMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quidelortho.com/20240630", "localname": "CustomerOneMember", "presentation": [ "http://www.quidelortho.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer One", "label": "Customer One [Member]", "documentation": "Customer One" } } }, "auth_ref": [] }, "qdel_CustomerThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quidelortho.com/20240630", "localname": "CustomerThreeMember", "presentation": [ "http://www.quidelortho.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Customer Three", "label": "Customer Three [Member]", "documentation": "Customer Three" } } }, "auth_ref": [] }, "qdel_CustomerTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quidelortho.com/20240630", "localname": "CustomerTwoMember", "presentation": [ "http://www.quidelortho.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer Two", "label": "Customer Two [Member]", "documentation": "Customer Two" } } }, "auth_ref": [] }, "qdel_CustomersWithBalancesDueInExcessOf10OfAccountsReceivableMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quidelortho.com/20240630", "localname": "CustomersWithBalancesDueInExcessOf10OfAccountsReceivableMember", "presentation": [ "http://www.quidelortho.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customers With Balances Due In Excess of 10% Of Accounts Receivable", "label": "Customers With Balances Due In Excess of 10% Of Accounts Receivable [Member]", "documentation": "Customers With Balances Due In Excess of 10% Of Accounts Receivable" } } }, "auth_ref": [] }, "us-gaap_DebtAndCapitalLeaseObligations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtAndCapitalLeaseObligations", "crdr": "credit", "calculation": { "http://www.quidelortho.com/role/BorrowingsScheduleofBorrowingsDetails": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.quidelortho.com/role/BorrowingsScheduleofBorrowingsDetails_1": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.quidelortho.com/role/BorrowingsScheduleofBorrowingsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total borrowings", "label": "Debt and Lease Obligation", "documentation": "Amount of short-term and long-term debt and lease obligation." } } }, "auth_ref": [ "r138", "r141" ] }, "us-gaap_DebtCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtCurrent", "crdr": "credit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Current portion of borrowings", "label": "Debt, Current", "documentation": "Amount of debt and lease obligation, classified as current." } } }, "auth_ref": [ "r177" ] }, "us-gaap_DebtDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Debt Disclosure [Abstract]", "label": "Debt Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DebtDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtDisclosureTextBlock", "presentation": [ "http://www.quidelortho.com/role/Borrowings" ], "lang": { "en-us": { "role": { "terseLabel": "Borrowings", "label": "Debt Disclosure [Text Block]", "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants." } } }, "auth_ref": [ "r126", "r212", "r355", "r356", "r357", "r358", "r359", "r370", "r371", "r381", "r387", "r388", "r389", "r390", "r391", "r392", "r397", "r404", "r405", "r407", "r558" ] }, "us-gaap_DebtInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentAxis", "presentation": [ "http://www.quidelortho.com/role/BorrowingsInterestExpenseDetails", "http://www.quidelortho.com/role/BorrowingsNarrativeDetails", "http://www.quidelortho.com/role/BorrowingsScheduleofBorrowingsDetails", "http://www.quidelortho.com/role/FairValueMeasurementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument [Axis]", "label": "Debt Instrument [Axis]", "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities." } } }, "auth_ref": [ "r18", "r77", "r78", "r138", "r141", "r215", "r382", "r383", "r384", "r385", "r386", "r388", "r393", "r394", "r395", "r396", "r398", "r399", "r400", "r401", "r402", "r403", "r783", "r784", "r785", "r786", "r787", "r816", "r955", "r999", "r1000", "r1001", "r1039", "r1040" ] }, "us-gaap_DebtInstrumentCarryingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentCarryingAmount", "crdr": "credit", "calculation": { "http://www.quidelortho.com/role/BorrowingsScheduleofBorrowingsDetails_1": { "parentTag": "us-gaap_DebtAndCapitalLeaseObligations", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quidelortho.com/role/BorrowingsNarrativeDetails", "http://www.quidelortho.com/role/BorrowingsScheduleofBorrowingsDetails", "http://www.quidelortho.com/role/FairValueMeasurementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term debt", "label": "Long-Term Debt, Gross", "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt." } } }, "auth_ref": [ "r18", "r141", "r408" ] }, "qdel_DebtInstrumentCovenantInterestCoverageRatioMinimum": { "xbrltype": "pureItemType", "nsuri": "http://www.quidelortho.com/20240630", "localname": "DebtInstrumentCovenantInterestCoverageRatioMinimum", "presentation": [ "http://www.quidelortho.com/role/BorrowingsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest coverage ratio, minimum", "label": "Debt Instrument, Covenant, Interest Coverage Ratio, Minimum", "documentation": "Debt Instrument, Covenant, Interest Coverage Ratio, Minimum" } } }, "auth_ref": [] }, "qdel_DebtInstrumentCovenantLeverageRatioMaximum": { "xbrltype": "pureItemType", "nsuri": "http://www.quidelortho.com/20240630", "localname": "DebtInstrumentCovenantLeverageRatioMaximum", "presentation": [ "http://www.quidelortho.com/role/BorrowingsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Leverage ratio maximum", "label": "Debt Instrument, Covenant, Leverage Ratio, Maximum", "documentation": "Debt Instrument, Covenant, Leverage Ratio, Maximum" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentLineItems", "presentation": [ "http://www.quidelortho.com/role/BorrowingsInterestExpenseDetails", "http://www.quidelortho.com/role/BorrowingsNarrativeDetails", "http://www.quidelortho.com/role/BorrowingsScheduleofBorrowingsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument [Line Items]", "label": "Debt Instrument [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r215", "r382", "r383", "r384", "r385", "r386", "r388", "r393", "r394", "r395", "r396", "r398", "r399", "r400", "r401", "r402", "r403", "r406", "r783", "r784", "r785", "r786", "r787", "r816", "r955", "r1039", "r1040" ] }, "us-gaap_DebtInstrumentNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentNameDomain", "presentation": [ "http://www.quidelortho.com/role/BorrowingsInterestExpenseDetails", "http://www.quidelortho.com/role/BorrowingsNarrativeDetails", "http://www.quidelortho.com/role/BorrowingsScheduleofBorrowingsDetails", "http://www.quidelortho.com/role/FairValueMeasurementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument, Name [Domain]", "label": "Debt Instrument, Name [Domain]", "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "auth_ref": [ "r18", "r215", "r382", "r383", "r384", "r385", "r386", "r388", "r393", "r394", "r395", "r396", "r398", "r399", "r400", "r401", "r402", "r403", "r783", "r784", "r785", "r786", "r787", "r816", "r955", "r999", "r1000", "r1001", "r1039", "r1040" ] }, "us-gaap_DebtInstrumentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentTable", "presentation": [ "http://www.quidelortho.com/role/BorrowingsInterestExpenseDetails", "http://www.quidelortho.com/role/BorrowingsNarrativeDetails", "http://www.quidelortho.com/role/BorrowingsScheduleofBorrowingsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Long-term Debt Instruments [Table]", "label": "Schedule of Long-Term Debt Instruments [Table]", "documentation": "Disclosure of information about long-term debt instrument or arrangement." } } }, "auth_ref": [ "r18", "r41", "r42", "r73", "r127", "r128", "r215", "r382", "r383", "r384", "r385", "r386", "r388", "r393", "r394", "r395", "r396", "r398", "r399", "r400", "r401", "r402", "r403", "r406", "r783", "r784", "r785", "r786", "r787", "r816", "r955", "r1039", "r1040" ] }, "us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtRelatedCommitmentFeesAndDebtIssuanceCosts", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/BorrowingsInterestExpenseDetails": { "parentTag": "us-gaap_InterestIncomeExpenseNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.quidelortho.com/role/BorrowingsInterestExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization of deferred financing costs", "label": "Debt Related Commitment Fees and Debt Issuance Costs", "documentation": "Represents the charge against earnings during the period for commitment fees and debt issuance expenses." } } }, "auth_ref": [ "r108" ] }, "us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible", "crdr": "debit", "presentation": [ "http://www.quidelortho.com/role/IncomeTaxesDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Decrease in unrecognized tax benefits is reasonably possible", "label": "Decrease in Unrecognized Tax Benefits is Reasonably Possible", "documentation": "Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit." } } }, "auth_ref": [ "r152" ] }, "us-gaap_DeferredFinanceCostsNoncurrentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredFinanceCostsNoncurrentNet", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/BorrowingsScheduleofBorrowingsDetails_1": { "parentTag": "us-gaap_DebtAndCapitalLeaseObligations", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.quidelortho.com/role/BorrowingsScheduleofBorrowingsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Unamortized deferred financing costs", "label": "Debt Issuance Costs, Noncurrent, Net", "documentation": "Amount, after accumulated amortization, of debt issuance costs classified as noncurrent. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs." } } }, "auth_ref": [ "r1038", "r1039", "r1040" ] }, "us-gaap_DeferredIncomeTaxAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredIncomeTaxAssetsNet", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred tax asset", "label": "Deferred Income Tax Assets, Net", "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting." } } }, "auth_ref": [ "r474", "r475" ] }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredIncomeTaxLiabilitiesNet", "crdr": "credit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred tax liability", "label": "Deferred Income Tax Liabilities, Net", "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting." } } }, "auth_ref": [ "r474", "r475", "r614" ] }, "us-gaap_DeferredRevenueCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredRevenueCurrent", "crdr": "credit", "calculation": { "http://www.quidelortho.com/role/BalanceSheetAccountDetailsOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quidelortho.com/role/BalanceSheetAccountDetailsOtherCurrentLiabilitiesDetails", "http://www.quidelortho.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Deferred revenue, current", "terseLabel": "Deferred revenue", "label": "Deferred Revenue, Current", "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current." } } }, "auth_ref": [ "r944" ] }, "us-gaap_DeferredRevenueNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredRevenueNoncurrent", "crdr": "credit", "presentation": [ "http://www.quidelortho.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred revenue, noncurrent", "label": "Deferred Revenue, Noncurrent", "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent." } } }, "auth_ref": [ "r945" ] }, "us-gaap_DeferredRevenueRevenueRecognized1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredRevenueRevenueRecognized1", "crdr": "credit", "presentation": [ "http://www.quidelortho.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred revenue, revenue recognized", "label": "Deferred Revenue, Revenue Recognized", "documentation": "Amount of revenue recognized that was previously reported as deferred or unearned revenue." } } }, "auth_ref": [] }, "us-gaap_DepreciationDepletionAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DepreciationDepletionAndAmortization", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 }, "http://www.quidelortho.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited", "http://www.quidelortho.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation and amortization", "negatedTerseLabel": "Depreciation and amortization", "label": "Depreciation, Depletion and Amortization", "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets." } } }, "auth_ref": [ "r10", "r248", "r259", "r276", "r774", "r775" ] }, "us-gaap_DerivativeAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeAssets", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails": { "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quidelortho.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative assets", "label": "Derivative Asset", "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r186", "r187", "r526", "r527", "r537", "r545", "r675", "r676", "r677", "r678", "r679", "r680", "r681", "r682", "r683", "r684", "r700", "r701", "r739", "r742", "r745", "r746", "r747", "r748", "r766", "r804", "r809", "r830", "r1022", "r1023", "r1024", "r1084" ] }, "us-gaap_DerivativeAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeAssetsCurrent", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/BalanceSheetAccountDetailsPrepaidexpensesandothercurrentassetsDetails": { "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.quidelortho.com/role/BalanceSheetAccountDetailsPrepaidexpensesandothercurrentassetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivatives", "label": "Derivative Asset, Current", "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r186" ] }, "us-gaap_DerivativeContractTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeContractTypeDomain", "presentation": [ "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails", "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofCurrencyHedgingInstrumentsDetails", "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofFairValueDetails", "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofGainLossDetails", "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofInterestRateDerivativesDetails", "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNetInvestmentHedgeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Contract [Domain]", "label": "Derivative Contract [Domain]", "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset." } } }, "auth_ref": [ "r682", "r684", "r699", "r700", "r701", "r702", "r703", "r704", "r705", "r707", "r708", "r709", "r710", "r720", "r721", "r722", "r723", "r726", "r727", "r728", "r729", "r739", "r740", "r745", "r747", "r828", "r830", "r1025", "r1026", "r1027", "r1028", "r1029", "r1030", "r1032", "r1033" ] }, "us-gaap_DerivativeFairValueOfDerivativeAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeFairValueOfDerivativeAsset", "crdr": "debit", "presentation": [ "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofFairValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Asset, Fair Value, Gross Asset", "label": "Derivative Asset, Subject to Master Netting Arrangement, before Offset", "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement." } } }, "auth_ref": [ "r16", "r95", "r133", "r134", "r185", "r766" ] }, "us-gaap_DerivativeFairValueOfDerivativeLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeFairValueOfDerivativeLiability", "crdr": "credit", "presentation": [ "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofFairValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Liability, Fair Value, Gross Liability", "label": "Derivative Liability, Subject to Master Netting Arrangement, before Offset", "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement." } } }, "auth_ref": [ "r16", "r95", "r133", "r134", "r185", "r766" ] }, "us-gaap_DerivativeFixedInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeFixedInterestRate", "presentation": [ "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofInterestRateDerivativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative, Fixed Interest Rate", "label": "Derivative, Fixed Interest Rate", "documentation": "Fixed interest rate related to the interest rate derivative." } } }, "auth_ref": [] }, "us-gaap_DerivativeInstrumentRiskAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeInstrumentRiskAxis", "presentation": [ "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails", "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofCurrencyHedgingInstrumentsDetails", "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofFairValueDetails", "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofGainLossDetails", "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofInterestRateDerivativesDetails", "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNetInvestmentHedgeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Instrument [Axis]", "label": "Derivative Instrument [Axis]", "documentation": "Information by type of derivative contract." } } }, "auth_ref": [ "r58", "r61", "r63", "r135", "r682", "r684", "r699", "r700", "r701", "r702", "r703", "r704", "r705", "r707", "r708", "r709", "r710", "r720", "r721", "r722", "r723", "r726", "r727", "r728", "r729", "r739", "r740", "r745", "r747", "r766", "r828", "r830", "r1025", "r1026", "r1027", "r1028", "r1029", "r1030", "r1032", "r1033" ] }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]", "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "presentation": [ "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivities" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Instruments and Hedging Activities", "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]", "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts." } } }, "auth_ref": [ "r132", "r512", "r520" ] }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems", "presentation": [ "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails", "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofGainLossDetails", "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNetInvestmentHedgeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Line Items]", "label": "Derivative Instruments and Hedging Activities Disclosures [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable", "presentation": [ "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails", "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofGainLossDetails", "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNetInvestmentHedgeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Table]", "label": "Derivative Instruments and Hedging Activities Disclosures [Table]", "documentation": "Disclosure of information about derivatives and hedging activities." } } }, "auth_ref": [] }, "qdel_DerivativeInstrumentsAndOther": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quidelortho.com/20240630", "localname": "DerivativeInstrumentsAndOther", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/BorrowingsInterestExpenseDetails": { "parentTag": "us-gaap_InterestIncomeExpenseNet", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.quidelortho.com/role/BorrowingsInterestExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative instruments and other", "label": "Derivative instruments and other", "documentation": "Derivative instruments and other" } } }, "auth_ref": [] }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis", "presentation": [ "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNetInvestmentHedgeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging Relationship [Axis]", "label": "Hedging Relationship [Axis]", "documentation": "Information by type of hedging relationship." } } }, "auth_ref": [ "r14", "r58", "r61" ] }, "us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet", "crdr": "credit", "presentation": [ "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value gain (loss) on derivative instruments not designated as hedging instruments", "label": "Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net", "documentation": "Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments." } } }, "auth_ref": [ "r62", "r930" ] }, "us-gaap_DerivativeLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeLiabilities", "crdr": "credit", "calculation": { "http://www.quidelortho.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails": { "parentTag": "us-gaap_LiabilitiesFairValueDisclosure", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quidelortho.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative liabilities", "label": "Derivative Liability", "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r186", "r187", "r526", "r527", "r537", "r545", "r675", "r676", "r677", "r678", "r680", "r681", "r682", "r683", "r684", "r707", "r709", "r710", "r740", "r741", "r742", "r745", "r746", "r747", "r748", "r766", "r1022", "r1023", "r1024", "r1084" ] }, "us-gaap_DerivativeLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.quidelortho.com/role/BalanceSheetAccountDetailsOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.quidelortho.com/role/BalanceSheetAccountDetailsOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivatives", "label": "Derivative Liability, Current", "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r186" ] }, "us-gaap_DerivativeLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeLineItems", "presentation": [ "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofCurrencyHedgingInstrumentsDetails", "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofFairValueDetails", "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofInterestRateDerivativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative [Line Items]", "label": "Derivative [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r520" ] }, "us-gaap_DerivativeNotionalAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeNotionalAmount", "presentation": [ "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofCurrencyHedgingInstrumentsDetails", "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofInterestRateDerivativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative, Notional Amount", "label": "Derivative, Notional Amount", "documentation": "Nominal or face amount used to calculate payment on derivative." } } }, "auth_ref": [ "r1016", "r1017" ] }, "us-gaap_DerivativeTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeTable", "presentation": [ "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofCurrencyHedgingInstrumentsDetails", "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofFairValueDetails", "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofInterestRateDerivativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative [Table]", "label": "Derivative [Table]", "documentation": "Disclosure of information about derivative instrument or group of derivative instruments, including, but not limited to, type of derivative instrument, risk being hedged, notional amount, hedge designation, related hedged item, inception date, and maturity date." } } }, "auth_ref": [ "r14", "r52", "r53", "r54", "r56", "r59", "r61", "r64", "r65", "r67", "r520" ] }, "us-gaap_DesignatedAsHedgingInstrumentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DesignatedAsHedgingInstrumentMember", "presentation": [ "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofCurrencyHedgingInstrumentsDetails", "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofFairValueDetails", "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofInterestRateDerivativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Designated cash flow hedges", "label": "Designated as Hedging Instrument [Member]", "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP)." } } }, "auth_ref": [ "r14" ] }, "us-gaap_DisaggregationOfRevenueLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisaggregationOfRevenueLineItems", "presentation": [ "http://www.quidelortho.com/role/RevenueDisaggregationofRevenueDetails", "http://www.quidelortho.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disaggregation of Revenue [Line Items]", "label": "Disaggregation of Revenue [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r424", "r789", "r790", "r791", "r792", "r793", "r794", "r795" ] }, "us-gaap_DisaggregationOfRevenueTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisaggregationOfRevenueTable", "presentation": [ "http://www.quidelortho.com/role/RevenueDisaggregationofRevenueDetails", "http://www.quidelortho.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disaggregation of Revenue [Table]", "label": "Disaggregation of Revenue [Table]", "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor." } } }, "auth_ref": [ "r424", "r789", "r790", "r791", "r792", "r793", "r794", "r795" ] }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisaggregationOfRevenueTableTextBlock", "presentation": [ "http://www.quidelortho.com/role/RevenueTables" ], "lang": { "en-us": { "role": { "terseLabel": "Disaggregation of Revenue", "label": "Disaggregation of Revenue [Table Text Block]", "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor." } } }, "auth_ref": [ "r1011" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "presentation": [ "http://www.quidelortho.com/role/StockbasedCompensation" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-based Compensation", "label": "Share-Based Payment Arrangement [Text Block]", "documentation": "The entire disclosure for share-based payment arrangement." } } }, "auth_ref": [ "r435", "r438", "r466", "r467", "r468", "r800" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://www.quidelortho.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Period Focus (Q1,Q2,Q3,FY)", "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://www.quidelortho.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Year Focus", "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.quidelortho.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentQuarterlyReport", "presentation": [ "http://www.quidelortho.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Quarterly Report", "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r844" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentTransitionReport", "presentation": [ "http://www.quidelortho.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Transition Report", "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r876" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentType", "presentation": [ "http://www.quidelortho.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year", "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]" } } }, "auth_ref": [ "r887" ] }, "qdel_EMEASegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quidelortho.com/20240630", "localname": "EMEASegmentMember", "presentation": [ "http://www.quidelortho.com/role/GoodwillandIntangibleAssetsNetGoodwillRollforwardDetails", "http://www.quidelortho.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails", "http://www.quidelortho.com/role/SegmentandGeographicInformationTotalRevenuesbyReportableSegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "EMEA", "label": "EMEA Segment [Member]", "documentation": "EMEA Segment" } } }, "auth_ref": [] }, "qdel_EUMedicalDeviceRegulationTransitionCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quidelortho.com/20240630", "localname": "EUMedicalDeviceRegulationTransitionCosts", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0, "order": 10.0 } }, "presentation": [ "http://www.quidelortho.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "EU medical device regulation transition costs", "label": "EU medical device regulation transition costs", "documentation": "EU medical device regulation transition costs" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareAbstract", "lang": { "en-us": { "role": { "terseLabel": "Earnings Per Share [Abstract]", "label": "Earnings Per Share [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareBasic", "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofLossUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Basic loss per share", "label": "Earnings Per Share, Basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r208", "r221", "r222", "r224", "r225", "r226", "r228", "r234", "r236", "r241", "r242", "r243", "r247", "r495", "r499", "r523", "r524", "r609", "r630", "r767" ] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareDiluted", "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofLossUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Diluted loss per share", "label": "Earnings Per Share, Diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r208", "r221", "r222", "r224", "r225", "r226", "r228", "r236", "r241", "r242", "r243", "r247", "r495", "r499", "r523", "r524", "r609", "r630", "r767" ] }, "us-gaap_EarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareTextBlock", "presentation": [ "http://www.quidelortho.com/role/ComputationofEarningsPerShare" ], "lang": { "en-us": { "role": { "terseLabel": "Computation of Earnings Per Share", "label": "Earnings Per Share [Text Block]", "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r233", "r244", "r245", "r246" ] }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Effect of exchange rates on cash", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations", "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r549" ] }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EffectiveIncomeTaxRateContinuingOperations", "presentation": [ "http://www.quidelortho.com/role/IncomeTaxesDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Effective income tax rate", "label": "Effective Income Tax Rate Reconciliation, Percent", "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r477", "r802" ] }, "us-gaap_EmployeeBenefitsAndShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EmployeeBenefitsAndShareBasedCompensation", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0, "order": 11.0 } }, "presentation": [ "http://www.quidelortho.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Employee compensation charges", "label": "Employee Benefits and Share-Based Compensation", "documentation": "Amount of expense for employee benefit and equity-based compensation." } } }, "auth_ref": [] }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EmployeeRelatedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued payroll and related expenses", "label": "Employee-related Liabilities, Current", "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r78" ] }, "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems", "presentation": [ "http://www.quidelortho.com/role/StockbasedCompensationCompensationExpenseRelatedtoStockBasedCompensationPlansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]", "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EmployeeStockOptionMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Employee Stock Option", "label": "Share-Based Payment Arrangement, Option [Member]", "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.quidelortho.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.quidelortho.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.quidelortho.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.quidelortho.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.quidelortho.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r842" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://www.quidelortho.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Common Stock, Shares Outstanding", "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://www.quidelortho.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Current Reporting Status", "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.quidelortho.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r842" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFileNumber", "presentation": [ "http://www.quidelortho.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFilerCategory", "presentation": [ "http://www.quidelortho.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Filer Category", "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r842" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.quidelortho.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://www.quidelortho.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Interactive Data Current", "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r926" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityRegistrantName", "presentation": [ "http://www.quidelortho.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r842" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityShellCompany", "presentation": [ "http://www.quidelortho.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Shell Company", "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r842" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntitySmallBusiness", "presentation": [ "http://www.quidelortho.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Small Business", "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r842" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.quidelortho.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r842" ] }, "ecd_EqtyAwrdsAdjFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "EqtyAwrdsAdjFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Awards Adjustments, Footnote", "label": "Equity Awards Adjustments, Footnote [Text Block]" } } }, "auth_ref": [ "r881" ] }, "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table", "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]" } } }, "auth_ref": [ "r922" ] }, "ecd_EqtyAwrdsAdjsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "EqtyAwrdsAdjsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Awards Adjustments", "label": "Equity Awards Adjustments [Member]" } } }, "auth_ref": [ "r922" ] }, "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table", "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]" } } }, "auth_ref": [ "r922" ] }, "us-gaap_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EquityAbstract", "lang": { "en-us": { "role": { "terseLabel": "Equity [Abstract]", "label": "Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EquityComponentDomain", "presentation": [ "http://www.quidelortho.com/role/AccumulatedOtherComprehensiveLossDetails", "http://www.quidelortho.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Component [Domain]", "label": "Equity Component [Domain]", "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r13", "r165", "r202", "r203", "r204", "r216", "r217", "r218", "r220", "r226", "r229", "r231", "r249", "r319", "r322", "r352", "r412", "r485", "r486", "r492", "r493", "r494", "r496", "r498", "r499", "r514", "r515", "r516", "r517", "r518", "r519", "r522", "r550", "r552", "r553", "r554", "r555", "r557", "r560", "r562", "r568", "r626", "r655", "r656", "r657", "r673", "r732" ] }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Valuation Assumption Difference, Footnote", "label": "Equity Valuation Assumption Difference, Footnote [Text Block]" } } }, "auth_ref": [ "r891" ] }, "ecd_ErrCompAnalysisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ErrCompAnalysisTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Erroneous Compensation Analysis", "label": "Erroneous Compensation Analysis [Text Block]" } } }, "auth_ref": [ "r849", "r859", "r869", "r901" ] }, "ecd_ErrCompRecoveryTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ErrCompRecoveryTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Erroneously Awarded Compensation Recovery", "label": "Erroneously Awarded Compensation Recovery [Table]" } } }, "auth_ref": [ "r846", "r856", "r866", "r898" ] }, "ecd_ExecutiveCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ExecutiveCategoryAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Executive Category:", "label": "Executive Category [Axis]" } } }, "auth_ref": [ "r897" ] }, "qdel_ExpectedValueContractCustomersMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quidelortho.com/20240630", "localname": "ExpectedValueContractCustomersMember", "presentation": [ "http://www.quidelortho.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected Value Contract Customers", "label": "Expected Value Contract Customers [Member]", "documentation": "Expected Value Contract Customers" } } }, "auth_ref": [] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract", "presentation": [ "http://www.quidelortho.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Assets:", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]" } } }, "auth_ref": [] }, "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems", "presentation": [ "http://www.quidelortho.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails", "http://www.quidelortho.com/role/FairValueMeasurementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]", "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_FairValueByBalanceSheetGroupingTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueByBalanceSheetGroupingTable", "presentation": [ "http://www.quidelortho.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails", "http://www.quidelortho.com/role/FairValueMeasurementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]", "label": "Fair Value, by Balance Sheet Grouping [Table]", "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities." } } }, "auth_ref": [ "r69", "r70" ] }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueByFairValueHierarchyLevelAxis", "presentation": [ "http://www.quidelortho.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Hierarchy and NAV [Axis]", "label": "Fair Value Hierarchy and NAV [Axis]", "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient." } } }, "auth_ref": [ "r395", "r428", "r429", "r430", "r431", "r432", "r433", "r525", "r527", "r528", "r529", "r530", "r536", "r537", "r539", "r572", "r573", "r574", "r784", "r785", "r796", "r797", "r798", "r804", "r809" ] }, "us-gaap_FairValueDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueDisclosuresAbstract", "lang": { "en-us": { "role": { "terseLabel": "Fair Value Disclosures [Abstract]", "label": "Fair Value Disclosures [Abstract]" } } }, "auth_ref": [] }, "us-gaap_FairValueDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueDisclosuresTextBlock", "presentation": [ "http://www.quidelortho.com/role/FairValueMeasurements" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Measurements", "label": "Fair Value Disclosures [Text Block]", "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information." } } }, "auth_ref": [ "r532", "r534", "r535", "r536", "r539", "r540", "r541", "r542", "r543", "r603", "r804", "r810" ] }, "us-gaap_FairValueInputsLevel1Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueInputsLevel1Member", "presentation": [ "http://www.quidelortho.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Level 1", "label": "Fair Value, Inputs, Level 1 [Member]", "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date." } } }, "auth_ref": [ "r395", "r428", "r433", "r527", "r537", "r572", "r796", "r797", "r798", "r804" ] }, "us-gaap_FairValueInputsLevel2Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueInputsLevel2Member", "presentation": [ "http://www.quidelortho.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Level\u00a02", "label": "Fair Value, Inputs, Level 2 [Member]", "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets." } } }, "auth_ref": [ "r395", "r428", "r433", "r527", "r528", "r537", "r573", "r784", "r785", "r796", "r797", "r798", "r804" ] }, "us-gaap_FairValueInputsLevel3Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueInputsLevel3Member", "presentation": [ "http://www.quidelortho.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Level 3", "label": "Fair Value, Inputs, Level 3 [Member]", "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r395", "r428", "r429", "r430", "r431", "r432", "r433", "r527", "r528", "r529", "r530", "r537", "r574", "r784", "r785", "r796", "r797", "r798", "r804", "r809" ] }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueMeasurementsFairValueHierarchyDomain", "presentation": [ "http://www.quidelortho.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Hierarchy and NAV [Domain]", "label": "Fair Value Hierarchy and NAV [Domain]", "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "auth_ref": [ "r395", "r428", "r429", "r430", "r431", "r432", "r433", "r525", "r527", "r528", "r529", "r530", "r536", "r537", "r539", "r572", "r573", "r574", "r784", "r785", "r796", "r797", "r798", "r804", "r809" ] }, "us-gaap_FinanceLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FinanceLeaseLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://www.quidelortho.com/role/BorrowingsScheduleofBorrowingsDetails_1": { "parentTag": "us-gaap_DebtAndCapitalLeaseObligations", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quidelortho.com/role/BorrowingsScheduleofBorrowingsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Financing lease obligation", "label": "Finance Lease, Liability, Noncurrent", "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent." } } }, "auth_ref": [ "r564" ] }, "us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList", "presentation": [ "http://www.quidelortho.com/role/BorrowingsScheduleofBorrowingsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]", "label": "Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes noncurrent finance lease liability." } } }, "auth_ref": [ "r565" ] }, "us-gaap_FinancialInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FinancialInstrumentAxis", "presentation": [ "http://www.quidelortho.com/role/BalanceSheetAccountDetailsMarketableSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Eligible Item or Group for Fair Value Option", "label": "Financial Instrument [Axis]", "documentation": "Information by type of financial instrument." } } }, "auth_ref": [ "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r324", "r325", "r326", "r327", "r328", "r330", "r331", "r332", "r406", "r411", "r520", "r544", "r569", "r570", "r571", "r572", "r573", "r574", "r575", "r576", "r577", "r578", "r579", "r580", "r581", "r582", "r583", "r585", "r586", "r587", "r588", "r589", "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r627", "r780", "r804", "r807", "r809", "r810", "r811", "r812", "r813", "r814", "r815", "r818", "r933", "r934", "r935", "r936", "r937", "r938", "r939", "r977", "r978", "r979", "r980", "r1019", "r1022", "r1023", "r1024", "r1031", "r1034" ] }, "us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months", "crdr": "credit", "presentation": [ "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign currency cash flow hedge, gain (loss) to be reclassified during next 12 months", "label": "Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months", "documentation": "The estimated net amount of unrealized gains or losses on foreign currency cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months." } } }, "auth_ref": [ "r68" ] }, "us-gaap_ForeignExchangeContractMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ForeignExchangeContractMember", "presentation": [ "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofCurrencyHedgingInstrumentsDetails", "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofFairValueDetails", "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNetInvestmentHedgeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign exchange contracts", "label": "Foreign Exchange Contract [Member]", "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates." } } }, "auth_ref": [ "r766", "r796", "r803", "r804" ] }, "us-gaap_ForeignExchangeForwardMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ForeignExchangeForwardMember", "presentation": [ "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails", "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofGainLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign Exchange Forward", "label": "Foreign Exchange Forward [Member]", "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate." } } }, "auth_ref": [ "r700", "r704", "r709", "r722", "r728", "r743", "r744", "r745", "r830" ] }, "us-gaap_ForeignGovernmentDebtSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ForeignGovernmentDebtSecuritiesMember", "presentation": [ "http://www.quidelortho.com/role/BalanceSheetAccountDetailsMarketableSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Sovereign government bonds", "label": "Debt Security, Government, Non-US [Member]", "documentation": "Debt security issued by government not domiciled in United States of America (US)." } } }, "auth_ref": [ "r818", "r1012", "r1080" ] }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount", "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "auth_ref": [ "r853", "r863", "r873", "r905" ] }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount", "label": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "auth_ref": [ "r853", "r863", "r873", "r905" ] }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount", "label": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "auth_ref": [ "r853", "r863", "r873", "r905" ] }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery, Explanation of Impracticability", "label": "Forgone Recovery, Explanation of Impracticability [Text Block]" } } }, "auth_ref": [ "r853", "r863", "r873", "r905" ] }, "ecd_ForgoneRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Forgone Recovery, Individual Name" } } }, "auth_ref": [ "r853", "r863", "r873", "r905" ] }, "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year", "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]" } } }, "auth_ref": [ "r886" ] }, "us-gaap_Goodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Goodwill", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited", "http://www.quidelortho.com/role/GoodwillandIntangibleAssetsNetGoodwillRollforwardDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill", "periodStartLabel": "Balance at December 31, 2023", "periodEndLabel": "Balance at June 30, 2024", "label": "Goodwill", "documentation": "Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized." } } }, "auth_ref": [ "r173", "r335", "r604", "r775", "r781", "r805", "r817", "r985", "r992" ] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "presentation": [ "http://www.quidelortho.com/role/GoodwillandIntangibleAssetsNet" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill and Intangible Assets, Net", "label": "Goodwill and Intangible Assets Disclosure [Text Block]", "documentation": "The entire disclosure for goodwill and intangible assets." } } }, "auth_ref": [ "r983", "r995" ] }, "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GoodwillForeignCurrencyTranslationGainLoss", "crdr": "credit", "presentation": [ "http://www.quidelortho.com/role/GoodwillandIntangibleAssetsNetGoodwillRollforwardDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign currency translation", "label": "Goodwill, Foreign Currency Translation Gain (Loss)", "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) asset representing future economic benefit from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized." } } }, "auth_ref": [ "r343" ] }, "us-gaap_GoodwillImpairmentLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GoodwillImpairmentLoss", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 3.0 }, "http://www.quidelortho.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0, "order": 6.0 }, "http://www.quidelortho.com/role/ConsolidatedStatementsofLossUnaudited": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited", "http://www.quidelortho.com/role/ConsolidatedStatementsofLossUnaudited", "http://www.quidelortho.com/role/GoodwillandIntangibleAssetsNetGoodwillRollforwardDetails", "http://www.quidelortho.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails", "http://www.quidelortho.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill impairment charge", "negatedTerseLabel": "Goodwill impairment charge", "negatedLabel": "Impairment charge", "label": "Goodwill, Impairment Loss", "documentation": "Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized." } } }, "auth_ref": [ "r10", "r336", "r342", "r347", "r781", "r805" ] }, "us-gaap_GoodwillLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GoodwillLineItems", "presentation": [ "http://www.quidelortho.com/role/GoodwillandIntangibleAssetsNetGoodwillRollforwardDetails", "http://www.quidelortho.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill [Line Items]", "label": "Goodwill [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r781" ] }, "us-gaap_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GrossProfit", "crdr": "credit", "presentation": [ "http://www.quidelortho.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross Profit", "label": "Gross Profit", "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity." } } }, "auth_ref": [ "r101", "r104", "r150", "r213", "r318", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r546", "r769", "r774", "r964", "r966", "r967", "r968", "r969", "r1008" ] }, "us-gaap_HedgingDesignationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "HedgingDesignationAxis", "presentation": [ "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofCurrencyHedgingInstrumentsDetails", "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofFairValueDetails", "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofInterestRateDerivativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging Designation [Axis]", "label": "Hedging Designation [Axis]", "documentation": "Information by designation of purpose of derivative instrument." } } }, "auth_ref": [ "r14", "r511" ] }, "us-gaap_HedgingDesignationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "HedgingDesignationDomain", "presentation": [ "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofCurrencyHedgingInstrumentsDetails", "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofFairValueDetails", "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofInterestRateDerivativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging Designation [Domain]", "label": "Hedging Designation [Domain]", "documentation": "Designation of purpose of derivative instrument." } } }, "auth_ref": [ "r14" ] }, "us-gaap_HedgingRelationshipDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "HedgingRelationshipDomain", "presentation": [ "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNetInvestmentHedgeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging Relationship [Domain]", "label": "Hedging Relationship [Domain]", "documentation": "Nature or intent of a hedge." } } }, "auth_ref": [ "r14" ] }, "us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ImpairmentOfLongLivedAssetsToBeDisposedOf", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 4.0 }, "http://www.quidelortho.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0, "order": 7.0 }, "http://www.quidelortho.com/role/ConsolidatedStatementsofLossUnaudited": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://www.quidelortho.com/role/AssetsHeldforSaleDetails", "http://www.quidelortho.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails", "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited", "http://www.quidelortho.com/role/ConsolidatedStatementsofLossUnaudited", "http://www.quidelortho.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Asset impairment charge", "terseLabel": "Asset impairment charge", "negatedTerseLabel": "Asset impairment charge", "label": "Impairment of Long-Lived Assets to be Disposed of", "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale." } } }, "auth_ref": [ "r10", "r123", "r806" ] }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "presentation": [ "http://www.quidelortho.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Assets Held for Sale", "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets." } } }, "auth_ref": [ "r0", "r124" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedStatementsofLossUnaudited": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 }, "http://www.quidelortho.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofLossUnaudited", "http://www.quidelortho.com/role/IncomeTaxesDetail", "http://www.quidelortho.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Loss before income taxes", "terseLabel": "Loss before income taxes", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r102", "r146", "r150", "r610", "r624", "r769", "r774", "r964", "r966", "r967", "r968", "r969" ] }, "us-gaap_IncomeLossFromEquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeLossFromEquityMethodInvestments", "crdr": "credit", "calculation": { "http://www.quidelortho.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://www.quidelortho.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gain (loss) on investments", "label": "Income (Loss) from Equity Method Investments", "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss)." } } }, "auth_ref": [ "r10", "r103", "r145", "r248", "r261", "r276", "r317", "r623" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "terseLabel": "Income Statement [Abstract]", "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeStatementLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeStatementLocationAxis", "presentation": [ "http://www.quidelortho.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails", "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails", "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofGainLossDetails", "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNetInvestmentHedgeDetails", "http://www.quidelortho.com/role/StockbasedCompensationCompensationExpenseRelatedtoStockBasedCompensationPlansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Statement Location [Axis]", "label": "Statement of Income Location, Balance [Axis]", "documentation": "Information by location in statement of income where disaggregated amount has been reported." } } }, "auth_ref": [ "r353", "r360", "r361", "r531", "r533", "r538", "r652", "r654", "r717", "r755", "r808", "r1053" ] }, "us-gaap_IncomeStatementLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeStatementLocationDomain", "presentation": [ "http://www.quidelortho.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails", "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails", "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofGainLossDetails", "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNetInvestmentHedgeDetails", "http://www.quidelortho.com/role/StockbasedCompensationCompensationExpenseRelatedtoStockBasedCompensationPlansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Statement Location [Domain]", "label": "Statement of Income Location, Balance [Domain]", "documentation": "Location in statement of income where disaggregated amount has been reported." } } }, "auth_ref": [ "r360", "r361", "r531", "r533", "r538", "r652", "r654", "r717", "r755", "r808", "r1053" ] }, "us-gaap_IncomeTaxDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Income Tax Disclosure [Abstract]", "label": "Income Tax Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxDisclosureTextBlock", "presentation": [ "http://www.quidelortho.com/role/IncomeTaxes" ], "lang": { "en-us": { "role": { "terseLabel": "Income Taxes", "label": "Income Tax Disclosure [Text Block]", "documentation": "The entire disclosure for income tax." } } }, "auth_ref": [ "r214", "r472", "r477", "r478", "r479", "r480", "r483", "r484", "r487", "r489", "r490", "r491", "r671", "r802" ] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedStatementsofLossUnaudited": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofLossUnaudited", "http://www.quidelortho.com/role/IncomeTaxesDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Benefit from income taxes", "label": "Income Tax Expense (Benefit)", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r153", "r163", "r230", "r231", "r248", "r262", "r276", "r476", "r477", "r488", "r632", "r802" ] }, "qdel_IncomeTaxReceivablesAndOtherTaxReceivablesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quidelortho.com/20240630", "localname": "IncomeTaxReceivablesAndOtherTaxReceivablesCurrent", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/BalanceSheetAccountDetailsPrepaidexpensesandothercurrentassetsDetails": { "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quidelortho.com/role/BalanceSheetAccountDetailsPrepaidexpensesandothercurrentassetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income taxes and other tax receivables", "label": "Income Tax Receivables And Other Tax Receivables, Current", "documentation": "Income Tax Receivables And Other Tax Receivables, Current" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInAccountsPayable", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable", "label": "Increase (Decrease) in Accounts Payable", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business." } } }, "auth_ref": [ "r9" ] }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInAccountsReceivable", "crdr": "credit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 10.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Accounts receivable", "label": "Increase (Decrease) in Accounts Receivable", "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services." } } }, "auth_ref": [ "r9" ] }, "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 15.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Income taxes payable", "label": "Increase (Decrease) in Income Taxes Payable", "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction." } } }, "auth_ref": [ "r9" ] }, "qdel_IncreaseDecreaseInDeferredTaxAssetsAndLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quidelortho.com/20240630", "localname": "IncreaseDecreaseInDeferredTaxAssetsAndLiabilities", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Change in deferred tax assets and liabilities", "label": "Increase (Decrease) In Deferred Tax Assets And Liabilities", "documentation": "Increase (Decrease) In Deferred Tax Assets And Liabilities" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 14.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued payroll and related expenses", "label": "Increase (Decrease) in Employee Related Liabilities", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits." } } }, "auth_ref": [ "r9" ] }, "us-gaap_IncreaseDecreaseInInventories": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInInventories", "crdr": "credit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 11.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Inventories", "label": "Increase (Decrease) in Inventories", "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities." } } }, "auth_ref": [ "r9" ] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Changes in assets and liabilities:", "label": "Increase (Decrease) in Operating Capital [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInOtherOperatingLiabilities", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 16.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Other current and non-current liabilities", "label": "Increase (Decrease) in Other Operating Liabilities", "documentation": "Amount of increase (decrease) in operating liabilities classified as other." } } }, "auth_ref": [ "r9" ] }, "us-gaap_IncreaseDecreaseInPrepaidExpensesOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInPrepaidExpensesOther", "crdr": "credit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 12.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Prepaid expenses and other current and non-current assets", "label": "Increase (Decrease) in Prepaid Expenses, Other", "documentation": "Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods." } } }, "auth_ref": [ "r9" ] }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "calculation": { "http://www.quidelortho.com/role/ComputationofEarningsPerShareCalculationofBasicandDilutedEarningsPerShareDetails": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quidelortho.com/role/ComputationofEarningsPerShareCalculationofBasicandDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Dilutive potential shares issuable from stock options and RSUs", "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements", "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method." } } }, "auth_ref": [ "r237", "r238", "r239", "r243", "r437" ] }, "qdel_IndemnificationReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quidelortho.com/20240630", "localname": "IndemnificationReceivable", "crdr": "debit", "presentation": [ "http://www.quidelortho.com/role/IncomeTaxesDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Indemnification receivable", "label": "Indemnification Receivable", "documentation": "Indemnification Receivable" } } }, "auth_ref": [] }, "ecd_IndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "IndividualAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Individual:", "label": "Individual [Axis]" } } }, "auth_ref": [ "r853", "r863", "r873", "r897", "r905", "r909", "r917" ] }, "qdel_IndustryAndGeographicInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.quidelortho.com/20240630", "localname": "IndustryAndGeographicInformationAbstract", "lang": { "en-us": { "role": { "terseLabel": "Industry And Geographic Information [Abstract]", "label": "Industry And Geographic Information [Abstract]", "documentation": "Industry and Geographic Information [Abstract]" } } }, "auth_ref": [] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "InsiderTradingArrLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Arrangements [Line Items]" } } }, "auth_ref": [ "r915" ] }, "ecd_InsiderTradingPoliciesProcLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "InsiderTradingPoliciesProcLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]" } } }, "auth_ref": [ "r845", "r921" ] }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "InsiderTrdPoliciesProcAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "terseLabel": "Insider Trading Policies and Procedures Adopted", "label": "Insider Trading Policies and Procedures Adopted [Flag]" } } }, "auth_ref": [ "r845", "r921" ] }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "terseLabel": "Insider Trading Policies and Procedures Not Adopted", "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]" } } }, "auth_ref": [ "r845", "r921" ] }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IntangibleAssetsNetExcludingGoodwill", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible assets, net", "label": "Intangible Assets, Net (Excluding Goodwill)", "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges." } } }, "auth_ref": [ "r348", "r996", "r997" ] }, "us-gaap_InterestAndDividendsPayableCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InterestAndDividendsPayableCurrentAndNoncurrent", "crdr": "credit", "calculation": { "http://www.quidelortho.com/role/BalanceSheetAccountDetailsOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.quidelortho.com/role/BalanceSheetAccountDetailsOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued interest", "label": "Interest and Dividends Payable", "documentation": "Sum of the carrying values as of the balance sheet date of (a) interest payable on all forms of debt, including trade payables, that has been incurred, and (b) dividends declared but unpaid on equity securities issued by the entity and outstanding (also includes dividends collected on behalf of another owner of securities that are being held by the entity)." } } }, "auth_ref": [ "r140" ] }, "us-gaap_InterestExpenseDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InterestExpenseDebt", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/BorrowingsInterestExpenseDetails": { "parentTag": "us-gaap_InterestIncomeExpenseNet", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.quidelortho.com/role/BorrowingsInterestExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest expense, debt", "label": "Interest Expense, Debt", "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt." } } }, "auth_ref": [ "r108", "r401", "r409", "r786", "r787" ] }, "us-gaap_InterestExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InterestExpenseMember", "presentation": [ "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofGainLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest expense, net", "label": "Interest Expense [Member]", "documentation": "Primary financial statement caption encompassing interest expense." } } }, "auth_ref": [ "r15" ] }, "us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InterestIncomeAndInterestExpenseDisclosureTableTextBlock", "presentation": [ "http://www.quidelortho.com/role/BorrowingsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Interest Expense", "label": "Interest Income and Interest Expense Disclosure [Table Text Block]", "documentation": "Tabular disclosure of interest income and expense, including, but not limited to, interest income and expense from investments, loans, and securities." } } }, "auth_ref": [] }, "us-gaap_InterestIncomeExpenseNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InterestIncomeExpenseNet", "crdr": "credit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedStatementsofLossUnaudited": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 2.0 }, "http://www.quidelortho.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 3.0 }, "http://www.quidelortho.com/role/BorrowingsInterestExpenseDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.quidelortho.com/role/BorrowingsInterestExpenseDetails", "http://www.quidelortho.com/role/ConsolidatedStatementsofLossUnaudited", "http://www.quidelortho.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Interest expense, net", "terseLabel": "Interest expense, net", "negatedTotalLabel": "Interest expense, net", "label": "Interest Income (Expense), Operating", "documentation": "Amount of interest income (expense) classified as operating." } } }, "auth_ref": [ "r606", "r966" ] }, "us-gaap_InterestIncomeOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InterestIncomeOther", "crdr": "credit", "calculation": { "http://www.quidelortho.com/role/BorrowingsInterestExpenseDetails": { "parentTag": "us-gaap_InterestIncomeExpenseNet", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.quidelortho.com/role/BorrowingsInterestExpenseDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Interest income", "label": "Interest Income, Other", "documentation": "Amount of interest income earned from interest bearing assets classified as other." } } }, "auth_ref": [] }, "us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet", "crdr": "credit", "presentation": [ "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest rate cash flow hedge, pre-tax gain (loss) from reclassification", "label": "Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net", "documentation": "The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months." } } }, "auth_ref": [ "r68" ] }, "qdel_InterestRateSwapFiveMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quidelortho.com/20240630", "localname": "InterestRateSwapFiveMember", "presentation": [ "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofInterestRateDerivativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest Rate Swap Five", "label": "Interest Rate Swap Five [Member]", "documentation": "Interest Rate Swap Five" } } }, "auth_ref": [] }, "qdel_InterestRateSwapFourMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quidelortho.com/20240630", "localname": "InterestRateSwapFourMember", "presentation": [ "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofInterestRateDerivativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest Rate Swap Four", "label": "Interest Rate Swap Four [Member]", "documentation": "Interest Rate Swap Four" } } }, "auth_ref": [] }, "us-gaap_InterestRateSwapMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InterestRateSwapMember", "presentation": [ "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofFairValueDetails", "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofGainLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest Rate Swap", "label": "Interest Rate Swap [Member]", "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period." } } }, "auth_ref": [ "r756", "r835", "r836" ] }, "qdel_InterestRateSwapOneMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quidelortho.com/20240630", "localname": "InterestRateSwapOneMember", "presentation": [ "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofInterestRateDerivativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest Rate Swap One", "label": "Interest Rate Swap One [Member]", "documentation": "Interest Rate Swap One" } } }, "auth_ref": [] }, "qdel_InterestRateSwapThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quidelortho.com/20240630", "localname": "InterestRateSwapThreeMember", "presentation": [ "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofInterestRateDerivativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest Rate Swap Three", "label": "Interest Rate Swap Three [Member]", "documentation": "Interest Rate Swap Three" } } }, "auth_ref": [] }, "qdel_InterestRateSwapTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quidelortho.com/20240630", "localname": "InterestRateSwapTwoMember", "presentation": [ "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofInterestRateDerivativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest Rate Swap Two", "label": "Interest Rate Swap Two [Member]", "documentation": "Interest Rate Swap Two" } } }, "auth_ref": [] }, "qdel_InventoriesIncludingNoncurrentPortionNet": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quidelortho.com/20240630", "localname": "InventoriesIncludingNoncurrentPortionNet", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/BalanceSheetAccountDetailsInventoriesDetails": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.quidelortho.com/role/BalanceSheetAccountDetailsInventoriesDetails_1": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.quidelortho.com/role/BalanceSheetAccountDetailsInventoriesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Inventories, including noncurrent portion, net", "label": "Inventories, including noncurrent portion, net", "documentation": "Inventories, including noncurrent portion, net" } } }, "auth_ref": [] }, "us-gaap_InventoryFinishedGoodsNetOfReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryFinishedGoodsNetOfReserves", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/BalanceSheetAccountDetailsInventoriesDetails_1": { "parentTag": "qdel_InventoriesIncludingNoncurrentPortionNet", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.quidelortho.com/role/BalanceSheetAccountDetailsInventoriesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finished goods (materials, labor and overhead)", "label": "Inventory, Finished Goods, Net of Reserves", "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale." } } }, "auth_ref": [ "r120", "r763" ] }, "us-gaap_InventoryNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryNet", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/BalanceSheetAccountDetailsInventoriesDetails": { "parentTag": "qdel_InventoriesIncludingNoncurrentPortionNet", "weight": 1.0, "order": 1.0 }, "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.quidelortho.com/role/BalanceSheetAccountDetailsInventoriesDetails", "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Inventories", "label": "Inventory, Net", "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r181", "r759", "r817" ] }, "us-gaap_InventoryNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryNoncurrent", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/BalanceSheetAccountDetailsInventoriesDetails": { "parentTag": "qdel_InventoriesIncludingNoncurrentPortionNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quidelortho.com/role/BalanceSheetAccountDetailsInventoriesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Inventory, Noncurrent", "label": "Inventory, Noncurrent", "documentation": "Inventories not expected to be converted to cash, sold or exchanged within the normal operating cycle." } } }, "auth_ref": [ "r942" ] }, "us-gaap_InventoryRawMaterialsNetOfReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryRawMaterialsNetOfReserves", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/BalanceSheetAccountDetailsInventoriesDetails_1": { "parentTag": "qdel_InventoriesIncludingNoncurrentPortionNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quidelortho.com/role/BalanceSheetAccountDetailsInventoriesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Raw materials", "label": "Inventory, Raw Materials, Net of Reserves", "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process." } } }, "auth_ref": [ "r120", "r765" ] }, "us-gaap_InventoryWorkInProcessNetOfReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryWorkInProcessNetOfReserves", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/BalanceSheetAccountDetailsInventoriesDetails_1": { "parentTag": "qdel_InventoriesIncludingNoncurrentPortionNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quidelortho.com/role/BalanceSheetAccountDetailsInventoriesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Work-in-process (materials, labor and overhead)", "label": "Inventory, Work in Process, Net of Reserves", "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing." } } }, "auth_ref": [ "r120", "r764" ] }, "qdel_LabsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quidelortho.com/20240630", "localname": "LabsMember", "presentation": [ "http://www.quidelortho.com/role/RevenueDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Labs", "label": "Labs [Member]", "documentation": "Labs" } } }, "auth_ref": [] }, "us-gaap_LetterOfCreditMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LetterOfCreditMember", "presentation": [ "http://www.quidelortho.com/role/BorrowingsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Letter of Credit", "label": "Letter of Credit [Member]", "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit)." } } }, "auth_ref": [] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities", "label": "Liabilities", "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others." } } }, "auth_ref": [ "r18", "r77", "r78", "r79", "r81", "r82", "r83", "r84", "r213", "r318", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r502", "r504", "r505", "r546", "r692", "r768", "r840", "r1008", "r1041", "r1042" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities and stockholders\u2019 equity", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r91", "r143", "r621", "r817", "r956", "r981", "r1035" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY", "label": "Liabilities and Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Total current liabilities", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r79", "r171", "r213", "r318", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r502", "r504", "r505", "r546", "r817", "r1008", "r1041", "r1042" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Current liabilities:", "label": "Liabilities, Current [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesFairValueDisclosure", "crdr": "credit", "calculation": { "http://www.quidelortho.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.quidelortho.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities measured at fair value", "label": "Liabilities, Fair Value Disclosure", "documentation": "Fair value of financial and nonfinancial obligations." } } }, "auth_ref": [ "r527", "r1020" ] }, "us-gaap_LiabilitiesFairValueDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesFairValueDisclosureAbstract", "presentation": [ "http://www.quidelortho.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Liabilities:", "label": "Liabilities, Fair Value Disclosure [Abstract]" } } }, "auth_ref": [] }, "qdel_LineOfCreditFacilityAmendmentFeeAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quidelortho.com/20240630", "localname": "LineOfCreditFacilityAmendmentFeeAmount", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://www.quidelortho.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Credit Agreement amendment fees", "label": "Line Of Credit Facility, Amendment Fee Amount", "documentation": "Line Of Credit Facility, Amendment Fee Amount" } } }, "auth_ref": [] }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "crdr": "credit", "presentation": [ "http://www.quidelortho.com/role/BorrowingsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Line of credit, maximum borrowing capacity", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility." } } }, "auth_ref": [ "r76", "r80" ] }, "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LineOfCreditFacilityRemainingBorrowingCapacity", "crdr": "credit", "presentation": [ "http://www.quidelortho.com/role/BorrowingsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Remaining borrowing capacity", "label": "Line of Credit Facility, Remaining Borrowing Capacity", "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding)." } } }, "auth_ref": [ "r76", "r80", "r371" ] }, "us-gaap_LineOfCreditMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LineOfCreditMember", "presentation": [ "http://www.quidelortho.com/role/BorrowingsInterestExpenseDetails", "http://www.quidelortho.com/role/BorrowingsNarrativeDetails", "http://www.quidelortho.com/role/BorrowingsScheduleofBorrowingsDetails", "http://www.quidelortho.com/role/FairValueMeasurementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Line of Credit", "label": "Line of Credit [Member]", "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LocalPhoneNumber", "presentation": [ "http://www.quidelortho.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "us-gaap_LongTermDebtAndCapitalLeaseObligations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermDebtAndCapitalLeaseObligations", "crdr": "credit", "calculation": { "http://www.quidelortho.com/role/BorrowingsScheduleofBorrowingsDetails": { "parentTag": "us-gaap_DebtAndCapitalLeaseObligations", "weight": 1.0, "order": 2.0 }, "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.quidelortho.com/role/BorrowingsScheduleofBorrowingsDetails", "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term borrowings", "label": "Long-Term Debt and Lease Obligation", "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent." } } }, "auth_ref": [ "r18", "r615" ] }, "us-gaap_LongTermDebtCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermDebtCurrent", "crdr": "credit", "calculation": { "http://www.quidelortho.com/role/BorrowingsScheduleofBorrowingsDetails": { "parentTag": "us-gaap_DebtAndCapitalLeaseObligations", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quidelortho.com/role/BorrowingsScheduleofBorrowingsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Less: current portion", "label": "Long-Term Debt, Current Maturities", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation." } } }, "auth_ref": [ "r176" ] }, "us-gaap_LongTermDebtFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermDebtFairValue", "crdr": "credit", "presentation": [ "http://www.quidelortho.com/role/FairValueMeasurementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term debt, fair value", "label": "Long-Term Debt, Fair Value", "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission." } } }, "auth_ref": [ "r1020", "r1022", "r1023", "r1024" ] }, "qdel_LongTermMarketableSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quidelortho.com/20240630", "localname": "LongTermMarketableSecuritiesMember", "presentation": [ "http://www.quidelortho.com/role/BalanceSheetAccountDetailsMarketableSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total marketable securities", "label": "Long-Term Marketable Securities [Member]", "documentation": "Long-Term Marketable Securities" } } }, "auth_ref": [] }, "us-gaap_LongtermDebtTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongtermDebtTypeAxis", "presentation": [ "http://www.quidelortho.com/role/BorrowingsInterestExpenseDetails", "http://www.quidelortho.com/role/BorrowingsNarrativeDetails", "http://www.quidelortho.com/role/BorrowingsScheduleofBorrowingsDetails", "http://www.quidelortho.com/role/FairValueMeasurementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term Debt, Type [Axis]", "label": "Long-Term Debt, Type [Axis]", "documentation": "Information by type of long-term debt." } } }, "auth_ref": [ "r18", "r999", "r1000", "r1001" ] }, "us-gaap_LongtermDebtTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongtermDebtTypeDomain", "presentation": [ "http://www.quidelortho.com/role/BorrowingsInterestExpenseDetails", "http://www.quidelortho.com/role/BorrowingsNarrativeDetails", "http://www.quidelortho.com/role/BorrowingsScheduleofBorrowingsDetails", "http://www.quidelortho.com/role/FairValueMeasurementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term Debt, Type [Domain]", "label": "Long-Term Debt, Type [Domain]", "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r18", "r40", "r999", "r1000", "r1001" ] }, "qdel_LossContingencyNumberOfExecutiveDefendants": { "xbrltype": "integerItemType", "nsuri": "http://www.quidelortho.com/20240630", "localname": "LossContingencyNumberOfExecutiveDefendants", "presentation": [ "http://www.quidelortho.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of executive defendants", "label": "Loss Contingency, Number Of Executive Defendants", "documentation": "Loss Contingency, Number Of Executive Defendants" } } }, "auth_ref": [] }, "srt_MajorCustomersAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "MajorCustomersAxis", "presentation": [ "http://www.quidelortho.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer [Axis]", "label": "Customer [Axis]" } } }, "auth_ref": [ "r282", "r791", "r820", "r824", "r1011", "r1050", "r1054", "r1055", "r1057", "r1058", "r1059", "r1060", "r1061", "r1062", "r1063", "r1064", "r1065", "r1066", "r1067", "r1068", "r1069", "r1070", "r1071", "r1072", "r1073", "r1074", "r1075", "r1076", "r1077", "r1078", "r1079", "r1081", "r1082" ] }, "us-gaap_MarketableSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MarketableSecurities", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails": { "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quidelortho.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Marketable securities", "label": "Marketable Securities", "documentation": "Amount of investment in marketable security." } } }, "auth_ref": [ "r144", "r943" ] }, "us-gaap_MarketableSecuritiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MarketableSecuritiesCurrent", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Marketable securities", "label": "Marketable Securities, Current", "documentation": "Amount of investment in marketable security, classified as current." } } }, "auth_ref": [ "r943" ] }, "us-gaap_MarketableSecuritiesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MarketableSecuritiesLineItems", "presentation": [ "http://www.quidelortho.com/role/BalanceSheetAccountDetailsMarketableSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Marketable Securities [Line Items]", "label": "Marketable Securities [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_MarketableSecuritiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MarketableSecuritiesNoncurrent", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Marketable securities", "label": "Marketable Securities, Noncurrent", "documentation": "Amount of investment in marketable security, classified as noncurrent." } } }, "auth_ref": [ "r943" ] }, "us-gaap_MarketableSecuritiesTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MarketableSecuritiesTable", "presentation": [ "http://www.quidelortho.com/role/BalanceSheetAccountDetailsMarketableSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Marketable Securities [Table]", "label": "Marketable Securities [Table]", "documentation": "Disclosure of information about investment in marketable security." } } }, "auth_ref": [] }, "us-gaap_MarketableSecuritiesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MarketableSecuritiesTextBlock", "presentation": [ "http://www.quidelortho.com/role/BalanceSheetAccountDetailsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Marketable Securities", "label": "Marketable Securities [Table Text Block]", "documentation": "Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets." } } }, "auth_ref": [] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "MaximumMember", "presentation": [ "http://www.quidelortho.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum", "label": "Maximum [Member]" } } }, "auth_ref": [ "r366", "r367", "r368", "r369", "r434", "r470", "r530", "r600", "r651", "r653", "r665", "r683", "r684", "r735", "r736", "r737", "r738", "r749", "r753", "r754", "r779", "r788", "r799", "r809", "r810", "r814", "r815", "r821", "r1010", "r1043", "r1044", "r1045", "r1046", "r1047", "r1048" ] }, "ecd_MeasureAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "MeasureAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Measure:", "label": "Measure [Axis]" } } }, "auth_ref": [ "r889" ] }, "ecd_MeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "MeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Measure Name" } } }, "auth_ref": [ "r889" ] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "MinimumMember", "presentation": [ "http://www.quidelortho.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum", "label": "Minimum [Member]" } } }, "auth_ref": [ "r366", "r367", "r368", "r369", "r434", "r470", "r530", "r600", "r651", "r653", "r665", "r683", "r684", "r735", "r736", "r737", "r738", "r749", "r753", "r754", "r779", "r788", "r799", "r809", "r810", "r814", "r821", "r1010", "r1043", "r1044", "r1045", "r1046", "r1047", "r1048" ] }, "ecd_MnpiDiscTimedForCompValFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "MnpiDiscTimedForCompValFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "MNPI Disclosure Timed for Compensation Value", "label": "MNPI Disclosure Timed for Compensation Value [Flag]" } } }, "auth_ref": [ "r908" ] }, "qdel_MolecularDiagnosticsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quidelortho.com/20240630", "localname": "MolecularDiagnosticsMember", "presentation": [ "http://www.quidelortho.com/role/RevenueDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Molecular Diagnostics", "label": "Molecular Diagnostics [Member]", "documentation": "Molecular Diagnostics" } } }, "auth_ref": [] }, "ecd_MtrlTermsOfTrdArrTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "MtrlTermsOfTrdArrTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Material Terms of Trading Arrangement", "label": "Material Terms of Trading Arrangement [Text Block]" } } }, "auth_ref": [ "r916" ] }, "srt_NameOfMajorCustomerDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "NameOfMajorCustomerDomain", "presentation": [ "http://www.quidelortho.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer [Domain]", "label": "Customer [Domain]" } } }, "auth_ref": [ "r282", "r791", "r820", "r824", "r1011", "r1050", "r1054", "r1055", "r1057", "r1058", "r1059", "r1060", "r1061", "r1062", "r1063", "r1064", "r1065", "r1066", "r1067", "r1068", "r1069", "r1070", "r1071", "r1072", "r1073", "r1074", "r1075", "r1076", "r1077", "r1078", "r1079", "r1081", "r1082" ] }, "ecd_NamedExecutiveOfficersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NamedExecutiveOfficersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Named Executive Officers, Footnote", "label": "Named Executive Officers, Footnote [Text Block]" } } }, "auth_ref": [ "r890" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by (used for) financing activities", "label": "Net Cash Provided by (Used in) Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r210" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "FINANCING ACTIVITIES", "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used for investing activities", "label": "Net Cash Provided by (Used in) Investing Activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r210" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "INVESTING ACTIVITIES", "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash (used for) provided by operating activities", "label": "Net Cash Provided by (Used in) Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r112", "r113", "r114" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "OPERATING ACTIVITIES", "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedStatementsofComprehensiveLossIncomeUnaudited": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 1.0 }, "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 }, "http://www.quidelortho.com/role/ConsolidatedStatementsofLossUnaudited": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited", "http://www.quidelortho.com/role/ConsolidatedStatementsofComprehensiveLossIncomeUnaudited", "http://www.quidelortho.com/role/ConsolidatedStatementsofLossUnaudited", "http://www.quidelortho.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "totalLabel": "Net loss", "terseLabel": "Net loss", "verboseLabel": "Net loss", "label": "Net Income (Loss) Attributable to Parent", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r105", "r114", "r147", "r169", "r197", "r200", "r204", "r213", "r219", "r221", "r222", "r224", "r225", "r226", "r230", "r231", "r240", "r318", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r495", "r499", "r524", "r546", "r625", "r714", "r730", "r731", "r838", "r1008" ] }, "us-gaap_NetInvestmentHedgingMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetInvestmentHedgingMember", "presentation": [ "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNetInvestmentHedgeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net Investment Hedging Relationships", "label": "Net Investment Hedging [Member]", "documentation": "Hedges of a net investment in a foreign operation." } } }, "auth_ref": [ "r55" ] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://www.quidelortho.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Recent Accounting Pronouncements", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "ecd_NonGaapMeasureDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonGaapMeasureDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-GAAP Measure Description", "label": "Non-GAAP Measure Description [Text Block]" } } }, "auth_ref": [ "r889" ] }, "ecd_NonNeosMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonNeosMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-NEOs", "label": "Non-NEOs [Member]" } } }, "auth_ref": [ "r853", "r863", "r873", "r897", "r905" ] }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount", "label": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "auth_ref": [ "r880" ] }, "ecd_NonPeoNeoAvgTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonPeoNeoAvgTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO Average Total Compensation Amount", "label": "Non-PEO NEO Average Total Compensation Amount" } } }, "auth_ref": [ "r879" ] }, "ecd_NonPeoNeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonPeoNeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO", "label": "Non-PEO NEO [Member]" } } }, "auth_ref": [ "r897" ] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted", "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]" } } }, "auth_ref": [ "r916" ] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated", "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]" } } }, "auth_ref": [ "r916" ] }, "qdel_NoncashOfPartNoncashAcquisitionFixedAssetsTransferredFromInventories": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quidelortho.com/20240630", "localname": "NoncashOfPartNoncashAcquisitionFixedAssetsTransferredFromInventories", "crdr": "debit", "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Transfer of instrument inventories to fixed assets", "label": "Noncash of Part Noncash Acquisition, Fixed Assets transferred from inventories", "documentation": "Noncash of Part Noncash Acquisition, Fixed Assets transferred from inventories" } } }, "auth_ref": [] }, "us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1", "crdr": "debit", "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Purchase of property, equipment and intangibles by incurring current liabilities", "label": "Noncash or Part Noncash Acquisition, Fixed Assets Acquired", "documentation": "The amount of fixed assets that an Entity acquires in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r26", "r27", "r28" ] }, "us-gaap_NondesignatedMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NondesignatedMember", "presentation": [ "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofCurrencyHedgingInstrumentsDetails", "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofFairValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Non-designated hedging instruments", "label": "Not Designated as Hedging Instrument [Member]", "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP)." } } }, "auth_ref": [ "r14" ] }, "qdel_NorthAmericaSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quidelortho.com/20240630", "localname": "NorthAmericaSegmentMember", "presentation": [ "http://www.quidelortho.com/role/GoodwillandIntangibleAssetsNetGoodwillRollforwardDetails", "http://www.quidelortho.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails", "http://www.quidelortho.com/role/SegmentandGeographicInformationTotalRevenuesbyReportableSegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "North America", "label": "North America Segment [Member]", "documentation": "North America Segment" } } }, "auth_ref": [] }, "us-gaap_NumberOfOperatingSegments": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NumberOfOperatingSegments", "presentation": [ "http://www.quidelortho.com/role/SegmentandGeographicInformationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of operating segments", "label": "Number of Operating Segments", "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues." } } }, "auth_ref": [ "r775", "r965" ] }, "us-gaap_NumberOfReportableSegments": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NumberOfReportableSegments", "presentation": [ "http://www.quidelortho.com/role/SegmentandGeographicInformationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of reportable segments", "label": "Number of Reportable Segments", "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements." } } }, "auth_ref": [ "r770", "r778", "r965" ] }, "qdel_NumberOfStockholdersThatFiledComplaints": { "xbrltype": "integerItemType", "nsuri": "http://www.quidelortho.com/20240630", "localname": "NumberOfStockholdersThatFiledComplaints", "presentation": [ "http://www.quidelortho.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of stockholders that filed complaints", "label": "Number Of Stockholders That Filed Complaints", "documentation": "Number Of Stockholders That Filed Complaints" } } }, "auth_ref": [] }, "qdel_OnOrBeforeJune302023Member": { "xbrltype": "domainItemType", "nsuri": "http://www.quidelortho.com/20240630", "localname": "OnOrBeforeJune302023Member", "presentation": [ "http://www.quidelortho.com/role/BorrowingsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "On or Before June 30, 2023", "label": "On or Before June 30, 2023 [Member]", "documentation": "On or Before June 30, 2023" } } }, "auth_ref": [] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedStatementsofLossUnaudited": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofLossUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Operating (loss) income", "label": "Operating Income (Loss)", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r150", "r769", "r964", "r966", "r967", "r968", "r969" ] }, "us-gaap_OperatingLeaseLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseLiabilityCurrent", "crdr": "credit", "calculation": { "http://www.quidelortho.com/role/BalanceSheetAccountDetailsOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.quidelortho.com/role/BalanceSheetAccountDetailsOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease liabilities", "label": "Operating Lease, Liability, Current", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current." } } }, "auth_ref": [ "r564" ] }, "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList", "presentation": [ "http://www.quidelortho.com/role/BalanceSheetAccountDetailsOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]", "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes current operating lease liability." } } }, "auth_ref": [ "r565" ] }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease liabilities", "label": "Operating Lease, Liability, Noncurrent", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent." } } }, "auth_ref": [ "r564" ] }, "us-gaap_OperatingLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Right-of-use assets", "label": "Operating Lease, Right-of-Use Asset", "documentation": "Amount of lessee's right to use underlying asset under operating lease." } } }, "auth_ref": [ "r563" ] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]", "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherAccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.quidelortho.com/role/BalanceSheetAccountDetailsOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.quidelortho.com/role/BalanceSheetAccountDetailsOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Other Accrued Liabilities, Current", "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r78" ] }, "qdel_OtherAdjustments": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quidelortho.com/20240630", "localname": "OtherAdjustments", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0, "order": 14.0 } }, "presentation": [ "http://www.quidelortho.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Other adjustments", "label": "Other adjustments", "documentation": "Other adjustments" } } }, "auth_ref": [] }, "us-gaap_OtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherAssetsCurrent", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/BalanceSheetAccountDetailsPrepaidexpensesandothercurrentassetsDetails": { "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.quidelortho.com/role/BalanceSheetAccountDetailsPrepaidexpensesandothercurrentassetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Other Assets, Current", "documentation": "Amount of current assets classified as other." } } }, "auth_ref": [ "r183", "r817" ] }, "us-gaap_OtherAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherAssetsMember", "presentation": [ "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofFairValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other assets", "label": "Other Assets [Member]", "documentation": "Primary financial statement caption encompassing other assets." } } }, "auth_ref": [ "r57", "r66" ] }, "us-gaap_OtherAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherAssetsNoncurrent", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Other assets", "label": "Other Assets, Noncurrent", "documentation": "Amount of noncurrent assets classified as other." } } }, "auth_ref": [ "r174" ] }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax", "crdr": "debit", "presentation": [ "http://www.quidelortho.com/role/AccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "OCI, foreign currency transaction and translation gain (loss), arising during period, tax", "label": "OCI, Foreign Currency Transaction and Translation Gain (Loss), Arising During Period, Tax", "documentation": "Amount of tax expense (benefit), before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature." } } }, "auth_ref": [ "r3", "r6", "r547", "r548", "r556" ] }, "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax", "crdr": "credit", "calculation": { "http://www.quidelortho.com/role/AccumulatedOtherComprehensiveLossDetails": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quidelortho.com/role/AccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Current period deferrals", "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax", "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss)." } } }, "auth_ref": [ "r17", "r21", "r203", "r550", "r553", "r557", "r626", "r947" ] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax", "crdr": "credit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedStatementsofComprehensiveLossIncomeUnaudited": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofComprehensiveLossIncomeUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Total change in unrealized gains from cash flow hedges, net of tax", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax", "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness." } } }, "auth_ref": [ "r188", "r193", "r626" ] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax", "crdr": "credit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedStatementsofComprehensiveLossIncomeUnaudited": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofComprehensiveLossIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Net unrealized gains on derivative instruments", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax", "documentation": "Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness." } } }, "auth_ref": [ "r188", "r193" ] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax", "crdr": "credit", "presentation": [ "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofGainLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount of Loss (Gain) Recognized in OCI on Hedges", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax", "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness." } } }, "auth_ref": [ "r188", "r193", "r506", "r507", "r513" ] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax", "crdr": "debit", "presentation": [ "http://www.quidelortho.com/role/AccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tax impact related to cash flow hedges", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax", "documentation": "Amount, before reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness." } } }, "auth_ref": [ "r194" ] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedStatementsofComprehensiveLossIncomeUnaudited": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofComprehensiveLossIncomeUnaudited" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Reclassification of net realized gains on derivative instruments included in net income", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax", "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness." } } }, "auth_ref": [ "r193", "r196" ] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax", "crdr": "debit", "presentation": [ "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofGainLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount of Loss (Gain) Reclassified From AOCI Into Income", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax", "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness." } } }, "auth_ref": [ "r160", "r193", "r196" ] }, "us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax", "crdr": "credit", "presentation": [ "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNetInvestmentHedgeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments and Tax", "label": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments and Tax", "documentation": "Amount, before tax and adjustments, of gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method." } } }, "auth_ref": [ "r189", "r193", "r508", "r510", "r513" ] }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "crdr": "credit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedStatementsofComprehensiveLossIncomeUnaudited": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofComprehensiveLossIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Changes in cumulative translation adjustment, net of tax", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax", "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature." } } }, "auth_ref": [ "r3", "r626" ] }, "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax", "crdr": "credit", "presentation": [ "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNetInvestmentHedgeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax", "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax", "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge." } } }, "auth_ref": [ "r509" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Other comprehensive income, net of tax", "label": "Other Comprehensive Income (Loss), Net of Tax", "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss)." } } }, "auth_ref": [ "r13", "r17", "r198", "r201", "r206", "r226", "r550", "r551", "r557", "r607", "r626", "r947", "r948" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "crdr": "credit", "calculation": { "http://www.quidelortho.com/role/AccumulatedOtherComprehensiveLossDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.quidelortho.com/role/AccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net change", "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent", "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity." } } }, "auth_ref": [ "r8", "r12", "r131", "r198", "r201", "r226" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract", "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofComprehensiveLossIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Other comprehensive (loss) income", "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax", "crdr": "credit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedStatementsofComprehensiveLossIncomeUnaudited": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofComprehensiveLossIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Changes in unrealized (losses) gains from investments, net of tax", "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax", "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale." } } }, "auth_ref": [ "r190", "r193", "r316" ] }, "us-gaap_OtherCostAndExpenseOperating": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherCostAndExpenseOperating", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedStatementsofLossUnaudited": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofLossUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Other operating expenses", "label": "Other Cost and Expense, Operating", "documentation": "The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation." } } }, "auth_ref": [ "r106", "r631", "r774" ] }, "us-gaap_OtherCurrentLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherCurrentLiabilitiesMember", "presentation": [ "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofFairValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other current liabilities", "label": "Other Current Liabilities [Member]", "documentation": "Primary financial statement caption encompassing other current liabilities." } } }, "auth_ref": [] }, "us-gaap_OtherCurrentLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherCurrentLiabilitiesTableTextBlock", "presentation": [ "http://www.quidelortho.com/role/BalanceSheetAccountDetailsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Other Current Liabilities", "label": "Other Current Liabilities [Table Text Block]", "documentation": "Tabular disclosure of other current liabilities." } } }, "auth_ref": [] }, "us-gaap_OtherLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 5.0 }, "http://www.quidelortho.com/role/BalanceSheetAccountDetailsOtherCurrentLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.quidelortho.com/role/BalanceSheetAccountDetailsOtherCurrentLiabilitiesDetails", "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Other current liabilities", "totalLabel": "Total other current liabilities", "label": "Other Liabilities, Current", "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r78", "r817" ] }, "us-gaap_OtherLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherLiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Other liabilities", "label": "Other Liabilities, Noncurrent", "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r82" ] }, "us-gaap_OtherLongTermDebtNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherLongTermDebtNoncurrent", "crdr": "credit", "calculation": { "http://www.quidelortho.com/role/BorrowingsScheduleofBorrowingsDetails_1": { "parentTag": "us-gaap_DebtAndCapitalLeaseObligations", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.quidelortho.com/role/BorrowingsScheduleofBorrowingsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other long-term borrowings", "label": "Other Long-Term Debt, Noncurrent", "documentation": "Amount of long-term debt classified as other, payable after one year or the operating cycle, if longer." } } }, "auth_ref": [ "r18", "r691" ] }, "qdel_OtherMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quidelortho.com/20240630", "localname": "OtherMember", "presentation": [ "http://www.quidelortho.com/role/GoodwillandIntangibleAssetsNetGoodwillRollforwardDetails", "http://www.quidelortho.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails", "http://www.quidelortho.com/role/SegmentandGeographicInformationTotalRevenuesbyReportableSegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Other [Member]", "documentation": "Other nonreportable segments" } } }, "auth_ref": [] }, "us-gaap_OtherNoncurrentLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherNoncurrentLiabilitiesMember", "presentation": [ "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofFairValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other liabilities", "label": "Other Noncurrent Liabilities [Member]", "documentation": "Primary financial statement caption encompassing other noncurrent liabilities." } } }, "auth_ref": [] }, "us-gaap_OtherNonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherNonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedStatementsofLossUnaudited": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofLossUnaudited" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Other expense, net", "label": "Other Nonoperating Income (Expense)", "documentation": "Amount of income (expense) related to nonoperating activities, classified as other." } } }, "auth_ref": [ "r109" ] }, "us-gaap_OtherNonoperatingIncomeExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherNonoperatingIncomeExpenseMember", "presentation": [ "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails", "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNetInvestmentHedgeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Nonoperating Income (Expense)", "label": "Other Nonoperating Income (Expense) [Member]", "documentation": "Primary financial statement caption encompassing other nonoperating income (expense)." } } }, "auth_ref": [] }, "us-gaap_OtherOperatingActivitiesCashFlowStatement": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherOperatingActivitiesCashFlowStatement", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Other non-cash, net", "label": "Other Operating Activities, Cash Flow Statement", "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities)." } } }, "auth_ref": [] }, "ecd_OtherPerfMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "OtherPerfMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Other Performance Measure, Amount", "label": "Other Performance Measure, Amount" } } }, "auth_ref": [ "r889" ] }, "us-gaap_OtherReceivablesNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherReceivablesNetCurrent", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/BalanceSheetAccountDetailsPrepaidexpensesandothercurrentassetsDetails": { "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.quidelortho.com/role/BalanceSheetAccountDetailsPrepaidexpensesandothercurrentassetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other receivables", "label": "Other Receivables, Net, Current", "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer." } } }, "auth_ref": [] }, "us-gaap_OtherShortTermBorrowings": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherShortTermBorrowings", "crdr": "credit", "calculation": { "http://www.quidelortho.com/role/BorrowingsScheduleofBorrowingsDetails_1": { "parentTag": "us-gaap_DebtAndCapitalLeaseObligations", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.quidelortho.com/role/BorrowingsScheduleofBorrowingsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other short-term borrowings", "label": "Other Short-Term Borrowings", "documentation": "Amount of borrowings classified as other, maturing within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r74", "r691" ] }, "ecd_OutstandingAggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "OutstandingAggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount", "label": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r851", "r861", "r871", "r903" ] }, "ecd_OutstandingRecoveryCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "OutstandingRecoveryCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Amount", "label": "Outstanding Recovery Compensation Amount" } } }, "auth_ref": [ "r854", "r864", "r874", "r906" ] }, "ecd_OutstandingRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "OutstandingRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Outstanding Recovery, Individual Name" } } }, "auth_ref": [ "r854", "r864", "r874", "r906" ] }, "ecd_PayVsPerformanceDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PayVsPerformanceDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Line Items]" } } }, "auth_ref": [ "r878" ] }, "qdel_PaymentOfAccretedInterestOnContingentConsiderationLiabilityAndDeferredConsiderationOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quidelortho.com/20240630", "localname": "PaymentOfAccretedInterestOnContingentConsiderationLiabilityAndDeferredConsiderationOperatingActivities", "crdr": "credit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Payment of accreted interest on deferred consideration", "label": "Payment Of Accreted Interest On Contingent Consideration Liability And Deferred Consideration, Operating Activities", "documentation": "Payment Of Accreted Interest On Contingent Consideration Liability And Deferred Consideration, Operating Activities" } } }, "auth_ref": [] }, "qdel_PaymentOnAcquisitionDeferredConsideration": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quidelortho.com/20240630", "localname": "PaymentOnAcquisitionDeferredConsideration", "crdr": "credit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Principal payments of deferred consideration", "label": "Payment On Acquisition Deferred Consideration", "documentation": "Payment On Acquisition Deferred Consideration" } } }, "auth_ref": [] }, "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsForProceedsFromOtherInvestingActivities", "crdr": "credit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Other payments", "label": "Payments for (Proceeds from) Other Investing Activities", "documentation": "Amount of cash (inflow) outflow from investing activities classified as other." } } }, "auth_ref": [ "r927", "r950" ] }, "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation", "crdr": "credit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Payments of tax withholdings related to vesting of stock-based awards", "label": "Payment, Tax Withholding, Share-Based Payment Arrangement", "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement." } } }, "auth_ref": [ "r209" ] }, "us-gaap_PaymentsToAcquireMarketableSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsToAcquireMarketableSecurities", "crdr": "credit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Purchases of marketable securities", "label": "Payments to Acquire Marketable Securities", "documentation": "Amount of cash outflow for purchase of marketable security." } } }, "auth_ref": [ "r973" ] }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Acquisitions of property, plant, equipment, investments and intangibles", "label": "Payments to Acquire Property, Plant, and Equipment", "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets." } } }, "auth_ref": [ "r110" ] }, "ecd_PeerGroupIssuersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeerGroupIssuersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Peer Group Issuers, Footnote", "label": "Peer Group Issuers, Footnote [Text Block]" } } }, "auth_ref": [ "r888" ] }, "ecd_PeerGroupTotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeerGroupTotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Peer Group Total Shareholder Return Amount", "label": "Peer Group Total Shareholder Return Amount" } } }, "auth_ref": [ "r888" ] }, "ecd_PeoActuallyPaidCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeoActuallyPaidCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Actually Paid Compensation Amount", "label": "PEO Actually Paid Compensation Amount" } } }, "auth_ref": [ "r880" ] }, "ecd_PeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO", "label": "PEO [Member]" } } }, "auth_ref": [ "r897" ] }, "ecd_PeoName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeoName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Name", "label": "PEO Name" } } }, "auth_ref": [ "r890" ] }, "ecd_PeoTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeoTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Total Compensation Amount", "label": "PEO Total Compensation Amount" } } }, "auth_ref": [ "r879" ] }, "ecd_PnsnAdjsPrrSvcCstMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PnsnAdjsPrrSvcCstMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pension Adjustments Prior Service Cost", "label": "Pension Adjustments Prior Service Cost [Member]" } } }, "auth_ref": [ "r881" ] }, "ecd_PnsnAdjsSvcCstMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PnsnAdjsSvcCstMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pension Adjustments Service Cost", "label": "Pension Adjustments Service Cost [Member]" } } }, "auth_ref": [ "r925" ] }, "ecd_PnsnBnftsAdjFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PnsnBnftsAdjFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pension Benefits Adjustments, Footnote", "label": "Pension Benefits Adjustments, Footnote [Text Block]" } } }, "auth_ref": [ "r880" ] }, "qdel_PointOfCareMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quidelortho.com/20240630", "localname": "PointOfCareMember", "presentation": [ "http://www.quidelortho.com/role/RevenueDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Point of Care", "label": "Point of Care [Member]", "documentation": "Point of Care" } } }, "auth_ref": [] }, "qdel_PotentialDilutiveEffectOnWeightedAverageNumberOfSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://www.quidelortho.com/20240630", "localname": "PotentialDilutiveEffectOnWeightedAverageNumberOfSharesOutstanding", "presentation": [ "http://www.quidelortho.com/role/ComputationofEarningsPerShareCalculationofBasicandDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "PotentialWeightedAverageNumberOfDilutedSharesOutstandingDiluted weighted-average shares of common stock outstanding", "label": "Potential Dilutive Effect On Weighted Average Number Of Shares Outstanding", "documentation": "PotentialWeightedAverageNumberOfDilutedSharesOutstanding" } } }, "auth_ref": [] }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockParOrStatedValuePerShare", "presentation": [ "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, par value per share (in dollars per share)", "label": "Preferred Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r85", "r410" ] }, "us-gaap_PreferredStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockSharesAuthorized", "presentation": [ "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, shares authorized (in shares)", "label": "Preferred Stock, Shares Authorized", "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r85", "r694" ] }, "us-gaap_PreferredStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockSharesIssued", "presentation": [ "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, shares issued (in shares)", "label": "Preferred Stock, Shares Issued", "documentation": "Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt." } } }, "auth_ref": [ "r85", "r410" ] }, "us-gaap_PreferredStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockSharesOutstanding", "presentation": [ "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, shares outstanding (in shares)", "label": "Preferred Stock, Shares Outstanding", "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased." } } }, "auth_ref": [ "r85", "r694", "r712", "r1086", "r1087" ] }, "us-gaap_PreferredStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockValue", "crdr": "credit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, $0.001 par value per share; 5.0 shares authorized; none issued or outstanding at June\u00a030, 2024 and December\u00a031, 2023", "label": "Preferred Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r85", "r617", "r817" ] }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PrepaidExpenseAndOtherAssetsCurrent", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 5.0 }, "http://www.quidelortho.com/role/BalanceSheetAccountDetailsPrepaidexpensesandothercurrentassetsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.quidelortho.com/role/BalanceSheetAccountDetailsPrepaidexpensesandothercurrentassetsDetails", "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaid expenses and other current assets", "totalLabel": "Total prepaid expenses and other current assets", "label": "Prepaid Expense and Other Assets, Current", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r946" ] }, "us-gaap_PrepaidExpenseCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PrepaidExpenseCurrent", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/BalanceSheetAccountDetailsPrepaidexpensesandothercurrentassetsDetails": { "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quidelortho.com/role/BalanceSheetAccountDetailsPrepaidexpensesandothercurrentassetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaid expenses", "label": "Prepaid Expense, Current", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r182", "r333", "r334", "r761" ] }, "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PrepaidExpensesAndOtherCurrentAssetsMember", "presentation": [ "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofFairValueDetails", "http://www.quidelortho.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaid expenses and other current assets", "label": "Prepaid Expenses and Other Current Assets [Member]", "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets." } } }, "auth_ref": [] }, "us-gaap_PriorPeriodReclassificationAdjustmentDescription": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PriorPeriodReclassificationAdjustmentDescription", "presentation": [ "http://www.quidelortho.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Reclassifications", "label": "Reclassification, Comparability Adjustment [Policy Text Block]", "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error." } } }, "auth_ref": [ "r940" ] }, "us-gaap_ProceedsFromContributionInAidOfConstruction": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromContributionInAidOfConstruction", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from government assistance allocated to fixed assets", "label": "Proceeds from Contribution in Aid of Construction, Investing Activity", "documentation": "Amount of cash inflow from contribution in aid of construction, classified as investing activity. Includes, but is not limited to, contribution from developer, builder, government agency, and municipality." } } }, "auth_ref": [ "r23" ] }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromIssuanceOfCommonStock", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from issuance of common stock", "label": "Proceeds from Issuance of Common Stock", "documentation": "The cash inflow from the additional capital contribution to the entity." } } }, "auth_ref": [ "r7" ] }, "us-gaap_ProceedsFromLinesOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromLinesOfCredit", "crdr": "debit", "presentation": [ "http://www.quidelortho.com/role/BorrowingsNarrativeDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Proceeds from lines of credit", "label": "Proceeds from Lines of Credit", "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements." } } }, "auth_ref": [ "r24", "r955" ] }, "us-gaap_ProceedsFromRepaymentsOfLinesOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromRepaymentsOfLinesOfCredit", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Revolving credit facility, net", "label": "Proceeds from (Repayments of) Lines of Credit", "documentation": "The net cash inflow or cash outflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with either short term or long term maturity that is collateralized (backed by pledge, mortgage or other lien in the entity's assets)." } } }, "auth_ref": [] }, "us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Short-term borrowings, net", "label": "Proceeds from (Repayments of) Short-Term Debt, Maturing in Three Months or Less", "documentation": "The cash inflow from a borrowing net of the cash outflow from repayment of a borrowing having initial term of repayment within three months." } } }, "auth_ref": [ "r951", "r952", "r953" ] }, "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from sale of marketable securities", "label": "Proceeds from Sale and Maturity of Marketable Securities", "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period." } } }, "auth_ref": [] }, "us-gaap_ProductConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProductConcentrationRiskMember", "presentation": [ "http://www.quidelortho.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product Concentration Risk", "label": "Product Concentration Risk [Member]", "documentation": "Reflects the percentage that revenues during the period from a specified product are to a specified benchmark, such as total net revenues, segment revenues or product line revenues. May also reflect the percentage contribution the product made to operating results. Risk is materially adverse effects of a loss of sales of a significant product or line of products, which could occur upon loss of rights to sell, distribute or license others; loss of patent or copyright protection; or technological obsolescence." } } }, "auth_ref": [ "r117" ] }, "srt_ProductOrServiceAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ProductOrServiceAxis", "presentation": [ "http://www.quidelortho.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product and Service [Axis]", "label": "Product and Service [Axis]" } } }, "auth_ref": [ "r279", "r602", "r644", "r645", "r646", "r647", "r648", "r649", "r650", "r757", "r789", "r819", "r821", "r822", "r825", "r827", "r1004", "r1005", "r1011", "r1050", "r1054", "r1055", "r1056", "r1057", "r1058", "r1059", "r1060", "r1061", "r1062", "r1063", "r1064", "r1065", "r1066", "r1067", "r1068", "r1069", "r1070", "r1071", "r1072", "r1073", "r1074", "r1075", "r1076", "r1077", "r1078", "r1079", "r1081", "r1082" ] }, "srt_ProductsAndServicesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ProductsAndServicesDomain", "presentation": [ "http://www.quidelortho.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product and Service [Domain]", "label": "Product and Service [Domain]" } } }, "auth_ref": [ "r279", "r602", "r644", "r645", "r646", "r647", "r648", "r649", "r650", "r757", "r789", "r819", "r821", "r822", "r825", "r827", "r1004", "r1005", "r1011", "r1050", "r1054", "r1055", "r1056", "r1057", "r1058", "r1059", "r1060", "r1061", "r1062", "r1063", "r1064", "r1065", "r1066", "r1067", "r1068", "r1069", "r1070", "r1071", "r1072", "r1073", "r1074", "r1075", "r1076", "r1077", "r1078", "r1079", "r1081", "r1082" ] }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentAbstract", "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "presentation": [ "http://www.quidelortho.com/role/AssetsHeldforSale" ], "lang": { "en-us": { "role": { "terseLabel": "Assets Held for Sale", "label": "Property, Plant and Equipment Disclosure [Text Block]", "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r121", "r157", "r161", "r162" ] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Property, plant and equipment, net", "label": "Property, Plant and Equipment, Net", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r11", "r566", "r611", "r622", "r817" ] }, "ecd_PvpTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PvpTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pay vs Performance Disclosure", "label": "Pay vs Performance Disclosure [Table]" } } }, "auth_ref": [ "r878" ] }, "ecd_PvpTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PvpTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pay vs Performance Disclosure, Table", "label": "Pay vs Performance [Table Text Block]" } } }, "auth_ref": [ "r878" ] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "RangeAxis", "presentation": [ "http://www.quidelortho.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement [Axis]", "label": "Statistical Measurement [Axis]" } } }, "auth_ref": [ "r366", "r367", "r368", "r369", "r427", "r434", "r461", "r462", "r463", "r470", "r530", "r575", "r584", "r600", "r651", "r653", "r665", "r683", "r684", "r735", "r736", "r737", "r738", "r749", "r753", "r754", "r779", "r788", "r799", "r809", "r810", "r814", "r815", "r821", "r830", "r1002", "r1010", "r1023", "r1044", "r1045", "r1046", "r1047", "r1048" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "RangeMember", "presentation": [ "http://www.quidelortho.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement [Domain]", "label": "Statistical Measurement [Domain]" } } }, "auth_ref": [ "r366", "r367", "r368", "r369", "r427", "r434", "r461", "r462", "r463", "r470", "r530", "r575", "r584", "r600", "r651", "r653", "r665", "r683", "r684", "r735", "r736", "r737", "r738", "r749", "r753", "r754", "r779", "r788", "r799", "r809", "r810", "r814", "r815", "r821", "r830", "r1002", "r1010", "r1023", "r1044", "r1045", "r1046", "r1047", "r1048" ] }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/AccumulatedOtherComprehensiveLossDetails": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.quidelortho.com/role/AccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Amounts reclassified to Net loss", "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax", "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss)." } } }, "auth_ref": [ "r17", "r21", "r203", "r550", "r555", "r557", "r626", "r947" ] }, "us-gaap_ReclassificationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ReclassificationLineItems", "presentation": [ "http://www.quidelortho.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reclassification [Line Items]", "label": "Reclassification [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r167" ] }, "us-gaap_ReclassificationTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ReclassificationTable", "presentation": [ "http://www.quidelortho.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reclassification [Table]", "label": "Reclassification [Table]", "documentation": "Disclosure of information about reclassification adjustment affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error." } } }, "auth_ref": [ "r167" ] }, "us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ReconciliationFromSegmentTotalsToConsolidatedAbstract", "presentation": [ "http://www.quidelortho.com/role/SegmentandGeographicInformationTotalRevenuesbyReportableSegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segment Reconciliation [Abstract]", "label": "Segment Reconciliation [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract", "presentation": [ "http://www.quidelortho.com/role/SegmentandGeographicInformationTotalRevenuesbyReportableSegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]", "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable", "presentation": [ "http://www.quidelortho.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails", "http://www.quidelortho.com/role/SegmentandGeographicInformationTotalRevenuesbyReportableSegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]", "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]", "documentation": "Disclosure of information about the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment." } } }, "auth_ref": [ "r38", "r39" ] }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "RecoveryOfErrCompDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]" } } }, "auth_ref": [ "r846", "r856", "r866", "r898" ] }, "us-gaap_RepaymentsOfDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RepaymentsOfDebt", "crdr": "credit", "presentation": [ "http://www.quidelortho.com/role/BorrowingsNarrativeDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Payments of term loan", "label": "Repayments of Debt", "documentation": "Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation." } } }, "auth_ref": [ "r952" ] }, "us-gaap_RepaymentsOfLongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RepaymentsOfLongTermDebt", "crdr": "credit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Payments on long-term borrowings", "label": "Repayments of Long-Term Debt", "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer." } } }, "auth_ref": [ "r111", "r669" ] }, "qdel_ReportingUnitPercentageOfDecreaseInFairValue": { "xbrltype": "pureItemType", "nsuri": "http://www.quidelortho.com/20240630", "localname": "ReportingUnitPercentageOfDecreaseInFairValue", "presentation": [ "http://www.quidelortho.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reporting unit, estimated percentage of decrease in fair value (in percent)", "label": "Reporting Unit, Percentage Of Decrease In Fair Value", "documentation": "Reporting Unit, Percentage Of Decrease In Fair Value" } } }, "auth_ref": [] }, "us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount", "presentation": [ "http://www.quidelortho.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reporting unit, percentage of fair value in excess of carrying amount (in percent)", "label": "Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount", "documentation": "Percentage of fair value of reporting unit in excess of carrying amount." } } }, "auth_ref": [] }, "qdel_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmountAdjustedForDecrease": { "xbrltype": "pureItemType", "nsuri": "http://www.quidelortho.com/20240630", "localname": "ReportingUnitPercentageOfFairValueInExcessOfCarryingAmountAdjustedForDecrease", "presentation": [ "http://www.quidelortho.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reporting unit, percentage of fair value in excess of carrying amount, adjusted for decrease (in percent)", "label": "Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount, Adjusted For Decrease", "documentation": "Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount, Adjusted For Decrease" } } }, "auth_ref": [] }, "us-gaap_ResearchAndDevelopmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ResearchAndDevelopmentExpense", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedStatementsofLossUnaudited": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofLossUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Research and development", "label": "Research and Development Expense", "documentation": "Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity." } } }, "auth_ref": [ "r471", "r755", "r774", "r1049" ] }, "us-gaap_ResearchAndDevelopmentExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ResearchAndDevelopmentExpenseMember", "presentation": [ "http://www.quidelortho.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails", "http://www.quidelortho.com/role/StockbasedCompensationCompensationExpenseRelatedtoStockBasedCompensationPlansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Research and development", "label": "Research and Development Expense [Member]", "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included." } } }, "auth_ref": [] }, "qdel_RespiratoryMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quidelortho.com/20240630", "localname": "RespiratoryMember", "presentation": [ "http://www.quidelortho.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Respiratory", "label": "Respiratory [Member]", "documentation": "Respiratory" } } }, "auth_ref": [] }, "srt_RestatementAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "RestatementAxis", "presentation": [ "http://www.quidelortho.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revision of Prior Period [Axis]", "label": "Revision of Prior Period [Axis]" } } }, "auth_ref": [ "r166", "r216", "r217", "r218", "r219", "r220", "r221", "r222", "r223", "r224", "r227", "r228", "r229", "r230", "r231", "r232", "r247", "r320", "r321", "r493", "r494", "r495", "r496", "r498", "r499", "r521", "r522", "r523", "r524", "r559", "r561", "r567", "r568", "r655", "r656", "r657", "r658", "r659", "r660", "r661", "r662", "r663", "r664", "r667", "r970" ] }, "ecd_RestatementDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "RestatementDateAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement Determination Date:", "label": "Restatement Determination Date [Axis]" } } }, "auth_ref": [ "r847", "r857", "r867", "r899" ] }, "ecd_RestatementDeterminationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "RestatementDeterminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement Determination Date", "label": "Restatement Determination Date" } } }, "auth_ref": [ "r848", "r858", "r868", "r900" ] }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "RestatementDoesNotRequireRecoveryTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement does not require Recovery", "label": "Restatement Does Not Require Recovery [Text Block]" } } }, "auth_ref": [ "r855", "r865", "r875", "r907" ] }, "srt_RestatementDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "RestatementDomain", "presentation": [ "http://www.quidelortho.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revision of Prior Period [Domain]", "label": "Revision of Prior Period [Domain]" } } }, "auth_ref": [ "r166", "r216", "r217", "r218", "r219", "r220", "r221", "r222", "r223", "r224", "r227", "r228", "r229", "r230", "r231", "r232", "r247", "r320", "r321", "r493", "r494", "r495", "r496", "r498", "r499", "r521", "r522", "r523", "r524", "r559", "r561", "r567", "r568", "r655", "r656", "r657", "r658", "r659", "r660", "r661", "r662", "r663", "r664", "r667", "r970" ] }, "us-gaap_RestrictedCashNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RestrictedCashNoncurrent", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/BalanceSheetAccountDetailsCashCashEquivalentsandRestrictedCashDetails": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quidelortho.com/role/BalanceSheetAccountDetailsCashCashEquivalentsandRestrictedCashDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted cash included in Other assets", "label": "Restricted Cash, Noncurrent", "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits." } } }, "auth_ref": [ "r154", "r942", "r954" ] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Retained earnings", "label": "Retained Earnings (Accumulated Deficit)", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r88", "r129", "r620", "r659", "r664", "r670", "r695", "r817" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RetainedEarningsMember", "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Retained earnings", "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r165", "r216", "r217", "r218", "r220", "r226", "r229", "r231", "r319", "r322", "r352", "r485", "r486", "r492", "r493", "r494", "r496", "r498", "r499", "r514", "r516", "r517", "r519", "r522", "r560", "r562", "r655", "r657", "r673", "r1086" ] }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RevenueFromContractWithCustomerAbstract", "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RevenueFromContractWithCustomerIncludingAssessedTax", "crdr": "credit", "presentation": [ "http://www.quidelortho.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Revenue", "label": "Revenue from Contract with Customer, Including Assessed Tax", "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise." } } }, "auth_ref": [ "r148", "r149", "r248", "r255", "r256", "r270", "r276", "r279", "r281", "r282", "r423", "r424", "r602" ] }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RevenueFromContractWithCustomerTextBlock", "presentation": [ "http://www.quidelortho.com/role/Revenue" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue", "label": "Revenue from Contract with Customer [Text Block]", "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts." } } }, "auth_ref": [ "r164", "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r426" ] }, "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "presentation": [ "http://www.quidelortho.com/role/SegmentandGeographicInformationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue from External Customers by Geographic Areas", "label": "Revenue from External Customers by Geographic Areas [Table Text Block]", "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue." } } }, "auth_ref": [ "r118" ] }, "us-gaap_Revenues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Revenues", "crdr": "credit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedStatementsofLossUnaudited": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofLossUnaudited", "http://www.quidelortho.com/role/RevenueDisaggregationofRevenueDetails", "http://www.quidelortho.com/role/SegmentandGeographicInformationTotalRevenuesbyReportableSegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total revenues", "label": "Revenues", "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)." } } }, "auth_ref": [ "r148", "r149", "r205", "r213", "r248", "r255", "r256", "r270", "r276", "r279", "r281", "r282", "r318", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r546", "r610", "r774", "r1008" ] }, "srt_RevisionOfPriorPeriodReclassificationAdjustmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "RevisionOfPriorPeriodReclassificationAdjustmentMember", "presentation": [ "http://www.quidelortho.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revision of Prior Period, Reclassification, Adjustment", "label": "Revision of Prior Period, Reclassification, Adjustment [Member]" } } }, "auth_ref": [ "r167", "r970" ] }, "us-gaap_RevolvingCreditFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RevolvingCreditFacilityMember", "presentation": [ "http://www.quidelortho.com/role/BorrowingsInterestExpenseDetails", "http://www.quidelortho.com/role/BorrowingsNarrativeDetails", "http://www.quidelortho.com/role/BorrowingsScheduleofBorrowingsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revolving Credit Facility", "label": "Revolving Credit Facility [Member]", "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount." } } }, "auth_ref": [] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Rule 10b5-1 Arrangement Adopted", "label": "Rule 10b5-1 Arrangement Adopted [Flag]" } } }, "auth_ref": [ "r916" ] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Rule 10b5-1 Arrangement Terminated", "label": "Rule 10b5-1 Arrangement Terminated [Flag]" } } }, "auth_ref": [ "r916" ] }, "us-gaap_SalesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SalesMember", "presentation": [ "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofGainLossDetails", "http://www.quidelortho.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total revenues", "label": "Sales [Member]", "documentation": "Primary financial statement caption encompassing revenue from sale of goods and services rendered in the normal course of business." } } }, "auth_ref": [ "r15" ] }, "us-gaap_SalesRevenueNetMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SalesRevenueNetMember", "presentation": [ "http://www.quidelortho.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue Benchmark", "label": "Revenue Benchmark [Member]", "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation." } } }, "auth_ref": [ "r282", "r928" ] }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "presentation": [ "http://www.quidelortho.com/role/AccumulatedOtherComprehensiveLossTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Accumulated Other Comprehensive Income (Loss)", "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r21", "r1036", "r1037" ] }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "presentation": [ "http://www.quidelortho.com/role/ComputationofEarningsPerShareNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Table]", "label": "Antidilutive Security, Excluded EPS Calculation [Table]", "documentation": "Disclosure of information about security that could potentially dilute basic earnings per share (EPS) in future that was not included in calculation of diluted EPS." } } }, "auth_ref": [ "r29" ] }, "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock", "presentation": [ "http://www.quidelortho.com/role/BalanceSheetAccountDetailsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Cash, Cash Equivalents and Restricted Cash", "label": "Schedule of Cash and Cash Equivalents [Table Text Block]", "documentation": "Tabular disclosure of the components of cash and cash equivalents." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfDebtInstrumentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfDebtInstrumentsTextBlock", "presentation": [ "http://www.quidelortho.com/role/BorrowingsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Debt", "label": "Schedule of Long-Term Debt Instruments [Table Text Block]", "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer." } } }, "auth_ref": [ "r18", "r41", "r42", "r73", "r127", "r128", "r784", "r786", "r957", "r1039" ] }, "us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfDerivativeAssetsAtFairValueTableTextBlock", "presentation": [ "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Derivative Assets at Fair Value", "label": "Schedule of Derivative Assets at Fair Value [Table Text Block]", "documentation": "Tabular disclosure of derivative assets at fair value." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock", "presentation": [ "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Derivative Instruments, Effect on Other Comprehensive (Loss) Income", "label": "Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss) [Table Text Block]", "documentation": "Tabular disclosure of the effective portion of the gains and losses on derivative instruments designated (and non-derivative instruments) designated and qualifying in cash flow hedges and net investment hedges that was recognized in other comprehensive income (loss) during the current period." } } }, "auth_ref": [ "r136" ] }, "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "presentation": [ "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Net Investment Hedges", "label": "Derivative Instruments, Gain (Loss) [Table Text Block]", "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments." } } }, "auth_ref": [ "r58", "r61", "r511" ] }, "us-gaap_ScheduleOfDerivativeInstrumentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfDerivativeInstrumentsTextBlock", "presentation": [ "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Currency Hedging Instruments", "label": "Schedule of Derivative Instruments [Table Text Block]", "documentation": "Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item." } } }, "auth_ref": [ "r14", "r52", "r53", "r54", "r56", "r59", "r61", "r64", "r65" ] }, "us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock", "presentation": [ "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Derivative Liabilities at Fair Value", "label": "Schedule of Derivative Liabilities at Fair Value [Table Text Block]", "documentation": "Tabular disclosure of derivative liabilities at fair value." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "presentation": [ "http://www.quidelortho.com/role/ComputationofEarningsPerShareTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Earnings Per Share, Basic and Diluted", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations." } } }, "auth_ref": [ "r962" ] }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable", "presentation": [ "http://www.quidelortho.com/role/StockbasedCompensationCompensationExpenseRelatedtoStockBasedCompensationPlansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]", "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]", "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements." } } }, "auth_ref": [ "r44" ] }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "presentation": [ "http://www.quidelortho.com/role/StockbasedCompensationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Expense Related to Stock-Based Compensation Plans", "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]", "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement." } } }, "auth_ref": [ "r44" ] }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "presentation": [ "http://www.quidelortho.com/role/FairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis", "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]", "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)." } } }, "auth_ref": [ "r1020", "r1021" ] }, "us-gaap_ScheduleOfGoodwillTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfGoodwillTable", "presentation": [ "http://www.quidelortho.com/role/GoodwillandIntangibleAssetsNetGoodwillRollforwardDetails", "http://www.quidelortho.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Goodwill [Table]", "label": "Goodwill [Table]", "documentation": "Disclosure of information about goodwill, including, but not limited to, change from acquisition, sale, impairment, and other reason." } } }, "auth_ref": [ "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r781" ] }, "us-gaap_ScheduleOfGoodwillTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfGoodwillTextBlock", "presentation": [ "http://www.quidelortho.com/role/GoodwillandIntangibleAssetsNetTables" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill", "label": "Schedule of Goodwill [Table Text Block]", "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule." } } }, "auth_ref": [ "r781", "r984", "r985", "r986", "r987", "r988", "r989", "r990", "r991", "r992", "r993", "r994" ] }, "us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfInterestRateDerivativesTableTextBlock", "presentation": [ "http://www.quidelortho.com/role/DerivativeInstrumentsandHedgingActivitiesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Interest Rate Derivatives", "label": "Schedule of Interest Rate Derivatives [Table Text Block]", "documentation": "Tabular disclosure of interest rate derivatives, including, but not limited to, the fair value of the derivatives, statement of financial position location, and statement of financial performance location of these instruments." } } }, "auth_ref": [ "r61" ] }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfInventoryCurrentTableTextBlock", "presentation": [ "http://www.quidelortho.com/role/BalanceSheetAccountDetailsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Inventories", "label": "Schedule of Inventory, Current [Table Text Block]", "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process." } } }, "auth_ref": [ "r19", "r92", "r93", "r94" ] }, "us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfOtherCurrentAssetsTableTextBlock", "presentation": [ "http://www.quidelortho.com/role/BalanceSheetAccountDetailsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaid Expenses and Other Current Assets", "label": "Schedule of Other Current Assets [Table Text Block]", "documentation": "Tabular disclosure of the carrying amounts of other current assets." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "presentation": [ "http://www.quidelortho.com/role/SegmentandGeographicInformationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Segment Reporting Information, by Segment", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss." } } }, "auth_ref": [ "r35", "r36", "r37" ] }, "us-gaap_SecuredDebtMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SecuredDebtMember", "presentation": [ "http://www.quidelortho.com/role/BorrowingsInterestExpenseDetails", "http://www.quidelortho.com/role/BorrowingsNarrativeDetails", "http://www.quidelortho.com/role/BorrowingsScheduleofBorrowingsDetails", "http://www.quidelortho.com/role/FairValueMeasurementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Term Loan", "label": "Secured Debt [Member]", "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets." } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12bTitle", "presentation": [ "http://www.quidelortho.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r841" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityExchangeName", "presentation": [ "http://www.quidelortho.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r843" ] }, "qdel_SegmentAdjustedEBITDA": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quidelortho.com/20240630", "localname": "SegmentAdjustedEBITDA", "crdr": "credit", "calculation": { "http://www.quidelortho.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quidelortho.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segment Adjusted EBITDA", "label": "Segment Adjusted EBITDA", "documentation": "Segment Adjusted EBITDA" } } }, "auth_ref": [] }, "us-gaap_SegmentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SegmentDomain", "presentation": [ "http://www.quidelortho.com/role/GoodwillandIntangibleAssetsNetGoodwillRollforwardDetails", "http://www.quidelortho.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails", "http://www.quidelortho.com/role/SegmentandGeographicInformationTotalRevenuesbyReportableSegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segments [Domain]", "label": "Segments [Domain]", "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r148", "r149", "r150", "r151", "r248", "r251", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r276", "r277", "r278", "r282", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r351", "r362", "r363", "r633", "r634", "r635", "r636", "r637", "r638", "r639", "r640", "r641", "r642", "r643", "r771", "r774", "r775", "r781", "r823", "r1050", "r1054", "r1055", "r1056", "r1057", "r1058", "r1059", "r1060", "r1061", "r1062", "r1063", "r1064", "r1065", "r1066", "r1067", "r1068", "r1069", "r1070", "r1071", "r1072", "r1073", "r1074", "r1075", "r1076", "r1077", "r1078", "r1079", "r1081", "r1082" ] }, "us-gaap_SegmentReportingDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SegmentReportingDisclosureTextBlock", "presentation": [ "http://www.quidelortho.com/role/SegmentandGeographicInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Segment and Geographic Information", "label": "Segment Reporting Disclosure [Text Block]", "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments." } } }, "auth_ref": [ "r151", "r248", "r250", "r251", "r252", "r253", "r254", "r266", "r268", "r269", "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r282", "r770", "r772", "r773", "r774", "r776", "r777", "r778" ] }, "us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems", "presentation": [ "http://www.quidelortho.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails", "http://www.quidelortho.com/role/SegmentandGeographicInformationTotalRevenuesbyReportableSegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]", "label": "Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_SellingAndMarketingExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SellingAndMarketingExpenseMember", "presentation": [ "http://www.quidelortho.com/role/StockbasedCompensationCompensationExpenseRelatedtoStockBasedCompensationPlansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Selling, marketing and administrative", "label": "Selling and Marketing Expense [Member]", "documentation": "Primary financial statement caption encompassing selling and marketing expense." } } }, "auth_ref": [ "r107" ] }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SellingGeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedStatementsofLossUnaudited": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofLossUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Selling, marketing and administrative", "label": "Selling, General and Administrative Expense", "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc." } } }, "auth_ref": [ "r107" ] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensation", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-based compensation expense", "label": "Share-Based Payment Arrangement, Noncash Expense", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r9" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsShareBasedLiabilitiesPaid": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsShareBasedLiabilitiesPaid", "crdr": "credit", "presentation": [ "http://www.quidelortho.com/role/StockbasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based liabilities paid", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Share-Based Liabilities Paid", "documentation": "Amount of cash paid to settle liability for award under share-based payment arrangement." } } }, "auth_ref": [ "r457" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Award Types", "label": "Award Type [Domain]", "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464" ] }, "us-gaap_SharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharesOutstanding", "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance (in shares)", "periodEndLabel": "Balance (in shares)", "label": "Shares, Outstanding", "documentation": "Number of shares issued which are neither cancelled nor held in the treasury." } } }, "auth_ref": [] }, "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation", "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Tax withholdings related to vesting of stock-based awards (in shares)", "label": "Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation", "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement." } } }, "auth_ref": [] }, "qdel_ShortTermMarketableSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quidelortho.com/20240630", "localname": "ShortTermMarketableSecuritiesMember", "presentation": [ "http://www.quidelortho.com/role/BalanceSheetAccountDetailsMarketableSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total marketable securities, current", "label": "Short-Term Marketable Securities [Member]", "documentation": "Short-Term Marketable Securities" } } }, "auth_ref": [] }, "us-gaap_StatementBusinessSegmentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementBusinessSegmentsAxis", "presentation": [ "http://www.quidelortho.com/role/GoodwillandIntangibleAssetsNetGoodwillRollforwardDetails", "http://www.quidelortho.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails", "http://www.quidelortho.com/role/SegmentandGeographicInformationTotalRevenuesbyReportableSegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segments [Axis]", "label": "Segments [Axis]", "documentation": "Information by business segments." } } }, "auth_ref": [ "r148", "r149", "r150", "r151", "r168", "r248", "r251", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r276", "r277", "r278", "r282", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r351", "r354", "r362", "r363", "r633", "r634", "r635", "r636", "r637", "r638", "r639", "r640", "r641", "r642", "r643", "r771", "r774", "r775", "r781", "r823", "r1050", "r1054", "r1055", "r1056", "r1057", "r1058", "r1059", "r1060", "r1061", "r1062", "r1063", "r1064", "r1065", "r1066", "r1067", "r1068", "r1069", "r1070", "r1071", "r1072", "r1073", "r1074", "r1075", "r1076", "r1077", "r1078", "r1079", "r1081", "r1082" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://www.quidelortho.com/role/AccumulatedOtherComprehensiveLossDetails", "http://www.quidelortho.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Components [Axis]", "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r13", "r86", "r89", "r90", "r165", "r202", "r203", "r204", "r216", "r217", "r218", "r220", "r226", "r229", "r231", "r249", "r319", "r322", "r352", "r412", "r485", "r486", "r492", "r493", "r494", "r496", "r498", "r499", "r514", "r515", "r516", "r517", "r518", "r519", "r522", "r550", "r552", "r553", "r554", "r555", "r557", "r560", "r562", "r568", "r626", "r655", "r656", "r657", "r673", "r732" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementLineItems", "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Line Items]", "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r216", "r217", "r218", "r249", "r562", "r602", "r668", "r674", "r685", "r686", "r687", "r688", "r689", "r690", "r694", "r697", "r698", "r699", "r700", "r701", "r702", "r703", "r704", "r705", "r707", "r708", "r709", "r710", "r711", "r713", "r715", "r716", "r718", "r719", "r720", "r721", "r722", "r723", "r724", "r725", "r726", "r727", "r728", "r729", "r732", "r831" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Cash Flows [Abstract]", "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Financial Position [Abstract]", "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Comprehensive Income [Abstract]", "label": "Statement of Comprehensive Income [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfStockholdersEquityAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Stockholders' Equity [Abstract]", "label": "Statement of Stockholders' Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementTable", "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Table]", "label": "Statement [Table]", "documentation": "Disclosure of information about statement of comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity." } } }, "auth_ref": [ "r216", "r217", "r218", "r249", "r283", "r562", "r602", "r668", "r674", "r685", "r686", "r687", "r688", "r689", "r690", "r694", "r697", "r698", "r699", "r700", "r701", "r702", "r703", "r704", "r705", "r707", "r708", "r709", "r710", "r711", "r713", "r715", "r716", "r718", "r719", "r720", "r721", "r722", "r723", "r724", "r725", "r726", "r727", "r728", "r729", "r732", "r831" ] }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "StkPrcOrTsrEstimationMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Price or TSR Estimation Method", "label": "Stock Price or TSR Estimation Method [Text Block]" } } }, "auth_ref": [ "r850", "r860", "r870", "r902" ] }, "us-gaap_StockAppreciationRightsSARSMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockAppreciationRightsSARSMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Appreciation Rights (SARs)", "label": "Stock Appreciation Rights (SARs) [Member]", "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period." } } }, "auth_ref": [] }, "us-gaap_StockCompensationPlanMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockCompensationPlanMember", "presentation": [ "http://www.quidelortho.com/role/ComputationofEarningsPerShareNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-Based Payment Arrangement", "label": "Share-Based Payment Arrangement [Member]", "documentation": "Share-based payment arrangement in which award of equity shares are granted. Arrangement includes, but is not limited to, grantor incurring liability for product and service based on price of its shares." } } }, "auth_ref": [ "r963" ] }, "us-gaap_StockIssued1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssued1", "crdr": "credit", "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Reduction of accrued payroll and related expenses upon issuance of restricted share units", "label": "Stock Issued", "documentation": "The fair value of stock issued in noncash financing activities." } } }, "auth_ref": [ "r26", "r27", "r28" ] }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of common stock under equity compensation plans (in shares)", "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture", "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r13", "r85", "r86", "r129" ] }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "crdr": "credit", "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of common stock under equity compensation plans", "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture", "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r43", "r85", "r86", "r129" ] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited", "http://www.quidelortho.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Total stockholders\u2019 equity", "periodStartLabel": "Balance", "periodEndLabel": "Balance", "label": "Equity, Attributable to Parent", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r86", "r89", "r90", "r119", "r696", "r712", "r733", "r734", "r817", "r840", "r956", "r981", "r1035", "r1086" ] }, "us-gaap_StockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockholdersEquityAbstract", "presentation": [ "http://www.quidelortho.com/role/ConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Stockholders\u2019 equity:", "label": "Equity, Attributable to Parent [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "presentation": [ "http://www.quidelortho.com/role/AccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "label": "Equity, Including Portion Attributable to Noncontrolling Interest", "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r49", "r50", "r51", "r165", "r166", "r203", "r216", "r217", "r218", "r220", "r226", "r229", "r319", "r322", "r352", "r412", "r485", "r486", "r492", "r493", "r494", "r496", "r498", "r499", "r514", "r515", "r516", "r517", "r518", "r519", "r522", "r550", "r552", "r557", "r561", "r568", "r656", "r657", "r672", "r696", "r712", "r733", "r734", "r750", "r839", "r956", "r981", "r1035", "r1086" ] }, "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SupplementalBalanceSheetDisclosuresTextBlock", "presentation": [ "http://www.quidelortho.com/role/BalanceSheetAccountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Balance Sheet Account Details", "label": "Supplemental Balance Sheet Disclosures [Text Block]", "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity." } } }, "auth_ref": [ "r941" ] }, "us-gaap_SupplementalCashFlowInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SupplementalCashFlowInformationAbstract", "presentation": [ "http://www.quidelortho.com/role/ConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION", "label": "Supplemental Cash Flow Information [Abstract]" } } }, "auth_ref": [] }, "ecd_TabularListTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TabularListTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Tabular List, Table", "label": "Tabular List [Table Text Block]" } } }, "auth_ref": [ "r896" ] }, "qdel_TaxIndemnificationIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quidelortho.com/20240630", "localname": "TaxIndemnificationIncomeExpense", "crdr": "credit", "calculation": { "http://www.quidelortho.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 12.0 } }, "presentation": [ "http://www.quidelortho.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tax indemnification income", "label": "Tax Indemnification Income (Expense)", "documentation": "Tax Indemnification Income (Expense)" } } }, "auth_ref": [] }, "ecd_TotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Total Shareholder Return Amount", "label": "Total Shareholder Return Amount" } } }, "auth_ref": [ "r888" ] }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Total Shareholder Return Vs Peer Group", "label": "Total Shareholder Return Vs Peer Group [Text Block]" } } }, "auth_ref": [ "r895" ] }, "ecd_TradingArrAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TradingArrAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Arrangement:", "label": "Trading Arrangement [Axis]" } } }, "auth_ref": [ "r915" ] }, "ecd_TradingArrByIndTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TradingArrByIndTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Arrangements, by Individual", "label": "Trading Arrangements, by Individual [Table]" } } }, "auth_ref": [ "r917" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "TradingSymbol", "presentation": [ "http://www.quidelortho.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "presentation": [ "http://www.quidelortho.com/role/BalanceSheetAccountDetailsMarketableSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Option, Eligible Item or Group", "label": "Financial Instruments [Domain]", "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms." } } }, "auth_ref": [ "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r406", "r411", "r520", "r544", "r569", "r570", "r571", "r572", "r573", "r574", "r575", "r576", "r577", "r578", "r579", "r580", "r581", "r582", "r583", "r585", "r586", "r587", "r588", "r589", "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r627", "r804", "r807", "r809", "r810", "r811", "r812", "r813", "r814", "r815", "r818", "r933", "r934", "r935", "r936", "r937", "r938", "r939", "r977", "r978", "r979", "r980", "r1019", "r1022", "r1023", "r1024", "r1031", "r1034" ] }, "qdel_TransfusionMedicineMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quidelortho.com/20240630", "localname": "TransfusionMedicineMember", "presentation": [ "http://www.quidelortho.com/role/RevenueDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Transfusion Medicine", "label": "Transfusion Medicine [Member]", "documentation": "Transfusion Medicine" } } }, "auth_ref": [] }, "ecd_TrdArrAdoptionDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrAdoptionDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Adoption Date", "label": "Trading Arrangement Adoption Date" } } }, "auth_ref": [ "r918" ] }, "ecd_TrdArrDuration": { "xbrltype": "durationItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrDuration", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Arrangement Duration", "label": "Trading Arrangement Duration" } } }, "auth_ref": [ "r919" ] }, "ecd_TrdArrExpirationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrExpirationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Expiration Date", "label": "Trading Arrangement Expiration Date" } } }, "auth_ref": [ "r919" ] }, "ecd_TrdArrIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Trading Arrangement, Individual Name" } } }, "auth_ref": [ "r917" ] }, "ecd_TrdArrIndTitle": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrIndTitle", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Title", "label": "Trading Arrangement, Individual Title" } } }, "auth_ref": [ "r917" ] }, "ecd_TrdArrSecuritiesAggAvailAmt": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrSecuritiesAggAvailAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Available", "label": "Trading Arrangement, Securities Aggregate Available Amount" } } }, "auth_ref": [ "r920" ] }, "ecd_TrdArrTerminationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrTerminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Termination Date", "label": "Trading Arrangement Termination Date" } } }, "auth_ref": [ "r918" ] }, "us-gaap_TypeOfArrangementAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TypeOfArrangementAxis", "presentation": [ "http://www.quidelortho.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]", "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r500" ] }, "us-gaap_UnbilledContractsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "UnbilledContractsReceivable", "crdr": "debit", "calculation": { "http://www.quidelortho.com/role/BalanceSheetAccountDetailsPrepaidexpensesandothercurrentassetsDetails": { "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.quidelortho.com/role/BalanceSheetAccountDetailsPrepaidexpensesandothercurrentassetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contract assets", "label": "Unbilled Contracts Receivable", "documentation": "Unbilled amounts due for services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the entity and, at a minimum, one other party. An example would be amounts associated with contracts or programs where the recognized revenue for performance thereunder exceeds the amounts billed under the terms thereof as of the date of the balance sheet." } } }, "auth_ref": [ "r601" ] }, "ecd_UndrlygSecurityMktPriceChngPct": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "UndrlygSecurityMktPriceChngPct", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Underlying Security Market Price Change", "label": "Underlying Security Market Price Change, Percent" } } }, "auth_ref": [ "r914" ] }, "us-gaap_UnrecognizedTaxBenefits": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "UnrecognizedTaxBenefits", "crdr": "credit", "presentation": [ "http://www.quidelortho.com/role/IncomeTaxesDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Unrecognized tax benefits", "label": "Unrecognized Tax Benefits", "documentation": "Amount of unrecognized tax benefits." } } }, "auth_ref": [ "r473", "r481", "r801" ] }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued", "crdr": "credit", "presentation": [ "http://www.quidelortho.com/role/IncomeTaxesDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Unrecognized tax benefits, income tax interest and penalties accrued", "label": "Unrecognized Tax Benefits, Income Tax Penalties Accrued", "documentation": "Amount of statutory penalties accrued for a tax position claimed or expected to be claimed by the entity, in its tax return." } } }, "auth_ref": [ "r1014" ] }, "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate", "crdr": "credit", "presentation": [ "http://www.quidelortho.com/role/IncomeTaxesDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Unrecognized tax benefits the could impact effective tax rate", "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate", "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate." } } }, "auth_ref": [ "r482", "r801" ] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "UseOfEstimates", "presentation": [ "http://www.quidelortho.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Use of Estimates", "label": "Use of Estimates, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r32", "r33", "r34", "r155", "r156", "r158", "r159" ] }, "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year", "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]" } } }, "auth_ref": [ "r884" ] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "calculation": { "http://www.quidelortho.com/role/ComputationofEarningsPerShareCalculationofBasicandDilutedEarningsPerShareDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.quidelortho.com/role/ComputationofEarningsPerShareCalculationofBasicandDilutedEarningsPerShareDetails", "http://www.quidelortho.com/role/ConsolidatedStatementsofLossUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-average shares outstanding - diluted", "totalLabel": "Diluted weighted-average shares of common stock outstanding", "label": "Weighted Average Number of Shares Outstanding, Diluted", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r235", "r243" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "calculation": { "http://www.quidelortho.com/role/ComputationofEarningsPerShareCalculationofBasicandDilutedEarningsPerShareDetails": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quidelortho.com/role/ComputationofEarningsPerShareCalculationofBasicandDilutedEarningsPerShareDetails", "http://www.quidelortho.com/role/ConsolidatedStatementsofLossUnaudited" ], "lang": { "en-us": { "role": { "verboseLabel": "Weighted-average shares outstanding - basic", "terseLabel": "Basic weighted-average shares of common stock outstanding", "label": "Weighted Average Number of Shares Outstanding, Basic", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r234", "r243" ] }, "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested", "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]" } } }, "auth_ref": [ "r882" ] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "4", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482338/360-10-05-4" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(j)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(k)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-12" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-20" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-2" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(c)(2)", "SubTopic": "20", "Topic": "860", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4D" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482739/220-10-55-15" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483489/210-10-50-1" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-5" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-4" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-5" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-20" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-8" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "30", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-5" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-8" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-12" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-13" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "25", "Paragraph": "23", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479405/805-10-25-23" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "30", "Section": "25", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479668/805-30-25-6" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-15" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-16" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4I", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4I" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1A" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1B" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-2" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4C", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4D", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-5" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "55", "Paragraph": "182", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-182" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "25", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480238/815-25-50-1" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-1" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-12" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-20" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "470", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-7" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/220/tableOfContent" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r104": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r105": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r106": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r107": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r108": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r109": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r110": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13" }, "r111": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15" }, "r112": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24" }, "r113": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25" }, "r114": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r115": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/235/tableOfContent" }, "r116": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18" }, "r117": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18" }, "r118": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41" }, "r119": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2" }, "r120": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.BB)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480581/330-10-S99-2" }, "r121": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/360/tableOfContent" }, "r122": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "15", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482309/360-10-15-4" }, "r123": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482130/360-10-45-15" }, "r124": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.CC)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480091/360-10-S99-2" }, "r125": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/440/tableOfContent" }, "r126": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/470/tableOfContent" }, "r127": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6" }, "r128": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-7" }, "r129": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1" }, "r130": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479613/805-30-35-1" }, "r131": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19" }, "r132": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "815", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/815/tableOfContent" }, "r133": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B" }, "r134": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B" }, "r135": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B" }, "r136": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C" }, "r137": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r138": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r139": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r140": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r141": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r142": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r143": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r144": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r145": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(13)(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r146": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r147": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r148": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r149": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r150": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r151": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r152": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "SubTopic": "210", "Topic": "954", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477220/954-210-45-5" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-1" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-11" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-6" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-7" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "606", "Publisher": "FASB", "URI": "https://asc.fasb.org/606/tableOfContent" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483504/205-10-50-1" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(3)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-10" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(dd)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-12" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-15" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-12" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 11.M.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480530/250-10-S99-5" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/260/tableOfContent" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-22" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-23" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-28A" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-3" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "270", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/280/tableOfContent" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(j)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26A" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(ee)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "34", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-4" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(aa)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(aaa)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(aaa)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-9" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481664/323-10-45-1" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479344/326-20-45-1" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-11" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-14" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-16" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-5" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479130/326-30-45-1" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-4" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-7" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-9" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482955/340-10-05-5" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483032/340-10-45-1" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482598/350-20-45-1" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482598/350-20-45-2" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1A" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-2" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-2" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4.d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-6" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-1" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-3" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-10" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-13" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-15" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-4" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-8" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-9" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(C)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/718/tableOfContent" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-2" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480454/718-10-45-1" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "720", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "730", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/740/tableOfContent" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-10B" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-4" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-6" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.5.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 11.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "808", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4CCC", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4CCC" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4CCC", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4CCC" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4E" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-5C" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480627/815-20-45-3" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-5" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "54B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r527": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r528": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r529": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r530": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r531": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r532": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r533": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r534": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r535": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r536": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E" }, "r537": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3" }, "r538": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3" }, "r539": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r540": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r541": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r542": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r543": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r544": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6B" }, "r545": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-10" }, "r546": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28" }, "r547": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481839/830-10-45-9" }, "r548": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481956/830-20-45-5" }, "r549": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "230", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1" }, "r550": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17" }, "r551": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r552": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r553": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r554": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r555": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r556": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-21" }, "r557": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1" }, "r558": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2" }, "r559": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-5" }, "r560": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8" }, "r561": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8" }, "r562": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "12A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A" }, "r563": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1" }, "r564": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1" }, "r565": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-2" }, "r566": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A" }, "r567": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2" }, "r568": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2" }, "r569": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r570": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r571": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r572": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r573": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r574": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r575": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r576": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r577": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r578": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r579": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r580": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r581": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r582": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481444/860-30-45-1" }, "r583": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7" }, "r584": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7" }, "r585": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3" }, "r586": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3" }, "r587": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3" }, "r588": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(4)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3" }, "r589": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r590": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r591": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r592": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r593": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r594": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r595": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r596": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r597": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r598": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r599": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r600": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6" }, "r601": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "912", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478345/912-310-45-2" }, "r602": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1" }, "r603": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "940", "SubTopic": "820", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478119/940-820-50-1" }, "r604": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r605": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r606": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r607": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r608": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r609": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r610": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1" }, "r611": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1" }, "r612": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r613": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r614": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(15)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r615": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r616": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r617": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r618": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r619": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r620": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r621": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r622": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r623": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r624": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r625": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r626": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r627": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r628": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r629": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r630": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r631": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(7)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r632": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r633": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r634": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r635": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r636": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r637": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r638": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r639": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r640": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r641": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r642": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column J))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r643": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column K))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r644": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r645": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r646": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r647": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r648": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r649": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r650": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4E" }, "r651": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r652": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r653": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r654": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9" }, "r655": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r656": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r657": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r658": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r659": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r660": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r661": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r662": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r663": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r664": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r665": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.W.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1" }, "r666": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "825", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B" }, "r667": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-3" }, "r668": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r669": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r670": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11" }, "r671": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13" }, "r672": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3" }, "r673": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4" }, "r674": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4" }, "r675": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1" }, "r676": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1" }, "r677": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1" }, "r678": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1" }, "r679": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-12" }, "r680": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r681": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r682": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r683": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r684": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r685": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r686": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r687": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r688": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r689": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r690": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r691": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r692": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r693": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r694": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r695": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r696": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r697": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r698": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r699": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r700": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r701": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r702": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r703": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r704": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r705": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r706": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r707": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r708": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r709": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r710": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r711": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2" }, "r712": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2" }, "r713": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3" }, "r714": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7" }, "r715": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r716": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r717": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r718": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r719": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r720": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r721": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r722": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r723": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r724": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r725": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r726": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r727": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r728": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r729": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r730": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r731": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r732": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r733": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r734": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r735": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1" }, "r736": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2" }, "r737": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r738": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r739": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5" }, "r740": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5" }, "r741": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5" }, "r742": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5A", "Subparagraph": "(SX 210.12-13A(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5A" }, "r743": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5B" }, "r744": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5B" }, "r745": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5B" }, "r746": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5B" }, "r747": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5C" }, "r748": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5C" }, "r749": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6" }, "r750": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-3" }, "r751": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478785/954-310-50-2" }, "r752": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1" }, "r753": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1" }, "r754": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1" }, "r755": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "985", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2" }, "r756": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)(1)", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D" }, "r757": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(a)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H" }, "r758": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r759": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r760": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r761": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r762": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "8", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-8" }, "r763": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r764": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r765": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r766": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-22" }, "r767": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52" }, "r768": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r769": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31" }, "r770": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r771": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r772": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r773": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r774": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "48", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48" }, "r775": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "49", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49" }, "r776": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "54", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54" }, "r777": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "54", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54" }, "r778": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "54", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54" }, "r779": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A" }, "r780": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479081/326-30-55-8" }, "r781": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482548/350-20-55-24" }, "r782": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482640/350-30-55-40" }, "r783": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r784": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B" }, "r785": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C" }, "r786": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E" }, "r787": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69F", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F" }, "r788": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r789": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r790": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r791": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r792": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r793": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r794": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r795": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r796": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r797": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r798": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17" }, "r799": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8" }, "r800": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r801": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "217", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-217" }, "r802": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "231", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231" }, "r803": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D" }, "r804": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "100", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100" }, "r805": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "100", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100" }, "r806": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "100", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100" }, "r807": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "101", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-101" }, "r808": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "102", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102" }, "r809": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "103", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103" }, "r810": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r811": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r812": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r813": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r814": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r815": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r816": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8" }, "r817": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10" }, "r818": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481395/860-30-55-4" }, "r819": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479401/944-30-55-2" }, "r820": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H" }, "r821": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F" }, "r822": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C" }, "r823": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C" }, "r824": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9C", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C" }, "r825": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9E" }, "r826": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-17" }, "r827": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-18" }, "r828": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1" }, "r829": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r830": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1" }, "r831": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1" }, "r832": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1" }, "r833": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2" }, "r834": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r835": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column A)(Footnote 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5C" }, "r836": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column B)(Footnote 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5C" }, "r837": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6" }, "r838": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10" }, "r839": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11" }, "r840": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12" }, "r841": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r842": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r843": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r844": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r845": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16", "Subsection": "J", "Paragraph": "a" }, "r846": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1" }, "r847": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i" }, "r848": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r849": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r850": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r851": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r852": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r853": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii" }, "r854": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "iii" }, "r855": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "2" }, "r856": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a" }, "r857": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1" }, "r858": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r859": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r860": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r861": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r862": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r863": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "2" }, "r864": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "3" }, "r865": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "b" }, "r866": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a" }, "r867": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1" }, "r868": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r869": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r870": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r871": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r872": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r873": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "2" }, "r874": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "3" }, "r875": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "b" }, "r876": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r877": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v" }, "r878": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "1" }, "r879": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "ii" }, "r880": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii" }, "r881": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "B", "Clause": "1", "Subclause": "ii" }, "r882": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "i" }, "r883": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "ii" }, "r884": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "iii" }, "r885": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "iv" }, "r886": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "v" }, "r887": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "vi" }, "r888": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iv" }, "r889": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "vi" }, "r890": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "3" }, "r891": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "4" }, "r892": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "i" }, "r893": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "ii" }, "r894": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iii" }, "r895": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iv" }, "r896": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6" }, "r897": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6", "Subparagraph": "i" }, "r898": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1" }, "r899": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i" }, "r900": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r901": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r902": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r903": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r904": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r905": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "ii" }, "r906": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "iii" }, "r907": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "2" }, "r908": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "1" }, "r909": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2" }, "r910": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "A" }, "r911": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "C" }, "r912": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "D" }, "r913": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "E" }, "r914": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "F" }, "r915": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a" }, "r916": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "1" }, "r917": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "A" }, "r918": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "B" }, "r919": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "C" }, "r920": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "D" }, "r921": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "b", "Paragraph": "1" }, "r922": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "402", "Number": "229", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1" }, "r923": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "A", "Number": "229" }, "r924": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "B", "Clause": "1", "Number": "229" }, "r925": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "B", "Clause": "1", "Subclause": "i", "Number": "229" }, "r926": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r927": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12" }, "r928": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18" }, "r929": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "SubTopic": "825", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B" }, "r930": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4CC", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4CC" }, "r931": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2)(a))", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r932": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2)(d))", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r933": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "a", "Publisher": "SEC" }, "r934": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "b", "Subparagraph": "(1)", "Publisher": "SEC" }, "r935": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "b", "Subparagraph": "(2)", "Publisher": "SEC" }, "r936": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "b", "Subparagraph": "(3)", "Publisher": "SEC" }, "r937": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "c", "Subparagraph": "(2)(i)", "Publisher": "SEC" }, "r938": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "c", "Subparagraph": "(2)(ii)", "Publisher": "SEC" }, "r939": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "c", "Subparagraph": "(2)(iii)", "Publisher": "SEC" }, "r940": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "205", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483504/205-10-50-1" }, "r941": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/210/tableOfContent" }, "r942": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r943": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r944": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r945": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r946": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r947": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4" }, "r948": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5" }, "r949": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6" }, "r950": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13" }, "r951": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14" }, "r952": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15" }, "r953": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-9" }, "r954": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8" }, "r955": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r956": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r957": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3" }, "r958": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23" }, "r959": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24" }, "r960": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5" }, "r961": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6" }, "r962": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r963": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r964": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "270", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1" }, "r965": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-18" }, "r966": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r967": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r968": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(ee)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r969": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r970": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "34", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34" }, "r971": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2" }, "r972": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481830/320-10-45-1" }, "r973": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481830/320-10-45-11" }, "r974": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3" }, "r975": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r976": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B" }, "r977": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-9" }, "r978": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3" }, "r979": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3" }, "r980": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3" }, "r981": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r982": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13" }, "r983": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/350-20/tableOfContent" }, "r984": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r985": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r986": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r987": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r988": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r989": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r990": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r991": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r992": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r993": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1A" }, "r994": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-2" }, "r995": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/350-30/tableOfContent" }, "r996": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r997": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r998": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "30", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/405-30/tableOfContent" }, "r999": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r1000": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r1001": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r1002": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10" }, "r1003": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/450/tableOfContent" }, "r1004": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9" }, "r1005": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1" }, "r1006": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6" }, "r1007": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6" }, "r1008": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r1009": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r1010": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r1011": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5" }, "r1012": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r1013": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "720", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483384/720-30-45-1" }, "r1014": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15" }, "r1015": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "808", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1" }, "r1016": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1A" }, "r1017": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1B" }, "r1018": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r1019": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "54B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B" }, "r1020": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1021": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1022": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1023": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1024": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1025": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1026": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1027": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1028": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1029": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1030": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1031": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E" }, "r1032": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3" }, "r1033": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3" }, "r1034": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r1035": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28" }, "r1036": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r1037": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1" }, "r1038": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-1A" }, "r1039": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2" }, "r1040": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1" }, "r1041": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7" }, "r1042": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7" }, "r1043": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r1044": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r1045": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r1046": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r1047": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r1048": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r1049": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "912", "SubTopic": "730", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479532/912-730-25-1" }, "r1050": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B" }, "r1051": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3" }, "r1052": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3" }, "r1053": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3" }, "r1054": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B" }, "r1055": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B" }, "r1056": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C" }, "r1057": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D" }, "r1058": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4G", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G" }, "r1059": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r1060": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r1061": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r1062": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r1063": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1064": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1065": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1066": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1067": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1068": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1069": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1070": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1071": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1072": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1073": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1074": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1075": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1076": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1077": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r1078": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r1079": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r1080": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-1" }, "r1081": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2" }, "r1082": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2" }, "r1083": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4" }, "r1084": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r1085": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r1086": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r1087": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" } } } ZIP 88 0001906324-24-000045-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001906324-24-000045-xbrl.zip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�)EVY[$WXC[[FL++#\JD5%.[/^^-^Y5U2E7W-I7#]E(+4I=Q M'M3%S;R/5KAD:97$36?>Y6PY9$G# @Y;\H/8DUFF9B1V/T?G M99(L;%*9:Z;,!398E2HS3\2:7((R9Y"LU9KB)_L([#-G9.+'43\8^'L\"Z%Q M:2T_MW) #U[.,FZ;W#Y2PT0!?;"='P#GC9CNV+Y9UMC$>%('#F\..0477;N:T]EQI]?//0C-<#?.7X&L MQD\5$OVX,YR4.Q<_ZC#[TL=7N$_C*L[J7,BB2'W!AI[ZUB*2<)A.B M%G:I04\5]KCKK0ZW@K42\[]LURN2.Y([[I.;GHN;A'\Z>.\:[_Y0UI+9XZ^ #\N@*+!<9_ M.:%#11GO#QYN1TZ2\9)H@<7U]1UUC8QXX; +&_I>%EE-Q7D:9XCN%^K+J5P& MJ<_7H<_EZC,=J=":YB\%(2[WVS9N&WIM@J[F)WW.TG(5LPF.*2%>0_VN-+E1 MJEVCU.ZD6K?[ "*M6#V^?)X\<;BR\[3=6Y):N,'RJ0MXZH52:NNP]^5YLSF%>3JUS E66*Q3E@LNG\I2C,Z[ Y:4TY5 MI+Z]0/!*P)4&7!G7?5@GHR>=<_E4/9WSIAU,W3XP2UO+4ZD7\WTR '*)2Y': M/;T?CCA)/UP^50<_ M_/P=E$]=QE,7?QKS$SETLZ\_M4,>5[D1?+D@^!$7H)ON):4*L%6^152ZK6E_ M7!E]S/FOXM?P%.>B %PN0>U(!!^U*!.1N_B8URY&Q(;W3.U"M5F MC#;4-$AUENI\QI6]S&ZJSU?T(5D[(^B95-"J:GKW9&6,)H9;L& M/O/&86 *C4>VJ5ST]V2]I6"XW(O% MRJBEH:&X+B@_\2OTF70U,%VP;-ZR3$;P9$!F*#+8V M'I9?\QRJ,T*SGG\RO 594B^J13 M+O[M/#+W35X]P8NLSS;I=$?EJFCM:DKI=0;*I%13IR_(A9U2U;U-76_-J$:5 MB,%JDB0L)%EB<#DA@$;)X*CB9\W/"LA8*TY'W7YA>[4KIJ[/2S]+N5T\B'(G M4DRR]F##UK37'W74)O#55W!0*G5*ZE39"$=IG1J!3DT&S2BA=/&'R-&^$U-$ M^,SC;,"R.Z,>$ULIV+>(*=[IBEUFYG.IJ/Z.E>=/G9EO$GO[0,+?A8!O+?T^ M%&^6KHQ;TV$OXU2O=-2^!J%W"9=PR&VIJJ MPTG5W()'3583LVJDBDH5/3S:M%]%L=QHM]?I-5Q%=V30;!(.:I8 D)U(\=%Z MA&FRG?@%A?*Y$S^T!=-]DWV=A^VM P#LR);H]9N8+1$3%D]F<#U,^B34(]Z" M$7!UF8,I#9KM>N35W'!<[\:PVD3\R_:]UY@.@7D/(D&49R@\4M-G'1)O.LBZ M@)8Q[V*!VUGTHQ&L,DE")DG()(FZ)@C()(FK3Y+X3I\P%0Y^#-Z23(^01[E' M[G\C?PJ ]3G$%?C77^??@\3)+!=[ +M@53W>Q98I$E*O:C3P"C>MA^G5$/1* M43NC)NC5Q4>L_\=V?L'^ZF;EV!JFF+^*UMTV,2G(EF=*(('1@E%]M[-YF4?? MIUB#4.(?K6]"WKG*,FI-)Y/*PCPUB*A*Q)2VKN40,P;$5."UR'R)8A/^P; , M=\%T\F#;^FGL9W./P4]A/T.!_Q/EG:L-D]:TITQJP]TC,R?.84!+0:;?1^,RT]_LM1_7UIR;%CH(^69OHX_B^V%1"N?D/2 M(=L",Y"E_$IK"A8@(UFJXL)@SO M.XQC#XQCMP*.V?H$^B34+Q7J1;?=.Z".]%^C467\7PV)4$:SRY/.SC'%7[T% M$4JZT(\/.H$!/,EC.T'NXZ74R$N!FU&780&OZ2GF=3-R3,=3#%Z'( M9<]2T$%KVAL?OP66(=,:(J2P[=Z+D&%KVA]4EADC(Z0O%"$]@"/SNN(\50CH M5TS#2U*> M31RVI(9% %8+S%F9L;6-J2L!"6UG:_/5O%MZWQRVHH"=]S!FRPTXH(2 @GMV MY)8+JI([?+SAH%W1[(Y;?/U)$V_QA<)D<6':7)B!%0E1)R_BR8MX\B)> R^A MR8MX5W\1#YQ#>\F(1Y\3%A[^CG/75W9CXZ+W*N4&?SG[D/U1!,373_J\H;U M*D#N.R4_W4V%,4!:M,&PTS_U?:(Z1+*E:DG5*KK%KT"UD#FNVS_]53UY!) ' MB^W]EKR(=^@A:"#)( JP!_R8KSBNS44J>?7N!8]!"V,$T[9&M5D(-,8[EP7S?FO:[]?F1I3,"'E!4U@2*0- RK"R MLC+2+2R4T[(,H M/<1B\WP//WOD2<72.SS8%&Z$*$ZN]\![W)HJBJ17N$B4Y-C!$BB9P#8YH]B3 M= I/YQ1*1_ H1S /TL,N.(#'0UKZ?S7$1Q'_+QOT V)5=&D MM ,/KF0&]@L(Z'+L2*F#J/!L-M>PJ$A/U:W,Y6[&[8GC4R*D[DK=/=4!86'= M[6%A+;7J"M'UN3O1P%L!R0L GPPZ,TS#.ZZ23SSW/];BC@L PT:6\?F:<*O, MS2AEPK],^)<)_TU,=I<)_U>?\'^K:; "X>"62\-U$>9MXH@:[7PW[3#/=RR9 M\B_SD@],^;^#U=L&+^JCAB8_/X# M]&@(>M0[GG=-)O,?GZ0P9S!+N)H^,LMG\JSN\$P%(1"I>8'&V]7,U?^B]0@/!I7*&!&E=UHGX.28R^. TV]-E5%M\A OWF.5UPLJO5X0.QS? M@W&\4U@;[T"ZDF>Y8E ,*4.PAM6EUTA'LJ C:> I+G,]Z3T>7IE!2/#6TN^- M1T-GENXF _KPS5Y._M$(L'\\"9;T(&L(GMRB#4>#!P.?W=I<9\XQG&%"%W24 M[0;;*9]J>@>;[X@??L?M.ARK0G?(=<7']S=Z5DBW+!.,7V4*YJ.O=D9XK2A=[#2Z3?3WY$VO8+S= MS4_H#(;F>[M_LON2E+A9<::[8$^@CJ"=*]3__8ZPJH[>NN$KDX4=89(R2%4 ) M_^4RTVP3]36AC]0P@R0AWIJQ7#+=H(!7;)<8,,_P^I7#7&P$.J9S\]@FO=?P M)?Q;@,&>$V@95YY'!D_;#PY=XHLP((I2AW?/_#5SVJ3_&K^?A>_$'V(W5R;# M6ZO\I4^&M^#%T$3ULS89O Z:-M- $VR;4M?B=U!0CD/1=6 MW^8CQE&$N[,Y@(\\4M-G;7ZO:O@:-FR_F&DL;)M?G'4!+R!HC>*0%]1Z !Q M&WB?EDOPR3!-F"OHB\X(=,-;0!]2W^(P=(<^61WR$48)'P9W73#X7(=Y:///+>;%H1#,!PJ,K:@#CX%D8,3I)K:10H*> A!AOPIO MY8*ACK/F:%N"2^#AD#8R(B9S$4FNYX;0X5(S7&+9T Y(QP%G!KJD(6YT_#6T M RO\7_#'T\(P]T*W0U U[@ !U%KS,>+_B;O+FSYPF."[;DRT$$(6HF?XLZW> M>811;0'SO\)NP+C CAHPM=AM&)]A\N9%&XEA[.MG@VKP99N@6\PT<[P0:H'( M8[;"A?;H(\C+C53[D;GM^--D 7*9,681AA,C4G\10J!_)IAE#RW'W+8]4$( M$JH __F##5_S.H=@R_$9G HT?.@^XM_8ABV2%^%3KK%+L!./3,PZZ,L2?NSZ MIN=V"(R$!G^E>X=^M2ZJ*KXR7@M$X#.?M?^&?Z(Y^0&ROS?8@]TF=[> ,DV8 M(NS2*R/^D^\4-)6"L?OR>WOS7#0H/'H5EM7U9R[[TX>_0 ]%)C1ZV/PI[O+B M0SY\RHU$L*Z#61 :ZS*TJ^1/'V9'*"5> F[''\:[_6@I>(/P)L/AAM[E\ 3- M"W"K"7LW=^QE])HVMTH>'QX+78@VMRBX)@BCDK013PN&=A\F6H-U.[#7)HO9 MN4VOGFS?Q(4+=P+ZMND6RAV9ETB7(_6#WU,$C^YK8LH0!P CV!EY_(Z.\-MS MS)& H>BA>N0$?D7:+Z=!_[.OY79GPUR3OTV#LRVV_+3?L>$3\/TK_.L'=N@ M-1UD,3*&E]N%F%$N0=%0/.07Y3'3(\LP2^G=43&?'Q,AF^94C\LZU?^$)1X7 M:/"G/UJ@VP\& %O,W%ZW>ICA5@_3;G78/->VS0N"XJ9@2)AWF)?-WY71 [6L M[[VIDAKV-6.THR:ZV'>!IP;*\A!. S@Y:&D"U]N]2A*4WKC3'9=C*-G)-]+M M#";E^%1>@ 1%=JKAG1IV>Y+#IOG\+5]@M[4@MWP9HE?*8?/^\_O;*QWZ'7C^ MUSKM^U.B+GOL/ 'B'%1-9SWM>Q>$V6"KMI^W2C++5#+XRSG[5=23?#+K,@"%@1IC_J]RLH]2+ZFFN!+:E6^5@V+:E5: M<2:MZ6"LRC+F4FVN3VU&!ZO-I-N:CJO+-)9:4Q/\2*W)UYKQX5JC@-947D-" M:LVY\2.UYLBDUT.W/1.D,&KW)VH#=.J%;L.<%1(?M\^HK^QJ^JM2*TFWH%9L MI/K)=MW2.M+;'1I(G4.4!*.\H'Y>7Z1;T!?9AZ"Y\!I]^:\C0Q M]6U-+JE+!%6*($4]-8(&$D&7C:""P;?#$324"&H:@LHY0B_B!HUJY ;5GLCD M&IZZAJ/J#[8#?UK!_1=M33P'6A-W8R2-R_%;LT"^=X%X?VZD^T]J6&47NG%E M"YWD>ZGE0I?>K^%],_C7,?A*XVC2FHXR6(V++W,2/K6$3WJS=@+XC+I((Y11 M0T#"I^GP2>W43@(?I34=2OA<'GQ>!#PJV)Y!'=:N:SBNB26R[BU"FS?FOU7'!ZN8M"9REDE5E:JZ4=5>]]!$IU&W MWYH.1OW*2OI)A90**16R5_"@)$LA!YQ'6I7Z*/51ZF-5^E@P=R)+'X>MZ:AW M?*%.J8]2'Z4^%B+"WJ>-(]1&M?'J6(!#MP%D/G%20(\AV5?$Z2-H*J,<8YM3 M?E'+\JE)9M0U7&(+7K6YX;A(HK@.*YQ+:3$ FKUTXMP'5*9*_H?20L8]3 MXL$0*#2MHS;C.T)VRVW60M>SM5\!Y2>?3TX/"C.P,CR0QE\!/:G&1\!V53P6*7Q)Z@ .7.G)2K!&1.80#:0V59$;+N&B67;!83C:+)5(-9-S\ M)+. P]"P=BL9AV">=-M('2M(7".R6TKF?E(.@6&/1 3 YORB>LC7N^\5@IUR MR\!D35CXFGV-<:T7^AZ146[ZB6R.8*1 E4 /B.X8H+]DAO/]:""*W04T)5A. MN14S=/$'TD$#""*B3_B9+PS=^WI)77#JQR: W0E\'O..1LI*CQAH'1=E"72C28UVA5 MPDT<9#G4 M!<N"6=9W38&W\,7_PO:^1;U^NO\ PSX#^SN M1^L]E\G7^5TPC%M.(!T9C!MU8S$F6*@B93#^CHI:NN/]%^RX@IDP@XR>=\@] MS%A@9^*4X1N@Y$!#0,G=GF-!N;SF3-^<[1;,'U:E>.1OTS8TEZ%UP!7-7ZZX M$0"LVB$Y,POHA<6O [KU+69M&*_FFX$!\5U!-AM7F:SE!]4HPFH9E4RN=@!? MDW-MD\5ZA16T^(ZF+!S41$3TXY]UE3-FJ3J MC/,+#:2/%7"RC'4C72%PG"W/\ 0'^F'[.E%>Q.6%&;"(0K;I%SL>,$XSZ(#8S^!8XVE-N W@?,MH -_AS(1W\<#$4O<"ZS,T(<$@?RO MV._O:3_NWT>O2&\O-FU%\R"J@\S"E0$6!L]V^)* ^P3'8%80)N&+NT7-,&X6 ME%[ 5DW +-^7L">L2+..U95I0S.>0U>V*0I]/#(GB*L%?HBHLP&.T98\'-QF MX8:&AW1")!6AK@^43A;V A]T=V&O6E?HVDUIKS:#6%Y\B2X& !Y="ZP^(?P+ M'F4D-%B549' ZU.ME,'1N'SEIE(*G !BQEHD_ K1?TC_IC) MKWGI3-\\'[T#NIX12N +"!HB?X5/S,!8+-"*!0T8K($QPO@QP@RD"*-VP^HC MX1(0U-O "&M\_U-F$:+M_$^&RBKI/IVL&BXJ;J."4686-3-"/\G"0+@\$UL/ZP9 MCN8O70_SF=WXN4S6D0P>&O&:*@+Q2[HFEHTU;W@0%C5]AM6I_LE#=6)#K >^ M!=<@6%!5?T1/-Q6,$@#%-X&% M@?U,0$W<[Y#OR=_ $ZGYP*)82X"S[PADTL"\&*[PJPH)%"Q>X./X5LQGM/CI M3.2O1.5:"S64'9,>8?L1%F0&9:7RAA+Z&J% M,Q-S7:*#@5T-\VI&$7R$VV;9\5EAS\(;%[.32+FOLIC/L'G%?"9EB_GG@Y,% KVQ+F&]R,2/:R6 ]\/IQTNJ-R)5IV%E;I=0;*I&[57J!3JBJKO51V MGZQ^]2#VWB+;,Z&75!-C?TF(%R(= 6MXIHR]GWAV_9RKGM1+" M*KV<2AA)+VC[K+84]]-(&2%-;$\9=93:T\1*ZF6I:15K6@Y!7Z6:-N:$S&KW M^*M&ET+(?+ZE^#M[M$TLZDWN'*8;'OD0U+&^,E;FZQ(B9I]0OI^,X&SCBVT) MRLLLFZSV6M-N95N!&CC\$BQ%"XT< )8^@J6J\G#29\V9:UY--WXG8A8[H)%> MZV$FD@OU!\H4HW.;(Z\R'HBD\;]H!.78S=T(2B-EB/?#T@Q^TD\]H<'D.0E5 MV,OK\!**V,M/(%($.V[A]GL((_00JHIW27>R3D I8A:+ V4L751G>_G3Q@L-U?B/1QPQUT\5*C6: M,^_6TN_$[1$>AOH:A83+UK0:]10\;1T,>\=OMYJ0UR !6(4IKA2 HOZRTF\ M "_>W_W$7/=-4.G+(_RRV8%%OJ[$:\FQU?%]W=W.35VOUYKV!L.,;9UT:IL- MCQQ+6A >R$K0F]1ASW,UCNRG L'0@NM0-H5G=Q^+YW7E458AH'K;C!.M*!4Z M80-TPM3NJ.J=Q7^"7/:Y!VU?N&=V.#V M>IM\Z=QV^#-47QJ6X7J.H*.@#_Q^/S3I/O&\0J0',9FE8ROA]77!)R$^%9Q" MGWZ[(X;K^O@W+>CQ2SRC07=G+G5P MWY)$5]"$Y*VR1+DY=8\^@<2_SL7LAQGUG^FSL?0WB1&@_/"-M\X:Q[@U'7>S M1A%>&"4[$_<[Y/:1&F9(X.#C_/()W_D+P 1R <& =%_S1"*JYR$*D,1&/%N> M2CBG$,TWQ^:$YA\<>XG20F80_B#^0LL6A4U 9C308 M!_3'67-REX?9 +A2]_8EF"'X*>M&'E6AHA M?;4=$LBX,(?P':R"#V"DD!U(A\EE.A@1_A,F>/L>F>N)GO E#VO+BJEU \HE M&*MI( -=\V;QJT5N5XYA$G60I4O\PCOGJH+%&]P%2^?3_,7N$)6\PB05O%5G:]CL9[-3(IZ1TNEU4*I "0 EE82?LX8C')G$ M*#@V]PP3BWIH!PQS<+IA#G"8&82[>X;9SQKF-LT$#E4_8*C#TPUU6&Q&4R/) MF]6!*+/"#ACMZ'2CA>U)KS/:,[%99B4]V0-A&? &UHPRU!<@P+Y):(PY5@B9,5+ 3XL2=OK/UFX"Q-UQQT8E'BD'\B<$+IG,?0Y#[\71"^.G&Z=GI/4O2 MVU*DM\/FDMX6IWT+5>(CY]R^M?3P@_?/*_!U68SC#IV8-!E#X9E-0VSKVHZ$'%*XZ UMH,N[)^JASJ)"@HI$19$)Z;B4VJN" MO2\SWV323+*WG]RD?!:FY#V:DF-9[QHJB!]@47>*0=(Z[BH1FY_G6.]I+TOX MF#_L'"K(BY$;[$'4#'[(HW@R)=HDVDJA[>)O1TLV4LF16.BT,2>187M7GGW@ M..BVIOU^93=\:WT9Y^#.7[L.7;(:#7)29PJJD<+5Z.0,HDW7I*M6HXO5H;S$ MEX(ZI+:FXW%G(IC^*,W-O*B:RTADG-MK2!$!LANER!.RY]7RY%T'162!.E;?,6N/Z7?V625H&0!:E,[H_&BY^"A:=.W,X+?X MKBQ8=IS+M>\ZY$YH#[./FHHC6VY,ZPB.G'A807#P$X1C^'8E..H(CH+Y/#G@ M&",XCN'JEN"H(SAR8EH%P8&UVNM@.2X^:)5Y3[^L6WHXC^E%)WU6+)UZ&XDJ MHWW9QB)(5\@N4C7""S_5I2M4-&=GVM%+?97Z>M+3\0KT56E->\/*DA2EODI] ME?I:-.9]B+[B+:;=A-]27Z6^2GVM+ ^D GW%X\Q>91G>9]37'64JDH2-684K M4!*&.M:4X63XQ,?/L8J17U/(1\*0(1 M3LCWQ?884;H=4H[<<$->^'6.9)H '"ZY*+W(]=P?"^JP=]1E^K> B#W-<3CJ M"^R"Y)E^ZP6?X?N2S(<_//C5S0P;(_'WI28JP>2W@RZ1OZ DF^,/;<%TWX3A MOE^N3'O-V _F/!H:VXPRWJ];$X;)__5U_IUI]H.%QP)V9Z]I8Y"#]EQ9Z&F-IS]-'.I9/&2=VZ8-W*28,Z7+=X M3F4C6+"D;DG=.HENC4^E6V/,.DQ?TY"Z)77K6G0KAWW[<-WB&;V-6+=.D/,; M'(#49U/Y@YGPX4.;+*GSB_%JY+P<;:*$[)5=6"^E*,,#OPY/+F'@[^/5]ZK*N=0 M@T" 1$T,-3FL"(>C!CE ,@AC)&HN 36G.DD;\Y,T:6LN$S6G.B,:CS#6)GD? M7_ *_8,CTC Q-3G6(,QY7$FB6.]I:HN94QQ/C26O:/]YD2M34 M$36C4\7J)UVLQ72T>R914TO4G"I6/U%:TTEM5JB+#Y[]M#UJPDOWWWL[\ 0Z M^T+LE=[OKE(TEV-(3A51FHBSFXIK,Q\U:_7.9)*Z*G7U.-K3PW55')@=?3PO M=57JJM350BRTA^MJOS55NY4=U4A=E;IZ];IZJI..R: U[57 ^GEF7=U!<;1- M:!1TOZ[4,C\7C A^%SJS>1$LO*D*[6?RS(0G)9Y-3(/.>/7X&\VDKFO,#?B< M/E%'=_%>Z]\J].!VL/\X#K4>&*;4O%NG:)!NL2?O__2A@[%Z'YRZ^N>"6E]7 MV$2,/>E3,!R#N=^HH6?!=IA-;QVR+/ \GU+#SE&PF@Q[A$6G]PQ[;CO$0Q1Q M@A$4@FL\DZ7-&388,FR0^#WP-H#(73$-<]7-=9L\+0QM01;4)3/&+ *-&2[' MFQ8 ;<:(RSS/A+\,BVC4773([1(,@>?&\9C;A=@5?O+$'$8LVR-+^+EC4+.3 MI$Q*"ATH5M MPF*'YA>U :T&M=9D;J#NX,.>*'3(#38)#!3:>9,:E@>F"G^,OYPS^!?&7YGF M.]PX$),^P4\>*!9)3+2.L[/3Z&$];$NGEI<.U">RHS]^^9 HUO3)=MW-E*]A MHF?,^3I__PP=PB'; 8$_::_%B['EN2QP[YO[X!P_SJ> L;GL,YY%AM$P8O-CMM<@?&F7RQ M.T1YH_9OM,>;KCKN]F\^__7 M.#_&%F"QQ\KHK4ONOO[Q\?Y&F1#=H ^6#=JG$8^Y@4G 7PR@I[]>$]>?+0WP M08+5"*?Q!WVDED7)]S^^]7'D="WF;I>8 .OL%S1,_M?7'_ALZ0R6!KQ9!=WT M%E2@'M4 %E>8;@L7IB7^%/X?]0M_G- L?C?K*1@H_EB\R9C/^5=;ZJC3)7U MKI"5PV[$ S#BFZ@[1D C"O,('JACL;4;"(H_C"LF3&[XT9QA4_@%3VK96MZ: M9.[4063NK& 95Y7PHYV&)V8.TZ:GM\_TA+;FQZ8%%UPG[P-:T0@N)>W.N-O= ML_?:V]G^&3H+'HSW9*=,9-IF9JX_V_H<+$ N6U$PR_F64Q;T$^=,@[ MGVD+DSEM\FT!Z].^E:RGC(;[5K+-*[(6,1C"#X\]PE;AFV'] C.(';FW_0>P MHF#=UQ27Y9TO[X\&O7WO#MOC/9L:"V MR"^,RR>Y):O'BK^!$[:1 MFF"7K_S1LN]NENPH F([ZV#%!AN IBI8JQ,&R+!@5049@]L<60C0)9T;%3$O MX!AHZ';PB5D7^]6VJ[WS1WP/3'^QP/O@?QM+0-$CRQ3U WSA6%B)7HS-L36F MPYXMZ[:($_H@8/W8WUW?A[VQ' MWULN:Z 7\S,V>\B/[ .8A#P+;;O(>=\.%%NY+^ZW+K[ M5KA2\E43M,?VT*L%#U0W>/CER?#P_MHZ7%(]T*E;F$0.#8S><+<8MC\>2*V= M "M\B,WQT"*, Y386'(S@7ZMBX1WQ$3C MK+ UK81_X!][67=(UQ(M_TR!P, MX7;O,>1D1QXZ@Q6+H8T$LP#&#EL!,**7C?$EVP?57]!'?'48[B%4!UE!BVP^ M!T5#'P.;!?L'K>&OYP:J!CX)ME W!+Y%A[@T;4!L.'T.,8T_84-G@'2*A)$" M# 9 Z:N=$?)B@U3X:]YP PI69D.'_?=DA"*(='K3-1Q%TM;ER89A8V"QN+]" F6+= M8&@.W/@"$!BEN#< 3X('XFT.#@)7"DW]$EQ2KFV1D0S-(-A)S?/%BW"5V/P* MW+TG^!K_%[P+W^3K-+A^O'+ QE,1?0^\MEAWXOHN'(5HF=4TQV?"Q1.##'X- M5L82C0;Q9IA-=*O18K61V9/'I,'UL&$LD?GD"ZAH8,;0'.-09N+(!1=:!X]5 MJ&M;\-$ZL)/P98=\%*MK]"7;&%&P0)3\LNPG'C"/VN/VT\! !#>IHJ^6'72- M=TD=\+7 +T\& M3C:]UK,-?IL73C'F!BQ WB;\8N!L@5EUQ'3%NL?";O"9,);X'BX0L7SP$P-P MG_#@#[KT/O@A-]L)23$WL.C80&R5";&+,V-8Z'I;GHGK]QSZB"L2!S-?(@5P MJ$"H\)+@+= JJ ZVFH /KFEXF.'/7'2! .[0Z@*4$D.V #7[B8=?J14;8R3; MX)C%=D,P=S]'>RF M@VF UQ8X/0 (X<&$^W4!G\"A;PN'W 3M_EAG*6A 4)-()%QI":WCO S#X\M+2=#0@1YJ7Z$&U)LB=; M^*;N@LRQMDF5!W6C!A[4J64/ZCY0P_F#FC[;',NEZ^*,N[W4V1A\ECZ7P]8( M;XY\!ECXXF3CH!,YT?[!%8*B<=WRN,.M%3_+#OJF?[6^XQ&6 [;X'74-]R<: MKXS1]YM8%0B7'E'QAZ^TW"[#NN3RK7F6?BT,4"I'6ZRCF$D0L^'NW$9Z9!F( M#[=W4Q71V JZ@TF=W8'/ MO"24.""+;NT=0TMW:1P/64.\'*X&993#6+;!QX\('HE[)F_FQC/3;_YBCIV^ M!3[N#C J/U85]6U-*! K(,Z4ZG"YZI!#*7&L.@RE.DAU:) ZY%"-'*L.(ZD. M4AT:HPXY%=:.58:Q5 :I#(U1!F644]3C6'682'60ZM @==CC$MUYY$2.S7$3DZ(MHAI&4K37T-6XJ..^,B+AAUC6ZH[#)'8J2%V=FE:]-5J]*EZE%NT+^2):ORBXYRJU4?N,GUJHH#DE(KUK U M':J=D5RQI#Y=JS[E'2A5LFY5?@53JEJM$"=5[?CSMU(+U[@Y"]?%D]W%2GM4 MQ7C7 SGKMH^$.34DT9*]D[V3O;N\WDGF._F49+X[U7VO6 TK27UW+=N )4GLLH]4'J0QUNN>:L ?W65!UU!A+T M$O2U!WWQJ[L'+@*R#(+4A^;H0^'KR#E+P+!62X \0Y-/U?,,K;&.0.5$SD\,+U7"ZZ+AE1>C/@A>:1CU6M-N1Y$0ND (Y81U*P)0OTX MDC%?^50]8[[9AQKU#?4*QM/838EJ:4^%RF[?A9),/4>+YG*6K]S(>>PT\CA2 MA/ZIR'R.FLJ:'O-+!98*7-'91)X"IQ5U6&6BL512J:122?-.>*I;94]%/205 M6"KP]2IPSAE:^35V+-=8J:)215_R)+*Z-;9R#@*IP%*!I0+GG?667F4'W4IS MY:662BV56IIW9%Y>2Y5*#C>EDDHEE4I:*"FAO(JJ?"%M^GZ5GR?_YE%X%?RO M;CQ.PP%]\9F4EZ^$]OP6*GS&1A,(.9+*%3"Y] M3@0(+N,&R/0S=7XQ#@SB,@T&SP7'KU^Y7&B&]'Z@R^-=T,EL M399\L$2G'NV0KZG?&99F^C#"F6/_8@[YT[<]'(9.0>SA;V&O#.*S" S!89:V M)MBX& A\]40=G:Q GQ!#\ B(KLZ0&&5"XD,D\X\QF7^Q/?(YEJ.!]I/\DNF2&,'J"*75A[0$+S1_ZR9PE M^61#[Y^H2_Y6RI/LY:4>V-8#MG\/&A6M4\DXC>4O;W3;NPF:R5JZ>K!TM=7) ML#-.K5X$I&IB-V$BT:J)U2PT;:BY( &<:+"?.%B-.LX:,4V7L*IY;<*>457P M$Z[UANOZ@!G4.-<#E0%!5BL1E,0&C7=!=VYY;TH+!KE$VCUEE.%ZAX+ID/.# M).]XNQ*0#+@L "3=O2"Y9QI;SI@3 $7A0.F= RBYM)(5 @49!]I]M9M1ZBX; M*#B>&%0,ESPP"UP+$Q:0:,%".?&U10\7%5PQP+Q![\#I@(;!FP@%Q;T;$Z;Z MQD,L<2$^&=Y">"@P=&C#BU;BMX';3,$E32\04878S@?63SPI0?GYC:K9G= M] 3?FM$7V.TT90$/["]XDR9#:3!0,=^%=^@;\:'(0#8WL8_B;B38+.@*?6"A M'CJ&^PM]51N\'U1/KFC:@EH/?#.!^PG8?(!?G'#ZDOX@&#S^ _&,, _0+U3C M33=\K4.\7P]T^,^#%1+-N!LZ$:B"N*((F(23O%DS^"P' M^]@E=7'*+>@ 7V =!V$6ZR\(R<>5-28LV/- 1Y:&^ G\E(C^\_T:]B&.E^2R M$AO9.MF]"(,+RG5LO4N*0GUX=VZ"N3.Y7FG111 R9[A\L6 (3[9OZO#8G[X! MPH=1\/ESD0_$Q)^"5 HM7@$^ Q#UUXLPS!3[ M81"@Z6Y^0F>N;?K>[I_LUAV-S^*95$<9;\DK]M^%$_9F!4;P9N8P^NN&SJ&S M;ZCY1-K5;>G*=D ^ADO( M=W07P_4\MLXWSCC_S+#"B862Q'3?15\71H(1%=#MY'.AU>:6^1$>XL$9_A7Z MO>T@0!/&Y[ZS1]M\Q+^"]>$#U?@],KYJ1ENO#CPXQ_V83;!_:O=MD,+ ?<%) MA[R+=F[\>^4M7SDQXHK XZ$GL6] & ;^NUCN/1A%?(7 W9!M<=L7&/C"?8P; M6&XO<(VQ4B)RG^B*T >'L%YI7+.^B $*-X9; ";4^61MT%F9OV M$_A./@N?$BX.^@]B&X$R@<_=:(&9BY$8370H$LL9+6ZA( M2$+>;G+&'(:K/'@?%-8_/K7H8+!(H#$?,AU)B+N%N&3"0U_O/O)6H-UP(^<& MTA<;:S[SD2T!Q6'@F;3Y"F]8FT4<%G_#UM%S$?\23J'8)>)#/%)A\@T['Y8> M]P@(G<_!M09OBCH6JD<'WLA_!IM)6+H3?BE#OP8O?/*/,QHST&?@.UG0Q95C MS[AR8WQ> V7"+H)1Y_'76!,"TNB=+(Q5L@G&.P=":\<>-]"^V C:8$>@LYMH M?O4.^>:P&X\^P[AAK3,!,'HP967C$#EID>',H)&_ ^1\ ."@K6?_A+=] FC\ MM-^Q[YO)U>_YL<,7>(&B?N9G#E^8EQ62&+>F:K?3WQ.LX8-)!_6X.XM T3SA MH(H@;'(9W4)K/X3OJ'!C/EF^SK/"ZCS9;7 M_8FXR-@\3[:WR4VQ,W-P7?GR0H)C%G^)"^!?+'L#D[0_\O-^>3;XM(-AA7Z#KS0TSNL*]<]B;\Q]OPCJMA<3GQ'[U- MOA ]RNTKJOA"\?7&V>QTA<,9W) -WAQ\W8&O?LOXO-?IC7J97W4[2LG/>^-^ MJ5_LZE1/[0S40M4K[L?4SDWN?=W]HRBF0[']6 U.$3C>OM$UV8DYR\?,D!S8??SR83?N/N"ELW@\(((> M!OM#["FM::\S&J8OM?R=\%MK;8QG,)XU:-J4GW@Y\?5G>[-;%^&^4FYX7(7\ MZ\?]S8^O'[Z_WCH/V>T^U O2V:[(^:SD?13YVP[?%O#,I&CWBU;D@X7IT*J4 MZ)$2_0PF5AUQ88YVNLQ%+]=6-;Z+\<_4ZOPSO*[2K< _RY#WR;RP/1?# M3LY]6$-WX"!?2ZW8U^IQ7VND2F?KO,BMVRI5L4MUC0*LPG&Z/KD=YQX59>1N MJGN4-;Z+<8\*EY'/=X_ZL*Q5X1X=Q2=^GB#55;M'O8K=HX$(18VD>W1>Y-9M ME:IGQ*E1 JQ17*E!]2OV#T:M00]VA0L7LTD8=KM4!N MW58I&3VJA7MT?7+;[QXUB#^M]0*(B;T\@H M%"=<2-$5Z==;7VI<1Z@J 5QCW]# M^(0W_7=(+M&AZ%IND3XY+"&"C> -B]P":!S #P#F'F_$.FWRSJ%_&?R3[XR: M^#>(&>POIBW(?]N.;]$VN:<6ON&_'9CI-GGO._#$1XN_Y;N_8O#9[Q2&S=ME M5IM\9L]@H,*VOD$'C-4*WAM\\,/V/=XX=NM_;/C!CR<#Q [^C*4)AHL%-<@[ MNMCFG&N8HL4X(C0PVA1Y' H HIZT$:+VKH,D#GZ@U7>V(/MUP5=UXZ2-\#-8 MH_X*N$^0#=B#+AFP'KB2:*(&1!,?! K#%>Y KHF,S>ZHB[4)1@?P3!CN:6@F M&F8R8,+L!']; 8,1T]#3J'8NK][]0[MF3 Y@GDQZGS<7L$PD7(19O FH%[D7'$I M.X@-/EA'%VOSCQU2YC<)5,(X-N1U7J1NJA*IU1MV[\&6JO,U2RORK( MGU'=X41S""2./=!IE&BJX!RISPE8?3DZ2NN9-I]WY]KNNW?=0Z\_GR, ]B'7 M-SLLDBAD5*KDE61GN#)VAMR"!H4/*$=X^T\970P[PV[M>0D+5;<@/>[M"6[N M>1B[%*U.M5EO%V2@CZA)> 6U!2^T1J R'E5GIEE!OJM:L.*@C'PJ\5CF1A'==B"62Y_2+.7 MC ?PLRF11_U+B3_&*)%7P<%)*A3,SPTRP\EY97Z":/$M'CH$+/;P_PX3/RQ0 MY?-WWUP3590\N\J(ICKL="=J-2$_T.C>_I#?&>*0:F<\JAOC,9?4_J8*D@MG MKN[*H'$!00[<6)+ KNBDIN?UC0^6:YT.XP5S2'>LD7(O1/MA;E@=P&Z23QO +R 9=HOLQ^M'AY M$G1@3HO6*Y^2G7I09E+*A_Z/N!-P!B']Y+Z>R'0A[],^WC%)PB= Z(N1(C:@ M9Y<.-"_; MAD68FQVV99B=87R>@Y/F.L$5>AHKW]$6U"WC;1QS-[XA1N"@Z_$-,@*3BHW M?A]#E-+]/RWCV7O#+SO?_,4<.\L^C%K3H%+O62_JSZSK7A=O)C?R]AG^5-6&5%H_H*?JHM\IAW&6&E-AT>M M^3+ V8A35AFZO!!#6["$3PE[JE%5N36IH"TK&0%+\ MLN>*@0Q:T_[@J%-6&01ITBFKC(5(@W.^4]9A:ZKTC[K84FU$Y+ACUKH>+#7] M]\WU 8^X&;OA.JE#]9R+^;T,?J[S**J,+QWD;J6K/Y_(V)MEI%S*: M62=PR3NKTAR=TB?)J3U_4I]DTD6?I"<3OYIRFBKW(#74]Y+N1ZJ6RYG6:U!:'7'8>I WEFMP>^O\\[JD:>I=3T9 M/_?O98Q37EF]PH!"3N&RDV\K>AA3.)JR4X8V&W&0*H.6TL:\=-"RCTD:DYH8 MF(L/6LK;JC*PL,,*U*4"P61P[$&J#&1>T$&JC'->B#DZTAJ]I$\RK&33(Y.[ MY+74*]Z#E'0_4FS?YW(_1N!^#&4B5\W]#WDM51J'YK0UW M,W[C=<;#4N>_)-Z;6/,X5M=8$)M8F/J\D'P0Y8)>R@,T(BT4[/)LLC0N!V"G=K3!>JP>)E[ZHH>N=@1K%Q?I"/B);[E,)@%+(?,^T5LAYB 2&S+ MPK;<[?)G$V-02)W,L MG8N_I2@TE\L;?B$0 EK&-/R)Q;#R;O!^G7?>MO#WKSODCK_43;\56\WX230+ MB3+6R9%&7PMT4<<"17=YBP:8.!!A_FMP"D$9'8K*"+QV"63&,> MM9 IGDYDDKAU2!B';>NZ;41_:"!#WV1?Y_=1T[$B[J'I_&C]\$ )\+.O\P^& M12T-1O>-.9Q6R-+83WC'.]/6?FTL*-AQ!G9U!6^#YEBK,79*X"D4>3#9G!)I M]#9E?D*3(*J)&Q'+SI MP1B*2(ZO%M'*)(K\@@1-NG+9F_ ?;W7#79ET_<:PN!SXC]XF7SA8I?>C^$+Q M]=LG0_<6;R:3SGC0PTA"L!L.7BR^53H@U]_2G_<&G4E?S?RJVU$R/]_95+?3 M'0]*-;7[\U[)EO9V:KRWJ9P(PMZ-PZ0Q@,6GYG8IUS M%\8J&787K MT&MA.K]OK\E%)%9]!?8K%CGW']^+[3UY)39=K]L$-1C< 2+:8\;/7)P;/_:T;P5YVDDX/6=)"1;9WZ(#R\"A4M#M>=/O)+X9AD]>JE7HZ@!L.PX#D! M'@_^(TI=V/DLQ%\D.,?^V%PM-_=_(3.7-OTO=T_V6VDQ%'6F6R4VMV25^R_BRBPL*(/ M[&8&EN37#9U#9]]0\XFN7335\2'"^+9$6EX:29,]_0U39@:C MFWXSTF1PA]XAJ37B ,-^B,5.4>V\@#$WC>EUR&#G7>T\R#$Z] M/M@]#)RM7&.U85)IPZ+LKL3!KKFN.A'MUG49>'P>XNP/A-E/=*I2J6:3;CK5 M[.AW?S+HS##!/K(B'1@W-==M;INF_<154N2,^4OH+D]I1!@D4R7CR;" #!#P M3>RC19"R$\_;C"50!LFIJ>RX=]3$!$+R8\$8IEWR)#E<$,6MKC >R-\(NP*V MG#$G^$H1(&QV]ARL+YVN6&/*I,\-)YWNJ)I,-:77&2B3RM+G^I5U2MV?'GB] M&6"-RBTJ&]8O&'UOE Q"PT5"FW4YF4^IQ6:7!**%0J/N@LQAV0F2IT^2]51% MXM-Y&C_986 C3F=V7CI^SWR *[9)PGE=K\Y1!*;G5BT^4IM#3,VN$H7-[CI?7IC>?&D"ERN"J1N.E>C M DJ=5*!*WZ7V"YTXERZ+!J^4&GZG4#4>^DLHIK@;Y:FNJ]C,N[9^'(*A* M'U."1E52*;6'@(9?6/;^3\MX]M[,C6>FW_S%'#L+3+W6E%_Z5=_6!$]7M6<0 MIM3<1.$/LJ=%G:2FJT8JF:V4:H1G'>LRZM&O3#WJXVQ+3,4PEP, M6M/AI7$+-R*ZED\S+,-LC5TR#PZS2;,7,WN%TP'+;4V&F)UZB?4:)&94I7!V M9CG,C+)SCIJ_3-;>E,I 3D'D%T[%*X?\,3J(,HYSF9@IG/=831QG(N,X9[>D MH?\IXSG%5.2XP]%]>V^UBT[%T:95.J*UQ,UQ)XI[<:.TII.,RK+2&6U(*/Q* MO OUN*/%O2J@5E(2K89>Z7'$(DU'S''GBGL1TVM-QQG7;;*R?[?N]4D>G.;S MX!1,C?Z2>X_FFF+RM2?#J7T'+Y*MI^H3JPLW>,WP;$][8G4M'N]QR1^[8K!J M'V.PZ7);S?=V)694];CDCIV8&6!P*>WORCBKC+/64@V..^S?N_7CM4J/-I\R MSEI+W!QWX+\7-UCFLC:)(@6XS++^3I,6X>@,=:PIP\FX/YO/)WUU,J>#'NMJ ML[DR'_=5;3S[MX('OSMI'/A56?4\#!JIG;LJ=NX>(TJ_0\KQC630XF%+:5X1 M=2R@![)D^JT7?(8-)ME&;C7-7_HF#Q^(A2#Q"E[%(SU1 92.X6J)O7@?X=\. MVA1UDC&\27IX._B2 E%D"$B]& (6;5.VCM?PFXF:?)PK\2IY3WIJ9Z!6Q'O2 M[0PFU94-JXCW1':J.$-,;]2K8:?&^U]^3-4W\ Z."7W7CQBE5$6D)A#^C#H# M6?3M "!\0Y\AX-$3+LPWV_5N.(7B^^7*M-><+O =L]C<..Y$1%:#RYD+K)Y- ML'PV+\-X($&/%';!TGN/U##1B;J9___VWK2Y;21+%/TK"(^K0YZ@8(([[1E' MR+)JRY99<5>]^F@"!)(DV"+"Q2&;_^G?.R4PL)+B*(@$R;]RIEDDPD7GR M[*L?7#[@2.:TI[P"_4N"7L:6KF5LZ7MFL':FY[BZA)?$_S6VZP4:D&\T;DR> M<-NT8K>4[(YI1MH7,[#&LH'<0B.]=8?>#%M.M(/,AH8'-+4DB@)G$).E_]W_ZGL4>O=!=\7. MP[Q=6X$GLUE'#_@>1IILS.C*V)])T5W5Z6X[LEM3W/)RU&8 M;7TWIX"!XKF M2H)]BN;6T]R::IE]T=S&)6?-QKY[HRAR+ EBGB44&S^&+AS+7(!I_!SWP;, M&+(@ -1XF8EHG86X5]&N"L:4X15?-O6"G(&!&3)< ,C >)//=5!YX(O4WUQ3 M^;@J0:=X7"T.D;H;TKC-S77?=MG:+:C4\?VBV9IRR6>AV2(Z81IM4Y4AG"@N MK2E=.1#+ZBJ6534TVTXQ;NYC:O4.S*N'N=R+/3,VUX85/I60;:U)_M\S#O5! M -:?7Q!0KIJJ\EM/5Q.<54L3+,5=,5N+?%@^TEQ*I]_9'CF3(IEU]L@\%7P. M_,D&]03"K/U&5NT.TKY55XW+JX9W6TK[-1;*?A%O$<$,+)S>@P],X56Y^-D: M8^58_&SOP4:%=R7C9VN*]5^:GS71BEEL>Z;X6;7Q:HT9\])8U<)^DHM^O8-C MU6EU&"O&"S1:>"7ICXC)+,1>BZB86 X*A'9 M[65NVB8>S>UZL37A*+8?8RMEB57''L&E=J=VM\EPJ?-J/?S@_-Q3X^%RYPBI MCL2J(W'5[T)U)#X@L%5'8M61^)PO074DWC",_8E9;#( ^(BFQ$T5RE9NC97^ MQ(5.C0=W;+15*%O1W=G1W=$[,K8[6.ZSV)U8T9VBNRK1W59DUUI3-G3X6L([?@)S_]6'9KW< M622J+['J2WR*-4^-5BF:?';VU_:KF/#*7G1W\FBVIDO.?MLR=HQ7'UK-O576 M*5PJ%RXM:"Q'85G[2SY7:%9&O;C16J@Q.DA?XDZ3*HR>TZ)0(50)^=9!._-W M,$6XJ+NU:DS\H@BA&A._M$%RI$:>G?VU]E(-%\LI[H_;R+.#LU0:9>BYJ!#K MH.;*L1C:WJ.-"N]*QM".VT.VTWOUH:4Z$Y\<7AVW?W\'>V9U]Q$LJEI(Z!B( MH5H3'R^ZLM_&F]V]1UB.G^.P)[_3&:/G,Z(RN[4\[!JO/C0-O:UP4.'@\Z,Y M>V:1>X_H*/0L(WH>(0JT([-LTL#VY[B$%"*6&!$/%#W:$?E:V!A[7P&D$F7F M5;NJ@U72W MO^=6T\>@;'(1OJ6C)YG7[4HA5R>2=Q?JZ%WL>!T ML1KUR;&CL=36,C\4AZVG/S$'<*XX6OZ3B1F,'(^@T"EJQ7=XK&W@%AO&7.9Z MYK_CI,OWU!RQRT' S!^7YA V^\YTG\Q9B'>0/2*<;PZDVT,#FRTZPYD QP?J M^UJTQ;E[EGC=Z%\:KY9_V[ML%&XDQ=[WFVR-4"Y%!L)ON#'7G(;LG?SCO>V$ M4]>+-XFL=OGJ[^'FSH7>Z1N%7 M=;WX\V5+&76]U>IOM=3RSYN]UKXVU>ZWU:8VV%13;W:;)=Q4;_7+5>/TC'[Q M?1PP-M\ZW9UIC8(FH!L"3C5(KV"?7-4@O3QWH1JD'Q#8JD&Z:I!^SI>P58-T M;1M]X-1R::ZF@>,6*D:J2]Y>#E]N3]QV:: 'BJLM>.!Z]5L"*Y4R"Y M+5.OCQ[8ZO%IWWLHRB\-X6VG/RF25"29(\FCSPCI-5 >GM*,$$61BB*?09%' MGQ[2:[[ZT.R5>QRQ(DE%D@=KJ'[TFHD>UF[URRTDS[ZC>O4:JFL7#=51?:U M;J^9*W28]L2]_?4K5-UD2XEF!^TGV^N\^M JFM&A<*FZ%-TD%;7 MO2[:\GOH;Z#PJ5R\Z:#3'GJ]5Q^ZI6EUK5!IGZBT)NJV9T3J@Y#K%IA-JFGZ MBR*$:IK^TC;'D7H,]_?7=%#U@BVGXGC<;K!]'/2T#S^7PJMR\;-R#H'H[Z]# MH,*[4N+=06= ;(YW385W5<.[K>3H&C/GI:5HJR125+54W]3L/]L^F,\*K^RW M7W!_[R&6X^<_J#:M1PS+[-:HM=]Y]:'9?GZ&N,+!$N/@$<(Y.V+COD(Z"@_+ MB(<'"P/MB'U[#04I%*PZ"CXC?+0C O9I\OR^\B1*E'Y7[5+/I2TP5/KN&:3O M;B>UU@RD>:FL7=BJ*O54-'>>-'>D9N2P5>/5!Z.HP:$B.D5TE2.Z+=T$"^KQ M@0M58--4S;EHL)6H4$41GB*\?1/>L1L;P*:;-(BSH2A/4=[Y4-ZB1_+PA-<" MA;-3B=I,N0,)[S:0U7Y]E]MU92MH&O[A>J _$!@:TZ$*L.Q.=\"5MU(#[G!L2_F5YL!C/-4('I M\W1>;.#"?15L%IA7-G27-+717/!C-=7#N?5O1G**YZM/<=N&QSD*) MS^&]])3&ODA])7+2*\)3A+=OPELH7CH\X?5>?>B4O'6IHCQ%>?NEO.:Q6P;# MGOM >-UR=_%6/8-5S^!3+%-J=-;TNSE(SV"C;NRO7UR0C3D! MGW!\4K.@&E@ATRD@TYI"J7TC4Z.XLESATBG@TIH"H'WC$A]9HY#I%)%I(;G^ M95&I!7:3H9H&'QHC5-/@ES8ZCM/L$"AJ?WVU5+?#,GJ[UIHA+]OO$# ,8ZM% MTTQ4W^#28=9>39*CL;2N8FFGC7AK[)>C(5Y/(5[5$&\K6;K&V'EQ2=HOBR15 MO8,W-?_/MAO^T=;-0;>P^U'#_?84_NJ3/&ST,WS 0\Q/Y'^PO1*"2L M/A(^(ZRS*Q+N-;2C<+#Z./B,<-"N.+C?D)!"PJHCX3/"2+NB8.O5A_;^0DDE MRL.K>)GF\YL'\Z,4=1)1F;Y[@,[I<)TCMA]NO$25YW.OMMSY^8JL%5F7O<-Q MH_,2'8X572NZ/E&ZKEP3Y49WOTV4%6TKVE:T78X^S8W>GOLT*^)6Q*V(NQ2M MH!O]/;>"/@9MDR_P+9U=)EO#?^2.)V8P[++;BVF+:QJIB6F-U->V+;'HSF'&LA^4B\Z?F3*: JYH_U"Z<-]KK MK0AO=[\Z=C'%)J;4P_17T_&6UVPLR5=JTHBM_@+%R<:]U*QVJ^,\8][O'HYC M%,^[3(Y#Z,4+(RQL 3O$%K!C:@&+R2H:[ [^+V",#AXZ/[6)3WV;F>C;[#&M M62?7=ZL&JX539B&ZNK,:_>+".=#UB\:>LJ]GIJVG!-Q5X(3 R#[% 7)FREQ; M!K5&29!@KX=JOOK06'6H#"H,19=42W9)C3)=4LVT2^HS443/U^!40"PTWFC: M$CZW%3X\8^[HMDPAFW+FQ9-+VX\NQ;L+T:3UZD-_:5NYG0G@&<'2ESYP&PRH MI2.!]\8GTPCA2AK 72#D'"^F$Q5]DJ$3@9VMAMY%O6!1:WAR[&@L_=&9'PI- ML)[^Q!R TA='RW^2H,].XV>973ZO=9@..RW M&OVAV6ZRNC48&L->JV'U!O]GH(],_&J<##:9FB-V.0B8^>/2',(1WYGNDSD+ M4:W- @:@,G<1V\,PS]<^4!/\HH,5+V8T#L(E%ZYDH;\SUP2_WWSAY-/0^?\N M_O>+Z0%P48I0EFOW?:A]>Z[]CW;B>0S M]RR,W8@>N9NR@%?C;B)55D+_T"A\ZP'O@(/^,S8#P#)@%?=L"J8CJ%"N"]QB MR% *H\3Q-816H_[^B=7H+^.]_,2/ _D)0D9\&H?R0UH&5_AG[-C,O0NBL0_0 M#.!%9@)/!V 9QH/0L1TS<%A8(*$WI"=4I"N$LI_C* Z8]@> .8A QD1P>((( MJ&!/9F!?_N[[/T#%TAXBD /Y%O%50;/O13A&%I[8* Y.@3#W^%_1AS![E%F3[0KKB\9_7Z[ MAD_2=XWNE5PD\V-XE)L1R6/&C7SLYB>O=,"'=.W[F(4LLU?-#% 4S]*/Y$%! M&H.NP>@ 9J0!2#P_@L<"QXH *@"CR _0N*YICO3CU+1!'-%SKC-QN!Y0TP2J M9-\:@[0/M&\ 8NVVIMW"QRCU!61?D.5E*=_U+5)5F!NR)SRJ/&_ 1G"Q=%UQ M ."83%B +\"#1FR480,^->4'F,!"(\?21C[H;37QLQ"PSGR$94+X'>R+%(T0 M%[$!O8.9-@U\TF_$+]A/_ =L*$AW[B<[UT!Y&B9'E=H(O_4A)\JI"T@/:PW^ MQ94F^%MN#?_FZXO5B(G!:3SZIZ[]!;CJQ^+>\.B(.J@ZCGRZ5_SGDQ_8"?I/ MS-D\9WT"'7#A,S]V[?D/PW'1IQ,DP?D/^:;G/S5AVY8SA:/-?S-@KL,>%SYF MP$\F!8\CR.8_([ L[ ZO=N'7@?^O@MT)H"_ AU_3_*="9V7R8[CG$"[!-0,. M<+HX0(E08@%>A<=&A$Z((V%LC35@51/ZEJ,D(.W4#-"72-\X'K#.T8R(G1^/ MJ^@@X#QDM-IR9J9K#[C^',= 3QJ@/V=N!/,AQZD9^7W"@<76GKV9=P#%Z12. M!7+ 8X!6&O'%N<>@!7 QQT+-F,[(?>^2^;FF@-X#7P"T:D4L#_%\"0 M& -F[P 8(&WE?8;]3DPK\!F0D3]QK)HV8O[4=YV(BR;0,7ZP".52""(M)*!/ MIBQRB'I@D;=P1N!R6,;I T\6-Z69 'LKDC) _AH6APW"@6<9H2;@+0#KL1TKH6M*Y0T7GM+/4:L2R\WO.KL[Y.B@ MO8*RZH4<*[/?*,.9E6KYJZN)^M=YCBT$R),3,A0\ M%IL2TP[8OV,', $OQ36?-G)(ELMPNO #0 M*!C!OQ&3X5U/')* E4]/^K_)@D:!Y>M ZS7$I- GC@!O-D/?@[50#T97HD47 M0NXCKM*@OA:@L@MG9"[@:.![R-110#LNX"+:5Z06QX'GA&.NTI!E='.M:Y]) M;CH3HG7\7]@3(]:#'"NS5TXX2 X><_%(.4D(_TXWDL&AC*-3"">X_YF>,4>R M$JIP 6EE9'Z/9PU 08&;1L" ,!4LE$2FA5H@02G2QE$T#=^]?>L$\V!^R[6/ M' =,3#K.<.#?'K\'I__$SX(RWE\BM\A:67=) MG/^F$@E>!CL+X33(:J8H]I;RX-T=+LU*.5SN'EGPZ+"GRO$FY*N/#IGL#NFS MIOU(A4"V8XX\G[1._'CJ/Z'P N/;=.&J4>.-N;S_BU!'6,9!!"()I: SF<2> M#SH%4#+BS\1W26< ,8I6'JJ;%NP&.040-9LX9&OCDQ2<&\:TI0EJ-;!G8@JF M,R$+ ]1D\O3 8DY$1I%8RC&%]@MJJL/9H@\;=J>:!7PL0A,H0K[%SY!8&#H) MEY'K#SCM!Z94@YE0EJ5K =DA6EEB!^1 @-N#15 7!?T6=,\)6..H/WF:T:RC M[>!%@?2^P.R$\A_!&NO9$J M4BK"^(L)BWC>M/#!7IJ.A8@CWDM(17OFT"-7(MV49L\\V)R5:*RH.:,%FUD' M10QI=7 E3_#O,>*ZN,V:8,QQ('0 DKXA&TV$8H^W^I5LS2M 0MA43;OY_IB]^^W9UK5W\9B)4R4\7.B:8+[2Q-]S[,$F$H?!M$;:- MI+(!D@T?X]9!(@J*MBA-AJR&+ PCBI+JTB0">'.S+6+BO* !QRPUG*65GEP% M!FC!;/[=' "*?L]PC2\)U_CF@_!#V%^;@IB_)'SH4TIS^\/.I=6IAT+;S\+U MM"YQX44RJS;5A_V(>"E=<(B1=%0SN=IB&+\@4;TV:LU63Z^G.2JA\):EJDD( M^J\<&2&P9 K_"+09,P-TH#AP>[![S0Z :WFX^B-\8 X%X ;&03-5ETCF/V!EJ8V#.)B8(#,U'G[OOTL0)HUY'^Q:$Z121+Y0J-V#% M$Y IKL %3G)^"]8"G6H,$$+WC^\AW^5ZG/](0C><8.3,BR<#^">\0VXQ:Q!( M][TX5O&)-L,.SB3F8OQBLQF%>MEK4 5&L0=/H6PVI_#%3_+KPHI&ZQ=:OM'\ M16XUCPYK8GWP,H/@"-, I.?9,: M0>5$ZJVG?6:#@&8 /3X$YTC6^?1(M0GA!0EN-@$ MES"!2Z(IZ=J#D++ZN__^]SOMSYO[AYO;JV,-G%F9([LR M1?9O_V5T6^^/R&@]$^ ?LSB6@4Z02) M^H#FMQ-F, +C8J31+*4KE9[T(=,18B$]J8*)1J5BCSR809Z]I;P-N2"JVSE. M^-<8J8"4#)\[XG*LCCPSJUDF,4DB !GGS%K:W+AWR&S/&KQ(H;0BCZ2CTL+# M8V@Q.SRG=G,MRS[@5#( M9E/FD0]3Q#)L4.U8DX*#3@)#=H-WX3PG&G#_\(FT%]4T^PXDQO" )5'Y"85P1@R$3Q^LJQV M:SLA&BDYG7OHQI2\P:8U[?[A3VYUW_UY^^G2Z),;_8D!/#!>Y5&"A@CQ9H.[ M(L=%Q'DQXE(K,%I,P84*)+X)%>+YWF06IP*-% P+3DC-\",",?"7B MF =VG47,"[,M +W(PI+63W8)0$LPPZ+YB)N9,:22B']ZI_"7L$;E9:4HP@.1 MB$_SV,+U%3*M>,1$'C[Q_&0/RI_):4'1;"I<2N1 A)<\FB[&?FSNNB,?",*4 M^^A0!:@>AGP4@>B<1XUYCT[@>Y1X H(J,8.3^#_/NW*!ABXQ2R:K")(&&$F+ M/LM]$!N)D1232ZZ/0;X=Z47$TR)!L4 M/Z:+*].6 TZ;6EWE%L18B)B#.^;3Y)[\H,?EU0-P-#)ZP#:\_RH$\SG(2<$:@R3Z9C\()@K^3=S,GW_"?:.&0YIL0U>*J;QIM>:8Z^2;P#^ M2N<@;E?:%N*6A$618;=8XXE/8GB/OA4Q,M<$V3(6\;7,M2<+8@Y&\NL5!T7B M)(:4)A7ZI"NA3]+AJ3VV2FI(T#%EC$?V3(PZ.:63QB)FB0 M>+=)S\3,-([A"8'RFQ2Z0?7X$U>D,[=.?%MXODB2)?J0U'\H[VM;X39@(G.) M^SSQ-8ML+\<8.;YL(UED"F$.=7&C0Q]8#5+ -(AMGG!#@8Z%+*HYKI9PLP4@ MD!SC\>[$+TLA?0S0D\:&J((UX@ !1NRQF".*2+6,GNQN.[2-2CG_'L3-@H2J M',W<2_I(**'8)YQ+$ZV)NK)L.F>&(FHK-2DX&>CSH!3R!'+0N_>D3VE_3[+E M4>\+%D[F>/!6YOW'3,]%+BK4 I$P\#D,/B"^T_]2HAN*-! ]H$.22E*3";FI M18(<6F@T0#>9"@0X%(O6GGM.:E':QM7]P^6U_^=E0P,F$O,L6MJKS%I>@*[0 M6$PKC5DD$)!!.![RWYTL6Y4BRPW+L38\?*=T)42TXCO0GUW'V@@<'!LJQZ+R M6=X\0"V"B>%<] G%<2[ O'5-^$+P[-TZ>*5M3-YO D$18)>>96IT I!TS6G( MWLD_WMM."%KM[)WC$3SH1^_S+RR(*] +^=>I+U:O6?-WNMT]U43V_5MX/YF0*JE)N"VS.* MOY$KK>E#OK+UO=%>>*Z@]1>/+1VFRU5OG0RN<]Z-;/<+9[.HW=XV.^;%)Q1A >F<(ODG7&@05M1>;].67^6^Y9PNL9=C%Q+! M"<)M^= "!;:E8/M%NUX]8&]#IGIR@%%TJ.CPV'1XH+DS +LC=3#%U.T=>W^> M=6/;:O>M;;9;>N-9TQ@JW;-986YU,;=CZ*T3Q-R-!N0]'XO+=Z$7C5U[3^_[ M(H]S_E\V4=$.P@//G0U6C!-V#4,W]LP)2\(,%0J?"0HW&Z>*PN!J&WE$D6]++,?I;>X[5Y1Q*V!WA8LK 4T\^2I=KHK23>EUP MXJH@M='=U4E0,3] %2^GN7,@45W.RZO7V_MB*B\+%%JL5>'J3;VK:+:PN'Q:DPU)-W81?V(STS'W9KZZ0:9=0?Z&HZRM]2UJNY:/25 M UNAQ:+'0OFO2WLW774W9;V;BV;K_-CIR?NN\]T==LP-2ALT:+8?8_<%R@]2 M^?S/!4VY2:73[.KU9R4(/@LZY4Y_531QGC31:3\S:;:*-+&-9_'%Z*-\R'"Q MA<9T3"0H@Z:E.+/BS"]K6_*!26?'FQ55**I8115MPWAFM7D5J4)I+$N24K:/ MH9ZMRD+.H;?4.;)"S3X_Y_IU+O3IY)P@G8.X=!8A#B$D#T R@I#:^[XF"RC] M3 [46S6+4*<9E'T M@AJU&7:H^;$_'&('X<%,3DUP<*0U]KW'5JC)#WC?9#&CDZ9^C\3X>=\+XPFB MP$*K;NH0G#V87CQP:_'8QF['IF&RZ0"W%:/@LC.^TA?CGO,#0>76X-^O,=$S MN=8G,Y13(]-M !#Y)++,6)-_QH[UX\^8-US6KKS( < E(PF*[L'TDA$CN"$^ M:12%P'8B ME_$A$D]F(+K4FS@5+K")0\UR0UT])LMGD6;>/+&>B41%DL%V(X(BQ/@WU 94A%7P;H^S%Y=I<8G8I+##%H!F!]\W/*O/!$QJV$ M\00Q\C]X\Z4;$\*3@I. M9P"GSNJ5GC.'IF&4;?I*5V\?:1)-=6&A9M'L5H]2^FD%FR* &H^Q*^1^X1%( M?T@.-X,*!Q/]KVA/'<\(HH(0+-;7IW&;?&+W>24YMVB%3]C1R M81M]O5VJ^RQ#SNOA"A(4*ZPN*^SV]SXY1+'"8[+"CMXOU7V>.RL\=VY8,8;8 M[#?V3D"*)QY=/2R7C%,\4?'$*O'$GK%W^TKQQ"/SQ';)7"!EX(DGWZ+WGH7, M#*PQ^45M]LAGH=IKE_5N^D>Y M&D6W5< -PVAO;4 HPCV8P#U&(V=%N%7 #:.Q_5@R1;@'(]QC7$T9"/?D,YGF M:^H7:F3/;'9EV]@U*%,Q'V,%[Z9WE*FB96!#"CZF^Y1AE4K:@ MQ Y8YS;_MEG?VE!7_L(#W4WK*%=3!O:C<&-M.ICR\Y?V;K8WQ13=G@MNM)LJ ML%[6NVEM/<)*T>VYX ;0K=*32WHWYRMO3SZN_JOOVT^.ZU*+@9M'6V Q& M"UU 3MP5];?_ZC6,QOOJ>PJ?AYWENYBO;[\HE[="987*YXC*1JW;VEXQ5*BL M4+ET$%-U+XJVO4MK?O"U1"A\/S\+)\M[*K7#E?YTS] M%/S="HW/'8T5.R[CK2@\WMIB/4J,2Z'QRZKX57/KWT5C%A1,XSLSIWY_ZZXV M);2W3_-J=FZ@5OF8HL*-M;K@4=+"%=EN9&T>PQFOR+8*N&%TE;@M[=T73WY?.>=]KV?HKSM" X_PW]K7MU^T M2^VK'VD39GIP \/879Q?[]C_^\II]"RCT^^U!L-AO]7H#\UVD]6MP= 8]EH- MJS?X/_CVU>JS&XV#'#Z]0%KQG1/!ZZP-X)','_N2FS]VE1LWIMW,.R>.?MOK M,39_O/QXM?PTM<3WH@W]0(O&#/X/ATU/?!JQS'#$LI8;-ZDYGA4P,X3/!S/M M==*K7TPIKFFP3ELW?JEID:^]IME=NG4^NL_>GM+.W9#>50^!E MKOPL]'6]9]84("S=#P_CD+'AD59 M\.A8+-1/][;6,)C\7?5DIY/L7743)D-M9>=E 5:R'OVV-N4Z[8ISG?D^A;=I MG\*K?)_"JB#RVLZ+VI,9 ILP,N(-D>(UM4Q:0#S.G/"!U8A?TP(63IF%4MF= MU?B2[8Q\E2]I%&#WRI>D4Y7S[UC.8P0\6@V]BQ.(IW[H(#3>45\+^.W[)\>. MQL*,R?Z0VU/OZNE/S$'HNW&T_"?+T8"/6CX2%C3:>>AD_[L-??<2^AX'\@Q3 M<\0N!\#E?ER:0SCB.]-],FQCF2>D##4(N.E@UF4^VY\J] MZ+ERG>NY4A6FL[1[C 9BB('F7)_G-ECWO5]FDY.;\AW]/?$:[3O\5!H/*('Y MZ396X5 2FP%\#+(Y+[RE5$>NO"#&Y1M#_LJ,-$^@3+G (:@ )K!]TX7?^L,A M)@R#_B&5$?%S+XQ=,J2XL;&SU.\9%9?Z217E;9I4?9U/JJX*Y7V* [S1]9II M#4@1+AB.Z@P=^-+4HL 9C1C]'/1= $' _AT[ ;>T46^ [R;:J*#B%!6),*0_ MD0+\.(#?3E'O@-_&GH.6[!7HFDA#@'+TZH!9_LB#D^&K/=^[M,QP7+@Z1VG4 M75X;>E<;S!'P5WC/6+N:P.XL<^Z].O#1(2B^0#JW$9MH1DW#.HY&_?UGQS,] M"PA$>XB B__BOZVINYRS7#U MZ5*5;H[DIX$_="(M!"IB.2<32M/??!"_VL/05M 9_ W+8$![]>F7@L=SJ EQ,7.2DHE2).QB-["F8/(4'@H;$2BLK M1HAN>W69K[]7_M#LS NP;E/V$]P3F]A56/=U[:,?!/X3X'SX,OIGOU-Q0N L MN*I4D#E" 0G(^1,Y[$S&O^Z5"HQYVN*T(5-(7\"3$O*@QX(W9)WPO Z8#<+S M:@0[X!8I_-?F!BECX2&H;>=0+<"D,N16+(=O/QHL'+^A / MT'NJ?9:G0YZ&JWQ$9^]-X(>2&5YYD7-Y-8A#PG[-=9DCH$.- M?@ \%-/8\+[(DP'W!-<>T<]"6!?^1(-#O [X)7SDI>_+OZ>6,6L0"80CF061 M"?\;QH/0L1W8!WSN^9%XI;AH>*W8&YTXQ-1 )QP3CX:K?S3=F".8Z;K^$S!E M=&+?_\V<3-]_TBSB[SQ:C6@';(- )3XO]G;+!]E/"\XT8G++N,BOKC\ ,&:\ M>K_[3Y=XAYR952]AX?-&^0A;,(!Z+Y.#MA4;J_4[1FI@;\L$VGH[PP/6J!+X M2/8X$S_F^%1P*M2?$"U!8 .(X?:W.=0SN%I=[ZX^T %8VG*_>H8) -. #<7P M9B0(4NO@]=,XF/HA*E%;W,D+<#0@ZH-RGXWX1#'G>0G.FV>%M2(VF&./LRH[H[",[HE%OJ^R([:^DV*9X8",BSGMBM94R*VC_?S'!K9@6 X\,A"(X M8OXH,*=C+-IP9Y<#R@SD,4LLE=!"?NSP73ZL6=-NOMQ<$7U?C\%DU;6[./$Q M^QXQPM^1,R9Q4'STMV]7U]K%;R8>G[35T#&U;Z;E#!WK#3$?9Y((PY2WRCUD M!4-$Z0*.30R\8+\\%YL+3C=&F0![$38VN3)T83Q7[B+1/?&#S> \-L 5&+* MRQ-I]0Y\0.0!Y?1TML(B^]^!+@;8+Y"#&\2KAOM^]@)L8(GC!$E0Q"RH16'(4N2 M94/43D#<8_I#Y,+G E<%NT&=X"ZAKFUQ5UWL\R_VRD9 P<7S G:$5QZ+G&L,G\$.00K3-Z !2KQ EL6XYL<(*2C%QZG:[?T3M,-N8()?-WAV6# YZW8Y8M)536S'6"7B(*/<]4?TP#%Q 06 M_@MM"M=AJ$DCVXDRF)TYZC!V>7[8(^BVR*,P20 LGAE^"J]S9__A9R1AY,Y( M(P6MTR;1@<>RT.P9B AC3?!QROV)!,5PT+J8"U_CX@ NPHM \S6M &TG"F,* M?^T4;"14Z6SN//%32&=!RD7C-O"8OW^Q#Z+8KZ!]9XVXPDA23?LH;#2R0W*& M'L_UAZU;CK &/+(ITP1JPAG7 76-M/@+YTURJUXN&BG6]1,?O@9&R"3DGO4+ M!WZ'EIC%-YY= M.@:@"8.(P1$T'*4R2 ?IU*Y*R838[-W51<-ME^3FI+\860 M%7CL>R,?=UJ([+M[S%NZ)G4W,J 2A0>N(_&69SWI)AGPL*3K)$GJFU$Y;.[W M)3;[SL&O1KU7<6]\3G&LGKJ5%^B\W#2/#(@T^:0_"@YMH8$)R[4).]H$#@+K MI-4; #UAN;9K3D/V3O[Q'G2,J6O.WCD>G8I^]#[_0C3KYGN,X0OYUZG%I]>Y MU2=:G(DWBZ]U^.KMXN>-OMZI&X5?U?7BSY[J9[> M*=V>2@FH4FZJIW?KJU=:TVAP94<+H[WP7$'/"N[W.DPCA]XZSTN=&[SHJ/C" M_;LWZ-_=H!_+24+BP?FY' X;HL:&K2:/>>9M\VU9FF]U^84.WTD'B]0L=OMR= MW9KMNNPQ\S+G/U+S086Y)X^YW=ZNO:A+C;G;M,U\!A:7[T(O>@N6Z9$NL@Q- M-H_) \^=#5:,$W9[K:TGVVP+@JJ)<87"E4)AS"K?L9URV5'X?.6YH03Z<[P) MN\VN/>J)Y\+YSYFS=FH,N^B(Y49?H[O]>/?R#,Q3N%8M7.ML/06E/+BVD8BO M[MS,"V-S.;Z/2RF#M%8U%XO^3M7AR:L:;U0NYVR=NXR1);WZVI7=_]>?OITNAK(Q_(W>/%,D]F M4##+0Q14G?45SQ> 4",T\CSL0,)/8\<:9\:RA"Z^"<":NWVR-;>F[=. +&FY MSR,>4EY>B'@66^4O):>:9F(G9=XO%7=@^0$VG_,]F]?H89MS:K'!7'HK=GII M9EIPO231;5B/9E2GN7YQ/1IV+J@<86Q8AD9=&53UF:H^4]5G9094*3>EJL]4 M]9FJ/E/59Z4I;CEY@*JJ%U5]5F4"/16X*3I4U6>J^DS5\&QVZIZABL\4XE81 M<>M[3U;:YZN;A0&3("5/&.*M[9E'@Z[:T3Q2M2O*-0^%Q0V#A5%#Y; MF=Y0,EV5H*D2M"HG2AN&'(E9P3QIA6I50K6VJC\KZ]481OL(5U,&@:VXT)EQ MH49+WU9M+0\;4JA6)50S&OHQV*J2>!O<3?\86F\9!-X)U:%A;'/G&A99A;"L MA@7C3Z=?PE((5_(V/Z^$A;Q]VY6PU(HK5O+U(K^; UY/\#V 4P]CFB7^A=F. M!4=+SE&]>R@NTC+2L >)NFW!7!<0]VVS[?0^@ MJGXN@RH_.AXGK!@S--K=K1N"5Z3\2*'PN:"PJJ [-9F^;1;BZX=J5$R\H,(XQR+$, EMQH3/C0IUZAJ5@Q67Y:$+^YE5*>T7+,L[L>H[M.N?/>2P7E!'M-?R MNQSDJ5 $7^' 'JQ(&P;^1+,H;8?R6U>7!%7QDE 7?1Y)H(JQRZRU(US0IC5; MW8K7;-T!A(+*X>>&-5MT.%6SI6JV5,U6J0%5RDVIFBU5LZ5JME3-5FE*0DX> MH*I61-5L59E 3P5NB@Y5S9:JV5*E+YMVWMR^RVL5:E\4YIX#YI8K*5AE>*NJ M+56U=2*LL&+H3Z@(BA\MC*]7*9%&62ZJMI2F<65 MRBQNMK:>BUZ>S&*%:I5"M8X:?%;6N[GH+,2-7_12RB"K%0,Z,P;4Z2A95Z+K M.&54:_MF*HE:60/WN_#MV;">:$02NS2D63VGW+/3CP,ID-%4&!T,LRD5T MXCJ(Q"DZWB=FL(K0V(+G!4QQK.<*1Q>'!W7<1/H6+X7.H3<\#$B("^H M0G7E'$NJNH;>,O94_V+H?6/;.I<7+\IIZ-W^ZI>K*H=*I:ANFQ&]80)OI6 @ M^9\F6=\Q\G6!^1W)6+LVPS') 0O_8,#:'TT7+DGE[9Y?]F.]JYFS,_&W,/E)5Q/-'QQ0Q^,*&9,RL.G,C![D#P5P "9*DZ<9K^W;_] M5Z]A--XK]WLYKZ?5VSJ5=4]W<_(:Y!(VX/G>Y7-800$8*H)KN[&"XFLO>V9I M!:^GNVM2>TD4 @[E9IE9 @_QH$596[ KR=B<%/&,;3GS>>KMVQV^W*2XB\6Y M;8^+,J;-*,RM/.9V6[LV1RZ1Q5DU5?-J KN/-//1=%P2'I&O 3@#_TF#4S$> M!;UGC[[[B%'CZX#93J1]-BW'=:+9,UP#(&TUVX_QE2=/IEN>OMQTVFZV]N#3 M7 6 \CLU%?)6%'F[O>[6"9TOC[PG[]?\RP]^H/BP1.*'XUEN;/-/E@3+EALU M2_VA&ZH)::)$[A+/E+SW"IMR$W^KOGU,8Y_@*;?II,CB7,FBVWFFX75XLE@C M,67:FN=[;#D5O>13U=A@Y8H(EN5=UK0GIHU-6WM-#K DC]?QM*7I.#7-A,>S M T22+&J:8U"9N:'@G[KZ4_,0>B[<;3\)\L1A.>C'0D_ M&KT\=++_'0=I-MV(70[@JG]'F(] +H^2]F"5W=M( :./K0OP=Q"$L [MKLD;G^%,D$ M'@)$)"U>U_YBVH"Y#GQ+F=%^,#(]YS^$^I@>'05(4#A6@D9*:$!!Z(OR@"K# MT QF0''LIS,@/Q1ZK28^+#0$&87/ <&-QGX"T]R1C_(B$U M>-_3G(GB,69O5AQ1]O$CG]@@DBGW KZ5R[='GBM\CU? $8GGRF1Y$@G RANU M;KLN75.2I7]GP43[W3Z-G7MBOM$.8)MX P%>8+,!/ = MRSOP 9=%\ 'MS^+/PE^OC6;F_;BKUXUV]B/N?H7?PP_C*(S@$?A'C=>YD/\'0@N6"$"GK&E?]2N]1M+:!E8/B!20 ME-1 ..#ZO,30G/"Z'UQ\'@%YZ56R)2UDR JUB?G3F<03[1K0$R,1)-I_!S87 MP,K:/1*@=F$B7QP"&/!PA:N_28J0S.D4*)V\(!-03V*N#U]G&-X[BD"[HIEX"8O+%RFT5ZQ3*MHF?E$V<>E0N9WFQ^ZQ*#)CZ\-&"HFHD:66!-J'"B%,S_A@MF*B&%K="CCNE9\)$3 MC7E)DN/!!PZF(\ QX&_$^NP[]FZ M0YUD.6!#;ZPIEZMV.2!NZN7F8?6K64YV+D.@;K<<_G0:,SW4")D]CY Y^92E MKRSBCM.+."0=-GB#GJA'!Y41L K3'A>I#J!*+\^M@.VBW].W:(:HJB[+=7WG MB;1&N[=U;U55=;DW@2+EB3"&5XN0$R_ONVBW]?9AF\FJLLM-[L4 *[%Q\(LY M'ZTRJTIF-$SA]7P^2ZANF9_1VCGSNP3:TXE?SH71[NO-K15>I1RL@>O-<,@L M"MRRGQ9-']4P62?$X!+RBW-3"PR]K[2"\EU+0S>43O 2.D&2$^AXJ\JO,:P; M.!9&GHJXPH;66W$B[5PN[3F/3]L'@$I.R49#K^_JM]H#>,KMVU($H@C$,%H[ M*+K'I9"-L^W+DX=0G$8R'XPMR/FI8&I,UO=7%#[BN9<84=BZQSA7#H8N(]W MU#S0*5P_#'DJ:*W7;NK=7#8H=7FBF@7J<\ZK"_C#_:Z1]BC/=A\WP]"W',I[ MH3P:4QOYOOT$#VK.9&HZ 4]/&\,%,%X+P2T9!VL>ABR@'NCF3UR'"87&=3)I M-CA3 -:B-+5IP/!5&D6_]N!S0O ;,*V->R)<1K>AU M[1:6!#KC2SUA>KC'ADY2&8%I*#Q;B*POT[*P=T%(B6V@C %MA3)M$S.0 F<0 M2WT,3CJD+'($9';F1 T^&>*>,7!(F40<-)2>-)<3GDV7>MUO9P97T"O\..+O MD!YD+_*#3?./2DP01]UI9EK]P[*% M9<85O;:L^[+(9\EOCEQY^[TZ9&SP<@OK)CB]KLR6YY2837RO4=:V8[KN+$.4 M4W,F6* '?-,;74:8T9_-D4?66,]PT8KE^VTL9]T9E[/S21^51<_EDI;BH-L. MXU@I:;.#@%9*V48K@TJK9.P:2;A.VHF:*2M@D>!"CLP.]S-2F6I<;%&F)&JF MMA6*_%R@-;>+SF7S/%U3N[[[\_;3I=$'W0'T6(_7:SV9@;V-C*PHU]Q V%'< M;1><7"'LC&X&S?AS!7* M#$:^]DJ9FRD=C68Z':V6_@8W4,R_Z6?->F:S- \J>=F0C#"4+F,@3WI19E.2 M,<%C6>%"+%KN*&7Q%=."UHV-NHLCU_=_5.M02U2[,>@)'*-V.E^I:/2.S[3" MBA0QT2HWT*HF%(8(% 8JYDD0&YY:T9D!Q!8H.DQ8UL*LSG='T/GOEW9/D*HF M58X7%*]ER\>?&-5[)\7AGA],X)%$0:UE]0+8<,J+>)DXB5PO M8"X:5:TZ:>2/&(&(MKB0@5*H(PMMD_2\M',C+U'&UZXH42:?T "X8SPY M^Q;GY.X>1D=$'7Z7,R9Z8E]EFV+M7YB3H:]ZN#A1?&TRG0 M;W%MJRQB36M@U=4>\FJ1S\O:9;@T^Q$+W^E"X;HDEV9#8+B1NIA#7@R2"C+, M46I'X5W=!='83QL-@1D7$AE)Y_.U/QF IJ9XY*'O*\/E+'\R80%JW,(U*@DH M:]IF=672KV/J_"0F)>?4JCD&:H-J!4I.:**?$]:UF%#0F6LGSP9RSO![_%(A MPN$08>I' !F']_."VQXYEI83H-QYF3@SJV>[+W/AJ9$S0KR!R<,-,#F YC5[- QS"!!U)7(V&% M/#%NSP%U$(/4\@(L^T9!+G(S%C:5LBF/F2+E)H<4>?QM$W/&+<GX)]$@,". J2$O N*TRQ$2)ORW-4H)42//(F0_)D.4.0+ID@V3'A M)6-O&@4#B$-IM]^YN,/N6\24$WL//@J B7(1B,Y$]#8E#B/BZD7,(/%J\OPC M[F$=F"XQTW#,6 4YXE]<(@Y]BR(_/&#.6R!R5V-,?=XH7IZ0!L++2ING<>U/ MA#D=&PY#W1@3?PIEAR%[ H#R6"6H(F-G*B *;X[\";5"N\4.V,:9F MI='8";61S_/!$B;R+^!UH>V(2/S3F!JH 3,,L4_?Q(E TQ5-BA^Q32'O_V93 MIV!J.*BAS@#[F?@V<[D'.7&"@PCU1QX D;K]37QLBAK1";!?(3KXQ";R.Z>- MTGKT9G(;U;!Z*?'(A\RE4Z2 3)3Q9*&[1]'XDD G+"\)0=YU,4%V$&4\ ("? MILLB%+ ]GVVG=Y1[U Q#9Y9 3B(8R M@9YEVGCQHM?C *4L'#<@;')U[3,/?,)N0G/"$!8A-9$FU;0(R2A)0*23A//G M2P #D ,8(K,82<#E>O<2X"C@.G:&)/VIYRX99,DBI*:.<*H4-^5!?7-=C' 0 M2A(0!C-YJV3FF2)Q90R\@067G%T)1*DE6)+QM&&D-9Z(A!>)LZXS3)!,WDJ" MO/S7S!N+6 YN+<"T!]): C@<]K!+PC84A=*U3URIV21?#M )7N2%(A;\NM/7 M&_GVM#DVEDT:Y4Z,V\P'@ /?\ADA?/NIO/,8_&<8!P2.#"PYR*6-17DFJQ:J M6.2X6(S\GC#[TXBQ"H^(9""YUO."CX 9!9^:UDP:$&EH4+3%]H'A!X\.^4AF M&7EH8X?H3*]AOF)QN&K.'%G6Z%LZ>8CP;39EO!WKA)J4+C3"5Y&G SM3S;1O M>AA;Z(L8QIAW*YVLK-"_RL6S"^_7K, /<5? QC*\,IQY*"F8\K8>\4+E% M3$R:KDIT74YJCE5XX[@$)ZVY[$P)N#"1Z!UF:3+]%LB+U&[N0B756!"LNLH# M7B6EYM.%I"Q1NJHYQ\NJ-2J = Q2 ] $,^[\3Z-(6/=@#GR9[$>.&VD(3F#S M*-@P36TN6Z/@D9PLQ! ,&83DN>.=\GD )1,](<^2T*3](5AWF)JCTN178%>S MKM+D7\P\]+0O9F"-M61(!F6/\4%F@,1/9L#&/GJI8'<6DPZX/_0'G3M\ -EM M=!@.,0N20O0!&YE!XG+E2SE)/B3Y\(A?U-]_(1\44HCP=87:)R>TXC"4Z>U7 MGNG.0H>H[W.2?7OM>W8Z*^J>IJ71(W=) B^]P7@O]<\KST-_[3W#D'X!L3GV M_[YR&CW+Z/1[K<%PV&\U^D.SW61U:S TAKU6P^H-_@]XW*N2>3969L#?T] . M[8J7=>&-? M\#_X6CLW*.3.^DV>M^X7Q)#":B'62+1A-Z+(WJ NR :8J6Z13F8(E\((#)+,#E-%@$LR1R=DI[D\QZ9?/MR(B".QTTLZO5U??^)@A_E0V M\2UDA:@IO8)\4!XR?.Q:)Z^,GQD(:C+E)^ $PMO;\1@!J%?*\([*"D *K@/63H5*;"K$2<WEB.\62Z5?9V^8VZ3-3.9S_"^/IP(F2 M/CU4?)[VS2'T@_]/F 5RQ@FEDC)T@G3,'T^C=8C]Y/Q#\>PBOY#^N'HO*!'TY_#,S%9-8+X@CP84(:!?.&TZ1L'.3 M9OO9E K)DA@Y5O&*1(B,O\G*C6K5?(LRHW.J[Y(]7#CBE4,SC"0/2M3?S-N3 M5@^4*^W&F8P(G(KHR'7XR$#XI6O.I-T(/$=4(2( M9EPH\V@C[WWA3 K;5J$.$H8\80HM =>=1[/JX=/'K.:XV>&+4 SOXZN/U"^F MFLY!)I%\<\3+R1+%)=*H$"-VED*UJW2*.;T9J!R<3-W+S.3Y9OE7QENDJT23$UC MY&P\=VXN'X:F.-2DW.2H _^6,!%3'C)Z^03%^-25[!\ \B^N_JY8/RN:DU:.6$A7(R"U!#9D&5&X5L#X#]90[\>:+UM1Y'<#B?_^9I2ZD%_C E?]&9NSZ(:5> M7U&L03#'>^"HE>,\,A0<)M[P)"Z;]B?G-<%3.C2/N-"!N0CAX0\3/52A%3B# M7 #@-F(3K7NE:[N#]&52$)KM2@6"$6$Y;K:68NTUEM3XHIS[&U:WVPC1,J+D MEH4D-]P\%6JHG6 +KR*21YXF1WYWO RZ5Q^P+HO"2Z"]838/*F2>M+#Q"+Q' M'/=*3S&#+0F&);6DB6R-,@&XK.*8:MD4]KZYH]]??[ZK)?8E!3_1IR6,3E]$ MWU>#KL8'# Q)LP22NY$#UZXL(,<8U#*.;$;3O#3:%^P-_R6?J9IOD^E!R0N%36IR"@85Z9D[W 3TGH/@^U>OQ3$/.U7C )9M^ ME;:,&S"Y*:X,Q:'4P[BBC%DJ+L^1">,!+S05SZ67G8.D$R;.W)KL1(%_@AJ& M_DBJ,N4-R7AL'S$C]?TS81DDBGNJ& ;I%5%< ;JY1DY=8E):TRL X M:-]+T8)+!O08C\% I5$4P/"!6XBMBE9\-L[F\F3[1$ !:NI:< %H3U(QKS!E MP8SV91: -/F2G7H, 21Z@),WB(>S9(H %4@*+!.6,1D_HK R5V!,_<+\,,1& MS9WZ_1+S5!R7FYII#D=B[AV7<7)=A&C;R_DMDP#-)F?(Q^A" MM-9EK(,MF9;#T5\J/DFF"R(S&IM9^VFFN8E6FJM@:+1H;VM09%,]N;=&3SZ2-5.L)G^[NO^NW=YJFG;W_>\W M]]KMU\]W]U^NOM_>?=T9 BVCHI:"L=12^)V-@ ]]XX-BL&ZBC.)NK3<_JZWA M9(PAA5E!7'P#;J_=4MR]\3Y-*LLDU]$!M%FB/"RD-,.;2*,F\V1<5655'Q:BDN MHHF/O;'1#UU%--S,>Y+SME/> 2B^?AQBXD%B612G,GXF?[?-(I-L#.YEF68- MP^SB-8YGU*F"R$"@^NU5@NM9B$NT%2OMR;G2ZE843QM+T?0/+V C=)FC2?@@ M&Z/<@(T8S;2'9$X+,88_> JQX*\;834"Y%BGQ_J.0/N6'7NS<*YU9TA'>KXO M*ZW>>=I5/((M:$:7U/X&5]<_^F9 P=Q/U,:4"#2.QCZWPLENIAQ!( K98@EN M=A28DQKO%T1A,E%AG#P23VFZ4+->S\QXDYG4($A09M&R(CUT;F\M2OXJ=&J( M#E;V7'#^==KS8TD6'4.:B5D.SB0*\J> ?T!X=@,,NT0LSO?WL[:G:.T MFQ7E*,N##)_8T*2T]C^F -('YCF8K[DQQ96.OK[ZWC-4FW:U2@(W\<=_P6#X M@SEDP$DS$8X*7FPD,T& GSSCBJM5>Y=><7OI%?,RDXQAL>GE5JHMP87YYGA^ MP3RH.GH?Y]4O8S:G .Q!B8#=;)TXL*T2 9MC=J;*Q<4-#%FK"=9G3,2^-B^.:-]C_.SW>>[WV-*?>6O-1P'?=L" >_;+_2/'," M,&"6_0Y_:-0';>,J"*YX\?=GUQR]TCB_ Z[_,WI'TU4 /F[(7I$H&%X:]2:* M\XW? PCVC%>!L2DJT__G;>Z5'^;_C0#;>5??@XD7;;RIWC;GW_TU(%)Y'J"Y MR?%1H>?( "^[-"CSCG(' TKZY=4; =66K'OL(A.1%!WRT4AXN+GF(<@W*B5L M552BN9>4L$[U4L( 8M8EI;U:T3L>[9Z]KX .V%FJ ][\'#L#9[,N(,M/)P;^ M2D3'?M>7U%YI&K)W\H_WMA-.77/VSO%HK_2C]WD7#-[D(PNH!D&\A5[(OQ:7 MW._H1K^']QP%\'^V?+% 1W._K;@7GOG)QWVJ8_\ MQ[=7@37&W*&WS!Z9P5O;C,RWL$^C7^\T&RWZT^@WC4:[T3 Z1J_>>6LW&\UF MNV&SGTU#'T= TU<3[KH47224^J#BW27A/N'3_294/O$_O=>:K MBUP@,!L!1->P)&7 4%EU<4\1!M"QTIKASZ !:KW+?\@$,VPS-M,:PH$-QHLY M+W 1RT^'>AN*>L^7>K.DR_]L-'#SS=Y;)%F3$RO0:B!(=3!SS16$_!&^?@H/ M3[*?F,6H;LYHG@O=-A7=*KK-T&T3-V^TD&Z;1OWR!U(!I]0YZ.M.%++H+(" M$*$4Z+<8I]0'\:'((\@2[F:DV5HO-X$T_YF2ILB):)^'U#3JBC 58>8(LX6; M;R2$:=2-2])ZT07O^8V,KDM.^:^^KC60Q*Y!:@+!78T")@K&>$O4JVG@N%JC M+3.)@%*IQ<3$]T;+E.*:Z#^-QPJI,FW&FRA&/F^C\-'T?J# %KU<:MI7_4JG M.K(K>^)X1.=4IK6-&$=BV$K)%D?K\Z.= :]H7!AO%+M0[&*!7;0S[()SB)O) MU/5GQ"+N<%2"]CN+*)B]!X^8DEDAN M:G?SFQ^RZ5C[ M06AS]F-=CR .Z.R"_^EQF$/QPBRB^.-3:9JSWHVFWX(S!/ MG&*:AFXHEBT"+U55,$H/S*='N/4W[-#6 H')]5$MG/$$]AO M*<-1^_\^WO_^CJ8XY$8[?31=:B+T,&8T,8&&+N2>2,OX$:]^]T/^E/,FZ96V M[-GKW!R<"_SI&TKZF3!HVM9S]CZUDQ M!N(1#H8="*B^=(/Q5I$Y&O%.T0,7=L%[/P%6B#:ULFM84DX.SXH9O'_EOV_ MEYL;C \=_K1& T[[W\MRTS\3C6.P!LLU=&W#(JXC7=I_+S]'''A..,Z>I=Q' MN3!09O#Q32&U<$]ZV6%'<#GFCOQ]?C!+/LR4V)2C@&9=O4:IJFI:^ZFJ25O# M5J6J9D6)R8%NI+A^YN&/+U^N[O^?=O=9N_KX\?[FS]NK[S>?M.\W]U\>*E<' MORH<)B=#)-I9& ]"QW;, )O"X*S( >,A,=%2%$1N9KU:=O0M-OC@K4F (N/3>#EOF9&#W%4YYV]0Y-;JZ873V4IW4K>N= MWK.JDP:F]0.''7CVI4!TRV)L.'POH$<*"NBD&N&>AF0@OR)VD/^F,NI[KA/5 M!HK\.C %?.T7A1,1Q-&!13FM:9JK& @DRLAI^B1/C9=9Z<*+R@?7-[DC1V3/ M#V9:/KDH"=X77\_&WIK%VQK2_UN%U-5!W;OKVYTP-@^#0HRM&%Y:5CR)Q70; M:I62'S+L^F&X#^19SQ$K@SS7-WVJ X.QPX8%ONQM_%0GS6&N/^^&)"_% M8(Z')(L!C>2_,A'0QYZ M[AK ;J2R:!07@R6-PFS]FB;\!UGGQ 6-G4'S_MH/?,^T?>V[/[7@J5O/TM_@ M;RQ3^[OOVO(S',U!O]"L5E).G.E%HKE?+(X7+.^86A2S\(_"=,4%]>6V+F:TM,JBW!)4,*,5.8BQ>MI,,^N0TB M2UGP4W*N_O[V6G.H"_)S4/O(<$@K<$+DVR'@ M^'?S)TY)^L3 O 5]-'$,7TUPULM_\LU!SYUGX@3PL^>3-W'@3\5H\"^.;;M, MNZ'9[(@U0^1VBOM(4'U[.'O6(Q*1F.1 8-+PYNR*JR3-T=*>IV?/73(C*7*] M8$&7,OK-5L[-K_B, -JO5U??SI[1_,H\%M!0NRL@"$KHA3]P_#SJU2*7V&7) M"$Q,"58\2 (/?@5'/GOV(^"@?7+,D>>'L"GM 1.-T,&T#P?""3&=V^]GSW(R M Q2TB%EC#]X[FBFF(L#SF^]X4>)"/'O>-?!1%E"XT2+*P,LW)90,#[@Y% M@ZJ(+Y\ST_GMV]7UV;.=WTQ\*=G;H6-JWTP&%;/?LN8M(%(8O<#L933BD4!IWXKB*W4AXS20XDDADPM@V)& C3W?S,GT_>?2L6#C@(' M%C(SP#H0#T=//S+7GRYD.9PS*[EGC[[[B.:HR'OX#%:$ZT2SL^_A#\2(61H%C\:8)V('Z#\]1C"C%D#_/GN4 MADR=@%=4/\P\:Q9A9OB?3A _T_-W0ISDX68WQ]\I<9),-X+X@FY M7!R-_0"V3F4PV*3BHV\&-E6LB+'D869TBUBBL0\'Y GQQN\LF&B_^Z9W]@SR M=:/6;6?Q,F2>XP?P/YQQ8B\2S05(;>(O4-Q40/4/_1]ZJ3CG48#@.>@K^ =L MUO8G2B]+<.-A-]PX);8C<(,Z9^XU*TBT)RIN-%-MO'G8+1RR!7Q."*>T3YB= M5E!AOK25YB&[^I6U@5][/PW\>JJ!W[X:^-W^^O7J^Q_W-QNUZYO?>E&?U$:+ MP'HD#/N6JG\"N?HN<2S,)3:M;_%=HO,M\%J>CO/'[:>;W^_NO__]3KN^N_]V=W_U M_?;N:Y%V6B*T.94)!6_#M]K'^]NKKS15[?>KAYO[;>R"#<%Q ITYYR8_O@"0 M2N>;I17?.1&\S]H 0M\"%CJV[$>RI)O=@D0OR^XO5HR3>;/-+:EZ2;M$LDTOB@9$45E4 M6O>]P #V-QNDR$!6?I&<7Z2SW"_R=N#;,_B?<31Q/_S_4$L#!!0 ( *QY M 5F)Z?9;CQ *^[ 1 <61E;"TR,#(T,#8S,"YX,N)7;:S,V]3$ E*V%"$!@!]V:_?!DB*I'@!(#'B*!PUP:3$YZ7Q\N^^][ MOW[\Z:J)PB.27H=\:_T4>,;GTL/<9G M_?Y'+7;&YB^<3J82[0YV]Y-DR5-^/-[?.]@]?'?0/\+8Z^\?[1[TWQ^2@SX9 MCP?[XT/'.QR[OTR.=W^_['MF'9,[8Z^/WX_W^8'"P?S0D!\[^KJM! MG\6Q<*9DAA$4+1#'S^*D-Y5R?KRS\_3T]/9I[RWCDYW=P6"X\\?GZWN=M!>G M]6GP+9?Z>CGH\QH(DR?]RB9]+_E=(X1;C.FRVHTH\.-P;) (* MCM8HH(&0.' 6"ES)^_)E3L2P7 B>[ZCG2M&@/QCV=X<%4;/D;G^PU]\;9C/I MRH58-H<'.]'#'L)2$;$'#ND63U^_ DAQ3"=S>$I"@K2'A9CG5O!I1;KH<@:KIF#I39RE5(D M!2NDWR&^%.JJKZ[>/@NWM]-<:RCZ$XSG5IJS,I'V^(Y-#C*F/3PZ.MIY5K9: MGH-2R]/I^^IG?[@+QF"AMLJ$F^N&JWXBMXD\I.W4+@^)W)IY*&V55;9@DM37 M8MUL+)JX=39B2:MLE+N,AEPD HJ$ QN%@CAO)^QQQR6T2?M;3JY^V+2X' AQ M7!N=27+UHT0G#@(FM;RZ$]^;SVG@L>@&W%*V>IP8[!WQ$N==Z,)*O(+^[QAS MAS/?X$)VYIS-"9>4B&SWIP&FG'C@TL%3]Q,'_>>0DR1)04&^U:G'H($( MZ"=T>:_3 B40RO!.>@)X\$E416TNOTL\V_*#" WHWZ+T/A[;EAY$B/]_7W ' M^[8%!Q$G]%>Q>B7^ ,\1=4]Z9PQ&[[=X ME3][_>7=6.I+3J5"8!3J!36_PX MT/^&J)^.^?M(2R(E^F%G66 )*A3$O0D^ZM_+33P6CI/4""Y54F.Y?)LJ%8MO M)I596\6!8#YUU7SG%/MJE'(_)42*KP$.72K5:-:B[HU@-:0<'1WL#@\4*?=0 MFV3!2HJ)8E 4H:(W"]R?MY1E:OD6E$@*&=XH?WED(YF[JY&)WN3T=)7< M18J^XS-H&!3$@CZ2%3]7 5 $-DD MGT851HKWFU.<4X;>*'4_HTCAEOD<+?>2.=^FS'<)%Q= J'S9).EUZ$:^#YKS MG=7S3Q1IVA*=;W]83"]]]K11)UT":J3UT*(9 SS2^!TE\Q0+"M5\FRD$#MS[ M<#;#_ 6:%YT$U(,12"!'CL/"0-)@<@N5Z<#4R8+>M=08"7^G9C%4.#X3(2=P MH=4I?K,*$6A$L4K=I%.E*-6*$K4=,@+5F851YIEW@7D ]2!N";^?PAC4JA'7 MX1AI?+],8P9/$98@(H!$&K-#'-V11Q*$-FPD$L9Z/UJN]UBR0[5[3R:J3P / M\8FP"LF)!,;AX-E-F)$[;Y23)0![1!1T1#[ 3];=3]9 M*2,!PV4"XF&]%N]056?#'W'_>$XDIKY=QU\)8B1BM]BM9\(E29^-8KP.,3,2 M@DCQ&_%=< 'WV+?I%8JR1A[VEGF(,) "08""%$R'JO\38^X3]<$6W2OEZ2=T M[).H3KX0:<&% U(C1AN'E0H9Z_^@ MX* 6PAVJ9AT:4>M;KAJODT!8#YG* 8S5?U@8*2F@OD9"6:@.D0'%GE&IXQO@ M \Z8GM.2P'*Z7H=BI*4P&\^@:<>4P^L0-Y>8\G]C/R2?"595HVO$@I5R>2,? MA6FUPD$:"&61.L3$.>'T$?+P2*X"(7F86/IOQ)V 98X<>$2E79MICFEDK# A M3[%1!EPWIA@>I?@=XA&F .%,Y0+$Y93PPA*0S<#8B&7B[5UAZI[!1!IT:=U( MP7:(KG6BP-\YZ-PP^+R__ZX0+MA$\!F]27YU:3&B-G[\@&$F8SF(,:(9V2W$ M((PQ:?0FPNX2<7' V)JBO)R1C$(@(I;O8I4;XLS65#3#,U)4"$F8H]==9*\Z M+&I-G!'*R%DQC%$79^TB7?6!.FO*&L$9:2N$/QI$_[I(7AJ4LV];RZ)&4HI; M$1807:S[\M">?>=4!V/DI! J8H3=I&ATJ"2-4%U*$9^"N&.B@!5%^EI'%6R MILP6V43C^T+TPRIJU45RC2$G:U*;(AK)+$0UFH2RNLCA.D&F+YASW3Y6V5>Q M0;5&:RC9B;&!&%T[]$!K@HC6\C!VNT08*P:$F-M!M'Q%' M.-?@L K!R%8A+)1$6[>3N'TDMU=ER(!GY*L0#TKYRD.KIK:( MG'>0/T.H>XVV9HMLY+003FH03N]Z\S2M9#")_=C\Q?CECJ@7P*AI2RRW<=:; M*C0:0S&.U<08M/JDO0LT?D%I#A8(6SLIT'9''!8XU*?Z2K+H%,#&K:->C=$F M"K&S1C:15XHD6QQ=[J =9 Z'1*5?[6!)+&MB[*@0)LL>+TD(Z%+]5R]@JM.Y MZD\=MW[$?AR@O"-"QD5:3ME80K3&HD6Z[PTJ='Z155_UGS+^1>'SDA%PO#FR2VCI\(\N%*%8] MRZDNE"K;\IWC([X2,"8AX/:@KC;)=C6ZD>M"M*J>ZT032E5MF2H?UCK)--F(;?48K*$1"ZZT@UHT2Y7K0K=6C6#^*,K"UD1QGT0Z#J(:N M*1Y3?^.#-8,*HR64O!FHSA+BC0TQZ1F%G62^\*H >V8K(8S,%8*=92\=Z"0M M];N'DZ=WS/>AFIXP=^UI6UF%D=9"O++)IN5,JHS.+?D%9M:(A5@"&X@^&!3" MG,V([GA49+%97'VXQ@U]PKSTW@H=:R,\(Y?%4&:ZJ;V/$FB]0R>SVWW+7WE] MVTV0&B)N.=P\A^M$EJM!C$P5(\E9IK8.,JH*Z$$(%$5>1).V=2BJ@#(250P& M9XE*4%$,VTF^R@_N9'_'M7-']-9RR;3$Z;+$+8Q+5NC_7D6]T2Z*9V"KSAOU M\Y>)I<2Y4>ORD>AI451G:6M3BPI99]=6,T C[X7@8PWOW7;C->^76FF3L@G, M2%TA8EC[SJI.1YO=>L;=EORDP:N4CF1'L82F:NU$7S,+Z 984]-$TA MC407 I3-7NKR]Z;QP\ZS.,;S.0T\INY$UT' HKSK6W"'^-'G!!7)ZN/@?U[C ML?A,9F/">PA^2HX=>=*#QD)Z*, SSZ&A,5?E MY:3GAEPK["$1 AR5H;KZQ%DX/^E%R:DDLQZ247+)^^J7&!Z[; ;]^14\5$C1 MY\1+LWPVI0&NSW,N22LR'9U6!9_S%=B])=Q15C4A-]XY<3C! CSCPN5E2^5A M7RR*90=B+C<%MX@#V;#8L3RTN0;E'7DP-81L:0[VANH;] _L7V% ]@;P^Z"> MOH;"KT=L!^J%&>O'U,W'5A\G/R2-UR!V9Q"[[@6/H.J)55J&^;E%1XN8 M-EQ'S\;1'E]X0,;4KO@S%D!GQU^:.-.8I5N=D]$S%94^M23E!BS8E< MFFESS9=$'1D-)DW]S<)%[&7K&:PDZ/FU4VMAH)"R_R/1M7-EA[_X3G-P&I)ZU&H!6D?88QIQK6\G.* M)P%X-NH81H]U$JTHTG*5/SPQ.XXR NTLT)032[/+B;2B4+?X1=VX"48.S"ZC MGO6<>(1SM=T%.@^7)'FH\!X6"&OTU3 ,=U_/G]PR"B7PSC W$%J2L!4TGN+@ MVXT7]TIGNJXNL7J#BWRI+U #P584\"P4DD$NC9Z^)&$K"O" GY?ZV>C%+O&F MOLKF991K;:-:=GZ7+.1V[C(KT0H2=1"LO@RY)*W(]#4-"+BL7-N&!A^X*MDE M(:.9.N18:8!-Q=LZ$;MFP>2!\%G9BST, ;H&DFV8PN0GD.=:K-ED,TG;"CO- M3QCW'U@^4&4SVZP4;@-=]U.80:YFD8U$VU!&Z*-TW#2-GR9#0NC/HLV0H]R^ MS)K)J3526SU1YG424"H_=&DP^<*"^"4"MRH"S0+]B?#*NF@*T-)Y^Y=0F>B- MIW>^3YD/4P/Q,,7RDOK1[GH?S*LF+-A8_G6BGX!-)H1;3*N\D0-F*XF;#&UN M@L56<9F;'246_ +67#I]NIGK'_G/SQKF9*^MOK5CSYO@AI\2CW&21B -X[8: MB39XU&1>TR#J4)JT%5W\V12#Z5VEQG2M7/H=G4S!5K\*8M4SK ;6UL[A-!0P MT!9"K4#6K184T[5GK:!T.PH0H.=$-:M;M5)M)>R62;BFV-<<## M_DZ4"1)W%"W++?HL]<$"<1-*U>^HGKO:>Z^/O/'6'EN"UF3AK<3O5$[CE^J( M\Q 8OGB&7^+&&PYT[[3T]KUFCFU5U%;XP/+%W&N27<3%SRNL!Y=#_-!UX*O M!O.B#45/ZU#+ZIZUN\Z3FUNH4/R]^-7Q]5-^&Q16KI:#]I MKE BY<\>"0Q+539--6"46[V\KSOJ5/OATI.@+XE_OGB&.7IT],@C@8OK9C@V M$#]ZDA.O?H_<_P!AQ+TXO7HX'U66K")U:Z<0*L"N7JJM-WTI2E29%CV084]2 M(]E6=$?:KT2DZ(%7)7_%A&T=F9TQ/F>@F#2TS,KTK;7-D>^S)Z7HDO'$O.[( M&(J@N@JUAU>/@"I+W%B^K9Y6;P/S0C5?T1O%J&E9L$:@%J(LU83&^\6\QE?)'9\W%)GV%FJF,N46/3Y;WD;)8)6U='=C<"WM:JRP9M MZM?GRE*VHGG<$3&GH(5QPXZ2DH1MB)\6]A; 8-IR-T)&HB645)Q:6)Q52 ,C M9YCS%Q6]UZOUR4 'NO]D72[GO_"EW?UYM6[8NCW1/4UJT(N:F0Y.EY0]0JXAH$.%BT MS*^?K .0!"DN()&'/'0_6)8H".>KRN]D96;E\M?_^'8\>?:ES!?CV?37G_C/ M[*=G99IF>3S]_.M/OW]Z ^ZG__C;7_[RU_\#\%\O/KQ[]FJ65L=ENGSV?G K_S^>FG?]I\_-L/G_\JNT]S[_WS[F_//KH87_5!_%K^_+]^>_? M_AN_%IK,F9&L ?J_.WSK\W/0*4S2:M+MT3O\\^:[&SQZ_.7;LDQS6>_9*8#) M+%WXT*1);#8__9>3$,ND^^EHM8#/(9R,WHU#'$_&RW%9O%S-Y_B>C!0OH1:= M@6=>0 G&P0LGP;$<C:;YS)'W?;3LZ^EZ:&-FEO#"O/T Z,NOF*;3SQ? MK(Z/N^\$I,_QZ;^O\]DQ*0>6,_*M7TL9U[$O#5[C2S[[7E"53-J+=<5*D[=> MA\0@2.Y!:51&,44)7K*B0LHI.$_,B%M![4(.\33)02L0,IX@9^>KDM^B(7%< M/H5OYW"L0 A95!!!(1SO%7C'+(C$O%61B>RI^7$MF%UX(9\F+V@$0,:'5R4N M3P%H'4UF.D )37%5E\"AI0;3Z?_% DWM M,S+RF'!9&K))$3TW7*!WZ*R%(H/+ABLAJ.5_ <"^JWD9%D<'T]S^]QJ=C2]A M@E^Z.%B^#//Y=_23_S-,5F54?;2Y5@':H'95P@0(VG#@N,8<56&.<>)5[@1L M2*;Q_7EQF>[T,B$C_V]A_D=9-EO]8TFK^<4W/*%:#M)"Y14!57P;G:H&?78> MK$U%.T/]*MP 9TB&,1TUJ/:?TAKN/+@/)15D*@+[9SD[J;E5(F:E@?'DT![+ M>$B7V"SU*-$FBSHK:G/H)CQ#LHGI*$$F 3).O)U^P6?/YM\1R$@4%EDV&6J( M',]H=-1"] RT"E7Q:(3DC)@#V\\?DDU,)_-[[S"9C-_/RTD8Y]??3LIT4?"T MZFRTBRM4T@7A\4BJC"/Y=>%.H(V@ZPAF0GTS&"6A[$YO(_ MRB2_F)DM@B3O\]GJY.S/3 Y!Z<2<(57N'O?<" M$E.\AN1=5:*_Y0W)U2)EPN57X;Y;3L;S*]833'(U"@EXE!=0KN$P14'.C*4B M<$&56BO>QN7!7#70,V!/ ?2A\$8^!)8R2V#0RD-O7Q1P44JPKB8\U+60TCW4 MRT]R=1RRP8.I"K"1:SQ"= $?2VZW?4QG[U-PU,;A_6*FCZ#4[B3M&_37??:: M+F)^4N:X[NGG=R4LRBFJ[_^<3=-I^#8Q7A./P)5#ES0*#L%*U;2KUM78E+2D MCIW?!FJ@2FXO1M!*@DZ]S::?/Y7Y<;O;Z<*=)^-EF'08#^-D_+G;HL6H9B&] ML06D0#-3&;0Z@_()$%H9:4>R$;$CA)#+E02\3PHO66I"NYQ>_6XMN M<1".RLU:T7( D,G*90NAUM3TG=)*&9X#HW!2&F^DJ M>1;B7:.E#WO#>B?)7AWGNL_F$D;.9VB/+;^_GX1I.V.;AWG2LLZ;]G0%O589 M-%0NT#[W'%]$:064%'..T1A%GDYR$YXA6<,$TB?;^E[OT[<4J+!9ZH2>&LL% MCU 1%<3J-'!11%!6.U7L URIW^T >]@KU+T(0;C]/?G-']I&'M;?%Z5;[LC9 MY'E,[8JOK=8JCZME$80.)?.0E..U5Y_Y$J AF;@$A*#;?#(^_'TVRU_'D\G( M%Q.L2PRDTPP4FMD00^; N7#:LAS1RB(6_>FSAV2W$DCY7EM*F!ZQ#-//8U0Z MZZ7@X?/Z6YJL6EG:&;(H/!X[6D&+RX"*LH*W%H%JS8)WQ7-&+>Q=< WO]G,O M(I"+HK]@QQG D78UNR(8)-N*!0.3$&UDD#7SW#K/N:=V":Y'LPLA[-,A!-&V MTP8V-AC.[1(K4RAB&%.(CEOM=VT\5C364(04UB"E L?F4M0*K MXU57S-L=M>06Z&8L@'IZD, MI_"43Y'7*LD9(0XI^4#.G1V&1,>I#68;QM.3783Y%EVVQ!1HM^7$:+TKDJ$O7;D.L+LN JBIC!G =-SE3#R HE8E0"++ )5 MDT8MT++#><;.%3#VURU?RG15%J/D6$0SJ8*-O@!:4 :"L15?"<^$ M2"XP1^UXG3Y[2$[)OI+^45'<8W\)79$%'EPMQM./_Z7X^8MI()2NJQ:Q1C1E9T'QB%:0RQG)F;"K4YLG^ MJ._H[L"3HM0#"Y4NVE,FDQ9Q+E/"H/(0H&,VU&<54AUZHN"&P'=T5MZ6C2A$P6=O[VEV [K MY;NN4;*9&V;:A08B4047&EC6H$,PPMLT=/B!Z$PR CR8K5 M5VVQ0-\^CJ?KK4[H8"RZF-&F[UH[5-O2342#K((3WJ//%BKX&M&%,X9'D8,2 MY+ID=W1WO)5^6L3I24CD^2EOCT_">-Z47K?D$G1V3CNH1BDTI/!WB*I"UEPR MYZM5D3K_]FHD=[RA?EKD(-A\NKR6,PR'M=61O$/K**_5VZ?9B[(N)"_YL(Z$ M-4+I5AG@4NOO:5.C:,:U6U^=DL%*ZG+6G<'=\4[[:=&E'Q'19CLT5=9R<]>6 MT]D.C- ILSPFA. T!Z6*!&]#!FXD6E:\2J>HMKJ"OOZ&+AI+ 0W/^_2WN7Y?5@?\2MW;2 M[=6RS,MB.:J>J49WB*F5^KL4H;/5BU'2!,FS3]2&<(_+(8@)&4@Q,J*B"X;0[U#MT9T'S<:.A0^7IO ?$_I46:Y=JM9X]@HD99' M%[-ER>36J:IY.MG8=E&H<'5%>\%#9*:0OVU78QE2[L=0"44B1UH+ 5M%8!4L@UZLV(AI1:,E2&$="!EO;B?5B>LGRN?59 M/2?^W&VM5+E -^0)MF;F;R:SK_\H^7/Y>QA/VP\/*BJ1#R5-PF(QKN/UR+"# M:6[YA!9]%30I+/@JVKR F,!QZ4 SJ9E-!IG52]\.(OQ$H;#=L:PU^ ]@&L*V MG:+:C%:3AJAX>T%5;$T//.2BM/79Q!YZ;=$N84A'\Z,Q_9I W:/0A#KLN_LB MKH5?JK4BL0R:5]4R2R6$J@48Q6P4QC,NJ25R$%4IKGBM6KR#D4WP*'UF+ER:".)!$EY!RIQ!9$K M!=SB[ELC2I;4ES4W>,R/>UA0<>#RJW'_'7\0S?T&SYGQY^FZUU+Z_FD>IHN0 M3M5"^]-&(OG_KQ;+31>>]:X4[6(VC$$J+("J2D+,G.,OC*/Q;9FVU!6A_:QD M2 'FOF@X [TSN??I_,2)N/_*?D?LTG7'&)SVAQ.SQL''9T]]Z='76H84TGYH3C\H#Q[/ MOK[)F.-"J!3;H!G?VJ0YYL$'R4"68IU7S"?Q=/SRQZW8? R-W*N\'RVRMUE4 M/Q5[5WQ[W]&[6]9#%*]K<\+P2>_GLR\(+K_X_ONB=;YY,YZ&:4+==8 G]9?- M((Q@5)4H=F\J0[TE*H0H-$11.#<>#<] ?6P M;G5/P+>1H[G!$G!I\$U(P8/#EQ L%]9K(:+EU*[:K:"&Y.+TQ*0K^G<2"HJR MH^L9K _E)'SO7N/#^O$(W_?3;NJ_A65G$+R=?D*&E-]FT^71XG#^KJ#O%JNT M"G@GW)"L&(2@!E96&6[BJ^Z37?3 /R;-Y!/;U+N;>R?FN%17@RS,O>,", M$JOX>C +TGH%JK6W"WC, Q.61["NO>;!2]MBECHZ RI6!=X[#3(E M9T*Q,@;R1G#WQ#JH4L6'4DP/(=>]6=C\NE.HA]N5M/9O3A=NT3GP:"6-8 MS,: +FWRD>8"8FAI,3FIR$JTL5RZ%__1<;S;(P=5K-@S=7H4!MT5':Z__==Z M'WT)DS7#%\OY.+6Z2OR+@VF^^(.M3Z[#>V^G:=[ZA;\JZ__CG]%2U6"=B!*:=4SK456P#>BBNB=!4E MSPH;MBB9K',Q&06M/!J4+PH"*QJ"-K8$=/:4>Z"HQ!7HAN2?#YCC5]QJ]B%^ MRLSPJ_"UB>R+2_B,#L4YAD>>R*95X"5PL29@J"ZSR<4S09V-LCNZ(3GP3Y^> M^XJ_;WI>=:!['F-E.K5&$Q6=@V+!224@5"9"\IGAH3Z0F.XCWS(^>7KN*WXR M>JZ7>%BWEWTXW6N#1]$P);5,K0IYTUO'NX*_\S)5H3T/@KHM5@_+&-3%Y-,A M_&,3ZC'L"HG>-#>JU=FU_JG<2G!")-"6:81652:O0YN_9$H!9=%3Q.-6@Y$RY%B#9E7U%"^Z'=T=S?]'-:E:R*MFJY$U"): M>,X=!,=* MU3['$,C)M3N\(5GO#T6NGH1''O<^8_]5TP5'+O,BG"OH!F2/T-H6A.B!"6DT M*S8;\KY8.P$;5 _/Q])7>TNL%U7U$>T25)[KJ^7E]\-Z)4Q6?2ND\&"Z*'N6 M&7P+CG@N==99:*.H$_/N#')(1NXCJ"UZ09(KKS>S^3;B+I7PJBWQ3$2TARL( MB]!4:*T?BL[X9@092ZBM_+LG-;8CQ*=P1=>70NM#BGU[.E=%>'6RNJ9H< >T M0/_+!L"S7$/TVK/ JU>)VK6_;X!_WXHI%937;;Q@9AD-8N,$+CH9\($[';S/ MNE#W1!QLQ51/#+FY@.HN B <\[E#3_J81/ Z<9!"(3)N&#C3>M)'EX7*5:A$ M?8_0PRB!/P-CR,75=Q=>FZPO+N76G:4E #D%3CL&W.,/T"727E,KT/MWX7WD M1#YJLA"(Y!%Z\RICBLB"@VOC()5'NR"&RH&9*GCR-81(G0E*VIOWD=T':A+U M(SBZR2579WSIB&!29( .<@;5"MZ";+,QI!)MY'I.CKK\FR1/[\_ & *1T"3A MO>PN9+86^*Y=!'UH.WU8<>UK%N/I^6XV;+PTB(AD@_WB6>I@^>#6B_A%$5HP*+$IB* MW13P"EXS#L;7-@#<%W$YM>$:%MWYT7><-O#D*=2O;&BS@>M!0I#+M@?KYH6' MTW4OQ,_XMQ2?2/0S>00TZ> BJ#I &M"7^5Z YK20^JRX>)6N*]T* LS*B^R$4OG[&@4ZB M M\015MGDS"@T"SVN&4D/*D57M K7'>".@GL5"V5.JMB-V0[\>@A&T$_#H_V%MH# MG&AH'W;:L=8@2ZX!K'5MDFL,$(4L($)@J<@D?*6.F=\*:B<:_=75:XB545J#Y)0#^O@*M20;"BJ.J#+Y6ZI/DN^':BU9\M MHMZ7_/I54?-5VXRS^0RGKX!)&3=#,:A6:E"V!'#%*C 515 L9SE3#Z&_ [R= M^/4GB[_W);T>Z771";T0K,LYB\(9LMXF=#JS0X!&@O25UD7=T@ MZ1Z_.%PM%TN$U\:$=9O($(PT$+F(W(?,-7EUSATA[JM(KWG< M#\_IA-;RR[C*C $/S=NQ/D/4F8-PH99HF?::^J2^$\ A)0#VR;7+"K4_*=*> MV"T('":;9H<=N(/EN@BFF1*?9N?W_IN+CH/YO%WO=@G!HR)%T)47W)?:1L,S MM&%E:7.!30E"<"E4+W;B7JB'E&'XD)1\8'GW??1_+)^[Q4SSW\OL\SR<'(W3 MVVF=S=<;_Z&DV32AS=+]:3E;V\E['/-[/8_H2*=;,]'QW><,0!Z48-$52%DA MQ6(KX#;&@-)%&6F95;J'*,?0!FAWE\P;N:\'&J"!]N+MIU<'(^E-C;$6T)X[ M-/B3!9]% A:%-X%''76ZC=77?_V03NZAT.S"S?_^0B'*B)O-3V:X#>42$B>9 MJU4%,*XMS#$!GGL.(43MI:K5F]W2E:YYP)#.T4$2A$(P_4].#^C/FZ(8^)(X M+J\X\,E'-$#1GG#"VTK>3VJ?R>E_AKG6]V$4J1P?MM)(,'PX%Z@-391H*_J6 M39XCL,R2MU*'F"HQPZ@JC1ZLI^]0Z48N8#+JO5@M6N_J!?HR$;>@PW7>"G1S MZ_)RMD"W1;K*4] 13&:V#>GC$*7FD)*R6C+C9:8FX.[H!E51/%0:]B3LO@OE MM"Z>9=="Y6U&)6>M8PAK@T\-M])G%3UUM/+^A7(/UAYXJ"0C$.(CE-:)6*76 MJ&V#BP$4>AD0/&I@G;47J(4C-^0Y;I2E=?;?G7;]B)K&MWR'6O=T.L2;D-9I MZP@U-[AO2D$S8#5=CG1EB@>>P91F!:2J(=@40..>>)6=T?&2#W&-J[G;\P95 M9# T6O4E-QI";=N-A_6L_&$R6^7U?65;?@O'=G'.]JGUJ6Y<+)PG"86)A#ZS MEUT+!1 VHB]M-&+?+9AQ3P!W+"+X-Z3<0TB6AH.O?_\-WPN4X:OR99S*A_)Y M(\MN=NSX'%I.(IG #7C1Y@7H(L%9RX%YJ6LT)EM>=R+=KD\<5G'!(&G6B_#H M.A%ODOY>E&FIXZY*\9K*Z6R$4+P(/+Q;WKLPL04!*Q296%)<)>TDL=FV,[AA ME2D,C8;]RII&Q>$NO)WFO"^M[(O+JAPO M5=N=--LM#[IKH<*_%9'()469&K*U4ZV_[O+[;V5YU#IPMWYOZVP GJ6+4FG0 MO(TBB-Y!='AR<^FK%L8;1M_491=@@RIK&!KI^A,QC>;J\D[7%V9K"(DCU2/3 MX%36K;.1 )]CA6!R324%;43<255=_N:[EBG\>YUR^PNC[P2@%V'21O5^/"IE MN:GAV:2Z7-&H/UQNS;]')A#-@XE2@GK8!:+CG#2QOUV"[__TK<>+%^&^?P[OLS_&28KM 9B5=:SU 9NBE:; MYB"$@!YS,17]G"BCH?8:=@(VI&2AA^/=Y3.57H:$0W:W%]S.B=5\WAI J*1< MC"E#2JT/>B4@D]7AG[X^-(7HY::]_ M3._GZHXK)#I%?WQ:*PG;4,)&P042#:QK5Y.R-77/K$!1.A7N9F1$,Z]_FF]F\&]D2TO)#B6%96@CNU7BQQCL*7,C*<@*N58:N M(;T/DD.*H3#!HV)QM_3H'1]XQ^.K7W>2G Z];3V9B;,-[M5L%9=U-?EQ&T[W M@'DNO P6VK375L6*>Z!Y!9Z#82$5ESQU;Y<[ 1S4Y)S^E$MO,GL\"VBKNU$O MIL\5W]^[S7/;FO8T=C9-/\^><3;7\=S\?=]NEV?3ENFLDTB.60%6MYD*S23V MTDBH4I7$O"Y%[79YL>L3]P^GKY_SO:$OWM7(>4O,9K$ERP:(C*$9[PHOZ!>B M;J2VV;:?/P2;I3]Q_QCEON?.$UZEG"+8\N1,XKG-X3&AY4M'I< %7T&46$Q. MV>E,7]GV XPAN-N/P83[R6%(Y\F(]WVBX!,>X4RYO*X'/55XU;DV=1!UMFA< M, 4Q,H-^3:R:922;O'6+'^=4^1"^_H8F^'P<)@O\WL/ZH2S*_$OKJNY,\B$( M2$S+UC58 .I 7)U-24ECL@C4XY]N1_7T3J"[4.-:O4,C)?ISZ5^S^1^ME>(L ME<4E8*98JYC28&QH*531XH'I)4AMK>>5^RKI+_AOA?7TSBT2_A#)B9Y ;\;3 M\>*HY%8^<0E8U*%:V6HET#T#%;('GX)LO3A%TCF$<-E2IR/0];"&4&;Z" 0B MDM/C&4*;=J]ET^XU3/.LY2=LMBMT%1.]>-QW>7#O9M.]=X'H0N)BT]V#:5XG MB73//0W4\)!UD:ZT.U.\ :]]Q,>N\F_.PU.+T M*1=_>K8)1:7B50 IK0.5T64)203T,V06Q=7J=YS<<>='#\'"ZHLNE^?$]"@4 MPK';VWMP"@5AI"2$!0V4 M(4W,[)L=%-*@51\7<8@0?+*:@TLMBIY]:;]S@ 1ME[=%2?*& ;?9XH\[%/-! MU,7]9?!X#G<'? -YJP-X+S[V+<_JW:V^RUJ)/.GND5O/.B.'J5IYZ2 ;ST'Y MEDV5>02GDLZ".31+2Q\OZ(]0]NM+N%HLT3N;HY.&7X7J<#.?X'29TFO)"[X# MQK9N%BDH")5;T-IKFT-5YG*&_W7]"6]^T)"\80J17^PQ2+C)A/;(NOC_0_E2 MIJMS+%%PITT FY5ILP8CH!+T(+AFLDI=.:/F]=5(AN3Q4C*"8LHJE5+02N:")?2IT G'[T!^%BZ]DS6P0N[#W(AH2,YN']P@E ==YF8; M91,F;V;SKJYQ';X["M.M6L?S^%UE*L>VUN! \1P@)HF6M-3"*01?0P\9[SNB M&Y(/W =W>I)3#W[P%0OGWGF7*P>=@@ 5E(/ O 7%I'716T6?"W$3GB%YQ/V< M042R(.^ W&6JMVE*T[RX:"WAWVQEAR51T1$SK8UIHW!(&B)W"=UW4S@+'/]/ MGSQS)XA#5Z6H MZRMO1G3'GHQ/CC2$\N@]\C*;SV=?VZBMC^FHY-6DS.KYS_8)L^STQ50QE;NO M@BB \JK$95=O?3)>ADEGT![&R?CSNE\&BEIFG;5LLZ0E*%82_WY.I??O;Z6(Y7[4^4:?]3C9=AKW@1C-F\+V1M341L^!219,N M*&YB*M%&T<-JK\/SA,ZJN_#D1P><2"1DA]:;\;1=OET,/&ZY;UKKJ*LM8!1# M4"V!(HHJ0.12E!(*#UEJGMP"Z0D=4_M0A5(PM'[UQR-4ZNT$/5?<(RU=-EH; ML*&VE2(0YWEW/B<>@Z\^48> K\,RI,N"'OE!(@I:8FQ;5EM,-9%5M, Y5"&Z M;JD<8D(U)Y7-B1M9+'G%T@UPAG0?T#<]" 1"?O^\T6M=/_!S3%TI.(M"\I!; MSPK3!MEZM+BE:$."< .R2Y&\E="MH 8U"*I7PX12.@_G#YU&HS=Y8B3AN6N^ MD]P#V@4[V4C@:P84:BF*9(FCS=FN>C0ZN+&$A%ZNUL)JGE*D+P;<9=#D_==X MMIT12:N2-]E6D#;B*R%4!>\U@U2$-YZ9&!RU]7H%C#LZ-WWW-":@PG670O?= M>\)3)B[/)L\='X^7F]DZ72NLYGPM%JLS!3>23(ED+Z4+6!*\&!LT)K M'JM(G+X_T \PAN2]]'J2W'?K^S8]WX3QO&L9_1N:WZMY6;.UJR,(T^V[[Q$6XWTND_N 063@]KY#5$U\.TAGCVZ-,B>S!F@4G$]) M,PD+>AO [,OJKLMS#_ SH8T4IK:JJ&NJ([64,0XKD]R/_O7:=+C'A7.=>M4#%LZZIX@)S MZV$OC08GF (?O"_,^JK(XVXW(^HEY7BDO%,A*-QKW\8F.>_!:^,@QZID8,DK M01V&OA+(D+0>(3-VRC6^DQ#(^'_%H/KU+*?/[1)V-EV@%3/?&#N;B[81]S)X M4QQPSM#OR)9!3*BN=98)$4O)/75@[!XPAZ1!>^12WP+LVVDX2&EUO.JB'.N2 MUMGQR;PGV?NPJ;93+ 7#V]19V:KMNJZ.'JKDQ10IM2O:$3'(Q>\WCU\/K MT..:A,7B;-3E&:I12^K&+7*0"KZHJ)\]>O2\0)8R!Z=\5H6ZV&(/N$,Z5Q^2 MIU?>_#Z Q G'8%V$TV8MWJAEUNO9Y/J^1SMCEL]6$&(T,6@#W%54^X4+"&BF M(].*M8$K602U:TN)?U 1_\=D\:.18D=;8//S]DL,B_*WO_PO4$L#!!0 ( M *QY 5G38K]?.DH ,=, P 5 <61E;"TR,#(T,#8S,%]D968N>&UL[;U; M5__,^O%^<_?,'I;#09_]O?^+^R MO_V XS3)H_''?_O;/S_\ NYO__/?_^5?_L?_ _!_7[Y[\\-/DW1Y@>/Y#Z^F M&.:8?_AS-/_TP_P3_O!_)M,_1E_"#[^?AWF93"\ _GWQSUY-/G^;CCY^FO\@ MF%"K7UO]=/KWJ*06QFKP(1107FAP!C5@C$Q%DXJ)^?_[^'>C\9__+W^$<,,?Z#EC6>+O_[;WS[-YY___N./?_[Y MY[]^C=/S?YU,/_XHZ#-_7/WVWY:__O7>[_\I%[_-O?<_+GYZ_:NST;I?I(_E M/_[?7]^\3Y_P(L!H/)N'<;IY #T^SZ__X6TT^L>K']*OSD9_GRW^_9M)"O.% M@AY=P@\;?Z/^#5:_!O5;P 5(_J]?9_EO__XO/_QP);DP3=/).;[#\L/RRW^^ M>WT?Z6@\_S&/+GY<_LZ/X?R<$"\^8?[M,_[;WV:CB\_GN/K>IRF6C>A72ZZ@ M=(7S_]9/^W%O3)\(R#1=1@3Z+HXKQ1MB7/?I^V.^_BS(6,+E^;PAXON?W13O MY"*,6@KXWD3\6QR/LIU;WT_IS_K9CN;E/?S2?KCT^0\TU;],_W+^;=_CL-E'M&O M/;Z._Z+G0-U]F9%L 7B7Q]Q:%O%G-![5+>D-_77YK(I_@ 7BUSF.,U[M62M MYY/TW2^=UQUS-0TLGD0^@ MA%;@O49P(@540D@?RGV"S%:$*V$6%Q19/N+'*O$?\7P^6WUGH8.%_#>CN!)S M@W5]"/$&^*\F*Y6MGPY M.YTQ93JY:*K/^:29&*\T1:#_]L-D2G0FLXI^M-@Q_I[.)S/,__:W^?02;[XY M&<^)U3^?+QY(KS!^K%\T8\+5Z_1JA-G]A;X.@KMR88[F'Y:G%A; M@3J[8XDT8L-:0 U9L-&2>H #^RMNTI?4!Z.$Q\A%]@@I9@$*$P/G KT06BHM M?>%9IZ=+A>^,U,,SH8NP>V P;F8C!>FUZ\+V_4LJ:QMR)X6QAVH@/25EQ*L ME5QRIT04LK'V[X%HJ?EU!O]]M3=0SJ2E9.^KFC54]>MQ.K^L$9X7.2\$&\Y_ M#Z/\>OPJ?![-P_D2,.8,GCC$(3W)DD53+:J/RIL!_+$J-*# M9GK8-5ZD='EQ>5X]N+?S3SBMPICBI[K%?D%:PN0"ET!#SH8+$\"J;$!94R H MB\"44%D(D6)IO9ML#>X4J-./)NY31NQ+F7HN6RU0C MOIP.5.4A>I'!H/'1.\Z4%(WYL1[)*9"A@8SO:U[NJWEBX13##'_"J_^^'M^/ M]+R;G)__,IG^&:;Y3.FBDY8&BI.TM[G (#JO@4E%RV<*F6M]ZG2$.#Q7&L7>J:]M=&E",SI2(AX@$AF-5@,UAL=/*)K'L&Z MB^+$:;"?U'LP)*[,Y-GL$O-/EU,BYN\X'4WR%5\7?[XDF>1ZKI(5M+@U/U6&R"KQW%M/?)@^R!*-YC/@$D]ZJT'RV4#Y/\(YY>X 3%C MY.-',M\,9@7*NJ-\ED1KI;7[/%-[N]/Y/R]G\\4U MZ(?)!L=_@3S>1?X.272ST1S?X_3+*.'54M]AFGR\4NEBU6>BI.B#"\ ""5$Q MEB!X9T":$B*SAK[#6WOA/:_IM#E\5(RXSWC=QJ*ORR%I?0A?_\]H_JD*DMY6 M^L:&M]1S9751$; X1GXLN; !"QD>$9T0VJ&3K!>COQO.TV9F[YJ[SS;3<']] MAXM8V8?)MM!+%"XHQ\$R.A54, *\EG12."=5PF+H6_UMG5WAGC;WAM+C?0K: M?2FX*3C[9C*;_8;SMX76<6:R*RRD!-D7\JQ0>'I-!()/V7NI31:BM?&X#:[3 M)E5SS=QGC]N7/83C!M29M#Y:50(X4R^AR>.&F!.=W41DIZW-UK?.4OL.P&GS M87=9WU>\;Q_Y1.83G98%N' 5$!VE46H%+F;C>7+*Q>8IB@]'/IN$\GP0F$/- MI*B7'4JC@(B>@S*Q!/0I"1$'"N7]CQ_O\/H-_76/A%XZBT:S2?F=9$@GU^(T M(C&^O[RX"--OD_)^1(9Y&:4PGK](:7(YGE>7=7(^2B.<_1:F4_H77XCY\S Z MG^V2Z=OT^6U2@/L32:/<8/*7SL-LM@"Q7.'RVD5(J=/"<7(Q$5&S@JBB!FFE M,UIZH9O'G#>"V?].]OL/ODJ %"DIY;P'C-: \CZ#"S(!SUZE% -3,?2\PD'S MAMOH^OY=[+ZR/706\6PZIU7,5C>/B_PW'WUQB=>+Z5+QJP#>)TM[-2\RD2FD MXE:I@?39MWA!?[OAQ)K''BHSN($.)VUDV? ^[0Z45=K!%F"ZI %OK^!#I/WN MK8[U:MU#EKTKV!8M,Z9(.UA- LF:@2=;$30:7;C6/-BM#*SC4.R&)-Y^]=I% MA,WU^6545_Z6;*;19'H=U/UN>[H)CRP3?[1)R>5@H9B:2R1IUPO>!C!<.NL* MN46NS6Z] [CAG,@&RIP,J8D>$FBN'-J;)*)E-?'B_4@V\QC)36:)(ZBB/?E@ M3H-3EG%O W">_E'?6N8]I%!L@+9\,[8!UU-%T(/ #E,9U$R-V]%C M#QWTD'/U,$@;:0=E]$YHHUV]0R2061NPUKK,E-=6]I"H.31!'JD7.@P_NHB^ MEZJAV?QM>1_.<95C+'*0Q@@%EHY.VBES+8SR#%+B5EG/"XK6Q:3W0!PD+MU* M2?=*0O:1< \F!%E02!_XZ<4X_X1?\'SR>5$D][7>L*U*#+*-+*B$-4IBRA75*M&BMA3[.C(O/832ML-Z6-Y/QQS>C+YA?S&98 M4UE>XD^CV><:NWI;SEA$I0*Y8HQ)"2K5"@5))K@,.MO@,O+4.I2Z-;CA2=-/ M&+(?;6S<7UK?G=1[V\QW0YI87@[.>OM?80\R_$S5L8W][#>$--'X7+)FLP2A U:5\#9S-Y MT=E(B8Q<6]:Z5+P5]KTO,=,GS)?G^+;LB>C*U31.&5YRH ,!,RC+!7B9%!0F MHR)!VB1R8TFV7<%0US4'X>Z]++C#*?_0UT*-]/#RV_H/6#A.TG&=G&5 9YNI M^8(!' 8/V>;@>-0BN-;U&CTNYV"-;0Y(TKN9>T="ECYJX=WP9? M3_&TQ[ =)J1V-&38BJ1[:O(0C//&)4]>) B#'I3P"6+MK\K)DE=.E&)*ZY#^ M89CV2&SNR1*MBP+[*K6]G3W]^WD8KYK8Y&0-,J1UUZ- ,0%!!58[CR2!V236 M//GT 3C#N^EM=;>N=*V!X'N(_^WY+KVXJ&E\9\D5IYU ""PR$HXTX#FM*4MO M?= :23['9=A= 3\6G@WLY@RO],$B2^_P"XXOF\20-GU4FVC15D ;Q85^&LW" MQX]3_+A4Z/+9-V2R//,4DP$C"ZF2['\(GGN((7@M(TO,M6[G]!BF?3>V#9]_ MY?.H8)@4A8-$03Z/R@YBD@YJE:1A7K)@6U]K/81GJ!A+4Q[A812/F8@KO_H83-@&\E[TDQ8#7W4!9J:!)'F M>-7GY16=]-.0YM=<7271.!9#%.2<(YU!BOP2DLHHH$@ ITJF6@E%/=&IF[*N_GPTU'?C@)K MV!_M.SRSVG[C93BOT\UF/UWBZ_'/7^FKV=O"V=NRK-^=O<.$HR_5(UAM&TDC M'0@",G.BRJ% R!A 6T[?5:2@NXU_']'U;CA.AA8#J*&'SF=+P.\_(7Z?.HU9 M*;0F@L^*0>WG4&1GM;4&(/T?=P)_D 0HN/#[%#^'45ZFO<]>C)>S#RZGTUKUN\AN7IYOT9(+H@6#$I#. M-VXY.(D((I;D,\]%-N]\N3VZX6\56^ET,HA">KC&_D"_1^;0=!K&'V]JQ*4@ M.\L8 UZ[!$IB 8_6$\:2L#@ER,EMS)*U0$[.U-A?W#VT=;X%IU+UM\DXW'SG M WTU"ZG*8479;>#VE<#7#>IA+)(&2KZ;=S" AOI(S.L(F\O"LF"Q]@)P]&9) M#5%*!M;2#DF[H4JY^7"D8R#4(];,X?G413&]E->>TW+]8BK=[^[V$Z M__9ALNFW5S%YEXU(RM;FAY'68FC[%M8"]]D4L@A=T.V'N+7#?X#,JS[).4H* MKUG,7WSNGP.];,GD-M4+L+J$=Z/9'R^_O<1Q^G01IG\LCJ=@=18I9"!/J:99 M1D'R\QE$$$4H'RSWK5V(QS"=G#?15 D]1+/OXUNA6_K8V^#KR9-X#-MA7(>V M&GV4+@W4,<@=GB= MY02&Q**$DID%57,W GGXQ-5D$IG2]$=K'CP YSDX&CN)OH?):?>@56"KKI%; M0!O*O;B!=32>Q6XJ?(P:>\I_"'_B%D2=8G:2*1!%2U#.2@BH#11/T$MPM4/< M4Z=&=R^B=V9T$7L?C%@F"=Z#N#SI&.V.(=5*]7J^*9:0/"@R>[-QSBKE2VP^ M>.P12$=@8.RJOKNT:"C['ER.WZ>3?)GFF]!A5EP6YX"70FX0<@TN:1)$*,Q) MSG7!UI[FPXA.AQ@-)=^XXFV)[.UT.4-VL37FG$3M 6T+@XJ> X^>DLGL7)* MQ"A\WFH0YB/%;NN>?3+V91/AWE?VS@-2;^&I5T-+1+,EN;?1M/[&ZEJUD+FK;&2 .=/Z>)UTF4( RU+1L3!;\IWS?4,9 MSKV/'K:RII&\)\V$U4N"Q54%9KU!7UF5B]S:WW!^IC@:82T#QVM>+;(ZV<8K M<$%S@U%EC#W-6^UM1[)B5&A@;A[\/#OH/J-G(HE,&,#"+CM;@@$NN9!S=@3IL*.PJ]AZN#.\"N_Y,F'\>C_\;,SZQ&*7U04!SY ME,I) .<8\",(E_)&(00@X;"LXDR2?J_WO-A;^$Y,;8T$WW#8.+F MC!IRDE9F<@@\JN(E8*D9>HX398420.ZSE+^7RF0EE?V;\C[RP4U;]'99Q% ->[.TP7M?0&>607'/:M4+@(_=,/> M15CWY>6,I#*;_9,TL0CQJV)=1LG!&FE 287@XB*R@=0WZ6\/D0V@21LDEUD%J-6& MY-8$#[[4CB$\.\M,#(+[H]+@ADO%_A7815*M%??.9QAWD2VD_T%T[H?[J+DMEQ6AOZ*>91&UUUZK9,V M!YG!!O(*%:MCR;D48+5(,H0<@W_4O'[X$4]8>VW$UOIE^WTRJA-\7X7I"@T= MXD;$D, 910N4Y,U%SB2HG'D.5AHEM[NXO_?13UAY^XFI=8O;7TD$Z?(\3'\: MA8_CR6P^2M<;@\F,2^4 ;298@M,AH",=!UI$8>M/RW;:V_R,)ZS&1H+KXQ> !W8]11GH9[B%DIT'CD3L>C6+2E6SS["F-4^WN5.(AUL3-3[ M*X\SC/,_K%<1O[_ S_?OJ9RW_W1X!K$9/ M;A/AZD,,C4)@RT=%]('\%D;2-S2]V70K'V-=3]+V7_3 M6\)8OOX/@YA]CV*9+)VE5YX7.@H2O=N8"GCG# CK43+C3=*MZY?W1SU4\.X8 M&'Q_5QY4YX>.#%ZK8D[XZP>MS)G5 A>NNRDZH"P.- IRYVPD@\9Q3BN*F]*:FME-1'W?[RQ+LR@;EO;:<9=TZBV8 E3]26SN8QCL(MW4LYK=J M&[^XP.DHA26JE7-::_*<22 PT?JB"1"+BL!D2L*R6!)GCYG]#S]B>-]O#[E/ MF@NM^D MYB._/HW&X1I'SH;^5ZEC08F,X%%$P*!YY(JI>+=_\J890CRPY"./;]I"C-+& Y'7ULKF (X[.BB\1FN%M4DV#V:<;'S3&6ME M('^&IURJ$6MI"T@.)%FVR+D,*?P5WSPD@WN(;W;1^=.(;](ZN-6VNF*EU"FP M"AQZ#BZ5S(LT(F%NO26<:'RS$SDZQ3>[**GW(- ?A#A??Y"4J^I\&$;6H M#50"1 (#13%K"I>:F^UF-A]M?+.3W+>+;W816O_Q354[TAF9H3BC:J\2 TZI M K5AF74J:X';A:B/+KZYL^KV$U*?\4U67+5E$;00M)^4PB$DE0$+S]*3B6O< M=L'H(XIO[JRF70739WR3GB>RU1I0B3HS51OP]++3"QY]L4QZS&XK!1U1?'-G M!>TJF(;QS06.Y7)>Y/^\G)$]_O/+UQ]^>G'L!K0 ZB.LUDQ?@!7JHH5:9 M.89T=X;8!E6M_?C3"6;NXE0W$GOKT^_59/JY#A?#NYB<1&DX \9J!#\:VMY% MX(!)2"VR\_GN1,1-V^KZ!_Q%AB:B[\&#>3V>XQ1G\ZNH[7)<=6WAYA%1>YW MI^3K=#D+T14$[@NM%#4SS>0,;$,XF"]E:?I((DA4]9 M*#JP6J>9;8_N+\;UJ,T>NH7]8S+)?X[.SU]?? ZC:95'%<^98-D(AQJ,S76L MGHP0I'/5B'/6<4,^<>L6DNN1_,6G1EKJH1O8#9JWY-6G<6[&%O;@ON+8?WI MLF&OL:M">UKKV_)JBGDT_R54DM@O)[@C@+W8- MHKK[='/[7<3\<]%,(IS_A'4VP3O\>'E^53E;VTV,;D 6%KRT.@/*&B]33D!4 MD0.:8)+@F3F^76QJVR?^1:A^E'.?07Y?"^MG(O7D&^)+').:KF9=? I3?!EF MN* ^CF=7[BL7SHHL+83L!1 SZ'S&DJ&PI'-24231VL+:&MSS)ER_NEP3,MVS MB5#X^GJ<\6(\*O2"5#S?!>1H3Y5>1\&!:0RU)XX"%S4'PZQ.R;$H3=EJNWKD M0<^;-,U5L88G#6+K%W0F4#[*&V=R9#G(&SK_K]; 7O>!.M/AVN8UN#Z_>I6Z0J-D\&5.M\IE@7O M/>V4T3K:))5)6G N[\XN?>@._M8G/V]*["_L-:K?.S#^/4%KH_S1^)+$L90+ MK?XEELD4KWZ/MDR<_?QU/@T$8#0.TV\+>=0Y+;7%_N1\(=GE3=,93R%X$Q,P MK%D_,CH2D$!B"GKA1"@JM(ZD][B8^/+FG=!]5.R]3*]0G+;%\@#:U;Y\LKZ?BVG%G!;* ME,W9M;[RW@AFJ+JF=KJ_NVVUD?.Q%!W=?EO?3*Y\EZM\>8D\E(@@%SN[1@'! M,U]K7FUDF*5DK9OU;\)RJ%*C1IJ^>^/<0N(]Y%^MPW6==OHXLIXJB3:C.DQ9 M41OM;4&)/40_,#ER9E:C ?(OD$Q [<#5D!A7"I74)F7=NE9Y:%(\4G@T.">W M>-CPKE0KQ4QZE&KK;.V:9_ (/&E19W*[0"E+)E4P$:(A>#$GH7E04K'M!D,\ M_JS3T'ECF?:PZ?]";O8XC<+YZ_&,;-%%!4'=UC@Y_,?? .6T+,,6\NXAK?IJZ@).%_=@./U2YRY\?%O6H)U]H(^-JZF:Y(N26N4@U@\!V7K(.@4%<@8DT^! M16W#LV/J(Q;QT1.UBU)[(.AU"=9/&.?WCOUL&+(K8A"2 M*\TY:]VPZ$% P]M;A]/UO5F^K135T"1?@5LD_;X,Z0_,]Z QQ\@4"0EB1(*& M,H,3T8)FQ@6>M)?-VZ$_ .<9,ZB5DEH[\B\^XCA]>SD9YQ4:H:R7,GL(I3;[ MK3.(8V*%W)D8L[-X'BHC7WP)H_/J!1/: M]^'\SIFY3 V_JJ9[&69D#C(ADH@,(?@:'Y6\EAO0<1H5\SS8Q/3=88?['U(= M,0[/N?YN+GO53Q_VS<-X4[J\N%S49_YC.JG#[:88SNL":DK)5>K(A_#US 6G MC':,WH*:&&ZLK-DI#!P&0?NM*MJW3AUJ OP9,:\'3?;@M-U=Q.TDEMO+.=/< M9\2T:-"3ZAS$2!M]KL-(H^(BU1J\UO'1;;&=,JF:Z&.CT=4Z%VQ5*!S&^75M M:?UQ1"NY*N/\#>>KG[Z;G)\3_?\,T[Q'.MC.SVJ3$=9FJ8V2PE:/N^$@^IR( M:1IX,0%4+,3!XAFPS%B)W'O?_'6]!V+O]I_I$^;+Z_S9P.Y'DNJU\/]4;DU MZ"5G8-%&4%Z3CQK(@0@%-1.2_N-:#\T]RO[2333>J6ET%\GWWCEX&S#/M6ET M)T4]V$)X%RGWKOH@(YG46,"RVKC360>.U1 "&F:22DDWGP-[[$VCVVF\BW ' M'(J'1D?C)+ 0-2BT!;PH$8QRW*84 L_;E8@>;=/H3G+?!Z'UWS1:"ZE9 M8AJ"-;511Y;@(CK(FG'NB:;Y[BCLI](T>F?5[2>D/IM&2)SA]=C6E]U)ACV$]3>TR..L:%\9QBW6L8O90DPN ;/:9*%MY#OCWX&BM4RYO,5Y?3:;T<7]RP7G7T^0>):H$T"QY=[;')C/#$ST1( MD4@:0DH^,&&U,#TQX7%TI\*.QGKH(5GA>K^*+&+,Q4/VM$LI6EX=6)! 2#J^ M9!)"R-9]2;[?\X>-_?\6IK7^_R)/[]%]GXJD52C()C@RRLBWB5+1'UFIR#5W23:?"7AL MT?TN^MTVNM]%KH>.[L^F\[-W]*[A(F!EI!8Z,%?+CW1%;L#YDJ @&?LRY"38 M5JE;]*FWV$!_NV'"=P\\MBA])\U-]I5@0S/I&L32W]H&1I^N/AYY MWT/X=]6WA^1Z5"13-H;@(Q2F?>V0HR#4#CF1)^>Y=*K@5OW9#ZW #7'T]OKK M(K#&>ON5)'5Q>;$$$A-#;:0!CIH6$V4&KSD#LGQUW4Y,X%O-G7E$<]\]=#CO M8B^Q3UK(K&%H80$D?+T%1)E"0D[DZ*+1JRET+@##*)*4PI#'VT)YMQ_Z!)6W ML\QZC!#R5F/)&(U53+:.!>^.]JFS9R ]M;Y]VPC[)TQ3##-"?;V MLZ)T4-FZ>LFQ:--+&)5,D 5W4:(KY6ZJ^(;;GRY/?:K$Z%>\K2_Y=J?O:DKB M+Y/I:E%G47NF7#9@'19:B16UO62L9HYT=_MBKB)80TMC:(X'S0.89T1I\U J2 M"H9[:WSQK>>[K8$Q5'RWA8[O#Y7<3ZJ'CO"NUE$;1LUQ>E'74ZM-%Q&7$B4K M)2=(A=42\CJ>D."#D0ZU4-'27QK38QV.0\6!]];MI+&,>_"+[V):IO5L@ZJG M3.WUB Z3LKV_QAZAP![B'HX,FI%ES5( )VMC'<\->"TL9,FE#<4JJ?O>!@Z8 MQ#T4![I(N0_=WQK=M[KLH)5@,!DX"Z%V&*6]SMH, :5@"6.6NO4-\'T4P_L= M+?1S5^7[";>'R-B=&8V+^Q4LTCB70)A:C\!X3Z M!%>"<\BB .ETY;4NX(1/X!V7PN2H&+9N1? @H!-@0#N!]_#>?V_2++:V+%,. M!0447DPMM$'P7$40@M.6IW3PO-]HYBF9>'O*MX="IN\1_18N5K[+-KAZ,O,V M83J,J;>OSAZDP)X"[WT+N(5/(YU2GA?:Y1QM3Y-F#^??]DN_DR21!Q@@W#+@FJU1%7T?88S52 M!6:N0Q*F=<_FA_ KC]VT/B/;#AJEDLOJDI"V]&(2Z(6B>:+HKRYM>] M26ZUE?U],ELHX>=ZISZK!59O1K/YF8LN!Y'T65O4W\V+N2,O*60D'G PNN$<1[ )8N@D]>(CDE[]T3JFVK/ M@D"=Y-Y#;'K1#.)Z3ME-QL]949SQPA!B*@A*.P-U%!EDSDW0LB1YMZ?)WGS8 MA.4TB-!$TCVXK@M&WR(DR>>%SKG$4,JLP1O"6S*KLM+*)*6]$Z_OG M!^"<$ \:R/L^%=3^9FQ! I*7>U;M&#Z[0?<;SL\\!34:="BK>SODT.W\'%>C/.K\'DT#^>+\^QM/!]]7#27F)W9 M[$52'H%)%NMD0W+NE"]01R76SC-,Y=:FZL.(3H46S:1^GQ.F1=K2:AM[M=S# M;$9KHA& 6H>%;P_1*P09DD^HA73-1Q2M@7$:VM]7OO=5;ENJ_ %B&L=%+@0K MZD+>CB\:G&4"#'DZ4GFIN4\]LN#4MX4>M'"?*Z[O>HD6+7$>^+36E1&#M+K9 MQ!86E+>QT,%O"@/%JRKK.""4*EE++SV6?@L&WO19#H$ED!M,IY?AB5975)WE MX"20?2-283'DW+H:^ C+(;KH>)MRB"Y2/99RB#5I02IS&3TC8; Z(,9;VC*M M<[06;D.V69CMBOY/)CVRDUX?3X_L(M^A,N.VP?0'ID!\$.GAXIF6>1EP"Q. O*:0D^: 1& M1YDTM1UH\\&D3R$]:!PS6X#@!W>\MWAZN&==D?2G-C3,I0$YUWH:JIYE3!;Q/+/.0&-7XK"VP;7,\U([:3SK;-A-Q%X$-FQ"9T5FB,D+1+H$+D MM>#'@.-%B20PY-!O[.?X,F)[X4$7.0^?$1LC^2\Q<8AJ,EP)\AS AFQG532+2.VBSQ[L/C7UNYS*Y7WM$C'E:AE.81.6 4F&>]B2":Q MK5JO=KP4.N:N)OL<^GO+N(=LH@TE_-N@>JY=33II;+N.%KN(>[BN)J@,5S%K MH"/-@1)2@U>&'%%=//-)>=E\$,RQ=S7I@0-=I#Q,5Y-0<]LLG4$LUK2E$"(A ML@Q0EY""*,A+ZWN<^RB.IJM))_T\WM6DBW ;GO=7(_\F7W E:@2L@1^=LC-('$[8RY^Y_]E,_OEN(K&'RYQHX2X9N VC] MH;V5+@]Q$#>1_68][B&XUA[76F"1=IFHM(:LL([<8A:\#0*2RT5*1MO/W7^59JW/R,X8[)1M*?M!==ZV/R12$SX ;1A\GUUVH5I=<&@^0! MD]>><#%7*U.CA.A( B8KKW4RQ7JU@ZHW/.Z$U-U"H*W;T"\0?H_J%BGUBI1< M&69")A/1$!4%5Q *N7O9D[EHZKCRO-T<@JT>]_15WE2@#6-=:TBY0L0$NFS) M%>"A3EWA)D*4,H"+2DH7"->6?1W6?OS35^E> NNEXNV!-@*2,?*@N0$M5)W' M:SP$5!E,T3J'Q%#(UFV[GD;CAG9YRGM(O(]+BUMAE>OKE*M96M=5 *_"9_K) M_-N9$T:B3G3 2/(OE'0,?!8""D97(AH>FW?P[X+O--C2FT9ZB'C^/ITDQ#S[ MA213<<]6P,]T]DD*'4!S*6J42()'VNET\-X(Y#5ZTD74/:2_K M"/L.JYR(J?0"^;R&:$IT&7'K72 MPQWJ._PJUKSRR.MV5DRN@V) "69R4PY MD<-V<=OMG_FT%=ZG@!OV5G@ YNLQN4LX6_S]!N[55-XS7^N#?:K3/&E;4I8' MB*(@2!NX)3=PN -S]V2?+BV8"W]AGH;]"ZA7VG[]^QO&L33GUAL]L752] M#?2^)\UAUJ$(\A:L3*!4(I-1:@NT%3B-W&MY-R[WE$JK56(6'6?@;*B) =+4 MF8D,15M; ?2;9W\4I=5==+Q-:747J1Y+:?7:S*-42K0^&L@>4YWBZR"& M.GA!^9"3D464YJ.&CCPGLY-NM\G)["+CX=+PMD'U7',R.VELNWR\7<0](!D" MY[07(B2V*#A#!B$6^@J)^KZHI&-K%_/8$Z8TT+@2@URQH+.!5E;3TQITO*$WSAM+'W4IEG[-^3_GV$'U>7TN\!:;GV$JEDZZV:J>Q@Z"':J5" MAUDN]&@P@EP?98JBPTS7 0PQ).=XDKIU.^=C;J727/==Y#M(*Y6HK&6:?%UC M5:2S1THZRLAZH6/,D@^,2;/6;3B/M95*)]T\VDJEBV ';Z6B _$;B-3.0Z ?6Z<)\:IV4\!1:J>S#@'8"[[VH_LIM09VRXK2A%23+E24-7J(# M8\AX+0ZML_T.F#HE$V]/^?9P.?Q +?GCN)YK7XU..MN^GT)W@0_95R,49V(@ M:.2%TJ87:JE#]3X=L[$PP:UVK3LJ'7M?C5YXT$7.P_?5L"PC&E=J*Q%;;TD# M!$M?I6!U-B7(Y!Z]%'QR?34ZJ:1;7XTN\NS!_+MW71KG9Y@8:F\X,!,P:E6//FR6M@'%K];YK<]>TKWQY47C&\P_,PQ_QJS%>^"6O9[/+ZY$A9RQZ*2TC?DKR3%1,"-%:!2(:G64QHGT+S4X 3X,F_>FD M]0GQ$VUE7Q9=ZV]D4%$NQA"=*9FRD[71!'E"=22GA2C=HDVH9MYK0UO:EHE$ M#SSF:>N\L1A["/NN-JW7XS2YP"M(*3.%C@P<.OP0%*9"FQ;ADH$\U<"$MK+U MQ38&Y_O5S!\O2:3Q;_XN7=?_'[ M>1C/]L@C[ 5'F]S#_D74*%_Q9Q+TY!OB>YQ^&25\_RE,\1Z*%^>+#Z*OWI9W MF"8?QZ/_QGQ5LKFP/F[> A$56:S,@F9(6Q;7&IQW#!AZA5(KU+QU._W&2]C[ MFB1]PGQYCF]+&V!7 4:/5G.C,M2+ =H(3(+@F .KLB#W@.=PMZO*_E1_.<;8,O>>B;3+)0NV,#2J5#)Z<<*##'R5S@G/9VK6]!V)XG[:ADNXF M,NTEX1XBW>_Q_+PV QGG7\/T#YS3UTM7;(7/",V=KMD;@M>SDD%(M'BI!*IB MHU&R=0/QQS"=$B&:RK^'+>$=SI ^\-,BR/Z%'/O/50#?0S3:&)&5AGH91Q"Q M]KU'#SFK;),/48363NX6L$Z)):VUT$- _$7ZK\O1;"'AZUL:,KA7/:<"$\') M",D5\A'LQG.9V&P_SZG]0W*5U.I[5539B-]HG* M]P&C35"^=P$UBLE?/_1E.*\7_.\_(<[_,9U=]M]^;YW]8A6&;IJI(5 M'0&0+3-7\XH<.2!0;(E:&ENX:+WI;H-KJ)CXH+RZN[,V5]"QQ+1O+>SZR_\U MPFDU7[_51D#GBQ@*AA)CB0[VTV/PZVIYAV)Z"'B7'WH?%-I.I-70?G6 Z<7"B4D'R. M=7(SP8_10C',,16#D;IU5M<1<.N1\/C14:N+EOJDU.OQYTOROJH$^*I+?J)M M64N$F 5!2^361^X*8/0E"R\RT[XO MV',[Q#VZ,B-U%F3RWT$&=?!TVLRENS MUEF0^YQ3HE,=;:$71#JPEHM@#7T9>[.%[L-Y;@3910L#[2"K"3IY$607+?008+^&=A6B>;$V1//V)BY#O_#; M9#S]+DSS(L[FTY#F9X7E4)+,P$2=R>1-H=V0#N:@;,HF\YH"TQ>C&N _( 4/ M&BP86O4]'(17UYS5FUWT>5@LX-U=)+F?6J .A*.F>VSOB4OC83T)S>H5QKB84'(8S.A9L@>/L^ M"]]C>,84V4L=?=PX+U!GT:S&.4D:9UZ8P((R0"8_ Q4U@V S!^[1*&N+ M$MBZN_!&,,^8,&T4U,.E]"UYK$%WO7;NA M%>H@L$TH5/3@>+*$407D>+>;6 M?MEVR)Z9^=.#NGH]K6[A/?..$[UI4R0O4A,HS\%I$\$';C7C.DG5NB?86B ' MZ/?9@]8VGDB[BKP''KR\G-7I2+-7DXM(+\95H=NX)O8M)A^,9R-Z3KBZL;\" M_>U,1J-TG9S)Z@@ >9(D@J9\85 MS;F.(&(-9#%,$#C34'*REEDE6/-PXL.(3I(W#96PT<(9)"7JMS"=+O;0UDE. M]SZXQ[2EAQ=Q+(E(4J$LS O K(AOE@D(U:*6D1@7I5'!*)2#88JR0O M$)#5'/>@P)'O"#$5GB(W0F'K&H.32D3JPJN=$I&Z*.A8$I'6M" 6JC@5";=T MJO8DU0&"5AQ\,3G1L5T[SK>N9CJ:5NSM%?UX;_8N A^J+?>PO;!+;X(E50S/H[Y6 GT)Z[DTHZMN?N(,\>+("U@P0Y M\XEY$R$+3E8)K_WG8W9DT H7&2NDQU,>L=J[%;"WT/NXU5\_8' ;5,]UYFHG MC6TW;W,7<0\W^! %RD/ M,W.5*6^DS RL%@I41'^UUS',(F+M^1=:6W[W41S-S-5.^GE\YFH7X?9D 'Q8 M+O+ZX#MSW'F4VD#DB@Q;EA5$3[0N/A*Q)1D_JG6NZ%H@3S!7:Y_KI/V5T7N0 MZ%683K_5O,>+R>6X9CA:+J544&C1M%J5P#'O@3&"F)+RS/4QO6,3GF?&EV:J MV7B.M$ZB6#N6(HSS_\+\L4)/]*-%6DB+Q(K=']8FV:+18ALE8&R:"'(/S4TB MSBV:>HN::?)W5&)TZJ4<(4KZ*F=MC$09!6M=9+(7X'8)J=L_?-D?F3QYH32" MP6SK3'9Z[PRYAT'1>^AQ021K#<6]SEFN?>CR6M(UUJWTWFOUQ MY:L@&9=1*R!K+B39GI-OJ_) MNS6Y\W9(8@MLO=T#;<9UJ+N@5EK<2(]&*AB:)B:*XA@YKS+Z4*>,%_!"UQ&$ M2>6B,_JLGCP]'KTA.@0[NDB^C]8+DRF./HY__IH^A?%'I+_^&:9Y&=P(4F! M58 G33NF+QZBR0R*]L%G3^X(-J^4?P#/(:Z46FGN;N9I*['W$#%XJ/U_2D:@ M- YHB0*43 F"4 %8T4KJ6!C3 \U'>'XV2"N]]#(1\J$&S]N ^VOZ2FM9#+_;)U834=[3\5V'VZ9?SR9_UY,5_T.K?3&:S#Y.7^ [3>9C- M1F6$^:?+VMOA-_PZY^)7LN,^S>H\U6*LU;Q*R.8,2I.I%7TRF.T[<=%W*&+MOH69VXY32HVM?-9:'( M@HPZ9)$$N:;]N&-[(G].C#V KGL-%MV2WV^3^4\XH\75J1@O9DM9WOJ%U?H6 MXZHS"TD$LDVX-+7I"2W *3):N%),&1DR[Z_YQXZ@GQ-/A]7P1I_S8#?4J^FJ MDW+[C+GYY_O,/6D/8N ;[=V$T_RF^X;IBG&]Z,&7M(_D^!0.(68%629=,+F8 M6.LJ^34PVNVJ5]&@$C7/)= +:U5M,*8,N7,1H12))@BGHVC=K>0.A.%OD'?3 MZ>;=J[LDG\1M+P8TJ N#9&4@B]5)B(PY\.>NYRA]M% MWD-?SFV#[:\[W,Y:[')+MXL*AJ:)"XA!\ #6U1[=R0@(5B= 9J+UM)]F]KSO M<'MC1Q?)MZ[YNVV@O?\S?'X[OAZ*:C0RSC/XI#*HK!*$6M[(M/%H31(^\,LICNHUJR?!MZR+J7L,L#=V*KI%UR(PKJ#%)G"4K4 MJULC Z3D/#,\^2+:S^=Y%-;PYD(;'=Z+OK150"]UUJOC\;=)774X7Q;R.LMT M49)!7ER3>F? &SHV4_(FT8'IE&*]A>6^QW)(X['UO<\>4NY5^[^,OF*^;=V> M.;):"06'PE*HQ)3@E*9%E^"8IU5;UK[SVD8XI\2!_61]?%7S-]?NJ_2A^QD8 MPZ8E/([C8)D)'4748W)"MBRB)ZIQ1?Z/BK6UG'<>D$X[CEH+*]HW7>T].4&) MXI*A4SH%75OE!MM?R0F=M=CE M^GD7%0Q.$UVB-:S0NU&[[/N4P"O:3R7/K"#+B+:_5+>GD)S0'SLZ2+[_ O,5 MP%6L'YT4VC@@)RV!RC*#E\G1J8LYRAR=CJV-C _"7 M-P0/;=16>:&(]>0;JGJQX(T1X*T@7\Y(FYJWJCSN2Y9]3(H&,A[RDF4;7,_Y MDJ63WK8-K.\B]"$O64(L1@NE(*1:!I5B 2=T!NN9D1&LZ/*U+EDXZW.&2I8L">C ; M?IN,\S7*50=F7Z**)8+,J0YATA)BGP2]T)8N&0\ M*C#H:A*&C^"5CH!:\1AD5)KW=Q%ZC/="O3*B4WEK!\T,7MZZ!;:_;I Z:[%3 M>>L.*AB\O!5+0IX2"(GDUFA/AJAD#&QR.3'/3;E;]/8$Z;%7>6M?[.@B^:%; M%#/T6 2MM[C$Z>3V"$Z1FVJME=8F]#FVMH6>4(OB3IKKTJ*XB]A[;@%8JX=6 M*9U=L!C$CE+%D)I'20^J1[5^QBAK?0R>(_J;<#]U:.ZLQH[ M]2#>10>#]ZA6*2:E2@"N&>VEKI"5Q96'Q(P(,NABL?5UP]/J4=T?/[J(O@=> MO _G.%L>?RYD:=$Y\,%(@D)&4,@^ 1.Y%)$1M6[=W?+6XX^MXW0GQ4S:2+4' MJ_+59#9_6VX#"DGX:#$ N4_$93<"][ M_95U^WV#\RQ%2-IX8&0A@PJ<>*@<@C%)UNPXZ7+KMWLMD%-2_?Z2[L$F7+2[ M?S6Y^#S%3_7HJ\9R%4"]*5O;N?DE%G*+;WHW+\^]!UD"3PTG]#7= %/K?WQ/K6TIF68YT@3]\K7U@Z-(OQ%SICZN\NUCYL MLL?FYQ\L[6-+D1Q% H@6114C$I #R4 )88B&7(%.)4FEN2Z\O_ZE3RH!))GD ME5+D&)7,0=7^E%$F"\YJ[;@V&/P0S:%/* &D"_?:)8!TT>,Q)X!2%6W!LSJ7 MM7 -S@<+Q444N19%RM;)IP/S98?,DH/1I8LV>J#)/:.94*[B5<8*+#H"BSF1 MG;!H;.<-&(\Y^N\,EZB+?EY=4 YMN.RDF1ZBR@^G6FZ![:]LU\Y:[)3MNH,*ALYV M54(&0DDO@T9;9^PZB$X6VEE]5@71)-9?<=N3R';MBQU=)#]XOQ1NB]?1*7!) M(J@L'!VXM-R?<%%>2H64"K[D2*E0C M3$L%9))IRXHP0;?FQ$GE.^YCAK322\,A%=M=Y6\#[J]\Q\YJ[)3/MHL.!L]W ME"&;XF6M(E<,5 V/>Z,"1*LEBSR4T#S3[6GE._;'CRZB[X$7BQOFWR;C">W" M!*MV ZEHOT_@P10R\W00LD"'(YVQNHZ@9J!UB%:9E+1L77^S#:YCRYSJI,IU M-_TM]3!P!LK].^BM>UMS*$UAY0^U4\M8R4 M?>Y!#\R!@5E](V?R&,XO,^;ZBY,QK8]^:8IAAC_AU7^OEO@B_^?EU?IGR]7Q M&$C:(I"C8K 6VM2)&#I#ML8H9327S1,>^EW17VP_"#>..2?KES":_DO>8P^6@?6P 'J<2N #<^B0@Y2.:&2#!*_0@[$F>&V#,:)U-O( 4PGHE=12 M%SH":A\R5NLQ2[W M*+NH8/!;-BYS#B*"S9P,P,AJT\PLP07GDG+2!MVZVN%IW;+UQHXNDN^Q[N]. M5PMGI?&\T*EJ)2?3N[;0X;4^(TE6F+'D6-Q&B<0Z,XYHE6X)5[8N;GM)8BDXZW&$L11<%##260LILHL8 M6M;[JZ@5^)SI#UVBMP[4:JK4%LIY, MQLVH#F,TMM'>%I380_0#;0ZK0BEE1%!)0F9U.H\6'FJK*PB>]L7(F*;3ZHF3 MXA'C<6A.=)%X#USX?8J?PR@OT[7J_?Y5ZL!B?/W\Q6R&\U4S-.N+UJ'0VE6M M=G-T3CI#?VB'(BM!^R1OW>)\>W3#FQ*M=#H91"%]Y1]]!P@-*I%0 K>V=@R* M"6)MLRE+5IPE3J!Z:<]TDD383[Q]9=PN>?AF%.+H?)%,L@0GM'9.% M%1#*@ MM0P$SD2R?XWS69CH3.O4APQ'8;7,:;LIH7!TGY?I'1Y<7E>8V_WLY[WG*FY M]6>W2>#=;2F-LG0??/A-]O@-Y80IENFL(#%!/HC39'HHK8 QF9+GUCO1NL]? M5XS[[D];/F\91[3?"S!)&[[*&2&*E,"8+$I HP)K M'9)Y$-"A0OK]T>#N/(AFZNC!0;^#:>EA; .JIWC_6D"'"?4W5-RD+ZD/1HDD MHA8V1'"8<-F=)D1R/X7RDA5E4;0N7AV0"H\$^(=F0A=A]\" 6UOC3U7 F%_B MF+Z8_WX>QK.;TC[:)<\O\VC\\7G50WOUC6@SV;KZ!AT MWT, X=8*5R7;WXT7N%[9@XN0/B=MN""3T_DZZ8"#KWTA%-F#87@7V"\DR2UDMTSW^!VGHTF^7DMA M2JK$+'!=^TWEQ?M4!%FZDBR'P))+K?WLEOA/G*4'4_7 DT=7&->>!+^'NIBS M$*3Q-9G 5N-'.<;!)T(^<7(.J=#CM3G'@;<<#H, M@J-C07C(T3E.!P23O+7GTH>]V?9][C!/MNY,BQTH"@6FUK$IY1,X9@L4;[P1 M3'&E>VFIV@3],W[+>U3S_1=>]T7897^&JT,S?;OE(J^6]&(ZFM4*O\MI?<46 MIVI=CS&,.RL#)!\#*.,0/(\)2F'6)%3.Z=9AM-9K>*;D'43E]REL'LQ66WZ[ M_A'##/_]7_Y_4$L#!!0 ( *QY 5D_6/9L4_ )10"0 5 <61E;"TR M,#(T,#8S,%]L86(N>&ULS+U[;^0XDB_Z__D4O'. BV[ G-:#>LW=W0/7J\<' MU65OE;OG+!H7";[DTG0ZY9&4KO)^^D/JD:E\221%R8W!5)==(B/B)T4P& Q& M_-O_^OZX!L^\*+-\\^]_O\!QG_Y7__Q/_['O_T_ M$/Z?-Y\_@G%AQ7G(%O6?455%\Y^$=>_)$]8W"WQE6:%X\0_D<] M[&W^]%)D#U\KX#D>ZA[K_K7X&T%^X(51 !.,4X@2+X!QR /("7$0"6D:$G;U M\#?/"V/'\6.8HR2%."8(.DZ $I<'%'FLGG2=;?[XF_R#X)(#(=ZFK'_\ M][]\K:JGO_WTT[=OW_[ZG13KO^;%PT^>F/.G[NF_M(]_/WG^FU\_[29)\E/] MK[M'R^S<@V):]Z?_\\O'+_0K?\0PVY05WE!)H,S^5M:__)A37-6HC_(%+CXA M?X+=8U#^"KH>]-V_?B_97_[C?P#0P%'D:_Z9IT#^]]?/-Q=))C_))W[:\ ?Y M;N]XD>7L2X6+ZB,F?"VXKV>K7I[XO_^ES!Z?UKS[W=>"I^>G71?%P:R2RT1R MZ8:2R_]YB=A/$]BWQ&]URJL%YFIQ/]GB<0C33];8O1<6@L_/<(_,9):;#^K] MABWU[>Y(369]?HYM?19YA=<+?!9[,CV6U_(7'\7?6C)RH@%C6M-I37>/5?Z] MXAO&&VMY,#7(V+__1?QMM2WA \9/J\^EX< M2Y93=WW7128$+ M.H)L^\1/-!<>S5,%#T!.B_Q14]PJUWSS#=""C;^ O&"\$'[K&9%V7^2_F/C< MWN;/?(,W56.JK[]GY2J($(T\-X5A(%Q'Y$@7-(H\&'N!\"?=T/>#2$5I+\P_ MLZIV!$%#$?PN:2KJZ"5$AC73@IQZ^CB'B*S=O]1?UIRB'A R%7FZT1F1I#$U M\J':?CBA[]0VY-*P12S'",^=O1A[3,]*=-;GFOUS6U;RS97WN3!%@M5LS84G M?2.VQ8_\8UZ*W[_%Y=>[(G_.A./PYN77DK.;S>T3+\3+WCQD MK I,JY7K,Q1%+H6(D!"B(/4AB5P&4R?%,0L93GU/QS^8@\F9[56/95#EH.B8 M!F)/!=:"8?E;^7O; =OT P#!J.P0^2YQ_E/TNVP5WO5?T@60?9YD>PXQ[LV1>VO!7 MHF,U)[Z6?+)96%S4G9L3Y&-/<%9:>LM#652KST(]^"_\D?!B%88HBHD70-]A M!*(H03 )$PX#A] @\>'S'2;7R/=?A4GM2Z04A5P;SJ1] [F.>AK%' M8J$]_5"50KC@/"FESVTT^C;PU=VU9$&^$6[,Y@$*M7P$)"^*_)LP0*5NU.0" M8JI!DPDH&,9,GG8 I$#2A)(HD%1MADR&Y;(6,;E 9N& R;"PI_&2D><--T+/ M.!,_K_F'O/B"UUQ.^873;=$LIU1L;[=KJ2\_%V(=_G53<+S._ENHC_CI#1>N M.[_'WU=IRCS?=1 ,Y!_(]Q(88XJ@*WY+HL0)8]=?G43_QUUI&\P9V(9+YR # M&E)S /8L ,D#U[0+=EZ&XC9E,6R-+(YD!^SYN0([?J&@#27'XG=[+L'9%W % M2,TJ$+Q:W('8A,[6EL,*3\ON,6S">+*IL#JYGFUE/*LC5H5BY.#D^7F#K875 M;?E%YL]\V"6G?WW(GW\28YIO6OQE_RF?SK3(YWA1@.Z3NOR V9(KM[+R_^__ MMQ:;"*@8FOH MPK$L^UI;Y0OGU /Z(*-)VW8LD-69CY1?V5UWDQQX[-*W%AMM3=5E]Y\3'#)%O7?M?;;5$( M/E:IR\.($ 1YD&"(:$QA@A"&(8^#(*X/Y1V=D[(+=&:.L]94 6UH@?6>O-[: M< DD)E->4TP@$>LU1!'W((X#!J.$$APDC!(:Z"S<-D#27V'KK"Z0SPN5VGIG M 0"]A:GY0'H4Q2K5T+2W7(P(9$?784HX];F;2Y%:1Y@\;N5D4 M6\0W?,/3K"KOO^+J'_EVS6X>G\06H;&>V;/<14IKNDIP@%)A]& 0ATQ8O"B MF/((I@R[PA"Z,2>QCL4S8V-F@]AG"E3X.R M6_75 2KY EG-&. =9_5SA>!- MSQ(8O@8U0S$_N'IVY !700V\V>.**U#S!!JFP(ZK^L'/0\!JVYIIN%@R189, M+&JII@%U;,@FSJ8?O+HOL'0'O[P\DGR]0MR)7 _YD+G(AV1JUM$!#3,V\G$H_'KHSEDG/""B*HQ6X.\NZ4>#N<*;% G=G M!>@'[LX_H*<2G++5]7K=3G5=%'*/5!_%M:D1"A__V!QSY^6MUZ#[@/K$U;1B M%(!A);$INY[.7!(;_-Y0MA#_5A5N0*O$%.W"1]E>JT8G7D3)5,7K=$[Y>3/O MNW_R?;UA;_%3)G>D,HIQ2];90YV'7:X22G'J40*%BRV6+!\GD 1>#".*L.]$ M'B=AHN-MJY&=68<_3LX[441/S4FVCXF>;A]FH=2QW9HXV%.WY_GJ"6O)TU4D MNJAGJP?$L2>K.5I_F7Z;/SY=TVJ+U^N7.YRQW\I='ND]_UZ]$:+\H;I5$!I?SVV#HWGBHXH+^%UR VIV+"WV M.I(;+?I*!!9;_'7$[3L!6N,,<]?V61SOQ(YXPUF[-;X3'TNY3RO?G6_F9G>6:+="?43BJ=7&Z;\/9=7E80O']\6N=U?N(N.*69 M^S;_RU3S:_Y_Y[!]JM!* O@KSN9,]81E8_X*SX#:^W_#;=__*Z+'FU M(@XG@?@?)*[G011Y(<2!+Q8*CV-.$16KB*NS4*@0G=G4[ZF!FMP5D*R FI>K M-M^V_@<]0Z\$IYJIM@V2GK$]Q>?+EOR3TTJ:SE]P*2"7GFAU%'S:Y23?IND0 M>-HV5 <-2U90B>2B=DP'A&-+I#56?V\J3-0GGFO&C \&S:SP@A;\]/Y6(RA\ M*-+XKM%8&CW-[ 2Q'.8]R[W1%N]PIL7V+&V-'*E##D8V9=Z[B2]^DZOF3Z*:@YNP(U;_4NJ^5.;Y$U!5]MW5T M4CV%UT83_%ZS!JQ&ARS!8VEM-N5BT>5Z(E3'*_C4Z0Q*3LF-!RZ_WJ9WN*C: M'Z[IO[99FUYU#>"Q>P3'E11;>8%YDO%Q%Q,$10P$, MF8AV)#5R/<, FJ/9= :FK_=2P- MOT8!KZ5?@UG)KX5>AU[%,)O0#=88LT)HN:ID-G$YJ&-F=6+]'>AGL32Z#@G< MZZ*X9OF36 @_K/&#ZE[TPO"9UPI)%4BRT.V'44#+@?IF]9+TX]M6"X+K&>\1 MF<'ODKRE7>V(<$;[VTMS+K;3'1&JO^<=>]0@5_ ;+ECY=IV7_#[_9?.4O8.T^P)@QJRO(^['WV6)\$_?+I[@9()L0_; M5?V $C''%LX.# MYAF:(@3M%M)6"N&HI&8)A)>G72Y]<%2T@^3!\:>G'N-\W!6I3J(@(;'G0YY@ M#R+/]6&<< P)C)+#Q@IT#XAX^3CD]%'#A)WU.O\F.Z1\R(MW^994Z79]36F^K2\Q4R[("3WO M+G5Z0<0XPA2&+I&%*Q(,B1/&T O=**(>48, J:; \332V>#H>> M%JL):J;!(W,OI[UJ0AYHKN(0,T_WM,3.Z:*V\L(DC=,@$0YNZL@"+RXDQ/&@ M1P(>>;%/"$_U'%P5LO/[M9V_5NQHZOFR2N"IN;#6 #'2]3-UQ&1$Z8Q#:\]9 MU9'8DH^J1')1UU0'A&./5&OLU%!4$PCUDX"C*/5D3<8 (I[$,':C 8Q31T4 MISZ/#9.'EX@9]\,R(R%1)31T(T\SQX,UQ)L07F&F35(YJM:.^8GU'_G["';/'SFZ^9"]]?LJ>G.LB)I3((0(^@ZTN65B6Z8.A0F3D)\ MRGT:(**STEVD-+/&MG1!G[!F?YUQL-060BL0Z&FLF?3:J^.H9);6RY\BCDE 4B<2+FJ4<+%K32-(TD#H<12%2<"8PR.D MH\*#U&96X_V%MGXO*"49+:GT,*U%U5I) M[&/55ALTH2BS+,]0\*_R-O\S;\HR[)M@_#U?RXNV/PM3(H_4;C>]SAE%5HI_ M>B=^W#PTY:0_\>HVE8UG:,13$L0N] ,LL]B=%!(W#B%-" H(8@GR4^VJSC,P M.K-1>5O7T"YEI&>[;T?SP[IN"/0C>!#,EON,WK;SX57=%35/93E4@YK(<[Q. M-D;O]NW-%5#J+]3K)M0* :04;4/4W47>_1WU*X!3>>W7:KNAN1&V M62)Z#C:7KS$](]AGBU3/2<\P??7^\4$N/1\U#L?/CILQ+422D]F94BT/O)>/ MMD_"!R4SS\L\F7'9E,Q+ IUD8UY\T,S_J.M =0M?NX=I;Y 32CP_H1Z,0AQ" M%,8(8AX1Z,5QC#SN)!0Q'0_B,JFY(WIU!;*.,CBW8=;<90R@IK90V\%",[1W M'@;[]8/&A;.TR@T06G2=&A?X>*51&*&_5M3+E\Q_:;?/&EDI9X;.K)1MO;)> M_E1+^DH[ >6RB>,=KU^4'#5MPYH^/^>9+E=,_ MZLRO\G9;E17>R(W6RB.<^U%]%8C%$*4!@0ER(Q@0)+Q0UPV")-31O"%BB M:M*@E+2O0%E3!_F>//@AV[2__E&SH>40@FIJ:@L7/8UM(?G20-(0O@(]TA8[ M.2H(:*OOXA"I9;LD*@A]TM-09XNP?B>R\(0>]"G7%[^$\ML M3)P NG&"8^XZ,7>T:OM>)K6(7[O/MC1IJG<>(HT0\&3!3;S;'M$K66MQKOYZ M@\+9C)^>)[1\!'10X+,QS.$1IGF2@WTJ7!=SY'H!C)T4091X"4PCQ6IT\%NC?L6C?CC]3OPZS/AVS].>H*^!T M'4!^P<4?O*[=O#_.:,.941B1*,8!),@/Y#&R V,_2*%#7 >GA(2^%R@70QNG M-_/BW.CUXXX\*'?T-8IJ*< VK.,S@*&GY/MV/7OJO0/8\9BP$2@:=<3L@F-6 M)6P$)$MEO]0E'2SJI3#-X+*D+X]@-H>LRS)GXF1/:7?ZZ5]^$7**G].T>WOJZUS=VNPX1 MO"%<9[7H7OZZ %A,XC#P*(4\(#(L(]N08I1 +^1AD%+L>K%60'024N;KP9P0 M)4F*4$S UO]C&EZ*W M6.YD;KM8_= 2_?$*W#[Q E=6XU1C\EF[)GB!S,)7 X>%/;T../*\V;IP5^24 M5^"Y%,0EAX'L$(N0A MX6.DPF^-B1/[7L*C.%P]\X+D2OOS,R1TU*1/2/T(J*4):J(:&\YS>"ALNR?* MJ'F^=2"4"2P8WQN7'+[80'N#[8^@X]9WC6 MUKFF=<#P8X9)MA9V2=:Y;L^3XHA0BB(.61**3:^7!A S+#9R D".0M=G@5*- M7&6*C4?!*K@.@9GCT6->TKL*-^!?;T+1[,J8IJ MZWQNE-ZRQW2JXI^RHZ,F%;_R*JOG;FY)F7].\4/ M6G&V^3[KEH'&L^Y8 -\$#V"WZ/S>L6$Q]4M3<$L?N2K513]U32B./WC=X7J? M?5E4DD(FNR+?IG=%EA?-39S/G*YQ669I1FM?9G]+K#OG"J(X=1T/)B3P(.(> MAS@($NB@F <>=SPO2*]"P=06.&;OJ7:%36S?-41\V M.XM@J6V #&"T>,=B,B9#MDE,WK-+XJ>]33*GNXAUF@Q+9Z>F3S0A-:[I-M/S M,SU78" KM/ @<>6Y5"*L$O=AZ/@^]ID7L%#K"M99*G.[Y75RF$[CL&%,%'WO MJ9)J^MNUD V]F3SL(8%L9KV=T%@^X>V2F&=SW2X^K*>(C&>K]YM*.-_W^/L- M$Q/M5/W3MEZL4N9$"74"Z/B>+_;+#,$X9&*_[$4TB,7O'$=IOSQ*:6:%;&C+ M:_'@D#IHR*LIZ3A>PXIJ%04]934&0%EIE84;N)4EYFAT5OQEKZKC,R^BKLH" M=BJK/F!J@V.9+G>S:V/9*_[CAG$2!YQ")_*%_C(B*Z(P"FD8>B1(,?%CK:LD MXR1G5N1^HUW)@FE7XHN(J2VU=G'04^4^!/M\K3J'MRY=PKW"3_RMJI?$/HX]D,$$T^NZ2E*(7;D MPAYC'+,T\@A6ZO6K2G!FB] G?U!01W)@6!)Q%$,U*V$3&3T;,1$4_0XUBI+: M:DHS1F[9/C2*PI^TGE$=-[&*8K-;N-ZPC_O3H?;B.+O=?):49?T>\8#8413= MC[)A>;D+EJ,("[/A,.B[4=T+*X8D](0-01&CJ9>XJ>,9%5VTP-S-4UFJYOWNQ9[E?DSQGC[,W+KR5G-YO=X>X6M5 DO7>A*$Y SA:]T9YC;YNQ!Y'L8$QRG5:D>E2GC!V'53GX*^[$I2]O@QCVD/HJH?V;:% ME7E\N]?[ZC5BVRH S!#A'B3[:G%N%3"&HMU*XZ=:EFM*MX_;M;SJ>:FRM2QB M77\_>]5( I0R>. MP]W]S[K@O*EA,GLINO9J=JC-S9@6R@M9MTEP63=Z9MR\DBV0ZB5)6\$4*,UNW^C3\ M8XXO%V]2!$+1_DP13].B-*2:HW[[)BZ-/$1=0/L:145&2(V=Z2E7MCV M,=VV7(9) NPEM-14TA8&>MK9K>ME4TKN?571#E&;63D;DF!/$_PNJ6KFMPWCI>CXVD)!3VFU =#W@U4$L^43#]): MUC]6$?O$5U8:9*;4[Q^?UOD+YU]X\9Q17A=F?X-+SB0583N:*VGK^H76-]<^ M$[ H#F/(7>Q"Q,)4.-TIA3SB88 C-XP"K8ME MEOF;VW"TW(*6W:;S "228=#G^ KL>9:QJSW7[;W/VL=5['*WR(M5LU>O^+HT MM_GUBZE9 W?XI;Y,>UT4LJ=KT^*S73I9O<]H2R1+-KN^2C/U@ID)0$N6U#9W MB]K>F: ]MM9SD9E\_;?;)F"Q1XI#UX,H(K[X@[HP81&!U(FH[WA>P&)B>/=W MP4X8QC=^#;I>& MG$MSH[OK.T^/BK"CV;_F^7D^+LP(.W.^=MC?J=T_]A5=? M<[8_6E/LD'AA^,PZ=-!7MR&MWA?QDL3#*F5)6#V=.B,G^-WJH9^"6).:!Q_/ MN7C[X M"G6L@?.E1?:6Z+[#L"R5I:M2YL7.?AS4D^RZD,.'D M!0CZV7/&MGBMKEYG91_7K:EBZRF6@L3M&;LE'1L2STC!SDZXF'8-B=-7K<'G M#"^O/N-L+>?YD!>RNNS^6IP\CNM52,8QBE)7MBN@"1*;^2" <>R$,.(I3I(@ M]4A,M2ZQ*A*>65GWMZ,T+ZRJXJ;F6LZ!AIX.UV?<_8NK.Y9@FA=0,F7Q]JJF MN+9NL:J27?8VJR88)[=:=<=/.E4_FR&SSS5\_YVNMZS9X-:!2?%0(6?L'G]?4<;]@*01=%B80)1Z#&*:N)!$29P$ONO%L5ZAV%G9 M7>1D?R!E[:J7J"OC4XT4^R#]%>@$ 3]THHA!I):F5S2NN0LJ!#+*&9CK6]#8 MCO\IWK#)UOY/\7)-$R%FQMQN*L50:F3H!#I55)[Q;;>;36QLMM[XVP/.+)=O=[EZ\S*MQ9V1?E MH^*1I.(L\WVM+7'014HZ\O4*77=X85OYY=H]2-04VRARHC+_8H$4#6'[<16= M809-=60QP@WCCYM=-<*#UF(KYE&]?E3'F,6"?BWY;?J^K+)'7,G8W(Z45"CI!0BUR8RZ=G MC(Y%NVK\CA?P>_O?66X\GI?.TI[^:/)%]^#G!3O>,U]X:D+0M6M9+<.YO1KU MW(E3#R<<>BQ((,)N#./8\R'W$N['"4]23^O>X "M1<*=:UE:MY*7"4E>%/DW MX8J97&6Z@)9&3'$Z!B8!P-G*"^J.,[O&BJQN499E84G2]'1^YQ M/;$CLN;:M*<).J+S*<^XA$:J-##M8HHU+EI?S12>-NW5*'G-UEG]\NJ>TOQ! M&L5[66VTE+J]*<7F@,FB&+OR>@S% 8E=!A,OX! %*8,$80IC#[,H\G#J,ZV; M/$95FGL6@5;S4F>'3\]&F"-GT"-S@N36.F::\+!P_\P),)UV MTYPRF4&\7 ;=;].W!6=9]0'3NEGMM2#()-$/G#=R)X \E5?_.8IA M0AT,?18%U!66*HK=U88_2+84 N=J5)6T*&FTJ$];W;VH&0#7#P6O$VD![G@ M*5>-3NG J!!-MPB-D8&1],%M"EIL.A;DQJ3#1G"AY8SI(*019+>/E%FLW0YB M>D%W/=D'8^^*4RT7@M>3[2 2KSG4(+#P\%"]_;IYN-N4F]_P^F;S9?OXV/B+ M9;6Y)^L/>7']M";K_RK:0ENJT0?=B><.43P(HRA-*GC[5=XS -D&W(GGY==< MIW ?5_Y[PS<\%9]_FA?RCC6XDSE,PC.Y$].6PEUYRHNJKK<,I&3X>&=3Y]=K M1#VTWX-":&3.5Z 9/WD-]"U679L$IUD$1YO:4R .8D'&DY@F_'UYQ.OU MFVTI3&I9KB(2I'&81! AX?LAS%V(61C"Q/531KF#/%\SP^]@_IFM69O 5I,$ M'4W=!+Y#0(;MB04Q]2R&GH0&"7EGY9B0@7%.E/O9\QPVUN@D,T)I9*6M2P#=L?7D& M&K4#!4L"ZREEOS%E0_<*M/+/4&Q;043;'2//4'J=!I"71;[8SW%@B&G=^_6Z M:0#Y"R[^X+(@<)N+VGZIA(4\Q#)KU,&^#.=[$!,GA 2GGM!K3CP_UBN#/TQP M]N/$FOP5>.RHUW<],'O,-ID\(Y$WYW0KYH] J*;L-H'1T_B6<@W$CG9776^6 M OMJDEJKMS]";N'R^VK"GU;C5QRG[RN__U?U=]9GP-0T]SP&MY1BS 6)&&P,=.HMM M%0R$[V\>3(8;UCVBM/Y&/G/*LV?Y&<@RG-^PD%!0:D[KSK3(HACY7DQ]2 (9 MNGH<,E5+&M!MU587?H^+C;Q5<\>+^GY^F]^"_3 (7"^$;AH'$&&$(783 M)+9?J9^&*:4XUMIY6>%J9AMWEU=CV=8_JM]!CL7;W M6B9EA?RFZL?H+15]0VH3-UMVU0I/RYI9FS">6%VKD\_29?M];1YN-QJ-6%.$ MW,AQ/&&+957VU&>0D ##D,9!E#C<<&/@A1KV@CI$LZ)?$/N:^SL(X"Y F$9=E8>0T(7X<1S!D/(:( M!B'$U,JOWG@6Y?M=E)VHN MVFXSTR*K3773QU(;C>%'4GV#R8E M[8T<&M HBF'B1RE$S UA$E ?XI3Y+DI=1ARM3MLF3"QAMTOP=[YF=8QWL$J^ M/62U3)E;G0)T_)RU0,N4J9H"CWVSI,[":UDH;9 &C)7^7&9VZ_#6W;O\ M$6>;E8M9S"E#,(XX$=X/89"$$87"('$_"-/0=[6JU9TC,K/=.;K6"7YOJ&J6 M*#B+CIIMF2JSGNW0%E?;& S)8TG9SY)85)F'A#Q6UL%G#941EU_E_V6JQK-8 M*.O#,K&!SV0NOOR'ZPT[_$7OR56 W!!AL5.AB7 ID(=]2'"$(.$H2-,$>RC$ MJZ>Z:>:7"A>5HNY.X4GG@S_F3/W;%S2O !5_ KXG7:?0%3O&FG_'E7#<'[*- M#''+A;6AJ6D3)KTDXA+/3T(?ALB7A4"9 Q-,0QA3SL,P<' H7+Z&K?>;D:(, MK_2*.KYF>D%\PU[GU8A%+TCC0*QU:2)6O M6)C4H%?3E:UY4LDQGDZLL _S[8^ VR94G+& D1I"1$(E% M*0H@#I,$LE380Q=1+W25KHFK$IS9]Z^K+K6W"NICL[+7M&^L8JP9@L.6:PY< M-,\C)?&F=NZ>?#^79#3#UPP7C<) EO$QJPHTAI.E0D :L@Y6 5*99[D20!I2 M'=3_T1EGF 78;UZ^*R7(XSAT'+X,.9A &.$4L()B5Q/R>P-4ID[ MSM%0 [BF_3?-'+NSL*AY89.%U3-@7=RSDW>.THF#(ME*3SM+8]ETLR$Q3]+' M!A\VT\:?\YQ]R];KE>=Q[J(D@A%UQ6:8>SY,XMB%":)AQ!P>\52K/G\W\\RS);NZFW914WHL MS+'U//EW,X-YAU\>FQUC73?N/K_'W_^155^_YFM9_UIVM9:YNF]PV;08[6[O MK1PG3Y.8Q!0E:@5@I[)BD-"BIX =8S)V6.'O MX-N>J1(4#;-9;++;Z&\IVS!"(ED%6%Z+U&RF8OQ:U+1[5JB-K$'+D:R% M\QWT6&G;BL*:%= ^!:Z+0E9!?!S:;6N;CZF@6#(WQFPL:IZF@G5LSB;/IW\A M7LSYD&]X5^+_W9;?Y^^R\E];O-[U;;M-!1]M+1!"G'D;, M=PA*E2XC#5*9V?"T=.O#J9:P9L[,,$;#EL.:Y)K^C(G0RJJO)-20/R(FZ/DB MXJ>]E@_/O8@J*XG7Z:O:PV:[H_>/3^O\A?.ZJ_KMDU1[]0HYHY/,K'<=75 3 M!@UEO6W(9?G5]AE61-<]CAK<+ERU.,Q0\&I46$L;A,MT%MT!C(I[[.*/#S L M3ID7/'O8O/].Z]+XXD>YX6Z_4Y]%OL>("WV?R=B?%\"$>![$3NR@A'F84:TX M\!"Q^1UX21ITM$%+7+->Y1!::EIM"P-MA_NL^'.4JU00T%:]RB%2RQ:L5!#Z MI&*ERIB))6>%WTW7N:P57>[.$7V'NBA)?)BR4#8?B%*84(+EZ0[E$7-3''M& M-6?/$)M;J_>5U'K$C3O?#<*FJ-Z6P-!4;V,5&+M^6?WXF^EF%XX!S+\=X>+ZD4VN3O_M/#W[[]F!:L? MZTK9>@S)C%KHAHD+4>0Y,":80\]-P]BG)$18JUWF;)S.G;[1Y^30!>ZQ7A]F M@)JKIC/SA4'U1K:6H'E8,W=WMK>M9M+^%.]0SQ[.^_IF<)IFQ]A6NO!L?"Z; M2CPWW"=IQK,3-%M)SF7VM4E%*XRFIM(RZ]"S;B\'L!Z]NASE6FI6J9ANPT^*M7WB57VTO4H2Y B3&4 /R2"; M1V6A*NK#Q'<2YGC4BR.]2ZN7:6F90X,KJ8?E*==UWVB[O,J6%]VFC(I_NM,:' M&#=>*+:<-7.*Z?8; !]3UX\I@S'SL+PO@<5."?O0#<6O8^I'4:17AOP2I9D] MG_;CEFFZ3_A%O7G+.$)J^FU%;DV'I"'9Z75-=(;]T:AD]KH77*"S=(."87'/ M]" 8&6"8H2]@Y6(B5I^;URM_>;NMR@IO9&;L*O0<@IS4A]R)PZ8V2Q+["?1" MCF/&>)1Z6AN=$7JS)XNUU)L4^JNN+4"^YP#\D&W:7_^HF54_ J6:BEL$2$_1 M]]A\:;!I:(,><8O9\&I2VDIZ'Z&V;&Z[FN@G*>R*P_3,@&P^WNTRNW/V3_B1 MKYR4. $+')@F7.A]%'D0^S2"4AJK*:2RDHY),I#:+88V"BG^LM?#BQ,NHGACXG2:-OJ3V!\ZL+TUS/4E,TZ$]$$[1B3652]-QW8D$?I>4;-ZW/R>!+0?U M8.YEG=)S8ITXHFT-HV#U&9/EVAI Y)O=*]K#L.D&AFR)+QN;*B36]+5JMMC$/Y1$-%: M &B(UL(A( 6Q3X- *H.F5;?2I]J4_RFU.+GW&VD?'!51QY"79\!F,G M]&7^= *3*(U@DL:Q@[#+0LY-ZFB,DYY9W[MT8MIR *H]"V:5%1305+,$\V"D M9Q8Z'JY !U3'!NCQ 20C;239?AT'=?DM5WI0(/PJM2#4 ;E4+4)C!H."@#<; MH8B\K#X+L_7E&W[Z(+ZN=@UT_,#E6'@);N@%$ GS >/4<:$7AP%R"742I)2Q M/4)G]NAR0QA(RD"2!I*V1F6[ 8B&C8-%P?4LP06930(V=34E#1TJR^R@B4Q%$3/=#3-!PT,15\8#& K?(@[%;H40F 11C##V?8[:9@BF))(7BR@7-9E2:#P+GS*_(232.F2V=G99[8T M'3D@Z8U%WA6P4# O4R34LRJVA=.P(%.$-#,7I!@T$R>#EK,.E_@] M, H7'S+LR+AY%N\J+U[^D1=_W&SNBIR*R>LAYV/'991I75%7H#FSW9"$8;:!3PUI\,.C,+%%AM?E%5C+NU[U M)4-9,.LKQTPS-4<%4K7HJ66@=)V:EO@5D.1!M@$M [M$VXX)B\T4U26VU3M1 M@>*RK1+5(3CIC*@QU#2#+W_B1?5R)SX5>0%2ME]YDM9>$%D1U_69O)W$J2.[ M=N$8Q@GSH1-@AX:(H,C5NJX^1&QF ]&1O@)/DGAM#GA'_@ILN&(-227B+L=$._W0'P: ,(@3V]<0FM)>@.D%L[0&Q?Z-#U/88R9@G_F3VWY MVMM4'M>NHL@/"?5D M_@WWBU[+IC7K'&L>C)[ HJ:S4T35T],])2FEI&5/+R])84D73Z9?5/\N"7>L M?,].SCQDFLB5J)OUKFL1QS!!,N+S:G] 0DB0*(/?\.'023H,PTKF=UIM; M:YG4OXW6]!!;[^GI:54?!#6%,A1-3Y<^*LBCK41G.+>D/_V9%U6=,R(=:\VY M1PR"5F^W994_\N)VP]MP:)#Z;HB))S6%0Q1@"K%'A.)0CT4D)([#E:H)GY]^ M9N^RHP<$08V(SBD*"O&J2;+IZ4U?+)/@]ZE\&B&K27*:Q:R47J->R.JB%(,Q MJ]-1RP6M+G)\$+6Z_-34"AMM5]"C7J#UA?)[_KUZ(QC]8T5BBAT?88ACAT)$ MA=V(L?!D$^:Z"?>%%TM"LPH:*N3GMB9G6^J>:Z!K6CI#"6.U!7P^Y/1L5<>' M])9KZ"1<)Q@V!2^ Y ?4#,U2^T('">NU+92(OU+M"AU@+M>FT)K%N/;$8[ZI M+\O=X>*VJ(O6L+K>9%?B8I5BDC+9Q%XX*,(&,1I!XA(7,I?3V(U\G@9*R3L: M-.W6)UR Y[KHZ9-8$NM+K?7U5B;+IQ7E_K>:X705;-5LCV7$-)VC M!JSVNJN@+SXPT'#0UHH5/#378*T6J5"5V%ZQBE&*2Q>M4(7@3/$*Y:&3>S:] M_RXCS6U]G)O')UF8-J/-[NEEO\J:-6U2FWQFC4I#F1:;B_Y&*0](_> M\6>^SNMC!$&:;TJ^0FGHN> PSAI7HH8 D%W1."'@ ]PJ"E;/.\0$% :X<'0[06/DE0$/OT M6$%ED*ER/^?KYVSS\+;@+*L^8%K;CC:V%C$WX)$;0^*X0KE=SF",$PY)P%# M. D#'N@I]P"UV96[I0T:XJ"CKJO=0X"I:K?,UL;/_%*!@3O MBOPY8YR]>?FUE 7O9 9=W?G\6CC;S_6YY:[E$'8]&G@IA@%'%**8(IB$+H)> ME/B481HXB5;] 'T69E;2FT^_O?]R?_/I9W#]]O[FMYO[F_=?]!90 U355M5Y ML=+3=IG\6I\4=-P \@)^D R!;/,CV/$$]DS-TOO)'!-+:[,! XLNV.8 ':_B M$V::5M9$; MN-I7X^C*RYM=ER:MRW\!*4X>TYIQ/?3HVZGWHGA'0<-+KF#:+ MTAB!8+DFAQKM5RG+H07+II-,30!XQXOLN>G-4Y.ZKG:]WHY.J%/NN#Y& M*418%@!*.8*Q$TK9) [^%<@.T0;&>(*#.P2ME"6A#=#E50'\J,^MU^\3E3F;S\)%C MH>-MDN1+5Y_=Q2GW>9H(0^4+0\7#%!*.$LA1B%!(0R8V'SJ&:ICH&[0:',0G?GIUPN>##'O*BR_^;R.+MMII#6/,E5ADJV]-;7<435EE@[ !GI M3N9 M2Y"I:;P%(/3T_#"9MJ%Y!1JJLV3/GA/+?L;L 977RI(])^I 9NS9QPUWQ;*Z M7K/Q;E,N"'(8=X(4QF[,(?)B"N.()=#UO)"$<8IC7RL![83"W'O?NK BK@EJ M;G9/L%#0^ M]QUO_GNS.6WW=M?T&USY(?;=4.B?GR0Q1"@-8.*$"/)0K*1>(E0ST I$:="> M^ZQ[UUQ1K)Y&[15U<%33W9G0T=/JC@GP0\>&["][T)$1W(W@95#V25MR:^6? MU"DO7 9*&Y+3%SYZ/]:RMS(^O^ M0B40I+=E51?WD$TB\FJ3Z^2H74)@/-9E07@][5:0>X8[(R-B&H6_+LVY6/QK M1*A^ &SL4=,2,AMYN_4PKQ1_SQZWCV_RHLB_R:Q3_"3^I7I9T3 B2< 8#+B\ M >\$L=CVBC4]3&(4>K%+$ZJUDNL0GUF7)2ORP);6S%R!QX8-0#H^ &T9T:U. MHX&OV@H_%VIZ1J #["A3_ JTK( =+^#M&'(&=7#T(;!6*$>#],*5=/1!.2VU M8S"':8!-2+6IFF3P8BK'<0NA[% MV/4C/4LS1&QFR[*G)-6E$+0![7.C&V,;0$TUT&8'"]UH6X\JD&2OP)ZPS7C; MN'36@FX#I!:.O(T+?1I^4QAC4&;K.A5*\K^W&^X[ C'_/M_]';5!*(09HLQA M0J]E#KS#$(PIPS!)/1RBQ&4D4.]/,4IN9O6NZ0-)%/C.%9 \@"H_^ 72*%\U MCMZPDMO'1$_-5> P*>LUCHM&F2^K^)B5_9KTV>B5 U.6=K \V/@LRY4+4Y;H MH'R8^BC39((N[Z]?DC+P')Q0PB -DD!8/"^!V(^X0#C%*:&^AZA6W?NS5&:V M<;TL5N/$N_/HJ'DLDV76LV$]<7=Y7#8/_ >$L7;(?X[&P@?[ V*>'N8//:P? M3KS9E)EX\KY@=_DZHV(R6<;^FN5/%6W;<:D%,Q]BEGB08S?QW2@._%3K]IU5 M[N:.--2IY#*(*!D!/TB6?JS+N#ULZ@S>; -NW]Z ? -JEDV2A:R]*#7'_M7@ MUS-Z39+2 9]=+L,/DJL?V\K)DMT&^RL@.=[]*ZG9!L=\U]Z*X-QROI-M0&WF M2EGC;?D\*]NPGLW1LD[$-)9!*N')546]D,I3H9N*/Y:K-, Q]AT,799Z$#D\ M@HG/"4P]GQ$G#*+(4^J8,$)G]GB&S/#?D06_2\*@IJSHTXSAI!K7F"R];F3# M0'"#",>@6-9B'.>I+!SE&!3U-,XQ_+A^I.,3?N3L_7=.MS)ZMQ$Y.;DA=;ZNO>2$W^ZLX M%"ZWAV(8.HQ"% 4$$I*ZD%&?ABGQW(@DD^XA[FG-; 7.WD7$.^H6[R/VX%,S M")9 T3,$Y^XE@CWA&:\FGDHWU_7$'J77O:)X*O+H-<4S0TRZ$7Z555YO-H=U M0SYG#U^KV_37LJL=M&']XW**78^X4001)Q@B%I.FID\48)\Z#@I2HG[H8<+! MW)L 7@%:LR6#F?E1T9]"L@;S%&[%#[@MIR462^VLFL;DSXRF M3F?&F5$U;-XX"[J:W1XG(#/<$-)DX@5[1DZ0^["MY)2)#"S_^U]_X2RC>"V\ M1K&-_,P?MNOZL[LO\*;,Y-_J:A9BXQDF0<0=&#B>*TQ^$L$$D03&'">)%\9> MF+H:M6>TB"OISN3Z,^]_!8\-.W+[)_@!Q8XA4.TXTBE$HP>Q@CVWBIC9?;O7 M1DG#3L^!EIEMMH.:GBW6E7[0_BI/MIS-U97OP,YJ#S;;-+_!95;>IM>4RN-R M8<[K/*27YL]]!!C%Q$>N<* =%#.(4N%4$QZZ,,:>G[J.SR(_UMD_JY&=V7^N MF9 9 G?BH4YC]#;-BO"I[9_M@Z)G.7=X[#FX:G(%7\#O[7]GJ;VK)[BE7;8B MT44WW'I '.^]-4>;&8Q_<.GJ<7;]+/R_!_YI*R-WM^F[;+T5OVWV_+?;JJR$ M_RY86#$6A2[R"(Q#N1-'B0>3B L'+7"PYR6N[Q.MNXF:]&"IC>\8 2TGH&%%XM?&3GML7(%W M(U^NMJDW!,*2S=>EOJCQ-X3F>!4PG<9^PNHG7MVF]_C[G2R:FF^NJZK(R+:J MJ[KG=UA6GMSU4^%AZA LSV9"Y$-$'!_&<1!#Y 5!Z#.?$Z1U\=EJ-FT5X!8S]8I)*+*$+HP?8)3Z>G6O((^L_*6 M:# M49C&TA%$D&#DP3"F.$[3('!CI6,O':*+V,D^#SM%;MG0/.Q6 E+##%J$Q\3& M#2(S5Z%019EM&J4QDLM;'$40SIH3U;'Z>:Z_;)XRV?_K/GOD[$->&Z[?\%KG M+N_ %#,K^R^?[F[Z/>EJ#D":-TNYP*<)2FNTU!J#9%C1+:*AI]LZ0%B]LZL@ MK5%>Z]"\BV6T*@C7SV55>=RPF&"^>1#J\2C3W._%%-??LW(5D<#%Q.4P"<)$ M)JIY,'$2%Z:():&34(Z#4*MHX!DB,^NO) DE32")7@%)5GC/@K#F=9&S *DM MRE/%UE/46N)[/8GUJ_@-B&2K6M\Y$LM6Y1L0\J3ZWM"SABTN9>RPZ9A3-G5; M5W[D>!Z+4AC@4(95 QGB:AGM9OYKR[$>RQV%KTHDZW&H:<$ENT+>E' D[:?EY\T,]CR MAJ_8/;WC9?:PJ=WA=_DCSC8K-XUH&L84,N2X0O_<$,8I\6!$D!]30@+/T_*C M+A&:V9=JR8(>7?![0UG3F;J(E)IBVI!?3SV-1-=6SC&Y+*GH13*+*NJ8L,?J M.OJ\22;_5K@BC[RXJ>NI9L^\;8>P:\2+4!HF40*Q6#1E"T$7$L8P=+TP=A*' MX21DZDG[P\1F5MZV]4-],)V5I8"OO (%)[AJ2V\5===+K<3Q$?2&E=DV)GH* MW1$&.\I775N3\8:\^E#HI,O;@\0P,WX*-)H)\&JR#N>ZC\RQ8%J[FC2'&>R* M8TP3*FM_^5MD1 8N4,QC[!)'9J4+CR1R71@[$84X(F[H>D$<.:Y> M"N5Y0C,;M98LJ.F"CK!1?.@::69B;WU7=XF M1W=<7($.)=M!H#&9K>5&7B"S<#;DL+"G^8\CSQNX*W=YMJENT[=B3]B>"H9I MZ&),8HA\-X$H9!22)";0IRQ,J!=QYJK78S^9?F;MK>G5C4@$18W%]A0&!4]C MDG!ZFGD@ETG%Q5,!-?R'28*:>0QJ+U+/-;@HQJ S<#IJN>7_(L<'"_[EIQ8J MTGA<=*PI128+_SE>1''J1Q!SQH5%22-(4,H@#2F)I5L0AWS6"HT769M[;W2I M/&/+C=@V?1#O&ES+&HTWFRIOTQIFKM)X^4VI^22O@[^>K9QF ]BH::@EB36#(BU1Z.L3GWL(T=6K^SM=- M4N87K-O/7@M)-1,P%SZ:X9B6BRM0\U$?=NTXZ:>TVJW,.@4$2R9#B_2B-L0$ ME&.C8C2'I8:W,L6O35E(@P0G 4VA1X0]09YP%[!+.728S]*0N2A&6D9E@-;, M-N2TSVN;/&J4XS&$F9KYL(2$GK4P!F%ZN]M3\>;J=MNC]+K-;D]%'NUU>V:( MH?O/U^)?'W[F&U[@M3 @U^PQVV1E3>NYN_ZR"OPT0C1U(0XB5^BWZXEMNI>( M/Q+F1LCW8J*4 Z)'=F95;YFX H^X^(/7-[7DLH@/6-'<,:C!J;AYL Z2YCZB MPZ?EH$;GD(>NN+/%O826T+:V%6I$E]UA: %QLMG0&_TJI096+,0,>4D$21*D M$#FQ["T;>-"/:1KY<4!HX.ID\D_D1\O,^!/ M4RA@P1,0%6[^-,<>&M!9+@@P^8"#5%WT/O63./!C#JE#J;QJXDN_B4#B^)Y/ M0^X[CM89T!4CS.,Q-0]PB#S'%N< M\&ZQ3]0K'4^07P17=KG'Q+L,/F[RL,MHU6TT%NE4Z9 M\.Q9N@;":^A6L#C&#@N"" 9(5D,+Q.).9"F ($RB, I)$(9:C7N'B,U]2M*2 M!L6.]A78<,VN58-HI9@2Y.$0$I8XLM47@W&2^-!U'!9Z21@):ZZSL;.&ENEE M;3P_9FH^DBTD]*SY[I/YW!,?I^+C ]?K=?ZMSJRORZ 4G&55G4$X@Y.E(KPE MKVN0U*)NF(K0QWZ9TAC34Z!2;*7DR6JW# 4B95_\Y )-#6W M0J>8J9[]3$!"]\2G :$F-D-]LHNB6#O=.9Y_X3.="^*=GN1<>M#0:=E465W, M.GOF7X1?5-3M7=[7WS!G,F%;1D2VC]X4=>=_;CK^.S$R"=Q M&D&7"[<&A3H^@6"TJ7P]4WMOV_C9\CALL;6L=V(9S!-/QO;\ M9F;VDT #EU]OBSM<5.T/U_1?VZRY9_HA^\Y9VV=+_E9XP>XJ#&GJ42>$/,41 M1 0SX1=Q!B-&L!MC3KU$:\MHP,/,QO-._/ZK[!8GU/=IEV#&=VEE\KRXYS0! M\B*+: LW5'I7M TU:_?KF_).U"SLS$CK&=.6OOAPQ=@9HET.8_ M=DS9,YD3 +%D'4TX6-003H#HV.9-F'CJ0Q?A!**4N1"[&$&'DL!+(M]E-- Q:QJT9S9G;>W_UBY)X[7)-W"R MG=(!5\T^S029GEWJF _=&S(%@F@ 7''"OAHLV'H! LV2$=RHO:'P-(CNV. MR12&N];:>LD\_0]Y(3?#G_)*&CO9%*5\RDN\_KG(MT]=:#0(7-^)G0!Z6!@: M%(0!Q*'K0^9Y(4'88Q[6VYMJD9\['-\LVE^[2PNE]J4%3305=YFS8:2YEVSN M&4I&H( '2E:NA!-4-=Z0\#P[?D#-T!QA9R,H;&T+]8@ON_DS N9DBVU.S;ZZ"M9_LFUX5HJT".>4FX9'XQ^^>VK&28JP1W129OF_*B;M,MCWC4NZ!< F'8BEF27\\< MJ8EN\?!004JCKB>7YERLX\F(4/UN)V./ZJD=X]GJ79O%]B$K*5[?U47H/XC? ME2OB^IX3DA!Z*)&A'>Y"[)% [+,H)=Q+N(.56CX.4IE9/SNZH"$,&LJ@)@U^ M^$_WZC^]J__TKS[\EV)_LF'$AK74&@YZ>CH$P72E5!)J0"W%^$8MQ5_V:CD\ MZR**J218IYIJ#QL6K-V6V8:+A3A_)%E3Y;L7_OW'C3PRLVGYLGB]/ MSW!V/( >$U?]@S;0\E$[.A;CV?K"VRHKK$YXV4+#VH">>B(IS1]F5PXL7V,"KB]3NBD)>QZWWLRB4IBOTP@3$3/A3RY&U-%D20)BE#."0.HU3[5'L22W/O MD[K\O*>\DDT79$>ZFD60E>6VOC5=9^G5;>I _B2M9M,CY?.77TU.P*>]'S4G M8EG4]:Q.CS?0,-=D.98G5]5WK^9]FG+:I&7+)V'--&BY!GVV+1^M6X'0YHG[ M-(:6/XBW N#9\WD[,]NZ(?=S(0/&NV-ZS_/31.R@A"F%R)=M[@/DP"3R.>.N MAP*B94.'R^)IZV>L +#6#9@\"31?IW(6O]C3I=6]\G9-_MCM?!\1> M^=;7.<''[WV='66OCU);RB[Q,6:)'T".L L1"KGLP.) SAV/!8QXG"C=TA\G M-;/67^JE9%3\;P PQ9B(%1CT--^@HY+UHH#CDU2@*."ZS266E204"Y M17M;5Z=B=YP7=Q#GE<;L;]1#V@,03 > MS[ DO9[&#@ENN9ROHHQ&48VA>1<+:B@(UX]IJ#QN4 ]G7^G_9E-617W(5%YO M6)VUL0H9)CAF"&(W32'R2 @3G[C0B5',/1\S1)7N%8V3FCL$L>\FD>V)US&& M7)+7J!(SC-BPXMK%04]W%X- HU:.-2C,RN480Z)7.4=)RL'B.<,S+%<_1TF2 M@Q(Z:B.FI/9?$UEIE%8K$A&789[ A'A8-FBDD#@T@CP-G8AX+'*I5BF\P^GG MC@%\^?+^_HM),OY.?L5MOK%4FMOZYJ[![QTEF[>JSXI@-0E^-_DK)+D?"W8^ MB?WD*3,=^H"SXC>\WO(W+WT_OW8QLLU#WD,(R1T*R$(IBD80*I MEZ8ACH,HUDO]4"$ZL[Y)%D#-PY6\*WRX&>\8:3O9:.[%E2!54U;;0.FIL!V, MM-5;1VA+2J]$Y5% =!BOT(^FE,9+/D4*8Y"2N2^''$ M NP&CM9=.A6B,YN-]M[NP36)K&:BKM$F UG5P'T'?.$/TO/_S.MJSYN'SUS*E8D1#[)FRH=\?_7W MKLC3K)*T9)!+PUB M+_&NIHM_!.\2LWCD%=_BP8=5&;%V%K+E7FX7+A'RZQ0GS9UF9><^5TB MV8]J1?S03861AP&*J*P,@V#,O AZD<-00(3=1TH7HH\GGCL,W5V7D;3T+P75 MH@];ORD":<:3E60QNNO39WS2]9YZHL5O]/39/W>)Y^#?35N =&%5H69U'*C7 M[8]'-(F0F\ 0N2$4_RZ)=EL]X0_0RI5^J*?EGHRZW1!\:875!_LTFK\IK]TR 7XL+P MF;6SNZ7]AF^X< '*_G5MDXR(2R ,JZ EU7V6&\=GW9\R= =:SF3!?A2 M>4#P+)D#/X@?VP<5;[OK0S]L!F8%5,\X[+'\M<9RSPBX34''"KC9@/T1RUR@ M:61CS 6>67*&51#U$C9,@!C,W]":<+ET#A,Y#[([C"8PC"#3KYQMUV+NX]#$ MS2;-B\?ZXWKSTH4?=KX#"YCOQ6X B2^S0M(DAB1((YAZ2>+%*&*IKW53Q)"/ MN2/ +5?U!:[C."+H<5:?Y+9/:$9S#5^ 8K1V?E@UH[$FB+:'X<"JUV<)(EO! M5$,NE@V63H/J)!@Z<3K][6#="JR^7_Z@XWM9 H9MI.:DAMM+U5I++;=U!2Z MO_W4'6KF[+3W:2SV8#(+0+7D MY4EORP#8<]!KA63/ =&2V)*[H49S4>=""X9C5T)OL&%>_#/.UG+&MLBU;)V] MG_RZ:3785"1Z@\NL7/F,IJF?8.BFLL^&'[@P81&#D>^$*<44>;%6?J\N S/[ M'3N"&O52C;%4,QYS(J1[O$2JGK6X CO6>C7P%1'4S^0WA,%6KK\N^65O QB" MPT!-K_=HZ/. $)3 (':%88DXAW% $$R<-'(]/^%$[^+ \ MX,]\L]7U,O2[KR[2=W6N?JOS=5I]M1ZK"MU5I_=5+8MJ]0O^GCUN'W?MC1ER M/2[<>,9#B C!$".40IKPQ'5B%GB)DKJBTXO(#ABYLKQ_V;7JS:^S8W'U;X3!( M/1Q3R%.?BYTO..1\/EPTS,$ MNI#-$!HW@\(H0JY):K% N1D$_7BYX0R&7L.T#MYO7LY/R^6R0 MH BC#A,L.O!Q.<>\XWINCI_#G> M@Z:;9/8*]'VD^<&QY6#-R.FRWMG\D)^X=@N0G%8%^ Z_R !F5]#6#2**PRB" ML2_^0)B*[5]",.2^&U G?4S7V=4JGI7@RID,O/5 M\R##)!6:R1T8!ZX/$Q8'41J'24H< \T\0VH9[:QO6;>456I9Z>*EI:\343#2 M65T 3!5W0#:[RGN.T&LH\(# %Y1X:(3^=>K6%#0-Y?Z+X^+]AKW#%5^Y+@MX M&%)(8U[19_4/ #_+JK[U=M7Q:12$ M5%XG0PPBPE*('81@RGSJ4>K'%"O5VCV8=69%DQ7"^[D6.PT\8;]_$GCZCP87HGG^"3\J%6SM M/3[S]W[W_A9(,AI7FELQQB/O!A+H?=6CS.O=0SYDU^S><3O',#YD^N%=\ M]$]F6Z.W^5K\F!=U@8!>.Z1[\;=2.&Q9OOE'5GV]PT7U(DODG'^ZS8L0UC^) M_22&F.) >&)I E/"4QYXL4T\!W*M.IXV&1N;@^N3[S??NP*]+@%WP2[H.:W M*7AU89#>=LWJ.U3;X+W6F]'T,:V^E!DRT>: T=+NTRIKB^Y7YP#U>(<["PU] MG^-3OOF\77/7(8$KYKTO'C<5^[#&#ZI>R,4)9C:7@BZ4A(&D#-T#-;OGQ:/L M2LR9NM=R&8AQ/\8*!GJ&24U\\+ODPE)RP*B41@[1Y5D7L[3>,/F[E1 M^_JSS>F3#'YML\U#6W,PWY1OZ@:!S7/W^+L\KJH*+&B(=UV\U+4&!7-4EF@2 MUJ*^J2OTBI?5BO.8N$GL0L<-.42QRR#Q8@*]. QBEXO="VJ?K[F_ H?< M@HY=JWV4Y\;47H/EV3A=NO/RW)"?:LU@W[S M5\_5O5\V!]YJ MYONUH=:SVWN$9ZB8.B<4MN[/S<'BLA?Q9@3YY$;?G+2,@A$R)LWSZ^>'^C:J MY.KZL=*(19P=OT HHCYI$/^_?A9+TX-PA.K+M'U4Y8WRK6I@=A -I8#$9"#T MXQ'3,="-1PP*:1J..#_IDM&(0;&.@A'#S^KKX.VV*BN\86T#!/$J7VXV3.=< M\O(,<^NAUC'E@*#C"F9'1CT5Z]$$'=$KL;=BV7/&MD+3[)UTCHMGI%P#TRZF M7N.B]15,X6G#;@99B1\>"EDFJLXP_]R47?BX;_.4(,I1D$ :!3%$#I87X],4 M\C1)8HY#GZGEI*D2G%DW#\G+>ZXM Q.:+8UBJ.;@VT1&3Z,G@J+?\4!14EM= M#\;(+=OY0%'XD^X'JN,,(PE53O^X* Y,?-^'+L>NYPK#$5"D%4W0YV%F.CT(Y2,@FV M&UDIDC=796G?M7P2$Y1U4?:RYENQ)ON4]Z 80)@773V3TU %#3M73?G-LOTO MK/D [3;O,-L!I^(M@@]YD?*LVA86_ P+\-B*&1APL&Q(P!RBDQW_A*G,#-S/ M>OUS>,3S@KY-3RIC,C1C&F09 @B$(DF^31&":IX\&0N%Z8I 'RB=LAMC!8F@O@+/"H M+5C354EO3>KHBIYH).3[\-49NAOHT)'D:1+BU"B\6^3,3O1\.,QAM<$.-E M)5;,^JQ)7I!BL>=RQ_4@]I@#D>\@2").8.!'KL-1B%&J5/KNS-PSVXO/_#DK MV]#.G?"S"]"XV_JWQ8X@&5;]B8+J:;>IC'I7Q\Y+,^4"V=&,RUTC.R_*P66R M"X\8AIIYRHN"LUV63%._[A.O5@ZC-(R8T"?Q%[$)BY!PET-/.,XRPNSZ*8KU M@LP72M3^Y%0@MWR1T3^+1'[NB("?D0[ZM]4[^#7(;E.Z,311*3ZOZ MF0SV[FL-B# M3V')^U$#0IS-2K!2%WG???IF4U9%W5:S_!EG&[E5??/R=\X> MZM/9=9,1^C5[JCVD*/0XCYP0>IZLZ4$YAXG'7!CS( U"!T<.UZK#;\;&S+K7 M4@5]LD9%"0U!5ET;YX9.3\--4)O07=Y$:.M]Y[68>*6.]"9 7>Y5;S2;F8GZ MD&WD8>5'V?[U8X9)MLZJ%YEWWI:H\VCDAA3Y$ >)+S:P' M;Q&5KUC2.B!L[ MPCSIV*(1>C,;G8:Z5*!UW8XX)^NL.1S7LSECJ*D9%XM8Z%F1EC"H*5^!'>WF M]HOM8G^*8EJR&V/4%C40BJ(?6P+58?IN>9/[_/AP)_S]JGC<:-V7/CMX9HUM M+P5DCW5I.T&85_4589W[T>>%'O?;)\NKIY671;5Z%WI0*B.'_OR,B[GU@P+U MG?OA!\W63QGO*C(917Z+R__+W+LV-XXC:\)_A1$;L=L=8;S!"TB"9S^Y;CUU MMKKLM\H])V;G@P-7EZ9ER4/)[O;Y]0OP(E$212(AD.XX<69JJDADYD-E IG( MRX_.%L")$E&18B14JA .E41,%OHD+PJ>1!EC0H*2!,X1FCP,W)(-N*9KJEFK M/L/Z#\'-]HG$7-;N/T@04T4KR#P9"<9J,<$\O3#GF6S*Q;XYBPQWOB MZ/-N^OM5_M%IV%FN5_J/O*X?JMIWOM;_N;^YI#P)%1$%RF2L#\2*IHAE)$2* MZ--PFN5$*@[1:R@#D^L[KQ+H.OUD#WB"Z3D873O]GQ(S8,1-_G$>JZNZ%^]K M\,_FO[U>"E\*AB=K B8_JY5Q!>?8^CBOXV:5CIOV?S#M^J6XYZ$J6!'F2/"$ M(YRIR+32#Q%F49QF4H0922'&YPR=J6^\:BK!TG3)>-)'B"KK&699SB%D9T \ MR VS$RU!<\%<9RQ?!0U1?Y9@1"I/"G^.RJQZ/2+JL?J./0[3TG\+_1-[_[S9 MKA]E>?='>Q'$PSB1% M]'E"AF3FD4)%0C.(BS<*")'$1%S;*V;_\Q#K9T@LT M03M-/(/"L )>+AM,[[IBC5^)V<@GUKR*S-9E%-/)>4#'[V>T-BS#4M3VQ#Q3 M&8DP2\+*4)QY:Q;[,,QQ:Q9&GG*P!I]7O#31N@^R_N_/J_96?7>??KT2;2QO M(3?W$4TB@8L(L500A!/,$,U4C'*JHB(54ML/J_P5-_)36Y,?IOS&Q C$27;+ M)J KO??O>0&H(QQF"W,T*7@P<]6R$OS4,O-S\'D5[+)E]FDR@68I^#(3B "; M-RF8;C9Q E!A%M09DT$+"U]U/@OL+/&!A79?!7XQTN0 0YI%=%Z9.D\)U!VB M*\KX)8>C%#"[UJ;%^VOST,.VT]U%=YW9;BQZF._>4_3],WQDT,?5=K%]K9K& MF9[,+_(#W=)V\ER6)IFB:8Z*5.8("_TGHE*.DCQ)BJ1@21Q%MF.#A@A-K!@U MZ:!#VXS0H:,#ZV!@#2N13PB 005'Z4&#A&Q$M[! M@:CNTJ[%O[134D45[T.9D5RF$D6<2H0+QE A,XXR_3^%2(I(9!&@@+:7B-5/ M\^*ZV>::<$\6<%8]@<7B/.\DI5M;(Y^2 0[9ETCH=H:VEQ1V-#XGR>#)]^2E M^0ZVY_@].+>>?+;N)HZ#&$R%@Q'0<42\/+2#^YV M%Q*SHPDS=!WV L-?TUS[*CA"V/1T:Q@]UTA[@D$R7L'S-[_4 T]SCSKU!V// M5%2/B\/]^TY=XH>UW'Q=;[^93DRE;'OC@6O[[5>OLN'^C >N63.JQL0]29T:?<%->6_+YC*@Z@M7=X&KN\/=)R3*M,N(49ZE0OLZ M.$,D%3DJPI#GA.(B)@E$>\^3FEA]=X3K%I)737_(8%$1=^\8.8"=G3;[002F MSGLPOM=@'#2$]*?0X[)YTN@!0K.J]+C QSIM\0:\=\ZO]%_KLLW*V%1%N@5- M0A*%! E53123,:)*IDC0F!64D5@D5MUB^Y>?.OK0YN) .^;T #&LE9>+!]-$ M6\E ?7+."W!!JYR>16?KEG->H&[#G(&G'+LR\Q]2/"_EC?I$%^7?Z?)9]MV5 M-Y>,XF:E3]7/I>FG^HYN%IL[RI:=1FU1FL6I@LTO9^$\%Z%>RX#BJV@?V^5MWF;24\!ZTF9Z$B)>1VU4-.YI M2@3%>8(B&IN&#'&!2!)*Q+3O4\1"$AJ!8A1#Q":VM /3)"KR?J9KU+#9V4-? M8,#,FSL.O@9J' @X[3"-FM1?89#&@="60S0.WW'(^&C"(/4]L10?WWV^^W!] MG\BDD(01%)*<(4Q9A@@G"N4B(W$4R5C_P3HMO)?$U(>FFF;0$@UJJH#,B'Y@ MAM76C[C L\A$D@(202Z6V"T;!"HY+"=D4*C!Q)#^-^?+#AGD_"!%9/A)EW*T M'XL5;5(.(I7(4*8*R4(FVH:("!4)$RC%3"DI8BI2JSGLQPM/'2\QE""U61V1 M+:R#HR# R(@AXE1HUA$&4F+F)I1C<=G@!P)6E9TR/EQ/UGE^QDJR4RX/:\AZ M_MUUEE9SXZG=CKI)&5W>KC>+:J@MVVQ-MNF]C"*2%Z1 6(0QPIQ01"1/42%Y MD:29D!&W4FP(T:F/"[NK>>/1MTP$+1?!/UL^@"Z %9Z6H1'/* %/&9<#Y##7 MREYB;X.L+$C./+G*'H33456 =QVS0DU,XAWEOTOQW00@FJ!$M8$D198GDIFF M-(5V(O(H1#3,"5*Y8'D:4L8I*&@[0&OJ,\&Z?%J7&LRZ=A2QBHE@L^,"F-(Y M )J=,? $!S< .%8<)%HRC+(X5PFG"41%B@A*1Y#R6+!-I>''G=PA' M$YN$Z@KOQ5RQ! ]568%I"?6SN:T3.\Z#Q9ZS*K59[)C7AX+@1],1O?.4A_[Q MH*]F>:,PY[< 7COLP>Z0KO*D/QR W;:?[SQU=5@0XGEXBR?(INQ)#^+G[=O3 MN\!GU:G>:6$W0[N;5--LE^_D2JK%]CZA>2**1*(0FT*WK!"(4I(@'(8RDBS) M)0?UW#U#9V*CV% )S 1 =9H,Z@Z :DL%/#='S MR:U@BS(BEB<[<8[*K-H_(NJQ3H\]?NF12)L'?<*BR^M'TT7S/E.494S&*,Z) M:9;'(T1"DJ%"D9#&!>4% 84HSA&:.G%A1]:/R+S1=MTO[/E=^,SSEZILG?9TGV?"%$W$2%"]M6)&3?"! M*-.NCA)11#Q6H&J*8P*SJ:A3J_H3.* *"1?2^?!^/3@]\@+M.Y3!N]8UR[^1 MMAT*=U[+CIYS#/ ]/STMJZ /7;8%T)]7:ET^TH.K*<[37+&0F>;RILU\I!#A MJ41I1@B3848)LVK0!*0[=0CPM]O;+Q]__?CU[OI+\.'S]_=?;K[_]NWC]^#F M4_#^^OO?@D]?;OXK^/SUT\VW7Z_O/M]\!<8$+<&U#!+ZAPP8->PPT.FTT.%A MFML_F-R^8HB65.<-*L*@.(DR E^_M.!C<(+;_NX2$)$54Y0'(E"2"QDECH6?7CB<&HSU:DR^"JW6N->9-W+QZF1C/\/ M9&G WA)V'Q'(@]CB3 4;GJ'R7K3AB[\W*MSP#._YX@W?A"Y.ZZH#+->KZL:I ME#_D:E,Q5_UM>S)A&4L2DF8HC$U7\$)P1 N9(BK2C+)8D9 )QPPO&_IS)GL= ML-'.@?>0[F6%LZ4!G0X]X$G0!W"7I(%!Q/>?$69%_:V2PR#0#.2)@99Q,T;O MC6RK;5D=/K\M-K^_DRO^XY&6OW]8/VK+>$^2,%*I8D@R?=K#REB?4!:(1HP5 MVAO%*@&=^\8(3IX\UB$?&/K!CH'@GS4+0#LS"J&=8?$)#,R27(8)V(38"NK) M9HR2F]5(V I_;!6LWW,:5%(WU/NF#<_W/^C3G49>MG4CI,C2(HQ0FM (86S2 MRV,2(:YPJ,\?.92&-=RG[- +U'ZQ M7:I1AN0'#0/Q@H/KV _@SP ZU&-4MI'Q'>??GW-0QZ@41R,YQI]WL$K72B_[ MG\\KF80:J;3YI:6$QRHD,2**<82%U/9()3GB::J/*83D*K9*YSA/8F)+5-$, M#-$@":\"0Q>@A/V@6)B?BT6%&9X>*5UL3K^X &MSL=AN=@;RD6$F9E"@0>/2 M_^9\9F60\P.#,ORDFY]3!W3D%S,SJ.W8\;J?&#U4G//QSZUQO-A2O[C9WN,P MSD689XBP,$4X%PP5(I4HH6&1%2QE60RZA?/&V<2&J^$SJ!B]VK74>>W./;\* M1DO3]CP''U=:M>H3+=#E\O]P M'CN>_@DXCK]62O+M+OQU1_\TYTWM%F\7J^?%ZJ%I);M>;>YQ1&(1A2'*:2$1 M5I@ADG%]9 QS&DJ9LQP6LK(G/;$)WC'220$.3"4D<$ZV/91VYG$:@&#V;X]- M)VNX=Q T&Y&0X-WP%QW;O M-%)]7]>V^)G1MN*@GGK(X+I)<'_Q"R3.$$^UZ4FU0 M4*'-"L%IQ%A.[K?K+5W:F15[TB"SLF/ 6G5,.D-5:?AL:A'5NM3FI>$AH#LF M@*WA[7&ULS'3H 6S,0:H*N>JY2)@K\%/AA&-V,_!CI?@>APU>$]Y, "^FLS; M$YZWZSP8D),V]/ 5W*S,KL]];[]!!ZD_DNYP4^-^!EX TW->YT6[Y>U:,F?JR7^OW-QW\_+[:O]W$L&0Z3 M&$EFLN5B(A'!288RK#B.,AG'/(5LJV,$)]YC[\PKP;+3O]ST,]]TV/B?_X/$ M4?Z_ UFQ ]/R433M=-TG1C"-_W($S,=A$,"J;BN9)X4?)3>KVML*?ZS\UN\Y M'J;-*-W= 6%_1F^K*78AR7N>QI)DH4E;DQCA2!^VM:>>(97HHW?.54+R%+*Q M6U.>>)^O)R^OUBMDW/:K8#50X7<;^KJH$@'$U:'GX0KV?5R>2W^=;M-YHZE@IV^.752UG+9-*ZONUQM MUT&W!YR]9O7(/*Y5EXD+TZ@123VV#QV6S$F9>I:;39'.B])5HH&G'/.6VGE# M[UYW?_S;0F^.)?_Q^D6^:'G-+,"\P)@KFJ"4F1$AJ9G[DXY-">DCC?^OL[9N<=A(2(B"VTHL@1A'F6( MIBQ&G'#*$Z*/ 0J6(#-&<>KMF_/2S#Y^HJ]ZB66E!67-2]M(&!C^'L?0SDAX M109F'UK2J$6B0UR[Q#5YCTDPMI+ZRGT9I3=ORHNM^">9+M8O.LX$$&)1=P*[ MI0OQ>?6>/BVV='D?X4A1F:3:!G"B;0 K$$W" A4I$YSC,!0IJ"_F&3I3:_Z. MJE;^A4"+5-O_8:%\M?P_0V7> M=O_#HIZT^A]YW$U1F^:X;;];LI^D]:>>V MF,[G95]BPS2UTVFJ4S?C_8AL(YSW/IIO?3"V$?I\?TWOQ^%?:?F[;!)2VBD] M^VJ6^ZB(DRR/&(II2I$^(F.MQ@5'.8TB224A":S%YC"YB15Y3]QY.-8(7'9* M[0\$F%IWY-\3[M;#^5-M.Q$]*?<(L5G5VT[P8P6W?,OCR)WKE6@.!?L;Y0^+ M#5^N-\]EIXMB$D:< M3/"L/;I:U#'X_P30D\*TP#J?),8Q#?:L!?^ZIF, D//GQ^6E(^/BVUK(>N:WP>YX@?6<=>U M-94IYV$>(UZ0".FC6HZ8!@NQE.!(G]>HP@K6GQ) ?6)3U>&E.D(<<'-P>G!L MD0N#VLY 308@S#KYQ,ZAQ:4#!M[Z74)HS]S\T@&6TTZ8+HO TQ=_6XER^?K0 M.*BOO_Z^O2T77+[_L7JXUIH(=O3:R0>V+_8:]T1W*-*YF[2#"EVM/Q=J]YGGTG+3E::C:MZ!>A MJP5GGG#-\=DE=#=I1'?K._KG?RVV/TSAG;9ZG]9E_WCS>Q7F7$4B0X(3A7 1 M1K?:I?@^OMMERPY_KF6&\,M]3<2GHLC7(6>+ZPY9SE5*IH*$+,LAAJ.[ M^.3N2$T*?+][ ("=+)6(DBE$2,XFC*$]R:I78W+_\Q)K3 MH0<89W *PK#N7"X:3'LZI%RF-9R*!YC4<)&8;E,:;#XB;#K#62$&)S.5&]Z1 M:U L7WVX^HG,VWUK4-"3GEO#3\/4=%-N[V_+M7CFVYORNRQ?%EQ6L>>,Z#-M M5$B42V7V;.TILU2?=<-49(S%&8_LG.1S!"96S89D=1_<4 65(9W%95@C?4@+ MTT4'0:T5<4R:(174[W;43_^OO>J=7786I1L3JE6WT>=@BB;DXO[C:KO8OEX+ MH;_GIFIN=5-6':DUP_=%&A)!,9X*D(6X]2J'F&,T,2* M5Y,.&MK-&!J-4-#2M]._4;B&]= G"#!]=)??6BUMA1NX1]-+U-JI_[!7S-&% M9U%06_%:1;5^WNT NVM"]V67OIG23(0\S5 N6-54(T<%5@QE:99D@F9QGH . MKZ4O)E*((LFT9YF8[NYAQA&1E" LBQ G(DFB'-3VY@)>)E9E]S(4QT32 M2SZ+G8&8"6R8)9D2YSF*?29*0;V$D[]ZJ<]8>JJ/)>&Y;Q_+ZK+K>D67KYO% M9E],9YD%=^[]J?V"LEROY/IY<]B$LF7#/D?NK/S#QL67Z$!O8%AJS[6 -C(Z M)=>=772V-+LQL;H)=Z//PI6N6H]OG^ER^6HZ ?U]4TUKJ!)9ZH;WW[8KL"K" M5IU800]_H U7=<^IE\W_%]33*3JL!=_D]KD$-,P%8CBNSM/!!U-R1^0F4'XW M1)Q, I#4;(;"#8*N^7!4<(X34%:" M)>&I\Q0^7[_[_.7SW>>/WX/KKQ^"[WZAR-3N&4U> 9Y_;LUJ)[ M;M,^3O=-VK5;PW&N;;O] I?>=WU:_&F&D^N=7FZVW[1RWAM=T$1"N=TDP M#"ZX)SHKG?=[H%-*;W3/2CVL!)>) Q,Y1HR'BO[SC)_ M05;DX7JSI4/VBM'-@^Q_ 'Z-\DVK59,E\D%NF\F.>N?\8 RV[4C.@34F5H8. MZ>" =O#!>NL:A6'\WL,7 C --I730C*WV9Q#"\\WH=-"O(,YG3;/NQTV MOTF^I)O-0BUXM>2=J8"^YU0H6> $L8+&"*=ZOR()R1'##!.2QRIFH-$&O50F M5])#FL$_*ZK +*=^?.S.E!=+#55,H,#@8^2@0)X.D/TT9CTZ#HIY?&@9&Y6;;T,Z+TMW&!IZ"Z\GMRU-MBRVUHWU^8IVXI:_!R\;T%%3K\I%J MY#HYH/8ZLI-N7#-(AQ)C@K)8R1E1C+%+T)&[W/^?0 MB>C=\V:QDIO-;ZO%MDV1C'$4<1:B6"BN-TPF$%-F*G*415FA,AD65K.0SZP_ ML1JV! -#$=AIY!PBPRKG04Z8QDTA(J WT66BNC4G HH,ZU-T7J#!1D4]K\W7 MJ>@\SP>MB@8>N[#4NUWYNWRHB[JJCB@\$[%,!)+FF(TYCA!)"XE(GH>"%C+) M,:BF=)#:Q(:D)>4TFGD8)KMSMC?A8=;%5F[W0O A>7S7A/?2>IOR\"&QSU:* M#[[D4*3U8_7P>?6I_#M=7F]NU-\WV]7#!WU0A0V^4*_?B!?P[4849D.L ]IB?X@,ZM M,,R5Z'PE8A?"_GNJ'9Z8BF=3F]\^;[?I16X]&L9@0 MA4C3T'0UCQ$F881H&H8H35,22ZJ*4(;6CHX-Q:DC$ T+C;JU3 0[+@ N@A6 M%GZ1;UB L8DQ1%P:NUI! _"G?$/DYF&Y_WA@SA9$VD'WRVJA^1PRB%P'+AKH M17]M@KXM-K]7SDB212+)BPR%L8BT*4P8*J("(T5RI51(J2BLPJXVQ"8V@+T- M:)S\MT'$[-PW7SC +)X3!%Z:ZQS+-F'WG!VI-V^/,, M%):Q)CUU2D$IGTP/"6-#5YNF(K&9OEPS55\, F]) =!:AG(F 0P8UVEX,#Y7 M'T3-]4S@M>.&.P"^ D'VA.>-"H$!.0D1P5=P,S2WY?I)EMO76_USVEZOA/'2 MGXPA ]8NCZXS89I.0_HJJ(CO"I>?FMW1?^VRM;">?N?C]&;]>5N+?_RKMG_1 M]2C,MONM^#TM2S,&]_IQ_;S:WN$(25% AGG*)"92G*N$HHY2'-%*BW MP1"QB7?&_=P%H9F 'GX',+(]_/J1'*;FQT,7?BG7&P]^*T0H;Z?> 5(SGWK' MA3X]]5J\ [^\J.+"'_\L>34BV?9*XO"MR4-PLN2+C:SG:-M?#AR)-A[R=Y<* MIE(5GC&OL\\X1#1[DRG^[SBRV>3AO]5LU@? M^V[7I8GVF0%TVI=+E(IR) K)$,8\0D1&#.5*4IZG3"21NM^:=FT646U;JB"U MVM&V_A5VV+@RPSEK1H+5CI/@J6;E*E@-I(%>@*I%J'L*K&#*^O8P <+>4\#E M%OKV!!LL#@X5?S 6;KW8?/%PJ'P',7'PRX[-BFBY,G//;V4];WD?UN%%A*.8 M<50DLD XPAR12&$-/8E(6-"8$E#$["REJ1,?UH]/S[4ZF+A/RX8I6*G;[ !; M$)T%S,XM\ (#S":>BNRYJ:RU;+YZ")VE,V_/H#%Q3WH$C;[@IL3:0)2F\."# MK/_[\ZKM1M1,5^]T/KN/%(]PSG(4DC1%. ZUAT]HCF@NPT)1&6:AU00I%^(3 MJ_HUY^6S%,$3?=5++*L85UDS$<@F/@Z=:PQ ULX 3(47])Q44P]^:ODP(]^# M73>RAI>@PXS/X"[K,RZH KU]:VI3 MT*G.;DE"B]!W H['(MQE@ZEM7_'YJ'@.=>?'DEQ0<[Y;:N9Z\V,13FO-3YYP M;I*B>=):52UVHW;%@+?E6BVV7]:;S2?-7YN^?+=^OUYMULN%J/II5@5M28)% M+BE#*L*FR@B'B(FB0"+,,RYX+@0#M62_G*6)U?.0P>H^=E?;6O,8_&2X_#DP MGS;8)>1OUT&75>>N+9=^,+NM?M[/ +,D M;C:^5G8SM;^LU^*/Q7)YO3+]%_7/V0QNJ._[]STG]AXYR4@D:50@%4K3!55Q M5&2%0#F+0VUPXT0[.Q"S"B,_L0EMF:F\G#T[32K+5?#5-KSI"*Z="9P.,IBY M&T;KL&/)%*$1-QP\63 @\5FME1LPQY;)<17'9BM5LM'Z\:F4/^1J4V4V\O6C M-/;O/=W\^+1<_V&F^\E?Z&)E_O*=5.M2'O<"NU9:Z^_HG_;T/-7F:5TPWVA-UB M8.?!LM-G+Q# U-E->K *CTKF28//TYE5@4?%/=;?\1;:5XQU)W9M31N% MJD+TJ/XHB956XE@@%DM3O4D)(IA$2)(H5@434N2@=N2NC$R]EW>*ESHEC@?# MZ+:=7A.N]5Y ]"VW_QDPA5D3*)PSU8:YP>.]4@S(QAO5C;F!=;Z*S'$]A_;4 M4I;5F.'/F\VS-@6?X%/A!Y:8V! 9RO60Y*"A?15\6J^WJS6DS_L0!./W[9ZD MAYF,(<$G&--N(:-; ^R!=>?KB3TNW$&;;(O''8\=]655VP,RBJ525"!9%-I3 MT*X!HGG!$4]%EHI4_XL0H+-$=_6I#PB[KG6@=IC]0%ANZZ[B ?=J:\G@.V^? M!+ZVTX.UY]TC^\0ZV?AZ'X+O9K]NRZ4I.=S__# %-J2#&Q4TQ(,&BI:\2W.W<4@@ MG;)]0N/8.'L8(E\=M&T%'6ZH/;K*C/VU;24Z;+=M_99#]?MR^7DE%B\+\4R7 M&UA;WKYW)S9+FF30H0DHA>^3<_P <:F(,,MS))WGIK1#LK@5R/)A5=VHK[;7G)NN%":-<[U<@SX4W]-!R%NIA?"=*SO2!DJ>8P46LS!IB M\ ':<43"RYK.+=ZXE*)*8/]BY@W)861.6Z%.U#V WENJAC:6@;/>05=9CU.@^8G6GR @(P M@'\@_9=6^O?#TKLTOAN6S%_#NS-TYFYT-RQN3X.[D1=<;M36,']@]\+4MV4? M;R"78FOKT[Z3 $!]^7CC^5A_PK3C#=9Z[@/\">.'MU/'_^CQX&&*ZNK3F@J&!32H3G"D4 7]$9H5YJY-<*1 M *>=$8X?N*!.[NMZM6[+A&LE:SK5W],XS*,LYH@5H>DW3#-$LBA'6<9X@0O! M4R[O5_*A*AX&5K^=I6KU*RSJ7^$);>M?9%U8U;0< G0:M$3.;E_S ,0%565= MPKNBLH;VSYZKPD:%]%GD=9[8_#5;HX+WEF"-OW7A8-0;-5 O5,24ABQ7B!4K#E"B8$SQ.=')O>->+@C:=.\#'!2OL;)UA MOXA O>*^-B;FW-!V)&YY\'B$@(CLS5.V(#FSRVP/PJGO#'C7?\L-34!3&)$LD(PF7H%1O_RQ.;'DLNC\8 MY=LS#FD!4=WF#O5_F.LS WRE-_MX+O[56WTWKWT[+H-VAM8=C@S^9;IW7 8P MI(''A90*H2(SU?^"A(AD MVMK'F8JQ2$.<#\E1( 4Z0F@-;A_=^E=L?:[$_VNGSE)*%R-,"Q2G7 MYRG,8E04"4=*XY=E3!">QO!,E!&J$]N.VC5:5OVNM1.TV!-VR4890] V%.<9 M%V@LKN-2UAF339B^9J+C8/H=#6(OM->\E3&:;Y#!8@E#?RZ+[ZC-.,937(4\D*?3J0BB(4D15&D0I5%8<(4 ]T0ABYBAG"P M['0R>M*D@?>.;_!]+6\Q_]I?#7@G6GVPBF;0%>>@_)Z]!MWG&IF"2JBKUBAW MY KJ".%62Q8THET=K-!MQ/\=I_HY%[Y#5GQ M-6GOMI3&NC89-#4C]Z+ N4CT$9G%:89PD7/$""3 0,))GB"!JH^AB.Z5(H*E M<8AHQE*$59RC@F0YPFF1)D)*_><0/&J@67QB5?\FQ3-OA\=1B]&[P?.3B:UI MYJC^>N8MO?JV7'#ST*::2_V\6D#/"@=P6KJ0CB !?3M#I>X4ZM/#ZN'=YTR! M=NGYIP@<"=4[-^#XF4M;C;?C<;_+\F7!Y1F'9%E]EFKDG1F!][ RDXIN9;E8 MZ^/BVV]=RGJ^#ZT71V<)MF,,T'M30F;_V9W"-.TWRA"[J?3X"@]];H M/GE\H[[I$\!\OJGZ%,3@3M8GT\']NNHM4_ZC_+@2FK%_;U^O_]"'O5_*U588 MMT[_R^;34OQ]LUT]O#>WJA]*_8>74ORCA#67\$-M8EM]J\$M@W](6@::P^ZH M WTR:Z+*C;-*.=.O+BM'1DIM3)Z>E@M>.3!_U\<[ MD[1OI%M4<3DSK+S^FQ=9Z@7-&O8^H*>/..XFSO_]8$;\K_+I/'<'\0N[DPOK MB879O%R_D'4=8<\K7W#-O+EYWFZV^CBB?W[W(BEX%.<8<1EJASE/M>M,HP1E M*LEHF-)3^J=HXOF]IN05'SWO2@_7GO\7L$Z_WCK'W03>+M+\&^&U5[DZJ=_3/=W(EU6*[ M^;SYIO]]O=+;Z.OM>K,Q=7'W4L0)"\,"Y31C6AE3ADC("Q1'!16YXEQFH-B M$Q<3GR=;GLQ1X[G#5;"E?P:LX2M8;()RQUGPU+ &TVVW;V"G_Y,C"[,175"[ M#%6=H]YU0-TS%=R.@0HV)A>!XLG@N/$PJU&Z"*9CPW798F[&[9M\6I?FW/_; M:K'5WC!!YL+OI&=!9P'>9@9W(/^6P7Z[0'H'?]7P_IQ!WK+71.Y M]&/E@!V;1P\K.J1J/#QL/Y95">SUX]8Z*^/@K:D3,!X> MRBJS*] DURNY?MX<998.Z\*8S./!,W=Q83;A4DEAJ1.]0KEE21PN-5]"1*\( M![D/_4_ ]$3(Q?T7C>7R]H?^*'49XSU5$:>ARI'DQO_13@\B$G,D1!(318HP MM9O1W+?XQ I5D0LJ>D%-T$YW>G$8UIY+I8/I#T P:U49DF! 6?1KM;+H/^R5 MI7>Q6=1E2(Q680:?<9U!<)!8>+T2=<>%.I.V;J[3W&&$44B3(B9:@R*,L.EC M4^"\0)3DBM$BY2H%!13L24]^*S6>8>R040R UNZ4/ U@T&N@PQ3B"JNF/4R# M5_,T1+S0SGTD5)@GA77Y_WDZ$UN0FY4&(ZA)!X9VD(17 M@2$/J)H?0&G8/GB4'68,SHOMTC5@0'Y ^P _.+CU$7#X&<"Z"HP+-]A>8.#U M^?H,C,MPT'# XO'+IR]IS[[.2].>^Y>#P4))3B23,D94F@+@5(6(QB%'89:* M1'L160YK_VE%=?)PXLMZ^6*"5/40ID UTS(=^H#:H6A[OO&,#?1HTQW5]-.> M@V"M?IYG=-.HU!.,<3I/\\U&.HW",#3>:?SEBX)P7]?;?\CM!ZGU[E&O+N % M4Q9KO77 3C,6:,Z"/6M.P;OS6(%">EY@\ASH.T5H@I'U$ PNC0N>)_ 6T<)1 M<<_$$,??H(#FAK!"* M4- Q883>Y&D5-?4JC:)MZG%^:KD38G9' H\XP S #H+.U*P.[:K?K<]D!RLQ MO:4U#%.;.8'!2O335 6[UUS5G6V_U:6$VJH\+JK^19]D%2 Q__:Y*2BLZ@3N M65X0C".!3,85PGFA?80PYMI12)C,2"QE;M7MU8GZU$>%1W/E^=^T+;H4K5ZH MQ4KS4#D1A@VH<8#@:VLJ)D(-:CC8-FCX"/:,!(:3*EA:/= R$[P?!,_!D#B MX,VL0&C/;&0<8#DU.2Z+.(\FD:92N0G,ML%2+J.493D241PB'$J,]/E"H$20 MF"1%$A49:(Y1+Y6)#4I+\X)19?W@V%F)BT6&68.=M V]"6Y%!B7R-SRDA\;< MTT+.B]DS'F3@85]]F&[:B69-R>IN-E8>T2R6*4>1"F.$DSQ'3"F.TBA.N,!% M*!.@GMJ2GEAYW_\P1;L;D_)6WXA6.UJG[=]_7-ITZ2RFMNH]!5)0G>]MOK1C MI*UPGFKT+A" R;HPG27\QIV8Q@ 9[\8TNH+3,/F[M5X*F.=W]-K4B1(?;X** MW&7I?<>RC@<#+Q 3> ?@)"%T'GV?+*Y3Z0_6FG,V?9\01Q/J>Q]Q]8J#R-6(&2L$CTWIN%B!52(H$Q"6D8J2(#1N+L"$\> MDFLI[L)0KU>=+/2KX)=RO=GL_Q'JD%O":^N+^P<-ZH;WX?7]F?U+\FU5?4XW M6S,S6&ZW)X.\FT%5-TIM_$;Y8*AX\\LMR<[LDL/ ./7&@>]?,I]@-XWT2],R MY/K/Q>9>94*Q/"Y0H6T*PK%QQR6C*(E43(I$"HI!X_P&:$WNE%=![OVXW):V M/J-JZL#62$.861_C?2 !,QD'PX(;1%K*5T%;'3X"B./T@4%1O2:.]WZ],MN!7''MS.[[8^XOKC%3#,=1B HA3#Z0B!"- M"GV\$#Q)DY0F<6R5K^A&?FKW?L],W8JKRP[,!@!AM3,+TX$%LQ2#.'7:JGI. M";@,!D]6!$A\5L/B!LRQK7%ZJNU]\OU<]6I[-D0_OSXM)2[ M5-3Z0HQ2Q66D#QXDYC'"*DU1$7."1)2)),[W?V8Y.<^/%2LD.V[_? M>;R%Y(:_:O)DQ6"P.. 0@YA?]9":/:K'MP7EI_$8$@I%ML.I2R:&A*;#03GD@YV7RF/#1 M0V3VS([S@O:E< P\[>Y!KE=5K_ F%8'$4A2J"<+?O$ M[S\Y90KCSU@HW03K&64D\^E^'Z\_N8O6* MU^=%]3\(OQS]5=)*7TT T?)BM//*Q,K24++,?#@69U@]+I $IA0-$6_1S3., M.UUR=M>9[8*SA_GNY6;?/U\\FJ7N=EQW(*\N-/H;E]^G,LM%GN0HPHE$.-.> M?Y&E,8J37,5Q061B5S/MSL+4UQ&=>2V\-M>;REP_KS2P@:R[3?/N#?V37L!] MBHLM\G:;V;1X B\UJEZDS4B8J_:N>'0B U7FWJ;J@F#KA< R Y;#HFQ =F.@P/G82*UZNF461PHVW& M#JP/$X,%N'R@8 3W$J<%\:3<]1#8%:'Z+R QT[0P)-N&G?-M:E^KNK"O\KMY]6+ MW%398[_0Q<57SZ;,4"W)GU@O;K>;LL%>]Y6 [[77[5\VBYH69(8\8AF"&,1(A(6%)$H+K#D*A1)#M'RY!\9])_Q>=I;EK_$58!;J^N;]9^VG[3D/#+?!3X;?GZ_JIA;?]5Y6 M-NUQ3C_85;"3*SB4(=A5R?LW?--C[L"/#?H,%-TVAG-#E-J6 M1;=R19=&7;0$Y;,4]X3H\UAF4GJE4/H_6()H1A(D!&-1%LM(9!'$W$,9F-B( M_W9N0MM5L*C+;6@)1W4 MM(.&N/V@E2&DALV(1_EAUL)1=- H%@O!G*:R#*T[VX 6"^&ZLUIL'G>-\NQ: M[NS*G_>)K?>1RE7!>(X2FNG3A$@H*B)2(*D2D19IQ N>WF]-=P;;B,\0.9#" M[HA:_VKK?AR=)D/!8YU])0*Z[4P_A,:%!A&TC1'YP@4:+^IT(NV,(MS3]ADZ MLI'16QAID-C,(24;P4_#2U9O.28+5E?VMW0A/JU+O?'_UV+[X\=Z:9P;_1=G MDM8R)I-0Y1A%PK@6+(L02V6(1,Z3(A=$2H7;:D$[<^#"AI4R'!8* LV$/NC^ ML6?$S'RN Q7;=6!<0K/AK56=K8-8E?I&_Z"EV%PZ\!WX.>PLRV00NV<1#N4+ M-CD^%9=R*0*U+BO/H\-V<,.6BX>*4=\CY]U@\CJ5'LC"&PRN=P.I?[:]XUJN M[LA[_1LKZ?+S2L@__X]\O5+?@/*9Z7\D:9$.I*P_[:C(&[JR*ENUX=J [O8-!W4?I(:'J]U\QW]6? 23 MM#:!"N]K#[+)[/G@\>H5^N;Z^#=I:N X/]LF\%H ,FP'_6,"4?PB&"482(J9@B'DL> MBC2->(8=4U$&R$ZL\]IED8N'5;.U\=>@PTJPY\4]P60(4;OC@'^<8/:@F_)Q M M>>C:![JVY"+K>T/BQ,F=%A 8C_[(PAHF^5:6$!Q$#6A,W;KK;EW\^+S<*L MO)NMO*AK U' M&WAT&(PT#)BMQ? $ ]10[,BB0NQ31;=YR>GH M?RO77^7Z^N6AZO'.M\]TN7PUL4% G=_(,C,<^DW/_Z_Z_Z]?9$D?Y%'G_X:= MP/ #+NT;P\C*%? %#]P/\(<,U">PD=G5(1A<>TYOP$;((U? ZA6'^<;F(NSN M\>%OZS]^73TMWJ\VHG28;#RXRL2:7!$/[A:/B]7#5:!9"'[]>OO9%$-M%AH$ MT 3C833&E=8?$, M> R#*6846\GJ-IUX>.GYYA);B7@PD=CN#;=#]<>J_8TQ M .N5/JA_6#_2Q>H>,RE3988!LBQ#.$TYH@13)'&B3]ZE,?2]6 M-_;9$0W^69,%=H/L!\CN\'RQV, +,K#$X+/RH$2>SLC]-&8]&P^*>7PF'G[8 M1_.;6UK>E-6\@KK?SJVL+\?O(ZPPY7F"\BAB"%/!$&5%A.(LH6'(0J$BD)[: MD9U8<4^:X3S1)BDO>))EG5Q3I=F(]7))R\W^;R_JC',69#M=]P\=3/E/.N5H M%O1/KA[#(IJ4/LU&G5TS5=><,;DGZ9YSEN@;=M$9 V*XF\[HVVY6Y5,]9MO< M\F^V9=42H.H;R=(XPDR?F"3)*<)A)+09"6.4BB2GL>(RDZ#*T#-TIM[PEXN' MA0D8?][*1_/3_Z5/)GCB]QL_B/@36K(4UUA"R\3X?YE6Z;JF>/.??G!?.5:-]#8=[L^O,BGJ34#SSJF.LF'XR. M?Y/5#W;UT#>2BC."N: IBJDR.VR6HR(G$H59I,'$81P14+=*"YH3[[8-!U5A M[2]R_5#2IQ\+KG<L8$I=@O+COKT$[P \OK*<+.@.&]R MFST$)WEM@%<=NM-5U^'J>:/UX5*.WTA#Y ;TBO,B MOUMK.-!GA[5_&Y5JL-O;^;?G:^XV*L%!+[?QIQUNX(2HKNCI4I\L7OIV4MM+ MN+&%IKZ'V]$/- ,_O?QL4Y3J ,>PM?&.!,SH#($PQ1VS_2%+<]50RA]RM5F\R+IO1^/) MU#WYO\KMC;JC?]ZK, ^9I$1_ APAG-$"$9&&J" 9%ZF(R\VEFA]S)4AUS&1B%.^CS5C$:''#:]!;: MQT!J;J^JC[-6IO+7GZ\T!8Z>G"JOK,WJ?4T!ZK&;-@D-QSSD?2K_W7J_'YC$ MJ<^K]_1IL:7+ZK:&'=J*XIY3(D@4Y2B. M!498886($@*)/%02IWEBS#8DE7EBAJ>.-'6:+!R,:9)U,WE@4O347\_.H/^5 MO@GP.'K[^;W%T">M?Z74_US=OYDDX:##HL?D[9EP])7_/36[\Z:0SP3^21;Z M7'1=>TQ\_R&7R[9_&\VDR@3.49JD!.$8QX@E<80$#24NPECEU"K0U[_\U)?J M==.%BJ)K6[L#-(;-X^4RPHP92#R'?A)]4ES03.)@N9D[2?2)^OE\+>2\3)7(F$Q0R)1 F.4>$F=JOJ!!Y@G,5QE;) M;Y;TYE&T Q:NZNRMH-I!*T8"PPE4_X9AM%5(;^ X:>A%N#@HKI6T%VCR\/HS MJ[:5L*>Z;O<:/'Q]5PI]E/R\$G>+[=)JMOGI6U/?>QD:]A'H(XG&P\WNPH O MM*IV:D='=[%X68AGN@R&Y03%E?M%<@HB'RTU6\2X7X1N>/C,$Z[3G+5*/;8= M5NYI%'%<9";/VV1[\2Q'-"QB)"/,\CPK,IEGL$G-W>4G=^(;8DW''V 5QA$4 M=CZVNX P);*7S6' <9\(WH87'RP^\V#B/L%.AP[W/N6F3NTXAF8&H4D N\\2 MRA-22$19)+5O%A6HX#A$1)KQYV$61F$"T:D>&A,KUF[<21,-NPJ$)@K3KCYD M[%3L0GEA>K83]6,KZH*Q[0X\Z)$)=+Y?K/ZAF M\M.Z-+/K2LJWWR33^KVY7@ESD5I=T=VGBN=4ZETN8Y%)BR(QHJK(M%J2,!&D M2' 8VC48AI!UN(8$WD"V?%3Q4-YP$I0U*U46I6B9 202V:(ZK,W>D7(+++\M M1(#,JPF@1G5=-E$INDLW]G!2Y./5O)\ MOCE'Y:\P*.G<.6?L<7CP^OUB^WI=2EJ%5\,H+\*HP(AI]QQA12-]E*$"14ID MA(5A*"2QC5)W%YY8$0VIP- "1IP/9!\/+;M*!-,O2V% 8>(^SIWBP0<+S1;X M[6._&^'M_7>W'>M#4]G\3;[(U;/<_5>K=-$]4U+EF$.E&\M*,T? M@F_CH(#W.VM!/>U\X_1FW0.MQ3_>#>U?O'C66).;=\TVU5'YODA%J 1/D,JH M/L%2[?X7<:*-@BQ"$L=Q)N("-EG^'*FI]\XFD;4S9>P_G.>)':-DI^=^9(=$7A@<-BY-UP;$ZVYE&)C\F^_R:0OVIG^,?FIC3E_?>*$Y5AK>4Q$?H\S!.& M*)4%$E@#PW*1Y+"!'Y_IPRRA"[9V MQF]BQ&#VKF4FZ'!S%70@/&#H*MBQY,^R78"')V/FPL&L]NL"B(Y-UB5+P7/L M/M?KW97B=KU<<'U.-";SZWI[+=9/59$EL%3<>L')\R$J/H(VLZWEIKH,J[8% M\6RFBVK.@H8U^SP^>]2&+,7AE@0 5M##L!C=^KP)#),\_<-,4VZKZ&K3Q"U_!-, M6+$0T5>_R %*\_:,'!?YI&^DQ2MN.OS>\&P2$JH2N,7F]W>O[^2*_WBDY>]U M ]A(OYU[)"DB@B:(XSC)0URD:0[R/<8(3N]H[,D'AGZP(S_6"-4- M0#M5]PD+\ ;T D3 ZFXKIB>='R4WJ^+;"G^L_=;O.>1>-@7:-ZO.^*;VHN? ML[@G!999H7(D22809CQ!1:)"%*4)"4E,*++ MH!-!#$1[.^D0F0!B/&PK)H#,+=[:%/7?F.%,.R:"W2WN^\EQ B1D3H*76TJF M']Q@.9E@\0>S,NU7FR\O$RSA068F_&VW<]:Y+C1?UIM-,^ZTG79:M?VCW!"] M7O4/S=RUB&))*!-%!1(D-^DQ0J(BU^8YI80D)..,Y%8I9-.R.?69[H)\,Z_@)\/SSU>G M0WX[C%=1IOX9R=,T_YH67T^GV8F8G/4,/"W0QR?GB:FYNMR/CZ8H?LU_U]PL MGTU\]4RGFB9:1$DH)>4*94+$"&=)A(I(12B7.<$B-D/80*6(8 XF-N"=-J9/ MFC@RAKPF#_7%H M2G]F-]\1GE._WW4AQ^Z%FXWQ0"'&.<**4433-$4RH_IP*?(D MR:/[[5H3MS,Z!ZN##,J.AK66W)E7=M-B:$49V OP L[,^$L(90> M&^;U\>^KN]W!VO.VHNL3ZZ1O7.]#EW43J,\:^C1Q7"^];PUM>A?L;X:+,"\4 MQPJE(2FT-Q=C1"7A**1)&C*6;'I^7ZC\VN_B##3)%0NRD%B4V5!M-_8B8%@,@"*S-Q-@N=NA#U M$)O:1.WZ]F@;98@'%76;F@4X;G;&R!<:,(-S 1#N'8T&)/3=WZB/U-MT.QH0 M^FSOHZ%W7!JQ**TJ__F\DDEH$+M;?Y"\Z:/ JM,@+L24X=?C \!(:)( FO D/73(!H.0F2J/Y+2&<1*R0M MKON\XP/T-2RA<9ET98<1I/>*;ZP<.Z]<^G,"=EV!2#W<<\5JI1D[KD D.^RW M GH39BDWY?;^FSYH-2;XP_J1+E;W24ID'&FM_C;6_C5G4<1!<5J=&W[(M1I\)?7QII1BL?U$>574\$V: MA1>KAW=MO>1[^J3_;?MZGS.&<9XD2$B6(YR$#-$H2U!.%HN:"I"(-K1X'H6KGF4R'%4R[#1^5FU)Q$K2LF&X2+7X[;H+W8_@Y MU)Z[P."M'AU$?.8:=1=@3NO6G59Q;4S#MI]7VJ-ZWG<6ED1A24R&39KK+3[$ M1/^)423CG(=,B"C$5EO\ (T9 Z_5F/EM6Q4=[!G9N+5A[D/,SGQ]+"7Q*R*."3DL28./GO9]>JTWFU=WZG?S6&;?ZH6JU\%7^N8WBNM/"5[F]3_(T-/U)M;::&3XR$J@0 M"4%)%(8RR4BA4\E1*9UJ]N>ZZ4EY- /3[1KUPB]F9T_F_PXP"[3[!(;!_95'4/$8_%(A7Z6PFJ > MJUK4[0<'U[P&AMD@BIO&,E7*JO][5S\ >KZ%O9"I-[F3]0/DN1M:3ZM?4':P MZVRS\Y(V]RQ3BA""$4_-Q)@PQ(B2N$ Y%X50>492'H,+!WH(36POZSSS35\G M+8?L_CZ@[(R:#_%A9JJ6O-/5#SSMF M88Z/KJZL1^5A)P4FG&.)LIR&"!>*HX*J&"E64)IE4>*83TO&FH#J"<9*FZK.'JQ9G5[NB? MG4RR7?JDS%0LDD(APD."L) *%7&>(2YDG&.A*)<8YIN=)S:YQU6I@J8-C:D, M(F3K"_F1&^KAM"(?IHI.DR0Z+J$W%V2 U,R.Q;C0I^Z"Q3MNJOR1EN:.9'-K MCBNTE+O$0YS)F*<11@F)C!,0,<1"S)"*"A(GA!8\IA U/D=H8A5NR9K+_* B M[)RG>18J.WWV 0!,E]UD!ZOQF&">5/@LF5G5=TS88]4=?=Y1;?_];"9MM+] M$C%**,U1$JH"X;P(49$5!6(\99P658=8D+(>+#^UBE;$W-7R$ I+9706$*B" MUK+!U:Y7!%_*=KCXO"K6*]B)8O4_Y>Q7E\]T^6E=5F>]ZOQ\]X.N=ANOW)<^ MTC21&9-($&5&OV89*J(\1KG())9A&DN6 [UJ2]+3^]3EL_8)UY5/N#6$3:LC MXRZ /6=;,*W]Y@D@ GO-AH=J8&)%L?&=MYJ/H.LG3%%["9;?G\-L2WAN=QD( M2(^S#%W!U55^T8NLR]=O](]?M6]>+NAR4S6+^"8WLGR1FWLNBCC.)4$Q-R=M ME@A44"J0RB)""BDI@PZ3'B,YL271=(/'EC#4;QZ%R]9[]@D"U(=N:%\%!HH= M^5U[FI8%GZZTK;C>'.I1@C.[U;8 G#K7UF^ZF8!O1R#'C18)"GE.$298C(@E%&>=,IEFJ4@5JU35.C( %P5F-@#T QT8 \*9SR+R4=",_ MR/J_/Z]:NV.R[20E42PQ1ER:?*:0Q8B$18ZH#!GFC)&H(';3ZZWH6?WF+QE; MWZ$%CIL/P&0=.+]0=-?(>44N^*DE_+-IM60#A4OD?%Q$?Z'S 5ISQ\['Q>X) MGEN\=$$*S5?-?.TK=,;G-16J!8/:AJ@QIRVMO? MLW%EC(1^9(JI*!"1?#+@1M M6LC>ZM]4VSOB1GU:K.B*+^ARU[MEW_^G( EC+(U0)FF!<(P31"(E49*E"1>9 MR LE0 <('UQ-?$Y9/&$^.85X7OV!ZC3)W/7(K=UWP;D8'9&H6>^<\ MW#Q5?U@]7//MXJ4NE,SR, T3D:%4\1QAF@FD37*,4A;%*19%H6+J.OIF6M8= MHD N_@I9E(P\=@WY7BNBSW#N/UP\/U"UTLKQ^WMH.O!Y:8.M'KX:&L MMO.@(FB?X#4F^? 6Z5%HV+;6CJG6E,TLJ#H\L^D!%__0375 MSO JR[/0.7G'E>]"46%*=U9*CQ'1$:&86J_PJMZ8- MP6VY?M$[IGCW^MO&;+J-9WYP/@Z3+"W"9AC1;O[/P8X7KX=_=P \1?L A&<-Z<$!.8[;.:S@$)Q[OWZ1 M>L%MW6*W:0>,,4\3A4-$HCA#F"B**"E21,.(IE2E(I=6)8=G*4R\L[CX%/9.^-D%)K84FJ34-,VV:-')$"#WN!?@1628N:A(!KTR M>W6T1T5S\@C.KSJ;7S J6-<[&'_88;\^;,K:JO$7^2)+^B"_&2OZ*_US\?C\ M>"^*)&.4Y8CD88RP*4@F/&8FH5F&-,TX5U;E3$"Z$VML2S*HPHG!8TT4L.$! M$+38[Z?!!:;61XV1389 S<95L$.KXN0J^'5*N "GAFE@(0/=LJ @S!X M]@ L-]^)!"[CP3G%X7777O+U7<4WO?3J6;9UT3SG">$Y08R+%&$II2D)52B) M\C1.8BQX4<":4_<3@OS*G=I3[^X$RYKN53MX%]I OA@7K47 Z2P\YR#)$79.SB1Y?+"]TQ&E&_M;\&[[7RPR)Y M:Z??2V3FCOI#@IXVU1]\VG4>X.'HK+OU;JQ6VMQ*,%DPQ;A",:<4X2Q+$^HC(78JEN&/X"4U6_RX@SK7:KFHJ+L-MZC M"Y"="KK*>]G@C9K:5=U]R__&T_1]RA,#X5OLM6&:S[YVL//7!OZ45 M&&)V2G8J_;!J7203\+!N)XZU(IUE?>#.1;]3:X[^PUYA3E>:14W."M JQ_D' M'(?8KEZ67RM1W);OQD4)3O0J4IAN\&,+ @;2]"-GM3A?+#5.GPW&15X$A&?Q]4&3X M#-DAD7R-BNVE,>]$V"$Q3P:_#C[L4C6XWFKU7M#EA\7R>;MXD1^5UL?MS>J_ MY.+AASZ@7==W %^?C5MXHZJFSIN;Y^UF2UA))@C!F*9:P03M(,T83G M2&4)CO($2Q':A[PN9F=B5=_Q=X:?BFTI3MAJ_C[XHWD-T>;&:U,]::H%]='C M<;T*-MLU_SU8[U^%E(Q=_#$MHFZS?B*85=JQ%K2\!35SIJJK92]H^ MJ!DT5 M6,UB/RQ,V?QJ^Y4^ROLB#I.<\A@I(2*$&>.(YD6"!*6,<*SB7%J=),\1F'AG MJ4D&>YJ!(6KO=_5B,NY^72HIS$ #A01Y8T.2.#EEO0O.YIL-B=-UT0:?<_/4 MOILCR/734RGYHK+]WXQ&;[Y??_MN7VQFO=C$>E71#[H,!#4'P4^:A\WY=K2. MT-BY:UY1@>G@&" 3M/"REM:35S=.;U8/SUK\8V_/_D6'7'+QK[OUU_7J5JZ_ MRK49GO=IM1_99IM//K3(U '*78VEN3TV[>=N/]X$7_7_&S[D:E/_MC^MU]N5 M/JL LLT'D1G6;Z^@ ".<,#P\S[BS%MPM)WUPY?GRTFT$/,A-MWK!-95R;Q?T MGY>R:39U_;@NMTTCJGM!8H%I&B$J,4,8)_I/89J@."I83N.,Y;B 90R.$YU8 M[[LL5&W9:(TCHM2,Z;&[+M5IL[SDI)$UDAJ1B"F%5,%1$LD""Y06+LQ3'(:A1:6?MB0UH M12FH2<'4NRN_G18[2@535BN!P K9P[HGO>NN/*MZ]8ATK$5]CS@6JOYBPA$? M]*:TO\N$E*F>OCZQ7NSO, -:W]:8P M]Z"HIY'MX<&U:%<9YE J<",1Q@1%.C!<1 MR]2D>L>,)2S+0ZLN5T[4YPO\[0A7-SU?K_\.[/7H!BYPN_8-F>L&[H*6^PX. MD=KWGFY%^VUV>0@L9_=]T"(.529M@>4WNI7?_Z!/G[0?T1Q5(UQ0$=($Y=JH M()PKBI@L,D3S*,XSJO^O"*W+1\[3F=B$[.IU#>7 D X,;4 9P0!$P^;!H^ P M0W!&9I=V)P/" XHC_(#@5O4 _0' BAK&)1NL5AAX?;XRA'$9#NH++!YW,$0? M?_UX_5T^F._;_+Y(JN*(B@()7J0(X[A +,L*E$B2$1)&2@JK4$+_\A.;'4,/ MH&:GTEN8EHMD@ED40RIH:+F8D5/Y -;C(CG=C$977D^6XJP4@P;B]*WY[,)9 MC@_,P?FG'*S UW6Y_7']*,L%IX>_EX+2A$C"$0]#@; 984YDR!#/LR**:)Q+ MNRY%PV0FM@H5W: A#%"?\[!8F DOPL+,Q8&2L?QQJ! MV2XSG;:UU,U%GZ:_7LGU\V;9C+RJIF!VJ@RZT4+#6U QYZG. (*#4Y*1%8'9 M,HX@XG;3CT#O.8;W%QO:3!.L1ELW[5;OS$S!?5A;Q@4C7$A4I*9#/I,1(G%, M$(O"3-*8B20#W=9949UXCSWDP>C$-Z=VQE8 6MX+^(8%>$MP#I'@GQ4+P32W M!A"A?=TA6-&<]T8! L/)_0+H93=+\=N*+9;+:DAM->E^HZV37+P8$O4"'&4<%BH;!5"-""UM092 W%@&XVTG;"I0U$=A; D^ P MO6^)!CNJP9ZL/T6WD,V3>@]1FE6I+40^5F6;5US[;5P+H7\&F]OU9DN7_W?Q M]'XMY'TB"HP%H2C46[QVF%F("I$D*,FSF(0B%;%==N$PF:G#:'5;BH;R55#3 M#C3QP%"'-N'H!6I8@_V)#XRX.4KNT)EC2+ +^G/T+CMSEXXAT4Y[=0P^[;:[ MWNG7;E1GX'?56AJ'$0T5QV9@+48XPB&B/.,H(Y+(+(\CEH&*?WNI3+ZC+C4+ M:Y-/_2*[(\WK4LS._ZX36+<_Z"HX?,FE47<_H':[\,4PP51X>H3 >_4@ IYV MZ7X:L^[/@V(>[\S##SLVZN$_I'A>ZG4_/C[]O^J^K3=R'$GW?7\%'\[!J0;, MANZ776 !M\O5:Z#*]JGR]�#P9OMQ5$B/BDR-(!H-?K-:O0GP3Y4O.1$.V]1NIU$)@FY4Y7S6?KEOCL_5#D?]+ M\+8WY86,1M5VQQES2CPO3K%+XQ 'CA/A-.(>=C-*G3"-,R*T6(MGUW3V\#-( M:EW^5#^K OB5NFJO:#8:AA;J;9 M!9[6!*(OG>@O3:1^ZKDLQ21-7!SX3H@IH>J4,TN3**.9&P20F'Y8S.*%5F;] M']Y@HQ0QQ\SF]\&*[SJO.#7ZX)L_^1._E01UMQ$[()[ M0'C,>!)CDJ0"!T'J8^+X%"?4DYNG/LC. N MGU>Q?AO"$!U+LSA4^J+3NR$T;^=]TV'@IRK?!'LN\_K5]>A=7J_$/2>NRT*Y M0(^YJI/@F5R@QZHHF1(B%^H9]UFH>Y;R=O"9@U C0YWYN]X'^@OJI>N?G.R! M,7U>U59UF:- MF0G?ST(FI_N(!7+.3Q@F&75P[&:31MGB_)H1-*R=$?3)N]1'6F\8NK0J@52DU-O6?-X$!'. MO 1G:>+@P/$=G$:!BQEU_5"NW%F8$I@7[PJ8__1@T]+I#/TOYU?'<=$3Z9K# M*9ZBMO_3?\F))?K5ZYM!D>?Z^[I4R<'_0E'\J]LL.*/HU[A_(*^JYRZG/6@4 MA4C=--%NV42Z3MI!\U3?[KG[J[;KMG^&Y&!/@JFUZDISKC[ZJ73#A_D'@,:, M!OMO+?8]X4@#G,V <=@<:U'BS? +AX;#QNW'@R//&08!4GV7"V_U/Y?_?,ZE MJS1+\?I"KL-?Y:]Y^^N6QH2E7D0P"?Q81H;,Q2EU7!SQ*/(SUTGC!$0@HB5U M[G AA3?NRM0/8JL&T#6U -3T5]NP )VX1Z3Y8:#!F0IVO1*V&T^"C+;EZEHR ME_5_" Q[00'TLEFDZ$Y\JT_K\K9<,R%X]4E:T:1CKHH74=52T+F:WO(Z%]5] MG"6N&XH4^XPE,F:$"4Y4>8,3^20@@G,GR@R8_(%J:'G+R:3^;4[JJ5,-%D"@ MN.J%DCE@,NL2V2F"LG6)/O2Z(.4 OW2YO(T^:*N0O?ABB(2E2 .5OFC,,83F M;?0Q'09^JG?QO7BX*CXIQI2;3'4WY'+@@O^E>*EJ?OG/^O7\1\FKW\NBYE?% M;5G^K>S3X9IG?\8"9EZL_$V0$JO[95C]A"Z^JQPIRHL!BWAS4U &_[J[)%BU M9.-RYR(?NRUSZ7[JW0K=?9>SN=S9##NP-M/^7YIO-;)BM_@]QJ/88I\"%LL6 M_0H6BP^LP&ET9&HN=;&#U9.!&1Z_GCZ8(;WS=^K-RA_G,8Z&;@7CGK*@UPQ51:VNZ+K['E_&OP><(\\J?+;(\^PHM2RKGE4@]^CV[(Y^2BN! MEBG_[P9I$%/0 ML%D,%N2UJM1*[+=_5$)NA3_E!2G8CO!S6C6D"OC5]?GUQ=7U[^C\XN[JCZN[J\MOL$!G@*I>=)L7*UA(4VV/FIU@ MKPVBK^B#4@CEQ2]HH],PL/W9JV4QE)EC8BE^&2BP:- R!^AMI#IA)/CAPM_* MRX)WJ;NWJ;J+EY+_K7R;T(.=+9B.O\31@I#K LTD]H5*@,L?FQ1X;>\LP1C^ MZ:.$)9 W.$F8#73+1P>GPF=T)W#@J&YOODMQFCH4>W*/RHCO"R\ =;0](&/FB+:1J%,+&O[J'*H$+=9R M$]15?J[+DPH_@>4@!SZ)9LG':4 #RSHV&,];\SEBE*T*C0,2EJW".&[B7J7% MR*,&S.Q?Q=.Z5,49?RGR^E:4JM"DC1JGR'2*=Y42O%.=?1!OM0- M^ N 9-WNIQT/0._[P6!Q:_NM_M)\J]N=;S58C>6*@:C_5IO:U_/N6_4Z(ZDT MZK5^M\\#X,U_M\]DQK7_+I\+1MD_"Z*C-/]V)2[7&F 6I';:"T ;VVUI_32*_$#Q!A&BUN!1A(GG^3A, MN>-$(DGCT-.>2D_39>:YFS]LVA, M@\N!#9OW+.!LTNOE1, !$]MRP)O-9'/^HL,F+#M(C MU[.^KN<,;71M5J"]MJA7%_VY51A=%C)2M%>W@:4+UCZD7N[H/3X/; +;:+CH MMX$79ED&TE8-ERVUEBWWL@SF7F68[?$-B:55,F_(7:KHC+L54"@RWPUC7W%! MRS@\<-?.M7XX_;,K7W:;W^C3?5='OQ61$;MI_ M42^(B,,C3#WJJ2Y+,4[D4%BD0I$"1I$(02?@DQ)G]M1-*N&I%0?E\)["2\]C MK:( \]Y>-/K0"_]%'1AL<+F=P,6 Y5O35FN$WU/R%N;^UC1_GP9<]T73>I7=X\.7XBE7-QVV'7PT"WJ/#C#W?*[DHKO\467# MOES?7@WN[^C7VQXW?]Q[K5D.\]@QH]&?5CL*:5EH5-1Z?-3%JE8G#1N6I4X_ M;.!V_.]WZUNQ5MOM3P74!38[F;HUN+V]V^H^=H4_K=5VL:XC[ M'8%!P_E.1P#H>IK&S^&&X[::.>&1,9=SP7&C=AQPXE$#]WMXJ&^+JI C5]]> MV$55PVZQ''M_;@?L6J8+=*L2[W*%MOVMK%#7"0RIQEX %SP&A88/6D !Z(3: M %B^_3%EJID/'AMT.2><,&O'"Z>>/;6AZ._K-?^1KU9->\1[[O LYBS",4DR M' 3,P0F56](H\]S03>(X<$"MXX[(F?N\IY.J-E6]W*X!)/ L_!A.F@<]IUL/ M\U1M8T]H<7G0%.L-*G>EO%-[R8.F'F\.>?AQ4W:/*G\H%"?L>=5=CM_>F._F MBC2(7>('ZFQ6NFC U'4I[@DLF(AYZ+MQPGT8A\>DS)D==ZO!6R8T()>/#GQZ M/FP9%)@_#_ @U88]8RM_AE-;@+W6.#&F)2[,?*$-P3Z_A?ZK!ART.I[G3"4 /JPG5 M]'I[!I1@00 "T S[8*#]9ERMFC*68V:%&;W#PPI\U6Q],& 3ZVK&[@7W8]>/ M'>S%:8(#5ZBVSRG#+/2$7">$+/&C^WI=DY7>5'^:P3"G'LC:%)':F\2/6V)ISCX@8-$I^KB!;V?DD2?A$_ ?55T\?*P/ MLB6<%]+5MZ0)L-06>."9)^4_NJX(36-D':(0Q4'P1\L \H8S1'_.AJ,[/7O/ M"BS,Y2UB:CG/9@R2T60/E[;8M&\,Q' !8#Z(89?LJA)U=9^PP//#))!@$X$# M)G]*$R$P#[V(N(SY'DDATW\[[")3/FE$ 9M2MU;KS>QP6X 9\G$#X-V?=_2U MU=2Y'7397LT[ANRU8-[]V].:0]VMSYD,HZ6X+==/HJQ?52%U+1U.!=E*ZG#5]YAI5SN1THMBZMKRL>5'+H=2=$L,.4AK@ZWFJ94!/ MZQM5KU&G!;K=H'G;HJE@V^ABOV64OOV6NT5I"'Z71E'Z@!SK$048X03&_<%^ MXUI:V&U F4.#6%".(R>2DW/L1)C0*,1Q$K#,S7C$7%!MYW%1,V\,VFS3:1S[ MAR'2BP]V#(?%@];FG1W[5JQE8OU1TVRRZA\6M#RE_JC!!_GTQ]\P;4A=U>T! MGF*C[DH:+G^RU;/BW?LHGDK!\B8#*W]>"?6#?.[\45&^_*NEB& TCAV7!=A) M7=6HEG@XC8DOX7=H)H(PR6+0M?7359H]<5\UEYTKLE(N(7K5%*O81@?U@/'J MPL)7T8LJRV(-3?^W,#?:-M6,>Y/]S_I17*A[ M->7K9_+C_+'639%"QYTY^G7JH%X?Q)^%VC!L5%(^JY1"G59(JG76T<+IYT3! M:$ZG1.<$$A;:YL$0E/HT!<,H\PD6MECBTQ2&8=[3>(SE^A^UQ7O4CP/N12Z. M0I+@@ <^)C%K6Z&Y 9<;LWCVWD=+E$&>T(C'I%;2_(/H+=(6@1D6P.9#>)$N M1W.4<)KK\6_?W6BT#/3T JU:2ZP?A-/'1) ML(MU4:U7.6^*U/J6/,QW@HPE(>:^X^+ $QFF?AC@P'="X05"4 +B^K&BU:#ILZG4XZV4J8T]V5I,EX#[D+M8T&I89/*_QP> M<;$DSZA!PTS.^(.F^Y0743S+@,X3D5">9#CQJ8.#R(G55L/%F1O%6>@R/_9! M%&?]P',[5E.I5G;"H"O]SG;=Q3K<(NAZ>\(,@U7RKL[6%KK=L NO57>-V5]N MOOE[@S8='P6MMYD"5=Q;D$+^B?S5%%7S[R5Y$%^5^WW)B_SQ^?%>A#3*:.2J MJYZQW*3'7*XBO1"[?A@F41"&Q(VT6W/ Y<_L8+UHQ#K9J&'(/D./K7A ZP<# M;,<]H5^<,;7#L-4)?6QR_+($CH&W&O'B:MK]7\MPV#IB.E&;90^:[$"W=]QD:5BSP'>]+OB& MZ:"[BT<=E_I.$F'.(AG,!'3&-4E=E.&%M>P[(F#E 28EX*[+A'5&9 MAGQ[G@<+58=0T@L_)]H."RG7ZQJ] ]'(B(V6XL0A"8OZ_HB);_UY[%&#W66_ MZ)&+'?'M!WFZ*?J^=M*,(,QB!W/N^3A(.,4D\V+L,8<+-\A"Q]/O[WA4S%)[ M1248*NB[?N2J6U)IY,A-D4@P]>( BY#2@'EA&L7,(#]LHLOL!2B-9FU-0Z\; MVG;KI*]HJQYJ]#/*.QM]!E"J>FYPC;+;$%R[>CPTR^[) DAVT^E&FKQ'!OX4 MR(XD[4\:$A8-N_K]6%_/&FO%O_*.X]CR;?P\7S>3H2=:> M=- U9:A!V?PQ6ZS5P^\)6+C0_9B!^Q7L1Y\T)"9:-?@+ODU$#E.5ES_5C^(^ M=:,L]:G /HE5[;GOJH*0&*>QR^3?>5G P_L74=*UKCOJ"8;\T@[% TM&JL&Q M!QM2>8I6#2#MD1ZF>HYL'R>KAQGJ@O,X1'!B)9#%MHB7](0N2\P$ F*/N GV MMN$A@Y#A2'J,4.7;]X1S3A/JX2C,(AS$Q,5)*BB.TY2D<K.=T4&S M-9SE3,IJNM4"CP]V[(]%FB5.(' <^PP'-.0X9:Z'PY21V,_"S'5 -W3,[3=U7>;TN6XR*?5:AG2[!#D'#;-U5K0S]K*G1(?,VCL?.OB0 M24%[4SXM9]EFP:]=R3Y\:^9H<:#"^S\A9>P[!HZ[S&FVP?SE4.&ZK=W,<3L, MZ]1WAEJP0/V0";N5Z0>?./F40MT747? _IK7W_NLH/2WEC!%T53*_^=WY.>] M$,(/*6=81/(?@4\$)LPA-8Q ZA M*7'B$%+4 10_>[%'L\BLR4_1WK-<-WR,\M]1N=4%5 (!Q7<\3,V/&BQ"=8!) MJ6@@%DEMNF8Q;_YFN@&%#0Q!Y24S8FE:=F(;4VAEBB$D$Q4KT%&7K&0QM/A- MA8OI*,8L $^E^*[ZI"HF&"53L&<9#',.0\8.T?IUZA51CF9_=$62\L<-628 MF3G^$-QU-CUS5-=KQ5O[\ =9?7TJ5>.<;\^/C^6K\MNJ+N[H"M9G"S[RS,ZW MV_EIT%=]R.[<]HGZ*I[6Y:89U. @&>BA!NA.N_"\P,)\W!!3N7HY@*OE5EOF M.!E%#0-QBX45>$4>"!Z>,+Y]5-*1>ZY659/%2W_*;8*'!=JS__47W- M5DQ)OZM72O2G=6G2$=""J)E#U\?\)>>BD"ZV+KNU_R4I"^E<5=N=5KK0KBL6 MZ[I]\$=>*=_+5H)USM?6RNRXGYR@#1L)VOA,TR%OX2\$BX%+?QS+8=(BMD9Q MTX;\Q0*I1;"&D=7FL*:%\Y_RE;A^;APR\C,O=GF*HRCR<* ZK9"PJ8()8]=+ MLY@&6AR*AP:?>Y'75HXK>:@5""V0'^ P'IA.M0ZXTM(WS* 0?M^"$RK@!X,M M7/J^;\9^S?N!9T[N"ZY:S#:KW.UN?L,:+++,%6%",YM$^%C"GW&E4-N@SO-5A%IYDF-GV^Y"/ M"7VOWN0:0(ST*]=Y^X1.A0=RGRI)?4&J[Y]6ZQ^*!$+\3O)"_>%Y)OWQJV K M4E5YEC/2]0Q2-1R9STB6!CX.72_ @:>H'5U%(,\]WXM%%D2)!ZG,M:D<*.*8 MMB]FWU5!EUHH/Q>E(*O\7W)1_""5J]HB$2:51IG4NJ$445Y9B*:E5SU2$C+_ M=].+9N_U-6 Q[]#1T\[)RQE2RB*E;4-O(LZ04GCSMT1IC=ZJW90;6"W;#UI6\8L=8N#LV8>QR%+'>RDQ%4M*6.<"!694^KRD F7 M,ZVR(*C@F==Y"93@51#6E3J*(>-P+?:Z;43DB M8^X4="<5M6+;3&0C6#_!<@R=Z3R+!9N!25VXN:"TRX1!1MF78V,NEH29,&J8 MBYEZU&RZ;M<)WVI2-Y<^-MF$U''],&,>=B)7$>&G"4[=Q,>)DSAN&H5QX(,( M$X_(F=D%NU7V1JQQ.ZQC,.G-QQ:,A_FBB=W@F7;"*DL3ZS$IB\ZC$Z:^G3:G M'C^1J:?[G\]Y(=S[,!,LC=,,.UXQR$&8B(]8RT--=."%MT MRM4S_.W,J_F6#:ZN:_(H/JX?25[(O\3 MAJ#%\C%!O \V:.>YG)17)]DUW^;$_#%*/P3:$2X^J_JM+LA:Q4#>Y7(67G MJK),_<5YP7?_8/#D?1 GU(O3 *><2Y\/4CFODR#",2>")P'/G "4OIY!Q[E7 M[8W&ZJA0=#JKIEBB4M5[ZE01%C#F^$9ZL>:=D0?N&#:@]^JV7.,2-MD'ILZI$[YH5KPN+[?AF!-Q2])Q#PT4#[XP0OXW9 MGS-UC6YQ\X80JL'/&RF?!!V5G/6%#%#I1[*4^]MQ$,2XF J>)'^&0 MDXQE@6)G#2#+KW%Q,Z^D&N$&Q5;'X='S6GM&PURW+8CJ!*.=DE!KQ!0P&VU6 M*1T7MGS=T:3A!RN)IM^"WT[[).U8%^*K:#KHOEX57&WO="^<'7Y[9K=4(O3O M=1TQ<-P3[=@&\[Y.'NH%*D(PKFYD/ M3YIXTKQ,YE:4^9I?%EQUO;\G":&Q$Q+,J,MQ$) ,$Y]EV&5)QD,26Y*0E()#>-B6H&D%*.B:M.W9,L=FGD>2(D ML#S_$4FS)_I;N:AL!9^A8B,:FN8_AI5NGM\" M!$?V?\U][XZVGC#=+\$X99 MR_,?D[-PHG_"W/U,_]0+9L[[C7T7_'DE;K)A^\"/,CR\D#I_$6\[R8G0Y6&0 M.=A-'8*#+(XPH7)"S6@2^B&)4NG6$)<&RI_9T7MM5+YXMS?E0".8QT,!UHL# M,\(&BPY:B,W:D,\0"DOQ!"I]T2AC",W;V&,ZC&F%K8QP\I._?LJ+O)*2?U^O M>74MZIOLJZA$*>7="YJEL2O7%*GKR86%*Q*<9!G%+'(#DC"6^A[HQK.&S)DC M3R\8/2C)Z,.C1+C,R:HZ0U+1==ERYG)2YGST].J^7YD]1M9*6;7;]^%J+>GI=6@QSQ-N(AC#SN"J69J"<6I$\=8;E/3 MD >)FPI0Q3A$^,SS12<>-?+5 >#ZN:CESJHF^0JZ#X5 JKD)G0DHX YTH 7: M!6R@R$RWITT@L+7SA(A>=MMI ,K>GM-D#%.6__V;VDV5AERHWH=.&%(21SC@ MG.,@=6-,5=DJ==W,H5'L1$S 6D2-B8-XB5$OJ VU0%L+!27S'P%*+V38,AX6 M(HXU=FHD]W0QJ@WJCR9X-'28MM\;H/R)J83;_::/WF?PU MWH$O;&^>ZZHF1;-8>7BH+\N& ^;\L=;=-!X=8.Z"IZU<) 67XD%E6*7X=2'6 MS]4NF^OYHUHEZ&\GCZ,RO=JW @C,F6UB 5KV3]IJM.H_/NIBB_Y)PX9K_NF' MS6;A347D<+;_O5P_/TE)G_)"_EE.5IL[XA?DJ:FRWVY-&8OC,.(.%@EU<,"H MBQ,ODS.U[\:%/&>_9FU=OKV*1)6RT'S :]GGK[XGD^ ME=Y:8WJ!>:MM9XZ2=U1$$IK=5IQL/"RJG MV0UKI#9JFEDWM<-#+M=2;=2DG;YJXT^:%LRT13GG!=\TBKDEK\I[NVLH\F\& ME:91D%(W%10[J<=PD$8$)V[B8I8*)P[#+! NJ(0/*'_N(_;NEE3>:04ME8%A MJ;>3F1$AZ.*AJ]!3U43;KD*=+C;+9HP,ME9" Y.^<#F-$33[I35FPYB%F"^D M_(>HU>#?A!RQN>*V/2WD2: NE,:8\B!19?X!EI'%Q5GJT3"C69:)!!)01J7- M'#ZVLM%6."R&C(.E%S&L00"+#P>MG[5Z5\M02W%A7-:B44#+[+<^K_>202$= M__O=NEF+_,PK[?JYX4MSS^F;KI^H7N\L335; ^U;.;T&-S80YG+';4-_*LFV M*N0.66-6&+E>)+K\\N?ZF,(.9.VU[R;,_.>,L!) M4B_*H@![KFIAYU".:>P)',8D)&E,:.*!+K=IR)Q[]]MJ@$2K0M76G#?< ]TR MPJAL0 M,SXE\P4+LL83B@/HI5B7^V(W], BX2+AP(40SML$TI9QY>C](]18: MEH$"IATZ=#KI#3@=UT5'5F.=W@)@KS62T&F)"S.%:D.P3Q>J_ZHA%U5;XUAM M,Y =QZV7.)DK'!\+/Y&;#*H*L5B88>+1E$=^2!(.NO)S3-#\Z8E&+#AO/PF0 MGK_;,!NXP-FW> ;>WRF[;+%.'1.S+.G4A+%[G%-3SQN6;*Q+D3\4/9%=7[35 M_3XZGBO".(VPB*2;!JGJ[ALY"4XSZ;""AW$21:!ZC#%I5.U<$\C$5+B<,RS5/'K4($3+F=J/^4>X[%/8A;"]D0P M!68. V]U *_:@7#J+N'G PD6(]Z*/VOR&:1L:=%4WXY-KN//V_4J9Z_S)!5- M$;&VX@>*7WCY;P;._E[ 5O^>JU^PU+7.+QA%(Q.RNN&FVL13QXF=(!0X%*F# Q[X./7""$*2: M35\.OB$Y0OFFSTHE?V:K9]Y4&34OYHVU!HS45CZJWC9AV6]T L_UCHZH:\WY M06GT2]>N0ZF*&EW/D-)V\[?[&Y#V;J?4VC)#MDT@;9)I6]%K>=YMFW >I.BV M*L#@*L;%NI03@8Q7[=Y(\,O?KNX^GBL^12J"B&-'E4T%@F(6I$6[ 5DS,N('O?RJ)2Y(TLG#-A3<1R8\1!CS5Q@C-&V M5-NWM"P96WK( 0;+#OEOVR7'^-B+.)^6>;WWZ3UL7+'P_/B\4EN1L95&PWJH M5NM.&@9<7;U,I1]*QV0N)L(E.(@SPJCK49=P8"$#1/[\]0V]-GV=T\YR?C5& MJ&(%7[W=T(RHP3Q_")C&_J=C.K6ZH3'$PEY)!4CZTI46)M <*, P&@:>I[UL MNK9WM5AM\BDO'M3U\N?JGCL.92$/<4)\H6Y]"YS(E0'VB(BIEZ6^EVDQY4T) MFCG&M*+[VD"T$8Y:Z?IYVU&PII.WMB" !0Q3ZT%Y7!W3C)*YHP,OEM'5,6^8 MUM5ZWFSY\%61.19R*T#*0HY9=;5 8>HD(2,QSE@:X<")$YP20G'LQ"3)0B], M$E"YXV$QL]=+M$*1Z*3"9OXCT.A-\*<;#'/+C:V]P!GJHL9MLC0?'Q&RZ+0[ M;NC;V77B:0/F@J)2-0S5MQ=V4?75>;J\!0?>G=G-;M4Z0EW3WY1=5.B;*%]R MIJKT=*] 'S5\W-]LV SSM"ES+3K>E'%F= 6'!ER.K&#$G!VJ@K'GS+B(Y-S60U -M%4$#3="?O2Z:62X8JAJ)]3FP@GGV^\,$HS^R M#I63@GVLMG>X:\B?_A>"W[^(DKR M(*Z?59"^R;Y])_*W94#4^1NIC',: SE>Q]E-&FJM?L'T/@YP1<;S\X M&XRP*:Y7 W5ZH%81A5VK"AKHHMA%QWY;P1M((Q L[2MALA?=;AK!\G87:C8( M?'/ZK?[';*V5+NW=8GN MOGU%6U50JXO^!E8+G.D-K6U<8#%"!Q++_4R@1AMM?+4$++81AI@[W!B#WCNQ M!>: :2YQB,N)$V#7B2D.8BH7&'X8J\4YC(9::-Z6/IMV!AA'3L]3K>$!\]D3H+!" M>K=GXHRD=Y_?AV)?RVP=TKO]EPS;#*J%UO?U2KY17?[S.:]?KYJ+'7*5?JN. M>-?%>5V7.7UNY-^M5811]^O7*SGH0T_!>>_Y040])\19X/@X$*H;=^.N%]^41 MAX/7HJN+J72$^68YHA M9*4@E?@HVO^]*O9GH:]R@I'J_2 EO^<\\803,AG-/0\'8>1B2@7'C$2)\*GC M,%_ LH<@^;-G%ELMT(=>GU_4S?RA2O\'M4JA/Y5:J-,+F-Z HJZ;FIP-2VC: MTCJ,!KE-(S"LY3UATA?.B1I!LY\O-1L&?E)Y^5.P9\6=<4%J\; N7R']!0Z^ M/',CU3X#H]88G1H>'G&Q8\)1@X;G@N,/ M&G3E4-Y77<@-A=PS?BF>\H]YQ:X*KNZQ:C?I&!EC9E]2(@#-.<:,G?8A6W;" M7*F5BAJQ:J*\RQ^;Q-"7Z]LKI#20?_$LWU?))*Z:-#V3%1K%!=;20\-HLPX? M8P,OU_!#P[R=_A\ZSQN>$Y"5J+Z*%U$\BVO1WXN(:!H'3DJPRZA<4T=R89W& MOH=#D8DXY*E/(]!%[H-29O;23ASZ36Y>OC^2\A_ S/%!8#03P:>:"W/6/4MG MN)\U:I*M_.M!&L'Y4[Z2V_%NHKUGL4-CQ\]PXD5471F) M5:Y2NF,8QS0* N+JT4X?&7_N56=[H;<1N5F402\Q[P(R[H$6S 2N.4$6&EQ4 M/FC'"?>3=\=;^%KR06/V;R,??NR4TX.V>.9SWM)UJ^9RS8'%IFXR%$DBF%!' M CS&@>\[F+B9@]5M9)&0D/N1P9' A-2Y\_PMY49WF7Z@A4F>?@I 2/+=(BS MC/HQ1&;M PDRVFKF>TKF.Z2S-6$XG*/6?=DX\;Q^%(KY0*B+:I_7+45BQZWE MI8[G>4F"TR!RU*%AB)/8<7'F5%?'.1CCJI0/9R/20 MTTX5V\$#%A*V&*RSGI"HEZWNJ#0U)Q:IRT#FVDO]CLA:.M$[;?:!M*[&2Z9] M8-9,"%Y]DJHV#694,8,<_*HXS_E-)O](42,WQZWW<9A)5P\$CH2(<. &+B:$ MI%@0CSE4[HQ=/4)3 ]DS!X1>$Z2^&)++2%$6CUT'QUS=[I$^0%;-;[7@*@^4 MY3_E#V;]'?4!UXL<,\$(BR.[" [54.DSJ8B*+T-55.;L150-O=&Y_),7N>ZU MV28&C(FU#C'ZDA=N#@.&9+\O#'P(L[#T6=2UNF)W40J>]\FGQ$O\F'$/.YG\ M1Q#+T$-)X& F_SQD*6>A<"#QYY"0F0--*[+QA48H+'8<1$4O2)QJ*RP:O#5S MAH3/Y;1M'OZG.IDDV$>9F8MZ!!JU"*CTZ?#(RYV[#1JT/"\:?S! M8[XT1/VS_.F__Z/_$_D/2BKQW__Q_P!02P,$% @ K'D!62(W1ZMTE MH^ & !4 !Q9&5L+3(P,C0P-C,P7W!R92YX;6SLO>F76TEN+_C=?T5-S]=! M5^R+C^UWM%5;9U0EC4K]^LU\X8D%D:*;2D/NYW%(J MDWDOEE\@ 0"^)?_\>UT]M-77*ZFB_F__HG_F?WI)YRG19[.3_[U3W_]] NX M/_V/?_NG?_J7_P/@?[W\^.ZGUXMT=HKS]4^OEAC6F'_Z8[K^_-/Z,_[TM\7R M[].OX:4YZJ1$WCQT-IW_ M_9_K'S&L\"=B;[[:_/-?__1YO?[RSS___,Y]_[GS4\O/[J:WO=!>BS_^7_]^N[W]!E/ TSGJW68I_J" MU?2?5YMOOENDL-Y(_4FZ?GKP$_5?/;V^\\C_/IAEGB^7Z\^+/:7'Z<_W,SZ\6A(D/X:12O'G"^OL7 M_-<_K::G7V:7W_N\Q/*O?_I/^FVHJF5&LOK>__/JEW^^(N'+$E>$FPW+[^@; MY\^H;SN8'/RVQGG&+:<7+YHMTHT/S:J<%\N+WYR%B+/-=R<9IY/-DU_$U7H9 MTGH2+:'+!P,F1 :*>0&1!P6^!)6]S3'R>)/[2OF*2-^H987ISR>+KS_3@W^N M$JE?;$2S$2V:B%R__03<5UPN<3\;JN5!YG;<+8F\XJ;3[;0^/]S%I;TQ-GW MC_B%ELG$9)RD"DD!L9KPK2F/R+W&81DFJO!,D5/^0 M.$JB(Z/BS7P]77__93K#W\Y.(RXGQAG)G>8@K"+S9J(D.2 '58R4%HWG41^% MAMMOW D%NE\4'"7!+K3_$4^F50CS]6_A%"<49\G,:&_SF9$@%,D@2*= 1V=9 M\3'D>)RW>-];=T*!Z1T%1TBR"R2\I=!^229L(_C?2?[X:G$V7R^_OUIDG'"9 MM7!*@9Q#*^!YQ3($B8'/@HRATP6KI3B@=D&@'G@]3M!Q?4.E1:R[0(D M+W(F%:S._WHWG2.?6)0<=>"$[^Q)-,F"X]F"%%HIEV14OH5%N>?5.X'#]PZ. M8V7:$S!>T9?OEY\6?\PG6F$V.D6PTBA06 R$'(@95$XRCI9$U@X65R_>+77% M?A!4'"C0GC"QV1K?+S\L%U^G\X039QB&Y#P8\ITHW%84;FO%01:'.7$7DFYH M+VZ]?3=T=)S9;";:GB#R8;%:A]G_-_VR<9VL*D469< [0Y%W#@5<\>1$*<.D M349K/"ZW]?"[=X-'QPG/1F(=&1S5ZKU88MC0S;R/VE@'.4D!*DD'$;V%9 PW MV06>0SX*#M??MAL .DYQ'BRZD55>3TIG'SXOYA<9&(^&<"H)<&3U_X[I;$G0Y2)^FJYG9*T8M[*4#-'4 MB@&E-83HZ"LCLBE1.F6.4__M-^ZF_HYSF$>)<&3U?UJ&6HWR^_?3N)A-)(]% M,LS 0DJU#(3,ELL2C+2,B2*L\L<=9MQXW6Z*[SAM>;CP.EGT;[ZESV%^@IM\ MJ[%9^TP!;W:,@AOO,WBC(WA&KFP4F8Q::++PK[]U-PQTG)(\6I1=A .OSI95 M7-L3N IITL'9:F*3C%;5(+-<"PRCAY"8@^2S*"Q'$9EH )'[ MW[X;1+I/1#80;1<0J<>XRU=AC2>+Y?=)01%\HK W&$5.<. 2@BT4$KG"O)(< M([8XO[CQTMW*IKK/01XNR"YP\/MIF,U>GJVFGN#RA+>\OR\4?Z\^O%J=?POS[ M1$NCI5:"HF&7220Y@/,$9^5MPAB,9.:X,N!'7KX;+KI/,QXOV"[P\?MGG,TN MJ$\E&^1.@+,9*7RR$:*/Q$)RR2,WM D>%W[=N:.@XYWBD&+L 1%^6LLX M%NGOOW\FN:W>GZWK?8X:64\T4D1M"X.$U07*QD/4DC;!S)UQ)1;1Q%8\1L-N M(.DX.]E8S'V AB2W#+.W\XS?_F_\/G$ETTY8#/!0:\4B*G*61((4F&#>Z5S* M<8FK>U^[&S0ZSEP>+\RQSZNVH=(OTU4*L_\7P_*BM#P@YU[4VP6Z9F"T0HB, MO"96M H48&NMTG%G5P^\>3=,=)S4;"+23JKUKYCXA;ZSFEA=>"RE%GN1WZQ8 MTN!<\9",-3F@<#*;HU#QP(MW T7'6<)THD$HUODZ2 M=K\L-A>3.!(3RK9$Q;57[X:+CE.<;80Z,C)>$ =YP\4LG$R,=,88,FY%) .* M'"/P3 3@3%(013^TXKCRN1NOVPT!'6,ZW_R\]WA/>.OG'4!>WY:C&; MYGH'_V68UO77>3C+4_KN329VO;G]Y%/;7>G>CX$C[WJ?K> DA"^3 M35EI1,W((EST%RC)@[P,JKL/K\8I[K M7V_(V'\-,V)F]6+]*BR7WZ?SD_\99FPUQ]Q(2T+HBE MWW!]P8NF(,*)&(%[YT@R.8!W08#E' ,34N*C370.VMH>H6>4-&D\Q1%>X\;.JFE"&W,7 1Z(^L M @89[:,%S(? 90>RQFG2,1R*6FNB W!MB?]WG.5?%LO?R:G[;;'^$)84OKZ> MKKXL5F'VE^7B[,L%=ZQ$'RD^!4&VLQ;X&G!>R=K5RI-W)XV1CUVE/#Q2VY7" M<3J"#+C!#:>?;M!WZ?>)Y&GQ6"A&U,8WOD"0P=#2\25G$2R6UJ'<_N:J^6'5 MT-@Y1+J'0V.Q#K-&N][B"R[7WS_, HECGFO0^:4FUNH.7A-E 4D,Q6E%$8+8 MU/D(R$XHQV7,QC]6,W78=O

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end XML 89 qdel-20240630_htm.xml IDEA: XBRL DOCUMENT 0001906324 2024-01-01 2024-06-30 0001906324 2024-07-24 0001906324 2024-06-30 0001906324 2023-12-31 0001906324 2024-04-01 2024-06-30 0001906324 2023-04-03 2023-07-02 0001906324 2023-01-02 2023-07-02 0001906324 us-gaap:CommonStockMember 2023-12-31 0001906324 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2023-12-31 0001906324 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001906324 us-gaap:RetainedEarningsMember 2023-12-31 0001906324 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001906324 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001906324 2024-01-01 2024-03-31 0001906324 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0001906324 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001906324 us-gaap:CommonStockMember 2024-03-31 0001906324 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2024-03-31 0001906324 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0001906324 us-gaap:RetainedEarningsMember 2024-03-31 0001906324 2024-03-31 0001906324 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0001906324 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0001906324 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-04-01 2024-06-30 0001906324 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0001906324 us-gaap:CommonStockMember 2024-06-30 0001906324 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2024-06-30 0001906324 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0001906324 us-gaap:RetainedEarningsMember 2024-06-30 0001906324 us-gaap:CommonStockMember 2023-01-01 0001906324 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2023-01-01 0001906324 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 0001906324 us-gaap:RetainedEarningsMember 2023-01-01 0001906324 2023-01-01 0001906324 us-gaap:CommonStockMember 2023-01-02 2023-04-02 0001906324 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2023-01-02 2023-04-02 0001906324 2023-01-02 2023-04-02 0001906324 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-02 2023-04-02 0001906324 us-gaap:RetainedEarningsMember 2023-01-02 2023-04-02 0001906324 us-gaap:CommonStockMember 2023-04-02 0001906324 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2023-04-02 0001906324 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-02 0001906324 us-gaap:RetainedEarningsMember 2023-04-02 0001906324 2023-04-02 0001906324 us-gaap:CommonStockMember 2023-04-03 2023-07-02 0001906324 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2023-04-03 2023-07-02 0001906324 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-03 2023-07-02 0001906324 us-gaap:RetainedEarningsMember 2023-04-03 2023-07-02 0001906324 us-gaap:CommonStockMember 2023-07-02 0001906324 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2023-07-02 0001906324 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-02 0001906324 us-gaap:RetainedEarningsMember 2023-07-02 0001906324 2023-07-02 0001906324 srt:RevisionOfPriorPeriodReclassificationAdjustmentMember 2023-04-03 2023-07-02 0001906324 srt:RevisionOfPriorPeriodReclassificationAdjustmentMember 2023-01-02 2023-07-02 0001906324 srt:RevisionOfPriorPeriodReclassificationAdjustmentMember us-gaap:CostOfSalesMember 2023-04-03 2023-07-02 0001906324 srt:RevisionOfPriorPeriodReclassificationAdjustmentMember us-gaap:CostOfSalesMember 2023-01-02 2023-07-02 0001906324 srt:RevisionOfPriorPeriodReclassificationAdjustmentMember us-gaap:ResearchAndDevelopmentExpenseMember 2023-04-03 2023-07-02 0001906324 srt:RevisionOfPriorPeriodReclassificationAdjustmentMember us-gaap:ResearchAndDevelopmentExpenseMember 2023-01-02 2023-07-02 0001906324 us-gaap:StockCompensationPlanMember 2024-01-01 2024-06-30 0001906324 us-gaap:StockCompensationPlanMember 2024-04-01 2024-06-30 0001906324 us-gaap:StockCompensationPlanMember 2023-04-03 2023-07-02 0001906324 us-gaap:StockCompensationPlanMember 2023-01-02 2023-07-02 0001906324 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2024-06-30 0001906324 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2023-12-31 0001906324 qdel:CustomerOneMember 2023-12-31 0001906324 qdel:CustomerOneMember 2024-06-30 0001906324 qdel:ExpectedValueContractCustomersMember us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2024-06-30 0001906324 qdel:ExpectedValueContractCustomersMember us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2023-12-31 0001906324 qdel:CustomerTwoMember 2023-12-31 0001906324 qdel:CustomerTwoMember 2024-06-30 0001906324 us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember 2024-04-01 2024-06-30 0001906324 us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember 2024-01-01 2024-06-30 0001906324 us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember 2023-04-03 2023-07-02 0001906324 us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember 2023-01-02 2023-07-02 0001906324 us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementAndThirdPartyMember 2024-04-01 2024-06-30 0001906324 us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementAndThirdPartyMember 2024-01-01 2024-06-30 0001906324 us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementAndThirdPartyMember 2023-04-03 2023-07-02 0001906324 us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementAndThirdPartyMember 2023-01-02 2023-07-02 0001906324 qdel:LabsMember 2024-04-01 2024-06-30 0001906324 qdel:LabsMember 2023-04-03 2023-07-02 0001906324 qdel:LabsMember 2024-01-01 2024-06-30 0001906324 qdel:LabsMember 2023-01-02 2023-07-02 0001906324 qdel:TransfusionMedicineMember 2024-04-01 2024-06-30 0001906324 qdel:TransfusionMedicineMember 2023-04-03 2023-07-02 0001906324 qdel:TransfusionMedicineMember 2024-01-01 2024-06-30 0001906324 qdel:TransfusionMedicineMember 2023-01-02 2023-07-02 0001906324 qdel:PointOfCareMember 2024-04-01 2024-06-30 0001906324 qdel:PointOfCareMember 2023-04-03 2023-07-02 0001906324 qdel:PointOfCareMember 2024-01-01 2024-06-30 0001906324 qdel:PointOfCareMember 2023-01-02 2023-07-02 0001906324 qdel:MolecularDiagnosticsMember 2024-04-01 2024-06-30 0001906324 qdel:MolecularDiagnosticsMember 2023-04-03 2023-07-02 0001906324 qdel:MolecularDiagnosticsMember 2024-01-01 2024-06-30 0001906324 qdel:MolecularDiagnosticsMember 2023-01-02 2023-07-02 0001906324 qdel:CustomerThreeMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-06-30 0001906324 qdel:CustomersWithBalancesDueInExcessOf10OfAccountsReceivableMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-12-31 0001906324 qdel:RespiratoryMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2024-04-01 2024-06-30 0001906324 qdel:RespiratoryMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2024-01-01 2024-06-30 0001906324 qdel:RespiratoryMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2023-04-03 2023-07-02 0001906324 qdel:RespiratoryMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2023-01-02 2023-07-02 0001906324 qdel:NorthAmericaSegmentMember 2024-04-01 2024-06-30 0001906324 qdel:NorthAmericaSegmentMember 2023-04-03 2023-07-02 0001906324 qdel:NorthAmericaSegmentMember 2024-01-01 2024-06-30 0001906324 qdel:NorthAmericaSegmentMember 2023-01-02 2023-07-02 0001906324 qdel:EMEASegmentMember 2024-04-01 2024-06-30 0001906324 qdel:EMEASegmentMember 2023-04-03 2023-07-02 0001906324 qdel:EMEASegmentMember 2024-01-01 2024-06-30 0001906324 qdel:EMEASegmentMember 2023-01-02 2023-07-02 0001906324 qdel:ChinaMember 2024-04-01 2024-06-30 0001906324 qdel:ChinaMember 2023-04-03 2023-07-02 0001906324 qdel:ChinaMember 2024-01-01 2024-06-30 0001906324 qdel:ChinaMember 2023-01-02 2023-07-02 0001906324 qdel:OtherMember 2024-04-01 2024-06-30 0001906324 qdel:OtherMember 2023-04-03 2023-07-02 0001906324 qdel:OtherMember 2024-01-01 2024-06-30 0001906324 qdel:OtherMember 2023-01-02 2023-07-02 0001906324 qdel:ShortTermMarketableSecuritiesMember us-gaap:CorporateDebtSecuritiesMember 2023-12-31 0001906324 qdel:ShortTermMarketableSecuritiesMember us-gaap:AssetBackedSecuritiesMember 2023-12-31 0001906324 qdel:ShortTermMarketableSecuritiesMember qdel:AgencyBondsMember 2023-12-31 0001906324 qdel:ShortTermMarketableSecuritiesMember 2023-12-31 0001906324 qdel:LongTermMarketableSecuritiesMember us-gaap:CorporateDebtSecuritiesMember 2023-12-31 0001906324 qdel:LongTermMarketableSecuritiesMember us-gaap:AssetBackedSecuritiesMember 2023-12-31 0001906324 qdel:LongTermMarketableSecuritiesMember us-gaap:ForeignGovernmentDebtSecuritiesMember 2023-12-31 0001906324 qdel:NorthAmericaSegmentMember 2023-12-31 0001906324 qdel:EMEASegmentMember 2023-12-31 0001906324 qdel:ChinaMember 2023-12-31 0001906324 qdel:OtherMember 2023-12-31 0001906324 qdel:NorthAmericaSegmentMember 2024-06-30 0001906324 qdel:EMEASegmentMember 2024-06-30 0001906324 qdel:ChinaMember 2024-06-30 0001906324 qdel:OtherMember 2024-06-30 0001906324 srt:MinimumMember 2024-03-31 0001906324 srt:MaximumMember 2024-03-31 0001906324 us-gaap:SecuredDebtMember qdel:BankOfAmericaCreditFacilityMember us-gaap:LineOfCreditMember 2024-06-30 0001906324 us-gaap:SecuredDebtMember qdel:BankOfAmericaCreditFacilityMember us-gaap:LineOfCreditMember 2023-12-31 0001906324 us-gaap:RevolvingCreditFacilityMember qdel:BankOfAmericaCreditFacilityMember us-gaap:LineOfCreditMember 2024-06-30 0001906324 us-gaap:RevolvingCreditFacilityMember qdel:BankOfAmericaCreditFacilityMember us-gaap:LineOfCreditMember 2023-12-31 0001906324 us-gaap:SecuredDebtMember qdel:BankOfAmericaCreditFacilityMember us-gaap:LineOfCreditMember 2022-05-27 0001906324 us-gaap:RevolvingCreditFacilityMember qdel:BankOfAmericaCreditFacilityMember us-gaap:LineOfCreditMember 2022-08-04 0001906324 us-gaap:LetterOfCreditMember qdel:BankOfAmericaCreditFacilityMember us-gaap:LineOfCreditMember 2024-01-01 2024-06-30 0001906324 us-gaap:SecuredDebtMember qdel:BankOfAmericaCreditFacilityMember us-gaap:LineOfCreditMember 2024-01-01 2024-06-30 0001906324 qdel:BankOfAmericaCreditFacilityMember us-gaap:LineOfCreditMember qdel:OnOrBeforeJune302023Member 2024-06-30 0001906324 qdel:BankOfAmericaCreditFacilityMember us-gaap:LineOfCreditMember qdel:AfterJune302023ToJune302024Member 2024-06-30 0001906324 qdel:BankOfAmericaCreditFacilityMember us-gaap:LineOfCreditMember qdel:AfterJune302024ToDecember312024Member 2024-06-30 0001906324 qdel:BankOfAmericaCreditFacilityMember us-gaap:LineOfCreditMember qdel:AfterDecember312024ToJune302025Member 2024-06-30 0001906324 qdel:BankOfAmericaCreditFacilityMember us-gaap:LineOfCreditMember qdel:AfterJune302025Member 2024-06-30 0001906324 qdel:BankOfAmericaCreditFacilityMember us-gaap:LineOfCreditMember 2024-06-30 0001906324 us-gaap:SecuredDebtMember qdel:BankOfAmericaCreditFacilityMember us-gaap:LineOfCreditMember 2024-04-01 2024-06-30 0001906324 us-gaap:SecuredDebtMember qdel:BankOfAmericaCreditFacilityMember us-gaap:LineOfCreditMember 2023-04-03 2023-07-02 0001906324 us-gaap:SecuredDebtMember qdel:BankOfAmericaCreditFacilityMember us-gaap:LineOfCreditMember 2023-01-02 2023-07-02 0001906324 us-gaap:RevolvingCreditFacilityMember qdel:BankOfAmericaCreditFacilityMember us-gaap:LineOfCreditMember 2024-04-01 2024-06-30 0001906324 us-gaap:RevolvingCreditFacilityMember qdel:BankOfAmericaCreditFacilityMember us-gaap:LineOfCreditMember 2023-04-03 2023-07-02 0001906324 us-gaap:RevolvingCreditFacilityMember qdel:BankOfAmericaCreditFacilityMember us-gaap:LineOfCreditMember 2024-01-01 2024-06-30 0001906324 us-gaap:RevolvingCreditFacilityMember qdel:BankOfAmericaCreditFacilityMember us-gaap:LineOfCreditMember 2023-01-02 2023-07-02 0001906324 us-gaap:CostOfSalesMember 2024-04-01 2024-06-30 0001906324 us-gaap:CostOfSalesMember 2023-04-03 2023-07-02 0001906324 us-gaap:CostOfSalesMember 2024-01-01 2024-06-30 0001906324 us-gaap:CostOfSalesMember 2023-01-02 2023-07-02 0001906324 us-gaap:SellingAndMarketingExpenseMember 2024-04-01 2024-06-30 0001906324 us-gaap:SellingAndMarketingExpenseMember 2023-04-03 2023-07-02 0001906324 us-gaap:SellingAndMarketingExpenseMember 2024-01-01 2024-06-30 0001906324 us-gaap:SellingAndMarketingExpenseMember 2023-01-02 2023-07-02 0001906324 us-gaap:ResearchAndDevelopmentExpenseMember 2024-04-01 2024-06-30 0001906324 us-gaap:ResearchAndDevelopmentExpenseMember 2023-04-03 2023-07-02 0001906324 us-gaap:ResearchAndDevelopmentExpenseMember 2024-01-01 2024-06-30 0001906324 us-gaap:ResearchAndDevelopmentExpenseMember 2023-01-02 2023-07-02 0001906324 us-gaap:AcquisitionRelatedCostsMember 2024-04-01 2024-06-30 0001906324 us-gaap:AcquisitionRelatedCostsMember 2023-04-03 2023-07-02 0001906324 us-gaap:AcquisitionRelatedCostsMember 2024-01-01 2024-06-30 0001906324 us-gaap:AcquisitionRelatedCostsMember 2023-01-02 2023-07-02 0001906324 2024-04-12 0001906324 2024-06-21 0001906324 2024-04-25 0001906324 us-gaap:FairValueInputsLevel1Member 2024-06-30 0001906324 us-gaap:FairValueInputsLevel2Member 2024-06-30 0001906324 us-gaap:FairValueInputsLevel3Member 2024-06-30 0001906324 us-gaap:FairValueInputsLevel1Member 2023-12-31 0001906324 us-gaap:FairValueInputsLevel2Member 2023-12-31 0001906324 us-gaap:FairValueInputsLevel3Member 2023-12-31 0001906324 qdel:InterestRateSwapOneMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-06-30 0001906324 qdel:InterestRateSwapTwoMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-06-30 0001906324 qdel:InterestRateSwapThreeMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-06-30 0001906324 qdel:InterestRateSwapFourMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-06-30 0001906324 qdel:InterestRateSwapFiveMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-06-30 0001906324 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-06-30 0001906324 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2024-06-30 0001906324 us-gaap:ForeignExchangeForwardMember us-gaap:SalesMember 2024-04-01 2024-06-30 0001906324 us-gaap:ForeignExchangeForwardMember us-gaap:CostOfSalesMember 2024-04-01 2024-06-30 0001906324 us-gaap:InterestRateSwapMember us-gaap:InterestExpenseMember 2024-04-01 2024-06-30 0001906324 us-gaap:ForeignExchangeForwardMember us-gaap:SalesMember 2024-01-01 2024-06-30 0001906324 us-gaap:ForeignExchangeForwardMember us-gaap:CostOfSalesMember 2024-01-01 2024-06-30 0001906324 us-gaap:InterestRateSwapMember us-gaap:InterestExpenseMember 2024-01-01 2024-06-30 0001906324 us-gaap:ForeignExchangeForwardMember us-gaap:SalesMember 2023-04-03 2023-07-02 0001906324 us-gaap:ForeignExchangeForwardMember us-gaap:CostOfSalesMember 2023-04-03 2023-07-02 0001906324 us-gaap:InterestRateSwapMember us-gaap:InterestExpenseMember 2023-04-03 2023-07-02 0001906324 us-gaap:ForeignExchangeForwardMember us-gaap:SalesMember 2023-01-02 2023-07-02 0001906324 us-gaap:ForeignExchangeForwardMember us-gaap:CostOfSalesMember 2023-01-02 2023-07-02 0001906324 us-gaap:InterestRateSwapMember us-gaap:InterestExpenseMember 2023-01-02 2023-07-02 0001906324 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2024-04-01 2024-06-30 0001906324 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember us-gaap:OtherNonoperatingIncomeExpenseMember 2024-04-01 2024-06-30 0001906324 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2024-01-01 2024-06-30 0001906324 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember us-gaap:OtherNonoperatingIncomeExpenseMember 2024-01-01 2024-06-30 0001906324 us-gaap:ForeignExchangeForwardMember us-gaap:OtherNonoperatingIncomeExpenseMember 2024-04-01 2024-06-30 0001906324 us-gaap:ForeignExchangeForwardMember us-gaap:OtherNonoperatingIncomeExpenseMember 2024-01-01 2024-06-30 0001906324 us-gaap:ForeignExchangeForwardMember us-gaap:OtherNonoperatingIncomeExpenseMember 2023-04-03 2023-07-02 0001906324 us-gaap:ForeignExchangeForwardMember us-gaap:OtherNonoperatingIncomeExpenseMember 2023-01-02 2023-07-02 0001906324 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-06-30 0001906324 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-12-31 0001906324 us-gaap:OtherAssetsMember us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-06-30 0001906324 us-gaap:OtherAssetsMember us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-12-31 0001906324 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-06-30 0001906324 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-12-31 0001906324 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-06-30 0001906324 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-12-31 0001906324 us-gaap:OtherAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-06-30 0001906324 us-gaap:OtherAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-12-31 0001906324 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-06-30 0001906324 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-12-31 0001906324 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-06-30 0001906324 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-12-31 0001906324 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2024-06-30 0001906324 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2023-12-31 0001906324 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2024-06-30 0001906324 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2023-12-31 0001906324 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2024-03-31 0001906324 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2024-03-31 0001906324 us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2024-03-31 0001906324 us-gaap:AccumulatedTranslationAdjustmentMember 2024-03-31 0001906324 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2024-04-01 2024-06-30 0001906324 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2024-04-01 2024-06-30 0001906324 us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2024-04-01 2024-06-30 0001906324 us-gaap:AccumulatedTranslationAdjustmentMember 2024-04-01 2024-06-30 0001906324 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2024-06-30 0001906324 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2024-06-30 0001906324 us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2024-06-30 0001906324 us-gaap:AccumulatedTranslationAdjustmentMember 2024-06-30 0001906324 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2023-12-31 0001906324 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2023-12-31 0001906324 us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2023-12-31 0001906324 us-gaap:AccumulatedTranslationAdjustmentMember 2023-12-31 0001906324 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2024-01-01 2024-06-30 0001906324 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2024-01-01 2024-06-30 0001906324 us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2024-01-01 2024-06-30 0001906324 us-gaap:AccumulatedTranslationAdjustmentMember 2024-01-01 2024-06-30 0001906324 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2023-04-02 0001906324 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2023-04-02 0001906324 us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2023-04-02 0001906324 us-gaap:AccumulatedTranslationAdjustmentMember 2023-04-02 0001906324 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2023-04-03 2023-07-02 0001906324 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2023-04-03 2023-07-02 0001906324 us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2023-04-03 2023-07-02 0001906324 us-gaap:AccumulatedTranslationAdjustmentMember 2023-04-03 2023-07-02 0001906324 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2023-07-02 0001906324 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2023-07-02 0001906324 us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2023-07-02 0001906324 us-gaap:AccumulatedTranslationAdjustmentMember 2023-07-02 0001906324 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2023-01-01 0001906324 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2023-01-01 0001906324 us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2023-01-01 0001906324 us-gaap:AccumulatedTranslationAdjustmentMember 2023-01-01 0001906324 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2023-01-02 2023-07-02 0001906324 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2023-01-02 2023-07-02 0001906324 us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2023-01-02 2023-07-02 0001906324 us-gaap:AccumulatedTranslationAdjustmentMember 2023-01-02 2023-07-02 shares iso4217:USD iso4217:USD shares pure qdel:segment qdel:defendant qdel:stockholder 0001906324 --12-29 2024 Q2 false http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent 10-Q true 2024-06-30 false 001-41409 QUIDELORTHO CORP DE 87-4496285 9975 Summers Ridge Road San Diego CA 92121 858 552-1100 Common Stock, $0.001 Par Value QDEL NASDAQ Yes Yes Large Accelerated Filer false false false 67235394 107000000.0 118900000 0 48400000 269500000 303300000 602000000.0 577800000 310000000.0 262100000 52800000 0 1341300000 1310500000 1326700000 1443800000 0 7400000 177200000 169600000 732500000 2492000000 2836000000 2934300000 24700000 25900000 250800000 179600000 6689200000 8563100000 237400000 294800000 86000000.0 84800000 3500000 11100000 356400000 139800000 249100000 303300000 932400000 833800000 177700000 172800000 2207200000 2274800000 127900000 192200000 70500000 83600000 3515700000 3557200000 0.001 0.001 5000000.0 5000000.0 0 0 0 0 0 0 0.001 0.001 126200000 126200000 67100000 67100000 66700000 66700000 100000 100000 2863900000 2848000000 -24600000 -30000000.0 334100000 2187800000 3173500000 5005900000 6689200000 8563100000 637000000.0 665100000 1348000000 1511200000 361000000.0 368600000 739900000 766100000 188200000 179100000 392900000 381500000 56300000 62400000 115500000 124200000 51900000 51400000 103600000 102200000 30900000 24200000 53500000 53900000 0 0 1743900000 0 56900000 500000 56900000 1000000.0 9300000 5800000 17300000 9600000 -117500000 -26900000 -1875500000 72700000 -41000000.0 -36500000 -80000000.0 -73200000 -4400000 -1000000.0 -6300000 -3900000 -162900000 -64400000 -1961800000 -4400000 -15200000 -11200000 -108100000 0 -147700000 -53200000 -1853700000 -4400000 -2.20 -0.80 -27.67 -0.07 -2.20 -0.80 -27.67 -0.07 67100000 66800000 67000000.0 66700000 67100000 66800000 67000000.0 66700000 -147700000 -53200000 -1853700000 -4400000 -5300000 7400000 -26100000 38100000 0 -100000 0 100000 13100000 40000000.0 43600000 23100000 6200000 4300000 12100000 10000000.0 6900000 35700000 31500000 13100000 -146100000 -10200000 -1848300000 46900000 66700000 100000 2848000000 -30000000.0 2187800000 5005900000 200000 800000 800000 9000000.0 9000000.0 100000 5800000 5800000 3800000 3800000 -1706000000 -1706000000 66800000 100000 2852000000 -26200000 481800000 3307700000 400000 4100000 4100000 10300000 10300000 100000 2500000 2500000 1600000 1600000 -147700000 -147700000 67100000 100000 2863900000 -24600000 334100000 3173500000 66400000 0 2804300000 -67600000 2197900000 4934600000 300000 100000 3800000 3900000 10400000 10400000 100000 9500000 9500000 8300000 8300000 48800000 48800000 66600000 100000 2809000000 -59300000 2246700000 4996500000 200000 5500000 5500000 13700000 13700000 3000000.0 3000000.0 43000000.0 43000000.0 -53200000 -53200000 66800000 100000 2825200000 -16300000 2193500000 5002500000 -1853700000 -4400000 231000000.0 228700000 1743900000 0 56900000 1000000.0 20200000 25200000 100000 200000 -73600000 600000 0 9700000 -7400000 -2300000 -24200000 -214500000 95200000 86000000.0 11700000 37800000 -23900000 -35000000.0 2600000 -57000000.0 -58200000 -46300000 -53800000 -33400000 -98600000 158300000 101400000 117300000 0 2800000 7200000 50600000 63100000 53900000 10000000.0 0 -55500000 -111200000 4600000 7300000 -1600000 0 253000000.0 0 103700000 123800000 8300000 12500000 0 30300000 144000000.0 -159300000 -1900000 -2100000 -12000000.0 -114300000 119500000 293900000 107500000 179600000 9600000 18600000 69200000 67300000 300000 1900000 Basis of Presentation and Summary of Significant Accounting Policies<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited Consolidated Financial Statements of QuidelOrtho Corporation and its subsidiaries (the “Company” or “QuidelOrtho”) have been prepared in accordance with GAAP for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation (consisting of normal recurring accruals) have been included. Refer to the Summary of Abbreviated Terms at the end of this Quarterly Report for definitions of terms used throughout the document.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information at June 30, 2024, and for the three and six months ended June 30, 2024 and July 2, 2023, is unaudited. For further information, refer to the Company’s Consolidated Financial Statements and notes thereto for the fiscal year ended December 31, 2023 included in QuidelOrtho’s Annual Report. Operating results for any quarter are historically seasonal in nature and are not necessarily indicative of the results expected for the full year.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company follows the concept of a fiscal year that ends on the Sunday nearest to the end of the month of December, and fiscal quarters that end on the Sunday nearest to the end of the months of March, June and September. For 2024 and 2023, the Company’s fiscal year will end or has ended on December 29, 2024 and December 31, 2023, respectively. For 2024 and 2023, the Company’s second quarter ended on June 30, 2024 and July 2, 2023, respectively. The three and six months ended June 30, 2024 and July 2, 2023 each included 13 and 26 weeks, respectively.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and the related disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassifications</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain reclassifications have been made to prior periods amounts to conform to the current period presentation. Such amounts include a reclassification of $0.5 million and $1.0 million recognized in the three and six months ended July 2, 2023, respectively, related to impairment of long-lived assets from (i) Cost of sales, excluding amortization of intangibles (excludes $0.1 million for both the three and six months ended July 2, 2023), and (ii) Research and development (excludes $0.4 million and $0.9 million for the three and six months ended July 2, 2023, respectively), to Asset impairment charge. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reclassifications did not have an impact on the Company’s previously reported Consolidated Balance Sheets, Consolidated Statements of Comprehensive (Loss) Income, Consolidated Statements of Stockholders’ Equity or Consolidated Statements of Cash Flows.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no accounting pronouncements issued or adopted during the six months ended June 30, 2024 that are expected to have a material impact on the Company’s Consolidated Financial Statements.</span></div> <div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited Consolidated Financial Statements of QuidelOrtho Corporation and its subsidiaries (the “Company” or “QuidelOrtho”) have been prepared in accordance with GAAP for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation (consisting of normal recurring accruals) have been included. Refer to the Summary of Abbreviated Terms at the end of this Quarterly Report for definitions of terms used throughout the document.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information at June 30, 2024, and for the three and six months ended June 30, 2024 and July 2, 2023, is unaudited. For further information, refer to the Company’s Consolidated Financial Statements and notes thereto for the fiscal year ended December 31, 2023 included in QuidelOrtho’s Annual Report. Operating results for any quarter are historically seasonal in nature and are not necessarily indicative of the results expected for the full year.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company follows the concept of a fiscal year that ends on the Sunday nearest to the end of the month of December, and fiscal quarters that end on the Sunday nearest to the end of the months of March, June and September. For 2024 and 2023, the Company’s fiscal year will end or has ended on December 29, 2024 and December 31, 2023, respectively. For 2024 and 2023, the Company’s second quarter ended on June 30, 2024 and July 2, 2023, respectively. The three and six months ended June 30, 2024 and July 2, 2023 each included 13 and 26 weeks, respectively.</span></div> <div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and the related disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></div> <div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassifications</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain reclassifications have been made to prior periods amounts to conform to the current period presentation. Such amounts include a reclassification of $0.5 million and $1.0 million recognized in the three and six months ended July 2, 2023, respectively, related to impairment of long-lived assets from (i) Cost of sales, excluding amortization of intangibles (excludes $0.1 million for both the three and six months ended July 2, 2023), and (ii) Research and development (excludes $0.4 million and $0.9 million for the three and six months ended July 2, 2023, respectively), to Asset impairment charge. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reclassifications did not have an impact on the Company’s previously reported Consolidated Balance Sheets, Consolidated Statements of Comprehensive (Loss) Income, Consolidated Statements of Stockholders’ Equity or Consolidated Statements of Cash Flows.</span></div> 500000 1000000 100000 100000 400000 900000 <div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no accounting pronouncements issued or adopted during the six months ended June 30, 2024 that are expected to have a material impact on the Company’s Consolidated Financial Statements.</span></div> Computation of Earnings Per Share<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the calculation of the weighted-average shares used in computing basic and diluted EPS in the respective periods:</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.057%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.678%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">July 2, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">July 2, 2023</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted-average shares of common stock outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive potential shares issuable from stock options and RSUs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted-average shares of common stock outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) In the three and six months ended June 30, 2024 and July 2, 2023, all potential shares of common stock issuable for stock options and RSUs were excluded from the dilutive calculations above because the effect of including them would have been anti-dilutive. The dilutive </span></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:13.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">effect of potential shares of common stock issuable for stock options and RSUs on the weighted-average number of shares of common stock outstanding would have been as follows:</span></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:13.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"></td><td style="width:48.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.966%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.403%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.966%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.403%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.966%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.403%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.969%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">July 2, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">July 2, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic weighted-average shares of common stock outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dilutive potential shares issuable from stock options and RSUs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted weighted-average shares of common stock outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options and RSUs where the combined exercise price and unrecognized stock-based compensation was greater than the average market price for the Company’s common stock were not included in the computations of diluted weighted-average shares because the effect would have been anti-dilutive under the treasury stock method. These stock options and RSUs represented 2.1 million shares of common stock for both the three and six months ended June 30, 2024, and 1.2 million and 1.1 million shares of common stock for the three and six months ended July 2, 2023, respectively.</span></div> <div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the calculation of the weighted-average shares used in computing basic and diluted EPS in the respective periods:</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.057%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.678%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">July 2, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">July 2, 2023</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted-average shares of common stock outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive potential shares issuable from stock options and RSUs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted-average shares of common stock outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) In the three and six months ended June 30, 2024 and July 2, 2023, all potential shares of common stock issuable for stock options and RSUs were excluded from the dilutive calculations above because the effect of including them would have been anti-dilutive. The dilutive </span></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:13.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">effect of potential shares of common stock issuable for stock options and RSUs on the weighted-average number of shares of common stock outstanding would have been as follows:</span></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:13.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"></td><td style="width:48.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.966%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.403%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.966%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.403%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.966%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.403%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.969%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">July 2, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">July 2, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic weighted-average shares of common stock outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dilutive potential shares issuable from stock options and RSUs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted weighted-average shares of common stock outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 67100000 66800000 67000000.0 66700000 0 0 0 0 67100000 66800000 67000000.0 66700000 67100000 66800000 67000000.0 66700000 200000 400000 300000 500000 67300000 67200000 67300000 67200000 2100000 2100000 1200000 1100000 Revenue<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract Balances</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Timing of revenue recognition may differ from timing of invoicing to customers. The Company records an asset when revenue is recognized prior to invoicing a customer (a “contract asset”). Contract assets are included within Prepaid expenses and other current assets in the Company’s Consolidated Balance Sheets and are transferred to accounts receivable when the right to payment becomes unconditional. The balance of contract assets recorded in the Company’s Consolidated Balance Sheets as of June 30, 2024 and December 31, 2023 was $44.1 million and $46.2 million, respectively. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contract asset balance consisted of the following components:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a customer supply agreement under which the difference between the timing of invoicing and revenue recognition resulted in a contract asset of $1.9 million as of December 31, 2023. There was no contract asset remaining as of June 30, 2024;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">contractual arrangements with certain customers under which the Company invoices the customers based on reportable results generated by its reagents; however, control of the goods transfers to the customers upon shipment or delivery of the products, as determined under the terms of the contract. Using the expected value method, the Company estimates the number of reagents that will generate a reportable result. The Company records the revenue upon shipment and an associated contract asset, and relieves the contract asset upon completion of the invoicing. The balance of the contract asset related to these arrangements was $44.1 million and $41.8 million as of June 30, 2024 and December 31, 2023, respectively; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">one of the Company’s contract manufacturing agreements that recognizes revenue as the products are manufactured resulted in a contract asset of $2.5 million as of December 31, 2023. There was no contract asset remaining as of June 30, 2024.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews contract assets for expected credit losses resulting from the collectability of customer accounts. Expected losses are established based on historical losses, customer mix and credit policies, current economic conditions in customers’ country or industry, and expectations associated with reasonable and supportable forecasts. No credit losses related to contract assets were recognized during the three and six months ended June 30, 2024 and July 2, 2023.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes a contract liability when a customer pays an invoice prior to the Company transferring control of the goods or services (“contract liabilities”). The Company’s contract liabilities consist of deferred revenue primarily related to customer service contracts. The Company classifies deferred revenue as current or non-current based on the timing of the transfer of control or performance of the service. The balance of the Company’s current deferred revenue was $40.1 million and $36.8 million as of June 30, 2024 and December 31, 2023, respectively, and was included in Other current liabilities in the Consolidated Balance Sheets. The Company has one arrangement with a customer where the revenue is expected to be recognized beyond one year. The balance of the deferred revenue included in long-term liabilities was $15.9 million and $13.9 million as of June 30, 2024 and December 31, 2023, respectively, and was included in Other liabilities in the Consolidated Balance Sheets. The amount of deferred revenue as of December 31, 2023 that was recorded in Total revenues during the three and six months ended June 30, 2024 was $9.2 million and $27.0 million, respectively. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Joint Business with Grifols</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an ongoing Joint Business between Ortho and Grifols, under which Ortho and Grifols agreed to pursue a collaboration relating to Ortho’s Hepatitis and HIV diagnostics business. The governance of the Joint Business is shared </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">through a supervisory board made up of equal representation by Ortho and Grifols, which is responsible for all significant decisions relating to the Joint Business that are not exclusively assigned to either Ortho or Grifols, as defined in the Joint Business agreement. The Company’s portion of the pre-tax net profit shared under the Joint Business was $8.9 million and $17.0 million during the three and six months ended June 30, 2024, respectively, and $6.1 million and $29.7 million during the three and six months ended July 2, 2023, respectively. These amounts included the Company’s portion of the pre-tax net profit of $6.5 million and $11.5 million during the three and six months ended June 30, 2024, respectively, and $5.5 million and $6.7 million during the three and six months ended July 2, 2023, respectively, on sales transactions with third parties where the Company is the principal. The Company recognized revenues, cost of sales, excluding amortization of intangibles, and operating expenses, on a gross basis on these sales transactions in their respective lines in the Consolidated Statements of Loss. The Company’s portion of the pre-tax net profit also included revenue from collaboration and royalty agreements of $2.4 million and $5.5 million during the three and six months ended June 30, 2024, respectively, and $0.6 million and $23.0 million during the three and six months ended July 2, 2023, respectively, which is presented on a net basis within Total revenues.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disaggregation of Revenue</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes Total revenues by business unit:</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">July 2, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">July 2, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Labs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">361.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">711.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">732.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfusion Medicine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Point of Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">442.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molecular Diagnostics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">637.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">665.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,348.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,511.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentration of Revenue and Credit Risk</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the six months ended June 30, 2024, one customer represented 11% of Total revenues. For the six months ended July 2, 2023, no customers individually accounted for more than 10% of Total revenues. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2024, no customers had a balance due in excess of 10% of Accounts receivable, net. As of December 31, 2023, customers with a balance due in excess of 10% of Accounts receivable, net totaled $63.5 million. Revenue related to the Company’s respiratory products accounted for 9% and 14% of Total revenues for the three and six months ended June 30, 2024, respectively, and 13% and 23% for the three and six months ended July 2, 2023, respectively.</span></div> 44100000 46200000 1900000 0 44100000 41800000 2500000 0 40100000 36800000 15900000 13900000 9200000 27000000.0 8900000 17000000.0 6100000 29700000 6500000 11500000 5500000 6700000 2400000 5500000 600000 23000000.0 <div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes Total revenues by business unit:</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">July 2, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">July 2, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Labs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">361.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">711.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">732.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfusion Medicine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Point of Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">442.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molecular Diagnostics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">637.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">665.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,348.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,511.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 354200000 361400000 711100000 732100000 161300000 163300000 321600000 319200000 117100000 134200000 303700000 442300000 4400000 6200000 11600000 17600000 637000000.0 665100000 1348000000 1511200000 0.11 63500000 0.09 0.14 0.13 0.23 Segment and Geographic Information<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in three geographically-based reportable segments: North America, EMEA and China. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective January 1, 2024, Japan and Asia Pacific operating segments were combined into one operating segment: JPAC. The CODM reviews the Company’s performance and allocates resources based on five operating segments: North America, EMEA, China, Latin America and JPAC. North America, EMEA and China are the Company’s reportable segments; Latin America and JPAC are immaterial operating segments that are not considered reportable segments and are included in “Other.”</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenues by reportable segment are as follows:</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">July 2, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">July 2, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">784.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">961.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">637.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">665.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,348.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,511.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth Adjusted EBITDA by segment and the reconciliations to Loss before income taxes for the three and six months ended June 30, 2024 and July 2, 2023:</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">July 2, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">July 2, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">392.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">454.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment Adjusted EBITDA</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">543.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(165.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(134.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(321.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(225.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(116.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(114.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(231.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(228.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integration related costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment charge</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,743.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairment charge</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Credit Agreement amendment fees </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of deferred cloud computing implementation costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EU medical device regulation transition costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax indemnification income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,961.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Primarily consists of costs related to executive and staff functions, including certain finance, human resources, manufacturing and IT functions, which benefit the Company as a whole. These costs are primarily related to the general management of these functions on a corporate level and the design and development of programs, policies and procedures that are then implemented in the individual segments, with each segment bearing its own cost of implementation. The Company’s corporate function also includes debt and stock-based compensation associated with all employee stock-based awards.</span></div><div style="margin-top:6pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2) Represents incremental consulting costs and R&amp;D manufacturing site costs to align compliance of the Company’s existing, on-market products that were previously registered under the European In Vitro Diagnostics Directive regulatory framework with the requirements under the EU’s In Vitro Diagnostic Regulation, which generally apply from May 2022 onwards.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The CODM does not review capital expenditures, total depreciation and amortization or assets by segment, and therefore this information has been excluded as it does not comprise part of management’s key performance metrics.</span></div> 3 5 <div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenues by reportable segment are as follows:</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">July 2, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">July 2, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">784.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">961.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">637.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">665.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,348.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,511.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 350100000 378800000 784000000.0 961600000 81100000 80600000 165900000 161900000 81600000 81300000 157700000 151900000 124200000 124400000 240400000 235800000 637000000.0 665100000 1348000000 1511200000 <div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth Adjusted EBITDA by segment and the reconciliations to Loss before income taxes for the three and six months ended June 30, 2024 and July 2, 2023:</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">July 2, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">July 2, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">392.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">454.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment Adjusted EBITDA</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">543.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(165.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(134.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(321.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(225.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(116.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(114.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(231.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(228.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integration related costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment charge</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,743.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairment charge</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Credit Agreement amendment fees </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of deferred cloud computing implementation costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EU medical device regulation transition costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax indemnification income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,961.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Primarily consists of costs related to executive and staff functions, including certain finance, human resources, manufacturing and IT functions, which benefit the Company as a whole. These costs are primarily related to the general management of these functions on a corporate level and the design and development of programs, policies and procedures that are then implemented in the individual segments, with each segment bearing its own cost of implementation. The Company’s corporate function also includes debt and stock-based compensation associated with all employee stock-based awards.</span></div><div style="margin-top:6pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2) Represents incremental consulting costs and R&amp;D manufacturing site costs to align compliance of the Company’s existing, on-market products that were previously registered under the European In Vitro Diagnostics Directive regulatory framework with the requirements under the EU’s In Vitro Diagnostic Regulation, which generally apply from May 2022 onwards.</span></div> 173900000 176300000 392700000 454700000 11400000 5300000 24200000 12500000 35800000 30200000 60500000 58700000 34100000 36300000 66100000 58100000 255200000 248100000 543500000 584000000.0 -165300000 -134800000 -321600000 -225400000 -41000000.0 -36500000 -80000000.0 -73200000 116100000 114500000 231000000.0 228700000 30900000 24200000 53500000 53900000 0 0 1743900000 0 56900000 500000 56900000 1000000.0 4000000.0 0 4000000.0 0 3000000.0 1500000 5900000 3100000 500000 700000 1100000 1500000 0 0 5600000 0 0 400000 0 100000 700000 -200000 0 -200000 1100000 0 1800000 1500000 -162900000 -64400000 -1961800000 -4400000 Income Taxes<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company calculates its interim income tax provision in accordance with ASC 270,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Interim Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and ASC 740, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. At the end of each interim period, the Company estimates its annual effective tax rate and applies that rate to its ordinary quarterly earnings to calculate the tax related to ordinary income. The tax effects for other items that are excluded from ordinary income are discretely calculated and recognized in the period in which they occur.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended June 30, 2024, the Company recognized an income tax benefit of $15.2 million in relation to loss before income taxes of $162.9 million, resulting in an effective benefit tax rate of 9.3%. For the three months ended July 2, 2023, the Company recognized an income tax benefit of $11.2 million in relation to loss before income taxes of $64.4 million, resulting in an effective benefit tax rate of 17.4%. For the three months ended June 30, 2024, the effective tax rate differed from the U.S. federal statutory rate primarily due to Subpart F income and the Base Erosion and Anti-Abuse Tax liability. For the three months ended July 2, 2023, the effective tax rate differed from the U.S. federal statutory rate primarily due to non-U.S. earnings being taxed at rates that were different than the U.S. statutory rate, operating losses in certain subsidiaries not being benefited due to the establishment of valuation allowances, R&amp;D credits and foreign tax credits, partially offset by foreign exchange losses and the Global Intangible Low-Tax Income.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the six months ended June 30, 2024, the Company recognized an income tax benefit of $108.1 million in relation to loss before income taxes of $1,961.8 million, resulting in an effective tax rate of 5.5%. For the six months ended July 2, 2023, the recognized amount of income tax benefit was not material in relation to loss before income taxes of $4.4 million, resulting in an effective benefit tax rate of 0.7%. For the six months ended June 30, 2024, the effective tax rate differed from the U.S. federal statutory rate primarily due to goodwill impairment charges that are nondeductible for tax purposes. For the six months ended July 2, 2023, the effective tax rate differed from the U.S. federal statutory rate primarily due to net operating losses in certain subsidiaries not being benefited due to the establishment of valuation allowances and the Global Intangible Low-Tax Income, partially offset by U.S. earnings being taxed at rates that were different than the U.S. statutory rate, R&amp;D credits, foreign tax credits and foreign exchange losses.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The balance of unrecognized tax benefits at June 30, 2024, not including interest and penalties, was $29.3 million, of which $22.0 million could affect the effective income tax rate in future periods, if recognized. The Company also recognizes interest and penalties related to unrecognized tax benefits in tax expense. At June 30, 2024, the Company had approximately $4.1 million of interest and penalties accrued related to unrecognized tax benefits. The Company estimates that within the next 12 months, its uncertain tax positions, excluding interest, should decrease by $11.7 million.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to periodic audits by domestic and foreign tax authorities. Due to the carryforward of unutilized credits, the Company’s federal tax years from 2012 and onwards are subject to examination by the U.S. authorities. The Company’s state and foreign tax years for 2001 and onwards are subject to examination by applicable tax authorities. The Company believes that it has appropriate support for the income tax positions taken on its tax returns and that its accruals for tax liabilities are adequate for all open years based on an assessment of many factors, including past experience and interpretations of tax laws applied to the facts of each matter.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Indemnification Assets</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ortho is currently under audit in certain jurisdictions for tax years under the responsibility of Johnson &amp; Johnson. Pursuant to the stock and asset purchase agreement entered into by Ortho and Johnson &amp; Johnson in January 2014, Johnson &amp; Johnson retained all income tax liabilities accrued as of the date of acquisition, including reserves for unrecognized tax benefits. Accordingly, all tax liabilities related to these tax years are required to be indemnified by Johnson &amp; Johnson. The indemnification receivable from Johnson &amp; Johnson totaled $3.0 million as of June 30, 2024 and December 31, 2023, and is included as a component of Prepaid expenses and other current assets on the Consolidated Balance Sheet.</span></div> -15200000 -162900000 0.093 -11200000 -64400000 0.174 -108100000 -1961800000 0.055 0 -4400000 0.007 29300000 22000000.0 4100000 11700000 3000000.0 3000000.0 Balance Sheet Account Details<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash, Cash Equivalents and Restricted Cash</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Marketable Securities</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had no marketable securities outstanding as of June 30, 2024. The following table is a summary of marketable securities as of December 31, 2023:</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.344%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.698%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate asset-backed securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency bonds</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total marketable securities, current</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds, non-current</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate asset-backed securities, non-current</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sovereign government bonds, non-current</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total marketable securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounts Receivable, Net</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivables primarily consist of trade accounts receivables with maturities of one year or less and are presented net of reserves:</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for contract rebates and discounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accounts receivable, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269.5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303.3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventories</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are stated at the lower of cost (first-in, first-out) or net realizable value. Inventories consisted of the following:</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process (materials, labor and overhead)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods (materials, labor and overhead)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">318.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">640.6 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">623.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">602.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">640.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">623.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:3pt;padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Other assets includes inventory expected to remain on hand beyond one year.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Prepaid Expenses and Other Current Assets</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets consisted of the following:</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes and other tax receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total prepaid expenses and other current assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Current Liabilities</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current liabilities consisted of the following:</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued commissions, rebates and returns</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-669"><span style="-sec-ix-hidden:f-670">Operating lease liabilities</span></span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued other taxes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other current liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303.3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> <div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash, Cash Equivalents and Restricted Cash</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 107000000.0 118900000 500000 600000 107500000 119500000 0 The following table is a summary of marketable securities as of December 31, 2023:<div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.344%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.698%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate asset-backed securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency bonds</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total marketable securities, current</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds, non-current</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate asset-backed securities, non-current</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sovereign government bonds, non-current</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total marketable securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 38100000 100000 38000000.0 8900000 0 8900000 1500000 0 1500000 48500000 100000 48400000 4500000 0 4500000 900000 0 900000 2000000.0 0 2000000.0 55900000 100000 55800000 <div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivables primarily consist of trade accounts receivables with maturities of one year or less and are presented net of reserves:</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for contract rebates and discounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accounts receivable, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269.5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303.3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 347200000 395100000 63900000 77200000 13800000 14600000 269500000 303300000 <div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are stated at the lower of cost (first-in, first-out) or net realizable value. Inventories consisted of the following:</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process (materials, labor and overhead)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods (materials, labor and overhead)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">318.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">640.6 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">623.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">602.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">640.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">623.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:3pt;padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Other assets includes inventory expected to remain on hand beyond one year.</span></div> 222300000 212700000 99300000 92300000 319000000.0 318100000 640600000 623100000 602000000.0 577800000 38600000 45300000 640600000 623100000 <div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets consisted of the following:</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes and other tax receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total prepaid expenses and other current assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 156400000 104700000 68300000 67000000.0 44100000 46200000 27300000 34200000 11000000.0 6900000 2900000 3100000 310000000.0 262100000 <div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current liabilities consisted of the following:</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued commissions, rebates and returns</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-669"><span style="-sec-ix-hidden:f-670">Operating lease liabilities</span></span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued other taxes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other current liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303.3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 67100000 63800000 40100000 36800000 29500000 26700000 21600000 17900000 4700000 12100000 1400000 30300000 84700000 115700000 249100000 303300000 Assets Held for Sale<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following criteria are considered before concluding assets are classified as held for sale: 1) management’s commitment to a plan to sell, 2) availability for immediate sale in its present condition, 3) initiation of an active program to identify a buyer, 4) probability of a completed sale within one year, 5) actively marketed for sale at a reasonable price in relation to its current fair value, and 6) likelihood of significant changes to the plan will be made or that the plan will be withdrawn. If all of the criteria are met as of the balance sheet date, the net assets are presented separately in the balance sheet as held for sale at the lower of its carrying amount or fair value less costs to sell and is no longer depreciated or amortized while classified as held for sale. The Company assesses the fair value of a long-lived asset less any costs to sell at each reporting period and until the asset is no longer classified as held for sale.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the Company’s cost-savings initiatives, the Company has been evaluating its real estate footprint with the goal to relocate and consolidate its operations to improve long-term results. As a result, the Company has decided to (i) sell the McKellar, San Diego, CA facility and (ii) sell the Raritan, NJ, facility with the intent to subsequently lease back the right to use the property. In the second quarter of 2024, the properties met the requirements for reclassification from property, plant and equipment, net to assets held for sale when it became probable that the properties would be sold within one year. The carrying value of the assets was reduced to its estimated relative fair value less costs to sell resulting in an impairment charge of $56.9 million that was included in Asset impairment charge.</span></div> <div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following criteria are considered before concluding assets are classified as held for sale: 1) management’s commitment to a plan to sell, 2) availability for immediate sale in its present condition, 3) initiation of an active program to identify a buyer, 4) probability of a completed sale within one year, 5) actively marketed for sale at a reasonable price in relation to its current fair value, and 6) likelihood of significant changes to the plan will be made or that the plan will be withdrawn. If all of the criteria are met as of the balance sheet date, the net assets are presented separately in the balance sheet as held for sale at the lower of its carrying amount or fair value less costs to sell and is no longer depreciated or amortized while classified as held for sale. The Company assesses the fair value of a long-lived asset less any costs to sell at each reporting period and until the asset is no longer classified as held for sale.</span></div> 56900000 Goodwill and Intangible Assets, Net<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in goodwill were as follows:</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.603%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">North America</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">EMEA</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">China</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,743.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,492.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment charge</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,743.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,743.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2024</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">574.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">732.5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company tests goodwill for impairment on an annual basis on the first day of the fourth quarter and monitors throughout the year for impairment triggering events that indicate that the carrying value of one or more of its reporting units exceeds its fair value.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2024, the Company concluded that (i) the sustained decline in the Company’s stock price and market capitalization occurred during the first quarter of 2024, (ii) the faster than expected decline in COVID-19 and flu markets, and (iii) the recent delay in the timing of expected commercialization for Savanna were triggering events requiring an interim goodwill impairment assessment for all reporting units.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the Company’s interim goodwill impairment assessment, the Company concluded that the North America reporting unit’s carrying value exceeded its estimated fair value. As a result, the Company recorded a non-cash goodwill impairment charge of $1.7 billion in the first quarter of 2024 for the North America reporting unit, which represented a full impairment of the goodwill allocated to the North America reporting unit. The decline in the estimated fair value of the North America reporting unit and the resulting impairment was primarily driven by revised short-term and mid-term forecasts for revenue and EBITDA expectations in North America.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair values of the EMEA, Latin America and JPAC reporting units as of the interim testing date exceeded their respective carrying values. The excess of the estimated fair value over carrying value (expressed as a percentage of carrying value for the respective reporting unit) ranged from approximately 30% to 150%. Due to the significant excess of fair value over carrying value of these reporting units, they are less sensitive to changes in forecast assumptions. To evaluate the sensitivity of the fair value calculations used in the interim goodwill impairment test for the EMEA, Latin America and JPAC reporting units, the Company applied a hypothetical 5% decrease to the fair values of each reporting unit and compared those hypothetical values to the reporting unit carrying values. Based on this hypothetical 5% decrease, the excess of the estimated fair value over carrying value (expressed as a percentage of carrying value for the respective reporting unit) for each of the Company’s reporting units ranged from approximately 25% to 140%.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The quantitative goodwill impairment assessment for all reporting units consisted of a fair value calculation that combines an income approach, using a discounted cash flow method, and a market approach, using the guideline public company method. The quantitative goodwill impairment assessment requires the application of a number of significant assumptions, including estimates of future revenue growth rates, EBITDA margins, discount rates and market multiples. The projected future revenue growth rates and EBITDA margins, and the resulting projected cash flows are based on historical experience and internal annual operating plans reviewed by management, extrapolated over the forecast period. Discount rates are determined using a </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">weighted average cost of capital adjusted for risk factors specific to the reporting units. Market multiples are based on the guideline public company method using comparable publicly traded company multiples of revenue and EBITDA for a group of benchmark companies.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes the assumptions that were used in the quantitative goodwill impairment assessment are reasonable and consistent with assumptions that would be used by other marketplace participants.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also reviews long-lived assets, including intangible assets, for impairment when events or changes in circumstances indicate the carrying value of an asset group may not be recoverable. Given the indications of possible impairment that occurred during the first quarter of 2024, the Company tested its North America long-lived asset group for recoverability and impairment as of March 31, 2024. Recoverability of long-lived assets is measured by a comparison of the carrying value of an asset group to future undiscounted net cash flows expected to be generated by the asset group. The undiscounted cash flows for the North America long-lived asset group were above the carrying value and the Company determined that the long-lived asset group was recoverable, and no impairment existed as of June 30, 2024.</span></div> <div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in goodwill were as follows:</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.603%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">North America</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">EMEA</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">China</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,743.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,492.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment charge</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,743.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,743.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2024</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">574.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">732.5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 1743900000 582400000 85700000 80000000.0 2492000000 1743900000 0 0 0 1743900000 0 -7600000 -1500000 -6500000 -15600000 0 574800000 84200000 73500000 732500000 1700000000 0.30 1.50 0.05 0.05 0.25 1.40 Borrowings<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of borrowings were as follows:</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,317.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,420.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving Credit Facility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-721"><span style="-sec-ix-hidden:f-722">Financing lease obligation</span></span> </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other short-term borrowings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term borrowings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total borrowings</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,563.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,414.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(356.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(139.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term borrowings</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,207.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,274.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement, dated May 27, 2022, by and among the Company, as borrower, Bank of America, N.A., as administrative agent and swing line lender, and the other lenders and L/C issuers party thereto consists of a $2,750.0 million Term Loan and an $800.0 million Revolving Credit Facility. Availability under the Revolving Credit Facility, after deducting letters of credit of $13.0 million and $253.0 million borrowings outstanding, was $534.0 million as of June 30, 2024. During the six months ended June 30, 2024, the Company made $103.1 million in payments on the Term Loan.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement contains affirmative and negative covenants that are customary for credit agreements of this nature. The negative covenants include, among other things, limitations on asset sales, mergers, indebtedness, liens, investments and transactions with affiliates.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 25, 2024, the Company entered into Amendment No. 2 (the “Amendment”), by and among the Company, the lenders party thereto, and Bank of America, N.A., as administrative agent, which amends the Credit Agreement. The Amendment sets a maximum Consolidated Leverage Ratio (as defined in the Credit Agreement) for the applicable measurement period as of the last day of each fiscal quarter of (a) 4.50 to 1.00 on or prior to June 30, 2023, (b) 4.00 to 1.00 after June 30, 2023 and on or prior to June 30, 2024, (c) 4.25 to 1.00 after June 30, 2024 and on or prior to December 31, 2024, (d) 4.00 to 1.00 after December 31, 2024 and on or prior to June 30, 2025 and (e) 3.75 to 1.00 each fiscal quarter after June 30, 2025. The Credit Agreement contains a minimum Consolidated Interest Coverage Ratio (as defined in the Credit Agreement) of 3.00 to 1.00 as of the end of any fiscal quarter for the most recently completed four fiscal quarters. The Company was in compliance with the financial covenants as of June 30, 2024.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the detailed amounts within Interest expense, net for the three and six months ended June 30, 2024 and July 2, 2023:</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">July 2, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">July 2, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving Credit Facility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of deferred financing costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> <div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of borrowings were as follows:</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,317.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,420.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving Credit Facility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-721"><span style="-sec-ix-hidden:f-722">Financing lease obligation</span></span> </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other short-term borrowings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term borrowings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total borrowings</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,563.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,414.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(356.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(139.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term borrowings</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,207.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,274.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 2317100000 2420200000 253000000.0 0 100000 400000 0 1600000 200000 400000 6800000 8000000.0 2563600000 2414600000 356400000 139800000 2207200000 2274800000 2750000000 800000000.0 13000000.0 253000000.0 534000000.0 103100000 4.50 4.00 4.25 4.00 3.75 3.00 <div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the detailed amounts within Interest expense, net for the three and six months ended June 30, 2024 and July 2, 2023:</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">July 2, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">July 2, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving Credit Facility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of deferred financing costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 44400000 44200000 88900000 85100000 3400000 500000 5200000 1000000.0 800000 800000 1600000 1600000 -7100000 -7200000 -14300000 -11700000 500000 1800000 1400000 2800000 -41000000.0 -36500000 -80000000.0 -73200000 Stock-based Compensation<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense was as follows:</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">July 2, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">July 2, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales, excluding amortization of intangibles</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, marketing and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integration related costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table above includes compensation expense related to liability-classified awards of $2.8 million and $5.8 million for the three and six months ended July 2, 2023, respectively, which has been or is expected to be settled in cash. Amounts related to the three and six months ended June 30, 2024 were not material.</span></div> <div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense was as follows:</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">July 2, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">July 2, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales, excluding amortization of intangibles</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, marketing and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integration related costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 1500000 1100000 2700000 2100000 6700000 10000000.0 11800000 17200000 900000 1300000 1900000 2600000 2100000 4600000 3900000 9100000 11200000 17000000.0 20300000 31000000.0 2800000 5800000 Commitments and Contingencies<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 12, 2024, a purported stockholder of the Company filed a putative class action complaint under the federal securities laws against the Company and three of its current and former executives. The complaint, which is captioned Bristol County Retirement System v. QuidelOrtho Corporation, et al., Case No. 1:24-cv-02804-MKV (S.D.N.Y.) (the “Bristol County Complaint”), asserts claims for violations of Sections 10(b) and 20(a) of the Exchange Act and Rule 10b-5 promulgated thereunder related to statements regarding sales of the Company’s COVID-19 diagnostic tests and the 510(k) submission for its Savanna RVP4 assay. The Bristol County Complaint seeks a judgment determining that the lawsuit can be maintained as a class action and awarding the plaintiff and putative class damages, pre- and post-judgment interest, attorneys’ and experts’ fees, and costs.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 25, 2024, and June 21, 2024, two purported stockholders of the Company filed separate stockholder derivative complaints, purportedly on behalf of the Company, against the current and certain former members of the Company’s Board of Directors and three of its current and former executives. The complaints, which are captioned Matthew Whitfield v. Kenneth F. Buechler, Ph.D., et al., Case No. 1:24-cv-03176-MKV (S.D.N.Y.) (the “Whitfield Complaint”), and Steven Pinkney v. Douglas Bryant, et al., Case No. 1:24-cv-4753-MKV (S.D.N.Y.) (the “Pinkney Complaint”), assert claims for violations of Sections 10(b), 14(a), and 20(a) of the Exchange Act and Rules 10b-5 and 14a-9 promulgated thereunder, breach of fiduciary duty, aiding and abetting breach of fiduciary duty, unjust enrichment, abuse of control, gross mismanagement, and waste of corporate assets related to statements regarding sales of the Company’s COVID-19 diagnostic tests and the 510(k) submission for its Savanna RVP4 assay. The Whitfield and Pinkney Complaints seek judgments awarding compensatory and punitive damages against the individual defendants, directing an accounting by the individual defendants, directing the Company and the individual defendants to take actions to improve the Company’s governance and procedures, and awarding the costs and disbursements of the action, including attorneys’ fees, accountants’ and experts’ fees, costs, and expenses.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company disputes the allegations of wrongdoing and intends to defend itself vigorously in these matters. Nevertheless, the outcomes of these lawsuits are uncertain and cannot be predicted with any certainty. Accordingly, at this time, the Company is not able to estimate a possible loss or range of loss that may result from these lawsuits or to determine whether such loss, if any, would have a material adverse effect on its business, financial condition, results of operations or liquidity.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company is involved in other litigation and legal proceedings, including matters related to product liability claims, commercial disputes and intellectual property claims, as well as regulatory, employment, and other claims related to its business. The Company accrues for legal claims when, and to the extent that, amounts associated with the claims become probable and are reasonably estimable. If the reasonable estimate of a known or probable loss is a range, and no amount within the range is a better estimate than any other, the minimum amount of the range is accrued. When determining the estimated loss or range of loss, significant judgment is required to estimate the amount and timing of a loss to be recorded. Estimates of probable losses resulting from these matters are inherently difficult to predict. The actual costs of resolving legal claims may be substantially higher or lower than the amounts accrued for those claims. For those matters as to which the Company is not able to estimate a possible loss or range of loss, the Company is not able to determine whether the loss will have a material adverse effect on its business, financial condition, results of operations or liquidity.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management believes that all such current legal actions, in the aggregate, are not expected to have a material adverse effect on the Company. However, the resolution of, or increase in any accruals for, one or more matters may have a material adverse effect on the Company’s results of operations and cash flows.</span></div> 3 2 2 3 Fair Value Measurements<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company’s hierarchy for its assets and liabilities measured at fair value on a recurring basis as of the following periods:</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.7 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.7 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities measured at fair value</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no transfers of assets or liabilities into or out of Level 3 of the fair value hierarchy during the six months ended June 30, 2024 and fiscal year 2023.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketable securities consist of investment-grade corporate and government debt securities, corporate asset-backed securities and commercial paper. Derivative financial instruments are based on observable inputs that are corroborated by market data. Observable inputs include broker quotes, daily market foreign currency rates and forward pricing curves.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Instruments Not Measured at Fair Value</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of the Company’s borrowings under the Term Loan was $2,296.8 million at June 30, 2024, compared to the carrying amount, excluding debt issuance costs, of $2,317.1 million. The estimated fair value of the Company’s borrowings under the Term Loan was $2,396.0 million at December 31, 2023, compared to the carrying amount, excluding debt issuance costs, of $2,420.2 million. The estimate of fair value is generally based on the quoted market prices for similar issuances of long-term debt with the same maturities, which is classified as a Level 2 input.</span></div> <div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company’s hierarchy for its assets and liabilities measured at fair value on a recurring basis as of the following periods:</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.7 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.7 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities measured at fair value</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 0 0 0 0 0 55800000 0 55800000 0 42200000 0 42200000 0 6900000 0 6900000 0 42200000 0 42200000 0 62700000 0 62700000 0 5600000 0 5600000 0 27500000 0 27500000 0 0 0 0 0 0 100000 100000 0 5600000 0 5600000 0 27500000 100000 27600000 2296800000 2317100000 2396000000 2420200000 Derivative Instruments and Hedging Activities<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company selectively uses derivative and non-derivative instruments to manage market risk associated with changes in interest rates and foreign currency exchange rates. The use of derivatives is intended for hedging purposes only, and the Company does not enter into derivative transactions for speculative purposes.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Credit risk represents the Company’s gross exposure to potential accounting loss on derivative instruments that are outstanding or unsettled if all counterparties failed to perform according to the terms of the contract. The Company generally enters into master netting arrangements that reduce credit risk by permitting net settlement of transactions with the same counterparty. The Company does not have any derivative instruments with credit-risk related contingent features that would require it to post collateral.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Rate Hedging Instruments</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s interest rate risk relates primarily to interest rate exposures on variable rate debt, including the Revolving Credit Facility and Term Loan. Refer to “—Note 9. Borrowings” for additional information on the currently outstanding components of the Revolving Credit Facility and Term Loan. The Company entered into interest rate swap agreements to hedge the related risk of the variability to the Company’s cash flows due to the rates specified for these credit facilities.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company designates its interest rate swaps as cash flow hedges. The Company records gains and losses due to changes in fair value of the derivatives within OCI and reclassifies these amounts to Interest expense, net in the same period or periods for which the underlying hedged transaction affects earnings. In the event the Company determines the hedged transaction is no longer probable to occur or concludes the hedge relationship is no longer effective, the hedge is prospectively de-designated. Pre-tax unrealized gains of $20.4 million as of June 30, 2024 are expected to be reclassified from OCI to earnings in the next 12 months.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company’s interest rate derivative agreements as of June 30, 2024, all of which were interest rate swaps:</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.297%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.303%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Notional Amount<br/>(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Hedge Designation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Expiration Date</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">550.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Pay 3.765% fixed, receive floating rate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(1-month USD-SOFR)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Designated cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">December 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">May 27, 2027</span></td></tr><tr><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">200.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Pay 3.7725% fixed, receive floating rate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(1-month USD-SOFR)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Designated cash flow hedge</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">December 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">May 27, 2027</span></td></tr><tr><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">300.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Pay 3.7675% fixed, receive floating rate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(1-month USD-SOFR)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Designated cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">December 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">May 27, 2027</span></td></tr><tr><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">400.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Pay 3.7575% fixed, receive floating rate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(1-month USD-SOFR)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Designated cash flow hedge</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">December 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">May 27, 2027</span></td></tr><tr><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">350.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Pay 3.7725% fixed, receive floating rate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(1-month USD-SOFR)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Designated cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">December 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">May 27, 2027</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Currency Hedging Instruments</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has currency risk exposures relating primarily to foreign currency denominated monetary assets and liabilities and forecasted foreign currency denominated intercompany and third-party transactions. The Company uses foreign currency forward contracts and may use option contracts and cross currency swaps to manage its currency risk exposures. The Company’s foreign currency forward contracts are denominated primarily in Australian Dollar, Brazilian Real, British Pound, Canadian Dollar, Chilean Peso, Chinese Yuan/Renminbi, Colombian Peso, Czech Koruna, Danish Krone, Euro, Indian Rupee, Japanese Yen, Mexican Peso, Philippine Peso, South Korean Won, Swiss Franc and Thai Baht.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company designates certain foreign currency forward contracts as cash flow hedges. The Company records gains and losses due to changes in fair value of the derivatives within OCI and reclassifies these amounts to Total revenues and Cost of sales, excluding amortization of intangibles in the same period or periods for which the underlying hedged transaction affects earnings. In the event the Company determines the hedged transaction is no longer probable to occur or concludes the hedge relationship is no longer effective, the hedge is prospectively de-designated. Pre-tax unrealized gains of $0.7 million as of June 30, 2024 is expected to be reclassified from OCI to earnings in the next 12 months.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also enters into foreign currency forward contracts that are not part of designated hedging relationships and which are intended to mitigate exchange rate risk of monetary assets and liabilities and related forecasted transactions. The Company records these non-designated derivatives at mark-to-market with gains and losses recognized in earnings within Other expense, net.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides details of the currency hedging instruments outstanding as of June 30, 2024:</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.215%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.707%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.610%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Description</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Notional Amount<br/>(In millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Hedge Designation</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">217.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Cash Flow Hedge</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">710.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Non-designated</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes pre-tax gains and losses from designated derivative and non-derivative instruments within AOCI for the three and six months ended June 30, 2024 and July 2, 2023:</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.092%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.730%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.876%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.734%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Designated Hedging Instruments</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Loss (Gain) Recognized in OCI on Hedges</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Amounts Reclassified From AOCI Into Income</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Loss (Gain) Reclassified From AOCI Into Income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts (sales)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts (purchases)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales, excluding amortization of intangibles</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate derivatives</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts (sales)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts (purchases)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales, excluding amortization of intangibles</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate derivatives</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended July 2, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts (sales)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts (purchases)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales, excluding amortization of intangibles</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate derivatives</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended July 2, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts (sales)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts (purchases)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales, excluding amortization of intangibles</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate derivatives</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also uses forward exchange contracts to hedge a portion of its net investment in foreign operations against movements in exchange rates. The forward exchange contracts are designated as hedges of the net investment in foreign operations. The unrealized gains or losses on these contracts are recorded in foreign currency translation adjustments within OCI, and remain in AOCI until either the sale or complete or substantially complete liquidation of the subsidiary. The Company excludes certain portions of the change in fair value of its derivative instruments from the assessment of hedge effectiveness (excluded components). Changes in fair value of the excluded components are recognized in OCI. The Company recognizes in earnings the initial value of the excluded components on a straight-line basis over the life of the derivative instrument.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effect of the Company’s net investment hedges on OCI and the Consolidated Statements of Loss are shown below:</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:35.942%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.085%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Investment Hedging Relationships</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Pre-tax (Gain) Loss Recognized in OCI</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Pre-tax (Gain) Loss Recognized in Other Expense (Income), Net for Amounts Excluded from Effectiveness Testing</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value gains on foreign currency forward contracts, as determined using Level 2 inputs, that do not qualify for hedge accounting treatment are recorded in Other expense, net and were $5.7 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for both the three and six months ended June 30, </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024. Fair value gains that do not qualify for hedge accounting treatment were $3.2 million and $0.5 million for the three and six months ended July 2, 2023, respectively.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value of designated and non-designated hedging instruments recognized within the Consolidated Balance Sheets as of June 30, 2024 and December 31, 2023:</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Designated cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate derivatives:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-designated hedging instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 20400000 <div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company’s interest rate derivative agreements as of June 30, 2024, all of which were interest rate swaps:</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.297%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.303%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Notional Amount<br/>(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Hedge Designation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Expiration Date</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">550.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Pay 3.765% fixed, receive floating rate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(1-month USD-SOFR)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Designated cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">December 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">May 27, 2027</span></td></tr><tr><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">200.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Pay 3.7725% fixed, receive floating rate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(1-month USD-SOFR)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Designated cash flow hedge</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">December 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">May 27, 2027</span></td></tr><tr><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">300.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Pay 3.7675% fixed, receive floating rate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(1-month USD-SOFR)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Designated cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">December 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">May 27, 2027</span></td></tr><tr><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">400.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Pay 3.7575% fixed, receive floating rate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(1-month USD-SOFR)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Designated cash flow hedge</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">December 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">May 27, 2027</span></td></tr><tr><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">350.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Pay 3.7725% fixed, receive floating rate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(1-month USD-SOFR)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Designated cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">December 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">May 27, 2027</span></td></tr></table></div> 550000000.0 0.03765 200000000.0 0.037725 300000000.0 0.037675 400000000.0 0.037575 350000000.0 0.037725 700000 <div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides details of the currency hedging instruments outstanding as of June 30, 2024:</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.215%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.707%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.610%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Description</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Notional Amount<br/>(In millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Hedge Designation</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">217.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Cash Flow Hedge</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">710.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Non-designated</span></td></tr></table></div> 217000000.0 710400000 <div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes pre-tax gains and losses from designated derivative and non-derivative instruments within AOCI for the three and six months ended June 30, 2024 and July 2, 2023:</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.092%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.730%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.876%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.734%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Designated Hedging Instruments</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Loss (Gain) Recognized in OCI on Hedges</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Amounts Reclassified From AOCI Into Income</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Loss (Gain) Reclassified From AOCI Into Income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts (sales)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts (purchases)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales, excluding amortization of intangibles</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate derivatives</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts (sales)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts (purchases)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales, excluding amortization of intangibles</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate derivatives</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended July 2, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts (sales)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts (purchases)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales, excluding amortization of intangibles</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate derivatives</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended July 2, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts (sales)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts (purchases)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales, excluding amortization of intangibles</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate derivatives</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> -3200000 700000 0 100000 -10800000 -7000000.0 -6000000.0 2100000 800000 0 -45800000 -14200000 -400000 1800000 -2100000 1300000 -47000000.0 -7400000 1700000 900000 -2100000 1700000 -26100000 -12600000 <div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effect of the Company’s net investment hedges on OCI and the Consolidated Statements of Loss are shown below:</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:35.942%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.085%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Investment Hedging Relationships</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Pre-tax (Gain) Loss Recognized in OCI</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Pre-tax (Gain) Loss Recognized in Other Expense (Income), Net for Amounts Excluded from Effectiveness Testing</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> -7300000 -2900000 -18300000 -4900000 5700000 5700000 3200000 500000 <div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value of designated and non-designated hedging instruments recognized within the Consolidated Balance Sheets as of June 30, 2024 and December 31, 2023:</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Designated cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate derivatives:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-designated hedging instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> <div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value of designated and non-designated hedging instruments recognized within the Consolidated Balance Sheets as of June 30, 2024 and December 31, 2023:</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Designated cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate derivatives:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-designated hedging instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 200000 200000 24600000 0 0 6900000 4700000 3200000 6600000 0 3600000 9400000 900000 8500000 6100000 3500000 1100000 2700000 Accumulated Other Comprehensive Loss<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in AOCI by component:</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.381%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension and Other Post-<br/>Employment Benefits</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Available-for-Sale Investments</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive (Loss) Income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current period deferrals </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to Net loss</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2024</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension and Other Post-<br/>Employment Benefits</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Available-for-Sale Investments</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive (Loss) Income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current period deferrals </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to Net loss</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2024</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.671%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.381%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended July 2, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension and Other Post-<br/>Employment Benefits</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Available-for-Sale Investments</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive (Loss) Income </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at April 2, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current period deferrals</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to Net loss</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.7 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.0 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at July 2, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended July 2, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension and Other Post-<br/>employment Benefits</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Available-for-Sale Investments</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive (Loss) Income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current period deferrals</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to Net loss</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at July 2, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes tax impact of (i) $0.9 million and $7.4 million related to cash flow hedges for the three and six months ended June 30, 2024, respectively, and (ii) $0.9 million and $2.9 million related to foreign currency translation adjustments for the three and six months ended June 30, 2024, respectively.</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2) Includes tax impact of $9.5 million and $3.4 million related to cash flow hedges for the three and six months ended July 2, 2023, respectively.</span></div> <div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in AOCI by component:</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.381%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension and Other Post-<br/>Employment Benefits</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Available-for-Sale Investments</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive (Loss) Income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current period deferrals </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to Net loss</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2024</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension and Other Post-<br/>Employment Benefits</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Available-for-Sale Investments</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive (Loss) Income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current period deferrals </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to Net loss</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2024</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.671%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.381%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended July 2, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension and Other Post-<br/>Employment Benefits</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Available-for-Sale Investments</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive (Loss) Income </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at April 2, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current period deferrals</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to Net loss</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.7 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.0 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at July 2, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended July 2, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension and Other Post-<br/>employment Benefits</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Available-for-Sale Investments</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive (Loss) Income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current period deferrals</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to Net loss</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at July 2, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes tax impact of (i) $0.9 million and $7.4 million related to cash flow hedges for the three and six months ended June 30, 2024, respectively, and (ii) $0.9 million and $2.9 million related to foreign currency translation adjustments for the three and six months ended June 30, 2024, respectively.</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2) Includes tax impact of $9.5 million and $3.4 million related to cash flow hedges for the three and six months ended July 2, 2023, respectively.</span></div> -1300000 14800000 0 -39700000 -26200000 0 13100000 0 -2400000 10700000 0 6200000 0 2900000 9100000 0 6900000 0 -5300000 1600000 -1300000 21700000 0 -45000000.0 -24600000 -1300000 -9800000 0 -18900000 -30000000.0 0 43600000 0 -21200000 22400000 0 12100000 0 4900000 17000000.0 0 31500000 0 -26100000 5400000 -1300000 21700000 0 -45000000.0 -24600000 700000 -21100000 -300000 -38600000 -59300000 0 40000000.0 -100000 7400000 47300000 0 4300000 0 0 4300000 0 35700000 -100000 7400000 43000000.0 700000 14600000 -400000 -31200000 -16300000 700000 1500000 -500000 -69300000 -67600000 0 23100000 100000 38100000 61300000 0 10000000.0 0 0 10000000.0 0 13100000 100000 38100000 51300000 700000 14600000 -400000 -31200000 -16300000 900000 7400000 900000 2900000 9500000 3400000 false false false false